<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29447249</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog.</ISOAbbreviation></Journal><ArticleTitle>A paralogous pair of mammalian host restriction factors form a critical host barrier against poxvirus infection.</ArticleTitle><Pagination><MedlinePgn>e1006884</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1006884</ELocationID><Abstract><AbstractText>Host restriction factors constitute a formidable barrier for viral replication to which many viruses have evolved counter-measures. Human SAMD9, a tumor suppressor and a restriction factor for poxviruses in cell lines, is antagonized by two classes of poxvirus proteins, represented by vaccinia virus (VACV) K1 and C7. A paralog of SAMD9, SAMD9L, is also encoded by some mammals, while only one of two paralogs is retained by others. Here, we show that SAMD9L functions similarly to SAMD9 as a restriction factor and that the two paralogs form a critical host barrier that poxviruses must overcome to establish infection. In mice, which naturally lack SAMD9, overcoming SAMD9L restriction with viral inhibitors is essential for poxvirus replication and pathogenesis. While a VACV deleted of both K1 and C7 (vK1L-C7L-) was restricted by mouse cells and highly attenuated in mice, its replication and virulence were completely restored in SAMD9L-/- mice. In humans, both SAMD9 and SAMD9L are poxvirus restriction factors, although the latter requires interferon induction in many cell types. While knockout of SAMD9 with Crispr-Cas9 was sufficient for abolishing the restriction for vK1L-C7L- in many human cells, knockout of both paralogs was required for abolishing the restriction in interferon-treated cells. Both paralogs are antagonized by VACV K1, C7 and C7 homologs from diverse mammalian poxviruses, but mouse SAMD9L is resistant to the C7 homolog encoded by a group of poxviruses with a narrow host range in ruminants, indicating that host species-specific difference in SAMD9/SAMD9L genes serves as a barrier for cross-species poxvirus transmission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Xiangzhi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Immunology and Molecular Medicine, Jining Medical College, Jining, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fushun</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Chuanping</ForeName><Initials>C</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7539-5092</Identifier><AffiliationInfo><Affiliation>Institute of Immunology and Molecular Medicine, Jining Medical College, Jining, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Laboratory Animals, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagamachi</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Oncology and Leukemia Program Project, Hiroshima University, Minami-ku, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lu-Zhe</ForeName><Initials>LZ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7117-4559</Identifier><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7633-1629</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29447249</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1006884</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-17-02530</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29447206</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene.</ArticleTitle><Pagination><MedlinePgn>e0192602</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0192602</ELocationID><Abstract><AbstractText>Anti-HCMV treatments used in immunosuppressed patients reduce viral replication, but resistant viral strains can emerge. Moreover, these drugs do not target latently infected cells. We designed two anti-viral CRISPR/Cas9 strategies to target the UL122/123 gene, a key regulator of lytic replication and reactivation from latency. The singleplex strategy contains one gRNA to target the start codon. The multiplex strategy contains three gRNAs to excise the complete UL122/123 gene. Primary fibroblasts and U-251 MG cells were transduced with lentiviral vectors encoding Cas9 and one or three gRNAs. Both strategies induced mutations in the target gene and a concomitant reduction of immediate early (IE) protein expression in primary fibroblasts. Further detailed analysis in U-251 MG cells showed that the singleplex strategy induced 50% of indels in the viral genome, leading to a reduction in IE protein expression. The multiplex strategy excised the IE gene in 90% of all viral genomes and thus led to the inhibition of IE protein expression. Consequently, viral genome replication and late protein expression were reduced by 90%. Finally, the production of new viral particles was nearly abrogated. In conclusion, the multiplex anti-UL122/123 CRISPR/Cas9 system can target the viral genome efficiently enough to significantly prevent viral replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gergen</LastName><ForeName>Janina</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LabEx Immunograft Oncology (LABEX IGO), Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coulon</LastName><ForeName>Flora</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Creneguy</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elain-Duret</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LabEx Immunograft Oncology (LABEX IGO), Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CIRI-International Center for Infectiology Research, Team EVIR, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinkenburg</LastName><ForeName>Olaf</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Institut für medizinische Mikrobiologie, und Krankenhaushygiene, Universität Marburg, Hans-Meerwein-Strasse 2, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhoeyen</LastName><ForeName>Els</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>CIRI-International Center for Infectiology Research, Team EVIR, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), équipe "contrôle métabolique des morts cellulaires", Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anegon</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LabEx Immunograft Oncology (LABEX IGO), Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Tuan Huy</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halary</LastName><ForeName>Franck Albert</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haspot</LastName><ForeName>Fabienne</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0513-1387</Identifier><AffiliationInfo><Affiliation>Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LabEx Immunograft Oncology (LABEX IGO), Nantes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1986 Mar;153(3):478-88</RefSource><PMID Version="1">3005424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Virol. 2001 Dec;23(1-2):1-15</RefSource><PMID Version="1">11595579</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Dec 13;17 (11):2819-2826</RefSource><PMID Version="1">27974196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jun 02;9(6):e97231</RefSource><PMID Version="1">24887060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2016 Jun 30;12 (6):e1005701</RefSource><PMID Version="1">27362483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Mar;24(3):522-6</RefSource><PMID Version="1">26796669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2014 Aug 19;3:e186</RefSource><PMID Version="1">25137139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11321-6</RefSource><PMID Version="1">8876134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2000 Dec;74(23):11129-36</RefSource><PMID Version="1">11070009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2004 Aug;78(15):8191-200</RefSource><PMID Version="1">15254190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2011 May;121(5):1673-80</RefSource><PMID Version="1">21659716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2004 Feb;78(4):1817-30</RefSource><PMID Version="1">14747546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antiviral Res. 2006 Sep;71(2-3):154-63</RefSource><PMID Version="1">16765457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1991 Apr 11;324(15):1005-11</RefSource><PMID Version="1">1848679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 1986 Mar;17(3):373-87</RefSource><PMID Version="1">3009383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2006 Jan;80(2):920-8</RefSource><PMID Version="1">16378994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Gene Ther. 2015;15(5):447-59</RefSource><PMID Version="1">26264708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 2015 Aug;96(8):2252-61</RefSource><PMID Version="1">25904148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17234-9</RefSource><PMID Version="1">15572445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2000 Sep;74(17):8028-37</RefSource><PMID Version="1">10933712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Apr 19;15(3):481-489</RefSource><PMID Version="1">27068471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Host Microbe. 2014 Jul 9;16(1):43-54</RefSource><PMID Version="1">25011107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Genet Genomics. 2016 May 20;43(5):341-8</RefSource><PMID Version="1">27209567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2014 Nov 6;15(5):643-52</RefSource><PMID Version="1">25517468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proj Inf Perspect. 1998 Dec;(26):7</RefSource><PMID Version="1">11366499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jan 28;529(7587):490-5</RefSource><PMID Version="1">26735016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2002 May;76(9):4441-55</RefSource><PMID Version="1">11932411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1997 Sep;176(3):786-9</RefSource><PMID Version="1">9291334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2016 Sep;135(9):1071-82</RefSource><PMID Version="1">27272125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunotherapy. 2016 Sep;8(9):1135-49</RefSource><PMID Version="1">27485084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013;3:2510</RefSource><PMID Version="1">23974631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2006 Oct;80(19):9899-904</RefSource><PMID Version="1">16973595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2001 Feb;75(4):1870-8</RefSource><PMID Version="1">11160686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 1981;8(4):245-56</RefSource><PMID Version="1">6278069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13157-62</RefSource><PMID Version="1">25157128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Mar;34(3):339-44</RefSource><PMID Version="1">26789497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 1991 May;65(5):2273-82</RefSource><PMID Version="1">1850011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1991 Oct;164(4):781-4</RefSource><PMID Version="1">1654362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2003 Jan;77(2):1357-67</RefSource><PMID Version="1">12502852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 1;351(6268):84-8</RefSource><PMID Version="1">26628643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2009 Aug;6(8):577-9</RefSource><PMID Version="1">19578384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 2001 Jun;82(Pt 6):1429-38</RefSource><PMID Version="1">11369888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 1999 Jun;73(6):4806-12</RefSource><PMID Version="1">10233941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Feb 08;7:41968</RefSource><PMID Version="1">28176813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antimicrob Agents Chemother. 1988 Dec;32(12):1839-44</RefSource><PMID Version="1">2854454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72</RefSource><PMID Version="1">12121906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Rev. 2009 Jan;22(1):76-98, Table of Contents</RefSource><PMID Version="1">19136435</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29447206</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0192602</ArticleId><ArticleId IdType="pii">PONE-D-17-39111</ArticleId><ArticleId IdType="pmc">PMC5813945</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29446996</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1557-7422</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Human gene therapy</Title><ISOAbbreviation>Hum. Gene Ther.</ISOAbbreviation></Journal><ArticleTitle>Recent Advances in Therapeutic Genome Editing in China.</ArticleTitle><Pagination><MedlinePgn>136-145</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/hum.2017.210</ELocationID><Abstract><AbstractText>Editing of the genome to correct disease-causing mutations is a promising approach for the treatment of human diseases. Recent advances in the development of programmable nuclease-based genome editing tools have substantially improved the ability to make precise changes in the human genome. Genome editing technologies are already being used to correct genetic mutations in affected tissues and cells to treat diseases that are refractory to traditional gene therapies. Chinese scientists have made remarkable breakthroughs in the field of therapeutic genome editing, particularly with the first clinical trial involving the clustered regularly interspaced short palindromic repeats-caspase 9 system that began in China. Herein, current progress toward developing programmable nuclease-based gene therapies is introduced, as well as future prospects and challenges in China.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center , Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qingnan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center , Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center , Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Men</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center , Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhiyao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>2 Department of Pharmacy, and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center , Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Hongxin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center , Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Weizhi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>3 Yunnan Key Laboratory of Primate Biomedicine Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology , Kunming, China .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yuquan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center , Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Gene Ther</MedlineTA><NlmUniqueID>9008950</NlmUniqueID><ISSNLinking>1043-0342</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">gene therapy</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29446996</ArticleId><ArticleId IdType="doi">10.1089/hum.2017.210</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29446802</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1139-6709</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International microbiology : the official journal of the Spanish Society for Microbiology</Title><ISOAbbreviation>Int. Microbiol.</ISOAbbreviation></Journal><ArticleTitle>Mechanisms of the evolutionary arms race between Vibrio cholerae and Vibriophage clinical isolates.</ArticleTitle><Pagination><MedlinePgn>116-120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2436/20.1501.01.292</ELocationID><Abstract><AbstractText>This review highlights recent findings on the evolutionary arms race between the causative agent of cholera Vibrio cholerae and virulent bacteriophages (phages) ICP1, ICP2, and ICP3 isolated from cholera patient stool samples. We discuss mechanisms of phage resistance such as a unique phage-inhibitory chromosomal island and mutations that affect phage receptor expression. We also discuss the molecular characterization of ICP1 and its unique CRISPR-Cas system, which it uses to combat the phage-inhibitory chromosomal island. The role of phages in the life cycle of V. cholerae has been increasingly recognized and investigated in the past decade. This article will review hypotheses as to how the predator-prey relationship may have an impact on infections within individuals and on the self-limiting nature of cholera epidemics. In addition, we put forth a strategy of using phages as an intervention to reduce household transmission of cholera within a community.</AbstractText><CopyrightInformation>Copyright© by the Spanish Society for Microbiology and Institute for Catalan Studies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Minmin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Microbiology and Howard Hughes Medical Institute, Tufts University School of Medicine, Boston, MA 02111, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camilli</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Microbiology and Howard Hughes Medical Institute, Tufts University School of Medicine, Boston, MA 02111, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Int Microbiol</MedlineTA><NlmUniqueID>9816585</NlmUniqueID><ISSNLinking>1139-6709</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Vibrio cholerae</Keyword><Keyword MajorTopicYN="N">Vibriophage</Keyword><Keyword MajorTopicYN="N">cholera</Keyword><Keyword MajorTopicYN="N">evolution</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29446802</ArticleId><ArticleId IdType="doi">10.2436/20.1501.01.292</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29446800</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1139-6709</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International microbiology : the official journal of the Spanish Society for Microbiology</Title><ISOAbbreviation>Int. Microbiol.</ISOAbbreviation></Journal><ArticleTitle>Biology of Vibrio cholera. Editorial overview.</ArticleTitle><Pagination><MedlinePgn>105</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2436/20.1501.01.290</ELocationID><Abstract><AbstractText>In this monographic issue, we have the pleasure to present contributions from six of the leading laboratories at the forefront of Vibrio cholerae genetics, ecology and evolution, together with a brief tribute by Diego Romero to Doctor Jaime Ferrán y Clua, a pioneering Spanish bacteriologist who developed the first vaccine against this pathogen. V. cholerae is a free-living aquatic bacterium that interacts with and infects a variety of organisms. In humans it causes cholera, the deadly diarrhoea that was responsible for millions of deaths during seven pandemics since 1817, and still thousands every year. The Boucher lab presents a study of the ecology, evolution and dispersal of pandemic V. cholerae biotypes in relation to environmental reservoirs. They show how both species-specific and lineage-specific genetic determinants play a role in the ability of V. cholerae strains to cause pandemics, having evolved gradually over centuries. One of the key aspects that makes a particularly successful pathogen is its genomic plasticity. The V. cholerae genome contains a superintegron (SI) that is involved in development and dissemination of antibiotic resistance genes among diverse bacterial species, permitting population expansion in challenging conditions. Escudero and Mazel review the SI as a true hotspot of V. cholerae's genomic diversity and low-cost memory of adaptive functions in its complex lifestyle and ecology. Another remarkable aspect of V. cholerae 's genetics is the presence of two chromosomes. Segregation and division in multi-chromosomal becteria is relatively complex, and V. cholerae remains the paradigm. Espinosa and colleagues review the cell cycle of V. cholerae , comparing and contrasting with that of E. coli . In addition to genome plasticity, V. cholerae uses a variety of attack/defence strategies to compete and thrive in different niches, through interaction with bacteriophages, bacteria and eukaryotes. The role of phages in the life cycle of V. cholerae has been increasingly recognized and investigated over the past decade. Andrew Camilli and colleagues take us through the exciting evolutionary arms race between V. cholerae and virulent bacteriophages, based both on mechanisms of phage resistance in the bacterium and a unique phage-encoded CRISPR-Cas system used to counteract this resistance. Finally, the authors discuss the impact of these predator-prey dynamics in the context of infection, and their use as a strategy to limit cholera transmission within a community. In regards to its ability to coexist with other microbes, V. cholerae can produce effectors that are either released to the extracellular media, or delivered via intimate cell-to-cell contact such as those injected via the type VI secretion system (T6SS). The Pukatzki lab reviews the versatility of the T6SS to produce different combinations of such effectors, which establishes the strains of V. cholerae that can co-exist in the environment. After killing a cell, its DNA is released and incorporated by natural competence into other living cells, thereby being a potential source of diversification for V. cholerae's T6SS effectors. Finally, I revisisit the discovery of non-canonical D-amino acids, recently identified effectors secreted by V. cholerae which have increasingly been shown to be important in enhancing the ability of the bacterium to colonize and persist in a particular niche. I focus on recent observations that suggest different D-amino acids influence distinct cellular processes in bacteria, and dis cuss their role in modulating environmental bacterial biodiversity.</AbstractText><CopyrightInformation>Copyright© by the Spanish Society for Microbiology and Institute for Catalan Studies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cava</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The laboratory for Molecular Infection Medicine Sweden (MIMS), Department of Molecular Biology. Umeå University. 90187. Umeå. Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Int Microbiol</MedlineTA><NlmUniqueID>9816585</NlmUniqueID><ISSNLinking>1139-6709</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29446800</ArticleId><ArticleId IdType="doi">10.2436/20.1501.01.290</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29446747</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2212-3946</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Current stem cell research &amp; therapy</Title><ISOAbbreviation>Curr Stem Cell Res Ther</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9 Genome Editing: A Promising Tool For Therapeutic Applications of Induced Pluripotent Stem Cells.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.2174/1574888X13666180214124800</ELocationID><Abstract><AbstractText>Induced pluripotent stem cells hold tremendous potential for biological and therapeutic applications. The development of efficient technologies for the targeted genome alteration of stem cells in disease models is a prerequisite for utilizing stem cells to their full potential. The revolutionary technology for genome editing known as the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (Cas9) system is recently recognized as a powerful tool for editing DNA at specific loci. The ease of use of the CRISPR-Cas9 technology will allow us to improve our understanding of genomic variation in disease processes via cellular and animal models. More recently, this system was modified to repress (CRISPR interference, CRISPRi) or activate (CRISPR activation, CRISPRa) gene expression without alterations in the DNA, which amplified the scope of applications of CRISPR systems for stem cell biology. Here, we highlight latest advances of CRISPR-associated applications in human pluripotent stem cells. The challenges and future prospects of CRISPR-based systems for human research are also discussed.</AbstractText><CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanli</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Nanjing Agricultrual University Nanjing. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sastre</LastName><ForeName>Danuta</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Parkinson's Institute California. United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Nanjing Agricultrual University Nanjing. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Stem Cell Res Ther</MedlineTA><NlmUniqueID>101272517</NlmUniqueID><ISSNLinking>1574-888X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">CRISPRa</Keyword><Keyword MajorTopicYN="N">CRISPRi</Keyword><Keyword MajorTopicYN="N">Pluripotent Stem Cells</Keyword><Keyword MajorTopicYN="N">Therapeutic applications.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29446747</ArticleId><ArticleId IdType="pii">CSCR-EPUB-88581</ArticleId><ArticleId IdType="doi">10.2174/1574888X13666180214124800</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29446741</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-5631</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>02</Month><Day>14</Day></PubDate></JournalIssue><Title>Current gene therapy</Title><ISOAbbreviation>Curr Gene Ther</ISOAbbreviation></Journal><ArticleTitle>What´s new in Gene Therapy of Hemophilia</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.2174/1566523218666180214162312</ELocationID><Abstract><AbstractText Label="BACKGROUND">Several methods have been investigated to effectively and safely transmit genes that stimulate cells to release therapeutic factor VIII (FVIII) and factor IX (FIX) into the circulation of people with hemophilia (PWH).</AbstractText><AbstractText Label="OBJECTIVE">To review the role of gene therapy (GT) in PWH.</AbstractText><AbstractText Label="METHODS">A Cochrane Library and PubMed (MEDLINE) search related to the role of GT in hemophilia was analyzed.</AbstractText><AbstractText Label="RESULTS">The most promising vectors for hemophilia GT are adeno-associated virus (AAV) and lentivirus. Several gene methods are available to lessen risks related to random vector integration and insertional mutagenesis, based on designer nucleases or CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR associated system). However, off-target issues need to be more meticulously and widely evaluated. Some clinical studies on hemophilia B based on AAV have obtained transitory or subtherapeutic levels of FIX expression. Another problem is possible transitory liver toxicity. Therefore, to reduce unintentional immune responses, transitory immunosuppression must be used, particularly when administering high-vector doses. Codon-optimized FVIII or FIX transgenes are able to promote clotting factor expression levels. The inclusion of a hyper-active gain-of-function R338L mutation in the FIX gene (FIX-R338L [FIX Padua]) makes the procedure more effective.</AbstractText><AbstractText Label="CONCLUSION">Achieving a safe and efficient remedy for hemophilia A and B by means of GT vector engineering needs further improvement. No randomized or quasi-randomized clinical trials of GT for hemophilia have been found. Given it is in its incipient period, there is need for well-designed clinical trials to evaluate the long-term practicability, efficacy and risks of GT for PWH.</AbstractText><CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodriguez-Merchan</LastName><ForeName>E Carlos</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, La Paz University Hospital, Madrid. Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Gene Ther</MedlineTA><NlmUniqueID>101125446</NlmUniqueID><ISSNLinking>1566-5232</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Adeno-Associated Virus</Keyword><Keyword MajorTopicYN="Y">FIX Transgene</Keyword><Keyword MajorTopicYN="Y">FVIII Transgene</Keyword><Keyword MajorTopicYN="Y">Gene Therapy</Keyword><Keyword MajorTopicYN="Y">Hemophilia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29446741</ArticleId><ArticleId IdType="pii">CGT-EPUB-88590</ArticleId><ArticleId IdType="doi">10.2174/1566523218666180214162312</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29446503</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-313X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>The Plant journal : for cell and molecular biology</Title><ISOAbbreviation>Plant J.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9-mediated mutagenesis of lncRNA1459 alters tomato fruit ripening.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/tpj.13872</ELocationID><Abstract><AbstractText>With the development of high throughput sequencing, plenty of long non-coding RNAs (lncRNAs) have been discovered to play important roles in diverse biological processes. However, the biological functions of most plant lncRNAs are still unknown. Previously, we had discovered a tomato ripening-related lncRNA, lncRNA1459. Here, we cloned the full-length lncRNA1459, which obtained two transcript isoforms. In addition, lncRNA1459 exhibited specific location in the nucleus. Furthermore, in order to fully identify the function of lncRNA1459 in tomato ripening, loss-function mutants of lncRNA1459 were developed using clusterd regularly interspaced short palindromic repeats (CRISPR)/-associated protein 9 (Cas9)-induced genome editing technology. Compared with wild type fruits, tomato ripening process was significantly repressed in lncRNA1459 mutants. Ethylene production and lycopene accumulation were largely repressed in lncRNA1459 mutants. Additionally, genes related to ethylene and carotenoid biosynthesis were distinctly down-regulated in lncRNA1459 mutants compared with wild type fruits. Moreover, expression of numerous ripening-related genes were also changed significantly when lncRNA1459 was knocked out. As well as expression of potential tomato ripening-related lncRNAs were specifically changed after knocking out lncRNA1459. Taken together, these results provide insight into the role of lncRNA1459 in the tomato fruit ripening. This article is protected by copyright. All rights reserved.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Daqi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Benzhong</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yunbo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hongliang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Plant J</MedlineTA><NlmUniqueID>9207397</NlmUniqueID><ISSNLinking>0960-7412</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">fruit ripening</Keyword><Keyword MajorTopicYN="N">full-length</Keyword><Keyword MajorTopicYN="N">lncRNA</Keyword><Keyword MajorTopicYN="N">subcellular location</Keyword><Keyword MajorTopicYN="N">tomato</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29446503</ArticleId><ArticleId IdType="doi">10.1111/tpj.13872</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29446146</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2052</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Animal genetics</Title><ISOAbbreviation>Anim. Genet.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9-mediated MSTN disruption and heritable mutagenesis in goats causes increased body mass.</ArticleTitle><Pagination><MedlinePgn>43-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/age.12626</ELocationID><Abstract><AbstractText>Genetic engineering in livestock has been greatly enhanced through the use of artificial programmed nucleases such as the recently emerged clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) system. We recently reported our successful application of the CRISPR/Cas9 system to engineer the goat genome through micro-injection of Cas9 mRNA and sgRNAs targeting MSTN and FGF5 in goat embryos. The phenotypes induced by edited loss-of-function mutations of MSTN remain to be evaluated extensively. We demonstrate the utility of this approach by disrupting MSTN, resulting in enhanced body weight and larger muscle fiber size in Cas9-mediated gene-modified goats. The effects of genome modifications were further characterized by H&amp;E staining, quantitative PCR, Western blotting and immunofluorescence staining. Morphological and genetic analyses indicated the occurrence of phenotypic and genotypic modifications. We further provide sufficient evidence, including breeding data, to demonstrate the transmission of the knockout alleles through the germline. By phenotypic and genotypic characterization, we demonstrated the merit of using the CRISPR/Cas9 approach for establishing genetically modified livestock with an enhanced production trait.</AbstractText><CopyrightInformation>© 2017 Stichting International Foundation for Animal Genetics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Yangling, 712100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Yangling, 712100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shaanxi Provincial Engineering and Technology Research Center of Cashmere Goats, Yulin, 719000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Science Research Center, Yulin University, Yulin, 719000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Shaanxi Centre of Stem Cells Engineering &amp; Technology, Northwest A&amp;F University, Yangling, 712100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shaanxi Provincial Engineering and Technology Research Center of Cashmere Goats, Yulin, 719000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Science Research Center, Yulin University, Yulin, 719000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Yangling, 712100, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shaanxi Provincial Engineering and Technology Research Center of Cashmere Goats, Yulin, 719000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Science Research Center, Yulin University, Yulin, 719000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hua</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Shaanxi Centre of Stem Cells Engineering &amp; Technology, Northwest A&amp;F University, Yangling, 712100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shaanxi Provincial Engineering and Technology Research Center of Cashmere Goats, Yulin, 719000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Science Research Center, Yulin University, Yulin, 719000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Yangling, 712100, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>NM_001285737</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anim Genet</MedlineTA><NlmUniqueID>8605704</NlmUniqueID><ISSNLinking>0268-9146</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">animal breeding</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">germline transmission</Keyword><Keyword MajorTopicYN="N">livestock</Keyword><Keyword MajorTopicYN="N">muscle development</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29446146</ArticleId><ArticleId IdType="doi">10.1111/age.12626</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29446085</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0215</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of cancer</Title><ISOAbbreviation>Int. J. Cancer</ISOAbbreviation></Journal><ArticleTitle>DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.31318</ELocationID><Abstract><AbstractText>The single nucleotide polymorphism (SNP), -397G &gt; T (rs13278062) polymorphism, in the promoter of Death Receptor 4 (DR4) had been reported to be associated with a significantly increased risk for bladder cancer. However, the association of this SNP with the risk of colorectal cancer has not been reported. In this study, we performed a case-control study in 1,078 colorectal cancer patients and 1,175 matched healthy controls to evaluate the association of the potential functional genetic variants in DR4 with risk and survival of colorectal cancer. PCR-TaqMan were used to genotype the rs13278062, rs1000294 and rs2235126 polymorphisms. We found that subjects carrying the rs13278062 GT/TT genotypes had a significantly lower risk and increased survival time when compared to the GG genotype. We also constructed the rs13278062 GT/TT genotype in SW480 and SW620 cells (rs13278062 is GG in both cell lines) with the CRISPR/Cas9 system. Flow cytometry experiments showed that the rs13278062 TT genotype promoted apoptosis in colorectal cancer cells. In vitro and in vivo experiments established that the rs13278062 G to T mutation inhibited carcinogenesis and metastasis of colorectal cancer. Chromatin immunoprecipitation (ChIP) assays revealed that the rs13278062 G &gt; T polymorphism altered the binding affinity of the transcription factors Sp1/NF1 to the rs13278062 mutation region. Immunohistochemistry, western blot, and qPCR corroborated that the rs13278062 GT/TT genotypes increased the expression of DR4 protein in colorectal cancer tissues and cells. In conclusion, these findings indicate that DR4 mediated progression, invasion, metastasis and survival of colorectal cancer via the Sp1/NF1 switch axis on genomics locus.</AbstractText><CopyrightInformation>© 2018 UICC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shenshen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Qingtao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chengcheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Runze</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Bioinformatics, Heinrich Heine University, Düsseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hongbao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aschner</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209, 1300 Morris Park Avenue, Bronx, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rui</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7003-6602</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Cancer</MedlineTA><NlmUniqueID>0042124</NlmUniqueID><ISSNLinking>0020-7136</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DR4</Keyword><Keyword MajorTopicYN="N">colorectal cancer</Keyword><Keyword MajorTopicYN="N">development</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29446085</ArticleId><ArticleId IdType="doi">10.1002/ijc.31318</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29445519</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2056-306X</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Zoological letters</Title><ISOAbbreviation>Zoological Lett</ISOAbbreviation></Journal><ArticleTitle>Highly efficient generation of knock-in transgenic medaka by CRISPR/Cas9-mediated genome engineering.</ArticleTitle><Pagination><MedlinePgn>3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40851-017-0086-3</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED">Medaka (<i>Oryzias latipes</i>) is a popular animal model used in vertebrate genetic analysis. Recently, an efficient (~ 30%) knock-in system via non-homologous end joining (NHEJ) was established in zebrafish using the CRISPR/Cas9 system. If the same technique were applicable in medaka, it would greatly expand the usefulness of this model organism. The question of the applicability of CRISPR/Cas9 in medaka, however, has yet to be addressed.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">We report the highly efficient generation of knock-in transgenic medaka via non-homologous end joining (NHEJ). Donor plasmid containing a heat-shock promoter and a reporter gene was co-injected with a short guide RNA (sgRNA) targeted for genome digestion, an sgRNA targeted for donor plasmid digestion, and Cas9 mRNA. Broad transgene expression in the expression domain of a target gene was observed in approximately 25% of injected embryos. By raising these animals, we established stable knock-in transgenic fish with several different constructs for five genetic loci, obtaining transgenic founders at efficiencies of &gt; 50% for all five loci. Further, we show that the method is useful for obtaining mutant alleles. In the experiments where transgene integrations were targeted between the transcription start site and the initiation methionine, the resultant transgenic fish became mutant alleles.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">With its simplicity, design flexibility, and high efficiency, we propose that CRISPR/Cas9-mediated knock-in via NHEJ will become a standard method for the generation of transgenic and mutant medaka.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Watakabe</LastName><ForeName>Ikuko</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>1National Institutes of Natural Sciences, Okazaki Institute for Integrative Bioscience, National Institute for Basic Biology, Higashiyama 5-1, Myodaiji, Okazaki, Aichi 444-8787 Japan.</Affiliation><Identifier Source="ISNI">0000 0004 0618 8593</Identifier><Identifier Source="GRID">grid.419396.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Hisashi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>2Bioscience and Biotechnology Center, Nagoya University, Nagoya, Aichi 464-8601 Japan.</Affiliation><Identifier Source="ISNI">0000 0001 0943 978X</Identifier><Identifier Source="GRID">grid.27476.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Yukiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1National Institutes of Natural Sciences, Okazaki Institute for Integrative Bioscience, National Institute for Basic Biology, Higashiyama 5-1, Myodaiji, Okazaki, Aichi 444-8787 Japan.</Affiliation><Identifier Source="ISNI">0000 0004 0618 8593</Identifier><Identifier Source="GRID">grid.419396.0</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies (SOKENDAI), Okazaki, Aichi 444-8787 Japan.</Affiliation><Identifier Source="ISNI">0000 0004 1763 208X</Identifier><Identifier Source="GRID">grid.275033.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoi</LastName><ForeName>Saori</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>3National Institutes of Natural Sciences, National Institute for Basic Biology, Okazaki, Aichi 444-8585 Japan.</Affiliation><Identifier Source="ISNI">0000 0004 0618 8593</Identifier><Identifier Source="GRID">grid.419396.0</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>5Present address: Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060-0812 Japan.</Affiliation><Identifier Source="ISNI">0000 0001 2173 7691</Identifier><Identifier Source="GRID">grid.39158.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naruse</LastName><ForeName>Kiyoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>3National Institutes of Natural Sciences, National Institute for Basic Biology, Okazaki, Aichi 444-8585 Japan.</Affiliation><Identifier Source="ISNI">0000 0004 0618 8593</Identifier><Identifier Source="GRID">grid.419396.0</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies (SOKENDAI), Okazaki, Aichi 444-8787 Japan.</Affiliation><Identifier Source="ISNI">0000 0004 1763 208X</Identifier><Identifier Source="GRID">grid.275033.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higashijima</LastName><ForeName>Shin-Ichi</ForeName><Initials>SI</Initials><Identifier Source="ORCID">0000-0001-6350-4992</Identifier><AffiliationInfo><Affiliation>1National Institutes of Natural Sciences, Okazaki Institute for Integrative Bioscience, National Institute for Basic Biology, Higashiyama 5-1, Myodaiji, Okazaki, Aichi 444-8787 Japan.</Affiliation><Identifier Source="ISNI">0000 0004 0618 8593</Identifier><Identifier Source="GRID">grid.419396.0</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies (SOKENDAI), Okazaki, Aichi 444-8787 Japan.</Affiliation><Identifier Source="ISNI">0000 0004 1763 208X</Identifier><Identifier Source="GRID">grid.275033.0</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Zoological Lett</MedlineTA><NlmUniqueID>101664800</NlmUniqueID><ISSNLinking>2056-306X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 2004 Jul;121(7-8):619-28</RefSource><PMID Version="1">15210171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2010;44:217-41</RefSource><PMID Version="1">20731603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2014 Oct 08;4:6545</RefSource><PMID Version="1">25293390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Calcium. 2013 Sep;54(3):236-45</RefSource><PMID Version="1">23906585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2006 Oct;174(2):639-49</RefSource><PMID Version="1">16959904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2012 Feb 1;32(5):1771-83</RefSource><PMID Version="1">22302816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 1995 Jul;203(3):253-310</RefSource><PMID Version="1">8589427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 2004 Jul;121(7-8):605-18</RefSource><PMID Version="1">15210170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Jan;24(1):142-53</RefSource><PMID Version="1">24179142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zoological Lett. 2017 Jul 6;3:10</RefSource><PMID Version="1">28694996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Oct 11;6:34991</RefSource><PMID Version="1">27725766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20812-7</RefSource><PMID Version="1">19923430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 May 20;111(20):7343-8</RefSource><PMID Version="1">24803434</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2014 Apr 03;10(4):e1004246</RefSource><PMID Version="1">24699463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):227-9</RefSource><PMID Version="1">23360964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2015 Apr;199(4):905-18</RefSource><PMID Version="1">25855651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Reprod Dev. 2009 Feb;76(2):202-7</RefSource><PMID Version="1">18543284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zoolog Sci. 2010 May;27(5):410-5</RefSource><PMID Version="1">20443688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>G3 (Bethesda). 2017 Apr 3;7(4):1357-1363</RefSource><PMID Version="1">28258112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 2004 Jul;121(7-8):829-39</RefSource><PMID Version="1">15210189</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Knock-in</Keyword><Keyword MajorTopicYN="N">Medaka</Keyword><Keyword MajorTopicYN="N">Transgenic</Keyword></KeywordList><CoiStatement>Fish were maintained and used in accordance with the guidelines approved by the animal care and use committees of the National Institutes of Natural Sciences (approval number: 17A002) and Nagoya University.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29445519</ArticleId><ArticleId IdType="doi">10.1186/s40851-017-0086-3</ArticleId><ArticleId IdType="pii">86</ArticleId><ArticleId IdType="pmc">PMC5798193</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29445268</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1178-1998</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Clinical interventions in aging</Title><ISOAbbreviation>Clin Interv Aging</ISOAbbreviation></Journal><ArticleTitle>Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.</ArticleTitle><Pagination><MedlinePgn>221-233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/CIA.S155145</ELocationID><Abstract><AbstractText>Genetic variations play an important role in the clinical presentation and progression of Alzheimer's disease (AD), especially early-onset Alzheimer's disease. Hundreds of mutations have been reported with the majority resulting from alterations in β-amyloid precursor protein (<i>APP</i>), presenilin 1 (<i>PSEN1</i>), or presenilin 2 (<i>PSEN2</i>) genes. The roles of these mutations in the pathogenesis of AD have been classically confirmed or refuted through functional studies, where the mutations are cloned, inserted into cell lines, and monitored for changes in various properties including cell survival, amyloid production, or Aβ42/40 ratio. However, these verification studies tend to be expensive, time consuming, and inconsistent. Recently, the clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) system was developed, which improves sequence-specific gene editing in cell lines, organs, and animals. CRISPR-Cas9 is a promising tool for the generation of models of human genetic diseases and could facilitate the establishment of new animal AD models and the observation of dynamic bioprocesses in AD. Here, we recapitulated the history of CRISPR technology, recent progress, and, especially, its potential applications in AD-related genetic, animal modeling, and functional studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Giau</LastName><ForeName>Vo Van</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>Department of Bionano Technology, Gachon University, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lee</LastName><ForeName>Hyon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Gachon University Gil Medical Center, Incheon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Kyu Hwan</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Bionano Technology, Gachon University, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagyinszky</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Bionano Technology, Gachon University, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Seong Soo A</ForeName><Initials>SSA</Initials><AffiliationInfo><Affiliation>Department of Bionano Technology, Gachon University, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Clin Interv Aging</MedlineTA><NlmUniqueID>101273480</NlmUniqueID><ISSNLinking>1176-9092</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Neurodegener. 2016 May 17;11(1):39</RefSource><PMID Version="1">27184028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2011 Dec 1;20(23):4530-9</RefSource><PMID Version="1">21900357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Jan 25;482(7384):216-20</RefSource><PMID Version="1">22278060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transl Psychiatry. 2016 Jan 05;6:e703</RefSource><PMID Version="1">26731440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2016 Dec;1866(2):197-207</RefSource><PMID Version="1">27641687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):233-9</RefSource><PMID Version="1">23360965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Jul 22;146(2):318-31</RefSource><PMID Version="1">21757228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2017 Jan 10;241:136-146</RefSource><PMID Version="1">27845164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Curr. 2014 Apr 15;6:null</RefSource><PMID Version="1">24761311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 May 5;533(7601):125-9</RefSource><PMID Version="1">27120160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2012 Sep;30(9):2054-62</RefSource><PMID Version="1">22628015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 31;471(7340):602-7</RefSource><PMID Version="1">21455174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):230-2</RefSource><PMID Version="1">23360966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2016 Jan;238(2):267-87</RefSource><PMID Version="1">26446984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2015 Jan 1;77(1):43-51</RefSource><PMID Version="1">24951455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2013 Jan 29;2:e00471</RefSource><PMID Version="1">23386978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):577-582</RefSource><PMID Version="1">24770324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 1999 Apr 9;265(1):61-3</RefSource><PMID Version="1">10327206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1994 May 27;264(5163):1336-40</RefSource><PMID Version="1">8191290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1994 Nov 14;354(3):274-8</RefSource><PMID Version="1">7957938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2017 Aug;15(8):917-926</RefSource><PMID Version="1">28371222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Yale J Biol Med. 2016 Dec 23;89(4):471-486</RefSource><PMID Version="1">28018139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Oct 13;13(2):234-41</RefSource><PMID Version="1">26440889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 1997 Sep 22;103(3A):3S-10S</RefSource><PMID Version="1">9344401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Apr 4;12(4):487-96</RefSource><PMID Version="1">23434393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 Nov 28;27(48):13092-7</RefSource><PMID Version="1">18045903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Neurodegener. 2015 Aug 04;10:35</RefSource><PMID Version="1">26238861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Autism. 2015 Oct 19;6:55</RefSource><PMID Version="1">26491539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Sep 1;12(9):1414-29</RefSource><PMID Version="1">26299970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2005 Aug;151(Pt 8):2551-61</RefSource><PMID Version="1">16079334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):538-42</RefSource><PMID Version="1">25798939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Mol Biol Educ. 2017 May;45(3):262-269</RefSource><PMID Version="1">27677251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurosci. 2008 Jul;9(7):532-44</RefSource><PMID Version="1">18568014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Dec 5;155(6):1351-64</RefSource><PMID Version="1">24290359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Jan;33(1):102-6</RefSource><PMID Version="1">25326897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E476-E485</RefSource><PMID Version="1">27930341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):551-3</RefSource><PMID Version="1">24681508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1993 Jan 22;259(5094):514-6</RefSource><PMID Version="1">8424174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Discov. 2016 Aug 23;2:16026</RefSource><PMID Version="1">27625790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86</RefSource><PMID Version="1">22949671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2015 Dec;17 (12 ):1523-35</RefSource><PMID Version="1">26571212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Mar;32(3):279-284</RefSource><PMID Version="1">24463574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 2017 May 15;376:242-254</RefSource><PMID Version="1">28431620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 31;6:23549</RefSource><PMID Version="1">27030102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Aging Neurosci. 2017 Jun 28;9:209</RefSource><PMID Version="1">28701949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Korean J Intern Med. 2017 Jan;32(1):42-61</RefSource><PMID Version="1">28049282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arthritis Rheumatol. 2017 May;69(5):1111-1121</RefSource><PMID Version="1">27813286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2014 Jul 1;23(13):3523-36</RefSource><PMID Version="1">24524897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Jan 28;7:10548</RefSource><PMID Version="1">26817820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jan 08;9(1):e84547</RefSource><PMID Version="1">24416243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 1998 Oct;5(4):281-6</RefSource><PMID Version="1">9848098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Apr;33(4):390-394</RefSource><PMID Version="1">25690852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Mar 12;160(6):1246-60</RefSource><PMID Version="1">25748654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1987 Dec;169(12):5429-33</RefSource><PMID Version="1">3316184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Control Release. 2017 Nov 28;266:17-26</RefSource><PMID Version="1">28911805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Neurosci. 2009 Jun;41(2):166-74</RefSource><PMID Version="1">19281847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource><PMID Version="1">24584096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2015 Mar 4;85(5):967-81</RefSource><PMID Version="1">25741723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2006 Jul;27(7):686-95</RefSource><PMID Version="1">16752394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2016 Apr;283(7):1218-31</RefSource><PMID Version="1">26535798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Apr 20;43(7):e45</RefSource><PMID Version="1">25586224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res Bull. 2016 Apr;122:1-11</RefSource><PMID Version="1">26708939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1992 Dec 17;360(6405):672-4</RefSource><PMID Version="1">1465129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Nov 4;468(7320):67-71</RefSource><PMID Version="1">21048762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Med. 2016 May;18(5):421-30</RefSource><PMID Version="1">26312828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Mar;34(3):339-44</RefSource><PMID Version="1">26789497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 20;533(7603):420-4</RefSource><PMID Version="1">27096365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2005 Mar;151(Pt 3):653-63</RefSource><PMID Version="1">15758212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2016 Mar;19(3):517-22</RefSource><PMID Version="1">26829649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2015 Jul 1;24(13):3764-74</RefSource><PMID Version="1">25859012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 2006 Oct 2;406(1-2):33-7</RefSource><PMID Version="1">16916581</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Evol. 2005 Feb;60(2):174-82</RefSource><PMID Version="1">15791728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Neurosci. 2016 Jun;73:13-31</RefSource><PMID Version="1">26657644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1370-9</RefSource><PMID Version="1">23992847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:488-492</RefSource><PMID Version="1">28392484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neuropathol Commun. 2017 Oct 27;5(1):77</RefSource><PMID Version="1">29078805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1124-37</RefSource><PMID Version="1">27151939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2003 Jul 31;39(3):409-21</RefSource><PMID Version="1">12895417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 Nov 27;5(4):974-85</RefSource><PMID Version="1">24239350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Dec;32(12):1262-7</RefSource><PMID Version="1">25184501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jul;32(7):677-83</RefSource><PMID Version="1">24837660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2015 ;2015 :326042</RefSource><PMID Version="1">26697483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Feb 09;6:20620</RefSource><PMID Version="1">26857844</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer’s disease</Keyword><Keyword MajorTopicYN="N">Aβ42/40 ratio</Keyword><Keyword MajorTopicYN="N">CRISPR–Cas9</Keyword><Keyword MajorTopicYN="N">mutation</Keyword></KeywordList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29445268</ArticleId><ArticleId IdType="doi">10.2147/CIA.S155145</ArticleId><ArticleId IdType="pii">cia-13-221</ArticleId><ArticleId IdType="pmc">PMC5808714</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29445193</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy.</ArticleTitle><Pagination><MedlinePgn>231</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-018-0336-0</ELocationID><Abstract><AbstractText>While aberrant cancer cell growth is frequently associated with altered biochemical metabolism, normal mitochondrial functions are usually preserved and necessary for full malignant transformation. The transcription factor FoxO3A is a key determinant of cancer cell homeostasis, playing a dual role in survival/death response to metabolic stress and cancer therapeutics. We recently described a novel mitochondrial arm of the AMPK-FoxO3A axis in normal cells upon nutrient shortage. Here, we show that in metabolically stressed cancer cells, FoxO3A is recruited to the mitochondria through activation of MEK/ERK and AMPK, which phosphorylate serine 12 and 30, respectively, on FoxO3A N-terminal domain. Subsequently, FoxO3A is imported and cleaved to reach mitochondrial DNA, where it activates expression of the mitochondrial genome to support mitochondrial metabolism. Using FoxO3A<sup>-/-</sup>cancer cells generated with the CRISPR/Cas9 genome editing system and reconstituted with FoxO3A mutants being impaired in their nuclear or mitochondrial subcellular localization, we show that mitochondrial FoxO3A promotes survival in response to metabolic stress. In cancer cells treated with chemotherapeutic agents, accumulation of FoxO3A into the mitochondria promoted survival in a MEK/ERK-dependent manner, while mitochondrial FoxO3A was required for apoptosis induction by metformin. Elucidation of FoxO3A mitochondrial vs. nuclear functions in cancer cell homeostasis might help devise novel therapeutic strategies to selectively disable FoxO3A prosurvival activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Celestini</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology/Laboratory of Molecular Biology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, 20156, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tezil</LastName><ForeName>Tugsan</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0796-3718</Identifier><AffiliationInfo><Affiliation>Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Genetics, National Institute for Gastroenterology, IRCCS 'S. de Bellis', Castellana Grotte (Ba), 70013, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fasano</LastName><ForeName>Candida</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Genetics, National Institute for Gastroenterology, IRCCS 'S. de Bellis', Castellana Grotte (Ba), 70013, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanese</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forte</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Genetics, National Institute for Gastroenterology, IRCCS 'S. de Bellis', Castellana Grotte (Ba), 70013, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peserico</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepore Signorile</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, 00161, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longo</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rasmo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Biomembranes and Bioenergetics, National Research Council (CNR), Bari, 70126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Signorile</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gadaleta</LastName><ForeName>Raffaella Maria</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Division of Digestive Diseases, Department of Surgery and Cancer, Imperial College London, Queen Elizabeth the Queen Mother Wing (QEQM), London, W2 1NY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicina Interna Universitaria Frugoni', Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scialpi</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medicina Interna Universitaria Frugoni', Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terao</LastName><ForeName>Mineko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology/Laboratory of Molecular Biology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, 20156, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garattini</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology/Laboratory of Molecular Biology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, 20156, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cocco</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villani</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moschetta</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medicina Interna Universitaria Frugoni', Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grossi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy. grossi.labsimone@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simone</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy. cristiano.simone@uniba.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Genetics, National Institute for Gastroenterology, IRCCS 'S. de Bellis', Castellana Grotte (Ba), 70013, Italy. cristiano.simone@uniba.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2003;370:430-44</RefSource><PMID Version="1">14712665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2008 Apr 7;27(16):2258-62</RefSource><PMID Version="1">18391968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2015 Sep;16(9):530-42</RefSource><PMID Version="1">26281784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Jun 10;6(16):14385-98</RefSource><PMID Version="1">25965911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2010 Mar 15;9(6):1091-6</RefSource><PMID Version="1">20190568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2009 Sep;16(9):1203-14</RefSource><PMID Version="1">19343039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Jun 28;7(26):40767-40780</RefSource><PMID Version="1">27004404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2008 Apr 7;27(16):2276-88</RefSource><PMID Version="1">18391970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Feb 9;168(4):657-669</RefSource><PMID Version="1">28187287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2011 Feb;11(2):85-95</RefSource><PMID Version="1">21258394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2017 Jan 29;483(1):17-23</RefSource><PMID Version="1">28069382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2014 Sep 15;462(3):475-87</RefSource><PMID Version="1">25017630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2008 Oct;7(20):3133-6</RefSource><PMID Version="1">18927504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Sep 11;8(5):1583-94</RefSource><PMID Version="1">25159151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2014 Mar 1;344(1):110-118</RefSource><PMID Version="1">24215867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2009 Oct;5(7):1030-3</RefSource><PMID Version="1">19587525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2008 Oct;7(10 ):3237-46</RefSource><PMID Version="1">18852127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2002 Sep 2;1592(1):63-77</RefSource><PMID Version="1">12191769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2013 Jun;70(11):2015-29</RefSource><PMID Version="1">23283301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2015 Jan;11(1):9-15</RefSource><PMID Version="1">25517383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2009 Dec;8(12 ):2796-808</RefSource><PMID Version="1">19651622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2014 Aug 7;20(29):9744-58</RefSource><PMID Version="1">25110412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1323-32</RefSource><PMID Version="1">18812462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2002 Apr 19;296(5567):530-4</RefSource><PMID Version="1">11964479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2008 Apr 7;27(16):2312-9</RefSource><PMID Version="1">18391973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Mar 4;144(5):646-74</RefSource><PMID Version="1">21376230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(20):6984-94</RefSource><PMID Version="1">17940099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 Aug 21;138(4):628-44</RefSource><PMID Version="1">19703392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Cell Biol. 2001;65:189-215</RefSource><PMID Version="1">11381594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2015 Oct;230(10 ):2447-2460</RefSource><PMID Version="1">25728514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Mar 3;61(5):667-676</RefSource><PMID Version="1">26942671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Adv. 2016 May 27;2(5):e1600200</RefSource><PMID Version="1">27386546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 May 27;111(21):E2182-90</RefSource><PMID Version="1">24782546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 May 25;534(7605):55-62</RefSource><PMID Version="1">27251275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 May 22;324(5930):1029-33</RefSource><PMID Version="1">19460998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2008 Feb;10 (2):138-48</RefSource><PMID Version="1">18204439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Sep 03;8(9):e73207</RefSource><PMID Version="1">24019909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2007;2(2):287-95</RefSource><PMID Version="1">17406588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 Oct 01;3:null</RefSource><PMID Version="1">25271376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 May 13;3:e02242</RefSource><PMID Version="1">24843020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2005 Jun 4;330(7503):1304-5</RefSource><PMID Version="1">15849206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2017 Oct;23 (10 ):1234-1240</RefSource><PMID Version="1">28920959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Signal. 2010 Jan 12;3(104):ra3</RefSource><PMID Version="1">20068231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2014 Jul;11(7):385-400</RefSource><PMID Version="1">24840079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1999 Mar 19;96(6):857-68</RefSource><PMID Version="1">10102273</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2012 Oct;12(10):685-98</RefSource><PMID Version="1">23001348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Signal. 2012 Jun;24(6):1361-8</RefSource><PMID Version="1">22313691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2012 Sep;11(9):651-68</RefSource><PMID Version="1">22617229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2014 Jul;13(7):1690-704</RefSource><PMID Version="1">24719451</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Dec 6;7(49):80888-80900</RefSource><PMID Version="1">27825133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2011 Aug 15;12 (4):253-9</RefSource><PMID Version="1">21613825</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29445193</ArticleId><ArticleId IdType="doi">10.1038/s41419-018-0336-0</ArticleId><ArticleId IdType="pii">10.1038/s41419-018-0336-0</ArticleId><ArticleId IdType="pmc">PMC5833443</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29445053</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1347-3700</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Cell structure and function</Title><ISOAbbreviation>Cell Struct. Funct.</ISOAbbreviation></Journal><ArticleTitle>SPIRAL2 stabilises endoplasmic microtubule minus ends in the moss Physcomitrella patens.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1247/csf.18001</ELocationID><Abstract><AbstractText>Stabilisation of minus ends of microtubules (MTs) is critical for organising MT networks in land plant cells, in which all MTs are nucleated independent of centrosomes. Recently, Arabidopsis SPIRAL2 (SPR2) protein was shown to localise to plus and minus ends of cortical MTs, and increase stability of both ends. Here, we report molecular and functional characterisation of SPR2 of the basal land plant, the moss Physcomitrella patens. In protonemal cells of P. patens, where non-cortical, endoplasmic MT network is organised, we observed SPR2 at minus ends, but not plus ends, of endoplasmic MTs and likely also of phragmoplast MTs. Minus end decoration was reconstituted in vitro using purified SPR2, suggesting that moss SPR2 is a minus end-specific binding protein (-TIP). We generated a loss-of-function mutant of SPR2, in which frameshift-causing deletions/insertions were introduced into all four paralogous SPR2 genes by means of CRISPR/Cas9. Protonemal cells of the mutant showed instability of endoplasmic MT minus ends. These results indicate that moss SPR2 is a MT minus end stabilising factor. Key words: acentrosomal microtubule network, microtubule minus end, P. patens, CAMSAP/Nezha/Patronin.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leong</LastName><ForeName>Shu Yao</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Division of Biological Science, Graduate School of Science, Nagoya University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Moé</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Biological Science, Graduate School of Science, Nagoya University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanagisawa</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Transformative Bio-Molecules, Nagoya University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goshima</LastName><ForeName>Gohta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Biological Science, Graduate School of Science, Nagoya University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Cell Struct Funct</MedlineTA><NlmUniqueID>7608465</NlmUniqueID><ISSNLinking>0386-7196</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAMSAP/Nezha/Patronin</Keyword><Keyword MajorTopicYN="N">P. patens</Keyword><Keyword MajorTopicYN="N">acentrosomal microtubule network</Keyword><Keyword MajorTopicYN="N">microtubule minus end</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29445053</ArticleId><ArticleId IdType="doi">10.1247/csf.18001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29445007</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ji1701121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.1701121</ELocationID><Abstract><AbstractText>Adoptive cell transfer is an important approach for basic research and emerges as an effective treatment for various diseases, including infections and blood cancers. Direct genetic manipulation of primary immune cells opens up unprecedented research opportunities and could be applied to enhance cellular therapeutic products. In this article, we report highly efficient genome engineering in primary murine T cells using a plasmid-based RNA-guided CRISPR system. We developed a straightforward approach to ablate genes in up to 90% of cells and to introduce precisely targeted single nucleotide polymorphisms in up to 25% of the transfected primary T cells. We used gene editing-mediated allele switching to quantify homology-directed repair, systematically optimize experimental parameters, and map a native B cell epitope in primary T cells. Allele switching of a surrogate cell surface marker can be used to enrich cells, with successful simultaneous editing of a second gene of interest. Finally, we applied the approach to correct two disease-causing mutations in the<i>Foxp3</i>gene. Repairing the cause of the scurfy syndrome, a 2-bp insertion in<i>Foxp3,</i>and repairing the clinically relevant Foxp3<sup>K276X</sup>mutation restored Foxp3 expression in primary T cells.</AbstractText><CopyrightInformation>Copyright © 2018 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kornete</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedicine, Basel University Hospital and University of Basel, CH-4031 Basel, Switzerland; and Transplantation Immunology and Nephrology, Basel University Hospital, CH-4031 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marone</LastName><ForeName>Romina</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1474-1689</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Basel University Hospital and University of Basel, CH-4031 Basel, Switzerland; and Transplantation Immunology and Nephrology, Basel University Hospital, CH-4031 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeker</LastName><ForeName>Lukas T</ForeName><Initials>LT</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3359-8796</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Basel University Hospital and University of Basel, CH-4031 Basel, Switzerland; and Transplantation Immunology and Nephrology, Basel University Hospital, CH-4031 Basel, Switzerland lukas.jeker@unibas.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI106923</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29445007</ArticleId><ArticleId IdType="pii">jimmunol.1701121</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.1701121</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29444903</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-009X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Drug metabolism and disposition: the biological fate of chemicals</Title><ISOAbbreviation>Drug Metab. Dispos.</ISOAbbreviation></Journal><ArticleTitle>Generation and Characterization of a CYP2C11-null Rat Model by using the CRISPR/Cas9 method.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dmd.117.078444</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1124/dmd.117.078444</ELocationID><Abstract><AbstractText>CYP2C11 is involved in the metabolism of many drugs in rats. To assess the roles of CYP2C11 in physiology and drug metabolism, a CYP2C11-null rat model was generated using the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 method. A 2-bp insertion was added to exon 6 of CYP2C11 in Sprague-Dawley rats. CYP2C11 was not detected by Western blotting in liver microsomes of CYP2C11-null rats. No off-target effects were found at eleven predicted sites of the knockout model. The CYP2C11-null rats were viable and had no obvious abnormalities, with the exception of reduced fertility. Puberty in CYP2C11-null rats appeared to be delayed by ~20 days, and the average litter size fell by 43%. Tolbutamide was used as a probe in this drug metabolism study. In the liver microsomes of CYP2C11-null rats, Vmax and CLint decreased by ~21% and ~44%, respectively, compared to those of wild-type rats. The Km increased by 138% compared to that of wild-types. However, our pharmacokinetics study showed no major differences in any parameters between the two strains, in both males and females. In conclusion, a CYP2C11-null rat model was successfully generated and is a valuable tool to study the in vivo function of CYP2C11.</AbstractText><CopyrightInformation>The American Society for Pharmacology and Experimental Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jiangsu University; ywei@ujs.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Jiangsu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Jiangsu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sui</LastName><ForeName>Danjuan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Jiangsu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Changsuo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jiangsu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jiangsu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Mangting</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MtC BioPharma Co. Ltd.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Dayong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Model Animal Research Center of Nanjing University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Model Animal Research Center of Nanjing University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Drug Metab Dispos</MedlineTA><NlmUniqueID>9421550</NlmUniqueID><ISSNLinking>0090-9556</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HPLC</Keyword><Keyword MajorTopicYN="N">animal models</Keyword><Keyword MajorTopicYN="N">cytochrome P450</Keyword><Keyword MajorTopicYN="N">enzyme kinetics</Keyword><Keyword MajorTopicYN="N">genetically modified animal models</Keyword><Keyword MajorTopicYN="N">in vivo probes</Keyword><Keyword MajorTopicYN="N">pharmacokinetics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29444903</ArticleId><ArticleId IdType="pii">dmd.117.078444</ArticleId><ArticleId IdType="doi">10.1124/dmd.117.078444</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29444862</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>Targeted DNA demethylation of the<i>Arabidopsis</i>genome using the human TET1 catalytic domain.</ArticleTitle><Pagination><MedlinePgn>E2125-E2134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1716945115</ELocationID><Abstract><AbstractText>DNA methylation is an important epigenetic modification involved in gene regulation and transposable element silencing. Changes in DNA methylation can be heritable and, thus, can lead to the formation of stable epialleles. A well-characterized example of a stable epiallele in plants is<i>fwa</i>, which consists of the loss of DNA cytosine methylation (5mC) in the promoter of the<i>FLOWERING WAGENINGEN</i>(<i>FWA</i>) gene, causing up-regulation of<i>FWA</i>and a heritable late-flowering phenotype. Here we demonstrate that a fusion between the catalytic domain of the human demethylase TEN-ELEVEN TRANSLOCATION1 (TET1cd) and an artificial zinc finger (ZF) designed to target the<i>FWA</i>promoter can cause highly efficient targeted demethylation,<i>FWA</i>up-regulation, and a heritable late-flowering phenotype. Additional ZF-TET1cd fusions designed to target methylated regions of the<i>CACTA1</i>transposon also caused targeted demethylation and changes in expression. Finally, we have developed a CRISPR/dCas9-based targeted demethylation system using the TET1cd and a modified SunTag system. Similar to the ZF-TET1cd fusions, the SunTag-TET1cd system is able to target demethylation and activate gene expression when directed to the<i>FWA</i>or<i>CACTA1</i>loci. Our study provides tools for targeted removal of 5mC at specific loci in the genome with high specificity and minimal off-target effects. These tools provide the opportunity to develop new epialleles for traits of interest, and to reactivate expression of previously silenced genes, transgenes, or transposons.</AbstractText><CopyrightInformation>Copyright © 2018 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gallego-Bartolomé</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardiner</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wanlu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Biology Institute, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papikian</LastName><ForeName>Ashot</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghoshal</LastName><ForeName>Basudev</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Hsuan Yu</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jenny Miao-Chi</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8962-3105</Identifier><AffiliationInfo><Affiliation>Genome Center, Medical Investigation of Neurodevelopmental Disorders Institute, and Department of Biochemistry and Molecular Medicine, University of California, Davis, CA 95616.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsen</LastName><ForeName>Steven E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095; jacobsen@ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 CA204563</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Jan 15;31(2):166-9</RefSource><PMID Version="1">25260700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2002 Dec 13;111(6):803-14</RefSource><PMID Version="1">12526807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2017 Sep;18(9):517-534</RefSource><PMID Version="1">28555658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Jul 19;7(29):46545-46556</RefSource><PMID Version="1">27356740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2000 Oct;6(4):791-802</RefSource><PMID Version="1">11090618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2004 Oct;168(2):961-9</RefSource><PMID Version="1">15514067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 6;507(7490):124-128</RefSource><PMID Version="1">24463519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2003 Mar;163(3):1109-22</RefSource><PMID Version="1">12663548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Jun 15;292(5524):2077-80</RefSource><PMID Version="1">11349138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 1998 Dec;16(6):735-43</RefSource><PMID Version="1">10069079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Gen Genet. 1991 Sep;229(1):57-66</RefSource><PMID Version="1">1896021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Oct 24;502(7472):472-9</RefSource><PMID Version="1">24153300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 May 1;25(9):1105-11</RefSource><PMID Version="1">19289445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2010 Mar;11(3):204-20</RefSource><PMID Version="1">20142834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1999 Sep 9;401(6749):157-61</RefSource><PMID Version="1">10490023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Mar 28;153(1):193-205</RefSource><PMID Version="1">23540698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Mar 13;452(7184):215-9</RefSource><PMID Version="1">18278030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2002 Jul 9;12(13):1138-44</RefSource><PMID Version="1">12121623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Sep 22;167(1):219-232.e14</RefSource><PMID Version="1">27662090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 23;159(3):635-46</RefSource><PMID Version="1">25307933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Oct;34(10 ):1060-1065</RefSource><PMID Version="1">27571369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Discov. 2016 May 03;2:16009</RefSource><PMID Version="1">27462456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Feb;42(3):1563-74</RefSource><PMID Version="1">24194590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2007 Jan 9;17(1):54-9</RefSource><PMID Version="1">17208187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2003 Oct;133(2):462-9</RefSource><PMID Version="1">14555774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 1982 May;111(2):187-94</RefSource><PMID Version="1">6177706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jan 17;152(1-2):352-64</RefSource><PMID Version="1">23313553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2003 Dec 16;13(24):2212-7</RefSource><PMID Version="1">14680640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6752-7</RefSource><PMID Version="1">17409185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epigenetics Chromatin. 2017 May 8;10 :24</RefSource><PMID Version="1">28503202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2009 Jul 27;10:232</RefSource><PMID Version="1">19635165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Feb 09;7:42047</RefSource><PMID Version="1">28181538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2005 Mar;23(3):355-60</RefSource><PMID Version="1">15696158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2001 Jul 15;15(14):1753-8</RefSource><PMID Version="1">11459824</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Plant Biol. 2015;66:243-67</RefSource><PMID Version="1">25494460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1999 Dec 3;286(5446):1962-5</RefSource><PMID Version="1">10583961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Symp Quant Biol. 2012;77:161-73</RefSource><PMID Version="1">23197304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Dec;31(12 ):1137-42</RefSource><PMID Version="1">24108092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 1997 Dec;12(6):1447-51</RefSource><PMID Version="1">9450349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Genet Dev. 2017 Oct;46:9-14</RefSource><PMID Version="1">28651214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2014 Jan;21(1):64-72</RefSource><PMID Version="1">24336224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>G3 (Bethesda). 2016 Sep 08;6(9):2773-80</RefSource><PMID Version="1">27402357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1997 Aug 22;277(5329):1100-3</RefSource><PMID Version="1">9262479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Genet Genomics. 2004 Jan;270(6):524-32</RefSource><PMID Version="1">14608503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2009 Feb;57(3):542-54</RefSource><PMID Version="1">18826433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Sep 22;167(1):233-247.e17</RefSource><PMID Version="1">27662091</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arabidopsis</Keyword><Keyword MajorTopicYN="N">CRISPR/dCas9 SunTag</Keyword><Keyword MajorTopicYN="N">TET1</Keyword><Keyword MajorTopicYN="N">artificial zinc finger</Keyword><Keyword MajorTopicYN="N">targeted demethylation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29444862</ArticleId><ArticleId IdType="pii">1716945115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1716945115</ArticleId><ArticleId IdType="pmc">PMC5834696</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29444806</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1943-2631</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Genetics</Title><ISOAbbreviation>Genetics</ISOAbbreviation></Journal><ArticleTitle>Multiple Applications of a Transient CRISPR-Cas9 Coupled With Electroporation (TRACE) System in the<i>Cryptococcus neoformans</i>Species Complex.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">genetics.300656.2018</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1534/genetics.117.300656</ELocationID><Abstract><AbstractText><i>Cryptococcus neoformans</i>
is a fungal pathogen that claims hundreds of thousands of lives annually. Targeted genetic manipulation through biolistic transformation in<i>C. neoformans</i>drove the investigation of this clinically important pathogen at the molecular level. Although costly and inefficient, biolistic transformation remains the major method for editing<i>Cryptococcus</i>genome as foreign DNAs introduced by other methods such as electroporation are predominantly not integrated into the genome. Although the majority of DNAs introduced by biolistic transformation are stably inherited, the transformation efficiency and the homologous integration rate (1~10%) are low. Here, we developed a<u>Tra</u>nsient<u>C</u>RISPR-Cas9 coupled with<u>E</u>lectroporation (TRACE) system for targeted genetic manipulations in the<i>C. neoformans</i>species complex<i>.</i>This method took advantage of efficient genome integration due to double strand breaks created at specific sites by the transient CRISPR-Cas9 system and the high transformation efficiency of electroporation. We demonstrated that TRACE can efficiently generate precise single gene deletion mutants using the<i>ADE2</i>locus as an example. This system can also effectively delete multiple genes in a single transformation as evident by the successful generation of quadruple<i>mf</i>α<i>1</i>Δ<i>2</i>Δ<i>3</i>Δ<i>4</i>Δ mutants. In addition to generating gene deletion mutants, we complemented the<i>ade2</i>Δ mutant by integrating a wild-type<i>ADE2</i>allele at the safe haven region (<i>SH2</i>) via homologous recombination using TRACE. Interestingly, introduced DNAs can be inserted at a designated genetic site without any homologous sequences, opening up numerous other applications. We expect that TRACE, an efficient, versatile, and cost-effective gene editing approach, will greatly accelerate research in this field.</AbstractText><CopyrightInformation>Copyright © 2018, Genetics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yumeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>University of Georgia xiaorong.lin@uga.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genetics</MedlineTA><NlmUniqueID>0374636</NlmUniqueID><ISSNLinking>0016-6731</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">Cryptococcus neoformans</Keyword><Keyword MajorTopicYN="N">biolistic transformation</Keyword><Keyword MajorTopicYN="N">double strand break</Keyword><Keyword MajorTopicYN="N">ectopic integration</Keyword><Keyword MajorTopicYN="N">electroporation</Keyword><Keyword MajorTopicYN="N">gene complementation</Keyword><Keyword MajorTopicYN="N">gene disruption</Keyword><Keyword MajorTopicYN="N">gene family</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29444806</ArticleId><ArticleId IdType="pii">genetics.117.300656</ArticleId><ArticleId IdType="doi">10.1534/genetics.117.300656</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29443117</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-5053</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Nature reviews. Gastroenterology &amp; hepatology</Title><ISOAbbreviation>Nat Rev Gastroenterol Hepatol</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas-related technologies in basic and translational liver research.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/nrgastro.2018.11</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Chun-Qing</ForeName><Initials>CQ</Initials><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Medical School.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular, Cell and Cancer Biology and Program of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP2 HL137167</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL131471</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Gastroenterol Hepatol</MedlineTA><NlmUniqueID>101500079</NlmUniqueID><ISSNLinking>1759-5045</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29443117</ArticleId><ArticleId IdType="pii">nrgastro.2018.11</ArticleId><ArticleId IdType="doi">10.1038/nrgastro.2018.11</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29443066</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1940-087X</ISSN><JournalIssue CitedMedium="Internet"><Issue>132</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>02</Day></PubDate></JournalIssue><Title>Journal of visualized experiments : JoVE</Title><ISOAbbreviation>J Vis Exp</ISOAbbreviation></Journal><ArticleTitle>Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3791/56613</ELocationID><Abstract><AbstractText>In research models of liver cancer, regeneration, inflammation, and fibrosis, flexible systems for in vivo gene expression and silencing are highly useful. Hydrodynamic tail vein injection of transposon-based constructs is an efficient method for genetic manipulation of hepatocytes in adult mice. In addition to constitutive transgene expression, this system can be used for more advanced applications, such as shRNA-mediated gene knock-down, implication of the CRISPR/Cas9 system to induce gene mutations, or inducible systems. Here, the combination of constitutive CreER expression together with inducible expression of a transgene or miR-shRNA of choice is presented as an example of this technique. We cover the multi-step procedure starting from the preparation of sleeping beauty-transposon constructs, to the injection and treatment of mice, and the preparation of liver tissue for analysis by immunostaining. The system presented is a reliable and efficient approach to achieve complex genetic manipulations in hepatocytes. It is specifically useful in combination with Cre/loxP-based mouse strains and can be applied to a variety of models in the research of liver disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hubner</LastName><ForeName>Eric K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Klinikum rechts der Isar, Technische Universität München; Department of Pneumology, Center for Medicine, Medical Center University of Freiburg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lechler</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Klinikum rechts der Isar, Technische Universität München.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rösner</LastName><ForeName>Thomas N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Klinikum rechts der Isar, Technische Universität München.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohnke-Ertel</LastName><ForeName>Birgit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Klinikum rechts der Isar, Technische Universität München.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Roland M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Klinikum rechts der Isar, Technische Universität München.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehmer</LastName><ForeName>Ursula</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Klinikum rechts der Isar, Technische Universität München; ursula.ehmer@tum.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vis Exp</MedlineTA><NlmUniqueID>101313252</NlmUniqueID><ISSNLinking>1940-087X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29443066</ArticleId><ArticleId IdType="doi">10.3791/56613</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29443056</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1940-087X</ISSN><JournalIssue CitedMedium="Internet"><Issue>132</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of visualized experiments : JoVE</Title><ISOAbbreviation>J Vis Exp</ISOAbbreviation></Journal><ArticleTitle>Primordial Germ Cell Transplantation for CRISPR/Cas9-based Leapfrogging in Xenopus.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3791/56035</ELocationID><Abstract><AbstractText>The creation of mutant lines by genome editing is accelerating genetic analysis in many organisms. CRISPR/Cas9 methods have been adapted for use in the African clawed frog, Xenopus, a longstanding model organism for biomedical research. Traditional breeding schemes for creating homozygous mutant lines with CRISPR/Cas9-targeted mutagenesis have several time-consuming and laborious steps. To facilitate the creation of mutant embryos, particularly to overcome the obstacles associated with knocking out genes that are essential for embryogenesis, a new method called leapfrogging was developed. This technique leverages the robustness of Xenopus embryos to "cut and paste" embryological methods. Leapfrogging utilizes the transfer of primordial germ cells (PGCs) from efficiently-mutagenized donor embryos into PGC-ablated wildtype siblings. This method allows for the efficient mutation of essential genes by creating chimeric animals with wildtype somatic cells that carry a mutant germline. When two F0 animals carrying "leapfrog transplants" (i.e., mutant germ cells) are intercrossed, they produce homozygous, or compound heterozygous, null F1 embryos, thus saving a full generation time to obtain phenotypic data. Leapfrogging also provides a new approach for analyzing maternal effect genes, which are refractory to F0 phenotypic analysis following CRISPR/Cas9 mutagenesis. This manuscript details the method of leapfrogging, with special emphasis on how to successfully perform PGC transplantation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blitz</LastName><ForeName>Ira L</ForeName><Initials>IL</Initials><AffiliationInfo><Affiliation>Department of Developmental and Cell Biology, University of California, Irvine; ilblitz@uci.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 HD080684</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vis Exp</MedlineTA><NlmUniqueID>101313252</NlmUniqueID><ISSNLinking>1940-087X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29443056</ArticleId><ArticleId IdType="doi">10.3791/56035</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29443028</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1940-087X</ISSN><JournalIssue CitedMedium="Internet"><Issue>131</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of visualized experiments : JoVE</Title><ISOAbbreviation>J Vis Exp</ISOAbbreviation></Journal><ArticleTitle>Microinjection of CRISPR/Cas9 Protein into Channel Catfish, Ictalurus punctatus, Embryos for Gene Editing.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3791/56275</ELocationID><Abstract><AbstractText>The complete genome of the channel catfish, Ictalurus punctatus, has been sequenced, leading to greater opportunities for studying channel catfish gene function. Gene knockout has been used to study these gene functions in vivo. The clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) system is a powerful tool used to edit genomic DNA sequences to alter gene function. While the traditional approach has been to introduce CRISPR/Cas9 mRNA into the single cell embryos through microinjection, this can be a slow and inefficient process in catfish. Here, a detailed protocol for microinjection of channel catfish embryos with CRISPR/Cas9 protein is described. Briefly, eggs and sperm were collected and then artificial fertilization performed. Fertilized eggs were transferred to a Petri dish containing Holtfreter's solution. Injection volume was calibrated and then guide RNAs/Cas9 targeting the toll/interleukin 1 receptor domain-containing adapter molecule (TICAM 1) gene and rhamnose binding lectin (RBL) gene were microinjected into the yolk of one-cell embryos. The gene knockout was successful as indels were confirmed by DNA sequencing. The predicted protein sequence alterations due to these mutations included frameshift and truncated protein due to premature stop codons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elaswad</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Fisheries, Aquaculture and Aquatic Sciences, Auburn University; Department of Animal Wealth Development, Faculty of Veterinary Medicine, Suez Canal University; ahe0001@tigermail.auburn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Fisheries, Aquaculture and Aquatic Sciences, Auburn University; Anatomy and Embryology Department, Faculty of Veterinary Medicine, Cairo University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cline</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Fisheries, Aquaculture and Aquatic Sciences, Auburn University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Page-McCaw</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wenbiao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Life Science Institute, University of Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cone</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Life Science Institute, University of Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunham</LastName><ForeName>Rex</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Fisheries, Aquaculture and Aquatic Sciences, Auburn University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vis Exp</MedlineTA><NlmUniqueID>101313252</NlmUniqueID><ISSNLinking>1940-087X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29443028</ArticleId><ArticleId IdType="doi">10.3791/56275</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29442507</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5126</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of the American Chemical Society</Title><ISOAbbreviation>J. Am. Chem. Soc.</ISOAbbreviation></Journal><ArticleTitle>Functional Insights Revealed by the Kinetic Mechanism of CRISPR/Cas9.</ArticleTitle><Pagination><MedlinePgn>2971-2984</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/jacs.7b13047</ELocationID><Abstract><AbstractText>The discovery of prokaryotic adaptive immunity prompted widespread use of the RNA-guided clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) endonuclease Cas9 for genetic engineering. However, its kinetic mechanism remains undefined, and details of DNA cleavage are poorly characterized. Here, we establish a kinetic mechanism of Streptococcus pyogenes Cas9 from guide-RNA binding through DNA cleavage and product release. Association of DNA to the binary complex of Cas9 and guide-RNA is rate-limiting during the first catalytic turnover, while DNA cleavage from a pre-formed ternary complex of Cas9, guide-RNA, and DNA is rapid. Moreover, an extremely slow release of DNA products essentially restricts Cas9 to be a single-turnover enzyme. By simultaneously measuring the contributions of the HNH and RuvC nuclease activities of Cas9 to DNA cleavage, we also uncovered the kinetic basis by which HNH conformationally regulates the RuvC cleavage activity. Together, our results provide crucial kinetic and functional details regarding Cas9 which will inform gene-editing experiments, guide future research to understand off-target DNA cleavage by Cas9, and aid in the continued development of Cas9 as a biotechnological tool.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raper</LastName><ForeName>Austin T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, ‡Ohio State Biochemistry Program, and §The James Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio 43210, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Anthony A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, ‡Ohio State Biochemistry Program, and §The James Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio 43210, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suo</LastName><ForeName>Zucai</ForeName><Initials>Z</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3871-3420</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, ‡Ohio State Biochemistry Program, and §The James Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio 43210, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Chem Soc</MedlineTA><NlmUniqueID>7503056</NlmUniqueID><ISSNLinking>0002-7863</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29442507</ArticleId><ArticleId IdType="doi">10.1021/jacs.7b13047</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29441050</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Comparative Genomics of Completely Sequenced<i>Lactobacillus helveticus</i>Genomes Provides Insights into Strain-Specific Genes and Resolves Metagenomics Data Down to the Strain Level.</ArticleTitle><Pagination><MedlinePgn>63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2018.00063</ELocationID><Abstract><AbstractText>Although complete genome sequences hold particular value for an accurate description of core genomes, the identification of strain-specific genes, and as the optimal basis for functional genomics studies, they are still largely underrepresented in public repositories. Based on an assessment of the genome assembly complexity for all lactobacilli, we used Pacific Biosciences' long read technology to sequence and<i>de novo</i>assemble the genomes of three<i>Lactobacillus helveticus</i>starter strains, raising the number of completely sequenced strains to 12. The first comparative genomics study for<i>L. helveticus</i>-to our knowledge-identified a core genome of 988 genes and sets of unique, strain-specific genes ranging from about 30 to more than 200 genes. Importantly, the comparison of MiSeq- and PacBio-based assemblies uncovered that not only accessory but also core genes can be missed in incomplete genome assemblies based on short reads. Analysis of the three genomes revealed that a large number of pseudogenes were enriched for functional Gene Ontology categories such as amino acid transmembrane transport and carbohydrate metabolism, which is in line with a reductive genome evolution in the rich natural habitat of<i>L. helveticus</i>. Notably, the functional Clusters of Orthologous Groups of proteins categories "cell wall/membrane biogenesis" and "defense mechanisms" were found to be enriched among the strain-specific genes. A genome mining effort uncovered examples where an experimentally observed phenotype could be linked to the underlying genotype, such as for cell envelope proteinase PrtH3 of strain FAM8627. Another possible link identified for peptidoglycan hydrolases will require further experiments. Of note, strain FAM22155 did not harbor a CRISPR/Cas system; its loss was also observed in other<i>L. helveticus</i>strains and lactobacillus species, thus questioning the value of the CRISPR/Cas system for diagnostic purposes. Importantly, the complete genome sequences proved to be very useful for the analysis of natural whey starter cultures with metagenomics, as a larger percentage of the sequenced reads of these complex mixtures could be unambiguously assigned down to the strain level.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Institute of Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muri</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melidis</LastName><ForeName>Damianos</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varadarajan</LastName><ForeName>Adithi R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Institute of Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somerville</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Institute of Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wicki</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moser</LastName><ForeName>Aline</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Biochemistry of Milk and Microorganisms, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourqui</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Institute of Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenzel</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Biochemistry of Milk and Microorganisms, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eugster-Meier</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Agricultural, Forest and Food Sciences HAFL, Bern University of Applied Sciences, Zollikofen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frey</LastName><ForeName>Juerg E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irmler</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Biochemistry of Milk and Microorganisms, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahrens</LastName><ForeName>Christian H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Institute of Bioinformatics, Wädenswil, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2014 Aug 29;13 Suppl 1:S2</RefSource><PMID Version="1">25185941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jan;43(Database issue):D1099-106</RefSource><PMID Version="1">25348402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Food Sci. 2015 Nov;80(11):R2367-72</RefSource><PMID Version="1">26444151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Nov 15;31(22):3691-3</RefSource><PMID Version="1">26198102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2017 Dec;27(12 ):2083-2095</RefSource><PMID Version="1">29141959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2008 Sep 30;127(1-2):168-71</RefSource><PMID Version="1">18620769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 8;44(W1):W16-21</RefSource><PMID Version="1">27141966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Jun;10(6):563-9</RefSource><PMID Version="1">23644548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol Evol. 2009 Jul 14;1:239-57</RefSource><PMID Version="1">20333194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2009 Sep;19(9):1639-45</RefSource><PMID Version="1">19541911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2012 Nov 19;3:392</RefSource><PMID Version="1">23181058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jan 4;44(D1):D279-85</RefSource><PMID Version="1">26673716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2012 Jun;6(6):1186-99</RefSource><PMID Version="1">22170421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Sep 29;6:8322</RefSource><PMID Version="1">26415554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2012 Jul 01;30(7):693-700</RefSource><PMID Version="1">22750884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45</RefSource><PMID Version="1">26553804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jul 1;43(W1):W104-8</RefSource><PMID Version="1">25916842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Announc. 2013 Aug 22;1(4):null</RefSource><PMID Version="1">23969047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Oct;33(10):1041-3</RefSource><PMID Version="1">26448087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Feb 24;9(2):e89680</RefSource><PMID Version="1">24586960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stand Genomic Sci. 2016 Sep 26;11:75</RefSource><PMID Version="1">28300228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Res Microbiol. 2010 Jul-Aug;161(6):480-7</RefSource><PMID Version="1">20302928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brief Bioinform. 2016 Jan;17 (1):154-79</RefSource><PMID Version="1">26026159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Announc. 2016 Aug 25;4(4):null</RefSource><PMID Version="1">27563041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2004 Dec;22(12):1554-8</RefSource><PMID Version="1">15543133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Genet Dev. 2005 Dec;15(6):589-94</RefSource><PMID Version="1">16185861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Mar 19;32(5):1792-7</RefSource><PMID Version="1">15034147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Jan 2;323(5910):133-8</RefSource><PMID Version="1">19023044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Proteomics. 2014 Mar 17;99:123-37</RefSource><PMID Version="1">24486812</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2013 Jun;97(12):5225-43</RefSource><PMID Version="1">23677442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2000 Jun;16(6):276-7</RefSource><PMID Version="1">10827456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e48837</RefSource><PMID Version="1">23251337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2016 Nov 4;12 (11):e1006364</RefSource><PMID Version="1">27814362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 May 1;30(9):1312-3</RefSource><PMID Version="1">24451623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Jan 4;45(D1):D190-D199</RefSource><PMID Version="1">27899635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>IEEE/ACM Trans Comput Biol Bioinform. 2017 Feb 07;:null</RefSource><PMID Version="1">28186905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2008 Jan;74(2):416-23</RefSource><PMID Version="1">17993552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15611-6</RefSource><PMID Version="1">17030793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2007 Jan 20;8:18</RefSource><PMID Version="1">17239253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2011 Aug;193(16):4282-3</RefSource><PMID Version="1">21705605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2016 Sep 21;7:1475</RefSource><PMID Version="1">27708630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W52-7</RefSource><PMID Version="1">17537822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010 Jul 12;5(7):e11518</RefSource><PMID Version="1">20634954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2013 May;79(10):3148-55</RefSource><PMID Version="1">23475615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2011 May;193(10):2666-7</RefSource><PMID Version="1">21398542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2008 Aug;8(15):3154-63</RefSource><PMID Version="1">18615427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2004;5(2):R12</RefSource><PMID Version="1">14759262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiome. 2016 Mar 08;4:8</RefSource><PMID Version="1">26951112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2012 Oct 05;13:533</RefSource><PMID Version="1">23035691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2006 Jul 1;22(13):1600-7</RefSource><PMID Version="1">16606683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Feb;12(2):115-21</RefSource><PMID Version="1">25633503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2012 Sep;100(3):167-75</RefSource><PMID Version="1">22750556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2013;14(9):R101</RefSource><PMID Version="1">24034426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Top Microbiol Immunol. 2016;398:89-102</RefSource><PMID Version="1">27474081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Probiotics Antimicrob Proteins. 2012 Dec;4(4):217-26</RefSource><PMID Version="1">26782181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Aug 19;44(14 ):6614-24</RefSource><PMID Version="1">27342282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dairy Sci. 2010 Oct;93(10):4435-54</RefSource><PMID Version="1">20854978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2010 Nov;11(11):789-801</RefSource><PMID Version="1">20944666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carbohydr Res. 2013 Sep 20;379:7-12</RefSource><PMID Version="1">23831635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2011 Jul 15;148(1):1-7</RefSource><PMID Version="1">21571387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Ecol. 2012 Apr;63(3):651-73</RefSource><PMID Version="1">22031452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2008 Jan;190(2):727-35</RefSource><PMID Version="1">17993529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2013 Nov;23(11):1916-27</RefSource><PMID Version="1">23878158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Food Sci Technol. 2013;4:347-68</RefSource><PMID Version="1">23244395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome. 2016 Oct;59(10 ):783-791</RefSource><PMID Version="1">27603265</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2005 Feb 15;21(4):537-9</RefSource><PMID Version="1">15479716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Biol. 2012 May;19(5):455-77</RefSource><PMID Version="1">22506599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2013 Nov;7(11):2126-36</RefSource><PMID Version="1">23823494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Dec 29;16:294</RefSource><PMID Version="1">26714481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Food Microbiol. 2017 Feb;61:33-49</RefSource><PMID Version="1">27697167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2013 Jan 11;3:435</RefSource><PMID Version="1">23335916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Lett. 2007 Apr;269(1):22-8</RefSource><PMID Version="1">17343688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jan 4;44(D1):D286-93</RefSource><PMID Version="1">26582926</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">PacBio</Keyword><Keyword MajorTopicYN="N">comparative genomics</Keyword><Keyword MajorTopicYN="N">dairy industry</Keyword><Keyword MajorTopicYN="N">metagenomics</Keyword><Keyword MajorTopicYN="N">natural whey starter cultures</Keyword><Keyword MajorTopicYN="N">strain-specific genes</Keyword><Keyword MajorTopicYN="N">whole genome sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29441050</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2018.00063</ArticleId><ArticleId IdType="pmc">PMC5797582</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29440578</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>MBio</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e02406-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mBio.02406-17</ELocationID><Abstract><AbstractText>A powerful contributor to prokaryotic evolution is horizontal gene transfer (HGT) through transformation, conjugation, and transduction, which can be advantageous, neutral, or detrimental to fitness. Bacteria and archaea control HGT and phage infection through CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated proteins) adaptive immunity. Although the benefits of resisting phage infection are evident, this can come at a cost of inhibiting the acquisition of other beneficial genes through HGT. Despite the ability of CRISPR-Cas to limit HGT through conjugation and transformation, its role in transduction is largely overlooked. Transduction is the phage-mediated transfer of bacterial DNA between cells and arguably has the greatest impact on HGT. We demonstrate that in<i>Pectobacterium atrosepticum</i>, CRISPR-Cas can inhibit the transduction of plasmids and chromosomal loci. In addition, we detected phage-mediated transfer of a large plant pathogenicity genomic island and show that CRISPR-Cas can inhibit its transduction. Despite these inhibitory effects of CRISPR-Cas on transduction, its more common role in phage resistance promotes rather than diminishes HGT via transduction by protecting bacteria from phage infection. This protective effect can also increase transduction of phage-sensitive members of mixed populations. CRISPR-Cas systems themselves display evidence of HGT, but little is known about their lateral dissemination between bacteria and whether transduction can contribute. We show that, through transduction, bacteria can acquire an entire chromosomal CRISPR-Cas system, including<i>cas</i>genes and phage-targeting spacers. We propose that the positive effect of CRISPR-Cas phage immunity on enhancing transduction surpasses the rarer cases where gene flow by transduction is restricted.<b>IMPORTANCE</b>The generation of genetic diversity through acquisition of DNA is a powerful contributor to microbial evolution and occurs through transformation, conjugation, and transduction. Of these, transduction, the phage-mediated transfer of bacterial DNA, is arguably the major route for genetic exchange. CRISPR-Cas adaptive immune systems control gene transfer by conjugation and transformation, but transduction has been mostly overlooked. Our results indicate that CRISPR-Cas can impede, but typically enhances the transduction of plasmids, chromosomal genes, and pathogenicity islands. By limiting wild-type phage replication, CRISPR-Cas immunity increases transduction in both phage-resistant and -sensitive members of mixed populations. Furthermore, we demonstrate mobilization of a chromosomal CRISPR-Cas system containing phage-targeting spacers by generalized transduction, which might partly account for the uneven distribution of these systems in nature. Overall, the ability of CRISPR-Cas to promote transduction reveals an unexpected impact of adaptive immunity on horizontal gene transfer, with broader implications for microbial evolution.</AbstractText><CopyrightInformation>Copyright © 2018 Watson et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Bridget N J</ForeName><Initials>BNJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staals</LastName><ForeName>Raymond H J</ForeName><Initials>RHJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fineran</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4639-6704</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand peter.fineran@otago.ac.nz.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bio-Protection Research Centre, University of Otago, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2011 May-Jun;8(3):517-28</RefSource><PMID Version="1">21519197</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2005 Dec;71(12):8301-4</RefSource><PMID Version="1">16332816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 1998 Aug;64(8):2780-7</RefSource><PMID Version="1">9687430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5113-E5121</RefSource><PMID Version="1">28438998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Dec 19;322(5909):1843-5</RefSource><PMID Version="1">19095942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2014 Jul;12(7):479-92</RefSource><PMID Version="1">24909109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Virol. 2014 Nov;1(1):307-31</RefSource><PMID Version="1">26958724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2004 Oct;70(10):5842-6</RefSource><PMID Version="1">15466522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013;9(9):e1003844</RefSource><PMID Version="1">24086164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Oct 03;7:12853</RefSource><PMID Version="1">27694798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Evol. 2006 Jun;62(6):718-29</RefSource><PMID Version="1">16612537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Direct. 2011 Dec 21;6(1):65</RefSource><PMID Version="1">22188759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2015 Sep;9(9):2021-7</RefSource><PMID Version="1">25710183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2015 Apr 21;6(2):null</RefSource><PMID Version="1">25900652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Ecol Evol. 2013 Aug;28(8):489-95</RefSource><PMID Version="1">23706556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virology. 2007 Sep 1;365(2):241-9</RefSource><PMID Version="1">17482656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Microbiol. 2015 Feb;23:171-8</RefSource><PMID Version="1">25528295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1952 Nov;64(5):679-99</RefSource><PMID Version="1">12999698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Oct 1;330(6000):50</RefSource><PMID Version="1">20929803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2010 Oct 28;6(10):e1001171</RefSource><PMID Version="1">21060859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Jan 2;323(5910):139-41</RefSource><PMID Version="1">19119236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2016 Jan 11;198(6):941-50</RefSource><PMID Version="1">26755632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Feb 28;494(7438):489-91</RefSource><PMID Version="1">23446421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Jul 11;499(7457):219-22</RefSource><PMID Version="1">23748443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2017 Mar 31;83(8):null</RefSource><PMID Version="1">28159786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 May 23;320(5879):1047-50</RefSource><PMID Version="1">18497291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11105-10</RefSource><PMID Version="1">15263089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2010 Oct 12;1(4):null</RefSource><PMID Version="1">21060735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2017 Apr 7;356(6333):</RefSource><PMID Version="1">28385959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2010 Aug;26(8):335-40</RefSource><PMID Version="1">20598393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2017 Sep 19;8(5):null</RefSource><PMID Version="1">28928211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2012 May;84(4):648-63</RefSource><PMID Version="1">22524709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Sep 08;34(9):933-941</RefSource><PMID Version="1">27606440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Aug 5;353(6299):aad5147</RefSource><PMID Version="1">27493190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013 Apr;9(4):e1003454</RefSource><PMID Version="1">23637624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2011 Jun;9(6):467-77</RefSource><PMID Version="1">21552286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2012;8(10):e1003023</RefSource><PMID Version="1">23109916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2013;82:237-66</RefSource><PMID Version="1">23495939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2005 Sep;3(9):722-32</RefSource><PMID Version="1">16138100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiol Mol Biol Rev. 2004 Sep;68(3):560-602, table of contents</RefSource><PMID Version="1">15353570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2010 May;4(5):648-59</RefSource><PMID Version="1">20090786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 21;532(7599):385-8</RefSource><PMID Version="1">27074511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol. 2013 Feb;15(2):463-70</RefSource><PMID Version="1">23057534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2011 Oct;21(10):1616-25</RefSource><PMID Version="1">21880779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Microbiol. 2016 Jun 13;1(8):16085</RefSource><PMID Version="1">27573108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2016 Mar 31;7:397</RefSource><PMID Version="1">27065965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jul;42(13):8516-26</RefSource><PMID Version="1">24990370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Host Microbe. 2012 Aug 16;12(2):177-86</RefSource><PMID Version="1">22901538</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas</Keyword><Keyword MajorTopicYN="N">bacteriophages</Keyword><Keyword MajorTopicYN="N">genomic islands</Keyword><Keyword MajorTopicYN="N">horizontal gene transfer</Keyword><Keyword MajorTopicYN="N">plasmids</Keyword><Keyword MajorTopicYN="N">transduction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29440578</ArticleId><ArticleId IdType="pii">mBio.02406-17</ArticleId><ArticleId IdType="doi">10.1128/mBio.02406-17</ArticleId><ArticleId IdType="pmc">PMC5821089</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29440555</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J. Neurosci.</ISOAbbreviation></Journal><ArticleTitle>C8ORF37 is required for photoreceptor outer segment disc morphogenesis by maintaining outer segment membrane protein homeostasis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2964-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.2964-17.2018</ELocationID><Abstract><AbstractText><i>C8ORF37</i>
is a causative gene for three different clinical forms of incurable retinal degeneration. However, the completely unknown function of<i>C8ORF37</i>limits our understanding of the pathogenicity of<i>C8ORF37</i>mutations. Here, we performed a comprehensive phenotypic characterization of a<i>C8orf37</i>knockout mouse line, generated using CRISPR/Cas9 technology. Both<i>C8orf37</i>knockout male and female mice exhibited progressive and simultaneous degeneration of rod and cone photoreceptors but no non-ocular phenotypes. The major ultrastructural feature of<i>C8orf37</i>knockout photoreceptors was massive disorganization of the outer segment (OS) membrane discs, starting from the onset of disc morphogenesis during development. At the molecular level, the amounts of multiple OS-specific membrane proteins, including proteins involved in membrane disc organization, were reduced, although these proteins were targeted normally to the OS. Considering the distribution of C8ORF37 throughout the photoreceptor cell body, the normal structure of the knockout photoreceptor connecting cilium and the absence of defects in other ciliary organs of the knockout mice, our findings do not support the previous notion that C8ORF37 was a ciliary protein. Since C8ORF37 is absent in the photoreceptor OS, C8ORF37 may participate in the secretory pathway of OS membrane proteins in the photoreceptor cell body and thus maintain the homeostasis of these proteins. Taken together, this study established a valid animal model for future therapeutic studies of<i>C8ORF37</i>-associated retinal degeneration. This study also shed new light on the role of C8ORF37 in photoreceptors and on the pathogenic mechanism underlying retinal degeneration caused by<i>C8ORF37</i>mutations.<b>SIGNIFICANCE STATEMENT</b>Inherited retinal degeneration is a group of incurable conditions with poorly understood underlying molecular mechanisms. We investigated<i>C8ORF37</i>, a causative gene for three retinal degenerative conditions: retinitis pigmentosa, cone-rod dystrophy and Bardet-Biedl syndrome.<i>C8ORF37</i>encodes a protein with no known functional domains, and thus its biological function is unpredictable. We knocked out the<i>C8ORF37</i>ortholog in mice, which resulted in a retinal phenotype similar to that observed in patients. We further demonstrated that C8ORF37 is required for photoreceptor outer segment disc formation and alignment, a process that is critical for photoreceptor function and survival. This study advances our understanding of the pathogenesis of retinal degeneration and establishes a valuable mouse model for future therapeutic development.</AbstractText><CopyrightInformation>Copyright © 2018 the authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharif</LastName><ForeName>Ali S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loertscher</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Austin</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathur</LastName><ForeName>Pranav D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Junhuang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobanova</LastName><ForeName>Ekaterina S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Albert Eye Research Institute, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arshavsky</LastName><ForeName>Vadim Y</ForeName><Initials>VY</Initials><AffiliationInfo><Affiliation>Albert Eye Research Institute, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA jun.yang@hsc.utah.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Division of Otolaryngology, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EY020853</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY026521</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29440555</ArticleId><ArticleId IdType="pii">JNEUROSCI.2964-17.2018</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.2964-17.2018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29440496</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9 cleavages in budding yeast reveal templated insertions and strand-specific insertion/deletion profiles.</ArticleTitle><Pagination><MedlinePgn>E2040-E2047</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1716855115</ELocationID><Abstract><AbstractText>Harnessing CRISPR-Cas9 technology provides an unprecedented ability to modify genomic loci via DNA double-strand break (DSB) induction and repair. We analyzed nonhomologous end-joining (NHEJ) repair induced by Cas9 in budding yeast and found that the orientation of binding of Cas9 and its guide RNA (gRNA) profoundly influences the pattern of insertion/deletions (indels) at the site of cleavage. A common indel created by Cas9 is a 1-bp (+1) insertion that appears to result from Cas9 creating a 1-nt 5' overhang that is filled in by a DNA polymerase and ligated. The origin of +1 insertions was investigated by using two gRNAs with PAM sequences located on opposite DNA strands but designed to cleave the same sequence. These templated +1 insertions are dependent on the X-family DNA polymerase, Pol4. Deleting Pol4 also eliminated +2 and +3 insertions, which are biased toward homonucleotide insertions. Using inverted PAM sequences, we also found significant differences in overall NHEJ efficiency and repair profiles, suggesting that the binding of the Cas9:gRNA complex influences subsequent NHEJ processing. As with events induced by the site-specific HO endonuclease, CRISPR-Cas9-mediated NHEJ repair depends on the Ku heterodimer and DNA ligase 4. Cas9 events are highly dependent on the Mre11-Rad50-Xrs2 complex, independent of Mre11's nuclease activity. Inspection of the outcomes of a large number of Cas9 cleavage events in mammalian cells reveals a similar templated origin of +1 insertions in human cells, but also a significant frequency of similarly templated +2 insertions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lemos</LastName><ForeName>Brenda R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Biology, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Adam C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Biology, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Ji Eun</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Biology, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrazzoli</LastName><ForeName>Alexander E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Biology, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biology, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Ranjith P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Biology, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waterman</LastName><ForeName>David P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Biology, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haber</LastName><ForeName>James E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Biology, Brandeis University, Waltham, MA 02454; haber@brandeis.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM076020</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 GM105473</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 GM020056</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM020056</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007122</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Nov 20;5:5560</RefSource><PMID Version="1">25410609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2013 May;23(5):720-3</RefSource><PMID Version="1">23545779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1986 Oct;83(20):7831-5</RefSource><PMID Version="1">3020559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1997 Jan 15;25(2):451-2</RefSource><PMID Version="1">9016579</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Aug 5;19(3):357-66</RefSource><PMID Version="1">16061182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Nov 22;5:37584</RefSource><PMID Version="1">27874072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Jul;11(7):705-6</RefSource><PMID Version="1">24972169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2002;350:141-64</RefSource><PMID Version="1">12073310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Mar 1;30(5):614-20</RefSource><PMID Version="1">24142950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 May 20;280(20):20051-8</RefSource><PMID Version="1">15778218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2012 Jun 15;28(12):1647-9</RefSource><PMID Version="1">22543367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 May 5;44(8):e76</RefSource><PMID Version="1">26762978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Cell Biol. 2015 Aug;7(4):284-98</RefSource><PMID Version="1">25757625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Dec 6;414(6864):666-9</RefSource><PMID Version="1">11740566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Apr 7;44(6):2769-81</RefSource><PMID Version="1">26773053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6409-14</RefSource><PMID Version="1">10823903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2007;2(1):31-4</RefSource><PMID Version="1">17401334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2012 Feb 1;11(2):120-30</RefSource><PMID Version="1">22093869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Biol. 2014 Aug 07;6(9):a016428</RefSource><PMID Version="1">25104768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2016 Nov 23;50:1-28</RefSource><PMID Version="1">27732795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2014;11(10):1243-9</RefSource><PMID Version="1">25590615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Structure. 2016 Sep 6;24(9):1452-63</RefSource><PMID Version="1">27499438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Dec;23 (23 ):8820-8</RefSource><PMID Version="1">14612421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 1983;101:202-11</RefSource><PMID Version="1">6310324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1999 Nov;19(11):7681-7</RefSource><PMID Version="1">10523656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Apr 20;544(7650):377-380</RefSource><PMID Version="1">28405019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2003 Sep;4(9):844-9</RefSource><PMID Version="1">12949583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Aug;34(8):863-8</RefSource><PMID Version="1">27272384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Aug 18;63(4):633-646</RefSource><PMID Version="1">27499295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3108-15</RefSource><PMID Version="1">21292986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Feb 26;160(5):913-27</RefSource><PMID Version="1">25723166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Mar;34(3):339-44</RefSource><PMID Version="1">26789497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 20;533(7603):420-4</RefSource><PMID Version="1">27096365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2014 Jul 3;15(1):27-30</RefSource><PMID Version="1">24996167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2015 Jul 21;6(4):e00861</RefSource><PMID Version="1">26199327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Aug;24(7):1258-66</RefSource><PMID Version="1">27203444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2005;39:431-51</RefSource><PMID Version="1">16285867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 6;507(7490):62-7</RefSource><PMID Version="1">24476820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1998 Aug 7;94(3):399-409</RefSource><PMID Version="1">9708741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1996 May;16(5):2164-73</RefSource><PMID Version="1">8628283</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr;41(7):4336-43</RefSource><PMID Version="1">23460208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2017 Feb 10;292(6):2556</RefSource><PMID Version="1">28188222</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">DNA polymerase 4</Keyword><Keyword MajorTopicYN="N">double-strand breaks</Keyword><Keyword MajorTopicYN="N">nonhomologous end-joining</Keyword><Keyword MajorTopicYN="N">templated insertions</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>08</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29440496</ArticleId><ArticleId IdType="pii">1716855115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1716855115</ArticleId><ArticleId IdType="pmc">PMC5834694</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29440296</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-8514</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Molecular cancer therapeutics</Title><ISOAbbreviation>Mol. Cancer Ther.</ISOAbbreviation></Journal><ArticleTitle>PIM kinases are a potential prognostic biomarker and therapeutic target in neuroblastoma.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">molcanther.0868.2017</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1158/1535-7163.MCT-17-0868</ELocationID><Abstract><AbstractText>The majority of high-risk neuroblastoma patients are refractory to, or relapse on current treatment regimens, resulting in 5-year survival rates of less than 50%. This emphasizes the urgent need to identify novel therapeutic targets. Here, we report that high PIM kinase expression is correlated with poor overall survival. Treatment of neuroblastoma cell lines with the pan-PIM inhibitors AZD1208 or PIM-447 suppressed proliferation through inhibition of mTOR signaling. In a panel of neuroblastoma cell lines, we observed a marked binary response to PIM inhibition, suggesting that specific genetic lesions control responses to PIM inhibition. Using a genome-wide CRISPR-Cas9 genetic screen, we identified NF1 loss as the major resistance mechanism to PIM kinase inhibitors. Treatment with AZD1208 impaired the growth of NF1 wild type xenografts, while NF1 knock out cells were insensitive. Thus, our data indicate that PIM inhibition may be a novel targeted therapy in NF1 wild type neuroblastoma.</AbstractText><CopyrightInformation>Copyright ©2018, American Association for Cancer Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brunen</LastName><ForeName>Diede</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Molecular Carcinogenesis, Netherlands Cancer Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>Romy C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Molecular carcinogenesis, Netherlands Cancer Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieftink</LastName><ForeName>Cor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, The Netherlands Cancer Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beijersbergen</LastName><ForeName>Roderick L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, The Netherlands Cancer Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernards</LastName><ForeName>Rene</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Molecular Carcinogenesis, The Netherlands Cancer Institute r.bernards@nki.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cancer Ther</MedlineTA><NlmUniqueID>101132535</NlmUniqueID><ISSNLinking>1535-7163</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29440296</ArticleId><ArticleId IdType="pii">1535-7163.MCT-17-0868</ArticleId><ArticleId IdType="doi">10.1158/1535-7163.MCT-17-0868</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29440174</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-0432</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Clinical cancer research : an official journal of the American Association for Cancer Research</Title><ISOAbbreviation>Clin. Cancer Res.</ISOAbbreviation></Journal><ArticleTitle>Platelets enhance Multiple Myeloma progression via IL-1β upregulation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">clincanres.2003.2017</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1158/1078-0432.CCR-17-2003</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Tumor cell-platelet interactions contribute to tumor progression and metastasis in solid tumors. However, the role of platelets in hematological malignancies is not clear. We investigated the association of platelet activation status with clinical stages in multiple myeloma (MM) patients and explored the role of platelets in MM progression.</AbstractText><AbstractText Label="EXPERIMENTAL DESIGN" NlmCategory="METHODS"> Platelets were obtained from healthy donors and MM patients. We examined platelet activation status in MM patients by flow cytometry and transmission electron microscopy. We also observed the enriched pathways that are involved with platelet activation in RNA sequencing of platelets. MM cell lines were used to assess the effect of platelets on MM cell proliferation<i>in vitro</i>and their engraftment<i>in vivo</i>RNA sequencing of MM cell lines was performed to explore molecular mechanisms underlying MM cell-platelet interaction and a CRISPR/Cas9 knockout approach was used for validation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Platelets from MM patients were highly activated with disease progression. RNA sequencing of platelets revealed that genes involved in platelets were enriched in patients with smoldering MM (SMM) or MM. Platelets promoted MM cell proliferation<i>in vitro</i>and contributed to tumor engraftment in bone marrow<i>in vivo</i>RNA sequencing revealed that<i>IL-1β</i>was upregulated in MM cell lines co-cultured with platelets, whereas<i>IL-1β</i>knockout in MM cell lines abrogated the effects of platelets on MM cell proliferation and engraftment<i>in vivo</i>Conclusions: Platelets from MM patients were highly activated with disease progression. IL-1β is critical to platelet-mediated MM progression and might be a potential target for MM treatment.</AbstractText><CopyrightInformation>Copyright ©2018, American Association for Cancer Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsukamoto</LastName><ForeName>Shokichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jihye</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kelly E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawano</LastName><ForeName>Yawara</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dana-Farber Cancer Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moschetta</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Early Drug Development, Translational Oncology Unit, AstraZeneca (United Kingdom).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chia-Jen</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishima</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokubun</LastName><ForeName>Katsutoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinical Pathophysiology, Tokyo Dental College.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manier</LastName><ForeName>Salomon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dana Farber Cancer Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Karma</ForeName><Initials>K</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-0246-7785</Identifier><AffiliationInfo><Affiliation>Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huynh</LastName><ForeName>Daisy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacco</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Oncology, ASST Spedali Civili.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forward</LastName><ForeName>Jodi A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roccaro</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battinelli</LastName><ForeName>Elisabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghobrial</LastName><ForeName>Irene M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School irene_ghobrial@dfci.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Cancer Res</MedlineTA><NlmUniqueID>9502500</NlmUniqueID><ISSNLinking>1078-0432</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29440174</ArticleId><ArticleId IdType="pii">1078-0432.CCR-17-2003</ArticleId><ArticleId IdType="doi">10.1158/1078-0432.CCR-17-2003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29439199</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>Liprin-α3 controls vesicle docking and exocytosis at the active zone of hippocampal synapses.</ArticleTitle><Pagination><MedlinePgn>2234-2239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1719012115</ELocationID><Abstract><AbstractText>The presynaptic active zone provides sites for vesicle docking and release at central nervous synapses and is essential for speed and accuracy of synaptic transmission. Liprin-α binds to several active zone proteins, and loss-of-function studies in invertebrates established important roles for Liprin-α in neurodevelopment and active zone assembly. However, Liprin-α localization and functions in vertebrates have remained unclear. We used stimulated emission depletion superresolution microscopy to systematically determine the localization of Liprin-α2 and Liprin-α3, the two predominant Liprin-α proteins in the vertebrate brain, relative to other active-zone proteins. Both proteins were widely distributed in hippocampal nerve terminals, and Liprin-α3, but not Liprin-α2, had a prominent component that colocalized with the active-zone proteins Bassoon, RIM, Munc13, RIM-BP, and ELKS. To assess Liprin-α3 functions, we generated Liprin-α3-KO mice by using CRISPR/Cas9 gene editing. We found reduced synaptic vesicle tethering and docking in hippocampal neurons of Liprin-α3-KO mice, and synaptic vesicle exocytosis was impaired. Liprin-α3 KO also led to mild alterations in active zone structure, accompanied by translocation of Liprin-α2 to active zones. These findings establish important roles for Liprin-α3 in active-zone assembly and function, and suggest that interplay between various Liprin-α proteins controls their active-zone localization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Man Yan</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Changliang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shan Shan H</ForeName><Initials>SSH</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roquas</LastName><ForeName>Aram C F</ForeName><Initials>ACF</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fowler</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Kansas, Lawrence, KS 66045.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaeser</LastName><ForeName>Pascal S</ForeName><Initials>PS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1558-1958</Identifier><AffiliationInfo><Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA 02115; kaeser@hms.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 HD018655</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 NS072030</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH113349</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS083898</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2016 Oct;19(10 ):1311-20</RefSource><PMID Version="1">27526206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Neurosci. 2013 Sep;56:76-84</RefSource><PMID Version="1">23541703</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comp Neurol. 2011 Oct 15;519(15):3019-39</RefSource><PMID Version="1">21618221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Mar 13;323(5920):1500-3</RefSource><PMID Version="1">19286562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2011 Nov 9;31(45):16261-8</RefSource><PMID Version="1">22072677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2013 Jun 10;201(6):915-28</RefSource><PMID Version="1">23751498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Sep 23;6:33653</RefSource><PMID Version="1">27659488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11615-11620</RefSource><PMID Version="1">27671655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Aug 11;536(7615):210-4</RefSource><PMID Version="1">27462810</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2009 Mar;93(3):243-53</RefSource><PMID Version="1">19013515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2006 Dec;9(12):1479-87</RefSource><PMID Version="1">17115037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11601-6</RefSource><PMID Version="1">16864799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2016 Aug 17;91(4):777-791</RefSource><PMID Version="1">27537483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Oct 24;278(43):42377-85</RefSource><PMID Version="1">12923177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2007 Apr;12(4):587-602</RefSource><PMID Version="1">17419996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1999 Sep 23;401(6751):371-5</RefSource><PMID Version="1">10517634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Jan 17;415(6869):321-6</RefSource><PMID Version="1">11797009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2010 Nov 17;30(46):15358-68</RefSource><PMID Version="1">21084592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2006 Dec;9(12):1488-98</RefSource><PMID Version="1">17115039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2013 Jun 19;78(6):1012-23</RefSource><PMID Version="1">23791195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2010 Dec 9;68(5):843-56</RefSource><PMID Version="1">21144999</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2005 Apr 12;15(7):684-9</RefSource><PMID Version="1">15823543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2014 Oct 22;84(2):416-31</RefSource><PMID Version="1">25374362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2005 Aug 17;25(33):7517-28</RefSource><PMID Version="1">16107639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2004 Aug 5;43(3):387-400</RefSource><PMID Version="1">15294146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comp Neurol. 2011 Oct 15;519(15):3040-60</RefSource><PMID Version="1">21618222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2012 Jul 12;75(1):11-25</RefSource><PMID Version="1">22794257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2017 Feb;241(3):324-336</RefSource><PMID Version="1">27917469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2002 Mar 28;34(1):39-52</RefSource><PMID Version="1">11931740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2010 Feb 22;188(4):565-79</RefSource><PMID Version="1">20176924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2009 Jul 13;186(1):129-45</RefSource><PMID Version="1">19596851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Jun 19;273(25):15611-20</RefSource><PMID Version="1">9624153</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Liprin-α</Keyword><Keyword MajorTopicYN="N">active zone</Keyword><Keyword MajorTopicYN="N">active zone assembly</Keyword><Keyword MajorTopicYN="N">synaptic vesicle exocytosis</Keyword><Keyword MajorTopicYN="N">vesicle docking</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>08</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29439199</ArticleId><ArticleId IdType="pii">1719012115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1719012115</ArticleId><ArticleId IdType="pmc">PMC5834710</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29439167</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J. Neurosci.</ISOAbbreviation></Journal><ArticleTitle>Combinatorial effects of Alpha- and Gamma-Protocadherins on neuronal survival and dendritic self-avoidance.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3035-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.3035-17.2018</ELocationID><Abstract><AbstractText>The clustered Protocadherins (Pcdhs) comprise 58 cadherin-related proteins encoded by three tandemly-arrayed gene clusters,<i>Pcdh-alpha</i>,<i>-beta</i>, and<i>--gamma</i>(<i>Pcdha, Pcdhb, Pcdhg).</i>Pcdh isoforms from different clusters are combinatorially expressed in neurons. They form multimers that interact homophilically, and mediate a variety of developmental processes, including neuronal survival, synaptic maintenance, axonal tiling and dendritic self-avoidance. Most studies have analyzed clusters individually. Here, we assess functional interactions between<i>Pcdha</i>and<i>Pcdhg</i>clusters. To circumvent neonatal lethality associated with deletion of<i>Pcdhgs</i>, we used Crispr-Cas9 genome editing in mice to combine a constitutive<i>Pcdha</i>mutant allele with a conditional<i>Pcdhg</i>allele. We analyzed roles of Pcdhas and Pcdhgs in the retina and cerebellum from mice (both sexes) lacking one or both clusters. In retina, Pcdhgs are essential for survival of inner retinal neurons and dendrite self-avoidance of starburst amacrine cells, while Pcdhas are dispensable for both processes. Deletion of both<i>Pcdha</i>and<i>Pcdhg</i>clusters led to far more dramatic defects in survival and self-avoidance than<i>Pcdhg</i>deletion alone. Comparisons of an allelic series of mutants support the conclusion that Pcdhas and Pcdhgs function together in a dose-dependent and cell-type specific manner to provide a critical threshold of Pcdh activity. In the cerebellum, Pcdhas and Pcdhgs also act synergistically to mediate self-avoidance of Purkinje cell dendrites, with modest but significant defects in either single mutant and dramatic defects in the double mutant. Together, our results demonstrate complex patterns of redundancy between Pcdh clusters and the importance of Pcdh cluster diversity in postnatal CNS development.<b>SIGNIFICANCE STATEMENT</b>The formation of neural circuits requires diversification and combinatorial actions of cell surface proteins. Prominent among them are the clustered Protocadherins (Pcdhs), a family of ∼60 neuronal recognition molecules. Pcdhs are encoded by three closely-linked gene clusters called<i>Pcdh-alpha</i>,<i>-beta</i>and -<i>gamma</i>The Pcdhs mediate a variety of developmental processes including neuronal survival, synaptic maintenance, and spatial patterning of axons and dendrites. Most studies to date have been limited to single clusters. Here we use genome editing to assess interactions between<i>Pcdh-alpha</i>and<i>-gamma</i>gene clusters. We examine two regions of the central nervous system, the retina and cerebellum, and show that the 14 alpha- and 22 gamma-Pcdhs act synergistically to mediate neuronal survival and dendrite patterning.</AbstractText><CopyrightInformation>Copyright © 2018 the authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ing-Esteves</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Program for Neuroscience and Mental Health, Hospital for Sick Children; Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 0A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostadinov</LastName><ForeName>Dimitar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marocha</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Program for Neuroscience and Mental Health, Hospital for Sick Children; Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 0A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sing</LastName><ForeName>Anson D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Program for Neuroscience and Mental Health, Hospital for Sick Children; Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 0A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Kezia S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Program for Neuroscience and Mental Health, Hospital for Sick Children; Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 0A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laboulaye</LastName><ForeName>Mallory</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanes</LastName><ForeName>Joshua R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefebvre</LastName><ForeName>Julie L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Program for Neuroscience and Mental Health, Hospital for Sick Children; Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 0A4, Canada. julie.lefebvre@sickkids.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA 02138.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29439167</ArticleId><ArticleId IdType="pii">JNEUROSCI.3035-17.2018</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.3035-17.2018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29439141</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-4935</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>Bioscience reports</Title><ISOAbbreviation>Biosci. Rep.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9-Mediated Mosaic Mutation of<i>SRY</i>Gene Induces Hermaphroditism in Rabbits.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">BSR20171490</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1042/BSR20171490</ELocationID><Abstract><AbstractText>Hermaphroditism is a rare disorder that affects sexual development, resulting in individuals with both male and female sexual organs. Hermaphroditism is caused by anomalies in genes regulating sex determination, gonad development, or expression of hormones and their receptors during embryonic development during sexual differentiation.<i>SRY</i>is a sex-determination gene on the Y chromosome that is responsible for initiating male sex determination in mammals. In this study, we introduced CRISPR/Cas9-mediated mutations in the HMG region of the rabbit<i>SRY</i>As expected,<i>SRY</i>-mutant chimeric rabbits were diagnosed with hermaphroditism, characterized by possessing ovotestis, testis, ovary and uterus simultaneously. Histopathology analysis revealed that the testicular tissue was immature and lacked spermatogenic cells, while the ovarian portion appeared normal and displayed follicles at different stages. This is the first report of a rabbit hermaphroditism model generated by the CRISPR/Cas9 system. This novel rabbit model could advance our understanding of the pathogenesis of hermaphroditism, and identify novel therapies for human clinical treatment of hermaphroditism.</AbstractText><CopyrightInformation>©2018 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yuning</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin university, changchun, Arizona, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin university, changchun, Arizona, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Mingming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin university, changchun, Arizona, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin university, changchun, Arizona, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin university, changchun, Arizona, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jichao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin university, changchun, Arizona, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhanjun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun, China lizj_1998@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biosci Rep</MedlineTA><NlmUniqueID>8102797</NlmUniqueID><ISSNLinking>0144-8463</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">chimerism</Keyword><Keyword MajorTopicYN="N">hermaphrodite</Keyword><Keyword MajorTopicYN="N">rabbit</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29439141</ArticleId><ArticleId IdType="pii">BSR20171490</ArticleId><ArticleId IdType="doi">10.1042/BSR20171490</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29438979</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-3178</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>EMBO reports</Title><ISOAbbreviation>EMBO Rep.</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial tyrosyl-DNA phosphodiesterase 2 and its TDP2<sup>S</sup>short isoform.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e42139</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embr.201642139</ELocationID><Abstract><AbstractText>Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs abortive topoisomerase II cleavage complexes. Here, we identify a novel short isoform of TDP2 (TDP2<sup>S</sup>) expressed from an alternative transcription start site. TDP2<sup>S</sup>contains a mitochondrial targeting sequence, contributing to its enrichment in the mitochondria and cytosol, while full-length TDP2 contains a nuclear localization signal and the ubiquitin-associated domain in the N-terminus. Our study reveals that both TDP2 isoforms are present and active in the mitochondria. Comparison of isogenic wild-type (<i>WT</i>) and<i>TDP2</i>knockout (<i>TDP2</i><sup>-/-/-</sup>) DT40 cells shows that<i>TDP2</i><sup>-/-/-</sup>cells are hypersensitive to mitochondrial-targeted doxorubicin (mtDox), and that complementing<i>TDP2</i><sup>-/-/-</sup>cells with human<i>TDP2</i>restores resistance to mtDox. Furthermore, mtDox selectively depletes mitochondrial DNA in<i>TDP2</i><sup>-/-/-</sup>cells. Using CRISPR-engineered human cells expressing only the TDP2<sup>S</sup>isoform, we show that TDP2<sup>S</sup>also protects human cells against mtDox. Finally, lack of TDP2 in the mitochondria reduces the mitochondria transcription levels in two different human cell lines. In addition to identifying a novel TDP2<sup>S</sup>isoform, our report demonstrates the presence and importance of both TDP2 isoforms in the mitochondria.</AbstractText><CopyrightInformation>© 2018 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shar-Yin N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA shar-yin.huang@nih.gov pommier@nih.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalla Rosa</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaels</LastName><ForeName>Stephanie A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tulumello</LastName><ForeName>David V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agama</LastName><ForeName>Keli</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khiati</LastName><ForeName>Salim</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jean</LastName><ForeName>Sae Rin</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baechler</LastName><ForeName>Simone A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Factor</LastName><ForeName>Valentina M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varma</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murai</LastName><ForeName>Junko</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller Jenkins</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Shana O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pommier</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3108-0758</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA shar-yin.huang@nih.gov pommier@nih.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Rep</MedlineTA><NlmUniqueID>100963049</NlmUniqueID><ISSNLinking>1469-221X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mitochondrial DNA</Keyword><Keyword MajorTopicYN="N">topoisomerase</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29438979</ArticleId><ArticleId IdType="pii">embr.201642139</ArticleId><ArticleId IdType="doi">10.15252/embr.201642139</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29438517</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1567-1364</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>FEMS yeast research</Title><ISOAbbreviation>FEMS Yeast Res.</ISOAbbreviation></Journal><ArticleTitle>Genome editing in Kluyveromyces and Ogataea yeasts using a broad-host-range Cas9/gRNA co-expression plasmid.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/femsyr/foy012</ELocationID><Abstract><AbstractText>While CRISPR-Cas9-mediated genome editing has transformed yeast research, current plasmids and cassettes for Cas9 and guide-RNA expression are species specific. CRISPR tools that function in multiple yeast species could contribute to the intensifying research on non-conventional yeasts. A plasmid carrying a pangenomic origin of replication and two constitutive expression cassettes, for Cas9 and a ribozyme-flanked gRNAs was constructed. Its functionality was tested by analyzing inactivation of the ADE2 gene in four yeast species. In two Kluyveromyces species, near-perfect targeting ( ≥ 96%) and homologous repair (HR) was observed in at least 24% of transformants. In two Ogataea species, Ade- mutants were not observed directly after transformation, but prolonged incubation of transformed cells resulted in targeting efficiencies of 9 to 63% mediated by non-homologous end joining (NHEJ). In a O. parapolymorpha KU80 mutant, deletion of OpADE2 mediated by HR was achieved, albeit at low efficiencies ( &lt; 1%). Furthermore the expression of a dual polycistronic gRNA-array enabled simultaneous interruption of OpADE2 and OpYNR1 demonstrating flexibility of ribozyme-flanked gRNA design for multiplexing. While prevalence of NHEJ prevented HR-mediated editing in Ogataea, such targeted editing was possible in Kluyveromyces. This broad-host-range CRISPR/gRNA system may contribute to exploration of Cas9-mediated genome editing in other Saccharomycotina yeasts.</AbstractText><CopyrightInformation>© FEMS 2017.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Juergens</LastName><ForeName>Hannes</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629HZ Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varela</LastName><ForeName>Javier A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>School of Microbiology/Centre for Synthetic Biology and Biotechnology/Environmental Research Institute/APC Microbiome Institute, University College Cork, Cork T12 YN60, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>Arthur R Gorter</ForeName><Initials>ARG</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629HZ Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perli</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629HZ Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gast</LastName><ForeName>Veronica J M</ForeName><Initials>VJM</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629HZ Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyurchev</LastName><ForeName>Nikola Y</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629HZ Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajkumar</LastName><ForeName>Arun S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>School of Microbiology/Centre for Synthetic Biology and Biotechnology/Environmental Research Institute/APC Microbiome Institute, University College Cork, Cork T12 YN60, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mans</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629HZ Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pronk</LastName><ForeName>Jack T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629HZ Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrissey</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>School of Microbiology/Centre for Synthetic Biology and Biotechnology/Environmental Research Institute/APC Microbiome Institute, University College Cork, Cork T12 YN60, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daran</LastName><ForeName>Jean-Marc G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629HZ Delft, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>FEMS Yeast Res</MedlineTA><NlmUniqueID>101085384</NlmUniqueID><ISSNLinking>1567-1356</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9, ribozymes</Keyword><Keyword MajorTopicYN="N">Hansenula polymorpha</Keyword><Keyword MajorTopicYN="N">Kluyveromyces lactis</Keyword><Keyword MajorTopicYN="N">Kluyveromyces marxianus</Keyword><Keyword MajorTopicYN="N">Ogataea polymorpha</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29438517</ArticleId><ArticleId IdType="pii">4847887</ArticleId><ArticleId IdType="doi">10.1093/femsyr/foy012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29438503</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation></Journal><ArticleTitle>Lineage specific transcription factors and epigenetic regulators mediate TGFβ-dependent enhancer activation.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gky093</ELocationID><Abstract><AbstractText>During neurogenesis, dynamic developmental cues, transcription factors and histone modifying enzymes regulate the gene expression programs by modulating the activity of neural-specific enhancers. How transient developmental signals coordinate transcription factor recruitment to enhancers and to which extent chromatin modifiers contribute to enhancer activity is starting to be uncovered. Here, we take advantage of neural stem cells as a model to unravel the mechanisms underlying neural enhancer activation in response to the TGFβ signaling. Genome-wide experiments demonstrate that the proneural factor ASCL1 assists SMAD3 in the binding to a subset of enhancers. Once located at the enhancers, SMAD3 recruits the histone demethylase JMJD3 and the remodeling factor CHD8, creating the appropriate chromatin landscape to allow enhancer transcription and posterior gene activation. Finally, to analyze the phenotypical traits owed to cis-regulatory regions, we use CRISPR-Cas9 technology to demonstrate that the TGFβ-responsive Neurog2 enhancer is essential for proper neuronal polarization.</AbstractText><CopyrightInformation>© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fueyo</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Molecular Genomics. Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacobucci</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Genomics. Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappa</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Genomics. Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estarás</LastName><ForeName>Conchi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Molecular Genomics. Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lois</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vall d'Hebron Institute of Research (VHIR), Passeig de la Vall d'Hebron, 119; E-08035 Barcelona, Spain. Institut Català per la Recerca i Estudis Avançats (ICREA), Barcelona 08018, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicioso-Mantis</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Genomics. Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Molecular Genomics. Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz-Molina</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Molecular Medicine Cologne (CMMC), University of Cologne, Robert-Koch-Strasse 21, 50931 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>José Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Sevilla-Universidad Pablo de Olavide, Av. Americo Vespucio 41092 Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rada-Iglesias</LastName><ForeName>Álvaro</ForeName><Initials>Á</Initials><AffiliationInfo><Affiliation>Center for Molecular Medicine Cologne (CMMC), University of Cologne, Robert-Koch-Strasse 21, 50931 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Cruz</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Vall d'Hebron Institute of Research (VHIR), Passeig de la Vall d'Hebron, 119; E-08035 Barcelona, Spain. Institut Català per la Recerca i Estudis Avançats (ICREA), Barcelona 08018, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Balbás</LastName><ForeName>Marian A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Molecular Genomics. Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29438503</ArticleId><ArticleId IdType="pii">4846346</ArticleId><ArticleId IdType="doi">10.1093/nar/gky093</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29438445</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9 in Leishmania mexicana: A case study of LmxBTN1.</ArticleTitle><Pagination><MedlinePgn>e0192723</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0192723</ELocationID><Abstract><AbstractText>Leishmania parasites cause human cutaneous, mucocutaneous and visceral leishmaniasis. Several studies proposed involvement of certain genes in infectivity of these parasites based on differential mRNA expression data. Due to unusual gene expression mechanism, functions of such genes must be further validated experimentally. Here, we investigated a role of one of the putative virulence factors, LmxM.22.0010-encoded BTN1 (a protein involved in Batten disease in humans), in L. mexicana infectivity. Due to the incredible plasticity of the L. mexicana genome, we failed to obtain a complete knock-out of LmxM.22.0010 using conventional recombination-based approach even after ablating four alleles of this gene. To overcome this, we established a modified CRISPR-Cas9 system with genomic expression of Cas9 nuclease and gRNA. Application of this system allowed us to establish a complete BTN1 KO strain of L. mexicana. The mutant strain did not show any difference in growth kinetics and differentiation in vitro, as well as in the infectivity for insect vectors and mice hosts. Based on the whole-transcriptome profiling, LmxM.22.0010-encoded BTN1 was considered a putative factor of virulence in Leishmania. Our study suggests that ablation of LmxM.22.0010 does not influence L. mexicana infectivity and further illustrates importance of experimental validation of in silico-predicted virulence factors. Here we also describe the whole genome sequencing of the widely used model isolate L. mexicana M379 and report a modified CRISPR/Cas9 system suitable for complete KO of multi-copy genes in organisms with flexible genomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ishemgulova</LastName><ForeName>Aygul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biology Centre, Institute of Parasitology, Czech Academy of Sciences, České Budejovice (Budweis), Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hlaváčová</LastName><ForeName>Jana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majerová</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7701-5778</Identifier><AffiliationInfo><Affiliation>Department of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butenko</LastName><ForeName>Anzhelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biology Centre, Institute of Parasitology, Czech Academy of Sciences, České Budejovice (Budweis), Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukeš</LastName><ForeName>Julius</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biology Centre, Institute of Parasitology, Czech Academy of Sciences, České Budejovice (Budweis), Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of South Bohemia, Faculty of Sciences, České Budejovice (Budweis), Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Votýpka</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biology Centre, Institute of Parasitology, Czech Academy of Sciences, České Budejovice (Budweis), Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volf</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yurchenko</LastName><ForeName>Vyacheslav</ForeName><Initials>V</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4765-3263</Identifier><AffiliationInfo><Affiliation>Life Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biology Centre, Institute of Parasitology, Czech Academy of Sciences, České Budejovice (Budweis), Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Environmental Technologies, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1999 May;22(1):55-8</RefSource><PMID Version="1">10319861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>mSphere. 2017 Jan 18;2(1):</RefSource><PMID Version="1">28124028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Genom. 2015 Oct 30;1(4):e000033</RefSource><PMID Version="1">28348817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Microbiol. 2010 Dec;12(12):1765-79</RefSource><PMID Version="1">20636473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Syst Biol. 2012 May;61(3):539-42</RefSource><PMID Version="1">22357727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Folia Parasitol (Praha). 2016 May 18;63:null</RefSource><PMID Version="1">27311571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Model Mech. 2012 Mar;5(2):191-9</RefSource><PMID Version="1">22107873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Expr Purif. 2005 Jul;42(1):37-46</RefSource><PMID Version="1">15939291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2008 May 29;9:255</RefSource><PMID Version="1">18510761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasitology. 1994 Jan;108 ( Pt 1):1-9</RefSource><PMID Version="1">8152848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci Res. 2005 Mar 1;79(5):573-83</RefSource><PMID Version="1">15657902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2017 Jul 24;11(7):e0005782</RefSource><PMID Version="1">28742133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1999 Sep;93(6):599-611</RefSource><PMID Version="1">10707105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 2013 Jul;190(1):44-9</RefSource><PMID Version="1">23685343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Med. 2004 Sep;4(6):601-9</RefSource><PMID Version="1">15357211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1998 May 1;17(9):2619-28</RefSource><PMID Version="1">9564044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vector Ecol. 2011 Mar;36 Suppl 1:S1-9</RefSource><PMID Version="1">21366760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 2014 Nov;198(1):11-3</RefSource><PMID Version="1">25461484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15458-62</RefSource><PMID Version="1">14660799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Mar 19;32(5):1792-7</RefSource><PMID Version="1">15034147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2015 Mar 14;8:158</RefSource><PMID Version="1">25881258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2015 Oct 09;11(10):e1005186</RefSource><PMID Version="1">26452044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1975 Nov 5;98(3):503-17</RefSource><PMID Version="1">1195397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2015 Mar;31(3):100-8</RefSource><PMID Version="1">25638444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 1997 Sep;88(1-2):13-23</RefSource><PMID Version="1">9274863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(5):e35671</RefSource><PMID Version="1">22693548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2004 Mar;15(3):1313-23</RefSource><PMID Version="1">14699076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Eukaryot Microbiol. 2012 Nov-Dec;59(6):537-47</RefSource><PMID Version="1">22845426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasitology. 2002 May;124(Pt 5):495-507</RefSource><PMID Version="1">12049412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Entomol. 2008 Jan;45(1):133-8</RefSource><PMID Version="1">18283954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2014 Dec 30;6(1):e02097-14</RefSource><PMID Version="1">25550322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>R Soc Open Sci. 2017 May 3;4(5):170095</RefSource><PMID Version="1">28573017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(Database issue):D457-62</RefSource><PMID Version="1">19843604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Vet Entomol. 2013 Jun;27(2):123-47</RefSource><PMID Version="1">22924419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2014 Mar 3;588(5):783-8</RefSource><PMID Version="1">24492004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2015 Aug 28;11(8):e1005127</RefSource><PMID Version="1">26317207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Feb;40(3):1131-47</RefSource><PMID Version="1">21998295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2017 Oct 04;8:1940</RefSource><PMID Version="1">29046673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2015 Jul 21;6(4):e00861</RefSource><PMID Version="1">26199327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Apr 28;11(4):e0154101</RefSource><PMID Version="1">27123924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2016 Mar 03;10(3):e0004349</RefSource><PMID Version="1">26937644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>F1000Res. 2016 Sep 20;5:2350</RefSource><PMID Version="1">27703673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 2015 Jan;32(1):268-74</RefSource><PMID Version="1">25371430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2014 May 14;7:222</RefSource><PMID Version="1">24884857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2012 Dec 03;5:276</RefSource><PMID Version="1">23206339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Microbiol. 2015 Oct;17(10):1405-12</RefSource><PMID Version="1">25939677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Syst Biol. 2007 Aug;56(4):564-77</RefSource><PMID Version="1">17654362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 29;6:23704</RefSource><PMID Version="1">27021793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Apr 14;281(15):10273-80</RefSource><PMID Version="1">16423829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1994 Oct;14(10):6736-42</RefSource><PMID Version="1">7523857</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29438445</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0192723</ArticleId><ArticleId IdType="pii">PONE-D-18-02690</ArticleId><ArticleId IdType="pmc">PMC5811015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29438322</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>The Application of NHEJ-CRISPR/Cas9 and Cre-Lox System in the Generation of Bivalent Duck Enteritis Virus Vaccine against Avian Influenza Virus.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E81</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v10020081</ELocationID><Abstract><AbstractText>Duck-targeted vaccines to protect against avian influenza are critically needed to aid in influenza disease control efforts in regions where ducks are endemic for highly pathogenic avian influenza (HPAI). Duck enteritis virus (DEV) is a promising candidate viral vector for development of vaccines targeting ducks, owing to its large genome and narrow host range. The clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 system is a versatile gene-editing tool that has proven beneficial for gene modification and construction of recombinant DNA viral vectored vaccines. Currently, there are two commonly used methods for gene insertion: non-homologous end-joining (NHEJ) and homology-directed repair (HDR). Owing to its advantages in efficiency and independence from molecular requirements of the homologous arms, we utilized NHEJ-dependent CRISPR/Cas9 to insert the influenza hemagglutinin (HA) antigen expression cassette into the DEV genome. The insert was initially tagged with reporter green fluorescence protein (GFP), and a Cre-Lox system was later used to remove the<i>GFP</i>gene insert. Furthermore, a universal donor plasmid system was established by introducing double bait sequences that were independent of the viral genome. In summary, we provide proof of principle for generating recombinant DEV viral vectored vaccines against the influenza virus using an integrated NHEJ-CRISPR/Cas9 and Cre-Lox system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Pengxiang</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Pirbright Institute, Pirbright, Woking GU24 0NF, UK. pengxiang.chang@pirbright.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yongxiu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Pirbright Institute, Pirbright, Woking GU24 0NF, UK. yongxiu.yao@pirbright.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Shandong Binzhou Animal Science and Veterinary Medicine Academy, Binzhou 256600, Shandong, China. na.tang@pirbright.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadeyen</LastName><ForeName>Jean-Remy</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>The Pirbright Institute, Pirbright, Woking GU24 0NF, UK. jean-remy.sadeyen@pirbright.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sealy</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Pirbright Institute, Pirbright, Woking GU24 0NF, UK. joshua.sealy@pirbright.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clements</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Pirbright Institute, Pirbright, Woking GU24 0NF, UK. anabel.clements@pirbright.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhat</LastName><ForeName>Sushant</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1869-6176</Identifier><AffiliationInfo><Affiliation>The Pirbright Institute, Pirbright, Woking GU24 0NF, UK. sushant.bhat@pirbright.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munir</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Furness Building, Lancaster University, Bailrigg, Lancaster LA1 4YG, UK. Drmunir.muhammad@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bryant</LastName><ForeName>Juliet E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Laboratory of Emerging Pathogens, Fondation Mérieux, 69002 Lyon, France. jebryant13@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Munir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Pirbright Institute, Pirbright, Woking GU24 0NF, UK. munir.iqbal@pirbright.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Cre</Keyword><Keyword MajorTopicYN="N">Lox</Keyword><Keyword MajorTopicYN="N">NHEJ</Keyword><Keyword MajorTopicYN="N">duck enteritis virus</Keyword><Keyword MajorTopicYN="N">influenza</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29438322</ArticleId><ArticleId IdType="pii">v10020081</ArticleId><ArticleId IdType="doi">10.3390/v10020081</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29438257</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-7048</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Current opinion in hematology</Title><ISOAbbreviation>Curr. Opin. Hematol.</ISOAbbreviation></Journal><ArticleTitle>Recent insights into vascular development from studies in zebrafish.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/MOH.0000000000000420</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Zebrafish has provided a powerful platform to study vascular biology over the past 25 years, owing to their distinct advantages for imaging and genetic manipulation. In this review, we summarize recent progress in vascular biology with particular emphasis on vascular development in zebrafish.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">The advent of transcription activator-like effector nuclease and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 genome-editing technologies has dramatically facilitated reverse genetic approaches in zebrafish, as in other models. Here, we highlight recent studies on vascular development in zebrafish which mainly employed forward or reverse genetics combined with high-resolution imaging. These studies have advanced our understanding of diverse areas in vascular biology, including transcriptional regulation of endothelial cell differentiation, endothelial cell signaling during angiogenesis and lymphangiogenesis, vascular bed-specific developmental mechanisms, and perivascular cell recruitment.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">The unique attributes of the zebrafish model have allowed critical cellular and molecular insights into fundamental mechanisms of vascular development. Knowledge acquired through recent zebrafish work further advances our understanding of basic mechanisms underlying vascular morphogenesis, maintenance, and homeostasis. Ultimately, insights provided by the zebrafish model will help to understand the genetic, cellular, and molecular underpinnings of human vascular malformations and diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Ryota L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stainier</LastName><ForeName>Didier Y R</ForeName><Initials>DYR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Opin Hematol</MedlineTA><NlmUniqueID>9430802</NlmUniqueID><ISSNLinking>1065-6251</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29438257</ArticleId><ArticleId IdType="doi">10.1097/MOH.0000000000000420</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29438014</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1937-9145</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>516</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Science signaling</Title><ISOAbbreviation>Sci Signal</ISOAbbreviation></Journal><ArticleTitle>G protein-coupled receptors control the sensitivity of cells to the morphogen Sonic Hedgehog.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eaao5749</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/scisignal.aao5749</ELocationID><Abstract><AbstractText>The morphogen Sonic Hedgehog (SHH) patterns tissues during development by directing cell fates in a concentration-dependent manner. The SHH signal is transmitted across the membrane of target cells by the heptahelical transmembrane protein Smoothened (SMO), which activates the GLI family of transcription factors through a mechanism that is undefined in vertebrates. Using CRISPR-edited null alleles and small-molecule inhibitors, we systematically analyzed the epistatic interactions between SMO and three proteins implicated in SMO signaling: the heterotrimeric G protein subunit Gα<sub>S</sub>, the G protein-coupled receptor kinase 2 (GRK2), and the Gα<sub>S</sub>-coupled receptor GPR161. Our experiments uncovered a signaling mechanism that modifies the sensitivity of target cells to SHH and consequently changes the shape of the SHH dose-response curve. In both fibroblasts and spinal neural progenitors, the loss of GPR161, previously implicated as an inhibitor of basal SHH signaling, increased the sensitivity of target cells across the entire spectrum of SHH concentrations. Even in cells lacking GPR161, GRK2 was required for SHH signaling, and Gα<sub>s</sub>, which promotes the activation of protein Kinase A (PKA), antagonized SHH signaling. We propose that the sensitivity of target cells to Hedgehog morphogens, and the consequent effects on gene expression and differentiation outcomes, can be controlled by signals from G protein-coupled receptors that converge on Gα<sub>s</sub>and PKA.</AbstractText><CopyrightInformation>Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pusapati</LastName><ForeName>Ganesh V</ForeName><Initials>GV</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1406-2566</Identifier><AffiliationInfo><Affiliation>Departments of Medicine and Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Jennifer H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4573-3270</Identifier><AffiliationInfo><Affiliation>Departments of Medicine and Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Bhaven B</ForeName><Initials>BB</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1746-3277</Identifier><AffiliationInfo><Affiliation>Departments of Medicine and Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouti</LastName><ForeName>Mina</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7422-1605</Identifier><AffiliationInfo><Affiliation>The Francis Crick Institute, Midland Road, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagner</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5698-8191</Identifier><AffiliationInfo><Affiliation>The Francis Crick Institute, Midland Road, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sircar</LastName><ForeName>Ria</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9114-7432</Identifier><AffiliationInfo><Affiliation>Departments of Medicine and Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luchetti</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departments of Medicine and Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingham</LastName><ForeName>Philip W</ForeName><Initials>PW</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8224-9958</Identifier><AffiliationInfo><Affiliation>Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 639798, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Living Systems Institute, University of Exeter, Exeter EX4 4RJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briscoe</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1020-5240</Identifier><AffiliationInfo><Affiliation>The Francis Crick Institute, Midland Road, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohatgi</LastName><ForeName>Rajat</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7609-8858</Identifier><AffiliationInfo><Affiliation>Departments of Medicine and Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA. rrohatgi@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>DP2 GM105448</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112988</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM118082</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Signal</MedlineTA><NlmUniqueID>101465400</NlmUniqueID><ISSNLinking>1945-0877</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Feb 18;100(4):423-34</RefSource><PMID Version="1">10693759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12607-12</RefSource><PMID Version="1">16885213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Mar 11;286(10 ):8067-74</RefSource><PMID Version="1">21209076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jul 28;535(7613):517-522</RefSource><PMID Version="1">27437577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2013 Jan 14;23 (1):23-34</RefSource><PMID Version="1">23291299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2014 Nov 24;31(4):448-60</RefSource><PMID Version="1">25458012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Oct 13;437(7061):1018-21</RefSource><PMID Version="1">16136078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2010 Apr 1;24(7):670-82</RefSource><PMID Version="1">20360384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 2015 Aug;88(2):347-56</RefSource><PMID Version="1">26013542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2010 Sep 15;24(18):2054-67</RefSource><PMID Version="1">20844016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9067-72</RefSource><PMID Version="1">8799155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Genet Dev. 2013 Aug;23(4):423-8</RefSource><PMID Version="1">23725799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2004 Dec 24;306(5705):2257-60</RefSource><PMID Version="1">15618519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 2014 Apr;27:25-31</RefSource><PMID Version="1">24680427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Pharmacol Sci. 2012 Mar;33(3):154-64</RefSource><PMID Version="1">22277298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Biol. 2009 Aug;1(2):a002014</RefSource><PMID Version="1">20066087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 Sep 5;289(36):25262-75</RefSource><PMID Version="1">25049229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2015 Aug 1;128(15):2928-37</RefSource><PMID Version="1">26092933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Jul 20;317(5836):372-6</RefSource><PMID Version="1">17641202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2000 Oct;1(1):20-9</RefSource><PMID Version="1">11262869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Birth Defects Res A Clin Mol Teratol. 2015 Jan;103(1):12-9</RefSource><PMID Version="1">24917297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2006 Feb;10 (2):187-97</RefSource><PMID Version="1">16459298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2010 Oct 18;191(2):415-28</RefSource><PMID Version="1">20956384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Nov 29;450(7170):717-20</RefSource><PMID Version="1">18046410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2016 Oct 05;5:</RefSource><PMID Version="1">27705744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Jan 16;6(1):168-181</RefSource><PMID Version="1">24373970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2016 Mar 28;212(7):861-75</RefSource><PMID Version="1">27002170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2014 Mar 10;28(5):483-96</RefSource><PMID Version="1">24582806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2009 Aug 4;48(30):7325-33</RefSource><PMID Version="1">19715378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 2002 Feb;61(2):352-9</RefSource><PMID Version="1">11809860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Oct;26(20):7550-60</RefSource><PMID Version="1">16908539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Cell Dev Biol. 2011;27:513-37</RefSource><PMID Version="1">21801010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2012 Nov 13;23 (5):1006-19</RefSource><PMID Version="1">23153497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Aug 25;275(34):26322-7</RefSource><PMID Version="1">10835429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2011 Jun;9(6):e1001083</RefSource><PMID Version="1">21695114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1998;67:653-92</RefSource><PMID Version="1">9759500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13069-13074</RefSource><PMID Version="1">27799542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2008 Dec;19(12 ):5478-89</RefSource><PMID Version="1">18815277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2015 Mar 9;27(3):342-53</RefSource><PMID Version="1">25759020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2002 Nov 15;16(22):2865-78</RefSource><PMID Version="1">12435629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2014 Aug 26;12(8):e1001937</RefSource><PMID Version="1">25157815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2015 Jun;17 (6):793-803</RefSource><PMID Version="1">25961504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 2013 Mar;83(3):691-7</RefSource><PMID Version="1">23292797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2003 Apr;9(4):493-501</RefSource><PMID Version="1">12649500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Oct 23;326(5952):572-4</RefSource><PMID Version="1">19726788</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2014 Sep;20(9):1035-42</RefSource><PMID Version="1">25150496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Ther. 2012 Jan;133(1):40-69</RefSource><PMID Version="1">21903131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2011 Nov;138(22):4921-30</RefSource><PMID Version="1">22007132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Dec 18;456(7224):967-70</RefSource><PMID Version="1">18987629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2015 Mar 9;27(3):327-41</RefSource><PMID Version="1">25759019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jan 17;152(1-2):210-23</RefSource><PMID Version="1">23332756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2016 May;17 (5):739-52</RefSource><PMID Version="1">27113758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2003 Sep 25;40(1):81-95</RefSource><PMID Version="1">14527435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Feb 21;278(8):6050-8</RefSource><PMID Version="1">12427730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurooncol. 2013 Nov;115(2):161-8</RefSource><PMID Version="1">24026530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2013 Nov;19(11):1505-12</RefSource><PMID Version="1">24076664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 2011 Aug;80(2):294-303</RefSource><PMID Version="1">21596927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2011 Jan 15;71(2):435-44</RefSource><PMID Version="1">21123452</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>08</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29438014</ArticleId><ArticleId IdType="pii">11/516/eaao5749</ArticleId><ArticleId IdType="doi">10.1126/scisignal.aao5749</ArticleId><ArticleId IdType="pmc">PMC5828112</ArticleId><ArticleId IdType="mid">EMS76052</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29437974</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J. Virol.</ISOAbbreviation></Journal><ArticleTitle>HAVCR1 (CD365) and its mouse ortholog are functional hepatitis A virus (HAV) cellular receptors that mediate HAV infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">JVI.02065-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02065-17</ELocationID><Abstract><AbstractText>The Hepatitis A virus (HAV) cellular receptor 1 (HAVCR1), classified as CD365, was initially discovered as a HAV cellular receptor using an expression cloning strategy. Due to the lack of HAV receptor-negative replication-competent cells, it was not possible to fully prove that HAVCR1 was a functional HAV receptor. However, biochemistry, classical virology, and epidemiology studies further supported the functional role of HAVCR1 as a HAV receptor. Here, we show that an anti-HAVCR1 monoclonal antibody that protected African green monkey (AGMK) cells against HAV infection only partially protected monkey Vero E6 cells and human hepatoma Huh7 cells indicating that these two cell lines express alternative yet unidentified HAV receptors. Therefore, we focused our work on AGMK cells to further characterize the function of HAVCR1 as a HAV receptor. Advances in CRISPR/Cas9 technology allowed us to knock out HAVCR1 in AGMK cells. The resulting AGMK HAVCR1 KO cells lost susceptibility to HAV infection including HAV free viral particles (vpHAV) and exosomes purified from HAV-infected cells (exo-HAV). Transfection of HAVCR1 cDNA into AGMK HAVCR1 KO cells restored susceptibility to vpHAV and exo-HAV infection. Furthermore, transfection of the mouse ortholog of HAVCR1, mHavcr1, also restored the susceptibility of AGMK HAVCR1 KO cells to HAV infection. Taken together, our data clearly show that HAVCR1 and mHavcr1 are functional HAV receptors that mediate HAV infection. This work paves the way for the identification of alternative HAV receptors to gain a complete understanding of their interplay with HAVCR1 in the cell entry and pathogenic processes of HAV.<b>IMPORTANCE</b>HAVCR1, a HAV receptor, is expressed in different cell types including regulatory immune cells and antigen presenting cells. How HAV evades the immune response during a long incubation period of up to 4 weeks and the mechanism by which the subsequent necroinflammatory process clears the infection remain a puzzle that most likely involves the HAV-HAVCR1 interaction. Based on negative data, a recent paper from the Lemon and Maury laboratories (1) suggested that HAVCR1 is neither a functional HAV receptor nor required for HAV infection. However, our data based on regain of HAV-receptors function in HAVCR1 knockout cells transfected with the HAVCR1 cDNA disagree with their findings. Our positive data show conclusively that HAVCR1 is indeed a functional HAV receptor and lays the ground for the identification of alternative HAV receptors and how they interact with HAVCR1 in cell entry and pathogenesis of HAV.</AbstractText><CopyrightInformation>This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Costafreda</LastName><ForeName>Maria Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA gerardo.kaplan@fda.hhs.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29437974</ArticleId><ArticleId IdType="pii">JVI.02065-17</ArticleId><ArticleId IdType="doi">10.1128/JVI.02065-17</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29437875</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-009X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>02</Day></PubDate></JournalIssue><Title>Drug metabolism and disposition: the biological fate of chemicals</Title><ISOAbbreviation>Drug Metab. Dispos.</ISOAbbreviation></Journal><ArticleTitle>Inter-individual Differences in the Expression of ABC and SLC Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human<i>ABCC3</i>(MRP3) Gene.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dmd.117.079061</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1124/dmd.117.079061</ELocationID><Abstract><AbstractText>The identification of drug transporters expressed in human skin and inter-individual differences in gene expression are important for understanding the role of drug transporters in human skin. In the present study, we evaluated the expression of ABC and SLC transporters using human skin tissues. In skin samples, ABCC3 was expressed at the highest levels, followed by SLCO3A1, SLC22A3, SLC16A7, ABCA2, ABCC1, and SLCO2B1. Among the quantitated transporters, ABCC3 accounted for 20.0% of the total mean transporter mRNA content. The expression of ABCC3 mRNA showed large inter-individual variability (9.5-fold). None of the SNPs tested (-1767G&gt;A, - 1328G&gt;A, - 1213C&gt;G, - 897delC, - 260T&gt;A, and - 211C&gt;T) in the promoter region of the<i>ABCC3</i>gene showed a significant change in ABCC3 mRNA levels. ABCC3 expression levels negatively correlated with the methylation status of the CpG island (CGI) located approximately 10 kbp upstream of<i>ABCC3</i>(<i>Rs</i>: - 0.323,<i>P</i>&lt; 0.05). The reporter gene assay revealed a significant increase in transcriptional activity in the presence of CGI. ABCC3 mRNA was up-regulated in HaCaT cells by the demethylating agent 5-aza-2'-deoxycytidine. Furthermore, the deletion of the region surrounding CGI using the CRISPR/Cas9 system resulted in significantly lower ABCC3 mRNA levels than those in control clones in HaCaT cells. We herein demonstrated that large inter-individual differences in the expression of drug transporters in human skin. CGI may function as an enhancer of the transcription of<i>ABCC3</i>and methylation levels in CGI contribute to the variability of<i>ABCC3</i>expression in human skin.</AbstractText><CopyrightInformation>The American Society for Pharmacology and Experimental Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takechi</LastName><ForeName>Tomoki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kyushu University and Maruho Co., Ltd.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirota</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kyushu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakai</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kyushu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Natsumi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Kyushu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kyushu University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ieiri</LastName><ForeName>Ichiro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Kyushu University ieiri-ttr@umin.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Drug Metab Dispos</MedlineTA><NlmUniqueID>9421550</NlmUniqueID><ISSNLinking>0090-9556</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">efflux transporters (P-gp, BCRP, MRP, MATE, BSEP, etc)</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">gene regulation/transcription</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29437875</ArticleId><ArticleId IdType="pii">dmd.117.079061</ArticleId><ArticleId IdType="doi">10.1124/dmd.117.079061</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29437254</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-3673</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of leukocyte biology</Title><ISOAbbreviation>J. Leukoc. Biol.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/JLB.3MIA0917-352R</ELocationID><Abstract><AbstractText>The IFN-stimulated gene ubiquitin-specific proteinase 18 (USP18) encodes a protein that negatively regulates T1 IFN signaling via stearic inhibition of JAK1 recruitment to the IFN-α receptor 2 subunit (IFNAR2). Here, we demonstrate that USP18 expression is induced by HIV-1 in a T1 IFN-dependent manner. Experimental depletion of USP18 by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene editing results in a significant restriction of HIV-1 replication in an induced pluripotent stem cell (iPSC)-derived macrophage model. In the absence of USP18, macrophages have increased responsiveness to stimulation with T1 IFNs with prolonged phosphorylation of STAT1 and STAT2 and increased expression of IFN-stimulated genes that are key for antiviral responses. Interestingly, HIV-1 requires some signaling through the T1 IFN receptor to replicate efficiently because a neutralizing antibody that inhibits T1 IFN activity reduces HIV-1 replication rate in monocyte-derived macrophages. USP18 induction by HIV-1 tunes the IFN response to optimal levels allowing for efficient transcription from the HIV-1 LTR promoter while minimizing the T1 IFN-induced antiviral response that would otherwise restrict viral replication and spread. Finally, iPSC and CRISPR/Cas9 gene targeting offer a powerful tool to study host factors that regulate innate immune responses.</AbstractText><CopyrightInformation>©2018 Society for Leukocyte Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Jared P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7700-530X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Immunology &amp; Laboratory Medicine, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cash</LastName><ForeName>Melanie N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology &amp; Laboratory Medicine, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santostefano</LastName><ForeName>Katherine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology &amp; Laboratory Medicine, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cellular Reprogramming, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakanishi</LastName><ForeName>Mahito</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Center for Stem Cell Engineering, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terada</LastName><ForeName>Naohiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology &amp; Laboratory Medicine, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cellular Reprogramming, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallet</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology &amp; Laboratory Medicine, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Leukoc Biol</MedlineTA><NlmUniqueID>8405628</NlmUniqueID><ISSNLinking>0741-5400</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">IFN</Keyword><Keyword MajorTopicYN="N">Jak/STAT</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29437254</ArticleId><ArticleId IdType="doi">10.1002/JLB.3MIA0917-352R</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29437009</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-5666</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Current molecular medicine</Title><ISOAbbreviation>Curr. Mol. Med.</ISOAbbreviation></Journal><ArticleTitle>The bHLH protein Nulp1 is essential for femur development via acting as a cofactor in Wnt signaling in Drosophila.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.2174/1566524018666180212145714</ELocationID><Abstract><AbstractText>The basic helix-loop-helix (bHLH) protein families are a large class of transcription factors, which are associated with cell proliferation, tissue differentiation, and other important development process. We reported that the Nuclear localized protein-1 (Nulp1) might act as a novel bHLH transcriptional factor to mediate cellular functions. However, its role in development in vivo remains unknown. Here we show that Drosophila Nulp1 (dNulp1) mutants, generated by CRISPR/Cas9 targeting the Domain of Unknown Function (DUF654) in its C terminal, are partially homozygous lethal and the rare escapers have bent femurs, which are similar to the major manifestation of congenital bent-bone dysplasia in human Stuve-Weidemann syndrome. The fly phenotype can be rescued by dNulp1 over-expression, indicating that dNulp1 is essential for fly femur development and survival. Moreover, dNulp1 overexpression suppresses the notch wing phenotype caused by the overexpression of sgg/GSK3β, an inhibitor of the canonical Wnt cascade. Furthermore, qRT-PCR analyses show that seven target genes positively regulated by Wg signaling pathway are down-regulated in response to dNulp1 knockout, while two negatively regulated wg targets are up-regulated in dNulp1 mutants. Finally, dNulp1 overexpression significantly activates the Top-Flash Wnt signaling reporter. We conclude that bHLH protein dNulp1, is essential for femur development and survival in Drosophila by acting as a positive cofactor in Wnt/Wingless signaling.</AbstractText><CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Q</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510100. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha, 410013. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510100. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510100. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zha</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodmer</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Development, Aging and Regeneration Program, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA 92037. United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ocorr</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Development, Aging and Regeneration Program, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA 92037. United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510100. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Center for Heart Development, State Key Laboratory of Development Biology, Key Laboratory of MOE for Development Biology and Protein Chemistry, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Mol Med</MedlineTA><NlmUniqueID>101093076</NlmUniqueID><ISSNLinking>1566-5240</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N"/></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29437009</ArticleId><ArticleId IdType="pii">CMM-EPUB-88487</ArticleId><ArticleId IdType="doi">10.2174/1566524018666180212145714</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29436783</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1860-7314</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Biotechnology journal</Title><ISOAbbreviation>Biotechnol J</ISOAbbreviation></Journal><ArticleTitle>Advancing Metabolic Engineering of Saccharomyces cerevisiae using the CRISPR/Cas System.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/biot.201700601</ELocationID><Abstract><AbstractText>Thanks to its ease of use, modularity, and scalability, the clustered regularly interspaced short palindromic repeats (CRISPR) system has been increasingly used in the design and engineering of Saccharomyces cerevisiae, one of the most popular hosts for industrial biotechnology. This review summarizes the recent development of this disruptive technology for metabolic engineering applications, including CRISPR-mediated gene knock-out and knock-in as well as transcriptional activation and interference. More importantly, multi-functional CRISPR systems that combine both gain- and loss-of-function modulations for combinatorial metabolic engineering are highlighted.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lian</LastName><ForeName>Jiazhang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>HamediRad</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Chemistry, Biochemistry, and Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Biotechnol J</MedlineTA><NlmUniqueID>101265833</NlmUniqueID><ISSNLinking>1860-6768</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gene regulation</Keyword><Keyword MajorTopicYN="N">Genome engineering</Keyword><Keyword MajorTopicYN="N">Metabolic engineering</Keyword><Keyword MajorTopicYN="N">Saccharomyces cerevisiae</Keyword><Keyword MajorTopicYN="N">Synthetic biology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29436783</ArticleId><ArticleId IdType="doi">10.1002/biot.201700601</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29436709</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-4141</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>European journal of immunology</Title><ISOAbbreviation>Eur. J. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Fast and efficient genetic engineering of hematopoietic precursor cells for the study of dendritic cell migration.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/eji.201747358</ELocationID><Abstract><AbstractText>Estrogen inducible Hoxb8 leads to conditional immortalization of hematopoietic precursors. These cells can be cultured and infected with the CRISPR/Cas9 system for genome editing, circumventing resource consuming generation of mouse models. The resultant cells retain their ability to differentiate into migratory dendritic cells.</AbstractText><CopyrightInformation>© 2018 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leithner</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Science and Technology Austria, Am Campus 1, Klosterneuburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renkawitz</LastName><ForeName>Joerg</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Science and Technology Austria, Am Campus 1, Klosterneuburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Vries</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Science and Technology Austria, Am Campus 1, Klosterneuburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauschild</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Science and Technology Austria, Am Campus 1, Klosterneuburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Häcker</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sixt</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Science and Technology Austria, Am Campus 1, Klosterneuburg, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Immunol</MedlineTA><NlmUniqueID>1273201</NlmUniqueID><ISSNLinking>0014-2980</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CCL19</Keyword><Keyword MajorTopicYN="N">CCR7</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Cell migration</Keyword><Keyword MajorTopicYN="N">Genome editing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29436709</ArticleId><ArticleId IdType="doi">10.1002/eji.201747358</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29436394</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-9538</ISSN><JournalIssue CitedMedium="Internet"><Volume>215</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>The Journal of experimental medicine</Title><ISOAbbreviation>J. Exp. Med.</ISOAbbreviation></Journal><ArticleTitle>Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells.</ArticleTitle><Pagination><MedlinePgn>985-997</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1084/jem.20171626</ELocationID><Abstract><AbstractText>CRISPR (clustered, regularly interspaced, short palindromic repeats)/Cas9 (CRISPR-associated protein 9) has become the tool of choice for generating gene knockouts across a variety of species. The ability for efficient gene editing in primary T cells not only represents a valuable research tool to study gene function but also holds great promise for T cell-based immunotherapies, such as next-generation chimeric antigen receptor (CAR) T cells. Previous attempts to apply CRIPSR/Cas9 for gene editing in primary T cells have resulted in highly variable knockout efficiency and required T cell receptor (TCR) stimulation, thus largely precluding the study of genes involved in T cell activation or differentiation. Here, we describe an optimized approach for Cas9/RNP transfection of primary mouse and human T cells without TCR stimulation that results in near complete loss of target gene expression at the population level, mitigating the need for selection. We believe that this method will greatly extend the feasibly of target gene discovery and validation in primary T cells and simplify the gene editing process for next-generation immunotherapies.</AbstractText><CopyrightInformation>© 2018 Genentech.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seki</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cancer Immunology, Genentech, South San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutz</LastName><ForeName>Sascha</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2431-0938</Identifier><AffiliationInfo><Affiliation>Department of Cancer Immunology, Genentech, South San Francisco, CA saschar@gene.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Exp Med</MedlineTA><NlmUniqueID>2985109R</NlmUniqueID><ISSNLinking>0022-1007</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Mar 7;8(10 ):17002-17011</RefSource><PMID Version="1">28199983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2017 Jul 20;130(3):285-296</RefSource><PMID Version="1">28539325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2016;2016:5052369</RefSource><PMID Version="1">27057542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jan 28;6:20070</RefSource><PMID Version="1">26818188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2017 May 1;23 (9):2255-2266</RefSource><PMID Version="1">27815355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1999 Aug 15;163(4):1817-26</RefSource><PMID Version="1">10438914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Cell. 2017 Sep;8(9):634-643</RefSource><PMID Version="1">28434148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 2015 Aug;96(8):2381-93</RefSource><PMID Version="1">25854553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2017 Jan;27(1):154-157</RefSource><PMID Version="1">27910851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10437-42</RefSource><PMID Version="1">26216948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2014 Nov 6;15(5):643-52</RefSource><PMID Version="1">25517468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arthritis Res Ther. 2004;6(2):78-85</RefSource><PMID Version="1">15059269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1997 Jul 21;186(2):325-30</RefSource><PMID Version="1">9221762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8732-7</RefSource><PMID Version="1">11447288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Biotechnol. 2016 Jan 16;16:4</RefSource><PMID Version="1">26772810</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):957-63</RefSource><PMID Version="1">24076990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Sep;33(9):985-989</RefSource><PMID Version="1">26121415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Apr 7;7(1):737</RefSource><PMID Version="1">28389661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 9;159(2):440-55</RefSource><PMID Version="1">25263330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2008 Sep;38(9):2616-25</RefSource><PMID Version="1">18792414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Mar 2;543(7643):113-117</RefSource><PMID Version="1">28225754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Dec 26;9(12):e115987</RefSource><PMID Version="1">25541967</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29436394</ArticleId><ArticleId IdType="pii">jem.20171626</ArticleId><ArticleId IdType="doi">10.1084/jem.20171626</ArticleId><ArticleId IdType="pmc">PMC5839763</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29435650</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0878</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Cell and tissue research</Title><ISOAbbreviation>Cell Tissue Res.</ISOAbbreviation></Journal><ArticleTitle>Targeted knock-in of CreER<sup>T2</sup>in zebrafish using CRISPR/Cas9.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00441-018-2798-x</ELocationID><Abstract><AbstractText>New genome-editing approaches, such as the CRISPR/Cas system, have opened up great opportunities to insert or delete genes at targeted loci and have revolutionized genetics in model organisms like the zebrafish. The Cre-loxp recombination system is widely used to activate or inactivate genes with high spatial and temporal specificity. Using a CRISPR/Cas9-mediated knock-in strategy, we inserted a zebrafish codon-optimized CreER<sup>T2</sup>transgene at the otx2 gene locus to generate a conditional Cre-driver line. We chose otx2 as it is a patterning gene of the anterior neural plate that is expressed during early development. By knocking in CreER<sup>T2</sup>upstream of the endogenous ATG of otx2, we utilized this gene's native promoter and enhancer elements to perfectly match CreER<sup>T2</sup>and endogenous otx2 expression patterns. Next, by combining this novel driver line with a Cre-dependent reporter line, we show that only in the presence of tamoxifen can efficient Cre-loxp-mediated recombination be achieved in the anterior neural plate-derived tissues like the telencephalon, the eye and the optic tectum. Our results imply that the otx2:CreER<sup>T2</sup>transgenic fish will be a valuable tool for lineage tracing and conditional mutant studies in larval and adult zebrafish.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kesavan</LastName><ForeName>Gokul</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2828-1460</Identifier><AffiliationInfo><Affiliation>Center for Molecular and Cellular Bioengeneering (CMCB), DFG-Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Fetscherstr. 105, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammer</LastName><ForeName>Juliane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Molecular and Cellular Bioengeneering (CMCB), DFG-Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Fetscherstr. 105, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hans</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Molecular and Cellular Bioengeneering (CMCB), DFG-Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Fetscherstr. 105, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Molecular and Cellular Bioengeneering (CMCB), DFG-Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Fetscherstr. 105, 01307, Dresden, Germany. michael.brand@tu-dresden.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BR 1746/6-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country>United States</Country></Grant><Grant><GrantID>Post doctoral fellowship</GrantID><Agency>Vetenskapsrådet</Agency><Country>United States</Country></Grant><Grant><GrantID>Zf-BrainReg</GrantID><Agency>ERC advanced grant</Agency><Country>United States</Country></Grant><Grant><GrantID>ALTF 350-2011</GrantID><Agency>EMBO long-term fellowship</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Cell Tissue Res</MedlineTA><NlmUniqueID>0417625</NlmUniqueID><ISSNLinking>0302-766X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Cre-loxp recombination</Keyword><Keyword MajorTopicYN="N">CreER T2</Keyword><Keyword MajorTopicYN="N">Knock-in</Keyword><Keyword MajorTopicYN="N">Zebrafish</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29435650</ArticleId><ArticleId IdType="doi">10.1007/s00441-018-2798-x</ArticleId><ArticleId IdType="pii">10.1007/s00441-018-2798-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29435173</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>12</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes.</ArticleTitle><Pagination><MedlinePgn>5208-5215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.23730</ELocationID><Abstract><AbstractText>Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor that functions to attenuate T cell activation. In this study, we knocked out (KO) PD-1 in cytotoxic T lymphocytes (CTLs) using CRISPR-Cas9 system to evaluate its effect on the anti-tumor activity of the CTLs against multiple myeloma (MM). Results show that PD-1 KO CTLs facilitate apoptosis and caspase activation of the co-cultured MM cells and enhanced MM cell death by 36% compared with the control. PD-1 KO also increased TNF-α and IFN-γ secretion of the CTLs by 2.4 and 1.9-fold respectively. The effectiveness of PD-1 KO in enhancing anti-tumor activity of the CTLs was verified<i>in vivo</i>using mouse xenograft model. The xenografted mice treated with PD-1 KO CTLs demonstrated repressed MM tumor growth and prolonged survival compared with the control group. We conclude that CRISPR-Cas9 is an efficient system to knock out PD-1 from CTLs and PD-1 KO could significantly enhance the anti-tumor activity of CTLs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhilong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Oncology, Hebei Medical University Second Affiliated Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Surgery, Handan Central Hospital, Handan, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jinsheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Cangzhou Hospital of Traditional Chinese Medicine and Western Medicine Integrated Hebei, Cangzhou, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shaohui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Oncology, Hebei Medical University Third Affiliated Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Zexian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Oncology, Hebei University of Engineering Affiliated Hospital, Baoding, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Jianhui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery &amp; Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2004 Nov;5(11):897-907</RefSource><PMID Version="1">15520809</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2017 Jan 19;129(3):275-279</RefSource><PMID Version="1">27919908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 1996 May;8(5):765-72</RefSource><PMID Version="1">8671665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Jun 28;366(26):2443-54</RefSource><PMID Version="1">22658127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 2009 Sep;21(9):1065-77</RefSource><PMID Version="1">19651643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene Ther. 2012 Oct;19(10):959-66</RefSource><PMID Version="1">22113316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2006 Jul 15;119(2):317-27</RefSource><PMID Version="1">16482562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2011;29:235-71</RefSource><PMID Version="1">21219185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 2010 Aug;22(8):651-60</RefSource><PMID Version="1">20587542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Leukoc Biol. 2013 Jul;94(1):41-53</RefSource><PMID Version="1">23667165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2012 Mar 22;12(4):252-64</RefSource><PMID Version="1">22437870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2008 May 15;14(10):3044-51</RefSource><PMID Version="1">18483370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Aug;11(8):783-784</RefSource><PMID Version="1">25075903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2008;26:677-704</RefSource><PMID Version="1">18173375</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2013 Oct 15;19(20):5636-46</RefSource><PMID Version="1">23873688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2002 Nov 15;169(10):5538-45</RefSource><PMID Version="1">12421930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Jun 28;366(26):2455-65</RefSource><PMID Version="1">22658128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytometry B Clin Cytom. 2003 Nov;56(1):23-9</RefSource><PMID Version="1">14582134</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">PD-1</Keyword><Keyword MajorTopicYN="N">anti-tumor immunity</Keyword><Keyword MajorTopicYN="N">cytotoxic T lymphocyte</Keyword><Keyword MajorTopicYN="N">immune checkpoint</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST The authors declare that there is no conflicts of interest regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29435173</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.23730</ArticleId><ArticleId IdType="pii">23730</ArticleId><ArticleId IdType="pmc">PMC5797044</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29435024</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1792-1074</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Oncology letters</Title><ISOAbbreviation>Oncol Lett</ISOAbbreviation></Journal><ArticleTitle>Expression of EZH2 is associated with poor outcome in colorectal cancer.</ArticleTitle><Pagination><MedlinePgn>2953-2961</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/ol.2017.7647</ELocationID><Abstract><AbstractText>Enhancer of zeste homolog 2 (EZH2), the critical component of polycomb group protein family, has been demonstrated to be overexpressed in various types of human cancer, including hepatocellular carcinoma, breast, bladder and lung cancer. The mechanism of how EZH2 promotes oncogenesis has also been well studied. However, little is known about the role of EZH2 in colorectal cancer (CRC). The main purpose of the present study was to analyze the association between EZH2 expression and the clinicopathological features of CRC. Therefore, the mRNA and protein expression levels were analyzed in tumor tissues and adjacent non-cancerous tissues by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot analysis. The expression of EZH2 was demonstrated to be significantly increased in tumor tissues compared with adjacent noncancerous tissues, according to the results of western blot analysis and RT-qPCR in the majority of cases. Patients with low EZH2 expression had a longer overall survival rate compared with those with high EZH2 expression. An analysis of the association between clinicopathological features and EZH2 expression indicated that high EZH2 expression was significantly associated with tumor stage, tumor size, histological differentiation and lymph node metastasis. Multivariate analysis demonstrated that high EZH2 expression was an independent predictor of overall survival. In conclusion, to the best of our knowledge, the data presented in the present study is the first to indicate that EZH2 is upregulated in CRC and may serve as a predictor of poor outcome for patients with CRC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhuanpeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wanglin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Jianchang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Junbin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Huacui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Oncol Lett</MedlineTA><NlmUniqueID>101531236</NlmUniqueID><ISSNLinking>1792-1074</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):233-9</RefSource><PMID Version="1">23360965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Jan 20;469(7330):343-9</RefSource><PMID Version="1">21248841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):20980-5</RefSource><PMID Version="1">21078963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Lett. 2016 Apr;11(4):2583-2589</RefSource><PMID Version="1">27073521</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource><PMID Version="1">11846609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2011 Jan 18;19(1):86-100</RefSource><PMID Version="1">21215703</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Jan 10;24(2):268-73</RefSource><PMID Version="1">16330673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Jan 22;6:6051</RefSource><PMID Version="1">25609585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Aug 1;65(15):6910-8</RefSource><PMID Version="1">16061675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Jun 10;145(6):835-50</RefSource><PMID Version="1">21663790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11606-11</RefSource><PMID Version="1">14500907</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Onco Targets Ther. 2017 Jun 26;10 :3131-3144</RefSource><PMID Version="1">28706445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Dec 6;492(7427):108-12</RefSource><PMID Version="1">23051747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 May 30;121(22):4512-20</RefSource><PMID Version="1">23529930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Dec 26;109 (52):21360-5</RefSource><PMID Version="1">23236167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Oct 10;419(6907):624-9</RefSource><PMID Version="1">12374981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2002 May 1;94(9):2511-6</RefSource><PMID Version="1">12015777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2015 Nov;149(6):1425-37</RefSource><PMID Version="1">26253304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2013 Jan;63(1):11-30</RefSource><PMID Version="1">23335087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2010 Apr 21;102(8):538-46</RefSource><PMID Version="1">20357245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2008 Feb;214(2):295-300</RefSource><PMID Version="1">17786943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Feb 20;6(5):3136-46</RefSource><PMID Version="1">25605014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90</RefSource><PMID Version="1">21296855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2005 May 9;92 (9):1754-8</RefSource><PMID Version="1">15856046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Oct 15;22(20):5323-35</RefSource><PMID Version="1">14532106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 9;520(7546):239-42</RefSource><PMID Version="1">25629630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2012 Jan 10;3:623</RefSource><PMID Version="1">22233633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Med. 2005 Aug;16(2):349-53</RefSource><PMID Version="1">16012774</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clustered regularly interspaced short palindromic repeats</Keyword><Keyword MajorTopicYN="N">colorectal cancer</Keyword><Keyword MajorTopicYN="N">enhancer of zeste homolog</Keyword><Keyword MajorTopicYN="N">polycomb group protein</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29435024</ArticleId><ArticleId IdType="doi">10.3892/ol.2017.7647</ArticleId><ArticleId IdType="pii">OL-0-0-7647</ArticleId><ArticleId IdType="pmc">PMC5778885</ArticleId></ArticleIdList><?pmcsd?></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29434956</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1792-1074</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Oncology letters</Title><ISOAbbreviation>Oncol Lett</ISOAbbreviation></Journal><ArticleTitle>Dynamics of CRISPR/Cas9-mediated genomic editing of the<i>AXL</i>locus in hepatocellular carcinoma cells.</ArticleTitle><Pagination><MedlinePgn>2441-2450</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/ol.2017.7605</ELocationID><Abstract><AbstractText>Genomic editing using the CRISPR/Cas9 technology allows selective interference with gene expression. With this method, a multitude of haploid and diploid cells from different organisms have been employed to successfully generate knockouts of genes coding for proteins or small RNAs. Yet, cancer cells exhibiting an aberrant ploidy are considered to be less accessible to CRISPR/Cas9-mediated genomic editing, as amplifications of the targeted gene locus could hamper its effectiveness. Here we examined the suitability of CRISPR/Cas9 to knockout the receptor tyrosine kinase Axl in the human hepatoma cell lines HLF and SNU449. The genomic editing events were validated in two single cell clones each from putative HLF and SNU449 knockout cells (HLF-Axl<sup>-</sup>-1, HLF-Axl<sup>-</sup>-2, SNU449-Axl<sup>-</sup>-1, SNU449-Axl<sup>-</sup>-2). Sequence analysis of respective<i>AXL</i>loci revealed one to six editing events in each individual Axl<sup>-</sup>clone. The majority of insertions and deletions in the<i>AXL</i>gene at exon 7/8 resulted in a frameshift and thus a premature stop in the coding region. However, one genomic editing event led to an insertion of two amino acids resulting in an altered protein sequence rather than in a frameshift in the<i>AXL</i>locus of the SNU449-Axl<sup>-</sup>-1 cells. Notably, while no Axl protein expression could be detected by immunoblotting in all four cell clones, both expression of total Axl as well as release of soluble Axl into the supernatant was observed by ELISA in incompletely edited SNU449-Axl<sup>-</sup>-1 cells. Importantly, a comparative genomic hybridization array revealed comparable genomic changes in Axl knockout cells as well as in cells expressing Cas9 nickase without guide RNAs in SNU449 and HLF cells, indicating vast alterations in genomic DNA triggered by nickase. Together, these data show that the dynamics of CRISPR/Cas9 may cause incomplete editing events in cancer cell lines, as gene copy numbers vary based on genomic heterogeneity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scharf</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bierbaumer</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>Heidemarie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wittmann</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haider</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirker</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikulits</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Oncol Lett</MedlineTA><NlmUniqueID>101531236</NlmUniqueID><ISSNLinking>1792-1074</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Dec;24(12):2059-65</RefSource><PMID Version="1">25373145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2002 Oct;20(10):1006-10</RefSource><PMID Version="1">12244328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2015 May 21;58(4):575-85</RefSource><PMID Version="1">26000843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):233-240</RefSource><PMID Version="1">27699445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):233-9</RefSource><PMID Version="1">23360965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Naturae. 2014 Jul;6(3):19-40</RefSource><PMID Version="1">25349712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2015 Jul 15;137(2):385-394</RefSource><PMID Version="1">25529751</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2013 Jul;31(7):397-405</RefSource><PMID Version="1">23664777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2015 Mar;61(3):930-41</RefSource><PMID Version="1">25251599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(1):290-302</RefSource><PMID Version="1">21896617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2015 Jan;16(1):18-32</RefSource><PMID Version="1">25446316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Dec 16;42(22):e168</RefSource><PMID Version="1">25300484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Oncol. 2013 Dec 11;3:302</RefSource><PMID Version="1">24377086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2014 Sep 1;28(17):1859-72</RefSource><PMID Version="1">25184674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genet Cytogenet. 2003 Mar;141(2):128-37</RefSource><PMID Version="1">12606130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2011 Feb;29(2):143-8</RefSource><PMID Version="1">21179091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 Jul 11;4(1):220-8</RefSource><PMID Version="1">23827738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gan. 1975 Aug;66(4):385-92</RefSource><PMID Version="1">52570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Jan 12;168(1-2):150-158.e10</RefSource><PMID Version="1">28041849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2013 Jan;14(1):49-55</RefSource><PMID Version="1">23169466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2015 Aug 20;208:44-53</RefSource><PMID Version="1">26003884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Jun;24(6):1012-9</RefSource><PMID Version="1">24696461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):227-9</RefSource><PMID Version="1">23360964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7195-200</RefSource><PMID Version="1">12782788</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2016 Aug;6(8):900-13</RefSource><PMID Version="1">27260157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2016 Aug;6(8):914-29</RefSource><PMID Version="1">27260156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Aug;31(8):681-3</RefSource><PMID Version="1">23929336</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2004 Mar;3(3):145-9</RefSource><PMID Version="1">14980529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Dec 15;167(7):1829-1838.e9</RefSource><PMID Version="1">27984730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1983 Feb;47(2):233-44</RefSource><PMID Version="1">6572066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2008 Jun;47(6):2078-88</RefSource><PMID Version="1">18506893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Cell Biol. 2014 Feb;6(1):97-9</RefSource><PMID Version="1">24403564</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2016 Sep;17 (9):597-604</RefSource><PMID Version="1">27381243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr;41(7):4336-43</RefSource><PMID Version="1">23460208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">genomic editing</Keyword><Keyword MajorTopicYN="N">hepatocellular carcinoma cell lines</Keyword><Keyword MajorTopicYN="N">heterogeneity</Keyword><Keyword MajorTopicYN="N">polyploidy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29434956</ArticleId><ArticleId IdType="doi">10.3892/ol.2017.7605</ArticleId><ArticleId IdType="pii">OL-0-0-7605</ArticleId><ArticleId IdType="pmc">PMC5777348</ArticleId></ArticleIdList><?pmcsd?></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29434679</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1758-8340</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Therapeutic advances in medical oncology</Title><ISOAbbreviation>Ther Adv Med Oncol</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas9: a promising genetic engineering approach in cancer research.</ArticleTitle><Pagination><MedlinePgn>1758834018755089</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1758834018755089</ELocationID><Abstract><AbstractText>Bacteria and archaea possess adaptive immunity against foreign genetic materials through clustered regularly interspaced short palindromic repeat (CRISPR) systems. The discovery of this intriguing bacterial system heralded a revolutionary change in the field of medical science. The CRISPR and CRISPR-associated protein 9 (Cas9) based molecular mechanism has been applied to genome editing. This CRISPR-Cas9 technique is now able to mediate precise genetic corrections or disruptions in<i>in vitro</i>and<i>in vivo</i>environments. The accuracy and versatility of CRISPR-Cas have been capitalized upon in biological and medical research and bring new hope to cancer research. Cancer involves complex alterations and multiple mutations, translocations and chromosomal losses and gains. The ability to identify and correct such mutations is an important goal in cancer treatment. In the context of this complex cancer genomic landscape, there is a need for a simple and flexible genetic tool that can easily identify functional cancer driver genes within a comparatively short time. The CRISPR-Cas system shows promising potential for modeling, repairing and correcting genetic events in different types of cancer. This article reviews the concept of CRISPR-Cas, its application and related advantages in oncology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ratan</LastName><ForeName>Zubair Ahmed</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Khulna University of Engineering and Technology, Khulna, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Young-Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Sunchon National University, Suncheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haidere</LastName><ForeName>Mohammad Faisal</ForeName><Initials>MF</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2041-7087</Identifier><AffiliationInfo><Affiliation>Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Bhuiyan Mohammad Mahtab</ForeName><Initials>BMM</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Enam Medical College, Savar, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yusuf</LastName><ForeName>Md Abdullah</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Microbiology, National Institute of Neurosciences &amp; Hospital, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaman</LastName><ForeName>Sojib Bin</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jong-Hoon</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Physiology, College of Veterinary Medicine, Chonbuk National University, Iksan 54596, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banu</LastName><ForeName>Laila Anjuman</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka 1000, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jae Youl</ForeName><Initials>JY</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-8141-9927</Identifier><AffiliationInfo><Affiliation>Department of Genetic Engineering, Sungkyunkwan University, 2066 Seobu-ro, Suwon 16419, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Med Oncol</MedlineTA><NlmUniqueID>101510808</NlmUniqueID><ISSNLinking>1758-8340</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3945-50</RefSource><PMID Version="1">18308931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 May 22;54(4):698-710</RefSource><PMID Version="1">24837679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Ovarian Res. 2016 May 17;9(1):28</RefSource><PMID Version="1">27184254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jul;32(7):670-6</RefSource><PMID Version="1">24752079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Apr 4;12(4):393-4</RefSource><PMID Version="1">23561441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2011 Feb;77(2):510.e1-5</RefSource><PMID Version="1">21147498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cureus. 2017 Jun 9;9(6):e1325</RefSource><PMID Version="1">28690958</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2013 Dec 1;27(23):2602-14</RefSource><PMID Version="1">24298059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Dec 19;322(5909):1843-5</RefSource><PMID Version="1">19095942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 31;471(7340):602-7</RefSource><PMID Version="1">21455174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):230-2</RefSource><PMID Version="1">23360966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Apr 24;5:3728</RefSource><PMID Version="1">24759083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Sep;32(9):941-6</RefSource><PMID Version="1">24952903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Nov 20;9(4):1219-27</RefSource><PMID Version="1">25456124</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Mar 28;8(13):20881-20894</RefSource><PMID Version="1">28152509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2009 Jun;6(6):443-5</RefSource><PMID Version="1">19448642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Jun 11;6:7391</RefSource><PMID Version="1">26067104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Apr 15;11(4):e0153689</RefSource><PMID Version="1">27081855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Jun;33(6):661-7</RefSource><PMID Version="1">25961408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2016 Mar;16(2):308-10</RefSource><PMID Version="1">27345991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jun 30;6:29032</RefSource><PMID Version="1">27358011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2008 Feb;9(2):102-14</RefSource><PMID Version="1">18197166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2010 Nov;225(2):569-76</RefSource><PMID Version="1">20506188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Jul 18;487(7407):330-7</RefSource><PMID Version="1">22810696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Direct. 2006 Mar 16;1:7</RefSource><PMID Version="1">16545108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Scand J Soc Med. 1997 Jun;25(2):119-25</RefSource><PMID Version="1">9232722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2006;40:363-83</RefSource><PMID Version="1">16895466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2005 Aug;151(Pt 8):2551-61</RefSource><PMID Version="1">16079334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1992 May 1;256(5057):668-70</RefSource><PMID Version="1">1350108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Mar 4;144(5):646-74</RefSource><PMID Version="1">21376230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2017 Jun;16(6):387-399</RefSource><PMID Version="1">28337020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2010 Sep;11(9):636-46</RefSource><PMID Version="1">20717154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 8;163(2):506-19</RefSource><PMID Version="1">26451490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86</RefSource><PMID Version="1">22949671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96</RefSource><PMID Version="1">24556840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2009 Mar;155(Pt 3):733-40</RefSource><PMID Version="1">19246744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Nov 15;539(7630):479</RefSource><PMID Version="1">27882996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Med. 2014 Oct;16(10):741-50</RefSource><PMID Version="1">24784157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 May 29;137(5):835-48</RefSource><PMID Version="1">19490893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Oct 16;514(7522):380-4</RefSource><PMID Version="1">25119044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Onco Targets Ther. 2014 Dec 22;8:37-44</RefSource><PMID Version="1">25565864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Nov;39(21):9275-82</RefSource><PMID Version="1">21813460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2014 Aug 8;450(4):1422-6</RefSource><PMID Version="1">25044113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Apr;33(4):390-394</RefSource><PMID Version="1">25690852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15611-6</RefSource><PMID Version="1">17030793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2016 Jun 15;30(12 ):1470-80</RefSource><PMID Version="1">27340177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Mar 22;7(12 ):14125-42</RefSource><PMID Version="1">26871602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13982-7</RefSource><PMID Version="1">26508638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Mar;32(3):267-73</RefSource><PMID Version="1">24535568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1987 Dec;169(12):5429-33</RefSource><PMID Version="1">3316184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2002 May;2(5):342-50</RefSource><PMID Version="1">12044010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 1993 Aug;9(3):613-21</RefSource><PMID Version="1">8412707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Dec 18;516(7531):423-7</RefSource><PMID Version="1">25337876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jul 10;10 (7):e0132260</RefSource><PMID Version="1">26161782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Feb 7;8(6):9634-9646</RefSource><PMID Version="1">28038452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2015 Nov;230(11):2683-94</RefSource><PMID Version="1">25808524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2014 May 12;25(5):652-65</RefSource><PMID Version="1">24794707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Aug 15;321(5891):960-4</RefSource><PMID Version="1">18703739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Nov 4;468(7320):67-71</RefSource><PMID Version="1">21048762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Assay Drug Dev Technol. 2017 Apr;15(3):113-119</RefSource><PMID Version="1">28379727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cancer. 2016 Jun;2(6):313-324</RefSource><PMID Version="1">28603775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Mar;24(3):475-87</RefSource><PMID Version="1">26750397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2005 Mar;151(Pt 3):653-63</RefSource><PMID Version="1">15758212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-87</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2015 Jul 15;29(14):1576-85</RefSource><PMID Version="1">26178787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12029-33</RefSource><PMID Version="1">26310292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1992 Mar 15;52(6):1393-8</RefSource><PMID Version="1">1540947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 Jun;35(6):569-576</RefSource><PMID Version="1">28459449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Dec 18;516(7531):428-31</RefSource><PMID Version="1">25337879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Evol. 2005 Feb;60(2):174-82</RefSource><PMID Version="1">15791728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jul 18;154(2):442-51</RefSource><PMID Version="1">23849981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2005 Feb 2;293(5):615-7</RefSource><PMID Version="1">15687318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Jul 20;6(20):17865-6</RefSource><PMID Version="1">26203775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 23;159(3):647-61</RefSource><PMID Version="1">25307932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Med Insights Oncol. 2010 Dec 19;4:143-54</RefSource><PMID Version="1">21234295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Mar 2;543(7643):113-117</RefSource><PMID Version="1">28225754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Jul;35(7):6901-12</RefSource><PMID Version="1">24737584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Jul 1;11(13):4941-7</RefSource><PMID Version="1">16000593</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">medical research</Keyword></KeywordList><CoiStatement>Conflict of interest statement: The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29434679</ArticleId><ArticleId IdType="doi">10.1177/1758834018755089</ArticleId><ArticleId IdType="pii">10.1177_1758834018755089</ArticleId><ArticleId IdType="pmc">PMC5802696</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29434642</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1687-966X</ISSN><JournalIssue CitedMedium="Print"><Volume>2017</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Stem cells international</Title><ISOAbbreviation>Stem Cells Int</ISOAbbreviation></Journal><ArticleTitle>The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.</ArticleTitle><Pagination><MedlinePgn>8960236</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2017/8960236</ELocationID><Abstract><AbstractText>Genome-editing technology has emerged as a powerful method that enables the generation of genetically modified cells and organisms necessary to elucidate gene function and mechanisms of human diseases. The clustered regularly interspaced short palindromic repeats- (CRISPR-) associated 9 (Cas9) system has rapidly become one of the most popular approaches for genome editing in basic biomedical research over recent years because of its simplicity and adaptability. CRISPR/Cas9 genome editing has been used to correct DNA mutations ranging from a single base pair to large deletions in both<i>in vitro</i>and<i>in vivo</i>model systems. CRISPR/Cas9 has been used to increase the understanding of many aspects of cardiovascular disorders, including lipid metabolism, electrophysiology and genetic inheritance. The CRISPR/Cas9 technology has been proven to be effective in creating gene knockout (KO) or knockin in human cells and is particularly useful for editing induced pluripotent stem cells (iPSCs). Despite these progresses, some biological, technical, and ethical issues are limiting the therapeutic potential of genome editing in cardiovascular diseases. This review will focus on various applications of CRISPR/Cas9 genome editing in the cardiovascular field, for both disease research and the prospect of<i>in vivo</i>genome-editing therapies in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Motta</LastName><ForeName>Benedetta M</ForeName><Initials>BM</Initials><Identifier Source="ORCID">0000-0002-6681-2170</Identifier><AffiliationInfo><Affiliation>Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pramstaller</LastName><ForeName>Peter P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hicks</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossini</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stem Cells Int</MedlineTA><NlmUniqueID>101535822</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Trends Mol Med. 2015 Oct;21(10 ):609-21</RefSource><PMID Version="1">26432018</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fly (Austin). 2014;8(1):52-7</RefSource><PMID Version="1">24141137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5383-92</RefSource><PMID Version="1">25453094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Aug 24;548(7668):413-419</RefSource><PMID Version="1">28783728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2016 Dec;1866(2):197-207</RefSource><PMID Version="1">27641687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Lipidol. 2010 Oct;21(5):434-40</RefSource><PMID Version="1">20683327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2014 Nov 1;104(2):258-69</RefSource><PMID Version="1">25209314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2014 Aug 5;64(5):451-9</RefSource><PMID Version="1">25082577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Mar 6;370(10):901-10</RefSource><PMID Version="1">24597865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biotechnol. 2016 Jan;58(1):73-8</RefSource><PMID Version="1">26676479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cardiovasc Dev Dis. 2016 Jun;3(2):</RefSource><PMID Version="1">27335817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Cell Cardiol. 2011 Sep;51(3):288-98</RefSource><PMID Version="1">21723873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2014 Aug 15;115(5):488-92</RefSource><PMID Version="1">24916110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2013 Jul;31(7):397-405</RefSource><PMID Version="1">23664777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):230-2</RefSource><PMID Version="1">23360966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2015 Mar 23;32(6):756-64</RefSource><PMID Version="1">25752963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2015 Sep;33(9):2643-51</RefSource><PMID Version="1">26033645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Cardiol. 2012 Oct 26;4(10):288-95</RefSource><PMID Version="1">23110245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2006 Sep 29;313(5795):1922-7</RefSource><PMID Version="1">17008524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Feb 13;156(4):836-43</RefSource><PMID Version="1">24486104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Jun;12(6):535-40</RefSource><PMID Version="1">25867848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2013 Jan 29;2:e00471</RefSource><PMID Version="1">23386978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):543-8</RefSource><PMID Version="1">25803306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2012 Apr 18;4(130):130ra47</RefSource><PMID Version="1">22517884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2012 Sep;22(9):1775-89</RefSource><PMID Version="1">22955988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2014 Aug;15(8):541-55</RefSource><PMID Version="1">25022906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2015 Jan;16(1):18-32</RefSource><PMID Version="1">25446316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 9;520(7546):186-91</RefSource><PMID Version="1">25830891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2016 May;36(5):783-6</RefSource><PMID Version="1">26941020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Physiol. 2012 Jul 10;3:255</RefSource><PMID Version="1">22934012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2006 Feb 14;113(6):783-90</RefSource><PMID Version="1">16461811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 May 5;44(8):e75</RefSource><PMID Version="1">26740581</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2014 Jun 24;129(25 Suppl 2):S76-99</RefSource><PMID Version="1">24222015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1983 Aug;80(15):4709-13</RefSource><PMID Version="1">6308645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Int. 2013;2013:496501</RefSource><PMID Version="1">23766769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Virol. 2014 Nov;1(1):427-51</RefSource><PMID Version="1">26958729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Apr 2;141(1):142-53</RefSource><PMID Version="1">20371351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2005 Jun;6(6):507-12</RefSource><PMID Version="1">15931173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1972 Mar 3;175(4025):949-55</RefSource><PMID Version="1">5061866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 May;12 (5):401-403</RefSource><PMID Version="1">25775043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cardiol. 2017 Jan;14 (1):11-20</RefSource><PMID Version="1">27609628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1983 Jan;80(2):477-81</RefSource><PMID Version="1">6300847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2012 Feb;20(2):443-55</RefSource><PMID Version="1">22068425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2013 Mar 15;112(6):961-8</RefSource><PMID Version="1">23569105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2015 Oct 16;4:e09406</RefSource><PMID Version="1">26473617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Nov;41(20):9584-92</RefSource><PMID Version="1">23939622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2009 Jul;182(3):641-51</RefSource><PMID Version="1">19380480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genomics Hum Genet. 2016 Aug 31;17 :131-54</RefSource><PMID Version="1">27216776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2017 Jan 6;120(1):39-48</RefSource><PMID Version="1">27765793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47644</RefSource><PMID Version="1">23077655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Mar;24(3):564-9</RefSource><PMID Version="1">26449883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2013 Oct;23(10):1163-71</RefSource><PMID Version="1">23979020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2013 Sep 30;14(10):19774-81</RefSource><PMID Version="1">24084724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Feb;13(2):127-37</RefSource><PMID Version="1">26820547</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Sep 1;12(9):1385-90</RefSource><PMID Version="1">26299960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Aug 28;349(6251):982-6</RefSource><PMID Version="1">26315439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9591-6</RefSource><PMID Version="1">24927590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Assist Reprod Genet. 2016 May;33(5):581-588</RefSource><PMID Version="1">27052831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Coron Artery Dis. 2005 Feb;16(1):41-4</RefSource><PMID Version="1">15654199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Jun 6;12(6):656-68</RefSource><PMID Version="1">23746975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Dev Biol. 2009;53(8-10):1329-39</RefSource><PMID Version="1">19247935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2014 Oct;124(10):4154-61</RefSource><PMID Version="1">25271723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Jun;12(6):479</RefSource><PMID Version="1">26020497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1984 Jun 25;259(12):7842-9</RefSource><PMID Version="1">6203897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Rev. 2013 Dec;9(6):814-32</RefSource><PMID Version="1">23949886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Cell Biol. 2009 Sep;Chapter 19:Unit 19.12 19.12.1-17</RefSource><PMID Version="1">19731224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):538-42</RefSource><PMID Version="1">25798939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 Jul 11;4(1):220-8</RefSource><PMID Version="1">23827738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Biotechnol. 2011;2011:497841</RefSource><PMID Version="1">21403831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Dec 16;11(12 ):e0168486</RefSource><PMID Version="1">27992596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Mol Biol Transl Sci. 2014;124:65-91</RefSource><PMID Version="1">24751427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):551-3</RefSource><PMID Version="1">24681508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jul 23;523(7561):481-5</RefSource><PMID Version="1">26098369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 Aug 25;126(4):663-76</RefSource><PMID Version="1">16904174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2015 Feb;21(2):121-31</RefSource><PMID Version="1">25654603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Intern Med. 1995 Mar;237(3):229-39</RefSource><PMID Version="1">7891044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2012 Sep 11;60(11):990-1000</RefSource><PMID Version="1">22749309</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Ther. 2014 Mar;141(3):235-49</RefSource><PMID Version="1">24140081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2015 Apr 1;105(4):424-38</RefSource><PMID Version="1">25618410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2017 May 1;26(9):1670-1677</RefSource><PMID Version="1">28335032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2015 Jan 13;4(1):143-54</RefSource><PMID Version="1">25434822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2009 Mar;155(Pt 3):733-40</RefSource><PMID Version="1">19246744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Nov 15;539(7630):479</RefSource><PMID Version="1">27882996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 21;532(7599):289-90</RefSource><PMID Version="1">27111607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1993 May 14;260(5110):926-32</RefSource><PMID Version="1">8493530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2010 Oct 7;363(15):1397-409</RefSource><PMID Version="1">20660394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA Cardiol. 2017 Aug 1;2(8):914-919</RefSource><PMID Version="1">28614576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glob Heart. 2014 Mar;9(1):3-16</RefSource><PMID Version="1">25432106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2013 Jan;14(1):49-55</RefSource><PMID Version="1">23169466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Palliat Med. 2012;1(1):65-77</RefSource><PMID Version="1">22833840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Jun 12;510(7504):273-7</RefSource><PMID Version="1">24776797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genomics. 2015 Jun 16;9:10</RefSource><PMID Version="1">26076878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Dec 5;13(6):659-62</RefSource><PMID Version="1">24315440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2008 Jun 27;4(6):e1000110</RefSource><PMID Version="1">18584027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2013 Sep;195(1):289-91</RefSource><PMID Version="1">23833182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Cell. 2015 May;6(5):363-372</RefSource><PMID Version="1">25894090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):977-9</RefSource><PMID Version="1">23892898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 May 12;11(6):875-883</RefSource><PMID Version="1">25937281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2008 Feb;190(4):1401-12</RefSource><PMID Version="1">18065539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Dev. 2013 Jul 15;22(14):1991-2002</RefSource><PMID Version="1">23461462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):227-9</RefSource><PMID Version="1">23360964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1472-1479</RefSource><PMID Version="1">25838425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Genet. 2013 Apr 02;4:48</RefSource><PMID Version="1">23565119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 Dec 15;3:e04766</RefSource><PMID Version="1">25497837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Mar;24(3):430-46</RefSource><PMID Version="1">26755333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2008 Jan;5(1):16-8</RefSource><PMID Version="1">18165802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 1996 May 20;7(8):959-88</RefSource><PMID Version="1">8727509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2014 Oct;9(10):2493-512</RefSource><PMID Version="1">25255092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2002 Dec 13;298(5601):2188-90</RefSource><PMID Version="1">12481136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2008 Oct 1;7(10):1765-71</RefSource><PMID Version="1">18675941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2011 Jul 15;91(2):279-88</RefSource><PMID Version="1">21602174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Mar;32(3):267-73</RefSource><PMID Version="1">24535568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2014 Jun;20(6):616-23</RefSource><PMID Version="1">24813252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2012 May 25;110(11):1498-512</RefSource><PMID Version="1">22628574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Oct 5;550(7674):67-73</RefSource><PMID Version="1">28953884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Sep 25;513(7519):569-73</RefSource><PMID Version="1">25079318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2005 Apr;12 (4):304-12</RefSource><PMID Version="1">15778718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 May 19;473(7347):326-35</RefSource><PMID Version="1">21593865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genesis. 2015 Feb;53(2):225-36</RefSource><PMID Version="1">25378133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource><PMID Version="1">24584096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):400-3</RefSource><PMID Version="1">26721683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2180-96</RefSource><PMID Version="1">24136345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Oct;41(19):9049-61</RefSource><PMID Version="1">23907390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2009 Oct 13;120(15):1513-23</RefSource><PMID Version="1">19786631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Rev. 2015 Oct;11(5):774-87</RefSource><PMID Version="1">26059412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Sep 30;353(6307):1545-1549</RefSource><PMID Version="1">27708104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Nov;10(11):1116-21</RefSource><PMID Version="1">24076762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):957-63</RefSource><PMID Version="1">24076990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2014 Jul 3;15(1):27-30</RefSource><PMID Version="1">24996167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rev. 2016 Jul;96(3):1093-126</RefSource><PMID Version="1">27335446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2011 Aug;188(4):773-82</RefSource><PMID Version="1">21828278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2011 May;12(5):316-28</RefSource><PMID Version="1">21468099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2008 Sep;9(9):725-9</RefSource><PMID Version="1">18698329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2017 Mar 3;120(5):778-780</RefSource><PMID Version="1">28254802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Sep 5;345(6201):1184-1188</RefSource><PMID Version="1">25123483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):822-6</RefSource><PMID Version="1">23792628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Oct 27;10(10):e0141611</RefSource><PMID Version="1">26506092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Apr 7;7(1):737</RefSource><PMID Version="1">28389661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2002 Jul;161(3):1169-75</RefSource><PMID Version="1">12136019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Rev. 2017 Aug 9;117(15):9874-9906</RefSource><PMID Version="1">28640612</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2014 Apr;196(4):961-71</RefSource><PMID Version="1">24478335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Apr 15;6:24356</RefSource><PMID Version="1">27079678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2012 Jan 13;90(1):7-24</RefSource><PMID Version="1">22243964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jul 18;154(2):442-51</RefSource><PMID Version="1">23849981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1370-9</RefSource><PMID Version="1">23992847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2967-76</RefSource><PMID Version="1">25002478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2016 Apr 7;18(4):541-53</RefSource><PMID Version="1">26971820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):839-43</RefSource><PMID Version="1">23934178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cardiol. 2017 Jan 15;227:191-193</RefSource><PMID Version="1">27847153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2014 Jul 3;15(1):12-3</RefSource><PMID Version="1">24996165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2016 Mar 18;5(3):207-12</RefSource><PMID Version="1">26689101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2005 Aug;115(8):2018-24</RefSource><PMID Version="1">16075042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Feb 14;8:14454</RefSource><PMID Version="1">28195574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Nov 11;354(6313):769-773</RefSource><PMID Version="1">27708057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):338-43</RefSource><PMID Version="1">26719419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cardiol. 2017 Aug 15;241:379-386</RefSource><PMID Version="1">28377185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Aug 4;63(3):355-70</RefSource><PMID Version="1">27494557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 10;471(7337):230-4</RefSource><PMID Version="1">21307850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Sep 5;134(5):877-86</RefSource><PMID Version="1">18691744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2003 Mar;111(6):869-76</RefSource><PMID Version="1">12639993</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29434642</ArticleId><ArticleId IdType="doi">10.1155/2017/8960236</ArticleId><ArticleId IdType="pmc">PMC5757142</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29434619</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-8021</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in genetics</Title><ISOAbbreviation>Front Genet</ISOAbbreviation></Journal><ArticleTitle>From Bioengineering to CRISPR/Cas9 - A Personal Retrospective of 20 Years of Research in Programmable Genome Targeting.</ArticleTitle><Pagination><MedlinePgn>5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fgene.2018.00005</ELocationID><Abstract><AbstractText>Genome targeting of restriction enzymes and DNA methyltransferases has many important applications including genome and epigenome editing. 15-20 years ago, my group was involved in the development of approaches for programmable genome targeting, aiming to connect enzymes with an oligodeoxynucleotide (ODN), which could form a sequence-specific triple helix at the genomic target site. Importantly, the target site of such enzyme-ODN conjugate could be varied simply by altering the ODN sequence promising great applicative values. However, this approach was facing many problems including the preparation and purification of the enzyme-ODN conjugates, their efficient delivery into cells, slow kinetics of triple helix formation and the requirement of a poly-purine target site sequence. Hence, for several years genome and epigenome editing approaches mainly were based on Zinc fingers and TAL proteins as targeting devices. More recently, CRISPR/Cas systems were discovered, which use a bound RNA for genome targeting that forms an RNA/DNA duplex with one DNA strand of the target site. These systems combine all potential advantages of the once imagined enzyme-ODN conjugates and avoid all main disadvantageous. Consequently, the application of CRISPR/Cas in genome and epigenome editing has exploded in recent years. We can draw two important conclusions from this example of research history. First, evolution still is the better bioengineer than humans and, whenever tested in parallel, natural solutions outcompete engineered ones. Second, CRISPR/Cas system were discovered in pure, curiosity driven, basic research, highlighting that it is basic, bottom-up research paving the way for fundamental innovation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeltsch</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Genet</MedlineTA><NlmUniqueID>101560621</NlmUniqueID><ISSNLinking>1664-8021</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1995 May 9;34(18):6239-46</RefSource><PMID Version="1">7742329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biophys Biomol Struct. 2000;29:183-212</RefSource><PMID Version="1">10940247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antisense Res Dev. 1991 Fall;1(3):277-81</RefSource><PMID Version="1">1821648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Jun 2;435(7042):646-51</RefSource><PMID Version="1">15806097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2008 Jul 15;123(2):484-489</RefSource><PMID Version="1">18398839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(1):100-12</RefSource><PMID Version="1">17151075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Struct Biol. 1996 Jun;6(3):327-33</RefSource><PMID Version="1">8804836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Aug 27;162(5):1113-26</RefSource><PMID Version="1">26317473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome. 1989;31(1):413-21</RefSource><PMID Version="1">2687107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 31;471(7340):602-7</RefSource><PMID Version="1">21455174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2013 Jan 29;2:e00471</RefSource><PMID Version="1">23386978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Oct 26;33(18):5978-90</RefSource><PMID Version="1">16251401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6175-80</RefSource><PMID Version="1">8650239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 05;8(12):e82539</RefSource><PMID Version="1">24349308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5809-14</RefSource><PMID Version="1">18359850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2003 May;2(5):361-8</RefSource><PMID Version="1">12750739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Dec 15;63(24):8968-76</RefSource><PMID Version="1">14695215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 1992 Apr;10(4):132-6</RefSource><PMID Version="1">1374262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 1993 Dec 15;135(1-2):99-109</RefSource><PMID Version="1">8276285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2008 Jul;16(7):1200-1207</RefSource><PMID Version="1">28178480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Control Release. 2007 Nov 20;123(3):228-38</RefSource><PMID Version="1">17884225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 1993;16:107-200</RefSource><PMID Version="1">19082972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2005 Aug;23(8):967-73</RefSource><PMID Version="1">16082368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1991 May 10;252(5007):809-17</RefSource><PMID Version="1">2028256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Dec 14;33(22):7039-47</RefSource><PMID Version="1">16356926</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2001;70:313-40</RefSource><PMID Version="1">11395410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Biochem. 2002 Sep 12;3:27</RefSource><PMID Version="1">12323077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1997 Dec;17(4):376-8</RefSource><PMID Version="1">9398832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chembiochem. 2002 Apr 2;3(4):274-93</RefSource><PMID Version="1">11933228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Biotechnol. 2001 Dec;12(6):632-7</RefSource><PMID Version="1">11849947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2001 May 25;309(1):89-97</RefSource><PMID Version="1">11491304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Eng. 2000 Apr;13(4):275-81</RefSource><PMID Version="1">10810159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2002 Feb;20(2):135-41</RefSource><PMID Version="1">11821858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Mar;40(6):2623-38</RefSource><PMID Version="1">22135304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Eng. 1996 May;9(5):413-23</RefSource><PMID Version="1">8795041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 1996 Jul;14(7):235-8</RefSource><PMID Version="1">8771796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1361-6</RefSource><PMID Version="1">20080559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):957-63</RefSource><PMID Version="1">24076990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1998;283(1):59-69</RefSource><PMID Version="1">9761673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chembiochem. 2007 Jan 22;8(2):202-7</RefSource><PMID Version="1">17195251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1996 Sep 16;15(18):5104-11</RefSource><PMID Version="1">8890184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jul;42(12):7489-527</RefSource><PMID Version="1">24878924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2016 Feb;32(2):101-13</RefSource><PMID Version="1">26732754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biophys Biomol Struct. 1995;24:319-50</RefSource><PMID Version="1">7663120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2013 Feb 8;425(3):479-91</RefSource><PMID Version="1">23220192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 1998 Nov 15;258(1):184-91</RefSource><PMID Version="1">9851708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 1997 May 15;246(1):1-22</RefSource><PMID Version="1">9210460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">DNA methyltransferase</Keyword><Keyword MajorTopicYN="N">epigenome editing</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">restriction endonuclease</Keyword><Keyword MajorTopicYN="N">science funding</Keyword><Keyword MajorTopicYN="N">science policy</Keyword><Keyword MajorTopicYN="N">triple helix</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29434619</ArticleId><ArticleId IdType="doi">10.3389/fgene.2018.00005</ArticleId><ArticleId IdType="pmc">PMC5790776</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29434599</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-3224</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>RNA-Seq Analysis of IL-1B and IL-36 Responses in Epidermal Keratinocytes Identifies a Shared MyD88-Dependent Gene Signature.</ArticleTitle><Pagination><MedlinePgn>80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.00080</ELocationID><Abstract><AbstractText>IL-36 cytokines have recently emerged as mediators of inflammation in autoimmune conditions including psoriasis vulgaris (PsV) and generalized pustular psoriasis (GPP). This study used RNA-seq to profile the transcriptome of primary epidermal keratinocytes (KCs) treated with IL-1B, IL-36A, IL-36B, or IL-36G. We identified some early IL-1B-specific responses (8 h posttreatment), but nearly all late IL-1B responses were replicated by IL-36 cytokines (24 h posttreatment). Type I and II interferon genes exhibited time-dependent response patterns, with early induction (8 h) followed by no response or repression (24 h). Altogether, we identified 225 differentially expressed genes (DEGs) with shared responses to all 4 cytokines at both time points (8 and 24 h). These involved upregulation of ligands (<i>IL1A, IL1B</i>, and<i>IL36G</i>) and activating proteases (<i>CTSS</i>) but also upregulation of inhibitors such as<i>IL1RN</i>and<i>IL36RN</i>. Shared IL-1B/IL-36 DEGs overlapped significantly with genes altered in PsV and GPP skin lesions, as well as genes near GWAS loci linked to autoimmune and autoinflammatory diseases (e.g., PsV, psoriatic arthritis, inflammatory bowel disease, and primary biliary cholangitis). Inactivation of MyD88 adapter protein using CRISPR/Cas9 completely abolished expression responses of such DEGs to IL-1B and IL-36G stimulation. These results provide a global view of IL-1B and IL-36 expression responses in epidermal KCs with fine-scale characterization of time-dependent and cytokine-specific response patterns. Our findings support an important role for IL-1B and IL-36 in autoimmune or autoinflammatory conditions and show that MyD88 adaptor protein mediates shared IL-1B/IL-36 responses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swindell</LastName><ForeName>William R</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beamer</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarkar</LastName><ForeName>Mrinal K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loftus</LastName><ForeName>Shannon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fullmer</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Xianying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Case Western Reserve University, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoi</LastName><ForeName>Lam C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahlenberg</LastName><ForeName>Michelle J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudjonsson</LastName><ForeName>Johann E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 AR060802</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AR066337</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 AR063668</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR007197</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR069071</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR062546</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR071384</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Feb 15;186(4):2613-22</RefSource><PMID Version="1">21242515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Inflamm Bowel Dis. 2016 Feb;22(2):303-14</RefSource><PMID Version="1">26752465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2013 Jul 15;29(14):1830-1</RefSource><PMID Version="1">23740750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Jan 15;31(2):166-9</RefSource><PMID Version="1">25260700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2013 Dec 12;39(6):1003-18</RefSource><PMID Version="1">24332029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 2017 May;66(5):823-838</RefSource><PMID Version="1">26783184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2016 Oct 26;:null</RefSource><PMID Version="1">27783881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Feb 2;14 (4):708-722</RefSource><PMID Version="1">26776523</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2012 Nov;122(11):3965-76</RefSource><PMID Version="1">23064362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Nov 12;10 (11):e0138423</RefSource><PMID Version="1">26562662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Feb 15;31(4):608-9</RefSource><PMID Version="1">25677125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2016 Aug 1;214(3):464-74</RefSource><PMID Version="1">27389350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2010 Jan 1;26(1):139-40</RefSource><PMID Version="1">19910308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jan;41(Database issue):D165-70</RefSource><PMID Version="1">23180794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Allergy Clin Immunol. 2017 Dec;140(6):1545-1547</RefSource><PMID Version="1">28668225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2016 Nov;136(11):2251-2259</RefSource><PMID Version="1">27388993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2013 Apr 25;14(4):R36</RefSource><PMID Version="1">23618408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2015 Feb 15;16:45</RefSource><PMID Version="1">25887539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Huazhong Univ Sci Technolog Med Sci. 2013 Aug;33(4):594-9</RefSource><PMID Version="1">23904383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jan;43(Database issue):D1071-8</RefSource><PMID Version="1">25348409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jan;42(Database issue):D1001-6</RefSource><PMID Version="1">24316577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 09;8(12):e81415</RefSource><PMID Version="1">24349066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Rheum Dis. 2013 Sep 1;72(9):1569-74</RefSource><PMID Version="1">23268368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2016 Jun 17;7:955</RefSource><PMID Version="1">27379082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Allergy Clin Immunol. 2017 Jul;140(1):109-120</RefSource><PMID Version="1">28043870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2015 Dec 3;97(6):816-36</RefSource><PMID Version="1">26626624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013;3:1215</RefSource><PMID Version="1">23386971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Dermatol. 2010 Aug;19(8):e80-8</RefSource><PMID Version="1">19849712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Aug 15;25(16):2078-9</RefSource><PMID Version="1">19505943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1991 Apr;96(4):425-33</RefSource><PMID Version="1">1848877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2013 Nov;133(11):2514-2521</RefSource><PMID Version="1">23698098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Rheumatol. 2017 Mar;29(2):208-213</RefSource><PMID Version="1">27926540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Med. 2015 Aug 04;7(1):86</RefSource><PMID Version="1">26251673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mediators Inflamm. 2017;2017:8980534</RefSource><PMID Version="1">28611508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Allergy Clin Immunol. 2017 May;139(5):1423-1430</RefSource><PMID Version="1">28477721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2010;11(3):R25</RefSource><PMID Version="1">20196867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1999 May 21;451(2):142-6</RefSource><PMID Version="1">10371154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2015 Apr;135(4):1025-1032</RefSource><PMID Version="1">25525775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stat Appl Genet Mol Biol. 2004;3:Article3</RefSource><PMID Version="1">16646809</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Med. 2017 Mar 9;9(1):24</RefSource><PMID Version="1">28279190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Ther Pat. 2014 Apr;24(4):477-9</RefSource><PMID Version="1">24456078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2012 Jun 1;28(11):1530-2</RefSource><PMID Version="1">22539670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Dermatol. 2016 Aug;28(4):451-6</RefSource><PMID Version="1">27489427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2748-E2757</RefSource><PMID Version="1">28289191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Immunol. 2017 Dec;49:1-8</RefSource><PMID Version="1">28738209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Biol (Noisy-le-grand). 2016 Apr 30;62(4):31-4</RefSource><PMID Version="1">27188731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2012 Aug 15;28(16):2184-5</RefSource><PMID Version="1">22743226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2012 Mar 01;7(3):562-78</RefSource><PMID Version="1">22383036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Aug 18;365(7):620-8</RefSource><PMID Version="1">21848462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2000 Feb;20(4):1436-47</RefSource><PMID Version="1">10648628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med. 2013 Mar 18;11:73</RefSource><PMID Version="1">23497011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytokine. 2012 Oct;60(1):171-8</RefSource><PMID Version="1">22688014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Transl Med. 2015 Mar 19;4:13</RefSource><PMID Version="1">25883770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2007 Jan 15;23(2):257-8</RefSource><PMID Version="1">17098774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2015 Aug;181(2):230-8</RefSource><PMID Version="1">25902739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Apr 2;279(14):13677-88</RefSource><PMID Version="1">14734551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Syst Biol. 2006;2:2006.0015</RefSource><PMID Version="1">16738560</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2007 Feb 15;178(4):2229-40</RefSource><PMID Version="1">17277128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2007 Oct 29;204(11):2603-14</RefSource><PMID Version="1">17908936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Pharmacol. 2012 Aug;12(4):486-90</RefSource><PMID Version="1">22398321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2011 Dec;131(12):2428-37</RefSource><PMID Version="1">21881584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2011 Sep 9;89(3):432-7</RefSource><PMID Version="1">21839423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biostatistics. 2003 Apr;4(2):249-64</RefSource><PMID Version="1">12925520</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ETS1</Keyword><Keyword MajorTopicYN="N">IL-1</Keyword><Keyword MajorTopicYN="N">NF-kappaB</Keyword><Keyword MajorTopicYN="N">RNA-seq</Keyword><Keyword MajorTopicYN="N">epidermis</Keyword><Keyword MajorTopicYN="N">inflammatory bowel disease</Keyword><Keyword MajorTopicYN="N">keratinocytes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29434599</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2018.00080</ArticleId><ArticleId IdType="pmc">PMC5796909</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29433445</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2164</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>02</Month><Day>13</Day></PubDate></JournalIssue><Title>BMC genomics</Title><ISOAbbreviation>BMC Genomics</ISOAbbreviation></Journal><ArticleTitle>Comparative genomic analysis reveals the evolution and environmental adaptation strategies of vibrios.</ArticleTitle><Pagination><MedlinePgn>135</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12864-018-4531-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Vibrios are among the most diverse and ecologically important marine bacteria, which have evolved many characteristics and lifestyles to occupy various niches. The relationship between genome features and environmental adaptation strategies is an essential part for understanding the ecological functions of vibrios in the marine system. The advent of complete genome sequencing technology has provided an important method of examining the genetic characteristics of vibrios on the genomic level.</AbstractText><AbstractText Label="RESULTS">Two Vibrio genomes were sequenced and found to occupy many unique orthologues families which absent from the previously genes pool of the complete genomes of vibrios. Comparative genomics analysis found vibrios encompass a steady core-genome and tremendous pan-genome with substantial gene gain and horizontal gene transfer events in the evolutionary history. Evolutionary analysis based on the core-genome tree suggested that V. fischeri emerged ~ 385 million years ago, along with the occurrence of cephalopods and the flourish of fish. The relatively large genomes, the high number of 16S rRNA gene copies, and the presence of R-M systems and CRISPR system help vibrios live in various marine environments. Chitin-degrading related genes are carried in nearly all the Vibrio genomes. The number of chitinase genes in vibrios has been extremely expanded compared to which in the most recent ancestor of the genus. The chitinase A genes were estimated to have evolved along with the genus, and have undergone significant purifying selective force to conserve the ancestral state.</AbstractText><AbstractText Label="CONCLUSIONS">Vibrios have experienced extremely genome expansion events during their evolutionary history, allowing them to develop various functions to spread globally. Despite their close phylogenetic relationships, vibrios were found to have a tremendous pan-genome with a steady core-genome, which indicates the highly plastic genome of the genus. Additionally, the existence of various chitin-degrading related genes and the expansion of chitinase A in the genus demonstrate the importance of the chitin utilization for vibrios. Defensive systems in the Vibrio genomes may protect them from the invasion of external DNA. These genomic features investigated here provide a better knowledge of how the evolutionary process has forged Vibrio genomes to occupy various niches.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Heyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Marine Life Sciences, Ocean University of China, 5 Yushan Road, Qingdao, 266003, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Marine Life Sciences, Ocean University of China, 5 Yushan Road, Qingdao, 266003, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Marine Life Sciences, Ocean University of China, 5 Yushan Road, Qingdao, 266003, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Hua</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>College of Marine Life Sciences, Ocean University of China, 5 Yushan Road, Qingdao, 266003, People's Republic of China. xhzhang@ouc.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Marine Ecology and Environmental Science, Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266071, People's Republic of China. xhzhang@ouc.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Evolution &amp; Marine Biodiversity, Ocean University of China, Qingdao, 266003, People's Republic of China. xhzhang@ouc.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>41730530</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>41476112</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>41521064</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>41506154</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Genomics</MedlineTA><NlmUniqueID>100965258</NlmUniqueID><ISSNLinking>1471-2164</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2013 Dec 27;4:414</RefSource><PMID Version="1">24409173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 May 18;405(6784):299-304</RefSource><PMID Version="1">10830951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Aug 1;25(15):1972-3</RefSource><PMID Version="1">19505945</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2007 Nov;189(21):7932-6</RefSource><PMID Version="1">17704223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 1987 Jul;4(4):406-25</RefSource><PMID Version="1">3447015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2010 Aug 1;26(15):1910-2</RefSource><PMID Version="1">20551134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Feb 10;5:8365</RefSource><PMID Version="1">25666585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 1999 Oct;7(10):414-20</RefSource><PMID Version="1">10498950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2005 Dec 16;310(5755):1824-7</RefSource><PMID Version="1">16357262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 2013 Apr;30(4):772-80</RefSource><PMID Version="1">23329690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2009 Jan;5(1):e1000344</RefSource><PMID Version="1">19165319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2014 Mar 18;5:73</RefSource><PMID Version="1">24672511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Syst Evol Microbiol. 2007 Jan;57(Pt 1):81-91</RefSource><PMID Version="1">17220447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 May 26;106(21):8605-10</RefSource><PMID Version="1">19435847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2003 Sep;13(9):2178-89</RefSource><PMID Version="1">12952885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2000 Jul;66(7):3044-51</RefSource><PMID Version="1">10877804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2014 Apr 02;5:137</RefSource><PMID Version="1">24765090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Syst Evol Microbiol. 2014 Feb;64(Pt 2):346-51</RefSource><PMID Version="1">24505072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15909-14</RefSource><PMID Version="1">19805231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 1999 Dec 6;1473(1):108-22</RefSource><PMID Version="1">10580132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Nov 19;9(11):e112963</RefSource><PMID Version="1">25409509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 2007 Aug;24(8):1586-91</RefSource><PMID Version="1">17483113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioessays. 2011 Jan;33(1):43-51</RefSource><PMID Version="1">20979102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiol Mol Biol Rev. 2004 Sep;68(3):403-31, table of contents</RefSource><PMID Version="1">15353563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2010 Jun;4(6):777-83</RefSource><PMID Version="1">20200567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1996 Sep;178(17 ):5065-70</RefSource><PMID Version="1">8752320</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2004 Jul;70(7):4103-10</RefSource><PMID Version="1">15240289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2010 Jun 15;26(12):1481-7</RefSource><PMID Version="1">20439257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2011 Apr 12;2(2):null</RefSource><PMID Version="1">21486909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2011 Feb;5(2):274-84</RefSource><PMID Version="1">20703316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 1997 Feb;63(2):408-13</RefSource><PMID Version="1">16535505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2006 Mar 16;7:142</RefSource><PMID Version="1">16542435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Evol Biol. 2009 Oct 27;9:258</RefSource><PMID Version="1">19860885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 May 1;30(9):1312-3</RefSource><PMID Version="1">24451623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3160-5</RefSource><PMID Version="1">14973198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2008 Jan;74(1):44-51</RefSource><PMID Version="1">17933912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2005;39:121-52</RefSource><PMID Version="1">16285855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2005 May 1;21(9):2104-5</RefSource><PMID Version="1">15647292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Syst Bacteriol. 1995 Jan;45(1):139-44</RefSource><PMID Version="1">7531996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2000 Apr;66(4):1328-33</RefSource><PMID Version="1">10742207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1996 Dec 20;274(5295):2025-31</RefSource><PMID Version="1">8953025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol Rep. 2010 Feb;2(1):44-9</RefSource><PMID Version="1">23765997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 2016 Jul;33(7):1870-4</RefSource><PMID Version="1">27004904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2013 May 27;14(5):R47</RefSource><PMID Version="1">23710727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Syst Evol Microbiol. 2007 Dec;57(Pt 12):2823-9</RefSource><PMID Version="1">18048732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2003 Jan 22;19(2):301-2</RefSource><PMID Version="1">12538260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W52-7</RefSource><PMID Version="1">17537822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2010 Sep;8(9):623-33</RefSource><PMID Version="1">20676145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2013 Dec;79(24):7696-701</RefSource><PMID Version="1">24096415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Syst Bacteriol. 1992 Jan;42(1):58-63</RefSource><PMID Version="1">1371064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Microbiol. 2008 Oct;11(5):472-7</RefSource><PMID Version="1">19086349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2005 Aug 19;309(5738):1242-5</RefSource><PMID Version="1">16109880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2005 Apr;71(4):1811-5</RefSource><PMID Version="1">15812005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(9):3100-8</RefSource><PMID Version="1">17452365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 1998 Jan;15(1):6-16</RefSource><PMID Version="1">9491600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2002 May;12(5):669-71</RefSource><PMID Version="1">11997333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Biol Sci. 2017 Mar 15;284(1850):null</RefSource><PMID Version="1">28250188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):627-31</RefSource><PMID Version="1">14699052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1962 Apr;83:736-7</RefSource><PMID Version="1">13888946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Rev Mar Sci. 2010;2:305-31</RefSource><PMID Version="1">21141667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2006 Sep;4(9):697-704</RefSource><PMID Version="1">16894340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 2002 Jan;19(1):101-9</RefSource><PMID Version="1">11752195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1973 Jan;113(1):24-32</RefSource><PMID Version="1">4567138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Nov 4;468(7320):60-6</RefSource><PMID Version="1">21048761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2524-9</RefSource><PMID Version="1">14983042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2567-72</RefSource><PMID Version="1">15701695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Ecol. 2010 Dec;74(3):485-99</RefSource><PMID Version="1">20662928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 2006 Feb;23(2):254-67</RefSource><PMID Version="1">16221896</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2017 May;27(5):722-736</RefSource><PMID Version="1">28298431</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry (Mosc). 2015 Sep;80(9):1109-16</RefSource><PMID Version="1">26555464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol. 2014 Jun;16(6):1642-53</RefSource><PMID Version="1">25009843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W686-9</RefSource><PMID Version="1">15980563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13698-703</RefSource><PMID Version="1">22869754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carbohydr Res. 2002 Mar 15;337(6):557-9</RefSource><PMID Version="1">11890893</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Chitinase</Keyword><Keyword MajorTopicYN="Y">Comparative genomics</Keyword><Keyword MajorTopicYN="Y">Environmental adaptation</Keyword><Keyword MajorTopicYN="Y">Gene gain/loss</Keyword><Keyword MajorTopicYN="Y">Phylogeny</Keyword><Keyword MajorTopicYN="Y">Vibrio</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29433445</ArticleId><ArticleId IdType="doi">10.1186/s12864-018-4531-2</ArticleId><ArticleId IdType="pii">10.1186/s12864-018-4531-2</ArticleId><ArticleId IdType="pmc">PMC5809883</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29433437</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2164</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>02</Month><Day>13</Day></PubDate></JournalIssue><Title>BMC genomics</Title><ISOAbbreviation>BMC Genomics</ISOAbbreviation></Journal><ArticleTitle>Genomic insights into Staphylococcus equorum KS1039 as a potential starter culture for the fermentation of high-salt foods.</ArticleTitle><Pagination><MedlinePgn>136</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12864-018-4532-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Our previous comparative genomic analysis of Staphylococcus equorum KS1039 with five S. equorum strains illuminated the genomic basis of its safety and salt tolerance. However, a comprehensive picture of the cellular components and metabolic pathways involved in the degradation of macromolecules and development of sensory properties has not been obtained for S. equorum. Therefore, in this study, we examined the general metabolism of S. equorum based on information obtained from published complete genome sequences of six S. equorum strains isolated from different niches. Additionally, the utility of strain KS1039 as a starter culture for high-salt food fermentations was examined.</AbstractText><AbstractText Label="RESULTS">All six S. equorum strains contained genes involved in glycolysis, the tricarboxylic acid cycle, and amino acid metabolic pathways, as well as color development. Moreover, the strains had the potential to produce acetoin, butanediol, and branched chain fatty acids, all of which are important flavor compounds. None of the strains contained decarboxylase genes, which are required for histamine and tyramine production. Strain KS1039 contained bacteriocin and CRISPR/Cas gene clusters, and experimental results suggested that these genes were functional in vitro.</AbstractText><AbstractText Label="CONCLUSIONS">The comparative genomic analysis carried out herein provides important information on the usefulness of S. equorum KS1039 as a starter culture for the fermentation of high-salt foods in terms of safety, salt tolerance, bacteriocin production, and foreign plasmid restriction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong-Hoon</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Food Science and Biotechnology, Kyonggi University, Suwon, 16227, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heo</LastName><ForeName>Sojeong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Food Science and Biotechnology, Kyonggi University, Suwon, 16227, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food and Nutrition, Dongduk Women's University, Seoul, 02748, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Do-Won</ForeName><Initials>DW</Initials><Identifier Source="ORCID">0000-0001-6586-748X</Identifier><AffiliationInfo><Affiliation>Department of Food and Nutrition, Dongduk Women's University, Seoul, 02748, Republic of Korea. jeongdw@dongduk.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NRF-2016R1D1A1B01011421</GrantID><Agency>National Research Foundation of Korea</Agency><Country>International</Country></Grant><Grant><GrantID>NRF 2016R1D1A1B03930239</GrantID><Agency>National Research Foundation of Korea</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Genomics</MedlineTA><NlmUniqueID>100965258</NlmUniqueID><ISSNLinking>1471-2164</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2008 Jul;154(Pt 7):1989-97</RefSource><PMID Version="1">18599827</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2006 Apr 25;108(2):210-7</RefSource><PMID Version="1">16488037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2008 Sep 1;126(3):302-10</RefSource><PMID Version="1">17869361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Announc. 2013 Oct 17;1(5):null</RefSource><PMID Version="1">24136848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2014 Aug 18;185:121-6</RefSource><PMID Version="1">24960293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Dec 19;322(5909):1843-5</RefSource><PMID Version="1">19095942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Food Sci. 2015 Aug;80(8):M1794-803</RefSource><PMID Version="1">26147854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2003 Nov 15;88(1):41-54</RefSource><PMID Version="1">14527784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2016 Oct 18;7(5):</RefSource><PMID Version="1">27795388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Biotechnol. 2013 Oct 28;23(10):1428-33</RefSource><PMID Version="1">23851268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Microbiol. 2007 Mar;102(3):736-47</RefSource><PMID Version="1">17309623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Syst Evol Microbiol. 2007 Jan;57(Pt 1):81-91</RefSource><PMID Version="1">17220447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Agric Food Chem. 2011 Aug 10;59(15):8401-8</RefSource><PMID Version="1">21710980</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Meat Sci. 2004 May;67(1):149-58</RefSource><PMID Version="1">22061128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2012 Sep;194(18):5141-2</RefSource><PMID Version="1">22933766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2016 Feb 10;219:88-9</RefSource><PMID Version="1">26718562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8076-81</RefSource><PMID Version="1">26080436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Meat Sci. 1998;49S1:S125-38</RefSource><PMID Version="1">22060705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Meat Sci. 2007 May;76(1):138-46</RefSource><PMID Version="1">22064200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 1992 Mar 15;204(3):1149-54</RefSource><PMID Version="1">1551392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2008 Feb 08;9:75</RefSource><PMID Version="1">18261238</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Food Microbiol. 2011 Feb;28(1):101-13</RefSource><PMID Version="1">21056781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Nov;39(21):9275-82</RefSource><PMID Version="1">21813460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Res Microbiol. 2011 Dec;162(10):1052-9</RefSource><PMID Version="1">22019494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2001 Jan;69(1):159-69</RefSource><PMID Version="1">11119502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2002 May 5;75(1-2):99-109</RefSource><PMID Version="1">11999121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1997 Mar 21;275(5307):1796-800</RefSource><PMID Version="1">9065405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 Nov 25;139(5):945-56</RefSource><PMID Version="1">19945378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Syst Appl Microbiol. 2003 Mar;26(1):30-7</RefSource><PMID Version="1">12747407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Jul 14;7(1):5383</RefSource><PMID Version="1">28710456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 1996 Sep;142 ( Pt 9):2393-8</RefSource><PMID Version="1">21818877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2001 Jun 15;66(3):185-9</RefSource><PMID Version="1">11428577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Aug 15;321(5891):960-4</RefSource><PMID Version="1">18703739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 1998 Sep;64(9):3140-6</RefSource><PMID Version="1">9726851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 1991 Jul 15;103(1):101-5</RefSource><PMID Version="1">1652539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Microbiol. 2014 May;116(5):1084-93</RefSource><PMID Version="1">24443828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2006 Feb 15;106(3):270-85</RefSource><PMID Version="1">16213053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Microbiol. 2004;97(2):271-84</RefSource><PMID Version="1">15239693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antonie Van Leeuwenhoek. 2013 Dec;104(6):1049-62</RefSource><PMID Version="1">24057981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1999 Nov;181(21):6585-90</RefSource><PMID Version="1">10542157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Meat Sci. 2010 Nov;86(3):801-7</RefSource><PMID Version="1">20674188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2007 Oct;76(5):1161-71</RefSource><PMID Version="1">17701035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2014 Oct 1;188:108-15</RefSource><PMID Version="1">25106039</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bacteriocin</Keyword><Keyword MajorTopicYN="Y">CRISPR/Cas system</Keyword><Keyword MajorTopicYN="Y">Fermentation</Keyword><Keyword MajorTopicYN="Y">Jeotgal</Keyword><Keyword MajorTopicYN="Y">Staphylococcus equorum</Keyword><Keyword MajorTopicYN="Y">Starter</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29433437</ArticleId><ArticleId IdType="doi">10.1186/s12864-018-4532-1</ArticleId><ArticleId IdType="pii">10.1186/s12864-018-4532-1</ArticleId><ArticleId IdType="pmc">PMC5810056</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29433054</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0852</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>European journal of cancer (Oxford, England : 1990)</Title><ISOAbbreviation>Eur. J. Cancer</ISOAbbreviation></Journal><ArticleTitle>Hallmarks of cancer: The CRISPR generation.</ArticleTitle><Pagination><MedlinePgn>10-18</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0959-8049(18)30007-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejca.2018.01.002</ELocationID><Abstract><AbstractText>The hallmarks of cancer were proposed as a logical framework to guide research efforts that aim to understand the molecular mechanisms and derive treatments for this highly complex disease. Recent technological advances, including comprehensive sequencing of different cancer subtypes, have illuminated how genetic and epigenetic alterations are associated with specific hallmarks of cancer. However, as these associations are purely descriptive, one particularly exciting development is the emergence of genome editing technologies, which enable rapid generation of precise genetic and epigenetic modifications to assess the consequences of these perturbations on the cancer phenotype. The most recently developed of these tools, the system of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), consists of an RNA-guided endonuclease that can be repurposed to edit both genome and epigenome with high specificity, and facilitates the functional interrogation of multiple loci in parallel. This system has the potential to dramatically accelerate progress in cancer research, whether by modelling the genesis and progression of cancer in vitro and in vivo, screening for novel therapeutic targets, conducting functional genomics/epigenomics, or generating targeted cancer therapies. Here, we discuss CRISPR research on each of the ten hallmarks of cancer, outline potential barriers for its clinical implementation and speculate on the advances it may allow in cancer research in the near future.</AbstractText><CopyrightInformation>Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moses</LastName><ForeName>Colette</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cancer Epigenetics Laboratory, Harry Perkins Institute of Medical Research, Perth, Australia; School of Human Sciences, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Bloj</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cancer Epigenetics Laboratory, Harry Perkins Institute of Medical Research, Perth, Australia; School of Medicine, P. Universidad Catolica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvey</LastName><ForeName>Alan R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>School of Human Sciences, The University of Western Australia, Perth, Australia; Perron Institute for Neurological and Translational Science, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blancafort</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cancer Epigenetics Laboratory, Harry Perkins Institute of Medical Research, Perth, Australia; School of Human Sciences, The University of Western Australia, Perth, Australia. Electronic address: pilar.blancafort@uwa.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Cancer</MedlineTA><NlmUniqueID>9005373</NlmUniqueID><ISSNLinking>0959-8049</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas systems</Keyword><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">Clustered regularly interspaced short palindromic repeats</Keyword><Keyword MajorTopicYN="N">Epigenetic editing</Keyword><Keyword MajorTopicYN="N">Epigenetics</Keyword><Keyword MajorTopicYN="N">Gene editing</Keyword><Keyword MajorTopicYN="N">Genetic engineering</Keyword><Keyword MajorTopicYN="N">Oncogenes</Keyword><Keyword MajorTopicYN="N">Tumour-suppressor genes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29433054</ArticleId><ArticleId IdType="pii">S0959-8049(18)30007-8</ArticleId><ArticleId IdType="doi">10.1016/j.ejca.2018.01.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29432731</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2104</ISSN><JournalIssue CitedMedium="Internet"><Volume>497</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>02</Month><Day>26</Day></PubDate></JournalIssue><Title>Biochemical and biophysical research communications</Title><ISOAbbreviation>Biochem. Biophys. Res. Commun.</ISOAbbreviation></Journal><ArticleTitle>AntogomiR-451 protects human gastric epithelial cells from ethanol via activating AMPK signaling.</ArticleTitle><Pagination><MedlinePgn>339-346</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0006-291X(18)30305-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2018.02.082</ELocationID><Abstract><AbstractText>The prevention and treatment efficiency of ethanol-induced gastric epithelial injury are not satisfied. We have previously shown that AMP-activated protein kinase (AMPK) activation exerts a pro-survival function in human gastric epithelial cells (GECs). miroRNA-451 ("miR-451")'s inhibitor, antagomiR-451, can activate AMPK signaling. In the present study, we show that forced-expression of antagomiR-451 via a lentiviral vector depleted miR-451, leading to AMPK activation in established GES-1 cells and primary human GECs. AntagomiR-451 efficiently protected GES-1 cells and primary human GECs from ethanol-induced viability reduction and apoptosis. AMPK activation is required for antagomiR-451-induced GEC protection. AMPKα1 knockdown (by targeted-shRNAs) or knockout (by CRISPR-Cas-9 KO plasmid) blocked antagomiR-451-induced AMPK activation, and GEC protection against ethanol. Further experimental results show that antagomiR-451 significantly attenuated ethanol-induced reactive oxygen species (ROS) production, lipid peroxidation and DNA damage. Collectively, antagomiR-451 protects human GECs from ethanol via activating AMPK signaling.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Huanhuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Wuxi Third People's Hospital of Nantong University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Linjie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Wuxi Third People's Hospital of Nantong University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jianmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Wuxi Third People's Hospital of Nantong University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Wuxi Third People's Hospital of Nantong University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Wuxi Third People's Hospital of Nantong University, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yongkang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Affiliated Hospital of Nanjing University of TCM, Nanjing, China. Electronic address: zhuykwuxiys@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Guoqiang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Wuxi Third People's Hospital of Nantong University, Wuxi, China. Electronic address: lvguoqiangwuxivip@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochem Biophys Res Commun</MedlineTA><NlmUniqueID>0372516</NlmUniqueID><ISSNLinking>0006-291X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">AMPK</Keyword><Keyword MajorTopicYN="Y">AntogomiR-451</Keyword><Keyword MajorTopicYN="Y">Ethanol</Keyword><Keyword MajorTopicYN="Y">Gastric epithelial cells</Keyword><Keyword MajorTopicYN="Y">Oxidative stress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29432731</ArticleId><ArticleId IdType="pii">S0006-291X(18)30305-X</ArticleId><ArticleId IdType="doi">10.1016/j.bbrc.2018.02.082</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29432181</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>Three classes of recurrent DNA break clusters in brain progenitors identified by 3D proximity-based break joining assay.</ArticleTitle><Pagination><MedlinePgn>1919-1924</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1719907115</ELocationID><Abstract><AbstractText>We recently discovered 27 recurrent DNA double-strand break (DSB) clusters (RDCs) in mouse neural stem/progenitor cells (NSPCs). Most RDCs occurred across long, late-replicating RDC genes and were found only after mild inhibition of DNA replication. RDC genes share intriguing characteristics, including encoding surface proteins that organize brain architecture and neuronal junctions, and are genetically implicated in neuropsychiatric disorders and/or cancers. RDC identification relies on high-throughput genome-wide translocation sequencing (HTGTS), which maps recurrent DSBs based on their translocation to "bait" DSBs in specific chromosomal locations. Cellular heterogeneity in 3D genome organization allowed unequivocal identification of RDCs on 14 different chromosomes using HTGTS baits on three mouse chromosomes. Additional candidate RDCs were also implicated, however, suggesting that some RDCs were missed. To more completely identify RDCs, we exploited our finding that joining of two DSBs occurs more frequently if they lie on the same<i>cis</i>chromosome. Thus, we used CRISPR/Cas9 to introduce specific DSBs into each mouse chromosome in NSPCs that were used as bait for HTGTS libraries. This analysis confirmed all 27 previously identified RDCs and identified many new ones. NSPC RDCs fall into three groups based on length, organization, transcription level, and replication timing of genes within them. While mostly less robust, the largest group of newly defined RDCs share many intriguing characteristics with the original 27. Our findings also revealed RDCs in NSPCs in the absence of induced replication stress, and support the idea that the latter treatment augments an already active endogenous process.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Pei-Chi</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Cheng-Sheng</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Zhou</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwer</LastName><ForeName>Bjoern</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zurita</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alt</LastName><ForeName>Frederick W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115; alt@enders.tch.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):E1291-9</RefSource><PMID Version="1">24639501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2258-63</RefSource><PMID Version="1">26873106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2016 May;11(5):853-71</RefSource><PMID Version="1">27031497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Jul 5;341(6141):1237758</RefSource><PMID Version="1">23828942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1998 Dec 23;95(7):891-902</RefSource><PMID Version="1">9875844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Sep 3;525(7567):134-139</RefSource><PMID Version="1">26308889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2014 Oct 22;84(2):386-98</RefSource><PMID Version="1">25284007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2015 Feb;25(2):189-200</RefSource><PMID Version="1">25373142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2010;79:181-211</RefSource><PMID Version="1">20192759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Sep 30;147(1):107-19</RefSource><PMID Version="1">21962511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2008 Oct 7;6(10):e245</RefSource><PMID Version="1">18842067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Jan 19;315(5810):377-81</RefSource><PMID Version="1">17170253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Feb 11;164(4):644-55</RefSource><PMID Version="1">26871630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jan 31;152(3):417-29</RefSource><PMID Version="1">23374339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Nov 1;342(6158):632-7</RefSource><PMID Version="1">24179226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2017 Jul 25;17 (8):489-501</RefSource><PMID Version="1">28740117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1993 Apr 9;260(5105):207-10</RefSource><PMID Version="1">8469973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Feb;33(2):179-86</RefSource><PMID Version="1">25503383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 1998 Dec 17-31;8(25):1395-8</RefSource><PMID Version="1">9889105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Neurosci. 2000 Mar;23 (3):100-5</RefSource><PMID Version="1">10675909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Mar 2;148(5):908-21</RefSource><PMID Version="1">22341456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Nov 5;163(4):947-59</RefSource><PMID Version="1">26593423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2011 Dec 23;44(6):966-77</RefSource><PMID Version="1">22195969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jan 31;152(3):620-32</RefSource><PMID Version="1">23352430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2000 Jun;5(6):993-1002</RefSource><PMID Version="1">10911993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2017 Apr 28;356(6336):</RefSource><PMID Version="1">28450582</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Feb 11;164(4):593-5</RefSource><PMID Version="1">26871622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2016 Aug 22;213(9):1921-36</RefSource><PMID Version="1">27526713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1995 Dec 29;83(7):1079-89</RefSource><PMID Version="1">8548796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2013;47:1-32</RefSource><PMID Version="1">23909437</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">neural stem cells</Keyword><Keyword MajorTopicYN="N">neurodevelopment</Keyword><Keyword MajorTopicYN="N">nonhomologous end-joining</Keyword><Keyword MajorTopicYN="N">recurrent DNA break clusters</Keyword><Keyword MajorTopicYN="N">replication stress</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>08</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29432181</ArticleId><ArticleId IdType="pii">1719907115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1719907115</ArticleId><ArticleId IdType="pmc">PMC5828622</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29432158</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>16p11.2 transcription factor<i>MAZ</i>is a dosage-sensitive regulator of genitourinary development.</ArticleTitle><Pagination><MedlinePgn>E1849-E1858</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1716092115</ELocationID><Abstract><AbstractText>Genitourinary (GU) birth defects are among the most common yet least studied congenital malformations. Congenital anomalies of the kidney and urinary tract (CAKUTs) have high morbidity and mortality rates and account for ∼30% of structural birth defects. Copy number variation (CNV) mapping revealed that 16p11.2 is a hotspot for GU development. The only gene covered collectively by all of the mapped GU-patient CNVs was MYC-associated zinc finger transcription factor (<i>MAZ</i>), and<i>MAZ</i>CNV frequency is enriched in nonsyndromic GU-abnormal patients. Knockdown of<i>MAZ</i>in HEK293 cells results in differential expression of several WNT morphogens required for normal GU development, including Wnt11 and Wnt4.<i>MAZ</i>knockdown also prevents efficient transition into S phase, affects transcription of cell-cycle regulators, and abrogates growth of human embryonic kidney cells. Murine<i>Maz</i>is ubiquitously expressed, and a CRISPR-Cas9 mouse model of<i>Maz</i>deletion results in perinatal lethality with survival rates dependent on<i>Maz</i>copy number. Homozygous loss of<i>Maz</i>results in high penetrance of CAKUTs, and<i>Maz</i>is haploinsufficient for normal bladder development.<i>MAZ</i>, once thought to be a simple housekeeping gene, encodes a dosage-sensitive transcription factor that regulates urogenital development and contributes to both nonsyndromic congenital malformations of the GU tract as well as the 16p11.2 phenotype.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haller</LastName><ForeName>Meade</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; m.haller@wustl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Au</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Marisol</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamb</LastName><ForeName>Dolores J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Baylor College of Medicine, Houston, TX 77030.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 DK007763</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK078121</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA125123</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI036211</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR024574</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genomics. 1996 May 15;34(1):143-6</RefSource><PMID Version="1">8661037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet A. 2016 Nov;170(11):2895-2904</RefSource><PMID Version="1">27411073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010 Oct 26;5(10):e15392</RefSource><PMID Version="1">21048976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Reprod. 2013 Aug 22;89(2):39</RefSource><PMID Version="1">23843235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Nephrol. 2014 Apr;29(4):737-44</RefSource><PMID Version="1">24445433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Reproduction. 2014 Dec;148(6):R97-110</RefSource><PMID Version="1">25187620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2013 Nov;84(5):415-21</RefSource><PMID Version="1">23895381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Dev Biol. 2016 Aug 31;16(1):30</RefSource><PMID Version="1">27582005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurodev Disord. 2010 Mar;2(1):26-38</RefSource><PMID Version="1">21731881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2010 May;47(5):332-41</RefSource><PMID Version="1">19914906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2015 Jan;32(1):411</RefSource><PMID Version="1">25476480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2003 Jul;130(14):3175-85</RefSource><PMID Version="1">12783789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Med. 2013 Jun;15(6):478-81</RefSource><PMID Version="1">23258348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 2012 Apr;129(4):755-63</RefSource><PMID Version="1">22430448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Aug 31;478(7367):97-102</RefSource><PMID Version="1">21881559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2011 Aug 19;(54):null</RefSource><PMID Version="1">21876526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2001 Nov;12(11):2348-57</RefSource><PMID Version="1">11675411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage Clin. 2015 Aug 01;9:50-7</RefSource><PMID Version="1">26413471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jul;42(13):8379-88</RefSource><PMID Version="1">25013182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2000 Jun;66(6):1989-94</RefSource><PMID Version="1">10780922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Model Mech. 2012 Nov;5(6):834-51</RefSource><PMID Version="1">22566537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr;41(7):4049-64</RefSource><PMID Version="1">23471001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1489-97</RefSource><PMID Version="1">26929341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2015 Feb;20(1):140-7</RefSource><PMID Version="1">25421402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2014 Jan 1;385(1):41-51</RefSource><PMID Version="1">24479159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2002 May;39(5):E24</RefSource><PMID Version="1">12011165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Med. 2015 Feb;4(2):224-34</RefSource><PMID Version="1">25449683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA Psychiatry. 2016 Jan;73(1):20-30</RefSource><PMID Version="1">26629640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2012 Jun;26(6):2639-47</RefSource><PMID Version="1">22415301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 May 07;8(5):e63603</RefSource><PMID Version="1">23667645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nephrology (Carlton). 2015 May;20(5):309-11</RefSource><PMID Version="1">25605230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 1999 Feb;259(3):676-83</RefSource><PMID Version="1">10092852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet A. 2010 Oct;152A(10):2618-22</RefSource><PMID Version="1">20799338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet A. 2007 Jul 1;143A(13):1462-71</RefSource><PMID Version="1">17568417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2012 Aug;97(8):E1557-66</RefSource><PMID Version="1">22577170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2013;30(2):570</RefSource><PMID Version="1">23609189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Jun 8;276(23):19897-904</RefSource><PMID Version="1">11259406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Oct;39(18):8005-16</RefSource><PMID Version="1">21729868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2016 Jul 15;80(2):129-139</RefSource><PMID Version="1">26742926</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Feb 12;6:21534</RefSource><PMID Version="1">26867947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fetal Pediatr Pathol. 2014 Oct-Dec;33(5-6):293-320</RefSource><PMID Version="1">25313840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2008 Aug;124(1):1-17</RefSource><PMID Version="1">18512078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin J Am Soc Nephrol. 2013 Jan;8(1):67-74</RefSource><PMID Version="1">23085722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Sep;111(1):103-11</RefSource><PMID Version="1">17902047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Reproduction. 2015 Oct;150(4):R137-48</RefSource><PMID Version="1">26130815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Reprod. 2012 Jan 10;86(1):1-2</RefSource><PMID Version="1">21957192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2008 Aug;135(16):2815-25</RefSource><PMID Version="1">18635608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 1998 Sep 15;52(3):374-7</RefSource><PMID Version="1">9790757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet B Neuropsychiatr Genet. 2011 Mar;156(2):225-32</RefSource><PMID Version="1">21302351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Med. 2015 Feb 16;7(1):13</RefSource><PMID Version="1">25688292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Med Genet. 2009 Mar-Jun;52(2-3):77-87</RefSource><PMID Version="1">19306953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Brain Mapp. 2016 Aug;37(8):2833-48</RefSource><PMID Version="1">27219475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Nephrol. 2015 Dec;11(12):720-31</RefSource><PMID Version="1">26281895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nephrology (Carlton). 2015 Jun;20(6):413-8</RefSource><PMID Version="1">25645028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Pharm Bull. 2015 Sep;5(3):373-7</RefSource><PMID Version="1">26504759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Androl. 2011 Jul-Aug;32(4):383-93</RefSource><PMID Version="1">21051589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Kidney Int. 2008 Oct;74(8):1004-8</RefSource><PMID Version="1">18633347</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Autism Dev Disord. 2016 Aug;46(8):2734-48</RefSource><PMID Version="1">27207092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Aug 10;276(32):30429-34</RefSource><PMID Version="1">11395515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Genet Genomic Med. 2013 Jul;1(2):87-97</RefSource><PMID Version="1">24498606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Autism. 2016 Jun 27;7:30</RefSource><PMID Version="1">27354901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Genomics. 2008 Dec 12;36(1):1-14</RefSource><PMID Version="1">18854370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1994 Dec 1;13(23):5656-67</RefSource><PMID Version="1">7988563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genomics Hum Genet. 2009;10:451-81</RefSource><PMID Version="1">19715442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2016 Feb 12;12(2):e1005709</RefSource><PMID Version="1">26872257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dev Behav Pediatr. 2010 Oct;31(8):649-57</RefSource><PMID Version="1">20613623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2011 Mar;48(3):197-204</RefSource><PMID Version="1">21278390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7452-6</RefSource><PMID Version="1">1502157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Feb 4;463(7281):666-70</RefSource><PMID Version="1">19966786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1999 Jul 2;274(27):19498-506</RefSource><PMID Version="1">10383467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2009 May 15;437(1-2):54-9</RefSource><PMID Version="1">19268698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2016 Mar 15;25(6):1059-73</RefSource><PMID Version="1">26721931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prenat Diagn. 2016 Apr;36(4):321-7</RefSource><PMID Version="1">26833920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Nephrol. 2000 Nov;15(1-2):151-6</RefSource><PMID Version="1">11095034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2001 Sep;222(1):26-39</RefSource><PMID Version="1">11507767</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAKUT</Keyword><Keyword MajorTopicYN="N">copy number variation</Keyword><Keyword MajorTopicYN="N">genitourinary</Keyword><Keyword MajorTopicYN="N">haploinsufficient</Keyword><Keyword MajorTopicYN="N">transcription factor</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>08</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29432158</ArticleId><ArticleId IdType="pii">1716092115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1716092115</ArticleId><ArticleId IdType="pmc">PMC5828603</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29431740</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1696</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Deep learning improves prediction of CRISPR-Cpf1 guide RNA activity.</ArticleTitle><Pagination><MedlinePgn>239-241</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nbt.4061</ELocationID><Abstract><AbstractText>We present two algorithms to predict the activity of AsCpf1 guide RNAs. Indel frequencies for 15,000 target sequences were used in a deep-learning framework based on a convolutional neural network to train Seq-deepCpf1. We then incorporated chromatin accessibility information to create the better-performing DeepCpf1 algorithm for cell lines for which such information is available and show that both algorithms outperform previous machine learning algorithms on our own and published data sets.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hui Kwon</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Seonwoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Electrical and Computer Engineering, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Myungjae</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Soobin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jae Woo</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Younggwang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sangeun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Sungroh</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2367-197X</Identifier><AffiliationInfo><Affiliation>Electrical and Computer Engineering, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyongbum Henry</ForeName><Initials>HH</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4693-738X</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yonsei-IBS Institute, Yonsei University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Aug;34(8):807-8</RefSource><PMID Version="1">27272385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Aug;34(8):808-10</RefSource><PMID Version="1">27272387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2017 May 19;6(5):902-904</RefSource><PMID Version="1">28146356</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2017 Feb;14 (2):153-159</RefSource><PMID Version="1">27992409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2015 Aug;25(8):1147-57</RefSource><PMID Version="1">26063738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Feb;34(2):184-191</RefSource><PMID Version="1">26780180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brief Bioinform. 2017 Sep 1;18(5):851-869</RefSource><PMID Version="1">27473064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2017 Jun;15(6):713-717</RefSource><PMID Version="1">27875019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Sep 6;489(7414):57-74</RefSource><PMID Version="1">22955616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 Jan;35(1):31-34</RefSource><PMID Version="1">27918548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Sep;12(9):823-6</RefSource><PMID Version="1">26167643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2016 Jul;26(7):990-9</RefSource><PMID Version="1">27197224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 May 5;165(4):949-62</RefSource><PMID Version="1">27114038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Physiol. 2017 Mar 16;:null</RefSource><PMID Version="1">28303677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Aug;34(8):863-8</RefSource><PMID Version="1">27272384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2009;10(3):R25</RefSource><PMID Version="1">19261174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Aug;33(8):831-8</RefSource><PMID Version="1">26213851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Oct;12(10):982-8</RefSource><PMID Version="1">26322839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 May 28;521(7553):436-44</RefSource><PMID Version="1">26017442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2016 Jul 05;17 (1):148</RefSource><PMID Version="1">27380939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Dec;32(12):1262-7</RefSource><PMID Version="1">25184501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Nov 02;16:218</RefSource><PMID Version="1">26521937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Aug;34(8):869-74</RefSource><PMID Version="1">27347757</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29431740</ArticleId><ArticleId IdType="pii">nbt.4061</ArticleId><ArticleId IdType="doi">10.1038/nbt.4061</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29431739</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1696</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>A highly specific SpCas9 variant is identified by in vivo screening in yeast.</ArticleTitle><Pagination><MedlinePgn>265-271</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nbt.4066</ELocationID><Abstract><AbstractText>Despite the utility of CRISPR-Cas9 nucleases for genome editing, the potential for off-target activity limits their application, especially for therapeutic purposes. We developed a yeast-based assay to identify optimized Streptococcus pyogenes Cas9 (SpCas9) variants that enables simultaneous evaluation of on- and off-target activity. We screened a library of SpCas9 variants carrying random mutations in the REC3 domain and identified mutations that increased editing accuracy while maintaining editing efficiency. We combined four beneficial mutations to generate evoCas9, a variant that has fidelity exceeding both wild-type (79-fold improvement) and rationally designed Cas9 variants (fourfold average improvement), while maintaining near wild-type on-target editing efficiency (90% median residual activity). Evaluating evoCas9 on endogenous genomic loci, we demonstrated a substantially improved specificity and observed no off-target sites for four of the eight single guide RNAs (sgRNAs) tested. Finally, we showed that following long-term expression (40 d), evoCas9 strongly limited the nonspecific cleavage of a difficult-to-discriminate off-target site and fully abrogated the cleavage of two additional off-target sites.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Casini</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7709-4955</Identifier><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Molecular Virology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivieri</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0257-998X</Identifier><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Molecular Virology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petris</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2420-6359</Identifier><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Molecular Virology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montagna</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Molecular Virology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reginato</LastName><ForeName>Giordano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Molecular Virology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maule</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Molecular Virology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzin</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Computational Oncology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prandi</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Computational Oncology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romanel</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4855-8620</Identifier><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Computational Oncology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demichelis</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Computational Oncology, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inga</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), Laboratory of Transcriptional Networks, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cereseto</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Molecular Virology, Trento, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2016 Mar;26(3):406-15</RefSource><PMID Version="1">26786045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 Mar;89(5):2966-71</RefSource><PMID Version="1">25540359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Apr;11(4):399-402</RefSource><PMID Version="1">24584192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Dec 19;155(7):1479-91</RefSource><PMID Version="1">24360272</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2017 Mar;15(3):169-182</RefSource><PMID Version="1">28111461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Feb;33(2):187-197</RefSource><PMID Version="1">25513782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):973-6</RefSource><PMID Version="1">23892895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):833-8</RefSource><PMID Version="1">23907171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2013;533:103-31</RefSource><PMID Version="1">24182920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e54072</RefSource><PMID Version="1">23457446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2017 Feb;14 (2):153-159</RefSource><PMID Version="1">27992409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):577-582</RefSource><PMID Version="1">24770324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Dec;12(12):1150-6</RefSource><PMID Version="1">26480473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 9;520(7546):186-91</RefSource><PMID Version="1">25830891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Dec 16;42(22):e168</RefSource><PMID Version="1">25300484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Mar;34(3):328-33</RefSource><PMID Version="1">26829318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Biol. 2016 Mar 18;11(3):681-8</RefSource><PMID Version="1">26857072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Oct 19;550(7676):407-410</RefSource><PMID Version="1">28931002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 May 3;102(18):6431-6</RefSource><PMID Version="1">15843459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jul 23;523(7561):481-5</RefSource><PMID Version="1">26098369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Aug 15;25(16):2078-9</RefSource><PMID Version="1">19505943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 May 22;8:15334</RefSource><PMID Version="1">28530235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2007;2(1):31-4</RefSource><PMID Version="1">17401334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2010 Mar 1;26(5):589-95</RefSource><PMID Version="1">20080505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2008 Jun;26(6):702-8</RefSource><PMID Version="1">18500334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jan 28;529(7587):490-5</RefSource><PMID Version="1">26735016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):569-76</RefSource><PMID Version="1">24770325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2015 Aug 20;208:44-53</RefSource><PMID Version="1">26003884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Mar;32(3):279-284</RefSource><PMID Version="1">24463574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Jun;24(6):1012-9</RefSource><PMID Version="1">24696461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Jun;24(6):1020-7</RefSource><PMID Version="1">24696462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource><PMID Version="1">24584096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Feb 9;542(7640):237-241</RefSource><PMID Version="1">28005056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):944-9</RefSource><PMID Version="1">18187580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 May 6;34(5):483</RefSource><PMID Version="1">27153277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-87</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 1;351(6268):84-8</RefSource><PMID Version="1">26628643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):12028-33</RefSource><PMID Version="1">20508152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr;41(7):4336-43</RefSource><PMID Version="1">23460208</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>03</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29431739</ArticleId><ArticleId IdType="pii">nbt.4066</ArticleId><ArticleId IdType="doi">10.1038/nbt.4066</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29431645</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J. Neurosci.</ISOAbbreviation></Journal><ArticleTitle>Subretinal Human Umbilical Tissue-Derived Cell Transplantation Preserves Retinal Synaptic Connectivity and Attenuates Müller Glial Reactivity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1532-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.1532-17.2018</ELocationID><Abstract><AbstractText>Human umbilical tissue-derived cells (hUTC or palucorcel) are currently under clinical investigation for the treatment of geographic atrophy, a late stage of macular degeneration, but how hUTC transplantation mediates vision recovery is not fully elucidated. Subretinal administration of hUTC preserves visual function in the Royal College of Surgeons (RCS) rat, a genetic model of retinal degeneration caused by<i>Mertk</i>loss-of-function. hUTC secrete synaptogenic and neurotrophic factors that improve the health and connectivity of the neural retina. Therefore, we investigated the progression of synapse and photoreceptor loss and whether hUTC treatment preserves photoreceptors and synaptic connectivity in the RCS rats of both sexes. We found that RCS retinas display significant deficits in synaptic development already by postnatal day 21 (P21), prior to the onset of photoreceptor degeneration. Subretinal transplantation of hUTC at P21 is necessary to rescue visual function in RCS rats, and the therapeutic effect is enhanced with repeated injections. Synaptic development defects occurred concurrently with morphological changes in Müller glia, the major perisynaptic glia in the retina. hUTC transplantation strongly diminished Müller glia reactivity and specifically protected the α2δ-1-containing retinal synapses, which are responsive to Thrombospondin (TSP) family synaptogenic proteins secreted by Müller glia. Müller glial reactivity and reduced synaptogenesis observed in RCS retinas could be recapitulated by CRISPR/Cas9-mediated loss-of-<i>Mertk</i>in Müller glia in wildtype rats. Taken together, our results show that hUTC-transplantation supports the health of retina at least in part by preserving the functions of Müller glial cells, revealing a previously unknown aspect of hUTC transplantation-based therapy.<b>SIGNIFICANCE STATEMENT</b>Despite the promising effects observed in clinical trials and preclinical studies, how subretinal hUTC transplantation mediates vision improvements is not fully known. Using a rat model of retinal degeneration, the RCS rat (lacking<i>Mertk</i>), here we provide evidence that hUTC transplantation protects visual function and health by protecting photoreceptors and preserving retinal synaptic connectivity. Furthermore, we find that loss of<i>Mertk</i>function only in Müller glia is sufficient to impair synaptic development and cause activation of Müller glia. hUTC transplantation strongly attenuates the reactivity of Müller glia in RCS rats. These findings highlight novel cellular and molecular mechanisms within the neural retina which underlie disease mechanisms and pinpoint Müller glia as a novel cellular target for hUTC transplantation.</AbstractText><CopyrightInformation>Copyright © 2018 the authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koh</LastName><ForeName>Sehwon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Duke University, Durham, NC27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regeneration Next, Duke University, Durham, NC27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Duke University, Durham, NC27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Institute for Brain Sciences, Duke University, Durham, NC27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dejneka</LastName><ForeName>Nadine S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Spring House, PA19477, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Ian R</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Spring House, PA19477, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA90048, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girman</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA90048, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saylor</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA90048, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shaomei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA90048, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eroglu</LastName><ForeName>Cagla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Duke University, Durham, NC27710, USA c.eroglu@cellbio.duke.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, Duke University, Durham, NC27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Institute for Brain Sciences, Duke University, Durham, NC27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regeneration Next, Duke University, Durham, NC27710, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29431645</ArticleId><ArticleId IdType="pii">JNEUROSCI.1532-17.2018</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.1532-17.2018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29431636</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7445</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>Cancer research</Title><ISOAbbreviation>Cancer Res.</ISOAbbreviation></Journal><ArticleTitle>Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">canres.2463.2017</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1158/0008-5472.CAN-17-2463</ELocationID><Abstract><AbstractText>Comprehensive genetic analyses have identified germline SDHB and FH gene mutations as predominant causes of metastatic paraganglioma and pheochromocytoma. However, some suspicious cases remain unexplained. In this study, we performed whole-exome sequencing of a paraganglioma exhibiting a SDHx-like molecular profile in the absence of SDHx or FH mutations and identified a germline mutation in the SLC25A11 gene, which encodes the mitochondrial 2-oxoglutarate/malate carrier. Germline SLC25A11 mutations were identified in six other patients, five of whom had metastatic disease. These mutations were associated with loss of heterozygosity, suggesting that SLC25A11 acts as a tumor suppressor gene. Pseudo-hypoxic and hypermethylator phenotypes comparable to those described in SDHx- and FH-related tumors were observed both in tumors with mutated SLC25A11 and in Slc25a11∆/∆ immortalized mouse chromaffin knockout cells generated by CRISPR-Cas9 technology. These data show that SLC25A11 is a novel paraganglioma susceptibility gene for which loss of function correlates with metastatic presentation.</AbstractText><CopyrightInformation>Copyright ©2018, American Association for Cancer Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buffet</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>U970, INSERM.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morin</LastName><ForeName>Aurelie</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-2048-6805</Identifier><AffiliationInfo><Affiliation>U970, INSERM.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro-Vega</LastName><ForeName>Luis-Jaime</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>U970, INSERM.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habarou</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hôpital Necker-Enfants Malades, Service de Biochimie Métabolique, APHP.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lussey-Lepoutre</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>U970, INSERM.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Letouzé</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ligue Nationale Contre Le Cancer, Programme Cartes d'Identité des Tumeurs.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefebvre</LastName><ForeName>Hervé</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Service d'Endocrinologie, Diabète et Maladies Métaboliques, INSERM U982,, Centre Hospitalier Universitaire De Rouen.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guilhem</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Endocrinology Unit, Centre Hospitalier et Universitaire de Rennes.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magalie</LastName><ForeName>Haissaguerre</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Service d'Endocrinologie, Hôpital Haut-Lévêque, CHU de Bordeaux.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raingeard</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Service d'Endocrinologie, CHU Montpellier, Hôpital Lapeyronie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padilla-Girola</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>U970, INSERM.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Thi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>INSERM U970, PARCC (Paris Cardiovascular Research Center), Université Paris-Descartes, Sorbonne Paris Cité.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tchara</LastName><ForeName>Lucien</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hôpital Necker-Enfants Malades, Service de Biochimie Métabolique, APHP.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertherat</LastName><ForeName>Jerome</ForeName><Initials>J</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-2551-3008</Identifier><AffiliationInfo><Affiliation>Inserm U1016, Institut Cochin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amar</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service d'hypertension artérielle et médecine vasculaire, APHP-Hopital Européen Georges Pompidou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ottolenghi</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Biochemistry, Descartes University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burnichon</LastName><ForeName>Nelly</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Service de Génétique, APHP-Hopital Européen Georges Pompidou.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gimenez-Roqueplo</LastName><ForeName>Anne-Paule</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>U970, INSERM.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favier</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>U970, INSERM judith.favier@inserm.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Res</MedlineTA><NlmUniqueID>2984705R</NlmUniqueID><ISSNLinking>0008-5472</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29431636</ArticleId><ArticleId IdType="pii">0008-5472.CAN-17-2463</ArticleId><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-2463</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29430869</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1613-6829</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Small (Weinheim an der Bergstrasse, Germany)</Title><ISOAbbreviation>Small</ISOAbbreviation></Journal><ArticleTitle>Monoclonal Cell Line Generation and CRISPR/Cas9 Manipulation via Single-Cell Electroporation.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/smll.201702495</ELocationID><Abstract><AbstractText>Stably transfected cell lines are widely used in drug discovery and biological research to produce recombinant proteins. Generation of these cell lines requires the isolation of multiple clones, using time-consuming dilution methods, to evaluate the expression levels of the gene of interest. A new and efficient method is described for the generation of monoclonal cell lines, without the need for dilution cloning. In this new method, arrays of patterned cell colonies and single cell transfection are employed to deliver a plasmid coding for a reporter gene and conferring resistance to an antibiotic. Using a nanofountain probe electroporation system, probe positioning is achieved through a micromanipulator with sub-micron resolution and resistance-based feedback control. The array of patterned cell colonies allows for rapid selection of numerous stably transfected clonal cell lines located on the same culture well, conferring a significant advantage over slower and labor-intensive traditional methods. In addition to plasmid integration, this methodology can be seamlessly combined with CRISPR/Cas9 gene editing, paving the way for advanced cell engineering.</AbstractText><CopyrightInformation>© 2018 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ruiguo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, Northwestern University, Evanston, IL, 60208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iNfinitesimal LLC, Skokie, IL, 60077, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemaître</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>iNfinitesimal LLC, Skokie, IL, 60077, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Changjin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, Northwestern University, Evanston, IL, 60208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iNfinitesimal LLC, Skokie, IL, 60077, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddadi</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>iNfinitesimal LLC, Skokie, IL, 60077, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Electrical Engineering and Computer Science, Northwestern University, Evanston, IL, 60208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNaughton</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>iNfinitesimal LLC, Skokie, IL, 60077, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinosa</LastName><ForeName>Horacio D</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, Northwestern University, Evanston, IL, 60208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iNfinitesimal LLC, Skokie, IL, 60077, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Cellular Engineering Technologies, Northwestern University, Evanston, IL, 60208, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Small</MedlineTA><NlmUniqueID>101235338</NlmUniqueID><ISSNLinking>1613-6810</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cell line generation</Keyword><Keyword MajorTopicYN="N">electroporation</Keyword><Keyword MajorTopicYN="N">nanofountain probe</Keyword><Keyword MajorTopicYN="N">single cell</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29430869</ArticleId><ArticleId IdType="doi">10.1002/smll.201702495</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29429564</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1618-0984</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Systematic and applied microbiology</Title><ISOAbbreviation>Syst. Appl. Microbiol.</ISOAbbreviation></Journal><ArticleTitle>Genomic comparison between members of the Salinibacteraceae family, and description of a new species of Salinibacter (Salinibacter altiplanensis sp. nov.) isolated from high altitude hypersaline environments of the Argentinian Altiplano.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0723-2020(18)30025-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.syapm.2017.12.004</ELocationID><Abstract><AbstractText>The application of tandem MALDI-TOF MS screening with 16S rRNA gene sequencing of selected isolates has been demonstrated to be an excellent approach for retrieving novelty from large-scale culturing. The application of such methodologies in different hypersaline samples allowed the isolation of the culture-recalcitrant Salinibacter ruber second phylotype (EHB-2) for the first time, as well as a new species recently isolated from the Argentinian Altiplano hypersaline lakes. In this study, the genome sequences of the different species of the phylum Rhodothermaeota were compared and the genetic repertoire along the evolutionary gradient was analyzed together with each intraspecific variability. Altogether, the results indicated an open pan-genome for the family Salinibacteraceae, as well as the codification of relevant traits such as diverse rhodopsin genes, CRISPR-Cas systems and spacers, and one T6SS secretion system that could give ecological advantages to an EHB-2 isolate. For the new Salinibacter species, we propose the name Salinibacter altiplanensis sp. nov. (the designated type strain is AN15<sup>T</sup>=CECT 9105<sup>T</sup>=IBRC-M 11031<sup>T</sup>).</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier GmbH. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viver</LastName><ForeName>Tomeu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Marine Microbiology Group, Department of Ecology and Marine Resources, Mediterranean Institute for Advanced Studies (IMEDEA, CSIC-UIB), E-07190 Esporles, Spain. Electronic address: tviver@imedea.uib-csic.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orellana</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Civil &amp; Environmental Engineering, Georgia Institute of Technology, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González-Torres</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Díaz</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Marine Microbiology Group, Department of Ecology and Marine Resources, Mediterranean Institute for Advanced Studies (IMEDEA, CSIC-UIB), E-07190 Esporles, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urdiain</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Marine Microbiology Group, Department of Ecology and Marine Resources, Mediterranean Institute for Advanced Studies (IMEDEA, CSIC-UIB), E-07190 Esporles, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farías</LastName><ForeName>María Eugenia</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Laboratorio de Investigaciones Microbiológicas de Lagunas Andinas (LIMLA), Planta Piloto de Procesos Industriales Microbiológicos (PROIMI), CCT, CONICET, Tucumán, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benes</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>European Molecular Biology Laboratory (EMBL), Genomics Core Facility, Meyerhofstr. 1, D-69117 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaempfer</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institut für Angewandte Mikrobiologie, Justus-Liebig-Universität Giessen, IFZ-Heinrich-Buff-Ring, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahinpei</LastName><ForeName>Azadeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Extremophiles Laboratory, Department of Microbiology, Faculty of Biology and Center of Excellence in Phylogeny of Living Organisms, Collage of Science, University of Tehran, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali Amoozegar</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Extremophiles Laboratory, Department of Microbiology, Faculty of Biology and Center of Excellence in Phylogeny of Living Organisms, Collage of Science, University of Tehran, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amann</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Molecular Ecology, Max-Planck-Institut für Marine Mikrobiologie, Bremen D-28359, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antón</LastName><ForeName>Josefa</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konstantinidis</LastName><ForeName>Konstantinos T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>School of Civil &amp; Environmental Engineering, Georgia Institute of Technology, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosselló-Móra</LastName><ForeName>Ramon</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Marine Microbiology Group, Department of Ecology and Marine Resources, Mediterranean Institute for Advanced Studies (IMEDEA, CSIC-UIB), E-07190 Esporles, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Syst Appl Microbiol</MedlineTA><NlmUniqueID>8306133</NlmUniqueID><ISSNLinking>0723-2020</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Genomic</Keyword><Keyword MajorTopicYN="N">Halophiles</Keyword><Keyword MajorTopicYN="N">MALDI-TOF MS</Keyword><Keyword MajorTopicYN="N">Salinibacter ruber</Keyword><Keyword MajorTopicYN="N">Salt lake</Keyword><Keyword MajorTopicYN="N">Salterns</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29429564</ArticleId><ArticleId IdType="pii">S0723-2020(18)30025-0</ArticleId><ArticleId IdType="doi">10.1016/j.syapm.2017.12.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29428910</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1467-3045</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>11</Day></PubDate></JournalIssue><Title>Current issues in molecular biology</Title><ISOAbbreviation>Curr Issues Mol Biol</ISOAbbreviation></Journal><ArticleTitle>A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges.</ArticleTitle><Pagination><MedlinePgn>47-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21775/cimb.028.047</ELocationID><Abstract><AbstractText>Precise nucleic acid editing technologies have facilitated the research of cellular function and the development of novel therapeutics, especially the current programmable nucleases-based editing tools, such as the prokaryotic clustered regularly interspaced short palindromic repeats (CRISPR)-associated nucleases (Cas). As CRISPR-based therapies are advancing toward human clinical trials, it is important to understand how natural genetic variation in the human population may affect the results of these trials and even patient safety. The development of "base-editing" technique allows the direct, stable transformation of target DNA base into an alternative in a programmable way, without DNA double strand cleavage or a donor template. Genome-editing techniques hold promises for the treatment of genetic disease at the DNA level by blocking the sequences associated with disease from producing disease-causing proteins. Currently, scientists can select the gene they want to modify, use the Cas9 as a "molecular cutter" to cut it out, and transform it into a more desirable version. In this review, we focus on the recent advances of CRISPR/Cas system by outlining the evolutionary and biotechnological implications of current strategies for improving the specificity and accuracy of these genome-editing technologies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Hafiz Ishfaq</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education and Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Muhammad Jamil</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education and Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asif</LastName><ForeName>Akhtar Rasool</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>University of Veterinary and Animal Sciences, Lahore, sub campus, Jhang 35200, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adnan</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Plant Science, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Muhammad Kashif</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehmood</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muhammad</LastName><ForeName>Sayyed Aun</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>University of Veterinary and Animal Sciences, Lahore, sub campus, Jhang 35200, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhuiyan</LastName><ForeName>Ali Akbar</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education and Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elokil</LastName><ForeName>Abdelmotaleb</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education and Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Xiaoyong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education and Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Changzhi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education and Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiangdong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education and Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Shengsong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Agricultural Animal Genetics, Breeding, and Reproduction of Ministry of Education and Key Laboratory of Swine Genetics and Breeding of Ministry of Agriculture, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Issues Mol Biol</MedlineTA><NlmUniqueID>100931761</NlmUniqueID><ISSNLinking>1467-3037</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29428910</ArticleId><ArticleId IdType="doi">10.21775/cimb.028.047</ArticleId><ArticleId IdType="pii">v28/47</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29428462</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3096</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Trends in biotechnology</Title><ISOAbbreviation>Trends Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense: (Trends in Biotechnology 36, 127-130, 2018).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0167-7799(18)30031-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tibtech.2018.01.009</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Adrienne C</ForeName><Initials>AC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Biotechnol</MedlineTA><NlmUniqueID>8310903</NlmUniqueID><ISSNLinking>0167-7799</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Trends Biotechnol. 2018 Feb;36(2):127-130</RefSource><PMID Version="1">29157535</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29428462</ArticleId><ArticleId IdType="pii">S0167-7799(18)30031-3</ArticleId><ArticleId IdType="doi">10.1016/j.tibtech.2018.01.009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29427756</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-6356</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Mechanisms of development</Title><ISOAbbreviation>Mech. Dev.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/CAS9 ablation of individual miRNAs from a miRNA family reveals their individual efficacies for regulating cardiac differentiation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0925-4773(17)30803-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mod.2018.02.002</ELocationID><Abstract><AbstractText>Although it is well understood that genetic mutations, chromosomal abnormalities, and epigenetic miscues can cause congenital birth defects, many defects are still labeled idiopathic, meaning their origin is not yet understood. microRNAs are quickly entering the causal fray of developmental defects. miRNAs use a 7-8 base-pair seed sequence to target a corresponding sequence on one or multiple mRNAs resulting in rapid down-regulation of translation. miRNAs can also control protein 'amounts' in cells. As a result if miRNAs are over or under expressed during development protein homeostasis can be compromised resulting in defects in the development of organ systems. Here, we show that during differentiation of embryonic stem cells, individual miRNAs that reside in the miRNA17 family (composed of 14 miRNAs) do not share the same function even though they have the same seed sequence. The advent of CRISPR/CAS9 technology has not only yielded a true observation of individual miRNA function, it has also reconnected advanced molecular biology approaches to classical cell biology approaches such as gene rescue. We show that miRNA106a and to a lesser extent miR17 and 93 target the cardiac suppressor gene Fog2, which specifically suppress Gata-4 and Coup-TF2. However, when each miRNA is knocked out, we find that their targeting efficacies for Fog2 differ resulting in varying degrees of cardiac differentiation.</AbstractText><CopyrightInformation>Copyright © 2017. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ziyao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, 3900 Reservoir Rd, Washington, DC 20057-145, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ursin</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, 3900 Reservoir Rd, Washington, DC 20057-145, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahapatra</LastName><ForeName>Samiksha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, 3900 Reservoir Rd, Washington, DC 20057-145, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ian Gallicano</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, 3900 Reservoir Rd, Washington, DC 20057-145, United States. Electronic address: gig@georgetown.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Mech Dev</MedlineTA><NlmUniqueID>9101218</NlmUniqueID><ISSNLinking>0925-4773</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29427756</ArticleId><ArticleId IdType="pii">S0925-4773(17)30803-1</ArticleId><ArticleId IdType="doi">10.1016/j.mod.2018.02.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29427479</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1478-3231</ISSN><JournalIssue CitedMedium="Internet"><Volume>38 Suppl 1</Volume><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Liver international : official journal of the International Association for the Study of the Liver</Title><ISOAbbreviation>Liver Int.</ISOAbbreviation></Journal><ArticleTitle>Towards HBV curative therapies.</ArticleTitle><Pagination><MedlinePgn>102-114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/liv.13656</ELocationID><Abstract><AbstractText>Tremendous progress has been made over the last 2 decades to discover and develop approaches to control hepatitis B virus (HBV) infections and to prevent the development of hepatocellular carcinoma using various interferons and small molecules as antiviral agents. However, none of these agents have significant impact on eliminating HBV from infected cells. Currently the emphasis is on silencing or eliminating cccDNA, which could lead to a cure for HBV. Various approaches are being developed including the development of capsid effectors, CRISPR/Cas9, TALENS, siRNA, entry and secretion inhibitors, as well as immunological approaches. It is very likely that a combination of these modalities will need to be employed to successfully eliminate HBV or prevent virus rebound on discontinuation of therapy. In the next 5 years clinical data will emerge which will provide insight on the safety and feasibility of these approaches and if they can be applied to eradicate HBV infections globally. In this review, we summarize current treatments and we highlight and examine recent therapeutic strategies that are currently being evaluated at the preclinical and clinical stage.</AbstractText><CopyrightInformation>© 2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schinazi</LastName><ForeName>Raymond F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehteshami</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassit</LastName><ForeName>Leda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselah</LastName><ForeName>Tarik</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0024-0595</Identifier><AffiliationInfo><Affiliation>Department of Hepatology, Centre de Recherche sur l'Inflammation, Viral Hepatitis INSERM UMR 1149, AP-HP Hôpital Beaujon, Université Paris Diderot, Clichy, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Liver Int</MedlineTA><NlmUniqueID>101160857</NlmUniqueID><ISSNLinking>1478-3223</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HBV cure</Keyword><Keyword MajorTopicYN="N">antiviral agents</Keyword><Keyword MajorTopicYN="N">cccDNA</Keyword><Keyword MajorTopicYN="N">immunotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29427479</ArticleId><ArticleId IdType="doi">10.1111/liv.13656</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29426944</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Incorporation of a skeletal muscle-specific enhancer in the regulatory region of Igf1 upregulates IGF1 expression and induces skeletal muscle hypertrophy.</ArticleTitle><Pagination><MedlinePgn>2781</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-21122-5</ELocationID><Abstract><AbstractText>In this study, we upregulated insulin-like growth factor-1 (IGF1) expression specifically in skeletal muscle by engineering an enhancer into its non-coding regions and verified the expected phenotype in a mouse model. To select an appropriate site for introducing a skeletal muscle-specific myosin light chain (MLC) enhancer, three candidate sites that exhibited the least evolutionary conservation were chosen and validated in C2C12 single-cell colonies harbouring the MLC enhancer at each site. IGF1 was dramatically upregulated in only the site 2 single-cell colony series, and it exhibited functional activity leading to the formation of extra myotubes. Therefore, we chose site 2 to generate a genetically modified (GM) mouse model with the MLC enhancer incorporated by CRISPR/Cas9 technology. The GM mice exhibited dramatically elevated IGF1 levels, which stimulated downstream pathways in skeletal muscle. Female GM mice exhibited more conspicuous muscle hypertrophy than male GM mice. The GM mice possessed similar circulating IGF1 levels and tibia length as their WT littermates; they also did not exhibit heart abnormalities. Our findings demonstrate that genetically modifying a non-coding region is a feasible method to upregulate gene expression and obtain animals with desirable traits.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Yunlong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Agrobiotechnology, China Agricultural University, Beijing, 100193, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yanjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, China Agricultural University, Beijing, 100193, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Qingyong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Agrobiotechnology, China Agricultural University, Beijing, 100193, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yaofeng</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4499-8610</Identifier><AffiliationInfo><Affiliation>State Key Laboratory for Agrobiotechnology, China Agricultural University, Beijing, 100193, P. R. China. yaofengzhao@cau.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Agrobiotechnology, China Agricultural University, Beijing, 100193, P. R. China. ninglcau@cau.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nature. 1982 Dec 16;300(5893):611-5</RefSource><PMID Version="1">6958982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1985 Jun 20-26;315(6021):680-3</RefSource><PMID Version="1">3892305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e51152</RefSource><PMID Version="1">23251442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 May 25;8:15201</RefSource><PMID Version="1">28541289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2009 Dec;7(12):e1000256</RefSource><PMID Version="1">20016685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1995 May 19;270(20):12109-16</RefSource><PMID Version="1">7744859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1988 Dec;2(12B):1779-90</RefSource><PMID Version="1">3240859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol. 1995 Nov;269(5 Pt 1):E820-6</RefSource><PMID Version="1">7491931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2003 Jan;17(1):59-60</RefSource><PMID Version="1">12528713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E601-7</RefSource><PMID Version="1">11832363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1988 Feb;85(3):836-40</RefSource><PMID Version="1">3422466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2012 Jun 18;13(7):469-83</RefSource><PMID Version="1">22705667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Immunol. 2005 Oct;26(10):535-42</RefSource><PMID Version="1">16109502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1996 Aug;16(8):4524-34</RefSource><PMID Version="1">8754853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1975 Apr 11;188(4184):107-16</RefSource><PMID Version="1">1090005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Cell Biol. 1990;6:679-714</RefSource><PMID Version="1">2275824</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1242-6</RefSource><PMID Version="1">1847512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2005 Aug;15(8):1034-50</RefSource><PMID Version="1">16024819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 1998 Jun;83(6):1886-92</RefSource><PMID Version="1">9626114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1989 Aug;9(8):3393-9</RefSource><PMID Version="1">2796990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2003 Oct 23;425(6960):832-6</RefSource><PMID Version="1">14574411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):478-82</RefSource><PMID Version="1">1988947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2001 Nov;3(11):1009-13</RefSource><PMID Version="1">11715022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Growth Horm IGF Res. 2010 Jun;20(3):255-63</RefSource><PMID Version="1">20382057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1996 Apr;16(4):1649-58</RefSource><PMID Version="1">8657140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1974 Apr;71(4):1250-4</RefSource><PMID Version="1">4364530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1998 Jan;18(1):56-9</RefSource><PMID Version="1">9425901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocrinology. 2007 Jun;148(6):2984-93</RefSource><PMID Version="1">17363459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2006 Jul;38(7):813-8</RefSource><PMID Version="1">16751773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2001 Feb;27(2):195-200</RefSource><PMID Version="1">11175789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2014 Aug;9(8):1956-68</RefSource><PMID Version="1">25058643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 31;8(12):e83028</RefSource><PMID Version="1">24391734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2003 Apr;28(4):215-20</RefSource><PMID Version="1">12713906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1980 Dec;77(12):7380-4</RefSource><PMID Version="1">6261253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Growth Horm IGF Res. 2006 Jun;16(3):157-73</RefSource><PMID Version="1">16716629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1976 Apr;73(4):1260-4</RefSource><PMID Version="1">1063407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1988 Jul;8(7):2896-909</RefSource><PMID Version="1">3405222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1981 Nov 25;9(22):6047-68</RefSource><PMID Version="1">6273820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2001 Nov;3(11):1014-9</RefSource><PMID Version="1">11715023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2010 Mar 15;123(Pt 6):960-71</RefSource><PMID Version="1">20179101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1989 Oct;86(20):7780-4</RefSource><PMID Version="1">2813357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1981 Dec;27(2 Pt 1):299-308</RefSource><PMID Version="1">6277502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1996 Sep;16(9):5058-68</RefSource><PMID Version="1">8756664</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29426944</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-21122-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-21122-5</ArticleId><ArticleId IdType="pmc">PMC5807547</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29426832</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Genome-wide tracking of dCas9-methyltransferase footprints.</ArticleTitle><Pagination><MedlinePgn>597</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-017-02708-5</ELocationID><Abstract><AbstractText>In normal mammalian development cytosine methylation is essential and is directed to specific regions of the genome. Despite notable advances through mapping its genome-wide distribution, studying the direct contribution of DNA methylation to gene and genome regulation has been limited by the lack of tools for its precise manipulation. Thus, combining the targeting capability of the CRISPR-Cas9 system with an epigenetic modifier has attracted interest in the scientific community. In contrast to profiling the genome-wide cleavage of a nuclease competent Cas9, tracing the global activity of a dead Cas9 (dCas9) methyltransferase fusion protein is challenging within a highly methylated genome. Here, we report the generation and use of an engineered, methylation depleted but maintenance competent mouse ES cell line and find surprisingly ubiquitous nuclear activity of dCas9-methyltransferases. Subsequent experiments in human somatic cells refine these observations and point to an important difference between genetic and epigenetic editing tools that require unique experimental considerations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galonska</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charlton</LastName><ForeName>Jocelyn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattei</LastName><ForeName>Alexandra L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1450-8924</Identifier><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donaghey</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clement</LastName><ForeName>Kendell</ForeName><Initials>K</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3808-0811</Identifier><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Hongcang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammad</LastName><ForeName>Arman W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stamenova</LastName><ForeName>Elena K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cacchiarelli</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Armenise-Harvard Laboratory of Integrative Genomics, Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, 80078, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klages</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timmermann</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantz</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Translational Hepatology and Stem Cell Biology, Hannover Medical School, Hannover, 30625, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schöler</LastName><ForeName>Hans R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, 48149, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gnirke</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziller</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department for Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, 80804, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meissner</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195, Berlin, Germany. meissner@molgen.mpg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA. meissner@molgen.mpg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. meissner@molgen.mpg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Aug 8;500(7461):222-6</RefSource><PMID Version="1">23812591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Sep 5;13(3):360-9</RefSource><PMID Version="1">23850244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Sep 4;513(7516):115-9</RefSource><PMID Version="1">25043040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 8;44(12 ):5615-28</RefSource><PMID Version="1">26969735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014 Feb 24;15(2):R38</RefSource><PMID Version="1">24565500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Dec 14;480(7378):490-5</RefSource><PMID Version="1">22170606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jul;32(7):670-6</RefSource><PMID Version="1">24752079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2017 Jan;18(1):51-66</RefSource><PMID Version="1">27867193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10380-5</RefSource><PMID Version="1">15240889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2017 Sep 18;18(1):176</RefSource><PMID Version="1">28923089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1999 Oct 29;99(3):247-57</RefSource><PMID Version="1">10555141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2011 Feb 4;8(2):200-13</RefSource><PMID Version="1">21295276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2013 Mar;14(3):204-20</RefSource><PMID Version="1">23400093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Sep 22;167(1):219-232.e14</RefSource><PMID Version="1">27662090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 23;153(5):1149-63</RefSource><PMID Version="1">23664763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Open. 2016 Jun 15;5(6):866-74</RefSource><PMID Version="1">27170255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2016 Mar;17(3):139-54</RefSource><PMID Version="1">26883001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Oct 13;33(18):5868-77</RefSource><PMID Version="1">16224102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Aug 2;448(7153):553-60</RefSource><PMID Version="1">17603471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epigenetics Chromatin. 2015 Mar 18;8:12</RefSource><PMID Version="1">25901185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2009 Jul 27;10:232</RefSource><PMID Version="1">19635165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2011 Dec;7(12):e1002389</RefSource><PMID Version="1">22174693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Aug 22;500(7463):477-81</RefSource><PMID Version="1">23925113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Nov 19;462(7271):315-22</RefSource><PMID Version="1">19829295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2014 Dec;1839(12):1362-72</RefSource><PMID Version="1">24560929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2016 Feb;32(2):101-13</RefSource><PMID Version="1">26732754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 6;507(7490):62-7</RefSource><PMID Version="1">24476820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2000 Oct;9(16):2395-402</RefSource><PMID Version="1">11005794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 May 14;328(5980):916-9</RefSource><PMID Version="1">20395474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2008 Jan;6(1):e22</RefSource><PMID Version="1">18232738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2015 Oct 1;17 (4):462-70</RefSource><PMID Version="1">26235340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Sep 22;167(1):233-247.e17</RefSource><PMID Version="1">27662091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Feb 28;45(4):1703-1713</RefSource><PMID Version="1">27899645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Aug 7;454(7205):766-70</RefSource><PMID Version="1">18600261</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29426832</ArticleId><ArticleId IdType="doi">10.1038/s41467-017-02708-5</ArticleId><ArticleId IdType="pii">10.1038/s41467-017-02708-5</ArticleId><ArticleId IdType="pmc">PMC5807365</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29425516</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1523-6536</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3S</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation</Title><ISOAbbreviation>Biol. Blood Marrow Transplant.</ISOAbbreviation></Journal><ArticleTitle>Reprint of: Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.</ArticleTitle><Pagination><MedlinePgn>S15-S19</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1083-8791(17)31721-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbmt.2017.12.789</ELocationID><Abstract><AbstractText>Therapeutic T cell engineering has recently garnered widespread interest because of the success of CD19 chimeric antigen receptor (CAR) therapy. CARs are synthetic receptors for antigen that redirect the specificity and reprogram the function of the T cells in which they are genetically introduced. CARs targeting CD19, a cell surface molecule found in most leukemias and lymphomas, have yielded high remission rates in patients with chemorefractory, relapsed disease, including acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma. The toxicities of this treatment include B cell aplasia, cytokine release syndrome (CRS), and neurotoxicity. Although reversible in most instances, these toxicities may require specific medical interventions, including transfer to intensive care to treat severe CRS. Guidelines for managing these toxicities are emerging. The recent report of a nonhuman primate model for CRS is poised to help advance the management of this syndrome. Finally, new engineering modalities, based on the use of targeted nucleases like CRISPR, may further enhance the efficacy and safety of CAR T cells.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perales</LastName><ForeName>Miguel-Angel</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: peralesm@mskcc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kebriaei</LastName><ForeName>Partow</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kean</LastName><ForeName>Leslie S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Center, Seattle, Washington; The Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadelain</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biol Blood Marrow Transplant</MedlineTA><NlmUniqueID>9600628</NlmUniqueID><ISSNLinking>1083-8791</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adoptive T cell therapy</Keyword><Keyword MajorTopicYN="N">Adoptive immunotherapy</Keyword><Keyword MajorTopicYN="N">CART</Keyword><Keyword MajorTopicYN="N">Chimeric antigen receptor T cells</Keyword><Keyword MajorTopicYN="N">Cytokine release syndrome</Keyword><Keyword MajorTopicYN="N">Hematopoietic stem cell transplantation</Keyword><Keyword MajorTopicYN="N">Immunotherapy</Keyword><Keyword MajorTopicYN="N">Neurologic Toxicity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29425516</ArticleId><ArticleId IdType="pii">S1083-8791(17)31721-4</ArticleId><ArticleId IdType="doi">10.1016/j.bbmt.2017.12.789</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29425498</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>Hybridization Kinetics Explains CRISPR-Cas Off-Targeting Rules.</ArticleTitle><Pagination><MedlinePgn>1413-1423</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(18)30077-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2018.01.045</ELocationID><Abstract><AbstractText>Due to their specificity, efficiency, and ease of programming, CRISPR-associated nucleases are popular tools for genome editing. On the genomic scale, these nucleases still show considerable off-target activity though, posing a serious obstacle to the development of therapies. Off targeting is often minimized by choosing especially high-specificity guide sequences, based on algorithms that codify empirically determined off-targeting rules. A lack of mechanistic understanding of these rules has so far necessitated their ad hoc implementation, likely contributing to the limited precision of present algorithms. To understand the targeting rules, we kinetically model the physics of guide-target hybrid formation. Using only four parameters, our model elucidates the kinetic origin of the experimentally observed off-targeting rules, thereby rationalizing the results from both binding and cleavage assays. We favorably compare our model to published data from CRISPR-Cas9, CRISPR-Cpf1, CRISPR-Cascade, as well as the human Argonaute 2 system.</AbstractText><CopyrightInformation>Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Misha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kavli Institute of NanoScience and Department of BioNanoScience, Delft University of Technology, Delft 2629HZ, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eslami-Mossallam</LastName><ForeName>Behrouz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Kavli Institute of NanoScience and Department of BioNanoScience, Delft University of Technology, Delft 2629HZ, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arroyo</LastName><ForeName>Dylan Gonzalez</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Kavli Institute of NanoScience and Department of BioNanoScience, Delft University of Technology, Delft 2629HZ, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Depken</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kavli Institute of NanoScience and Department of BioNanoScience, Delft University of Technology, Delft 2629HZ, the Netherlands. Electronic address: s.m.depken@tudelft.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">Cpf1</Keyword><Keyword MajorTopicYN="N">RNA guided nuclease</Keyword><Keyword MajorTopicYN="N">genome engineering</Keyword><Keyword MajorTopicYN="N">kinetic modeling</Keyword><Keyword MajorTopicYN="N">off-target prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29425498</ArticleId><ArticleId IdType="pii">S2211-1247(18)30077-9</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2018.01.045</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29424307</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4316</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Current pharmaceutical biotechnology</Title><ISOAbbreviation>Curr Pharm Biotechnol</ISOAbbreviation></Journal><ArticleTitle>New Developments in CRISPR Technology: Improvements in Specificity and Efficiency.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.2174/1389201019666180209120533</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">RNA-guided endonuclease as a versatile genome editing technology opened new windows in various fields of biology. The simplicity of this revolutionary technique provides a promising future for its application in a broad range of approaches from functional annotation of genes to diseases, to genetic manipulation and gene therapy. Besides the site-specific activity of Cas9 endonuclease, the unintended cleavage known as off-target effect is still a major challenge for this genome editing technique.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Various strategies have been developed to resolve this bottleneck including development of new softwares for designing optimized guide RNA (gRNA), engineering Cas9 enzyme, improvement in off-target detection assays, etc.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This review dedicated to discuss on methods have been used for optimizing Cas9 specificity with the aim of improving this technology for therapeutic applications.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In addition, the applications and novel breakthroughs in the field of CRISPR technology will be described.</AbstractText><CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Safari</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz. Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farajnia</LastName><ForeName>Safar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz. Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghasemi</LastName><ForeName>Younes</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, and Pharmaceutical Sciences Research Centre, Shiraz University of Medical Sciences, Shiraz. Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarghami</LastName><ForeName>Nosratollah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz. Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Pharm Biotechnol</MedlineTA><NlmUniqueID>100960530</NlmUniqueID><ISSNLinking>1389-2010</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N"/></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29424307</ArticleId><ArticleId IdType="pii">CPB-EPUB-88423</ArticleId><ArticleId IdType="doi">10.2174/1389201019666180209120533</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29423928</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2443</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Genes to cells : devoted to molecular &amp; cellular mechanisms</Title><ISOAbbreviation>Genes Cells</ISOAbbreviation></Journal><ArticleTitle>Unexpected heterogeneity derived from Cas9 ribonucleoprotein-introduced clonal cells at the HPRT1 locus.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/gtc.12569</ELocationID><Abstract><AbstractText>Single-cell cloning is an essential technique for establishing genome-edited cell clones mediated by programmable nucleases such as CRISPR-Cas9. However, residual genome-editing activity after single-cell cloning may cause heterogeneity in the clonal cells. Previous studies showed efficient mutagenesis and rapid degradation of CRISPR-Cas9 components in cultured cells by introducing Cas9 ribonucleoproteins (RNPs). In this study, we investigated how the timing for single-cell cloning of Cas9 RNP-transfected cells affected the heterogeneity of the resultant clones. We carried out transfection of Cas9 RNPs targeting several loci in the HPRT1 gene in HCT116 cells, followed by single-cell cloning at 24, 48, 72 hr and 1 week post-transfection. After approximately 3 weeks of incubation, the clonal cells were collected and genotyped by high-resolution microchip electrophoresis and Sanger sequencing. Unexpectedly, long-term incubation before single-cell cloning resulted in highly heterogeneous clones. We used a lipofection method for transfection, and the media containing transfectable RNPs were not removed before single-cell cloning. Therefore, the active Cas9 RNPs were considered to be continuously incorporated into cells during the precloning incubation. Our findings provide a warning that lipofection of Cas9 RNPs may cause continuous introduction of gene mutations depending on the experimental procedures.</AbstractText><CopyrightInformation>© 2018 Molecular Biology Society of Japan and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sakuma</LastName><ForeName>Tetsushi</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0396-1563</Identifier><AffiliationInfo><Affiliation>Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mochida</LastName><ForeName>Keiji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakade</LastName><ForeName>Shota</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezure</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cell Business Development Section, Analytical &amp; Measuring Instruments Division, Life Science Business Department, Shimadzu Corporation, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minagawa</LastName><ForeName>Sachi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Innovation Center, Nippon Flour Mills Co. Ltd., Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genes Cells</MedlineTA><NlmUniqueID>9607379</NlmUniqueID><ISSNLinking>1356-9597</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">heterogeneity</Keyword><Keyword MajorTopicYN="N">ribonucleoprotein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29423928</ArticleId><ArticleId IdType="doi">10.1111/gtc.12569</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29423804</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>1706</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>Primary Airway Epithelial Cell Gene Editing Using CRISPR-Cas9.</ArticleTitle><Pagination><MedlinePgn>267-292</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-4939-7471-9_15</ELocationID><Abstract><AbstractText>The adaptation of the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated endonuclease 9 (CRISPR-Cas9) machinery from prokaryotic organisms has resulted in a gene editing system that is highly versatile, easily constructed, and can be leveraged to generate human cells knocked out (KO) for a specific gene. While standard transfection techniques can be used for the introduction of CRISPR-Cas9 expression cassettes to many cell types, delivery by this method is not efficient in many primary cell types, including primary human airway epithelial cells (AECs). More efficient delivery in AECs can be achieved through lentiviral-mediated transduction, allowing the CRISPR-Cas9 system to be integrated into the genome of the cell, resulting in stable expression of the nuclease machinery and increasing editing rates. In parallel, advancements have been made in the culture, expansion, selection, and differentiation of AECs, which allow the robust generation of a bulk edited AEC population from transduced cells. Applying these methods, we detail here our latest protocol to generate mucociliary epithelial cultures knocked out for a specific gene from donor-isolated primary human basal airway epithelial cells. This protocol includes methods to: (1) design and generate lentivirus which targets a specific gene for KO with CRISPR-Cas9 machinery, (2) efficiently transduce AECs, (3) culture and select for a bulk edited AEC population, (4) molecularly screen AECs for Cas9 cutting and specific sequence edits, and (5) further expand and differentiate edited cells to a mucociliary airway epithelial culture. The AEC knockouts generated using this protocol provide an excellent primary cell model system with which to characterize the function of genes involved in airway dysfunction and disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Everman</LastName><ForeName>Jamie L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, USA. evermanj@njhealth.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rios</LastName><ForeName>Cydney</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seibold</LastName><ForeName>Max A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, National Jewish Health, Denver, CO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway epithelial cells</Keyword><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Gene editing</Keyword><Keyword MajorTopicYN="N">Gene knockout</Keyword><Keyword MajorTopicYN="N">Lentivirus</Keyword><Keyword MajorTopicYN="N">Primary cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29423804</ArticleId><ArticleId IdType="doi">10.1007/978-1-4939-7471-9_15</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29423270</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2056-5968</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Cell discovery</Title><ISOAbbreviation>Cell Discov</ISOAbbreviation></Journal><ArticleTitle>ATF6 safeguards organelle homeostasis and cellular aging in human mesenchymal stem cells.</ArticleTitle><Pagination><MedlinePgn>2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41421-017-0003-0</ELocationID><Abstract><AbstractText>Loss of organelle homeostasis is a hallmark of aging. However, it remains elusive how this occurs at gene expression level. Here, we report that human mesenchymal stem cell (hMSC) aging is associated with dysfunction of double-membrane organelles and downregulation of transcription factor ATF6. CRISPR/Cas9-mediated inactivation of<i>ATF6</i>in hMSCs, not in human embryonic stem cells and human adipocytes, results in premature cellular aging, characteristic of loss of endomembrane homeostasis. Transcriptomic analyses uncover cell type-specific constitutive and stress-induced ATF6-regulated genes implicated in various layers of organelles' homeostasis regulation.<i>FOS</i>was characterized as a constitutive ATF6 responsive gene, downregulation of which contributes to hMSC aging. Our study unravels the first ATF6-regulated gene expression network related to homeostatic regulation of membrane organelles, and provides novel mechanistic insights into aging-associated attrition of human stem cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Si</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3University of Chinese Academy of Sciences, 100049 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 1797 8419</Identifier><Identifier Source="GRID">grid.410726.6</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 0632 3337</Identifier><Identifier Source="GRID">grid.413259.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hu</LastName><ForeName>Boqiang</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>5Beijing Advanced Innovation Center for Genomics (ICG), College of Life Sciences, Peking University, 100871 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 2256 9319</Identifier><Identifier Source="GRID">grid.11135.37</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>6Peking-Tsinghua Center for Life Sciences, Peking University, 100871 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 2256 9319</Identifier><Identifier Source="GRID">grid.11135.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Zhichao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3University of Chinese Academy of Sciences, 100049 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 1797 8419</Identifier><Identifier Source="GRID">grid.410726.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Yujiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>5Beijing Advanced Innovation Center for Genomics (ICG), College of Life Sciences, Peking University, 100871 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 2256 9319</Identifier><Identifier Source="GRID">grid.11135.37</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>6Peking-Tsinghua Center for Life Sciences, Peking University, 100871 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 2256 9319</Identifier><Identifier Source="GRID">grid.11135.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>7Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037 USA.</Affiliation><Identifier Source="ISNI">0000 0001 0662 7144</Identifier><Identifier Source="GRID">grid.250671.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3University of Chinese Academy of Sciences, 100049 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 1797 8419</Identifier><Identifier Source="GRID">grid.410726.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoling</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>8School of Pharmaceutical Sciences, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, 100084 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 0662 3178</Identifier><Identifier Source="GRID">grid.12527.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Bailong</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>8School of Pharmaceutical Sciences, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, 100084 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 0662 3178</Identifier><Identifier Source="GRID">grid.12527.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Weiqi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 0632 3337</Identifier><Identifier Source="GRID">grid.413259.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Ruotong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 0632 3337</Identifier><Identifier Source="GRID">grid.413259.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Jinghui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>4National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 0632 3337</Identifier><Identifier Source="GRID">grid.413259.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Huifang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>2State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3University of Chinese Academy of Sciences, 100049 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 1797 8419</Identifier><Identifier Source="GRID">grid.410726.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Piu</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>4National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 0632 3337</Identifier><Identifier Source="GRID">grid.413259.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3University of Chinese Academy of Sciences, 100049 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 1797 8419</Identifier><Identifier Source="GRID">grid.410726.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>2State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3University of Chinese Academy of Sciences, 100049 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 1797 8419</Identifier><Identifier Source="GRID">grid.410726.6</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 0632 3337</Identifier><Identifier Source="GRID">grid.413259.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Fuchou</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8625-7717</Identifier><AffiliationInfo><Affiliation>5Beijing Advanced Innovation Center for Genomics (ICG), College of Life Sciences, Peking University, 100871 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 2256 9319</Identifier><Identifier Source="GRID">grid.11135.37</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>6Peking-Tsinghua Center for Life Sciences, Peking University, 100871 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 2256 9319</Identifier><Identifier Source="GRID">grid.11135.37</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>9Ministry of Education Key Laboratory of Cell Proliferation and Differentiation, 100871 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 0369 313X</Identifier><Identifier Source="GRID">grid.419897.a</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>10Biomedical Institute for Pioneering Investigation via Convergence, Peking University, 100871 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0001 2256 9319</Identifier><Identifier Source="GRID">grid.11135.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guang-Hui</ForeName><Initials>GH</Initials><Identifier Source="ORCID">0000-0001-9289-8177</Identifier><AffiliationInfo><Affiliation>1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, 100101 Beijing, China.</Affiliation><Identifier Source="ISNI">0000000119573309</Identifier><Identifier Source="GRID">grid.9227.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3University of Chinese Academy of Sciences, 100049 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 1797 8419</Identifier><Identifier Source="GRID">grid.410726.6</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, 100053 Beijing, China.</Affiliation><Identifier Source="ISNI">0000 0004 0632 3337</Identifier><Identifier Source="GRID">grid.413259.8</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>11Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, 510632 Guangzhou, China.</Affiliation><Identifier Source="ISNI">0000 0004 1790 3548</Identifier><Identifier Source="GRID">grid.258164.c</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Discov</MedlineTA><NlmUniqueID>101661034</NlmUniqueID><ISSNLinking>2056-5968</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Aging (Albany NY). 2015 Dec;7(12 ):1028-9</RefSource><PMID Version="1">26684501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2017 Sep 5;26(3):460-474</RefSource><PMID Version="1">28826795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Jan 15;31(2):166-9</RefSource><PMID Version="1">25260700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Mar 23;276(12):9199-205</RefSource><PMID Version="1">11112790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2016 Jul 12;7(1):80-94</RefSource><PMID Version="1">27346680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Exp Med Biol. 2017;982:451-464</RefSource><PMID Version="1">28551802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2005;74:739-89</RefSource><PMID Version="1">15952902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2007 Sep;13(3):351-64</RefSource><PMID Version="1">17765679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jul 15;353(6296):aaf5549</RefSource><PMID Version="1">27418514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Dev. 2015 Feb 15;24(4):471-83</RefSource><PMID Version="1">25356638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2005 Sep;1(3):e37</RefSource><PMID Version="1">16184190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2008 Sep 11;3(3):301-13</RefSource><PMID Version="1">18786417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2013 Apr 25;14(4):R36</RefSource><PMID Version="1">23618408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2017 Sep;24(9):1478-1487</RefSource><PMID Version="1">28622296</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2007 Sep;13(3):365-76</RefSource><PMID Version="1">17765680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2001 Feb;21(4):1239-48</RefSource><PMID Version="1">11158310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2015 Sep 14;34(18):2334-49</RefSource><PMID Version="1">26228940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2015 Jul;47(7):757-65</RefSource><PMID Version="1">26029869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Jun 5;348(6239):1160-3</RefSource><PMID Version="1">25931448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2017 Sep;27(9):1178-1181</RefSource><PMID Version="1">28685772</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Cell. 2016 Jul;7(7):478-88</RefSource><PMID Version="1">27271327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Nov 6;9(3):1135-50</RefSource><PMID Version="1">25437566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2002 Jul;3(1):99-111</RefSource><PMID Version="1">12110171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hautarzt. 2016 Feb;67(2):107-11</RefSource><PMID Version="1">26636143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2016 Feb;17(2):69-82</RefSource><PMID Version="1">26627931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jun 18;522(7556):354-8</RefSource><PMID Version="1">26040720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2012 Sep;22(9):1813-31</RefSource><PMID Version="1">22955991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102</RefSource><PMID Version="1">22251901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jun 6;153(6):1194-217</RefSource><PMID Version="1">23746838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 Aug 7;138(3):549-61</RefSource><PMID Version="1">19665976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cell Biol. 2013;2013:638083</RefSource><PMID Version="1">24348562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2009;78:959-91</RefSource><PMID Version="1">19298183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 May 7;161(4):919-32</RefSource><PMID Version="1">25957690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2008;9(9):R137</RefSource><PMID Version="1">18798982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5311-5</RefSource><PMID Version="1">22431626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2017 Apr;27(4):483-504</RefSource><PMID Version="1">28139645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Jul 07;5:4330</RefSource><PMID Version="1">24999918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1988 Nov 4;55(3):395-7</RefSource><PMID Version="1">3141060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2013 Dec;14(12):759-74</RefSource><PMID Version="1">24201109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oxid Med Cell Longev. 2017;2017:2916985</RefSource><PMID Version="1">28593023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jun 2;165(6):1361-1374</RefSource><PMID Version="1">27259148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2000 Jul;20(14):5096-106</RefSource><PMID Version="1">10866666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 1992 Sep;202(1):161-6</RefSource><PMID Version="1">1511730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2012 Jun 25;197(7):857-67</RefSource><PMID Version="1">22733998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2014 Jul;10(7):1346-7</RefSource><PMID Version="1">24905224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1990 Jan 12;247(4939):205-9</RefSource><PMID Version="1">2104680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2011 Jun;7(6):351-8</RefSource><PMID Version="1">21499266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2000 Sep;20(18):6755-67</RefSource><PMID Version="1">10958673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Cell. 2016 Mar;7(3):210-21</RefSource><PMID Version="1">26874523</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Surv. 1985;4(4):655-81</RefSource><PMID Version="1">3939686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2000 Dec;6(6):1355-64</RefSource><PMID Version="1">11163209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 Apr 25;3(4):1279-92</RefSource><PMID Version="1">23583182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Dec 03;6:10068</RefSource><PMID Version="1">26632666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2016 Feb;26(2):190-205</RefSource><PMID Version="1">26768768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Aug 28;349(6251):aab3500</RefSource><PMID Version="1">26315442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2013 Feb;15(2):169-78</RefSource><PMID Version="1">23263280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Jul 15;25(14):1754-60</RefSource><PMID Version="1">19451168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Cell. 2017 May;8(5):365-378</RefSource><PMID Version="1">28401346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2008 Dec;9(12):944-57</RefSource><PMID Version="1">19002207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2009 May;6(5):339-42</RefSource><PMID Version="1">19404253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2008;3(6):1032-45</RefSource><PMID Version="1">18536650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 1999 Nov;10(11):3787-99</RefSource><PMID Version="1">10564271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014;15(12):550</RefSource><PMID Version="1">25516281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Sep 1;275(35):27013-20</RefSource><PMID Version="1">10856300</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29423270</ArticleId><ArticleId IdType="doi">10.1038/s41421-017-0003-0</ArticleId><ArticleId IdType="pii">3</ArticleId><ArticleId IdType="pmc">PMC5798892</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29423215</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1674-9782</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Journal of animal science and biotechnology</Title><ISOAbbreviation>J Anim Sci Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Development of genome engineering technologies in cattle: from random to specific.</ArticleTitle><Pagination><MedlinePgn>16</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40104-018-0232-6</ELocationID><Abstract><AbstractText>The production of transgenic farm animals (e.g., cattle) via genome engineering for the gain or loss of gene functions is an important undertaking. In the initial stages of genome engineering, DNA micro-injection into one-cell stage embryos (zygotes) followed by embryo transfer into a recipient was performed because of the ease of the procedure. However, as this approach resulted in severe mosaicism and has a low efficiency, it is not typically employed in the cattle as priority, unlike in mice. To overcome the above issue with micro-injection in cattle, somatic cell nuclear transfer (SCNT) was introduced and successfully used to produce cloned livestock. The application of SCNT for the production of transgenic livestock represents a significant advancement, but its development speed is relatively slow because of abnormal reprogramming and low gene targeting efficiency. Recent genome editing technologies (e.g., ZFN, TALEN, and CRISPR-Cas9) have been rapidly adapted for applications in cattle and great results have been achieved in several fields such as disease models and bioreactors. In the future, genome engineering technologies will accelerate our understanding of genetic traits in bovine and will be readily adapted for bio-medical applications in cattle.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yum</LastName><ForeName>Soo-Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>1Department of Veterinary Clinical Science, College of Veterinary Medicine and the Research Institute of Veterinary Science, Seoul National University, Seoul, 08826 Republic of Korea.</Affiliation><Identifier Source="ISNI">0000 0004 0470 5905</Identifier><Identifier Source="GRID">grid.31501.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youn</LastName><ForeName>Ki-Young</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>1Department of Veterinary Clinical Science, College of Veterinary Medicine and the Research Institute of Veterinary Science, Seoul National University, Seoul, 08826 Republic of Korea.</Affiliation><Identifier Source="ISNI">0000 0004 0470 5905</Identifier><Identifier Source="GRID">grid.31501.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Woo-Jae</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>1Department of Veterinary Clinical Science, College of Veterinary Medicine and the Research Institute of Veterinary Science, Seoul National University, Seoul, 08826 Republic of Korea.</Affiliation><Identifier Source="ISNI">0000 0004 0470 5905</Identifier><Identifier Source="GRID">grid.31501.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Goo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3804-1871</Identifier><AffiliationInfo><Affiliation>1Department of Veterinary Clinical Science, College of Veterinary Medicine and the Research Institute of Veterinary Science, Seoul National University, Seoul, 08826 Republic of Korea.</Affiliation><Identifier Source="ISNI">0000 0004 0470 5905</Identifier><Identifier Source="GRID">grid.31501.36</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Farm Animal Clinical Training and Research Center, Institute of GreenBio Science Technology, Seoul National University, PyeongChang-Gun, Gangwon-do 25354 Republic of Korea.</Affiliation><Identifier Source="ISNI">0000 0004 0470 5905</Identifier><Identifier Source="GRID">grid.31501.36</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3Emergence Center for Food-Medicine Personalized Therapy System, Advanced Institutes of Convergence Technology, Seoul National University, SuWon, Gyeonggi-do 16629 Republic of Korea.</Affiliation><Identifier Source="GRID">grid.410897.3</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>4College of Veterinary Medicine, Seoul National University, #85, Room631, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826 Republic of Korea.</Affiliation><Identifier Source="ISNI">0000 0004 0470 5905</Identifier><Identifier Source="GRID">grid.31501.36</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Anim Sci Biotechnol</MedlineTA><NlmUniqueID>101581293</NlmUniqueID><ISSNLinking>1674-9782</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1530-9</RefSource><PMID Version="1">25733846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2015 May;72(10):1907-29</RefSource><PMID Version="1">25636347</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vet Sci. 2016 Sep 30;17 (3):261-8</RefSource><PMID Version="1">27030199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnology (N Y). 1991 Sep;9(9):844-7</RefSource><PMID Version="1">1367358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Theriogenology. 2016 Apr 15;85(7):1297-311.e2</RefSource><PMID Version="1">26838464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jul 09;5:11735</RefSource><PMID Version="1">26156133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Genomics. 2010 Apr;11(2):115-28</RefSource><PMID Version="1">20885819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2013;4:2565</RefSource><PMID Version="1">24121612</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1998 May 22;280(5367):1256-8</RefSource><PMID Version="1">9596577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Reprogram. 2015 Apr;17(2):131-40</RefSource><PMID Version="1">25826726</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2014 Aug;46(8):858-65</RefSource><PMID Version="1">25017103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Dev. 2010 Aug;19(8):1211-20</RefSource><PMID Version="1">20380514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 21;532(7599):293</RefSource><PMID Version="1">27111611</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2005 Jun;6(6):507-12</RefSource><PMID Version="1">15931173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1981 Jul 9;292(5819):154-6</RefSource><PMID Version="1">7242681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 May 6;34(5):479-81</RefSource><PMID Version="1">27153274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2016 Jun;25(3):329-43</RefSource><PMID Version="1">26820414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Sep 24;5:14435</RefSource><PMID Version="1">26400270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1989 Jun 16;244(4910):1288-92</RefSource><PMID Version="1">2660260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Nov 26;527(7579):417-8</RefSource><PMID Version="1">26607518</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Sep 14;6:33225</RefSource><PMID Version="1">27624004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2005 Aug 12;122(3):473-83</RefSource><PMID Version="1">16096065</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2003 Nov;4(11):1054-60</RefSource><PMID Version="1">14566324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2015 Feb;24(1):147-53</RefSource><PMID Version="1">25204701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jun 21;6:27185</RefSource><PMID Version="1">27324781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2007 Jan;25(1):132-8</RefSource><PMID Version="1">17195841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Mar;12(3):237-43, 1 p following 243</RefSource><PMID Version="1">25664545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Genet Genomics. 2013 Jan 20;40(1):37-43</RefSource><PMID Version="1">23357343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prion. 2015;9(4):278-91</RefSource><PMID Version="1">26217959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Aug 10;293(5532):1093-8</RefSource><PMID Version="1">11498580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2017 Mar 3;12 (3):e0173278</RefSource><PMID Version="1">28257460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vet Med Sci. 2011 Nov;73(11):1453-7</RefSource><PMID Version="1">21747215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2017 Feb;16(2):115-130</RefSource><PMID Version="1">27980341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2011 Nov;21(11):1638-40</RefSource><PMID Version="1">21912434</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Feb 24;6:21953</RefSource><PMID Version="1">26905416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioengineered. 2016 Apr;7(3):123-31</RefSource><PMID Version="1">27166649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Theriogenology. 2016 Nov;86(8):1886-1896.e1</RefSource><PMID Version="1">27566851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16811-6</RefSource><PMID Version="1">23027958</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med Rep. 2016 Sep;14 (3):2527-33</RefSource><PMID Version="1">27430306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2007 Mar;27(5):1665-76</RefSource><PMID Version="1">17178833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Aug 25;10(8):e0136690</RefSource><PMID Version="1">26305800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jun 20;6:28343</RefSource><PMID Version="1">27320776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Sep 08;34(9):933-941</RefSource><PMID Version="1">27606440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Biol Int. 2009 Mar;33(3):309-17</RefSource><PMID Version="1">19166954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Oct 11;34(10 ):1014-1015</RefSource><PMID Version="1">27727209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Jan;34(1):20-2</RefSource><PMID Version="1">26641533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):822-6</RefSource><PMID Version="1">23792628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Reprod. 2004 Aug;71(2):405-9</RefSource><PMID Version="1">15044266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Aug 19;10(8):e0135403</RefSource><PMID Version="1">26287611</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):839-43</RefSource><PMID Version="1">23934178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Aug 4;548(7666):148</RefSource><PMID Version="1">28796219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):8874-8</RefSource><PMID Version="1">26195770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2017 Feb 23;13(2):e1006206</RefSource><PMID Version="1">28231264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jan 15;9(1):e86146</RefSource><PMID Version="1">24454957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2016 Jun;25(3):273-87</RefSource><PMID Version="1">26847670</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">Cattle</Keyword><Keyword MajorTopicYN="N">Genome engineering technologies</Keyword><Keyword MajorTopicYN="N">Transgenesis</Keyword><Keyword MajorTopicYN="N">Transposon</Keyword></KeywordList><CoiStatement>“Not applicable”“Not applicable”The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29423215</ArticleId><ArticleId IdType="doi">10.1186/s40104-018-0232-6</ArticleId><ArticleId IdType="pii">232</ArticleId><ArticleId IdType="pmc">PMC5789629</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29423214</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1674-9782</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Journal of animal science and biotechnology</Title><ISOAbbreviation>J Anim Sci Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Use of gene-editing technology to introduce targeted modifications in pigs.</ArticleTitle><Pagination><MedlinePgn>5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40104-017-0228-7</ELocationID><Abstract><AbstractText>Pigs are an important resource in agriculture and serve as a model for human diseases. Due to their physiological and anatomical similarities with humans, pigs can recapitulate symptoms of human diseases, making them a useful model in biomedicine. However, in the past pig models have not been widely used partially because of the difficulty in genetic modification. The lack of true embryonic stem cells in pigs forced researchers to utilize genetic modification in somatic cells and somatic cell nuclear transfer (SCNT) to generate genetically engineered (GE) pigs carrying site-specific modifications. Although possible, this approach is extremely inefficient and GE pigs born through this method often presented developmental defects associated with the cloning process. Advancement in the gene-editing systems such as Zinc-Finger Nucleases (ZFNs), Transcription activator-like effector nucleases (TALENs), and the Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated 9 (Cas9) system have dramatically increased the efficiency of producing GE pigs. These gene-editing systems, specifically engineered endonucleases, are based on inducing double-stranded breaks (DSBs) at a specific location, and then site-specific modifications can be introduced through one of the two DNA repair pathways: non-homologous end joining (NHEJ) or homology direct repair (HDR). Random insertions or deletions (indels) can be introduced through NHEJ and specific nucleotide sequences can be introduced through HDR, if donor DNA is provided. Use of these engineered endonucleases provides a higher success in genetic modifications, multiallelic modification of the genome, and an opportunity to introduce site-specific modifications during embryogenesis, thus bypassing the need of SCNT in GE pig production. This review will provide a historical prospective of GE pig production and examples of how the gene-editing system, led by engineered endonucleases, have improved GE pig production. We will also present some of our current progress related to the optimal use of CRISPR/Cas9 system during embryogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Junghyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1Department of Animal and Poultry Sciences, Virginia Tech, 175 W. Campus Drive, Blacksburg, VA 24061 USA.</Affiliation><Identifier Source="ISNI">0000 0001 0694 4940</Identifier><Identifier Source="GRID">grid.438526.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prather</LastName><ForeName>Randall S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>2Division of Animal Science, University of Missouri-Columbia, 920 East Campus Drive, Columbia, MO 65211 USA.</Affiliation><Identifier Source="ISNI">0000 0001 2162 3504</Identifier><Identifier Source="GRID">grid.134936.a</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>3National Swine Resource and Research Center, University of Missouri-Columbia, Columbia, MO 65211 USA.</Affiliation><Identifier Source="ISNI">0000 0001 2162 3504</Identifier><Identifier Source="GRID">grid.134936.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kiho</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>1Department of Animal and Poultry Sciences, Virginia Tech, 175 W. Campus Drive, Blacksburg, VA 24061 USA.</Affiliation><Identifier Source="ISNI">0000 0001 0694 4940</Identifier><Identifier Source="GRID">grid.438526.e</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Anim Sci Biotechnol</MedlineTA><NlmUniqueID>101581293</NlmUniqueID><ISSNLinking>1674-9782</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Xenotransplantation. 2015 Sep-Oct;22(5):379-90</RefSource><PMID Version="1">26381494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1985 Jul;82(13):4438-42</RefSource><PMID Version="1">3892534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1985 Jun 20-26;315(6021):680-3</RefSource><PMID Version="1">3892305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Nucleic Acid Res Mol Biol. 1998;58:263-99</RefSource><PMID Version="1">9308369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 1992 Mar;130(3):451-60</RefSource><PMID Version="1">1551570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Jun 2;435(7042):646-51</RefSource><PMID Version="1">15806097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2002 Feb 8;295(5557):1089-92</RefSource><PMID Version="1">11778012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1997 Feb 27;385(6619):810-3</RefSource><PMID Version="1">9039911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1997 Dec 19;278(5346):2130-3</RefSource><PMID Version="1">9405350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Jul;39(12):e82</RefSource><PMID Version="1">21493687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Dec 11;326(5959):1501</RefSource><PMID Version="1">19933106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anim Biotechnol. 2001 Nov;12(2):173-81</RefSource><PMID Version="1">11808633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vet Sci. 2016 Mar;17 (1):89-96</RefSource><PMID Version="1">27051344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):543-8</RefSource><PMID Version="1">25803306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2001 Dec;10(6):577-82</RefSource><PMID Version="1">11817545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2015 Apr;25(4):598-607</RefSource><PMID Version="1">25591789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Xenotransplantation. 2009 May-Jun;16(3):164-80</RefSource><PMID Version="1">19566656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jun 08;10(6):e0129457</RefSource><PMID Version="1">26053263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Reprod Dev. 2016 Jan;83(1):61-70</RefSource><PMID Version="1">26488621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Jan;18(1):93-101</RefSource><PMID Version="1">9418857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1996 Mar 7;380(6569):64-6</RefSource><PMID Version="1">8598906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 May 20;111(20):7260-5</RefSource><PMID Version="1">24799706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1998 Dec 15;12(24):3831-42</RefSource><PMID Version="1">9869637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Sep 26;321(5897):1837-41</RefSource><PMID Version="1">18818360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virology. 2003 Mar 15;307(2):406-13</RefSource><PMID Version="1">12667808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Reprod Domest Anim. 2015 Oct;50(5):872-80</RefSource><PMID Version="1">26138589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2010 Oct;186(2):757-61</RefSource><PMID Version="1">20660643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):538-42</RefSource><PMID Version="1">25798939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Reprod. 2014 Sep;91(3):78</RefSource><PMID Version="1">25100712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2017 Sep 22;357(6357):1303-1307</RefSource><PMID Version="1">28798043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2008 Apr;118(4):1571-7</RefSource><PMID Version="1">18324337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86</RefSource><PMID Version="1">22949671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Mar;18(3):1444-8</RefSource><PMID Version="1">9488460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):10993-8</RefSource><PMID Version="1">19541600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1995 Apr;15(4):1968-73</RefSource><PMID Version="1">7891691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Xenotransplantation. 2012 Mar-Apr;19(2):112-21</RefSource><PMID Version="1">22497513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2007 Jul;25(7):778-85</RefSource><PMID Version="1">17603475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Feb 15;482(7385):331-8</RefSource><PMID Version="1">22337052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Reprod Dev. 2011 Jan;78(1):2</RefSource><PMID Version="1">21268178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Reprod Dev. 2012 Mar;79(3):197-207</RefSource><PMID Version="1">22213403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Reprod. 1987 Nov;37(4):859-66</RefSource><PMID Version="1">3689854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2016 Jan;37(1):110-8</RefSource><PMID Version="1">26442986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Nov 27;350(6264):1101-4</RefSource><PMID Version="1">26456528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene Ther. 2013 Jan;20(1):35-42</RefSource><PMID Version="1">22257934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Reprod Dev. 2015;61(5):449-57</RefSource><PMID Version="1">26227017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Apr 24;10(4):e0122059</RefSource><PMID Version="1">25909512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Anim Sci. 2012 Apr;90(4):1111-7</RefSource><PMID Version="1">22038991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Theriogenology. 2003 Jan 1;59(1):95-106</RefSource><PMID Version="1">12499021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2017 Feb;26(1):97-107</RefSource><PMID Version="1">27744533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2008 Apr;16(4):707-17</RefSource><PMID Version="1">18334988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2006 Sep 8;5(9-10):1021-9</RefSource><PMID Version="1">16807135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Nov 12;5:16705</RefSource><PMID Version="1">26560187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Genet. 2016 May 09;7:78</RefSource><PMID Version="1">27242889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Feb 10;335(6069):720-3</RefSource><PMID Version="1">22223738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Apr 27;6:25222</RefSource><PMID Version="1">27118081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jan 8;327(5962):167-70</RefSource><PMID Version="1">20056882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Xenotransplantation. 2016 Sep;23 (5):338-46</RefSource><PMID Version="1">27610605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Sep 18;5:14253</RefSource><PMID Version="1">26381350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Reprod Dev. 2017 Sep;84(9):1012-1017</RefSource><PMID Version="1">28394093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2001 Jun;19(6):559-62</RefSource><PMID Version="1">11385461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1987 Dec;169(12):5429-33</RefSource><PMID Version="1">3316184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1974 Apr;71(4):1250-4</RefSource><PMID Version="1">4364530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2011 Feb;11(4):776-93</RefSource><PMID Version="1">21229584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Xenotransplantation. 2013 Jan-Feb;20(1):27-35</RefSource><PMID Version="1">23384142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2014 Mar;24(3):372-5</RefSource><PMID Version="1">24481528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2010 Apr;120(4):995-1003</RefSource><PMID Version="1">20364097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013;3:1981</RefSource><PMID Version="1">23760311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5128-32</RefSource><PMID Version="1">1594621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013 Oct 10;3:2847</RefSource><PMID Version="1">24108318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mamm Genome. 2014 Aug;25(7-8):327-34</RefSource><PMID Version="1">24879364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1993 Apr 30;260(5108):679-82</RefSource><PMID Version="1">8480178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2014 Sep 1;393(1):3-9</RefSource><PMID Version="1">24984260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6143-7</RefSource><PMID Version="1">8016127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1156-60</RefSource><PMID Version="1">8577732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1986 Mar 6-12;320(6057):63-5</RefSource><PMID Version="1">3951549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Mar 1;41(5):e63</RefSource><PMID Version="1">23275534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Aug 21;5:13348</RefSource><PMID Version="1">26293209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1985 Jun;4(6):1609-14</RefSource><PMID Version="1">4040853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):822-6</RefSource><PMID Version="1">23792628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1971 Feb;68(2):353-7</RefSource><PMID Version="1">5277085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Reprod. 1989 Sep;41(3):414-8</RefSource><PMID Version="1">2590712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17382-7</RefSource><PMID Version="1">23027955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1980 Dec;77(12):7380-4</RefSource><PMID Version="1">6261253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Theriogenology. 1994;42(1):204-12</RefSource><PMID Version="1">16727526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jun 29;6:29081</RefSource><PMID Version="1">27353424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2016 Dec 03;17 (12 ):</RefSource><PMID Version="1">27918485</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2011 Jun;21(6):979-82</RefSource><PMID Version="1">21502977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12013-7</RefSource><PMID Version="1">21730124</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16526-31</RefSource><PMID Version="1">24014591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):806-10</RefSource><PMID Version="1">7846056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Microbiol. 2009 Feb;12(1):37-43</RefSource><PMID Version="1">19168386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Feb 14;7:42458</RefSource><PMID Version="1">28195163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2015 Mar;72(6):1175-84</RefSource><PMID Version="1">25274063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Theriogenology. 2014 Jan 1;81(1):103-11</RefSource><PMID Version="1">24274415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2007 Jul;25(7):786-93</RefSource><PMID Version="1">17603476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cloning Stem Cells. 2009 Mar;11(1):101-10</RefSource><PMID Version="1">19226213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Phytopathol. 2008;46:189-215</RefSource><PMID Version="1">18422429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1987 Dec 10-16;330(6148):576-8</RefSource><PMID Version="1">3683574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Reprod Biol Endocrinol. 2016 Nov 8;14 (1):77</RefSource><PMID Version="1">27821126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Feb 09;6:20620</RefSource><PMID Version="1">26857844</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Gene-editing</Keyword><Keyword MajorTopicYN="N">Genetic engineering</Keyword><Keyword MajorTopicYN="N">Knock-in</Keyword><Keyword MajorTopicYN="N">Knockout</Keyword><Keyword MajorTopicYN="N">Pig</Keyword><Keyword MajorTopicYN="N">TALEN</Keyword><Keyword MajorTopicYN="N">ZFN</Keyword></KeywordList><CoiStatement>All recombinant DNA work was approved by IBC protocol 17-003.The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29423214</ArticleId><ArticleId IdType="doi">10.1186/s40104-017-0228-7</ArticleId><ArticleId IdType="pii">228</ArticleId><ArticleId IdType="pmc">PMC5787920</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29422612</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Csde1 binds transcripts involved in protein homeostasis and controls their expression in an erythroid cell line.</ArticleTitle><Pagination><MedlinePgn>2628</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-20518-7</ELocationID><Abstract><AbstractText>Expression of the RNA-binding protein Csde1 (Cold shock domain protein e1) is strongly upregulated during erythropoiesis compared to other hematopoietic lineages. Csde1 expression is impaired in the severe congenital anemia Diamond Blackfan Anemia (DBA), and reduced expression of Csde1 in healthy erythroblasts impaired their proliferation and differentiation. To investigate the cellular pathways controlled by Csde1 in erythropoiesis, we identified the transcripts that physically associate with Csde1 in erythroid cells. These mainly encoded proteins involved in ribogenesis, mRNA translation and protein degradation, but also proteins associated with the mitochondrial respiratory chain and mitosis. Crispr/Cas9-mediated deletion of the first cold shock domain of Csde1 affected RNA expression and/or protein expression of Csde1-bound transcripts. For instance, protein expression of Pabpc1 was enhanced while Pabpc1 mRNA expression was reduced indicating more efficient translation of Pabpc1 followed by negative feedback on mRNA stability. Overall, the effect of reduced Csde1 function on mRNA stability and translation of Csde1-bound transcripts was modest. Clones with complete loss of Csde1, however, could not be generated. We suggest that Csde1 is involved in feed-back control in protein homeostasis and that it dampens stochastic changes in mRNA expression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Kat S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department Hematopoiesis, Sanquin, and Landsteiner Laboratory AMC/UvA, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yagci</LastName><ForeName>Nurcan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department Hematopoiesis, Sanquin, and Landsteiner Laboratory AMC/UvA, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Alphen</LastName><ForeName>Floris</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Plasma proteins, Sanquin Research, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paolini</LastName><ForeName>Nahuel A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department Hematopoiesis, Sanquin, and Landsteiner Laboratory AMC/UvA, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horos</LastName><ForeName>Rastislav</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>European Molecular Biology Laboratory, 69117, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Held</LastName><ForeName>Ntsiki M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Laboratory Genetic Metabolic Diseases, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houtkooper</LastName><ForeName>Riekelt H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Laboratory Genetic Metabolic Diseases, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Akker</LastName><ForeName>Emile</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department Hematopoiesis, Sanquin, and Landsteiner Laboratory AMC/UvA, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meijer</LastName><ForeName>Alexander B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Plasma proteins, Sanquin Research, 1066 CX, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>'t Hoen</LastName><ForeName>Peter A C</ForeName><Initials>PAC</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4450-3112</Identifier><AffiliationInfo><Affiliation>Center for Human and Clinical Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Lindern</LastName><ForeName>Marieke</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department Hematopoiesis, Sanquin, and Landsteiner Laboratory AMC/UvA, 1066 CX, Amsterdam, The Netherlands. m.vonlindern@sanquin.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Sep 29;103(1):29-40</RefSource><PMID Version="1">11051545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Jan 15;31(2):166-9</RefSource><PMID Version="1">25260700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Haematologica. 2016 May;101(5):587-96</RefSource><PMID Version="1">26802050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2014 Jul;20(7):748-53</RefSource><PMID Version="1">24952648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 May 31;33(10):3095-108</RefSource><PMID Version="1">15928332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Hematol. 2012 Jul;19(4):268-72</RefSource><PMID Version="1">22517588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Apr 10;324(5924):218-23</RefSource><PMID Version="1">19213877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Nov 25;36(4):571-82</RefSource><PMID Version="1">19941818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Jan 5;119(1):262-72</RefSource><PMID Version="1">22058113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2006 Feb 1;20(3):380-9</RefSource><PMID Version="1">16452509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr F Struct Biol Commun. 2014 Dec 1;70(Pt 12):1649-52</RefSource><PMID Version="1">25484219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2016 Nov 14;30(5):694-707</RefSource><PMID Version="1">27908735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 2004 Aug;85(Pt 8):2279-87</RefSource><PMID Version="1">15269369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2005 Jul-Sep;2(3):e27-35</RefSource><PMID Version="1">17114922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Signal. 2015 Apr;27(4):789-97</RefSource><PMID Version="1">25576733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2012 Mar 13;13(4):227-32</RefSource><PMID Version="1">22411467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Syst Biol. 2010 Aug 24;6:400</RefSource><PMID Version="1">20739923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2013 Apr 25;14(4):R36</RefSource><PMID Version="1">23618408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2008 Dec;83(6):769-80</RefSource><PMID Version="1">19061985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2006 Dec;273(24):5678-90</RefSource><PMID Version="1">17212783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2013 Jan 1;29(1):15-21</RefSource><PMID Version="1">23104886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2012 Jul;122(7):2439-43</RefSource><PMID Version="1">22706301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2007 Jul;8(7):533-43</RefSource><PMID Version="1">17572691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioessays. 2010 Feb;32(2):109-18</RefSource><PMID Version="1">20091748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2015 Jun;43(3):323-7</RefSource><PMID Version="1">26009170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7480-5</RefSource><PMID Version="1">12802011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2015 Dec;43(6):1241-6</RefSource><PMID Version="1">26614667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2015 Dec;43(6):1277-84</RefSource><PMID Version="1">26614673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1994 Jul 11;22(13):2643-50</RefSource><PMID Version="1">7518919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Hematol. 2014 Jun;7(3):359-72</RefSource><PMID Version="1">24665981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 27;44(13):6318-34</RefSource><PMID Version="1">27342281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 03;6:22461</RefSource><PMID Version="1">26936655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 May 19;473(7347):337-42</RefSource><PMID Version="1">21593866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Syst Biol. 2010 Dec 21;6:450</RefSource><PMID Version="1">21179022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jan;42(Database issue):D859-64</RefSource><PMID Version="1">24185699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Aug 17;536(7616):285-91</RefSource><PMID Version="1">27535533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Oct 03;8(10):e76421</RefSource><PMID Version="1">24098497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2009 Dec 17;583(24):3966-73</RefSource><PMID Version="1">19850042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2008 Dec;26(12):1367-72</RefSource><PMID Version="1">19029910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2003 Mar;11(3):757-71</RefSource><PMID Version="1">12667457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Dec 14;33(22):7074-89</RefSource><PMID Version="1">16356927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2005 Apr 11;349:97-105</RefSource><PMID Version="1">15777708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2007;431:61-81</RefSource><PMID Version="1">17923231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Jul 4;499(7456):92-6</RefSource><PMID Version="1">23748442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2004 Aug 15;18(16):2010-23</RefSource><PMID Version="1">15314026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2007 Sep 4;581(22):4184-8</RefSource><PMID Version="1">17692847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2011 May 10;30(12):2420-30</RefSource><PMID Version="1">21556049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2016 May 15;32(10 ):1502-8</RefSource><PMID Version="1">26787660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 May 19;43(9):4746-57</RefSource><PMID Version="1">25855814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 May 19;43(9):4408-28</RefSource><PMID Version="1">25873627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Jun 1;25(11):1422-3</RefSource><PMID Version="1">19304878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Apr 15;27(8):1926-34</RefSource><PMID Version="1">10101203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Sep;13(9):731-40</RefSource><PMID Version="1">27348712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2007 Jan 10;26(1):158-69</RefSource><PMID Version="1">17159903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21</RefSource><PMID Version="1">11309499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2009 Feb;14(2):155-66</RefSource><PMID Version="1">19170763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wiley Interdiscip Rev RNA. 2016 Sep;7(5):661-82</RefSource><PMID Version="1">27173476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2012 Jan;18(1):53-64</RefSource><PMID Version="1">22101243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Blood Cancer. 2014 Jul;61(7):1319-21</RefSource><PMID Version="1">24453067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2004 Oct;3(10 ):960-9</RefSource><PMID Version="1">15238602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2006;1(1):302-7</RefSource><PMID Version="1">17406249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2006 Aug 4;23(3):401-12</RefSource><PMID Version="1">16885029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014;15(12):550</RefSource><PMID Version="1">25516281</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29422612</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-20518-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-20518-7</ArticleId><ArticleId IdType="pmc">PMC5805679</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29422502</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Glucose repression can be alleviated by reducing glucose phosphorylation rate in Saccharomyces cerevisiae.</ArticleTitle><Pagination><MedlinePgn>2613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-20804-4</ELocationID><Abstract><AbstractText>Microorganisms commonly exhibit preferential glucose consumption and diauxic growth when cultured in mixtures of glucose and other sugars. Although various genetic perturbations have alleviated the effects of glucose repression on consumption of specific sugars, a broadly applicable mechanism remains unknown. Here, we report that a reduction in the rate of glucose phosphorylation alleviates the effects of glucose repression in Saccharomyces cerevisiae. Through adaptive evolution under a mixture of xylose and the glucose analog 2-deoxyglucose, we isolated a mutant strain capable of simultaneously consuming glucose and xylose. Genome sequencing of the evolved mutant followed by CRISPR/Cas9-based reverse engineering revealed that mutations in the glucose phosphorylating enzymes (Hxk1, Hxk2, Glk1) were sufficient to confer simultaneous glucose and xylose utilization. We then found that varying hexokinase expression with an inducible promoter led to the simultaneous utilization of glucose and xylose. Interestingly, no mutations in sugar transporters occurred during the evolution, and no specific transporter played an indispensable role in simultaneous sugar utilization. Additionally, we demonstrated that slowing glucose consumption also enabled simultaneous utilization of glucose and galactose. These results suggest that the rate of intracellular glucose phosphorylation is a decisive factor for metabolic regulations of mixed sugars.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Haiqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Eun Joong</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Heejin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lesmana</LastName><ForeName>Anastashia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Deokyeol</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Food Science and Biotechnology, Kyungpook National University, Daegu, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guochang</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4081-0799</Identifier><AffiliationInfo><Affiliation>Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Ching-Sung</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Yong-Su</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Carl Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. ysjin@illinois.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. ysjin@illinois.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Soo Rin</ForeName><Initials>SR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5855-643X</Identifier><AffiliationInfo><Affiliation>School of Food Science and Biotechnology, Kyungpook National University, Daegu, Republic of Korea. soorinkim@knu.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Agricultural Science &amp; Technology, Kyungpook National University, Daegu, Republic of Korea. soorinkim@knu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2005 Sep;37(9):937-44</RefSource><PMID Version="1">16086016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e57048</RefSource><PMID Version="1">23468911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):131-6</RefSource><PMID Version="1">24344268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metab Eng Commun. 2015 Dec 1;2:109-116</RefSource><PMID Version="1">26478859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2007 Apr;74(5):937-53</RefSource><PMID Version="1">17294186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Yeast. 2004 Jun;21(8):671-84</RefSource><PMID Version="1">15197732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2015 Feb;35(4):747-57</RefSource><PMID Version="1">25512610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2014 Sep;1840(9):2878-85</RefSource><PMID Version="1">24821015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1991 Nov;10(11):3373-7</RefSource><PMID Version="1">1915298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 Mar 7;289(10):7247-56</RefSource><PMID Version="1">24451370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1990 Oct 2;29(39):9106-10</RefSource><PMID Version="1">2125473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2006 Mar;172(3):1427-39</RefSource><PMID Version="1">16361229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2017 Sep;114(9):1937-1945</RefSource><PMID Version="1">28464256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2001 May 1;15(9):1104-14</RefSource><PMID Version="1">11331606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1995 Apr;15(4):1915-22</RefSource><PMID Version="1">7891685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3132-6</RefSource><PMID Version="1">7724528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Yeast. 2012 Oct;29(10):425-34</RefSource><PMID Version="1">22968950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e50458</RefSource><PMID Version="1">23227176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2002 Sep;148(Pt 9):2783-8</RefSource><PMID Version="1">12213924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiol Mol Biol Rev. 1998 Jun;62(2):334-61</RefSource><PMID Version="1">9618445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Dec 17;462(7275):875-9</RefSource><PMID Version="1">20016593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Aug 28;158(5):1083-1093</RefSource><PMID Version="1">25171409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2009 Oct 1;23(19):2320-32</RefSource><PMID Version="1">19797769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Aug 28;158(5):1072-1082</RefSource><PMID Version="1">25171408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Yeast Res. 2007 Jan;7(1):40-7</RefSource><PMID Version="1">17311583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Mar;81(5):1601-9</RefSource><PMID Version="1">25527558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1998 Dec 28;441(3):343-7</RefSource><PMID Version="1">9891967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eukaryot Cell. 2006 Dec;5(12):1950-6</RefSource><PMID Version="1">17071825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Traffic. 2009 Dec;10(12):1856-67</RefSource><PMID Version="1">19912579</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 Mar;35(3):273-279</RefSource><PMID Version="1">28191902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2004 Apr;5(4):368-72</RefSource><PMID Version="1">15031717</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1987 Jun;7(6):2087-96</RefSource><PMID Version="1">3037344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 1997 Jun 1;246(2):283-90</RefSource><PMID Version="1">9208916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2015 Nov 02;8:176</RefSource><PMID Version="1">26535057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biochem. 1992 Mar;111(3):352-8</RefSource><PMID Version="1">1587797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2017 Jun 21;10 :160</RefSource><PMID Version="1">28649279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Jan 9;505(7482):239-43</RefSource><PMID Version="1">24291791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2014 Dec;80(24):7694-701</RefSource><PMID Version="1">25281382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metab Eng. 2016 Mar;34:88-96</RefSource><PMID Version="1">26724864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 1998 Jan;144 ( Pt 1):13-24</RefSource><PMID Version="1">9467897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1993 Nov 30;32(47):12725-9</RefSource><PMID Version="1">8251492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2014 Nov 29;7(1):168</RefSource><PMID Version="1">25505932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7963-8</RefSource><PMID Version="1">10859354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1993 Aug 23;329(1-2):51-4</RefSource><PMID Version="1">8354408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Rev. 2008 Jul;32(4):673-704</RefSource><PMID Version="1">18559076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2016 Mar;113(3):484-91</RefSource><PMID Version="1">26284760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5159-64</RefSource><PMID Version="1">24706835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Yeast Res. 2002 May;2(2):183-201</RefSource><PMID Version="1">12702307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2016 Jul 26;9:158</RefSource><PMID Version="1">27468310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 May 30;8:15188</RefSource><PMID Version="1">28555623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Adv. 2017 Nov 1;35(6):805-814</RefSource><PMID Version="1">28627424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2012 Mar 16;5:14</RefSource><PMID Version="1">22424089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Yeast Res. 2015 Sep;15(6):null</RefSource><PMID Version="1">26205245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2001 May 1;355(Pt 3):625-31</RefSource><PMID Version="1">11311123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Rev. 2014 Mar;38(2):254-99</RefSource><PMID Version="1">24483210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1636-41</RefSource><PMID Version="1">25605920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Ind Microbiol Biotechnol. 2003 May;30(5):279-91</RefSource><PMID Version="1">12698321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Rev Cell Mol Biol. 2008;269:111-50</RefSource><PMID Version="1">18779058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eukaryot Cell. 2004 Feb;3(1):221-31</RefSource><PMID Version="1">14871952</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jul 18;154(2):442-51</RefSource><PMID Version="1">23849981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2016 Jul 15;291(29):14973-85</RefSource><PMID Version="1">27261460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 1996 Jun;20(5):981-91</RefSource><PMID Version="1">8809751</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Nov;1830(11):5204-10</RefSource><PMID Version="1">23911748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Biofuels. 2016 Oct 10;9:212</RefSource><PMID Version="1">27766116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metab Eng. 2015 Mar;28:104-13</RefSource><PMID Version="1">25542851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Membr Biol. 2000 Jul 1;176(1):1-17</RefSource><PMID Version="1">10882424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Apr 28;275(17):12926-33</RefSource><PMID Version="1">10777592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1995 Dec 1;14(23):5939-46</RefSource><PMID Version="1">8846786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2016 Nov 29;5:</RefSource><PMID Version="1">27906649</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29422502</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-20804-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-20804-4</ArticleId><ArticleId IdType="pmc">PMC5805702</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29421512</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3700</ISSN><JournalIssue CitedMedium="Internet"><Volume>148</Volume><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Phytochemistry</Title><ISOAbbreviation>Phytochemistry</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9-mediated efficient targeted mutagenesis of RAS in Salvia miltiorrhiza.</ArticleTitle><Pagination><MedlinePgn>63-70</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0031-9422(18)30022-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.phytochem.2018.01.015</ELocationID><Abstract><AbstractText>The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 (CRISPR-associated) system is a powerful genome editing tool that has been used in many species. In this study, we focused on the phenolic acid metabolic pathway in the traditional Chinese medicinal herb Salvia miltiorrhiza, using the CRISPR/Cas9 system to edit the rosmarinic acid synthase gene (SmRAS) in the water-soluble phenolic acid biosynthetic pathway. The single guide RNA (sgRNA) was designed to precisely edit the most important SmRAS gene, which was selected from 11 family members through a bioinformatics analysis. The sequencing results showed that the genomes of 50% of the transgenic regenerated hairy roots had been successfully edited. Five biallelic mutants, two heterozygous mutants and one homozygous mutant were obtained from 16 independent transgenic hairy root lines when the sgRNA was driven by the Arabidopsis U6 promoter, while no mutants were obtained from 13 independent transgenic hairy root lines when the sgRNA was driven by the rice U3 promoter. Subsequently, expression and metabolomics analysis showed that the contents of phenolic acids, including rosmarinic acid (RA) and lithospermic acid B, and the RAS expression level were decreased in the successfully edited hairy root lines, particularly in the homozygous mutants. In addition, the level of the RA precursor 3,4-dihydroxyphenyllactic acid clearly increased. These results indicated that the CRISPR/Cas9 system can be utilized to identify important genes in a gene family with the assistance of bioinformatics analysis and that this new technology is an efficient and specific tool for genome editing in S. miltiorrhiza. This new system presents a promising potential method to regulate plant metabolic networks and improve the quality of traditional Chinese medicinal herbs.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Hexin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Junfeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Shouhong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wansheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China. Electronic address: chenwansheng@smmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, China. Electronic address: zhanglei@smmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Phytochemistry</MedlineTA><NlmUniqueID>0151434</NlmUniqueID><ISSNLinking>0031-9422</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Genome editing</Keyword><Keyword MajorTopicYN="N">Rosmarinic acid synthase</Keyword><Keyword MajorTopicYN="N">Salvia miltiorrhiza</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29421512</ArticleId><ArticleId IdType="pii">S0031-9422(18)30022-0</ArticleId><ArticleId IdType="doi">10.1016/j.phytochem.2018.01.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29421443</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-7035</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Clinical immunology (Orlando, Fla.)</Title><ISOAbbreviation>Clin. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1521-6616(18)30015-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clim.2018.02.001</ELocationID><Abstract><AbstractText>Autoimmune diseases are enigmatic and complex, and most been associated with epigenetic changes. Epigenetics describes changes in gene expression related to environmental influences mediated by a variety of effectors that alter the three-dimensional structure of chromatin and facilitate transcription factor or repressor binding. Recent years have witnessed a dramatic change and acceleration in epigenetic editing approaches, spurred on by the discovery and later development of the CRISPR/Cas9 system as a highly modular and efficient site-specific DNA binding domain. The purpose of this article is to offer a review of epigenetic editing approaches to date, with a focus on alterations of DNA methylation, and to describe a few prominent published examples of epigenetic editing. We will also offer as an example work done by our laboratory demonstrating epigenetic editing of the FOXP3 gene in human T cells. Finally, we discuss briefly the future of epigenetic editing in autoimmune disease.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeffries</LastName><ForeName>Matlock A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>University of Oklahoma Health Sciences Center, Department of Internal Medicine, Division of Rheumatology, Immunology, and Allergy, Oklahoma City, OK, United States; Oklahoma Medical Research Foundation, Arthritis &amp; Clinical Immunology Program, Oklahoma City, OK, United States. Electronic address: matlock-jeffries@ouhsc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Immunol</MedlineTA><NlmUniqueID>100883537</NlmUniqueID><ISSNLinking>1521-6616</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29421443</ArticleId><ArticleId IdType="pii">S1521-6616(18)30015-9</ArticleId><ArticleId IdType="doi">10.1016/j.clim.2018.02.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29420631</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7404</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>PLoS genetics</Title><ISOAbbreviation>PLoS Genet.</ISOAbbreviation></Journal><ArticleTitle>An alternatively spliced form affecting the Marked Box domain of Drosophila E2F1 is required for proper cell cycle regulation.</ArticleTitle><Pagination><MedlinePgn>e1007204</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgen.1007204</ELocationID><Abstract><AbstractText>Across metazoans, cell cycle progression is regulated by E2F family transcription factors that can function as either transcriptional activators or repressors. For decades, the Drosophila E2F family has been viewed as a streamlined RB/E2F network, consisting of one activator (dE2F1) and one repressor (dE2F2). Here, we report that an uncharacterized isoform of dE2F1, hereon called dE2F1b, plays an important function during development and is functionally distinct from the widely-studied dE2F1 isoform, dE2F1a. dE2F1b contains an additional exon that inserts 16 amino acids to the evolutionarily conserved Marked Box domain. Analysis of de2f1b-specific mutants generated via CRISPR/Cas9 indicates that dE2F1b is a critical regulator of the cell cycle during development. This is particularly evident in endocycling salivary glands in which a tight control of dE2F1 activity is required. Interestingly, close examination of mitotic tissues such as eye and wing imaginal discs suggests that dE2F1b plays a repressive function as cells exit from the cell cycle. We also provide evidence demonstrating that dE2F1b differentially interacts with RBF1 and alters the recruitment of RBF1 and dE2F1 to promoters. Collectively, our data suggest that dE2F1b is a novel member of the E2F family, revealing a previously unappreciated complexity in the Drosophila RB/E2F network.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minhee</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8135-645X</Identifier><AffiliationInfo><Affiliation>Department of Biology, Developmental Biology Research Initiative, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jack P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4479-9638</Identifier><AffiliationInfo><Affiliation>Department of Biology, Developmental Biology Research Initiative, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Nam-Sung</ForeName><Initials>NS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0455-927X</Identifier><AffiliationInfo><Affiliation>Department of Biology, Developmental Biology Research Initiative, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Genet</MedlineTA><NlmUniqueID>101239074</NlmUniqueID><ISSNLinking>1553-7390</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1998 Aug 1;12(15):2245-62</RefSource><PMID Version="1">9694791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2010 Aug 19;6(8):e1001071</RefSource><PMID Version="1">20808898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2000 Feb 14;1470(1):M1-12</RefSource><PMID Version="1">10656985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2008 Jan;14(1):62-75</RefSource><PMID Version="1">18194653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Oct 24;278(43):42041-9</RefSource><PMID Version="1">12893818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2017 May 9;114(19):4942-4947</RefSource><PMID Version="1">28439018</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6289-98</RefSource><PMID Version="1">14633988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Dec 15;64(6):1074-1087</RefSource><PMID Version="1">27889452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Mar;23(6):2123-34</RefSource><PMID Version="1">12612083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 May;26(9):3468-77</RefSource><PMID Version="1">16611989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2001 Mar;3(3):289-95</RefSource><PMID Version="1">11231579</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Jun;23(11):3707-20</RefSource><PMID Version="1">12748276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 May 6;280(18):18211-20</RefSource><PMID Version="1">15722552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2014 Mar;15(3):197-210</RefSource><PMID Version="1">24556841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2012 Nov;14(11):1181-91</RefSource><PMID Version="1">23064264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1995 Jun 15;9(12):1445-55</RefSource><PMID Version="1">7601349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2001 Dec;128(24):5085-98</RefSource><PMID Version="1">11748144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1989 Feb;9(2):578-85</RefSource><PMID Version="1">2523514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2005 Dec 16;123(6):1093-106</RefSource><PMID Version="1">16360038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2001 Aug 15;15(16):2146-60</RefSource><PMID Version="1">11511545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2012 Nov;32(21):4375-87</RefSource><PMID Version="1">22927638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2008 Mar;9(3):252-9</RefSource><PMID Version="1">18202719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 1999 Sep;153(1):275-87</RefSource><PMID Version="1">10471712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Nov 22;414(6862):457-62</RefSource><PMID Version="1">11719808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Oct 30;480(7375):123-7</RefSource><PMID Version="1">22037307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2016 Mar 15;411(2):195-206</RefSource><PMID Version="1">26859702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Oct;26(20):7601-15</RefSource><PMID Version="1">16954388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2011 Mar 1;434(2):297-308</RefSource><PMID Version="1">21143199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2008 Sep;9(9):713-24</RefSource><PMID Version="1">18719710</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 2002 Dec;14(6):684-91</RefSource><PMID Version="1">12473340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2005 Apr 18;24(17):2765-75</RefSource><PMID Version="1">15838513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1998 Jul 2;394(6688):82-4</RefSource><PMID Version="1">9665132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2003 Sep 15;17(18):2308-20</RefSource><PMID Version="1">12975318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Aug 28;454(7208):1137-41</RefSource><PMID Version="1">18594513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1999 Apr 1;13(7):827-40</RefSource><PMID Version="1">10197983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Aug 1;22(15):3865-75</RefSource><PMID Version="1">12881421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2003 Sep;12(3):639-49</RefSource><PMID Version="1">14527410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Sep 22;33(17):5458-70</RefSource><PMID Version="1">16179649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1997 Aug 1;11(15):1999-2011</RefSource><PMID Version="1">9271122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15948-53</RefSource><PMID Version="1">16249342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 2009 Mar;19(3):111-8</RefSource><PMID Version="1">19201609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6359-63</RefSource><PMID Version="1">8022787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>G3 (Bethesda). 2014 Sep 17;4(11):2279-82</RefSource><PMID Version="1">25236734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2012 Nov;14(11):1192-202</RefSource><PMID Version="1">23064266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 2002 Dec;119(2):225-37</RefSource><PMID Version="1">12464435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2003 Jan 8;13(1):53-8</RefSource><PMID Version="1">12526745</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29420631</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1007204</ArticleId><ArticleId IdType="pii">PGENETICS-D-17-01565</ArticleId><ArticleId IdType="pmc">PMC5821395</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29417930</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>MELK expression correlates with tumor mitotic activity but is not required for cancer growth.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.32838</ELocationID><ELocationID EIdType="pii" ValidYN="Y">e32838</ELocationID><Abstract><AbstractText>The Maternal Embryonic Leucine Zipper Kinase (MELK) has been identified as a promising therapeutic target in multiple cancer types. MELK over-expression is associated with aggressive disease, and MELK has been implicated in numerous cancer-related processes, including chemotherapy resistance, stem cell renewal, and tumor growth. Previously, we established that triple-negative breast cancer cell lines harboring CRISPR/Cas9-induced null mutations in MELK proliferate at wild-type levels in vitro (&lt;xref ref-type="bibr" rid="bib34"&gt;Lin et al., 2017&lt;/xref&gt;). Here, we generate several additional knockout clones of MELK and demonstrate that across cancer types, cells lacking MELK exhibit wild-type growth in vitro, under environmental stress, in the presence of cytotoxic chemotherapies, and in vivo. By combining our MELK-knockout clones with a recently described, highly specific MELK inhibitor, we further demonstrate that the acute inhibition of MELK results in no specific anti-proliferative phenotype. Analysis of gene expression data from cohorts of cancer patients identifies MELK expression as a correlate of tumor mitotic activity, explaining its association with poor clinical prognosis. In total, our results demonstrate the power of CRISPR/Cas9-based genetic approaches to investigate cancer drug targets, and call into question the rationale for treating patients with anti-MELK monotherapies.</AbstractText><CopyrightInformation>© 2018, Giuliano et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Giuliano</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-0586-6095</Identifier><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Joan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Google, Inc., New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palladino</LastName><ForeName>Ann C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheltzer</LastName><ForeName>Jason M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1381-1323</Identifier><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1DP5OD021385</GrantID><Agency>NIH Office of the Director</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2005;7(6):R953-64</RefSource><PMID Version="1">16280042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2015;2015:731938</RefSource><PMID Version="1">26339636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2006 Apr;172(4):2557-66</RefSource><PMID Version="1">16636113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Nov 1;65(21):9751-61</RefSource><PMID Version="1">16266996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Feb 2;7(5):6281-93</RefSource><PMID Version="1">26823390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2006 Jul;12(7):1179-87</RefSource><PMID Version="1">16682560</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(11):e27656</RefSource><PMID Version="1">22110708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Jul 20;547(7663):355-359</RefSource><PMID Version="1">28678782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Jan 23;347(6220):1260419</RefSource><PMID Version="1">25613900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1989 Dec 1;49(23):6449-65</RefSource><PMID Version="1">2684393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2011 Aug 26;412(2):207-13</RefSource><PMID Version="1">21806965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2015 Feb 10;4(2):226-38</RefSource><PMID Version="1">25601206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2016 Mar 10;24(8):434-52</RefSource><PMID Version="1">26421442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1990 Feb 1;50(3):717-21</RefSource><PMID Version="1">2297709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9810-5</RefSource><PMID Version="1">27528663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2014 Jun;13(6):1393-8</RefSource><PMID Version="1">24795222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1978 Mar;38(3):624-34</RefSource><PMID Version="1">626967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Dec 5;21(10 ):2829-2841</RefSource><PMID Version="1">29212029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2009;11(4):R60</RefSource><PMID Version="1">19671159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2006 Mar;9(3):157-73</RefSource><PMID Version="1">16530701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2014 Oct 27;(92):e51998</RefSource><PMID Version="1">25408172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2011 Jun;16(6):625-38</RefSource><PMID Version="1">21501344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Aug 16;288(33):24200-12</RefSource><PMID Version="1">23836907</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2006;1(5):2315-9</RefSource><PMID Version="1">17406473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2005 Nov;2(11):e313</RefSource><PMID Version="1">16187797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Feb 15;483(7390):479-83</RefSource><PMID Version="1">22343889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2012 Dec;3(12):1629-40</RefSource><PMID Version="1">23283305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2017 May;37(5):2343-2354</RefSource><PMID Version="1">28476800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biosci Rep. 2015 Oct 02;35(6):null</RefSource><PMID Version="1">26431963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2002 Feb 1;361(Pt 3):597-604</RefSource><PMID Version="1">11802789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 Mar 24;6:</RefSource><PMID Version="1">28337968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2007 Jul 04;2(7):e594</RefSource><PMID Version="1">17611626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2013 May;31(5):870-81</RefSource><PMID Version="1">23339114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2007;9(1):R17</RefSource><PMID Version="1">17280616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1975 Nov;72(11):4435-9</RefSource><PMID Version="1">172908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2008;10(3):R52</RefSource><PMID Version="1">18541018</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 May 20;3:e01763</RefSource><PMID Version="1">24844244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 2010 Aug 1;316(13):2166-73</RefSource><PMID Version="1">20420823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2002 Jan 1;30(1):207-10</RefSource><PMID Version="1">11752295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Immun. 2005 Jun;6(4):319-31</RefSource><PMID Version="1">15789058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2006 Feb;6(2):99-106</RefSource><PMID Version="1">16491069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Comput Biol. 2011 Oct;7(10):e1002240</RefSource><PMID Version="1">22028643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2015 Aug;21(8):938-945</RefSource><PMID Version="1">26193342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 Sep 19;6:null</RefSource><PMID Version="1">28926338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1982 Nov 11;300(5888):143-9</RefSource><PMID Version="1">6290897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2013 Jun;31(6):1051-63</RefSource><PMID Version="1">23404835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Nov 1;70(21):8863-73</RefSource><PMID Version="1">20861186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2015 Mar 22;(97):null</RefSource><PMID Version="1">25867607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 Mar 6;136(5):823-37</RefSource><PMID Version="1">19269363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1980 Feb;77(2):1039-43</RefSource><PMID Version="1">6928659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2003 Jun;21(6):635-7</RefSource><PMID Version="1">12754523</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-87</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2008;10(2):R25</RefSource><PMID Version="1">18366788</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Med (Berl). 2013 Feb;91(2):237-48</RefSource><PMID Version="1">22945237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2016 Dec 1;22(23 ):5864-5875</RefSource><PMID Version="1">27225691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Protoc. 2010 Feb;2010(2):pdb.prot5372</RefSource><PMID Version="1">20150135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Mar 5;279(10):8642-7</RefSource><PMID Version="1">14699119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 May 5;112(18):5708-13</RefSource><PMID Version="1">25902495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Feb 15;69(4):1302-13</RefSource><PMID Version="1">19190339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2010 Jul 1;16(13):3356-67</RefSource><PMID Version="1">20460471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Dec 12;283(50):34541-53</RefSource><PMID Version="1">18948261</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">cancer biology</Keyword><Keyword MajorTopicYN="N">cell cycle</Keyword><Keyword MajorTopicYN="N">drug targets</Keyword><Keyword MajorTopicYN="N">human</Keyword><Keyword MajorTopicYN="N">mitotic kinase</Keyword></KeywordList><CoiStatement>CG, AL, AP, JS No competing interests declared, JS Joan C. Smith is affiliated with Google Inc. The author has no financial interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29417930</ArticleId><ArticleId IdType="doi">10.7554/eLife.32838</ArticleId><ArticleId IdType="pii">32838</ArticleId><ArticleId IdType="pmc">PMC5805410</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29417095</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2398-502X</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Wellcome open research</Title><ISOAbbreviation>Wellcome Open Res</ISOAbbreviation></Journal><ArticleTitle>Knockdown of Laminin gamma-3 (Lamc3) impairs motoneuron guidance in the zebrafish embryo.</ArticleTitle><Pagination><MedlinePgn>111</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12688/wellcomeopenres.12394.1</ELocationID><Abstract><AbstractText><b>Background</b>
: Previous work in the zebrafish embryo has shown that laminin γ-3 (<i>lamc3</i>) is enriched in endothelial cells marked by expression of<i>fli1a</i>, but the role of Lamc3 has been unknown.<b>Methods</b>: We use antisense morpholino oligonucleotides, and CRISPR/Cas9 mutagenesis of F0 embryos, to create zebrafish embryos in which<i>lamc3</i>expression is compromised. Transgenic imaging, immunofluorescence, and<i>in situ</i>hybridisation reveal that Lamc3 loss-of-function affects the development of muscle pioneers, endothelial cells, and motoneurons.<b>Results</b>: <i>Lamc3</i>is enriched in endothelial cells during zebrafish development, but it is also expressed by other tissues. Depletion of Lamc3 by use of antisense morpholino oligonucleotides perturbs formation of the parachordal chain and subsequently the thoracic duct, but Lamc3 is not required for sprouting of the cardinal vein. F0 embryos in which<i>lamc3</i>expression is perturbed by a CRISPR/Cas9 approach also fail to form a parachordal chain, but we were unable to establish a stable<i>lamc3</i>null line. Lamc3 is dispensable for muscle pioneer specification and for the expression of<i>netrin-1a</i>in these cells. Lamc3 knockdown causes<i>netrin-1a</i>up-regulation in the neural tube and there is increased Netrin-1 protein throughout the trunk of the embryo. Axonal guidance of rostral primary motoneurons is defective in Lamc3 knockdown embryos.<b>Conclusions</b>: We suggest that knockdown of Lamc3 perturbs migration of rostral primary motoneurons at the level of the horizontal myoseptum, indicating that laminin γ3 plays a role in motoneuron guidance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eve</LastName><ForeName>Alexander M J</ForeName><Initials>AMJ</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3577-4324</Identifier><AffiliationInfo><Affiliation>Developmental Biology Laboratory, Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>James C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Developmental Biology Laboratory, Francis Crick Institute, London, NW1 1AT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Wellcome Open Res</MedlineTA><NlmUniqueID>101696457</NlmUniqueID><ISSNLinking>2398-502X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Development. 2008 May;135(10):1735-43</RefSource><PMID Version="1">18403413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 1995 Oct;121(10):3141-50</RefSource><PMID Version="1">7588049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Model Mech. 2011 Jul;4(4):433-8</RefSource><PMID Version="1">21708900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 1998 Oct;10(5):594-601</RefSource><PMID Version="1">9818169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 May 1;25(9):1189-91</RefSource><PMID Version="1">19151095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2011 Oct 28;12(11):1087-8</RefSource><PMID Version="1">22015689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2008;3(1):59-69</RefSource><PMID Version="1">18193022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vis Neurosci. 2007 Jul-Aug;24(4):549-62</RefSource><PMID Version="1">17711601</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2017 May 17;94(4):790-799.e3</RefSource><PMID Version="1">28434801</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2011 Jun;13(6):686-92</RefSource><PMID Version="1">21572418</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2009 Mar 13;104(5):576-88</RefSource><PMID Version="1">19286613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2011 Oct 28;12(11):1135-43</RefSource><PMID Version="1">21979816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 1996 Dec;123:103-15</RefSource><PMID Version="1">9007233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2012 Jun 15;28(12):1647-9</RefSource><PMID Version="1">22543367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2017 Feb 13;12 (2):e0172227</RefSource><PMID Version="1">28192479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cardiovasc Med. 1994 Sep-Oct;4(5):207-12</RefSource><PMID Version="1">21244869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1999 May 3;145(3):605-18</RefSource><PMID Version="1">10225960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comp Neurol. 2011 Jun 15;519(9):1797-815</RefSource><PMID Version="1">21452216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Ther. 2008 May;118(2):206-30</RefSource><PMID Version="1">18439684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2017 Aug 3;12 (8):e0182047</RefSource><PMID Version="1">28771527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(10):e25841</RefSource><PMID Version="1">22003409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 1995 Jul;203(3):253-310</RefSource><PMID Version="1">8589427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Nov 16;6:37172</RefSource><PMID Version="1">27849017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2006 Jan;235(1):213-24</RefSource><PMID Version="1">16261616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2017 Feb 9;12 (2):e0171143</RefSource><PMID Version="1">28182631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1997 Sep 1;11(17):2163-75</RefSource><PMID Version="1">9303533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Neurosci. 1997;9(4):293-313</RefSource><PMID Version="1">9268507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2013 May;140(9):2050-60</RefSource><PMID Version="1">23571221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Jun 10;280(23):22146-53</RefSource><PMID Version="1">15824114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Oct 9;326(5950):294-8</RefSource><PMID Version="1">19815777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rev. 2005 Jul;85(3):979-1000</RefSource><PMID Version="1">15987800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2000 Sep 1;20(17):6517-28</RefSource><PMID Version="1">10964957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2011 Jan;138(1):97-106</RefSource><PMID Version="1">21115608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 May 18;545(7654):350-354</RefSource><PMID Version="1">28445456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2015 Jan 12;32(1):97-108</RefSource><PMID Version="1">25533206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2011 Sep;138(17):3847-57</RefSource><PMID Version="1">21828101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013;9(12 ):e1003955</RefSource><PMID Version="1">24339784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2005 Jul 15;106(2):534-41</RefSource><PMID Version="1">15802528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2002 Jul;129(13):3137-46</RefSource><PMID Version="1">12070089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):227-9</RefSource><PMID Version="1">23360964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2011 Feb;240(2):422-31</RefSource><PMID Version="1">21246659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Jun 23;281(25):17286-303</RefSource><PMID Version="1">16608848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2002 Aug 15;248(2):307-18</RefSource><PMID Version="1">12167406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2014 Jan 3;114(1):56-66</RefSource><PMID Version="1">24122719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2017 Oct 19;13(10 ):e1007000</RefSource><PMID Version="1">29049395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2006 Nov 15;299(2):551-62</RefSource><PMID Version="1">16999953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13904-9</RefSource><PMID Version="1">23918387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jul;38(Web Server issue):W462-8</RefSource><PMID Version="1">20435679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1998 Dec 14;143(6):1713-23</RefSource><PMID Version="1">9852162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Cell Dev Biol. 2012;28:523-53</RefSource><PMID Version="1">23057746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene Expr Patterns. 2006 Oct;6(8):1007-13</RefSource><PMID Version="1">16765104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16210-5</RefSource><PMID Version="1">15520390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1999 Dec 13;147(6):1341-50</RefSource><PMID Version="1">10601345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Matrix Biol. 2005 Aug;24(5):326-32</RefSource><PMID Version="1">15979864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2006 Jan 1;289(1):64-76</RefSource><PMID Version="1">16321372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Neurobiol. 2008 Jun;68(7):960-71</RefSource><PMID Version="1">18418846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 2013 Feb;130(2-3):122-31</RefSource><PMID Version="1">23072875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2008 Feb;135(4):659-67</RefSource><PMID Version="1">18223200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2012 Jul;139(13):2381-91</RefSource><PMID Version="1">22627281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Oct 27;10(10):e0141611</RefSource><PMID Version="1">26506092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Aug 17;282(33):23750-8</RefSource><PMID Version="1">17588941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Matrix Biol. 2012 Mar;31(2):120-34</RefSource><PMID Version="1">22222602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Mar 4;464(7285):108-11</RefSource><PMID Version="1">20154733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Aug 13;524(7564):230-3</RefSource><PMID Version="1">26168398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 May 2;27(18):4978-83</RefSource><PMID Version="1">17475806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2008 Mar 15;22(6):734-9</RefSource><PMID Version="1">18347092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2014 Sep 19;4:6420</RefSource><PMID Version="1">25236476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Oct 17;283(42):28149-57</RefSource><PMID Version="1">18697739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2009 Apr;41(4):396-8</RefSource><PMID Version="1">19287381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1998 Oct 2;95(1):67-80</RefSource><PMID Version="1">9778248</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1773-82</RefSource><PMID Version="1">19907020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1999 Sep 2;401(6748):69-73</RefSource><PMID Version="1">10485706</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">axon</Keyword><Keyword MajorTopicYN="N">guidance</Keyword><Keyword MajorTopicYN="N">migration</Keyword><Keyword MajorTopicYN="N">motoneuron</Keyword><Keyword MajorTopicYN="N">netrin</Keyword><Keyword MajorTopicYN="N">parachordal chain</Keyword></KeywordList><CoiStatement>No competing interests were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29417095</ArticleId><ArticleId IdType="doi">10.12688/wellcomeopenres.12394.1</ArticleId><ArticleId IdType="pmc">PMC5785718</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29416773</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>05</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma.</ArticleTitle><Pagination><MedlinePgn>2304-2319</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.23409</ELocationID><Abstract><AbstractText>Fewer than 50% of patients with high-risk neuroblastoma survive five years after diagnosis with current treatment protocols. Molecular targeted therapies are expected to improve survival. Although MDM2 has been validated as a promising target in preclinical models, no MDM2 inhibitors have yet entered clinical trials for neuroblastoma patients. Toxic side effects, poor bioavailability and low efficacy of the available MDM2 inhibitors that have entered phase I/II trials drive the development of novel MDM2 inhibitors with an improved risk-benefit profile. We investigated the effect of the novel MDM2 small molecular inhibitor, DS-3032b, on viability, proliferation, senescence, migration, cell cycle arrest and apoptosis in a panel of six neuroblastoma cell lines with different<i>TP53</i>and<i>MYCN</i>genetic backgrounds, and assessed efficacy in a murine subcutaneous model for high-risk neuroblastoma. Re-analysis of existing expression data from 476 primary neuroblastomas showed that high-level<i>MDM2</i>expression correlated with poor patient survival. DS-3032b treatment enhanced TP53 target gene expression and induced G1 cell cycle arrest, senescence and apoptosis. CRISPR-mediated<i>MDM2</i>knockout in neuroblastoma cells mimicked DS-3032b treatment. TP53 signaling was selectively activated by DS-3032b in neuroblastoma cells with wildtype<i>TP53</i>, regardless of the presence of<i>MYCN</i>amplification, but was significantly reduced by<i>TP53</i>mutations or expression of a dominant-negative TP53 mutant. Oral DS-3032b administration inhibited xenograft tumor growth and prolonged mouse survival. Our<i>in vitro</i>and<i>in vivo</i>data demonstrate that DS-3032b reactivates TP53 signaling even in the presence of<i>MYCN</i>amplification in neuroblastoma cells, to reduce proliferative capacity and cause cytotoxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arnhold</LastName><ForeName>Viktor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health (BIH), Anna-Louisa-Karsch 2, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmelz</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proba</LastName><ForeName>Jutta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wünschel</LastName><ForeName>Jasmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toedling</LastName><ForeName>Joern</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deubzer</LastName><ForeName>Hedwig E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health (BIH), Anna-Louisa-Karsch 2, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroblastoma Research Group, Experimental and Clinical Research Center (ECRC), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Künkele</LastName><ForeName>Annette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health (BIH), Anna-Louisa-Karsch 2, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggert</LastName><ForeName>Angelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health (BIH), Anna-Louisa-Karsch 2, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Cancer Consortium (DKTK), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulte</LastName><ForeName>Johannes H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health (BIH), Anna-Louisa-Karsch 2, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Cancer Consortium (DKTK), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hundsdoerfer</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health (BIH), Anna-Louisa-Karsch 2, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Jan 31;8(5):8921-8946</RefSource><PMID Version="1">27888811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2009 Nov 18;101(22):1562-74</RefSource><PMID Version="1">19903807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1984 Jun 8;224(4653):1121-4</RefSource><PMID Version="1">6719137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2010 Jun 10;362(23):2202-11</RefSource><PMID Version="1">20558371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2006 Oct 1;66(19):9646-55</RefSource><PMID Version="1">17018622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):731-6</RefSource><PMID Version="1">15644444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2011 Dec 15;2:e243</RefSource><PMID Version="1">22170099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Chem Int Ed Engl. 2011 Mar 14;50(12 ):2680-8</RefSource><PMID Version="1">21341346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechniques. 2009 Apr;46(4):265-74</RefSource><PMID Version="1">19450233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1993 Feb;12 (2):461-8</RefSource><PMID Version="1">8440237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cancer. 2016 Sep;7(9-10):278-287</RefSource><PMID Version="1">28050229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2006 Sep;5(9):2358-65</RefSource><PMID Version="1">16985070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasia. 2009 Aug;11(8):753-62</RefSource><PMID Version="1">19649205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Oncol. 2015 Jun;37(2):111-5</RefSource><PMID Version="1">26112937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2010 Feb 15;16(4):1108-18</RefSource><PMID Version="1">20145180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2016 Sep;37(9):865-76</RefSource><PMID Version="1">27328919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2013 Jul 25;56(14 ):5979-83</RefSource><PMID Version="1">23808545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Blood Cancer. 2014 Oct;61(10 ):1867-70</RefSource><PMID Version="1">24391119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2011 Sep 1;10 (17 ):2994-3002</RefSource><PMID Version="1">21862876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2015 Sep 20;33(27):3008-17</RefSource><PMID Version="1">26304901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Apr 20;43(7):e47</RefSource><PMID Version="1">25605792</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2007;2(2):329-33</RefSource><PMID Version="1">17406593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1993 Sep 1;53(17):4053-8</RefSource><PMID Version="1">8358734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2015 Aug 13;34(33):4300-10</RefSource><PMID Version="1">25417702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2004 Nov 24;119(5):591-602</RefSource><PMID Version="1">15550242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2004 Feb 6;303(5659):844-8</RefSource><PMID Version="1">14704432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1993 Nov 1;53(21):5284-8</RefSource><PMID Version="1">8221663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2008 Feb 7;27(7):997-1003</RefSource><PMID Version="1">17700533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Apr 30;6(12 ):10207-21</RefSource><PMID Version="1">25844600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Genet. 2013;82:1-45</RefSource><PMID Version="1">23721719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2016 Feb 15;22(4):868-76</RefSource><PMID Version="1">26459177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2014 Mar;13(3):217-36</RefSource><PMID Version="1">24577402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Top Microbiol Immunol. 2011;348:151-72</RefSource><PMID Version="1">21046355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2013 Apr 11;4:e586</RefSource><PMID Version="1">23579273</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Feb 15;70(4):1377-88</RefSource><PMID Version="1">20145147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Blood Cancer. 2013 Apr;60(4):633-41</RefSource><PMID Version="1">22753001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2012 Nov;13(11):1133-40</RefSource><PMID Version="1">23084521</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Aug 20;29(24):3286-92</RefSource><PMID Version="1">21768459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2002;18 Suppl 1:S96-104</RefSource><PMID Version="1">12169536</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2012 Feb 9;31(6):752-63</RefSource><PMID Version="1">21725357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2014 Aug 12;111(4):716-25</RefSource><PMID Version="1">24921920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Discov. 2015;1:null</RefSource><PMID Version="1">26998348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Dec 13;7(50):82757-82769</RefSource><PMID Version="1">27764791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1993 Nov 1;53(21):5269-73</RefSource><PMID Version="1">8221661</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CDKN1A</Keyword><Keyword MajorTopicYN="N">MYCN</Keyword><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">pediatric tumors</Keyword><Keyword MajorTopicYN="N">targeted therapy</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29416773</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.23409</ArticleId><ArticleId IdType="pii">23409</ArticleId><ArticleId IdType="pmc">PMC5788641</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29416673</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Splice variants of the endonucleases XPF and XPG contain residual DNA repair capabilities and could be a valuable tool for personalized medicine.</ArticleTitle><Pagination><MedlinePgn>1012-1027</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.23105</ELocationID><Abstract><AbstractText>The two endonucleases XPF and XPG are essentially involved in nucleotide excision repair (NER) and interstrand crosslink (ICL) repair. Defects in these two proteins result in severe diseases like xeroderma pigmentosum (XP). We applied our newly CRISPR/Cas9 generated human<i>XPF</i>knockout cell line with complete loss of XPF and primary fibroblasts from an XP-G patient (XP20BE) to analyze until now uncharacterized spontaneous mRNA splice variants of these two endonucleases. Functional analyses of these variants were performed using luciferase-based reporter gene assays. Two<i>XPF</i>and<i>XPG</i>splice variants with residual repair capabilities in NER, as well as ICL repair could be identified. Almost all variants are severely C-terminally truncated and lack important protein-protein interaction domains. Interestingly, XPF-202, differing to XPF-003 in the first 12 amino acids only, had no repair capability at all, suggesting an important role of this region during DNA repair, potentially concerning protein-protein interaction. We also identified splice variants of<i>XPF</i>and<i>XPG</i>exerting inhibitory effects on NER. Moreover, we showed that the XPF and XPG splice variants presented with different inter-individual expression patterns in healthy donors, as well as in various tissues. With regard to their residual repair capability and dominant-negative effects, functionally relevant spontaneous<i>XPF</i>and<i>XPG</i>splice variants present promising prognostic marker candidates for individual cancer risk, disease outcome, or therapeutic success. This merits further investigations, large association studies, and translational research within clinical trials in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Janin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schubert</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Information Network of Departments of Dermatology (IVDK), University Medical Center Goettingen, Goettingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seebode</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apel</LastName><ForeName>Antje</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Venereology and Allergology, University Medical Center Goettingen, Goettingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohlenbusch</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Goettingen, Goettingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emmert</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, Venereology and Allergology, University Medical Center Goettingen, Goettingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Nov 15;20(22):6540-9</RefSource><PMID Version="1">11707424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 May 8;54(3):460-71</RefSource><PMID Version="1">24726325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14452-5</RefSource><PMID Version="1">8962072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2015 Dec 22;113(12 ):1687-93</RefSource><PMID Version="1">26633559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Biol. 2013 Oct 01;5(10):a012609</RefSource><PMID Version="1">24086042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2010 Oct 8;40(1):50-62</RefSource><PMID Version="1">20932474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Jul 10;35(1):116-27</RefSource><PMID Version="1">19595721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2011 Jun 10;10(6):603-10</RefSource><PMID Version="1">21546323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Aug 25;275(34):26632-6</RefSource><PMID Version="1">10882712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Dec 21;444(7122):1038-43</RefSource><PMID Version="1">17183314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2013;6(2):199-211</RefSource><PMID Version="1">23330005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2005 Jun;26(6):1085-90</RefSource><PMID Version="1">15731165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2010 Mar;1803(3):386-95</RefSource><PMID Version="1">20080130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1996 Oct;107(4):647-53</RefSource><PMID Version="1">8823375</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Transl Med. 2009 May 25;7:36</RefSource><PMID Version="1">19467152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2013 Jul;133(7):1841-9</RefSource><PMID Version="1">23370536</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2012 Aug 29;31(17):3550-63</RefSource><PMID Version="1">22863773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Feb 25;280(8):7030-7</RefSource><PMID Version="1">15590680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathol Res Pract. 2013 Jun;209(6):331-6</RefSource><PMID Version="1">23702380</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2011 Oct 21;413(2):337-46</RefSource><PMID Version="1">21875596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2004 Dec;24(24):10670-80</RefSource><PMID Version="1">15572672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Nov 1;40(20):9990-10004</RefSource><PMID Version="1">22941649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1997 Feb 3;16(3):625-38</RefSource><PMID Version="1">9034344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2017 Jun;74(11):2081-2094</RefSource><PMID Version="1">28130555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2010 Mar 05;6(3):e1000871</RefSource><PMID Version="1">20221251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2011 Dec;31(12):4135-9</RefSource><PMID Version="1">22199271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Graph Model. 2016 Apr;65:71-82</RefSource><PMID Version="1">26939044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Exp Med Biol. 2008;637:83-92</RefSource><PMID Version="1">19181113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1985 Jun 6-12;315(6019):458-9</RefSource><PMID Version="1">3889660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2004 Jun 20;110(3):352-61</RefSource><PMID Version="1">15095299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 May 4;3(5):505-13</RefSource><PMID Version="1">15084312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1995 Jun;104(6):933-6</RefSource><PMID Version="1">7769261</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e51329</RefSource><PMID Version="1">23272099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Sep 28;11(9):e0163328</RefSource><PMID Version="1">27681508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2004 Jan;24(1):123-34</RefSource><PMID Version="1">14673148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dtsch Dermatol Ges. 2014 Oct;12(10):867-72</RefSource><PMID Version="1">25262888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1998 Sep 15;26(18):4146-52</RefSource><PMID Version="1">9722633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jun 17;10(6):e0126898</RefSource><PMID Version="1">26083491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(6):e39249</RefSource><PMID Version="1">22745723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2013 Jul;133(7):1813-21</RefSource><PMID Version="1">23407396</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 Jul 10;138(1):78-89</RefSource><PMID Version="1">19596236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Apr 15;61(8):3321-5</RefSource><PMID Version="1">11309287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2003 Feb 19;95(4):308-15</RefSource><PMID Version="1">12591987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13122-7</RefSource><PMID Version="1">9371810</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Apr 1;29(7):1443-52</RefSource><PMID Version="1">11266544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Exp Biol. 2011 Nov;49(11):836-9</RefSource><PMID Version="1">22126014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2002 Jun;118(6):972-82</RefSource><PMID Version="1">12060391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2000 Nov;20(21):7980-90</RefSource><PMID Version="1">11027268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasia. 2000 Sep-Oct;2(5):426-32</RefSource><PMID Version="1">11191109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Jul 10;35(1):128-35</RefSource><PMID Version="1">19595722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2015 Mar;36(3):1549-59</RefSource><PMID Version="1">25355595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2002 Aug 15;30(16):3624-31</RefSource><PMID Version="1">12177305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2013 May 2;92(5):807-19</RefSource><PMID Version="1">23623389</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2006 Jul 1;119(Pt 13):2635-41</RefSource><PMID Version="1">16787944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Oct;21(10):1821-5</RefSource><PMID Version="1">11023539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 Jan;27(1):84-94</RefSource><PMID Version="1">16081512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eurasian J Med. 2014 Jun;46(2):84-8</RefSource><PMID Version="1">25610304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2002 Sep 1;30(17):3848-56</RefSource><PMID Version="1">12202770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2015 Jan 8;57(1):123-37</RefSource><PMID Version="1">25533188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2011 Jun;32(6):678-87</RefSource><PMID Version="1">21394826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Drug Metab. 2011 Dec;12(10):966-74</RefSource><PMID Version="1">21787266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1996 Nov;16(11):6553-62</RefSource><PMID Version="1">8887684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 2013 Jul;84(1):12-24</RefSource><PMID Version="1">23580445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2012 Oct 1;11(10):844-52</RefSource><PMID Version="1">22954786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Aug;28(16):5082-92</RefSource><PMID Version="1">18541667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Jun;35(6):5561-7</RefSource><PMID Version="1">24615519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Biochem. 2004 Jul;37(7):584-94</RefSource><PMID Version="1">15234240</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2000 Oct 16;19(20):5552-61</RefSource><PMID Version="1">11032822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Med. 2013 Apr 17;5(4):33</RefSource><PMID Version="1">23594586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2017 Jul 14;36(14 ):2047-2060</RefSource><PMID Version="1">28607004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1995 Apr;15(4):1993-8</RefSource><PMID Version="1">7891694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 1997 Nov;6(12):2011-9</RefSource><PMID Version="1">9328464</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">interstrand crosslink repair</Keyword><Keyword MajorTopicYN="N">nucleotide excision repair</Keyword><Keyword MajorTopicYN="N">spontaneous mRNA splice variants</Keyword><Keyword MajorTopicYN="N">xeroderma pigmentosum</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29416673</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.23105</ArticleId><ArticleId IdType="pii">23105</ArticleId><ArticleId IdType="pmc">PMC5787415</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29416123</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1751-7370</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>The ISME journal</Title><ISOAbbreviation>ISME J</ISOAbbreviation></Journal><ArticleTitle>Lysogeny is prevalent and widely distributed in the murine gut microbiota.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41396-018-0061-9</ELocationID><Abstract><AbstractText>Bacteriophages are central members and potential modulators of the gut microbiome; however, the ecological and evolutionary relationships of gut bacteria and phages are poorly understood. Here we investigated the abundance and diversity of lysogenic bacteria (lysogens) in the bacterial community of C57BL/6J mice by detecting integrated prophages in genomes reconstructed from the metagenome of commensal bacteria. For the activities of lysogens and prophages, we compared the prophage genomes with the metagenome of free phages. The majority of commensal bacteria in different taxa were identified as lysogens. More lysogens were found among Firmicutes and Proteobacteria, than among Bacteroidetes and Actinobacteria. The prophage genomes shared high sequence similarity with the metagenome of free phages, indicating that most lysogens appeared to be active, and that prophages are spontaneously induced as active phages; dietary interventions changed the composition of the induced prophages. By contrast, CRISPR-Cas systems were present in few commensal bacteria, and were rarely active against gut phages. The structure of the bacteria-phage infection networks was "nested-modular", with modularity emerging across taxonomic scales, indicating that temperate phage features have developed over a long phylogenetic timescale. We concluded that phage generalists contribute to the prevalence of lysogeny in the gut ecosystem.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min-Soo</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biology and Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Jin-Woo</ForeName><Initials>JW</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6433-5270</Identifier><AffiliationInfo><Affiliation>Department of Biology and Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea. baejw@khu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ISME J</MedlineTA><NlmUniqueID>101301086</NlmUniqueID><ISSNLinking>1751-7362</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29416123</ArticleId><ArticleId IdType="doi">10.1038/s41396-018-0061-9</ArticleId><ArticleId IdType="pii">10.1038/s41396-018-0061-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29416011</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.</ArticleTitle><Pagination><MedlinePgn>168</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-017-0246-6</ELocationID><Abstract><AbstractText>Emerging evidence indicates that lncRNAs play important roles in cancer tumourigenesis and could be used as potential diagnostic biomarkers or therapeutic targets. However, the clinical significance and molecular mechanism of lncRNAs in gastric cancer (GC) is still unclear. The aim of this study was to explore the expression and role of lncRNAs in GC. The relative expression level of lncRNAs in GC samples was examined by an lncRNA microarray analysis, northern blot analysis and qRT-PCR analysis. A Kaplan-Meier survival analysis and univariate and multivariate Cox proportional hazards models were performed to evaluate the clinical and prognostic significance of PANDAR (promoter of CDKN1A antisense DNA damage activated RNA) in GC patients. The binding activity of PANDAR with the p53 protein was analysed by an RNA immunoprecipitation analysis and RNA pull-down analysis. The depletion of PANDAR was conducted using the CRISPR/Cas9 system for PANDAR. The biological functions of PANDAR in GC cells were determined both in vitro and in vivo. Upregulated PANDAR in GC patients was positively correlated with increased tumour size, advanced TNM classification and a poor survival rate in GC patients. The ROC curves identified that the PANDAR level was a marker for discriminating the early-stage tumour group from the healthy group, the metastasis group from the non-metastasis group and the chemoresistance group from the chemosensitive group in GC patients. As a target, the CDKN1A gene was successfully downregulated by PANDAR. PANDAR controlled the transcription of the CDKN1A gene by competitively binding with p53 protein. In combination with a p53 activator (nutlin3), the knockout of PANDAR by CRISPR/Cas9 technology synergistically inhibited GC tumour growth in vivo. Our results suggest that the PANDAR is a powerful diagnostic and therapeutic marker for patients with GC and, combined with other chemotherapeutics, may have distinct antitumour effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 200080, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben</LastName><ForeName>Qiwen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Eryi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Stomatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200127, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xiangyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaoqun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pathology, Fudan University Shanghai Cancer Centre, 200032, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Integrative Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Integrative Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiming</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Oncology, Zhongshan Hospital, Fudan University, 200032, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tianshu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Oncology, Zhongshan Hospital, Fudan University, 200032, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jianjun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 200011, Shanghai, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongxia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 200080, Shanghai, PR China. whx365@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Crit Rev Oncol Hematol. 2009 Aug;71(2):127-64</RefSource><PMID Version="1">19230702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Mar 28;319(5871):1787-9</RefSource><PMID Version="1">18369136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Nov 25;468(7323):519-20</RefSource><PMID Version="1">21107421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Feb 8;445(7128):661-5</RefSource><PMID Version="1">17251932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Onco Targets Ther. 2016 Sep 16;9:5713-5720</RefSource><PMID Version="1">27695348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2015 Feb 26;6:e1665</RefSource><PMID Version="1">25719249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2014 Aug 15;4:6088</RefSource><PMID Version="1">25124853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2017 May 25;17 (1):373</RefSource><PMID Version="1">28545465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Immunol. 2014 Nov 13;5:573</RefSource><PMID Version="1">25431574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2014 Dec 1;74(23):6890-902</RefSource><PMID Version="1">25277524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocrinology. 2010 Mar;151(3):939-47</RefSource><PMID Version="1">20032057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Onco Targets Ther. 2017 Jun 06;10 :2873-2883</RefSource><PMID Version="1">28652769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2017 May 11;8(5):e2772</RefSource><PMID Version="1">28492542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Feb 8;445(7128):666-70</RefSource><PMID Version="1">17237763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2016 May 20;35(1):83</RefSource><PMID Version="1">27206339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11667-72</RefSource><PMID Version="1">19571010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2014 Dec 11;14:932</RefSource><PMID Version="1">25496320</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Pharmacother. 2016 Mar;78:172-176</RefSource><PMID Version="1">26898439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 Dec 29;127(7):1323-34</RefSource><PMID Version="1">17182091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013 Mar;9(3):e1003368</RefSource><PMID Version="1">23555285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2017 Feb 9;8(2):e2605</RefSource><PMID Version="1">28182000</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2014 Apr 30;5(8):2318-29</RefSource><PMID Version="1">24810858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2011 Jun 05;43(7):621-9</RefSource><PMID Version="1">21642992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2015 Mar 23;32(6):693-706</RefSource><PMID Version="1">25805135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2012 Aug 24;47(4):648-55</RefSource><PMID Version="1">22841487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2014 May;50(7):1330-44</RefSource><PMID Version="1">24650579</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014 Aug 27;15(8):428</RefSource><PMID Version="1">25315765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2013 Oct 15;133(8):1859-66</RefSource><PMID Version="1">23564267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2016 Feb 22;17 :24</RefSource><PMID Version="1">26898989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2014 May 06;14:319</RefSource><PMID Version="1">24884417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2017 Jan;143(1):71-81</RefSource><PMID Version="1">27629879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Oct 10;8(10):e77070</RefSource><PMID Version="1">24130837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 01;6:22366</RefSource><PMID Version="1">26927017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Mar 12;16:52</RefSource><PMID Version="1">25887447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2016 Apr;36(4):1605-11</RefSource><PMID Version="1">27069137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2017 Jan;37(1):81-85</RefSource><PMID Version="1">28011477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2015 Jun;34(25):3283-95</RefSource><PMID Version="1">25151965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Pharmacother. 2015 May;72:113-8</RefSource><PMID Version="1">26054684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2009 Feb 20;136(4):629-41</RefSource><PMID Version="1">19239885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2003 Jul;4(7):415-22</RefSource><PMID Version="1">12850192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12956-61</RefSource><PMID Version="1">19625619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Apr 15;464(7291):1071-6</RefSource><PMID Version="1">20393566</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29416011</ArticleId><ArticleId IdType="doi">10.1038/s41419-017-0246-6</ArticleId><ArticleId IdType="pii">10.1038/s41419-017-0246-6</ArticleId><ArticleId IdType="pmc">PMC5833854</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29415333</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-4141</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>European journal of immunology</Title><ISOAbbreviation>Eur. J. Immunol.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9: A tool for immunological research.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/eji.201747131</ELocationID><Abstract><AbstractText>The CRISPR/Cas9-system was originally identified as part of the adaptive immune system in bacteria and has since been adapted for the genetic manipulation of eukaryotic cells. The technique is of particular value for biomedical sciences, as it enables the genetic manipulation of cell lines and primary cells as well as whole organisms with unprecedented ease and efficiency. Furthermore, the CRISPR/Cas9-technology has the potential for future therapeutic applications in the clinic. Here, we discuss the use of CRISPR/Cas9 for the genetic modification of haematopoietic cells and the generation of mouse models for immunological research. Additionally, we explain how the technique can be applied as a screening-tool to identify genes involved in different immunological processes. Moreover, we will talk about recent extensions of using the CRISPR/Cas9 technology, such as a transcriptional activator or repressor. Finally, we discuss the first clinical trials that use CRISPR/Cas9 and discuss potential future applications.</AbstractText><CopyrightInformation>© 2018 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hochheiser</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, The University of Melbourne, the Peter Doherty Institute for Infection &amp; Immunity, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kueh</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>The Walter &amp; Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebhardt</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, The University of Melbourne, the Peter Doherty Institute for Infection &amp; Immunity, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herold</LastName><ForeName>Marco J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7539-7581</Identifier><AffiliationInfo><Affiliation>The Walter &amp; Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Immunol</MedlineTA><NlmUniqueID>1273201</NlmUniqueID><ISSNLinking>0014-2980</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Animal models</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Clinical trials</Keyword><Keyword MajorTopicYN="N">Gene therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29415333</ArticleId><ArticleId IdType="doi">10.1002/eji.201747131</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29414415</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-7753</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>02</Day></PubDate></JournalIssue><Title>Stem cell research</Title><ISOAbbreviation>Stem Cell Res</ISOAbbreviation></Journal><ArticleTitle>Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.</ArticleTitle><Pagination><MedlinePgn>29-32</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1873-5061(18)30027-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scr.2018.01.021</ELocationID><Abstract><AbstractText>The Retinoblastoma 1 (RB1) tumor suppressor, a member of the Retinoblastoma gene family, functions as a pocket protein for the functional binding of E2F transcription factors. About 1/3 of retinoblastoma patients harbor a germline RB1 mutation or deletion, leading to the development of retinoblastoma. Here, we demonstrate generation of a heterozygous deletion of the RB1 gene in the H1 human embryonic stem cell line using CRISPR/Cas9 nickase genome editing. The RB1 heterozygous knockout H1 cell line shows a normal karyotype, maintains a pluripotent state, and is capable of differentiation to the three germline layers.</AbstractText><CopyrightInformation>Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Zijun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Donghui</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>An</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ruoji</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gingold</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Women's Health Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Jingnan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China. Electronic address: shenjingnan@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ruiying</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Electronic address: ruiying.zhao@uth.tmc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dung-Fang</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA; Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Center for Precision Health, School of Biomedical Informatics and School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Electronic address: dung-fang.lee@uth.tmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 CA181496</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stem Cell Res</MedlineTA><NlmUniqueID>101316957</NlmUniqueID><ISSNLinking>1873-5061</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29414415</ArticleId><ArticleId IdType="pii">S1873-5061(18)30027-8</ArticleId><ArticleId IdType="doi">10.1016/j.scr.2018.01.021</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29414054</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0429</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><PubDate><Year>2018</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Current opinion in biotechnology</Title><ISOAbbreviation>Curr. Opin. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Hijacking CRISPR-Cas for high-throughput bacterial metabolic engineering: advances and prospects.</ArticleTitle><Pagination><MedlinePgn>146-157</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0958-1669(17)30199-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.copbio.2018.01.002</ELocationID><Abstract><AbstractText>High engineering efficiencies are required for industrial strain development. Due to its user-friendliness and its stringency, CRISPR-Cas-based technologies have strongly increased genome engineering efficiencies in bacteria. This has enabled more rapid metabolic engineering of both the model host Escherichia coli and non-model organisms like Clostridia, Bacilli, Streptomycetes and cyanobacteria, opening new possibilities to use these organisms as improved cell factories. The discovery of novel Cas9-like systems from diverse microbial environments will extend the repertoire of applications and broaden the range of organisms in which it can be used to create novel production hosts. This review analyses the current status of prokaryotic metabolic engineering towards the production of biotechnologically relevant products, based on the exploitation of different CRISPR-related DNA/RNA endonuclease variants.</AbstractText><CopyrightInformation>Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mougiakos</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosma</LastName><ForeName>Elleke F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet B220, 2800 Kgs. Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganguly</LastName><ForeName>Joyshree</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Corbion, Arkelsedijk 46, 4206 AC Gorinchem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Oost</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Kranenburg</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands; Corbion, Arkelsedijk 46, 4206 AC Gorinchem, The Netherlands. Electronic address: richard.vankranenburg@wur.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Biotechnol</MedlineTA><NlmUniqueID>9100492</NlmUniqueID><ISSNLinking>0958-1669</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29414054</ArticleId><ArticleId IdType="pii">S0958-1669(17)30199-4</ArticleId><ArticleId IdType="doi">10.1016/j.copbio.2018.01.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29413969</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0410</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Current opinion in cell biology</Title><ISOAbbreviation>Curr. Opin. Cell Biol.</ISOAbbreviation></Journal><ArticleTitle>Tracking the origin, development, and differentiation of hematopoietic stem cells.</ArticleTitle><Pagination><MedlinePgn>108-115</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0955-0674(17)30160-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ceb.2018.01.002</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">The hierarchical nature of the hematopoietic system provides an ideal model system to illustrate the features of lineage tracing. We have outlined the utility of lineage tracing methods in establishing the origin and development of hematopoietic cells.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Methods such as CRISPR/Cas9, Polylox barcoding, and single-cell RNA-sequencing have improved our understanding of hematopoiesis.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">This review chronicles the fate of the hematopoietic cells emerging from the mesoderm that subsequently develops into the adult blood lineages. Specifically, we explain classic techniques utilized in lineage tracing for the hematopoietic system, as well as novel state-of-the-art methods to elucidate clonal hematopoiesis and cell fate mapping at a single-cell level.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dharampuriya</LastName><ForeName>Priyanka R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scapin</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Colline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Boston College, Chestnut Hill, MA 02467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John Wagner</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Boston College, Chestnut Hill, MA 02467, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cillis</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Dhvanit I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02138, USA; Dana-Farber/Harvard Cancer Center, Boston, MA 02115, USA. Electronic address: dshah@research.bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL131645</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Cell Biol</MedlineTA><NlmUniqueID>8913428</NlmUniqueID><ISSNLinking>0955-0674</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2011 Jul 8;9(1):64-73</RefSource><PMID Version="1">21726834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genesis. 2007 May;45(5):237-58</RefSource><PMID Version="1">17440924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2011 Dec 19;208(13):2691-703</RefSource><PMID Version="1">22110168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2011 Jul 8;333(6039):218-21</RefSource><PMID Version="1">21737740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1985 Aug;42(1):71-9</RefSource><PMID Version="1">4016956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1996 Sep 20;86(6):897-906</RefSource><PMID Version="1">8808625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2003 Sep;4(9):866-73</RefSource><PMID Version="1">12925850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jul 02;10(7):e0131722</RefSource><PMID Version="1">26133370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Hematol. 2014 Aug;42(8):707-16</RefSource><PMID Version="1">25014737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Dev Biol. 2010;54(6-7):1151-63</RefSource><PMID Version="1">20711992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Immunol. 2008 Aug;20(4):207-12</RefSource><PMID Version="1">18583148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1990 Feb;4(2):220-32</RefSource><PMID Version="1">1970972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2017 Aug;591(15):2213-2225</RefSource><PMID Version="1">28524227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Jan 20;148(1-2):33-45</RefSource><PMID Version="1">22265400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 1994 Nov;1(8):661-73</RefSource><PMID Version="1">7541305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Aug 24;548(7668):456-460</RefSource><PMID Version="1">28813413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):773-7</RefSource><PMID Version="1">7846049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2015 Jan 7;85(1):49-59</RefSource><PMID Version="1">25569347</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1986 Jun 20;45(6):917-27</RefSource><PMID Version="1">2871944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 1999 Sep;11(3):299-308</RefSource><PMID Version="1">10514008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Feb 23;168(5):944-945</RefSource><PMID Version="1">28235203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Differ. 1978 Jun;7(3):115-30</RefSource><PMID Version="1">667951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1986 Feb 28;44(4):653-62</RefSource><PMID Version="1">2868799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Hematol. 2007 Feb;35(2):314-25</RefSource><PMID Version="1">17258080</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 1997 Nov;68(1-2):3-25</RefSource><PMID Version="1">9431800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2005 Apr 22;121(2):295-306</RefSource><PMID Version="1">15851035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2005 Mar;8(3):365-75</RefSource><PMID Version="1">15737932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2015 May 4;212(5):665-80</RefSource><PMID Version="1">25870199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Feb 12;457(7231):892-5</RefSource><PMID Version="1">19182774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2014 Oct 16;124(16):2523-32</RefSource><PMID Version="1">25139355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Chem. 2009 Aug 15;81(16):6813-22</RefSource><PMID Version="1">19601617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Nov;10(11):1096-8</RefSource><PMID Version="1">24056875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Jan 11;481(7382):506-10</RefSource><PMID Version="1">22237025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2016 Aug 25;128(8):e20-31</RefSource><PMID Version="1">27365425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Phys Lipids. 2011 Oct;164(7):636-42</RefSource><PMID Version="1">21722629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Immunol. 2013 Sep-Oct;285(1-2):141-8</RefSource><PMID Version="1">24185280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2015 Dec 24;126(26):2811-20</RefSource><PMID Version="1">26385351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Sep 21;443(7109):337-9</RefSource><PMID Version="1">16988712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2015 Jun 4;16(6):712-24</RefSource><PMID Version="1">26004780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Feb 12;457(7231):896-900</RefSource><PMID Version="1">19212410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Jun 12;510(7504):268-72</RefSource><PMID Version="1">24776803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2005 Mar;8(3):377-87</RefSource><PMID Version="1">15737933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2010 Jun 7;207 (6):1173-82</RefSource><PMID Version="1">20421392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2012 Oct;33(29):6987-97</RefSource><PMID Version="1">22800538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2004;22(2):158-68</RefSource><PMID Version="1">14990855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Apr 1;115(13):2610-8</RefSource><PMID Version="1">20093403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2008 Dec 4;3(6):625-36</RefSource><PMID Version="1">19041779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2001 Dec 15;167(12):6834-40</RefSource><PMID Version="1">11739500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2012 Aug;393(8):731-47</RefSource><PMID Version="1">22944676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Feb 22;132(4):631-44</RefSource><PMID Version="1">18295580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Mater Res A. 2006 Dec 1;79(3):689-97</RefSource><PMID Version="1">16845670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 1999 Jun;126(11):2563-75</RefSource><PMID Version="1">10226014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2008 May;237(5):1218-31</RefSource><PMID Version="1">18429046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 1993 Oct;159(2):706-19</RefSource><PMID Version="1">8405690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2011 Dec 2;9(6):541-52</RefSource><PMID Version="1">22136929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Rev. 2013 Jul;26(3):547-603</RefSource><PMID Version="1">23824373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2011 Oct 02;29(10):928-33</RefSource><PMID Version="1">21964413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1997 Mar 15;11(6):774-85</RefSource><PMID Version="1">9087431</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Aug 23;341(6148):1233151</RefSource><PMID Version="1">23845947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Mar 4;464(7285):108-11</RefSource><PMID Version="1">20154733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2000 Jun 1;19(11):2465-74</RefSource><PMID Version="1">10835345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2007 Aug 16;1(2):218-29</RefSource><PMID Version="1">18371352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 1999 Nov;126(22):5073-84</RefSource><PMID Version="1">10529424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1370-9</RefSource><PMID Version="1">23992847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1999 Jul 5;190(1):75-89</RefSource><PMID Version="1">10429672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Apr 28;117(17):4600-8</RefSource><PMID Version="1">21378272</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Nov 17;539(7629):384-389</RefSource><PMID Version="1">27820943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1988 Dec 1;141(11):3697-707</RefSource><PMID Version="1">2460547</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Ecol. 2004 Sep 1;49(3):455-67</RefSource><PMID Version="1">19712294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2000 Oct;13(4):423-31</RefSource><PMID Version="1">11070161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1987 Dec 20;6(13):3955-60</RefSource><PMID Version="1">2832146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2017 Jan 19;129(3):307-318</RefSource><PMID Version="1">27827829</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29413969</ArticleId><ArticleId IdType="pii">S0955-0674(17)30160-6</ArticleId><ArticleId IdType="doi">10.1016/j.ceb.2018.01.002</ArticleId><ArticleId IdType="pmc">PMC5821519</ArticleId><ArticleId IdType="mid">NIHMS934535</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29413750</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5875</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The international journal of biochemistry &amp; cell biology</Title><ISOAbbreviation>Int. J. Biochem. Cell Biol.</ISOAbbreviation></Journal><ArticleTitle>Barhl1 is required for the differentiation of inner ear hair cell-like cells from mouse embryonic stem cells.</ArticleTitle><Pagination><MedlinePgn>79-89</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1357-2725(18)30019-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biocel.2018.01.013</ELocationID><Abstract><AbstractText>Inner ear hair cells are mechanoreceptors responsible for hearing. Pathogenic defects of hair cell-specific genes are one of the major causes of deafness. The BarH class homeobox gene Barhl1 is a deafness gene expressed in developing hair cells, yet the role of Barhl1 during hair cell development remains poorly understood. In the present study, we first established an in vitro differentiation system to efficiently obtain mouse embryonic stem cell (mESC)-derived hair cell-like cells. Subsequently, a mESC line carrying a targeted disruption of Barhl1 was generated using CRISPR/Cas9 technology and subjected to the established in vitro hair cell differentiation protocol. Targeted disruption of Barhl1 does not affect the induction of mESCs toward early primitive ectoderm-like (EPL) cells and otic progenitors but strongly inhibits the differentiation of hair cell-like cells. Using RNA-sequencing and bioinformatics, we further unravel the molecular mechanism underlying Barhl1-mediated hair cell development. Our data demonstrate the essential role of Barhl1 during hair cell development and provide a basis for the treatment of Barhl1 mutation-based deafness.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhenhuang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xiaocui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cuicui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Jianzhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Minxin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Genetics, School of Medicine, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Liquan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China; Key Laboratory for Cell and Gene Engineering of Zhejiang Province, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinfu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Cell and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: wjfu@zju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Biochem Cell Biol</MedlineTA><NlmUniqueID>9508482</NlmUniqueID><ISSNLinking>1357-2725</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Int J Biochem Cell Biol. 2018 Feb 21;:</RefSource><PMID Version="1">29477628</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Barhl1</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Deafness</Keyword><Keyword MajorTopicYN="N">Differentiation</Keyword><Keyword MajorTopicYN="N">Inner ear hair cells</Keyword><Keyword MajorTopicYN="N">mESCs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29413750</ArticleId><ArticleId IdType="pii">S1357-2725(18)30019-0</ArticleId><ArticleId IdType="doi">10.1016/j.biocel.2018.01.013</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29412130</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2105-0686</ISSN><JournalIssue CitedMedium="Internet"><Volume>211</Volume><Issue>3</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Biologie aujourd'hui</Title><ISOAbbreviation>Biol Aujourdhui</ISOAbbreviation></Journal><ArticleTitle>[CRISPR-Cas9, germinal cells and human embryo].</ArticleTitle><Pagination><MedlinePgn>207-213</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1051/jbio/2017032</ELocationID><Abstract><AbstractText>The performance of the molecular tool using CRISPR-Cas9, which makes it possible to induce targeted modifications of the DNA, has found numerous applications in research and open promising prospects in human clinic. CRISPR-Cas9 has been widely used to generate transgenic animals after targeted modification of the genome at the zygotic stage. It was also tested on human embryos on an experimental basis. Although there are potential medical indications that may justify a targeted modification of the embryo or germ cell genome, the uncertainties regarding the efficacy and safety of the method do not allow us to consider implementing such germline gene therapy in the short-term. However, it is necessary to weigh the scientific and ethical issues involved in this approach.</AbstractText><CopyrightInformation>© Société de Biologie, 2018.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jouannet</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Université Paris Descartes, 12 Rue de l'École de Médecine, 75006 Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>CRISPR-Cas9, cellules germinales et embryon humain.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Biol Aujourdhui</MedlineTA><NlmUniqueID>101544020</NlmUniqueID><ISSNLinking>2105-0678</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29412130</ArticleId><ArticleId IdType="doi">10.1051/jbio/2017032</ArticleId><ArticleId IdType="pii">jbio170032</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29411201</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5535</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of industrial microbiology &amp; biotechnology</Title><ISOAbbreviation>J. Ind. Microbiol. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Characterization of a novel lytic bacteriophage from an industrial Escherichia coli fermentation process and elimination of virulence using a heterologous CRISPR-Cas9 system.</ArticleTitle><Pagination><MedlinePgn>153-163</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10295-018-2015-7</ELocationID><Abstract><AbstractText>Bacterial-bacteriophage interactions are a well-studied and ecologically-important aspect of microbiology. Many commercial fermentation processes are susceptible to bacteriophage infections due to the use of high-density, clonal cell populations. Lytic infections of bacterial cells in these fermentations are especially problematic due to their negative impacts on product quality, asset utilization, and fouling of downstream equipment. Here, we report the isolation and characterization of a novel lytic bacteriophage, referred to as bacteriophage DTL that is capable of rapid lytic infections of an Escherichia coli K12 strain used for commercial production of 1,3-propanediol (PDO). The bacteriophage genome was sequenced and annotated, which identified 67 potential open-reading frames (ORF). The tail fiber ORF, the largest in the genome, was most closely related to bacteriophage RTP, a T1-like bacteriophage reported from a commercial E. coli fermentation process in Germany. To eliminate virulence, both a fully functional Streptococcus thermophilus CRISPR3 plasmid and a customized S. thermophilus CRISPR3 plasmid with disabled spacer acquisition elements and seven spacers targeting the bacteriophage DTL genome were constructed. Both plasmids were separately integrated into a PDO production strain, which was subsequently infected with bacteriophage DTL. The native S. thermophilus CRISPR3 operon was shown to decrease phage susceptibility by approximately 96%, while the customized CRISPR3 operon provided complete resistance to bacteriophage DTL. The results indicate that the heterologous bacteriophage-resistance system described herein is useful in eliminating lytic infections of bacteriophage DTL, which was prevalent in environment surrounding the manufacturing facility.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halter</LastName><ForeName>Mathew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>DuPont Tate &amp; Lyle Bio Products, 198 Blair Bend Drive, Loudon, TN, 37774, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahn</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>DuPont Tate &amp; Lyle Bio Products, 198 Blair Bend Drive, Loudon, TN, 37774, USA. james.a.zahn@dupont.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Ind Microbiol Biotechnol</MedlineTA><NlmUniqueID>9705544</NlmUniqueID><ISSNLinking>1367-5435</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Bacteriophage. 2011 Jan;1(1):31-45</RefSource><PMID Version="1">21687533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2011 Apr;392(4):277-89</RefSource><PMID Version="1">21294681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virology. 2004 Jan 5;318(1):245-66</RefSource><PMID Version="1">14972552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Feb 10;5:8365</RefSource><PMID Version="1">25666585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bacteriophage. 2012 Jul 1;2(3):149-158</RefSource><PMID Version="1">23275866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2012 Jun 15;28(12):1647-9</RefSource><PMID Version="1">22543367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jan;42(Database issue):D206-14</RefSource><PMID Version="1">24293654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Viruses. 2015 Dec 08;7(12):6476-89</RefSource><PMID Version="1">26670247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 2013 Dec;30(12):2725-9</RefSource><PMID Version="1">24132122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2004 Dec;22(12):1554-8</RefSource><PMID Version="1">15543133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Anti Infect Ther. 2011 Sep;9(9):775-85</RefSource><PMID Version="1">21905786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86</RefSource><PMID Version="1">22949671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2008 Feb 08;9:75</RefSource><PMID Version="1">18261238</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2008 Feb;190(4):1401-12</RefSource><PMID Version="1">18065539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Nov;39(21):9275-82</RefSource><PMID Version="1">21813460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Food Sci Technol. 2012;3:143-62</RefSource><PMID Version="1">22224556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Jul;81(13):4295-305</RefSource><PMID Version="1">25888172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Ind Microbiol Biotechnol. 2016 Aug;43(8):1183-8</RefSource><PMID Version="1">27255973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Appl Microbiol. 2009;67:1-45</RefSource><PMID Version="1">19245935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Nov 4;468(7320):67-71</RefSource><PMID Version="1">21048762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jun 25;9(6):e100426</RefSource><PMID Version="1">24963920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Immunol. 2015 Feb;32:36-41</RefSource><PMID Version="1">25574773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Evol. 2005 Feb;60(2):174-82</RefSource><PMID Version="1">15791728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Food Microbiol. 2003 Dec 31;89(2-3):223-31</RefSource><PMID Version="1">14623388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1994 Nov 11;22(22):4673-80</RefSource><PMID Version="1">7984417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2006 Feb;188(4):1419-36</RefSource><PMID Version="1">16452425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e40913</RefSource><PMID Version="1">22911717</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">1,3-Propanediol</Keyword><Keyword MajorTopicYN="N">Bacteriophage</Keyword><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">Industrial fermentation</Keyword><Keyword MajorTopicYN="N">PDO</Keyword><Keyword MajorTopicYN="N">White biotechnology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29411201</ArticleId><ArticleId IdType="doi">10.1007/s10295-018-2015-7</ArticleId><ArticleId IdType="pii">10.1007/s10295-018-2015-7</ArticleId><ArticleId IdType="pmc">PMC5816109</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29411094</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-203X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Plant cell reports</Title><ISOAbbreviation>Plant Cell Rep.</ISOAbbreviation></Journal><ArticleTitle>OsPKS2 is required for rice male fertility by participating in pollen wall formation.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00299-018-2265-x</ELocationID><Abstract><AbstractText Label="KEY MESSAGE" NlmCategory="UNASSIGNED">OsPKS2, the rice orthologous gene of Arabidopsis PKSB/LAP5, encodes a polyketide synthase that is involved in pollen wall formation in rice. In flowering plants, the pollen wall protects male gametes from various environmental stresses and pathogen attacks, as well as promotes pollen germination. The biosynthesis of sporopollenin in tapetal cell is critical for pollen wall formation. Recently, progress has been made in understanding sporopollenin metabolism during pollen wall development in Arabidopsis. However, little is known about the molecular mechanism that underlies the sporopollenin synthesis in pollen wall formation in rice (Oryza sativa). In this study, we identified that a point mutation in OsPKS2, a plant-specific type III polyketide synthase gene, caused male sterility in rice by affecting the normal progress of pollen wall formation. Two other allelic mutants of OsPKS2 were generated using the CRISPR/Cas9 system and are also completely male sterile. This result thus further confirmed that OsPKS2 controls rice male fertility. We also showed that OsPKS2 is an orthologous gene of Arabidopsis PKSB/LAP5 and has a tapetum-specific expression pattern. In addition, its product localizes in the endoplasmic reticulum. Results suggested that OsPKS2 is critical for pollen wall formation, and plays a conserved but differentiated role in sporopollenin biosynthesis from Arabidopsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Economic Plant Biotechnology, Collaborative Innovation Center of Special Plant Industry in Chongqing, Institute of Special Plants, Chongqing University of Arts and Sciences, Yongchuan, 402160, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingxing</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Qiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Guoqiang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Economic Plant Biotechnology, Collaborative Innovation Center of Special Plant Industry in Chongqing, Institute of Special Plants, Chongqing University of Arts and Sciences, Yongchuan, 402160, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Hunan Hybrid Rice Research Center, Changsha, 410125, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yueyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Qiming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shiquan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Aiping</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lingxia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China. liping6575@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China. liping6575@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Hunan Hybrid Rice Research Center, Changsha, 410125, China. liping6575@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shuangcheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Sichuan Agricultural University, Chengdu, 611130, China. lisc926105@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rice Research Institute, Sichuan Agricultural University, 211 Huimin Road, Wenjiang, 611130, Sichuan, China. lisc926105@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Hybrid Rice, Hunan Hybrid Rice Research Center, Changsha, 410125, China. lisc926105@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>91435102</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country>United States</Country></Grant><Grant><GrantID>31570004</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country>United States</Country></Grant><Grant><GrantID>2015JQ0048</GrantID><Agency>the Sichuan provincial founding for Distinguished Young Scholars</Agency><Country>United States</Country></Grant><Grant><GrantID>2016KF10</GrantID><Agency>the Open Research Fund of State Key Laboratory of Hybrid Rice</Agency><Country>United States</Country></Grant><Grant><GrantID>2016NZ0103</GrantID><Agency>the Sichuan Science and Technology Support Project</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Plant Cell Rep</MedlineTA><NlmUniqueID>9880970</NlmUniqueID><ISSNLinking>0721-7714</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Exine</Keyword><Keyword MajorTopicYN="N">OsPKS2</Keyword><Keyword MajorTopicYN="N">PKSB/LAP5</Keyword><Keyword MajorTopicYN="N">Pollen</Keyword><Keyword MajorTopicYN="N">Rice</Keyword><Keyword MajorTopicYN="N">Sporopollenin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29411094</ArticleId><ArticleId IdType="doi">10.1007/s00299-018-2265-x</ArticleId><ArticleId IdType="pii">10.1007/s00299-018-2265-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29408822</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9778</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology</Title><ISOAbbreviation>Cell. Physiol. Biochem.</ISOAbbreviation></Journal><ArticleTitle>Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.</ArticleTitle><Pagination><MedlinePgn>656-666</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000487159</ELocationID><Abstract><AbstractText Label="BACKGROUND/AIMS" NlmCategory="OBJECTIVE">CRISPR-Cas9, a RNA-guided targeted genome editing tool, has revolutionized genetic engineering by offering the ability to precisely modify DNA. GPRC5B is an orphan receptor belonging to the group C family of G protein-coupled receptors (GPCRs). In this study, we analysed the functional roles of the Gprc5b receptor in MIN6 β-cells using CRISPR-Cas9 and transient over-expression of Gprc5b.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The optimal transfection reagent for use in MIN6 β-cells was determined by analysing efficiency of GFP plasmid delivery by cell sorting. A MIN6 β-cell line in which Gprc5b expression was knocked down (Gprc5b KD) was generated using CRISPR-Cas9 technology. Gprc5b receptor mRNA expression, proliferation, apoptosis, Cignal 45-Pathway Reporter Array signalling and western blot assays were carried out using Gpcr5b KD MIN6 β-cells that had been transiently transfected with different concentrations of mouse Gprc5b plasmid to over-express Gprc5b.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">JetPRIME® was the best candidate for MIN6 β-cell transfection, providing approximately 30% transfection efficiency. CRISPR-Cas9 technology targeting Gprc5b led to stable knock-down of this receptor in MIN6 β-cells and its re-expression induced proliferation and potentiated cytokine- and palmitate-induced apoptosis. The Cignal 45 Reporter analysis indicated Gprc5b-dependent regulation of apoptotic and proliferative pathways, and western blotting confirmed activation of signalling via TGF-β and IFNγ.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study provides evidence of CRISPR-Cas9 technology being used to down-regulate Gprc5b expression in MIN6 β-cells. This strategy allowed us to identify signalling pathways linking GPRC5B receptor expression to β-cell proliferation and apoptosis.</AbstractText><CopyrightInformation>© 2018 The Author(s). Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Atanes</LastName><ForeName>Patricio</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ruz-Maldonado</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Hawkes</LastName><ForeName>Ross</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Persaud</LastName><ForeName>Shanta J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Amisten</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Physiol Biochem</MedlineTA><NlmUniqueID>9113221</NlmUniqueID><ISSNLinking>1015-8987</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N"/><Keyword MajorTopicYN="N">Apoptosis</Keyword><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">GPRC5B</Keyword><Keyword MajorTopicYN="N">Proliferation</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes</Keyword><Keyword MajorTopicYN="N">β-cell</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29408822</ArticleId><ArticleId IdType="pii">000487159</ArticleId><ArticleId IdType="doi">10.1159/000487159</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29408560</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1899</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>03</Day></PubDate></JournalIssue><Title>Biotechnology advances</Title><ISOAbbreviation>Biotechnol. Adv.</ISOAbbreviation></Journal><ArticleTitle>Plants as sources of natural and recombinant anti-cancer agents.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0734-9750(18)30018-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biotechadv.2018.02.002</ELocationID><Abstract><AbstractText>Herbal remedies were the first medicines used by humans due to the many pharmacologically active secondary metabolites produced by plants. Some of these metabolites inhibit cell division and can therefore be used for the treatment of cancer, e.g. the mitostatic drug paclitaxel (Taxol). The ability of plants to produce medicines targeting cancer has expanded due to the advent of genetic engineering, particularly in recent years because of the development of gene editing systems such as the CRISPR/Cas9 platform. These technologies allow the introduction of genetic modifications that facilitate the accumulation of native pharmaceutically-active substances, and even the production heterologous recombinant proteins, including human antibodies, lectins and vaccine candidates. Here we discuss the anti-cancer agents that are produced by plants naturally or following genetic modification, and the potential of these products to supply modern healthcare systems. Special emphasis will be put on proteinaceous anti-cancer agents, which can exhibit an improved selectivity and reduced side effects compared to small molecule-based drugs.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buyel</LastName><ForeName>J F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Forckenbeckstraße 6, 52074 Aachen, Germany; Institute for Molecular Biotechnology, Worringerweg 1, RWTH Aachen University, 52074 Aachen, Germany. Electronic address: johannes.buyel@rwth-aachen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biotechnol Adv</MedlineTA><NlmUniqueID>8403708</NlmUniqueID><ISSNLinking>0734-9750</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lectins</Keyword><Keyword MajorTopicYN="N">Molecular farming</Keyword><Keyword MajorTopicYN="N">Monoclonal antibodies</Keyword><Keyword MajorTopicYN="N">Plant secondary metabolites</Keyword><Keyword MajorTopicYN="N">Therapeutic anti-cancer vaccines</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29408560</ArticleId><ArticleId IdType="pii">S0734-9750(18)30018-1</ArticleId><ArticleId IdType="doi">10.1016/j.biotechadv.2018.02.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29407196</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8057</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Molecular and cellular endocrinology</Title><ISOAbbreviation>Mol. Cell. Endocrinol.</ISOAbbreviation></Journal><ArticleTitle>Determination of EPAC2 function using EPAC2 null Min6 sublines generated through CRISPR-Cas9 technology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0303-7207(18)30020-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mce.2018.01.010</ELocationID><Abstract><AbstractText>Min6 cells, a mouse β cell line derived from transgenic mouse expressing the large T-antigen of SV40 in pancreatic beta cells, are commonly utilized as an in vitro cellular model for investigating targets involved in insulin secretion. Epac2, an exchange protein that can be directly activated by cyclic AMP (cAMP), is critical for pharmacologic stimuli-induced insulin secretion and has been hypothesized to be a direct target of sulfonylurea. Previous loss of function studies only specifically knocked out EPAC2 isoform A, leaving the other two isoforms intact. In this study, we investigated the function of EPAC2 in Min6 cells by generating EPAC2 knock-out sublines using CRISPR-Cas9 technology, by removing all three isoforms of EPAC2. Our results indicate that Min6 cells can be successfully cloned from a single cell after electroporation with plasmids expressing EPAC2 specific guide RNA, Cas9 and GFP, followed by sorting for GFP expressing single cells. Two clones were found to have a single nucleotide deletion in targeted site of EPAC2 gene by sequencing, therefore creating a frame shift in exon 13. The EPAC2 null clones unexpectedly have increased secretion of insulin at basal level and elevated total intracellular insulin content. However, EPAC2 deficiency impaired glucose and sulfonylurea induced insulin secretion without affecting sulfonylurea binding to cells. Potassium chloride induced insulin secretion remains intact. Interestingly, cAMP levels remained unchanged in EPAC2 null cells during these processes. To understand the global function of EPAC2, RNA Seq study was performed, which reveals that EPAC2 deficiency affects expression of multiple previously unrecognized genes, suggesting that EPAC2 can function through multiple pathways in addition to being a cAMP sensor.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Early Discovery Pharmacology, Cellular Pharmacology, Merck &amp; Co., Inc., 33 Ave. Louis Pasteur, Boston, MA 02115, USA. Electronic address: Haiyan.xu1@merck.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Early Discovery Pharmacology, Cellular Pharmacology, Merck &amp; Co., Inc., 33 Ave. Louis Pasteur, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yiping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Early Discovery Pharmacology, Cellular Pharmacology, Merck &amp; Co., Inc., 33 Ave. Louis Pasteur, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muller</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Early Discovery Pharmacology, Cellular Pharmacology, Merck &amp; Co., Inc., 33 Ave. Louis Pasteur, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Sharanya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Early Discovery Pharmacology, Cellular Pharmacology, Merck &amp; Co., Inc., 33 Ave. Louis Pasteur, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Presland</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Early Discovery Pharmacology, Cellular Pharmacology, Merck &amp; Co., Inc., 33 Ave. Louis Pasteur, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ruojing</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Early Discovery Pharmacology, Cellular Pharmacology, Merck &amp; Co., Inc., 33 Ave. Louis Pasteur, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kariv</LastName><ForeName>Ilona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Early Discovery Pharmacology, Cellular Pharmacology, Merck &amp; Co., Inc., 33 Ave. Louis Pasteur, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Mol Cell Endocrinol</MedlineTA><NlmUniqueID>7500844</NlmUniqueID><ISSNLinking>0303-7207</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">EPAC2</Keyword><Keyword MajorTopicYN="N">Insulin secretion</Keyword><Keyword MajorTopicYN="N">Min6</Keyword><Keyword MajorTopicYN="N">Sulfonylurea</Keyword><Keyword MajorTopicYN="N">β cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29407196</ArticleId><ArticleId IdType="pii">S0303-7207(18)30020-0</ArticleId><ArticleId IdType="doi">10.1016/j.mce.2018.01.010</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29407192</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1567-7257</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</Title><ISOAbbreviation>Infect. Genet. Evol.</ISOAbbreviation></Journal><ArticleTitle>The truncated Rv2820c of Mycobacterium tuberculosis Beijing family augments intracellular survival of M. smegmatis by altering cytokine profile and inhibiting NO generation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1567-1348(18)30027-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.meegid.2018.01.027</ELocationID><Abstract><AbstractText>Genetic variations among genes of Mycobacterium tuberculosis may be associated with antigenic variation and immune evasion, which complicates the pathogenesis of M. tuberculosis. The hyper-virulent M. tuberculosis Beijing strains harbored several large sequence deletions, among which RD207 attributed to the deletion of CRISPR loci and several Cas genes. RD207 also gave rise to a truncated gene Rv2820c-Bj with 60% deletion in length at the 3'-end and a new 3'-end of five amino acid mutations. It has been reported that Rv2820c-Bj correlated with enhanced intracellular survival of M. smegmatis in macrophages when compared to its full-length counterpart Rv2820c in M. tuberculosis, however, the respective contribution of the truncation and the new 3'-end of Rv2820c-Bj to this enhancement was unclear. Here, by infecting THP-1 macrophages with Ms_Rv2820c-Bj, Ms_Rv2820c and MS_Rv2820c-Tr (expressing the truncated Rv2820c without five amino acid mutations at 3'-end), we found only Ms_Rv2820c-Bj was responsible for the enhancement of survival of M. smegmatis in macrophages. Furthermore, we detected that Ms_Rv2820c-Tr and Ms_Rv2820c-Bj induced similar cytokine profile and NO production after infection of macrophages, which was distinctly different from Ms_Rv2820c. However, Ms_Rv2820c-Bj evoked higher levels of interleukin-10 (IL-10) and lower levels of interleukin- 6 (IL-6), interleukin-1β (IL-1β) and interleukin-12 (IL-12) in infected THP-1 macrophages than Ms_Rv2820c-Tr. Accordingly, we concluded that the new 3'-end of Rv2820c-Bj was important to dampen host defense and enhance the intracellular survival of M. smegmatis.</AbstractText><CopyrightInformation>Copyright © 2017. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Xiaoqian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Laboratory of Infection and Immunity, West China School of Basic Medical Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Infection and Immunity, West China School of Basic Medical Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, China. Electronic address: taoluo@scu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Laboratory of Infection and Immunity, West China School of Basic Medical Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Pengjiao</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Infection and Immunity, West China School of Basic Medical Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chuhan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Infection and Immunity, West China School of Basic Medical Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chunxi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Infection and Immunity, West China School of Basic Medical Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suo</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Infection and Immunity, West China School of Basic Medical Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Lang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Infection and Immunity, West China School of Basic Medical Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, China. Electronic address: baolang@scu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Infect Genet Evol</MedlineTA><NlmUniqueID>101084138</NlmUniqueID><ISSNLinking>1567-1348</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Genomic variation</Keyword><Keyword MajorTopicYN="N">Intracellular survival</Keyword><Keyword MajorTopicYN="N">Mycobacterium tuberculosis Beijing lineage</Keyword><Keyword MajorTopicYN="N">Rv2820c-Bj gene</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29407192</ArticleId><ArticleId IdType="pii">S1567-1348(18)30027-3</ArticleId><ArticleId IdType="doi">10.1016/j.meegid.2018.01.027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29406513</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1546-1696</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Erratum: Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.</ArticleTitle><Pagination><MedlinePgn>196</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nbt0218-196d</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Chu</LastName><ForeName>Trung</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Timm</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Wefers</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Wurst</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Sander</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rajewsky</LastName><ForeName>Klaus</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Kühn</LastName><ForeName>Ralf</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29406513</ArticleId><ArticleId IdType="pii">nbt0218-196d</ArticleId><ArticleId IdType="doi">10.1038/nbt0218-196d</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29406152</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>244</Volume><PubDate><Year>2018</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res.</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas Antiviral Strategies.</ArticleTitle><Pagination><MedlinePgn>285</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(17)30945-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2017.12.010</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Dong-Yan</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>The University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berkhout</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29406152</ArticleId><ArticleId IdType="pii">S0168-1702(17)30945-0</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2017.12.010</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29405266</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-169X</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Development, growth &amp; differentiation</Title><ISOAbbreviation>Dev. Growth Differ.</ISOAbbreviation></Journal><ArticleTitle>Nanos3 of the frog Rana rugosa: Molecular cloning and characterization.</ArticleTitle><Pagination><MedlinePgn>112-120</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dgd.12421</ELocationID><Abstract><AbstractText>Nanos is expressed in the primordial germ cells (PGCs) and also the germ cells of a variety of organisms as diverse as Drosophila, medaka fish, Xenopus and mouse. In Nanos3-deficient mice, PGCs fail to incorporate into the gonad and the size of the testis and ovary is thereby dramatically reduced. To elucidate the role of Nanos in an amphibian species, we cloned Nanos3 cDNA from the testis of the R. rugosa frog. RT-PCR analysis showed strong expression of Nanos3 mRNA in the testis of adult R. rugosa frogs, but expression was not sexually dimorphic during gonadal differentiation. In Nanos3-knockdown tadpoles produced by the CRISPR/Cas9 system, the number of germ cells decreased dramatically in the gonads of both male and female tadpoles before sex determination and thereafter. This was confirmed by three dimensional imaging of wild-type and Nanos3 knockdown gonads using serial sections immunostained for Vasa, a marker specific to germ cells. Taken together, these results suggest that Nanos3 protein function is conserved between R. rugosa and mouse.</AbstractText><CopyrightInformation>© 2018 Japanese Society of Developmental Biologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kodama</LastName><ForeName>Maho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Education and Integrated Arts and Sciences, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Madoka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Education and Integrated Arts and Sciences, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Endo</LastName><ForeName>Masami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Education and Integrated Arts and Sciences, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Tohru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Reproductive Biology, Institute for Environmental Sciences, Graduate Division of Nutritional and Environmental Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oike</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Education and Integrated Arts and Sciences, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasumasu</LastName><ForeName>Shigeki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3895-4622</Identifier><AffiliationInfo><Affiliation>Department of Biology, Faculty of Education and Integrated Arts and Sciences, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>NM_001098622</AccessionNumber><AccessionNumber>NM_194059</AccessionNumber><AccessionNumber>NM_001122828</AccessionNumber><AccessionNumber>NM_001088034</AccessionNumber><AccessionNumber>NM_001275794</AccessionNumber><AccessionNumber>LC218725</AccessionNumber><AccessionNumber>AB284116</AccessionNumber><AccessionNumber>NP_001081503</AccessionNumber><AccessionNumber>NP_988857</AccessionNumber><AccessionNumber>NP_001116300</AccessionNumber><AccessionNumber>NP_918948</AccessionNumber><AccessionNumber>NP_001092092</AccessionNumber><AccessionNumber>NP_476658</AccessionNumber><AccessionNumber>NP_001262723</AccessionNumber><AccessionNumber>NP_955631</AccessionNumber><AccessionNumber>NP_001025032</AccessionNumber><AccessionNumber>NP_848508</AccessionNumber><AccessionNumber>NP_918953</AccessionNumber><AccessionNumber>NP_001163808</AccessionNumber><AccessionNumber>NP_001153941</AccessionNumber><AccessionNumber>NP_001153919</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Dev Growth Differ</MedlineTA><NlmUniqueID>0356504</NlmUniqueID><ISSNLinking>0012-1592</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3D imaging</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Nanos3</Keyword><Keyword MajorTopicYN="N">frog</Keyword><Keyword MajorTopicYN="N">germ cell</Keyword><Keyword MajorTopicYN="N">immunohistology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29405266</ArticleId><ArticleId IdType="doi">10.1111/dgd.12421</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29404407</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing.</ArticleTitle><Pagination><MedlinePgn>eaap9004</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.aap9004</ELocationID><Abstract><AbstractText>Genome editing with CRISPR/Cas9 is a promising new approach for correcting or mitigating disease-causing mutations. Duchenne muscular dystrophy (DMD) is associated with lethal degeneration of cardiac and skeletal muscle caused by more than 3000 different mutations in the X-linked dystrophin gene (<i>DMD</i>). Most of these mutations are clustered in "hotspots." There is a fortuitous correspondence between the eukaryotic splice acceptor and splice donor sequences and the protospacer adjacent motif sequences that govern prokaryotic CRISPR/Cas9 target gene recognition and cleavage. Taking advantage of this correspondence, we screened for optimal guide RNAs capable of introducing insertion/deletion (indel) mutations by nonhomologous end joining that abolish conserved RNA splice sites in 12 exons that potentially allow skipping of the most common mutant or out-of-frame<i>DMD</i>exons within or nearby mutational hotspots. We refer to the correction of DMD mutations by exon skipping as myoediting. In proof-of-concept studies, we performed myoediting in representative induced pluripotent stem cells from multiple patients with large deletions, point mutations, or duplications within the<i>DMD</i>gene and efficiently restored dystrophin protein expression in derivative cardiomyocytes. In three-dimensional engineered heart muscle (EHM), myoediting of DMD mutations restored dystrophin expression and the corresponding mechanical force of contraction. Correcting only a subset of cardiomyocytes (30 to 50%) was sufficient to rescue the mutant EHM phenotype to near-normal control levels. We conclude that abolishing conserved RNA splicing acceptor/donor sites and directing the splicing machinery to skip mutant or out-of-frame exons through myoediting allow correction of the cardiac abnormalities associated with DMD by eliminating the underlying genetic basis of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Chengzu</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6236-7444</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, NY 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hui</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4114-8349</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiburcy</LastName><ForeName>Malte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Pharmacology and Toxicology, University Medical Center, Georg-August-University Göttingen, Göttingen, 37075, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Center for Cardiovascular Research), partner site Göttingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Caycedo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3814-2875</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyrychenko</LastName><ForeName>Viktoriia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Huanyu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3303-7312</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3384-8887</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Yi-Li</ForeName><Initials>YL</Initials><Identifier Source="ORCID">0000-0001-6205-9428</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shelton</LastName><ForeName>John M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2949-1638</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mammen</LastName><ForeName>Pradeep P A</ForeName><Initials>PPA</Initials><Identifier Source="ORCID">0000-0001-5688-7091</Identifier><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Norman Y</ForeName><Initials>NY</Initials><Identifier Source="ORCID">0000-0001-7804-8133</Identifier><AffiliationInfo><Affiliation>Institute of Pharmacology and Toxicology, University Medical Center, Georg-August-University Göttingen, Göttingen, 37075, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmermann</LastName><ForeName>Wolfram-Hubertus</ForeName><Initials>WH</Initials><Identifier Source="ORCID">0000-0003-1190-4040</Identifier><AffiliationInfo><Affiliation>Institute of Pharmacology and Toxicology, University Medical Center, Georg-August-University Göttingen, Göttingen, 37075, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Center for Cardiovascular Research), partner site Göttingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassel-Duby</LastName><ForeName>Rhonda</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7568-410X</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Jay W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olson</LastName><ForeName>Eric N</ForeName><Initials>EN</Initials><Identifier Source="ORCID">0000-0003-1151-8262</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL077439</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK099653</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL130253</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR067294</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HD087351</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2009 Mar;30(3):293-9</RefSource><PMID Version="1">19156838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Aug 24;548(7668):413-419</RefSource><PMID Version="1">28783728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2008 Jan;63(1):81-9</RefSource><PMID Version="1">18059005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2016 Mar;53(3):145-51</RefSource><PMID Version="1">26754139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):403-7</RefSource><PMID Version="1">26721684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Apr;11(4):399-402</RefSource><PMID Version="1">24584192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):833-8</RefSource><PMID Version="1">23907171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Heart Fail Rev. 2010 Jan;15(1):103-7</RefSource><PMID Version="1">19943106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2012;867:97-116</RefSource><PMID Version="1">22454057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Feb 18;44(3):1449-70</RefSource><PMID Version="1">26762977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2012 Mar;71(3):304-13</RefSource><PMID Version="1">22451200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Adv. 2017 Apr 12;3(4):e1602814</RefSource><PMID Version="1">28439558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Jan 3;12(1):127-37</RefSource><PMID Version="1">23168164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Mar;24(3):564-9</RefSource><PMID Version="1">26449883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Feb 18;6:6244</RefSource><PMID Version="1">25692716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2017 Jun 16;7:31-41</RefSource><PMID Version="1">28624206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2015 Jan 13;4(1):143-54</RefSource><PMID Version="1">25434822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JCI Insight. 2017 Sep 21;2(18):null</RefSource><PMID Version="1">28931764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2016 Apr 7;18(4):533-40</RefSource><PMID Version="1">26877224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2017 Nov 29;9(418):null</RefSource><PMID Version="1">29187645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2008 Jan 4;102(1):121-30</RefSource><PMID Version="1">17967782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jan 28;529(7587):490-5</RefSource><PMID Version="1">26735016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Mar;32(3):279-284</RefSource><PMID Version="1">24463574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2013 Jun;14 (6):373-8</RefSource><PMID Version="1">23609411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):400-3</RefSource><PMID Version="1">26721683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2017 May 9;135(19):1832-1847</RefSource><PMID Version="1">28167635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Nov 15;6:37051</RefSource><PMID Version="1">27845387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2017 Sep 29;121(8):923-929</RefSource><PMID Version="1">28790199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2016 Jan 7;98(1):90-101</RefSource><PMID Version="1">26686765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Sep 5;345(6201):1184-1188</RefSource><PMID Version="1">25123483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 1;351(6268):84-8</RefSource><PMID Version="1">26628643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2011;45:247-71</RefSource><PMID Version="1">21910633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Feb 14;8:14454</RefSource><PMID Version="1">28195574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2017 Jun 16;7:11-19</RefSource><PMID Version="1">28624187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2016 Jan 26;5:e283</RefSource><PMID Version="1">26812655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 1995 Mar;4(3):329-35</RefSource><PMID Version="1">7795584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):407-411</RefSource><PMID Version="1">26721686</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29404407</ArticleId><ArticleId IdType="doi">10.1126/sciadv.aap9004</ArticleId><ArticleId IdType="pii">aap9004</ArticleId><ArticleId IdType="pmc">PMC5796795</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29404013</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2095-1779</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of pharmaceutical analysis</Title><ISOAbbreviation>J Pharm Anal</ISOAbbreviation></Journal><ArticleTitle>Bioinformatic prediction and functional characterization of human KIAA0100 gene.</ArticleTitle><Pagination><MedlinePgn>10-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpha.2016.09.003</ELocationID><Abstract><AbstractText>Our previous study demonstrated that human KIAA0100 gene was a novel acute monocytic leukemia-associated antigen (MLAA) gene. But the functional characterization of human KIAA0100 gene has remained unknown to date. Here, firstly, bioinformatic prediction of human KIAA0100 gene was carried out using online softwares; Secondly, Human KIAA0100 gene expression was downregulated by the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 system in U937 cells. Cell proliferation and apoptosis were next evaluated in KIAA0100-knockdown U937 cells. The bioinformatic prediction showed that human KIAA0100 gene was located on 17q11.2, and human KIAA0100 protein was located in the secretory pathway. Besides, human KIAA0100 protein contained a signalpeptide, a transmembrane region, three types of secondary structures (alpha helix, extended strand, and random coil) , and four domains from mitochondrial protein 27 (FMP27). The observation on functional characterization of human KIAA0100 gene revealed that its downregulation inhibited cell proliferation, and promoted cell apoptosis in U937 cells. To summarize, these results suggest human KIAA0100 gene possibly comes within mitochondrial genome; moreover, it is a novel anti-apoptotic factor related to carcinogenesis or progression in acute monocytic leukemia, and may be a potential target for immunotherapy against acute monocytic leukemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Hematology, Affiliated No. 2 Hospital, Xi'an Jiaotong University, The West Five Road, 157#, Xi'an, Shaanxi 710004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lan</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, The Yanta West Road, 76#, Xi'an, Shaanxi 710061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Shemin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, The Yanta West Road, 76#, Xi'an, Shaanxi 710061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fujun</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, The Yanta West Road, 76#, Xi'an, Shaanxi 710061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wanggang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Clinical Hematology, Affiliated No. 2 Hospital, Xi'an Jiaotong University, The West Five Road, 157#, Xi'an, Shaanxi 710004, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Pharm Anal</MedlineTA><NlmUniqueID>101579451</NlmUniqueID><ISSNLinking>2214-0883</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 1990 May;75(1):41-8</RefSource><PMID Version="1">2375923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Hematol. 2008 Sep;88(2):192-196</RefSource><PMID Version="1">18642054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genet Cytogenet. 1983 Mar;8(3):203-12</RefSource><PMID Version="1">6572092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Jan 1;27(1):338-9</RefSource><PMID Version="1">9847221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc R Soc Med. 1910;3(Surg Sect):1-48</RefSource><PMID Version="1">19974799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Rev Oncol Hematol. 2016 Jul;103:62-77</RefSource><PMID Version="1">27247119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genet Cytogenet. 2003 Jan 15;140(2):153-6</RefSource><PMID Version="1">12645654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone. 2014 Dec;69:118-25</RefSource><PMID Version="1">25260929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1987 Dec 15;60(12):3071-9</RefSource><PMID Version="1">3479232</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Res. 1995;2(1):37-43</RefSource><PMID Version="1">7788527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Immunol Immunother. 2011 Apr;60(4):587-97</RefSource><PMID Version="1">21240483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Adv. 2015 Aug 14;1(7):e1500454</RefSource><PMID Version="1">26601238</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Direct. 2011 Jul 14;6:38</RefSource><PMID Version="1">21756346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Res. 1994;1(1):27-35</RefSource><PMID Version="1">7584026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Res. 2011 Mar;35(3):369-72</RefSource><PMID Version="1">20573399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Transl Res. 2015 Nov 15;7(11):2270-8</RefSource><PMID Version="1">26807175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2000 Jul 21;300(4):1005-16</RefSource><PMID Version="1">10891285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2011 Jun;153(6):796-9</RefSource><PMID Version="1">21477159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 05;9(3):e89413</RefSource><PMID Version="1">24598943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2006 Jan;1760(1):62-9</RefSource><PMID Version="1">16289875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jan 28;9(1):e86952</RefSource><PMID Version="1">24489812</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Dec 08;6:10124</RefSource><PMID Version="1">26644285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CSH Protoc. 2006 Aug 01;2006(3):null</RefSource><PMID Version="1">22485873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Plant. 2013 Sep;6(5):1384-7</RefSource><PMID Version="1">23718948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2001 Nov 15;98(10):2887-93</RefSource><PMID Version="1">11698267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Immunol Immunother. 2009 Feb;58(2):281-90</RefSource><PMID Version="1">18592235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Haematol Blood Transfus. 1990;33:145-9</RefSource><PMID Version="1">1691129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genet Cytogenet. 1996 Feb;86(2):153-5</RefSource><PMID Version="1">8603344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Chromosomes Cancer. 2000 Dec;29(4):333-8</RefSource><PMID Version="1">11066077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2005 Aug 4;24(33):5191-7</RefSource><PMID Version="1">15897884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Nanomedicine. 2013;8:4033-42</RefSource><PMID Version="1">24187495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2008 Jan 1;111(1):236-42</RefSource><PMID Version="1">17875804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2011 Aug 01;10 (8):591-600</RefSource><PMID Version="1">21804596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Ther Targets. 2009 Dec;13(12):1399-410</RefSource><PMID Version="1">19821797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Pathol. 1981 Feb;75(2):140-8</RefSource><PMID Version="1">6937136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2001 Jan;15(1):89-94</RefSource><PMID Version="1">11243405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Nov;39(21):9275-82</RefSource><PMID Version="1">21813460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Res. 2005 May;29(5):503-9</RefSource><PMID Version="1">15755502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2014 May;20(5):476-7</RefSource><PMID Version="1">24804755</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2013 Feb;29(2):491-506</RefSource><PMID Version="1">23135622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genet Cytogenet. 2000 Feb;117(1):24-7</RefSource><PMID Version="1">10700861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Res. 2001 Apr 27;8(2):85-95</RefSource><PMID Version="1">11347906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Res. 2005 Jan;29(1):3-9</RefSource><PMID Version="1">15541469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Pediatr. 1991 Mar;150(5):323-4</RefSource><PMID Version="1">2044602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genet Cytogenet. 1994 May;74(1):50-3</RefSource><PMID Version="1">8194047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2180-96</RefSource><PMID Version="1">24136345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Jan 1;32(Database issue):D502-4</RefSource><PMID Version="1">14681467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genet Cytogenet. 1991 Feb;51(2):189-94</RefSource><PMID Version="1">1993304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2003 Dec;10(23):2485-94</RefSource><PMID Version="1">14529464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>C R Acad Sci III. 1993 Jul;316(7):692-7</RefSource><PMID Version="1">8019892</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Vaccines. 2008 Sep;7(7):867-75</RefSource><PMID Version="1">18767937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Nov 4;468(7320):67-71</RefSource><PMID Version="1">21048762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Jan 12;119(2):368-76</RefSource><PMID Version="1">22025529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2015 Sep 04;34:91</RefSource><PMID Version="1">26338045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Jun;16(3):466-71</RefSource><PMID Version="1">18549609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Hematol. 2001 Jul;74(1):53-7</RefSource><PMID Version="1">11530805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Res. 2001 Aug 31;8(4):179-87</RefSource><PMID Version="1">11572484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2002 Jan 1;30(1):166-8</RefSource><PMID Version="1">11752282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2000 Mar;14 (3):520-2</RefSource><PMID Version="1">10720155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13824-9</RefSource><PMID Version="1">20631300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1986 Jan 17;231(4735):265-7</RefSource><PMID Version="1">3455787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jul 18;154(2):442-51</RefSource><PMID Version="1">23849981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Comput Appl Biosci. 1995 Dec;11(6):681-4</RefSource><PMID Version="1">8808585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Res. 1997 Feb 28;4(1):53-9</RefSource><PMID Version="1">9179496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Res. 2001 Dec 31;8(6):319-27</RefSource><PMID Version="1">11853319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Jan 1;28(1):331-2</RefSource><PMID Version="1">10592264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2003 Jul;17(7):1301-12</RefSource><PMID Version="1">12835718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Chem Int Ed Engl. 2016 Apr 25;55(18):5394-9</RefSource><PMID Version="1">26996256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Hematol. 2005 Jul;82(1):38-41</RefSource><PMID Version="1">16105757</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute monocytic leukemia associated antigen</Keyword><Keyword MajorTopicYN="N">Bioinformatic prediction</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9 system</Keyword><Keyword MajorTopicYN="N">Cell apoptosis</Keyword><Keyword MajorTopicYN="N">Cell proliferation</Keyword><Keyword MajorTopicYN="N">Human KIAA0100</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>09</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29404013</ArticleId><ArticleId IdType="doi">10.1016/j.jpha.2016.09.003</ArticleId><ArticleId IdType="pii">S2095-1779(16)30079-X</ArticleId><ArticleId IdType="pmc">PMC5686863</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29403034</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat. Neurosci.</ISOAbbreviation></Journal><ArticleTitle>CRISPR interference-based specific and efficient gene inactivation in the brain.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-018-0077-5</ELocationID><Abstract><AbstractText>CRISPR-Cas9 has been demonstrated to delete genes in postmitotic neurons. Compared to the establishment of proliferative cell lines or animal strains, it is more challenging to acquire a highly homogeneous consequence of gene editing in a stable neural network. Here we show that dCas9-based CRISPR interference (CRISPRi) can efficiently silence genes in neurons. Using a pseudotarget fishing strategy, we demonstrate that CRISPRi shows superior targeting specificity without detectable off-target activity. Furthermore, CRISPRi can achieve multiplex inactivation of genes fundamental for neurotransmitter release with high efficiency. By developing conditional CRISPRi tools targeting synaptotagmin I (Syt1), we modified the excitatory to inhibitory balance in the dentate gyrus of the mouse hippocampus and found that the dentate gyrus has distinct regulatory roles in learning and affective processes in mice. We therefore recommend CRISPRi as a useful tool for more rapid investigation of gene function in the mammalian brain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Genomics and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yao-Nan</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Huihui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Si-Yao</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yu-Zhou</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gage</LastName><ForeName>Fred H</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, Laboratory of Genetics, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mi</LastName><ForeName>Shuangli</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8883-3215</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Genomics and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China. mishl@big.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4916-3412</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua-Peking Joint Center for Life Sciences, IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China. jyao@mail.tsinghua.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29403034</ArticleId><ArticleId IdType="doi">10.1038/s41593-018-0077-5</ArticleId><ArticleId IdType="pii">10.1038/s41593-018-0077-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29403014</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2058-5276</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>Nature microbiology</Title><ISOAbbreviation>Nat Microbiol</ISOAbbreviation></Journal><ArticleTitle>Deaminase-mediated multiplex genome editing in Escherichia coli.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41564-017-0102-6</ELocationID><Abstract><AbstractText>In eukaryotes, the CRISPR-Cas9 system has now been widely used as a revolutionary genome engineering tool<sup>1, 2</sup>. However, in prokaryotes, the use of nuclease-mediated genome editing tools has been limited to negative selection for the already modified cells because of its lethality<sup>3, 4</sup>. Here, we report on deaminase-mediated targeted nucleotide editing (Target-AID)<sup>5</sup>adopted in Escherichia coli. Cytidine deaminase PmCDA1 fused to the nuclease-deficient CRISPR-Cas9 system achieved specific point mutagenesis at the target sites in E. coli by introducing cytosine mutations without compromising cell growth. The cytosine-to-thymine substitutions were induced mainly within an approximately five-base window of target sequences on the protospacer adjacent motif-distal side, which can be shifted depending on the length of the single guide RNA sequence. Use of a uracil DNA glycosylase inhibitor<sup>6</sup>in combination with a degradation tag (LVA tag)<sup>7</sup>resulted in a robustly high mutation efficiency, which allowed simultaneous multiplex editing of six different genes. The major multi-copy transposase genes that consist of at least 41 loci were also simultaneously edited by using four target sequences. As this system does not rely on any additional or host-dependent factors, it may be readily applicable to a wide range of bacteria.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banno</LastName><ForeName>Satomi</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5853-5003</Identifier><AffiliationInfo><Affiliation>Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishida</LastName><ForeName>Keiji</ForeName><Initials>K</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9371-4971</Identifier><AffiliationInfo><Affiliation>Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan. keiji_nishida@people.kobe-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arazoe</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitsunobu</LastName><ForeName>Hitoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1527-5288</Identifier><AffiliationInfo><Affiliation>Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan. akondo@kobe-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, Kobe, Hyogo, Japan. akondo@kobe-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Microbiol</MedlineTA><NlmUniqueID>101674869</NlmUniqueID><ISSNLinking>2058-5276</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29403014</ArticleId><ArticleId IdType="doi">10.1038/s41564-017-0102-6</ArticleId><ArticleId IdType="pii">10.1038/s41564-017-0102-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29403013</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2058-5276</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature microbiology</Title><ISOAbbreviation>Nat Microbiol</ISOAbbreviation></Journal><ArticleTitle>The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system.</ArticleTitle><Pagination><MedlinePgn>367-377</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41564-017-0103-5</ELocationID><Abstract><AbstractText>Specialized RNA endonucleases for the maturation of clustered regularly interspaced short palindromic repeat (CRISPR)-derived RNAs (crRNAs) are critical in CRISPR-CRISPR-associated protein (Cas) defence mechanisms. The Cas6 and Cas5d enzymes are the RNA endonucleases in many class 1 CRISPR-Cas systems. In some class 2 systems, maturation and effector functions are combined within a single enzyme or maturation proceeds through the combined actions of RNase III and trans-activating CRISPR RNAs (tracrRNAs). Three separate CRISPR-Cas systems exist in the cyanobacterium Synechocystis sp. PCC 6803. Whereas Cas6-type enzymes act in two of these systems, the third, which is classified as subtype III-B variant (III-Bv), lacks cas6 homologues. Instead, the maturation of crRNAs proceeds through the activity of endoribonuclease E, leaving unusual 13- and 14-nucleotide-long 5'-handles. Overexpression of RNase E leads to overaccumulation and knock-down to the reduced accumulation of crRNAs in vivo, suggesting that RNase E is the limiting factor for CRISPR complex formation. Recognition by RNase E depends on a stem-loop in the CRISPR repeat, whereas base substitutions at the cleavage site trigger the appearance of secondary products, consistent with a two-step recognition and cleavage mechanism. These results suggest the adaptation of an otherwise very conserved housekeeping enzyme to accommodate new substrates and illuminate the impressive plasticity of CRISPR-Cas systems that enables them to function in particular genomic environments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Behler</LastName><ForeName>Juliane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Experimental Bioinformatics, Faculty of Biology, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Kundan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Bioanalytics Research Group, Department of Clinical Chemistry, University Medical Centre, Göttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reimann</LastName><ForeName>Viktoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Genetics and Experimental Bioinformatics, Faculty of Biology, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilde</LastName><ForeName>Annegret</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0935-8415</Identifier><AffiliationInfo><Affiliation>Molecular Genetics, Faculty of Biology, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urlaub</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Bioanalytics Research Group, Department of Clinical Chemistry, University Medical Centre, Göttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Wolfgang R</ForeName><Initials>WR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5340-3423</Identifier><AffiliationInfo><Affiliation>Genetics and Experimental Bioinformatics, Faculty of Biology, University of Freiburg, Freiburg, Germany. wolfgang.hess@biologie.uni-freiburg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Freiburg Institute for Advanced Studies, University of Freiburg, Freiburg, Germany. wolfgang.hess@biologie.uni-freiburg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Microbiol</MedlineTA><NlmUniqueID>101674869</NlmUniqueID><ISSNLinking>2058-5276</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29403013</ArticleId><ArticleId IdType="doi">10.1038/s41564-017-0103-5</ArticleId><ArticleId IdType="pii">10.1038/s41564-017-0103-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29402929</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Generation of a rod-specific NRL reporter line in human pluripotent stem cells.</ArticleTitle><Pagination><MedlinePgn>2370</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-20813-3</ELocationID><Abstract><AbstractText>Reporter lines generated in human pluripotent stem cells can be highly useful for the analysis of specific cell types and lineages in live cultures. We created the first human rod reporter line using CRISPR/Cas9 genome editing to replace one allele of the Neural Retina Leucine zipper (NRL) gene with an eGFP transgene in the WA09 human embryonic stem cell (hESC) line. After confirming successful targeting, three-dimensional optic vesicle structures were produced to examine reporter specificity and to track rod differentiation in culture. The NRL<sup>+/eGFP</sup>hESC line robustly and exclusively labeled the entirety of rods throughout differentiation, eventually revealing highly mature structural features. This line provides a valuable tool for studying human rod development and disease and testing therapeutic strategies for retinitis pigmentosa.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>M Joseph</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capowski</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Alex D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barlow</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Kimberly L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamm</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Waisman Center, University of Wisconsin-Madison, Madison, WI, USA. dgamm@wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA. dgamm@wisc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, WI, USA. dgamm@wisc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 HD003352</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY021218</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HD090256</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2011 Aug;29(8):1206-18</RefSource><PMID Version="1">21678528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Nov 13;5:16595</RefSource><PMID Version="1">26563826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Oct 04;7:13028</RefSource><PMID Version="1">27701381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17819-24</RefSource><PMID Version="1">15591106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3890-5</RefSource><PMID Version="1">16505381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2011 Jul 15;52(8):5266-72</RefSource><PMID Version="1">21436277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2015 Feb 5;16(2):142-7</RefSource><PMID Version="1">25658371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Jul 11;20(2):384-396</RefSource><PMID Version="1">28700940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2012 Jun 14;10(6):771-85</RefSource><PMID Version="1">22704518</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2016 Jun 2;18(6):769-81</RefSource><PMID Version="1">27151457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2017 Sep 12;9(3):820-837</RefSource><PMID Version="1">28844659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Oct 21;286(42):36921-31</RefSource><PMID Version="1">21865162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Feb 19;6:6286</RefSource><PMID Version="1">25695148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2010 Nov;28(11):1997-2007</RefSource><PMID Version="1">20857496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2016 Sep 09;22:1077-1094</RefSource><PMID Version="1">27667917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2009 Oct;111(1):250-63</RefSource><PMID Version="1">19686387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5361-5371</RefSource><PMID Version="1">27732723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2014 Jun;32(6):1480-92</RefSource><PMID Version="1">24532057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2017 Mar 1;25(3):634-653</RefSource><PMID Version="1">28143742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Apr 10;7(1):766</RefSource><PMID Version="1">28396597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 1997 Jul 1;187(1):36-42</RefSource><PMID Version="1">9224672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Oct 04;7:13029</RefSource><PMID Version="1">27701378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2011;17:3034-54</RefSource><PMID Version="1">22162623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Nov 30;7:13537</RefSource><PMID Version="1">27901042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Physiol. 2005 Mar;125(3):287-304</RefSource><PMID Version="1">15738050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2016 Nov;34(11):2625-2634</RefSource><PMID Version="1">27301076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2004 Jul 15;13(14):1487-503</RefSource><PMID Version="1">15163632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2004 Nov;24(5):439</RefSource><PMID Version="1">15459973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2004 Jul 15;271(2):388-402</RefSource><PMID Version="1">15223342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2013 Jun;31(6):1149-59</RefSource><PMID Version="1">23495178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2016 Feb;34(2):311-21</RefSource><PMID Version="1">26608863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4422-4435</RefSource><PMID Version="1">28863214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 11;6:22867</RefSource><PMID Version="1">26965927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2001 Dec;29(4):447-52</RefSource><PMID Version="1">11694879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2008 Nov;87(5):415-26</RefSource><PMID Version="1">18778702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Jun 10;5:4047</RefSource><PMID Version="1">24915161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2015 Aug 6;17(2):233-44</RefSource><PMID Version="1">26145478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Nov 22;17 (9):2460-2473</RefSource><PMID Version="1">27880916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Stem Cell Biol. 2015 Feb 02;32:1H.8.1-20</RefSource><PMID Version="1">25640818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2156-67</RefSource><PMID Version="1">15914637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2012 Apr 18;53(4):2007-19</RefSource><PMID Version="1">22410558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2015 Dec;33(12 ):3504-18</RefSource><PMID Version="1">26235913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2017 Apr;35(4):932-939</RefSource><PMID Version="1">27977075</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29402929</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-20813-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-20813-3</ArticleId><ArticleId IdType="pmc">PMC5799252</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29402884</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>02</Month><Day>05</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes.</ArticleTitle><Pagination><MedlinePgn>502</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-017-02349-8</ELocationID><Abstract><AbstractText>Unraveling the mechanism of action and molecular target of small molecules remains a major challenge in drug discovery. While many cancer drugs target genetic vulnerabilities, loss-of-function screens fail to identify essential genes in drug mechanism of action. Here, we report CRISPRres, a CRISPR-Cas-based genetic screening approach to rapidly derive and identify drug resistance mutations in essential genes. It exploits the local genetic variation created by CRISPR-Cas-induced non-homologous end-joining (NHEJ) repair to generate a wide variety of functional in-frame mutations. Using large sgRNA tiling libraries and known drug-target pairs, we validate it as a target identification approach. We apply CRISPRres to the anticancer agent KPT-9274 and identify nicotinamide phosphoribosyltransferase (NAMPT) as its main target. These results present a powerful and simple genetic approach to create many protein variants that, in combination with positive selection, can be applied to reveal the cellular target of small-molecule inhibitors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neggers</LastName><ForeName>Jasper Edgar</ForeName><Initials>JE</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7267-179X</Identifier><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwanten</LastName><ForeName>Bert</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dierckx</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noguchi</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9052-1237</Identifier><AffiliationInfo><Affiliation>KU Leuven Department of Chemistry, Biochemistry Molecular and Structural Biology Section, Celestijnenlaan 200 G, 3001, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voet</LastName><ForeName>Arnout</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Chemistry, Biochemistry Molecular and Structural Biology Section, Celestijnenlaan 200 G, 3001, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bral</LastName><ForeName>Lotte</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minner</LastName><ForeName>Kristien</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massant</LastName><ForeName>Bob</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kint</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Hematology, University Hospital Leuven, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delforge</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, University Hospital Leuven, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vercruysse</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baloglu</LastName><ForeName>Erkan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Karyopharm Therapeutics Inc, 85 Wells Ave, Newton, MA, 02459, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senapedis</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Karyopharm Therapeutics Inc, 85 Wells Ave, Newton, MA, 02459, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacquemyn</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daelemans</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7092-1153</Identifier><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Herestraat 49, 3000, Leuven, Belgium. dirk.daelemans@kuleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Dec;24(12):2059-65</RefSource><PMID Version="1">25373145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Dec;13(12 ):1029-1035</RefSource><PMID Version="1">27723754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2012 Feb 12;8(3):235-7</RefSource><PMID Version="1">22327403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioorg Med Chem. 2008 Nov 1;16(21):9487-97</RefSource><PMID Version="1">18835718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Nov 29;120(23):4621-34</RefSource><PMID Version="1">23034282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Protein Chem. 2003;66:27-85</RefSource><PMID Version="1">14631816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501</RefSource><PMID Version="1">20383002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Dec;13(12 ):1036-1042</RefSource><PMID Version="1">27798611</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Oncol. 2014 Mar 06;4:40</RefSource><PMID Version="1">24639951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2015 Jan 22;22(1):107-16</RefSource><PMID Version="1">25579209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2010 Jul 15;10(2):119-25</RefSource><PMID Version="1">20647743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14440-5</RefSource><PMID Version="1">12374846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Dec 16;42(22):e168</RefSource><PMID Version="1">25300484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomark Res. 2013 Mar 01;1(1):13</RefSource><PMID Version="1">24252210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2013 Jan;45(1):104-8</RefSource><PMID Version="1">23202129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2012 Jul 24;12 (8):527-39</RefSource><PMID Version="1">22825217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2015 Dec;11(12):942-8</RefSource><PMID Version="1">26575241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cancer. 2013 Nov;4(11-12):447-56</RefSource><PMID Version="1">24386506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42</RefSource><PMID Version="1">21460441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Nov 1;40(20):10263-73</RefSource><PMID Version="1">22941639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2017 Feb 23;12 (2):e0172177</RefSource><PMID Version="1">28231254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2013 Nov 21;20(11):1352-63</RefSource><PMID Version="1">24183972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2002 Sep;8(9):2843-50</RefSource><PMID Version="1">12231525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2017 Apr 20;129(16):2233-2245</RefSource><PMID Version="1">28096095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Nov 1;63(21):7436-42</RefSource><PMID Version="1">14612543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Jul 28;7:12338</RefSource><PMID Version="1">27465542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Nov;29(21):5872-88</RefSource><PMID Version="1">19703994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2015 Jun;11(6):368-72</RefSource><PMID Version="1">25978985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2006 Jul;13(7):582-8</RefSource><PMID Version="1">16783377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2017 Jan;16(1):76-87</RefSource><PMID Version="1">28062705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21</RefSource><PMID Version="1">20124702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2011 Mar;7(3):182-8</RefSource><PMID Version="1">21278739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):965-71</RefSource><PMID Version="1">24161985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2013 Apr;9(4):232-40</RefSource><PMID Version="1">23508189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Oct 6;538(7623):114-117</RefSource><PMID Version="1">27680702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2017 Jan;13(1):12-14</RefSource><PMID Version="1">27820796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2007 Jan;7(1):54-60</RefSource><PMID Version="1">17186018</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2017 Jan 24;12 (1):e0170445</RefSource><PMID Version="1">28118392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-87</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>F1000Res. 2014 Apr 24;3:95</RefSource><PMID Version="2">24860646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2002 Jan;2(1):48-58</RefSource><PMID Version="1">11902585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Dec 3;163(6):1515-26</RefSource><PMID Version="1">26627737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2007 Nov;6(11):891-903</RefSource><PMID Version="1">17917669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2014 Aug;10(8):623-5</RefSource><PMID Version="1">24929529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2014 Aug;10 (8):626-8</RefSource><PMID Version="1">24929528</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29402884</ArticleId><ArticleId IdType="doi">10.1038/s41467-017-02349-8</ArticleId><ArticleId IdType="pii">10.1038/s41467-017-02349-8</ArticleId><ArticleId IdType="pmc">PMC5799254</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29402392</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-564X</ISSN><JournalIssue CitedMedium="Internet"><Volume>435</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Developmental biology</Title><ISOAbbreviation>Dev. Biol.</ISOAbbreviation></Journal><ArticleTitle>Phenotypic novelty by CRISPR in plants.</ArticleTitle><Pagination><MedlinePgn>170-175</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0012-1606(17)30760-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ydbio.2018.01.015</ELocationID><Abstract><AbstractText>Genome editing by CRISPR is now routinely used in plant biology for unravelling gene functions and improving agronomical traits. CRISPR opens up the possibility of genome manipulations which would have been unthinkable a few years ago. In this perspective, we discuss and suggest CRISPR-mediated approaches for steering plant development, also highlighting potential challenges.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Plant Biology, Uppsala BioCenter, Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moschou</LastName><ForeName>Panagiotis N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Department of Plant Biology, Uppsala BioCenter, Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, Uppsala, Sweden. Electronic address: panagiotis.moschou@slu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dev Biol</MedlineTA><NlmUniqueID>0372762</NlmUniqueID><ISSNLinking>0012-1606</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Allelic variation</Keyword><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">Epigenome</Keyword><Keyword MajorTopicYN="N">Plant biotechnology</Keyword><Keyword MajorTopicYN="N">Plant development</Keyword><Keyword MajorTopicYN="N">Proteostasis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29402392</ArticleId><ArticleId IdType="pii">S0012-1606(17)30760-1</ArticleId><ArticleId IdType="doi">10.1016/j.ydbio.2018.01.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29402189</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8534</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>Stem cells and development</Title><ISOAbbreviation>Stem Cells Dev.</ISOAbbreviation></Journal><ArticleTitle>Simplified footprint-free Cas9/CRISPR editing of cardiac-associated genes in human pluripotent stem cells.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1089/scd.2017.0268</ELocationID><Abstract><AbstractText>Modelling disease with hPSCs is hindered because the impact on cell phenotype from genetic variability between individuals can be greater than from the pathogenic mutation. While 'footprint-free' Cas9/CRISPR editing solves this issue, existing approaches are inefficient or lengthy. Here, a simplified PiggyBac strategy shortened hPSC editing by 2 weeks and required one round of clonal expansion and genotyping rather than two, with similar efficiencies to the longer conventional process. Success was shown across 4 cardiac-associated loci (ADRB2, GRK5, RYR2, ACTC1) by genomic cleavage and editing efficiencies of 8-93% and 8-67%, respectively, including mono- and/or bi-allelic events. Pluripotency was retained, as was differentiation into high purity cardiomyocytes (CMs; 88-99%). Using the GRK5 isogenic lines as an exemplar, chronic stimulation with the b-adrenoceptor agonist, isoprenaline, reduced beat rate in hPSC-CMs expressing GRK5-Q41 but not GRK5-L41; this was reversed by the b-blocker, propranolol. This simplified, footprint-free approach will be useful for mechanistic studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kondrashov</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM), Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland ; PAZAVK@exmail.nottingham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duc Hoang</LastName><ForeName>Minh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM), Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland ; v.duchm3@vinmec.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM), Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland ; James.Smith@nottingham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhagwan</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM), Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland ; msxjb4@exmail.nottingham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM), Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland ; gary.duncan91@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosqueira</LastName><ForeName>Diogo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM), Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland ; mzxdm@exmail.nottingham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM), Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland ; mgzmdm@exmail.nottingham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vo</LastName><ForeName>Nguyen T N</ForeName><Initials>NTN</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM), Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland ; mzxnnv@exmail.nottingham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denning</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Nottingham, Wolfson Centre for Stem Cells, Tissue Engineering &amp; Modelling (STEM) , Centre for Biomolecular Sciences , Room A61 , Nottingham, Notts, United Kingdom of Great Britain and Northern Ireland , NG7 2RD.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>United Kingdom of Great Britain and Northern Ireland ; Chris.Denning@nottingham.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stem Cells Dev</MedlineTA><NlmUniqueID>101197107</NlmUniqueID><ISSNLinking>1547-3287</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29402189</ArticleId><ArticleId IdType="doi">10.1089/scd.2017.0268</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29401578</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-6860</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>08</Day></PubDate></JournalIssue><Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title><ISOAbbreviation>FASEB J.</ISOAbbreviation></Journal><ArticleTitle>Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia.</ArticleTitle><Pagination><MedlinePgn>fj201700962R</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201700962R</ELocationID><Abstract><AbstractText>Stroke-induced immune suppression predisposes the host to infections and can contribute to high morbidity and mortality in stroke patients. Because ischemic stroke has a profound effect on the systemic immune response, which may explain the increased susceptibility of stroke patients to infection, an urgent need persists for a better understanding of mechanisms associated with immune suppression; new and effective treatments for stroke can then be identified. NK cells play a key role in early host defense against pathogens by killing infected cells and/or producing cytokines such as IFN-γ. Because the phenotype and function of peripheral NK cells have been widely investigated in ischemic stroke, nCounter Inflammation Gene Array Analysis was used to build immune-related gene profiles of NK cells to comprehensively analyze the molecular signature of NK cells after ischemic brain injury. We observed distinct gene expression profiles reflecting different splenic NK-cell phenotypes and functional properties across the time course of transient middle cerebral artery occlusion (MCAO). Based on gene expression and pathway-network analysis, lower expression levels of signal transducer and activator of transcription-3 (STAT3) were observed in animals with MCAO compared with sham control animals. Genetic activation of STAT3 through the introduction of STAT3 clustered regularly interspaced short palindromic repeats (CRISPR) plasmid prevented the loss of NK-cell-derived IFN-γ production after MCAO, together with reduced bacterial burden and mortality. Our data suggest that brain ischemia impairs NK-cell-mediated immune defense in the periphery, at least in part through the JAK-STAT3 pathway, which can be readdressed by modulating STAT3 activation status.-Jin, W.-N., Ducruet, A. F., Liu, Q., Shi, S. X.-Y., Waters, M., Zou, M., Sheth, K. N., Gonzales, R., Shi, F.-D. Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Wei-Na</ForeName><Initials>WN</Initials><AffiliationInfo><Affiliation>Center for Neuroinflammation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology and Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ducruet</LastName><ForeName>Andrew F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Division of Neurology and Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology and Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Samuel Xiang-Yu</ForeName><Initials>SX</Initials><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona, USA; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waters</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neurology and Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheth</LastName><ForeName>Kevin N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales</LastName><ForeName>Rayna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona, USA; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Fu-Dong</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Center for Neuroinflammation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology and Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS092713</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>FASEB J</MedlineTA><NlmUniqueID>8804484</NlmUniqueID><ISSNLinking>0892-6638</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">immune suppression</Keyword><Keyword MajorTopicYN="N">ischemic stroke</Keyword><Keyword MajorTopicYN="N">multigene signature</Keyword><Keyword MajorTopicYN="N">natural killer cell</Keyword><Keyword MajorTopicYN="N">poststroke infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29401578</ArticleId><ArticleId IdType="doi">10.1096/fj.201700962R</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29401421</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-1551</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>22</Day></PubDate></JournalIssue><Title>Developmental cell</Title><ISOAbbreviation>Dev. Cell</ISOAbbreviation></Journal><ArticleTitle>CRISPR Screens Uncover Genes that Regulate Target Cell Sensitivity to the Morphogen Sonic Hedgehog.</ArticleTitle><Pagination><MedlinePgn>271</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1534-5807(18)30002-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.devcel.2018.01.002</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pusapati</LastName><ForeName>Ganesh V</ForeName><Initials>GV</Initials></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Jennifer H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Bhaven B</ForeName><Initials>BB</Initials></Author><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Arunkumar</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sagner</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kinnebrew</LastName><ForeName>Maia</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Briscoe</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Aravind</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Rohatgi</LastName><ForeName>Rajat</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP2 GM105448</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112988</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM118082</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dev Cell</MedlineTA><NlmUniqueID>101120028</NlmUniqueID><ISSNLinking>1534-5807</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Dev Cell. 2018 Jan 8;44(1):113-129.e8</RefSource><PMID Version="1">29290584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 Sep 14;6:null</RefSource><PMID Version="1">28906251</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29401421</ArticleId><ArticleId IdType="pii">S1534-5807(18)30002-9</ArticleId><ArticleId IdType="doi">10.1016/j.devcel.2018.01.002</ArticleId><ArticleId IdType="pmc">PMC5804815</ArticleId><ArticleId IdType="mid">NIHMS936517</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29399409</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2162-4011</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>3</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Oncoimmunology</Title><ISOAbbreviation>Oncoimmunology</ISOAbbreviation></Journal><ArticleTitle>Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines.</ArticleTitle><Pagination><MedlinePgn>e1407898</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/2162402X.2017.1407898</ELocationID><Abstract><AbstractText>Relapsed T-cell malignancies have poor outcomes when treated with chemotherapy, but survival after allogeneic bone marrow transplantation (BMT) approaches 50%. A limitation to BMT is the difficulty of achieving remission prior to transplant. Chimeric antigen receptor (CAR) T-cell therapy has shown successes in B-cell malignancies. This approach is difficult to adapt for the treatment of T-cell disease due to lack of a T-lymphoblast specific antigen and the fratricide of CAR T cells that occurs with T-cell antigen targeting. To circumvent this problem two approaches were investigated. First, a natural killer (NK) cell line, which does not express CD5, was used for CAR expression. Second, CRISPR-Cas9 genome editing technology was used to knockout CD5 expression in CD5-positive Jurkat T cells and in primary T cells, allowing for the use of CD5-negative T cells for CAR expression. Two structurally distinct anti-CD5 sequences were also tested, i) a traditional immunoglobulin-based single chain variable fragment (scFv) and ii) a lamprey-derived variable lymphocyte receptor (VLR), which we previously showed can be used for CAR-based recognition. Our results show i) both CARs yield comparable T-cell activation and NK cell-based cytotoxicity when targeting CD5-positive cells, ii) CD5-edited CAR-modified Jurkat T cells have reduced self-activation compared to that of CD5-positive CAR-modified T cells, iii) CD5-edited CAR-modified Jurkat T cells have increased activation in the presence of CD5-positive target cells compared to that of CD5-positive CAR-modified T cells, and iv) although modest effects were seen, a mouse model using the CAR-expressing NK cell line showed the scFv-CAR was superior to the VLR-CAR in delaying disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raikar</LastName><ForeName>Sunil S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischer</LastName><ForeName>Lauren C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moot</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedanov</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paik</LastName><ForeName>Na Yoon</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Kristopher A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doering</LastName><ForeName>Christopher B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spencer</LastName><ForeName>H Trent</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncoimmunology</MedlineTA><NlmUniqueID>101570526</NlmUniqueID><ISSNLinking>2162-4011</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Blood. 2005 Oct 15;106(8):2781-9</RefSource><PMID Version="1">15998834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1996 Dec 13;274(5294):1906-9</RefSource><PMID Version="1">8943203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Blood Marrow Transplant. 2012 Dec;18(12):1897-904</RefSource><PMID Version="1">22824185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1991 Apr 1;77(7):1546-54</RefSource><PMID Version="1">1826223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Oncolytics. 2016 Dec 07;3:16026</RefSource><PMID Version="1">27933313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Structure. 2012 Mar 7;20(3):479-86</RefSource><PMID Version="1">22405006</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jul 21;535(7613):476-7</RefSource><PMID Version="1">27466105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pediatr Hematol Oncol. 2013 Jul;35(5):e200-4</RefSource><PMID Version="1">23652878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Pharmacol. 2015 Feb 12;6:21</RefSource><PMID Version="1">25729364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Blood Marrow Transplant. 2015 Dec;21(12 ):2154-2159</RefSource><PMID Version="1">26327632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncoimmunology. 2013 Oct 1;2(10):e26527</RefSource><PMID Version="1">24404423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncoimmunology. 2014 Apr 15;3:e28147</RefSource><PMID Version="1">25340009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autoimmun Rev. 2009 Feb;8(4):349-53</RefSource><PMID Version="1">19041428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Oct 16;371(16):1507-17</RefSource><PMID Version="1">25317870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2010 Jul;391(7):753-60</RefSource><PMID Version="1">20482318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2015 Feb 7;385(9967):517-528</RefSource><PMID Version="1">25319501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Rheumatol. 2012 Mar;18(2):83-8</RefSource><PMID Version="1">22334268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2010 Aug 1;185(3):1367-74</RefSource><PMID Version="1">20660361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2015 Aug 20;126(8):983-92</RefSource><PMID Version="1">26056165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2014 Feb 19;6(224):224ra25</RefSource><PMID Version="1">24553386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Immunol. 2014;122:59-90</RefSource><PMID Version="1">24507155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Dec 16;42(22):e168</RefSource><PMID Version="1">25300484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2004 Dec 15;173(12):7647-53</RefSource><PMID Version="1">15585893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2015;1239:197-217</RefSource><PMID Version="1">25408407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1991 Sep 1;78(5):1166-72</RefSource><PMID Version="1">1878583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1991 Sep 1;78(5):1173-82</RefSource><PMID Version="1">1878584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 1994 May;13(5):571-5</RefSource><PMID Version="1">7519937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1993 Jul 15;82(2):343-62</RefSource><PMID Version="1">8329694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2014 Apr;28(4):917-27</RefSource><PMID Version="1">24067492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2017 Oct;31(10 ):2151-2160</RefSource><PMID Version="1">28074066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2002;20:253-300</RefSource><PMID Version="1">11861604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol Methods. 2012 Dec 14;386(1-2):43-9</RefSource><PMID Version="1">22964555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 1994 Apr;8(4):652-8</RefSource><PMID Version="1">8152260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1998 Dec 21;188(12):2301-11</RefSource><PMID Version="1">9858516</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2013;969:127-38</RefSource><PMID Version="1">23296932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Aug 20;26(24):3971-8</RefSource><PMID Version="1">18711187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2007 Jul;7(7):532-42</RefSource><PMID Version="1">17589543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2016 Oct;27(10 ):758-771</RefSource><PMID Version="1">27479233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Immunol Res. 2015 Apr;3(4):333-44</RefSource><PMID Version="1">25492700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol Methods. 2001 Jun 1;252(1-2):83-92</RefSource><PMID Version="1">11334968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2009 Mar;155(Pt 3):733-40</RefSource><PMID Version="1">19246744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Oncol. 2014 Mar;8(2):297-310</RefSource><PMID Version="1">24388357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Feb 15;482(7385):331-8</RefSource><PMID Version="1">22337052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1995 Jul 28;269(5223):535-7</RefSource><PMID Version="1">7542801</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2014 Dec 02;3:e214</RefSource><PMID Version="1">25462530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1986 Sep;68(3):752-61</RefSource><PMID Version="1">3488778</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Mol Med. 2012 Mar;16(3):569-81</RefSource><PMID Version="1">21595822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2016;1441:215-30</RefSource><PMID Version="1">27177669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Nov 1;23(31):7942-50</RefSource><PMID Version="1">16258094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Sep 25;513(7519):569-73</RefSource><PMID Version="1">25079318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 May 26;6:26871</RefSource><PMID Version="1">27226350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Immunol Immunother. 2016 Apr;65(4):485-92</RefSource><PMID Version="1">26559813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 1992 Nov;22(11):2995-3000</RefSource><PMID Version="1">1385158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Eng. 1994 Jun;7(6):805-14</RefSource><PMID Version="1">7937712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytotherapy. 2017 Feb;19(2):235-249</RefSource><PMID Version="1">27887866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Aug 15;321(5891):960-4</RefSource><PMID Version="1">18703739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytotherapy. 2016 Nov;18(11):1422-1434</RefSource><PMID Version="1">27497701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2012;30:203-20</RefSource><PMID Version="1">22224775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1990 Apr 1;75(7):1426-32</RefSource><PMID Version="1">2180494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Rev Immunol. 1993;10(2-3):195-217</RefSource><PMID Version="1">8360586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene Ther. 2011 Jan;18(1):62-72</RefSource><PMID Version="1">20944680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Mol Med. 2016 Jul;20(7):1287-94</RefSource><PMID Version="1">27008316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Dec;32(12):1262-7</RefSource><PMID Version="1">25184501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1986 Jun;67(6):1680-7</RefSource><PMID Version="1">3085747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2015 Feb;23(2):330-8</RefSource><PMID Version="1">25373520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Immunol. 2015 Apr 28;6:195</RefSource><PMID Version="1">25972867</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T-cell lenkemia</Keyword><Keyword MajorTopicYN="N">anti-cds scFv</Keyword><Keyword MajorTopicYN="N">chimeric antigen receptor</Keyword><Keyword MajorTopicYN="N">immunotheraphy</Keyword><Keyword MajorTopicYN="N">lamprey variable lymphocyte receptor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29399409</ArticleId><ArticleId IdType="doi">10.1080/2162402X.2017.1407898</ArticleId><ArticleId IdType="pii">1407898</ArticleId><ArticleId IdType="pmc">PMC5790337</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29399388</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2162-4011</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>3</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Oncoimmunology</Title><ISOAbbreviation>Oncoimmunology</ISOAbbreviation></Journal><ArticleTitle>T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy.</ArticleTitle><Pagination><MedlinePgn>e1382793</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/2162402X.2017.1382793</ELocationID><Abstract><AbstractText>Cancers frequently evade immune-recognition by lowering peptide:MHC-I complexes on their cell surface. Limited peptide supply due to TAP-deficiency results in such MHC-I<sup>low</sup>immune-escape variants. Previously, we reported on a category of TAP-independent self-peptides, called TEIPP, with selective presentation by these tumors. Here we demonstrate that in contrast to T cells specific for conventional tumor antigens, TEIPP-directed T cells remain naïve in mice bearing immune-escaped tumors. This unaffected state was caused by low levels of MHC-I on the tumors and the failure to cross-present low levels of antigenic protein by host APCs. Importantly, increased levels of MHC-I, antigen or co-stimulation resulted in potent activation of TEIPP-specific T cells via direct presentation. Genetic knockdown by CRISPR/Cas9 technology of the relevant MHC-I allele in tumor cells indeed abrogated T cell activation. Vaccine-mediated priming of TEIPP-specific T cells induced efficient homing to MHC-I<sup>low</sup>tumors and subsequently protected mice against outgrowth of their MHC-I<sup>low</sup>tumor. Thus, our data open up the search of TEIPP-specific T cells in cancer patients to explore their application against MHC-I<sup>low</sup>tumor cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doorduijn</LastName><ForeName>Elien M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sluijter</LastName><ForeName>Marjolein</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marijt</LastName><ForeName>Koen A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Querido</LastName><ForeName>Bianca J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Burg</LastName><ForeName>Sjoerd H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Hall</LastName><ForeName>Thorbald</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncoimmunology</MedlineTA><NlmUniqueID>101570526</NlmUniqueID><ISSNLinking>2162-4011</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1976 May 1;143(5):1283-8</RefSource><PMID Version="1">1083422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunotherapy. 2013 May;5(5):513-531</RefSource><PMID Version="1">23638746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2016 Apr;16(4):219-33</RefSource><PMID Version="1">26965076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Nov 10;9(11):e108192</RefSource><PMID Version="1">25383875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Jun 27;272(26):16585-90</RefSource><PMID Version="1">9195970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2016 Sep 21;8(357):357ra123</RefSource><PMID Version="1">27655849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Transl Med. 2016 Sep 20;14 :273</RefSource><PMID Version="1">27650038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2011 Nov;41(11):3114-24</RefSource><PMID Version="1">21898382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2004 Dec 1;173(11):6753-9</RefSource><PMID Version="1">15557168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11496-501</RefSource><PMID Version="1">9326638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2013 Oct 15;191(8):4020-8</RefSource><PMID Version="1">24048903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Cancer Drug Targets. 2007 Feb;7(1):41-53</RefSource><PMID Version="1">17305477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2004 May 28;304(5675):1314-7</RefSource><PMID Version="1">15166378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5561-6</RefSource><PMID Version="1">11929985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunogenetics. 2017 Aug;69(8-9):547-556</RefSource><PMID Version="1">28699110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2016 Aug 8;30(2):324-336</RefSource><PMID Version="1">27424807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1999 Oct 15;163(8):4224-31</RefSource><PMID Version="1">10510359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2006 Apr;12(4):417-24</RefSource><PMID Version="1">16550190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2015 Nov 5;373(19):1803-13</RefSource><PMID Version="1">26406148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Sep 22;118(12):3273-9</RefSource><PMID Version="1">21791425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2016 Oct 17;213(11):2333-2348</RefSource><PMID Version="1">27697836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2003 Aug 18;198(4):569-80</RefSource><PMID Version="1">12925674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Oct 6;167(2):397-404.e9</RefSource><PMID Version="1">27667683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2001;19:47-64</RefSource><PMID Version="1">11244030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2000 Dec 18;192(12):1685-96</RefSource><PMID Version="1">11120766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Cell Biol. 2000 Apr;78(2):110-7</RefSource><PMID Version="1">10762410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2016 Feb;126(2):784-94</RefSource><PMID Version="1">26784543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2015 Jul 2;373(1):23-34</RefSource><PMID Version="1">26027431</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2006 Nov 1;177(9):6018-24</RefSource><PMID Version="1">17056526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2016 Sep 1;375(9):819-29</RefSource><PMID Version="1">27433843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2006 Apr 15;176(8):4573-80</RefSource><PMID Version="1">16585547</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 31;471(7340):629-32</RefSource><PMID Version="1">21455179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Mar 10;434(7030):238-43</RefSource><PMID Version="1">15724150</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8+ T cells</Keyword><Keyword MajorTopicYN="N">cancer immunotherapy</Keyword><Keyword MajorTopicYN="N">immune escape</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>09</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>09</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29399388</ArticleId><ArticleId IdType="doi">10.1080/2162402X.2017.1382793</ArticleId><ArticleId IdType="pii">1382793</ArticleId><ArticleId IdType="pmc">PMC5790395</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29399048</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1756-2856</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Therapeutic advances in neurological disorders</Title><ISOAbbreviation>Ther Adv Neurol Disord</ISOAbbreviation></Journal><ArticleTitle>The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders.</ArticleTitle><Pagination><MedlinePgn>1756285617741837</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1756285617741837</ELocationID><Abstract><AbstractText>Over the past few decades, as gene discovery methods and sequencing technologies have evolved, many genetic variations that significantly increase the risk of or cause neurodegenerative diseases have been identified. However, knowledge of those pathogenic mutations and subsequent mechanism-focused studies has rarely yielded effective treatments, warranting alternative strategies for refining rational therapeutic targets. Nevertheless, with the evolution of gene targeting methods, it has been increasingly recognized that the disease-causing gene itself is the best therapeutic target even when we do not have a full understanding of its biological functions. Considering this, CRISPR/Cas gene editing technology offers the promise of permanently silencing or correcting the disease-causing mutations, potentially overcoming key limitations of RNA-targeting approaches. The versatile CRISPR/Cas-based strategies have the potential to become treatment options for challenging disorders such as neurodegenerative diseases. Here, we summarize recent reports of preclinical applications of CRISPR/Cas in models of neurodegenerative disorders to provide perspectives on therapeutic gene editing for diseases of the nervous system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Jun Wan</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA; Department of Neurology, Harvard Medical School, Boston, MA 02115, USA; Medical and Population Genetics Program, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong-Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA Department of Neurology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Neurol Disord</MedlineTA><NlmUniqueID>101480242</NlmUniqueID><ISSNLinking>1756-2856</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Science. 1993 Aug 20;261(5124):1047-51</RefSource><PMID Version="1">8351519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2005 Oct 19;25(42):9773-81</RefSource><PMID Version="1">16237181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):403-7</RefSource><PMID Version="1">26721684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1998 Sep 18;281(5384):1851-4</RefSource><PMID Version="1">9743498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2868-73</RefSource><PMID Version="1">26929348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2005 Jul;16(7):781-91</RefSource><PMID Version="1">16000060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Feb;33(2):187-197</RefSource><PMID Version="1">25513782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17204-9</RefSource><PMID Version="1">17940007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jul;32(7):670-6</RefSource><PMID Version="1">24752079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Curr. 2014 Apr 15;6:null</RefSource><PMID Version="1">24761311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Somat Cell Mol Genet. 1994 Jan;20(1):27-38</RefSource><PMID Version="1">8197474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2017 Mar 14;8(3):619-633</RefSource><PMID Version="1">28238795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2014 Sep 8;30(5):625-36</RefSource><PMID Version="1">25155554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2016 Nov;17 (3):466-469</RefSource><PMID Version="1">27789395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cerebellum. 2016 Oct;15(5):599-610</RefSource><PMID Version="1">27277287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Jun;12(6):535-40</RefSource><PMID Version="1">25867848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Obstet Gynecol. 2008 Mar;111(3):596-601</RefSource><PMID Version="1">18310361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2016 Nov;17 (3):576-579</RefSource><PMID Version="1">27934586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2014 Jan;10(1):e1004086</RefSource><PMID Version="1">24453986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Genet. 2015 Jun 03;6:192</RefSource><PMID Version="1">26089834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 9;520(7546):186-91</RefSource><PMID Version="1">25830891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Mar 31;101(1):57-66</RefSource><PMID Version="1">10778856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2016 Dec;24(12 ):1826-1827</RefSource><PMID Version="1">27329733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2003 Jul 1;12 (13):1555-67</RefSource><PMID Version="1">12812983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Jun 11;6:7391</RefSource><PMID Version="1">26067104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2017 Nov;25(11):1202-1209</RefSource><PMID Version="1">28832564</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2003 Nov 1;12 (21):2827-36</RefSource><PMID Version="1">12952868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1992 Mar;12(3):1292-303</RefSource><PMID Version="1">1545810</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Mar 22;113(12 ):3359-64</RefSource><PMID Version="1">26951659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Oct 13;13(2):234-41</RefSource><PMID Version="1">26440889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Dis Primers. 2015 Apr 23;1:15005</RefSource><PMID Version="1">27188817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1997 Dec;17 (4):404-10</RefSource><PMID Version="1">9398841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2011 Oct 20;72(2):245-56</RefSource><PMID Version="1">21944778</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Jan;24(1):132-41</RefSource><PMID Version="1">24253446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Feb;34(2):184-191</RefSource><PMID Version="1">26780180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2016 Nov;17 (3):600-602</RefSource><PMID Version="1">27934590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1995 Oct;11(2):155-63</RefSource><PMID Version="1">7550343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2017 Apr 02;18(4):null</RefSource><PMID Version="1">28368337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Aging. 2012 Jan;33(1):209.e3-8</RefSource><PMID Version="1">21925771</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Neurosci. 2007;30:575-621</RefSource><PMID Version="1">17417937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Mar 4;362(6415):59-62</RefSource><PMID Version="1">8446170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2016 Oct 15;25(20):4566-4576</RefSource><PMID Version="1">28172889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Jan;33(1):102-6</RefSource><PMID Version="1">25326897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1991 Feb 21;349(6311):704-6</RefSource><PMID Version="1">1671712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2012 Aug 3;11(2):253-63</RefSource><PMID Version="1">22748967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurosci. 2016 Jan;17(1):36-44</RefSource><PMID Version="1">26656253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Aug 22;500(7463):472-476</RefSource><PMID Version="1">23877069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Nov 09;7:13272</RefSource><PMID Version="1">27827362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1993 Mar 26;72(6):971-83</RefSource><PMID Version="1">8458085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jan 28;529(7587):490-5</RefSource><PMID Version="1">26735016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Feb 27;323(5918):1208-1211</RefSource><PMID Version="1">19251628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Mar;32(3):279-284</RefSource><PMID Version="1">24463574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2017 Jan 4;25(1):12-23</RefSource><PMID Version="1">28129107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 31;6:23549</RefSource><PMID Version="1">27030102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Oct;8(10):2061-78</RefSource><PMID Version="1">24071911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2015 May;11(5):316-8</RefSource><PMID Version="1">25848930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2012 Mar 6;78(10):690-5</RefSource><PMID Version="1">22323755</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jun 24;6:28420</RefSource><PMID Version="1">27341390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Aug;34(8):863-8</RefSource><PMID Version="1">27272384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2011 Oct 20;72(2):257-68</RefSource><PMID Version="1">21944779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jan 8;327(5962):167-70</RefSource><PMID Version="1">20056882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2007 Mar;18(3):195-206</RefSource><PMID Version="1">17343566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Aging. 2011 Mar;32(3):548.e1-4</RefSource><PMID Version="1">20018407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2014 Dec;22(12 ):2093-106</RefSource><PMID Version="1">25101598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Genet. 2014 Jul 17;5:226</RefSource><PMID Version="1">25101111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2016 Sep;17 (2):285-288</RefSource><PMID Version="1">27879212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Nov 4;468(7320):67-71</RefSource><PMID Version="1">21048762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1995 Jun 2;81(5):811-23</RefSource><PMID Version="1">7774020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2016 Jan 7;98(1):90-101</RefSource><PMID Version="1">26686765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 May;35(5):431-434</RefSource><PMID Version="1">28191903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Evol. 2005 Feb;60(2):174-82</RefSource><PMID Version="1">15791728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein Cell. 2017 May;8(5):365-378</RefSource><PMID Version="1">28401346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Aug 20;9(8):e105584</RefSource><PMID Version="1">25140704</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 1;351(6268):84-8</RefSource><PMID Version="1">26628643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2016 Nov;17 (3):556-559</RefSource><PMID Version="1">27789409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2004 Oct 6;24(40):8853-61</RefSource><PMID Version="1">15470152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Jan;33(1):73-80</RefSource><PMID Version="1">25357182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Aug;34(8):869-74</RefSource><PMID Version="1">27347757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2000 Nov;26(3):300-6</RefSource><PMID Version="1">11062468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 1992 Aug;51(2):273-82</RefSource><PMID Version="1">1642228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 22;351(6271):407-411</RefSource><PMID Version="1">26721686</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">PAM</Keyword><Keyword MajorTopicYN="N">allele-specific</Keyword><Keyword MajorTopicYN="N">gRNA</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword></KeywordList><CoiStatement>Conflict of interest statement: The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29399048</ArticleId><ArticleId IdType="doi">10.1177/1756285617741837</ArticleId><ArticleId IdType="pii">10.1177_1756285617741837</ArticleId><ArticleId IdType="pmc">PMC5784517</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29396999</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1860-7314</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>03</Day></PubDate></JournalIssue><Title>Biotechnology journal</Title><ISOAbbreviation>Biotechnol J</ISOAbbreviation></Journal><ArticleTitle>Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/biot.201700591</ELocationID><Abstract><AbstractText>The carbon footprint caused by unsustainable development and its environmental and economic impact has become a major concern in the past few decades. Photosynthetic microbes such as microalgae and cyanobacteria are capable of accumulating value-added compounds from carbon dioxide, and have been regarded as environmentally friendly alternatives to reduce the usage of fossil fuels, thereby contributing to reducing the carbon footprint. This light-driven generation of green chemicals and biofuels has triggered the research for metabolic engineering of these photosynthetic microbes. CRISPR-Cas systems are successfully implemented across a wide range of prokaryotic and eukaryotic species for efficient genome editing. However, the inception of this genome editing tool in microalgal and cyanobacterial species took off rather slowly due to various complications. In this review, we elaborate on the established CRISPR-Cas based genome editing in various microalgal and cyanobacterial species. The complications associated with CRISPR-Cas based genome editing in these species are addressed along with possible strategies to overcome these issues. It is anticipated that in the near future this will result in improving and expanding the microalgal and cyanobacterial genome engineering toolbox.</AbstractText><CopyrightInformation>© 2018 The Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH &amp; Co. KGaA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naduthodi</LastName><ForeName>Mihris Ibnu Saleem</ForeName><Initials>MIS</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Wageningen University and Research, Wageningen, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioprocess Engineering, AlgaePARC, Wageningen University and Research, Wageningen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Maria J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Bioprocess Engineering, AlgaePARC, Wageningen University and Research, Wageningen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Oost</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Wageningen University and Research, Wageningen, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Biotechnol J</MedlineTA><NlmUniqueID>101265833</NlmUniqueID><ISSNLinking>1860-6768</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas</Keyword><Keyword MajorTopicYN="N">Cas12a (Cpf1)</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">cyanobacteria</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword><Keyword MajorTopicYN="N">microalgae</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29396999</ArticleId><ArticleId IdType="doi">10.1002/biot.201700591</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29396264</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-0024</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Molecular therapy : the journal of the American Society of Gene Therapy</Title><ISOAbbreviation>Mol. Ther.</ISOAbbreviation></Journal><ArticleTitle>Boosting, Not Breaking: CRISPR Activators Treat Disease Models.</ArticleTitle><Pagination><MedlinePgn>334-336</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1525-0016(18)30011-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ymthe.2018.01.004</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gemberling</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA; Center for Genomic and Computational Biology, Duke University, Durham, NC 27708, USA. Electronic address: mpg13@duke.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gersbach</LastName><ForeName>Charles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA; Center for Genomic and Computational Biology, Duke University, Durham, NC 27708, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Ther</MedlineTA><NlmUniqueID>100890581</NlmUniqueID><ISSNLinking>1525-0016</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):973-6</RefSource><PMID Version="1">23892895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Dec 14;171(7):1495-1507.e15</RefSource><PMID Version="1">29224783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Feb;13(2):127-37</RefSource><PMID Version="1">26820547</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 23;159(3):635-46</RefSource><PMID Version="1">25307933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Nov;12(11):1051-4</RefSource><PMID Version="1">26344044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Ther Targets. 2014 Aug;18(8):835-9</RefSource><PMID Version="1">24917359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Nov;33(11):1159-61</RefSource><PMID Version="1">26436575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):977-9</RefSource><PMID Version="1">23892898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 Jun;35(6):561-568</RefSource><PMID Version="1">28369033</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Mar;24(3):430-46</RefSource><PMID Version="1">26755333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Oct;13(10 ):868-74</RefSource><PMID Version="1">27595405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Apr;12(4):326-8</RefSource><PMID Version="1">25730490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jan 29;517(7536):583-8</RefSource><PMID Version="1">25494202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Chem Biomol Eng. 2016 Jun 7;7:637-62</RefSource><PMID Version="1">27146557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):510-7</RefSource><PMID Version="1">25849900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jul 18;154(2):442-51</RefSource><PMID Version="1">23849981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 23;159(3):647-61</RefSource><PMID Version="1">25307932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 9;159(2):440-55</RefSource><PMID Version="1">25263330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Sep 22;167(1):233-247.e17</RefSource><PMID Version="1">27662091</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29396264</ArticleId><ArticleId IdType="pii">S1525-0016(18)30011-X</ArticleId><ArticleId IdType="doi">10.1016/j.ymthe.2018.01.004</ArticleId><ArticleId IdType="pmc">PMC5835121</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29396142</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1673-8527</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of genetics and genomics = Yi chuan xue bao</Title><ISOAbbreviation>J Genet Genomics</ISOAbbreviation></Journal><ArticleTitle>Generation of ApoE deficient dogs via combination of embryo injection of CRISPR/Cas9 with somatic cell nuclear transfer.</ArticleTitle><Pagination><MedlinePgn>47-50</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1673-8527(17)30196-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jgg.2017.11.003</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Beijing SINOGENE Biotechnology Co., Ltd, Beijing 102200, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; University of Chinese Academy of Sciences, Beijing 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Quanmei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Beijing SINOGENE Biotechnology Co., Ltd, Beijing 102200, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Beijing SINOGENE Biotechnology Co., Ltd, Beijing 102200, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Quanjun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yumin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yougang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Electronic address: 18911223116@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mi</LastName><ForeName>Jidong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Beijing SINOGENE Biotechnology Co., Ltd, Beijing 102200, China. Electronic address: jidong-m@sinogene.com.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Liangxue</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China; Jilin Provincial Key Laboratory of Animal Embryo Engineering, College of Veterinary Medicine, Jilin University, Changchun 130062, China. Electronic address: lai_liangxue@gibh.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Genet Genomics</MedlineTA><NlmUniqueID>101304616</NlmUniqueID><ISSNLinking>1673-8527</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29396142</ArticleId><ArticleId IdType="pii">S1673-8527(17)30196-0</ArticleId><ArticleId IdType="doi">10.1016/j.jgg.2017.11.003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29395917</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-0445</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>Current biology : CB</Title><ISOAbbreviation>Curr. Biol.</ISOAbbreviation></Journal><ArticleTitle>Modulation of Host Learning in Aedes aegypti Mosquitoes.</ArticleTitle><Pagination><MedlinePgn>333-344.e8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0960-9822(17)31617-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cub.2017.12.015</ELocationID><Abstract><AbstractText>How mosquitoes determine which individuals to bite has important epidemiological consequences. This choice is not random; most mosquitoes specialize in one or a few vertebrate host species, and some individuals in a host population are preferred over others. Mosquitoes will also blood feed from other hosts when their preferred is no longer abundant, but the mechanisms mediating these shifts between hosts, and preferences for certain individuals within a host species, remain unclear. Here, we show that olfactory learning may contribute to Aedes aegypti mosquito biting preferences and host shifts. Training and testing to scents of humans and other host species showed that mosquitoes can aversively learn the scent of specific humans and single odorants and learn to avoid the scent of rats (but not chickens). Using pharmacological interventions, RNAi, and CRISPR gene editing, we found that modification of the dopamine-1 receptor suppressed their learning abilities. We further show through combined electrophysiological and behavioral recordings from tethered flying mosquitoes that these odors evoke changes in both behavior and antennal lobe (AL) neuronal responses and that dopamine strongly modulates odor-evoked responses in AL neurons. Not only do these results provide direct experimental evidence that olfactory learning in mosquitoes can play an epidemiological role, but collectively, they also provide neuroanatomical and functional demonstration of the role of dopamine in mediating this learning-induced plasticity, for the first time in a disease vector insect.</AbstractText><CopyrightInformation>Copyright © 2017 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vinauger</LastName><ForeName>Clément</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lahondère</LastName><ForeName>Chloé</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolff</LastName><ForeName>Gabriella H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locke</LastName><ForeName>Lauren T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Jessica E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrish</LastName><ForeName>Jay Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari</LastName><ForeName>Omar S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Department of Entomology, University of California, Riverside, Riverside, CA 92521, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickinson</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riffell</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Washington, Seattle, WA 98195, USA. Electronic address: jriffell@uw.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Biol</MedlineTA><NlmUniqueID>9107782</NlmUniqueID><ISSNLinking>0960-9822</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aedes aegypti</Keyword><Keyword MajorTopicYN="N">aversive conditioning</Keyword><Keyword MajorTopicYN="N">disease vector</Keyword><Keyword MajorTopicYN="N">dopamine</Keyword><Keyword MajorTopicYN="N">mosquito</Keyword><Keyword MajorTopicYN="N">neuromodulation</Keyword><Keyword MajorTopicYN="N">olfactory learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29395917</ArticleId><ArticleId IdType="pii">S0960-9822(17)31617-2</ArticleId><ArticleId IdType="doi">10.1016/j.cub.2017.12.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29395380</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0168-9525</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Trends in genetics : TIG</Title><ISOAbbreviation>Trends Genet.</ISOAbbreviation></Journal><ArticleTitle>A Toolkit of Engineered Recombinational Balancers in C. elegans.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0168-9525(18)30023-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tig.2018.01.009</ELocationID><Abstract><AbstractText>Dejima and colleagues report using CRISPR/Cas9 to generate a new collection of greatly improved balancer chromosomes in the standard laboratory nematode Caenorhabditis elegans, using methods previously reported by the same laboratory, expanding the set of C. elegans balancers to cover nearly 90% of coding genes.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Hillel T</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sternberg</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Electronic address: pws@caltech.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R24 OD023041</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Genet</MedlineTA><NlmUniqueID>8507085</NlmUniqueID><ISSNLinking>0168-9525</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Caenorhabditis elegans</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">balancer</Keyword><Keyword MajorTopicYN="N">recombinational suppression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29395380</ArticleId><ArticleId IdType="pii">S0168-9525(18)30023-4</ArticleId><ArticleId IdType="doi">10.1016/j.tig.2018.01.009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29395072</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6605</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of human genetics</Title><ISOAbbreviation>Am. J. Hum. Genet.</ISOAbbreviation></Journal><ArticleTitle>Truncated SALL1 Impedes Primary Cilia Function in Townes-Brocks Syndrome.</ArticleTitle><Pagination><MedlinePgn>249-265</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0002-9297(17)30507-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajhg.2017.12.017</ELocationID><Abstract><AbstractText>Townes-Brocks syndrome (TBS) is characterized by a spectrum of malformations in the digits, ears, and kidneys. These anomalies overlap those seen in a growing number of ciliopathies, which are genetic syndromes linked to defects in the formation or function of the primary cilia. TBS is caused by mutations in the gene encoding the transcriptional repressor SALL1 and is associated with the presence of a truncated protein that localizes to the cytoplasm. Here, we provide evidence that SALL1 mutations might cause TBS by means beyond its transcriptional capacity. By using proximity proteomics, we show that truncated SALL1 interacts with factors related to cilia function, including the negative regulators of ciliogenesis CCP110 and CEP97. This most likely contributes to more frequent cilia formation in TBS-derived fibroblasts, as well as in a CRISPR/Cas9-generated model cell line and in TBS-modeled mouse embryonic fibroblasts, than in wild-type controls. Furthermore, TBS-like cells show changes in cilia length and disassembly rates in combination with aberrant SHH signaling transduction. These findings support the hypothesis that aberrations in primary cilia and SHH signaling are contributing factors in TBS phenotypes, representing a paradigm shift in understanding TBS etiology. These results open possibilities for the treatment of TBS.</AbstractText><CopyrightInformation>Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bozal-Basterra</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martín-Ruíz</LastName><ForeName>Itziar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirone</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yinwen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurðsson</LastName><ForeName>Jón Otti</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Santamarta</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Immacolata</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabicagogeascoa</LastName><ForeName>Estibaliz</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Luca</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodríguez</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Genetics, Physical Anthropology, and Animal Physiology, University of the Basque Country (UPV/EHU), Leioa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkie</LastName><ForeName>Andrew O M</ForeName><Initials>AOM</Initials><AffiliationInfo><Affiliation>Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohlhase</LastName><ForeName>Jürgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>SYNLAB Center for Human Genetics Freiburg, Heinrich-von-Stephan-Straße 5, 79100 Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastwood</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yale</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ipswich Hospital NHS Trust, Heath Road, Ipswich IP4 5PD, Suffolk, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>Jesper V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauchman</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Saint Louis University School of Medicine, 1100 South Grand Boulevard, St. Louis, MO 63104, USA; VA St. Louis Health Care System, St. Louis, MO 63106, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Kathryn V</ForeName><Initials>KV</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutherland</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain. Electronic address: jsutherland@cicbiogune.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrio</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>CIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain. Electronic address: rbarrio@cicbiogune.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hum Genet</MedlineTA><NlmUniqueID>0370475</NlmUniqueID><ISSNLinking>0002-9297</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BioID</Keyword><Keyword MajorTopicYN="N">SALL1</Keyword><Keyword MajorTopicYN="N">Townes-Brocks syndrome</Keyword><Keyword MajorTopicYN="N">primary cilia</Keyword><Keyword MajorTopicYN="N">rare disease</Keyword><Keyword MajorTopicYN="N">spalt</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29395072</ArticleId><ArticleId IdType="pii">S0002-9297(17)30507-4</ArticleId><ArticleId IdType="doi">10.1016/j.ajhg.2017.12.017</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29394276</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Lactobacillus gasseri CRISPR-Cas9 characterization In Vitro reveals a flexible mode of protospacer-adjacent motif recognition.</ArticleTitle><Pagination><MedlinePgn>e0192181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0192181</ELocationID><Abstract><AbstractText>While the CRISPR-Cas9 system from S. pyogenes is a powerful genome engineering tool, additional programmed nucleases would enable added flexibility in targeting space and multiplexing. Here, we characterized a CRISPR-Cas9 system from L. gasseri and found that it has modest activity in a cell-free lysate assay but no activity in mammalian cells even when altering promoter, position of tag sequences and NLS, and length of crRNA:tracrRNA. In the lysate assay we tested over 400 sequential crRNA target sequences and found that the Lga Cas9 PAM is NNGA/NDRA, different than NTAA predicted from the native bacterial host. In addition, we found multiple instances of consecutive crRNA target sites, indicating flexibility in either PAM sequence or distance from the crRNA target site. This work highlights the need for characterization of new CRISPR systems and highlights the non-triviality of porting them into eukaryotes as gene editing tools.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Emily M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Dharmacon, a Horizon Discovery Group Company, Lafayette, CO, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClelland</LastName><ForeName>Shawn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dharmacon, a Horizon Discovery Group Company, Lafayette, CO, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maksimova</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dharmacon, a Horizon Discovery Group Company, Lafayette, CO, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strezoska</LastName><ForeName>Žaklina</ForeName><Initials>Ž</Initials><AffiliationInfo><Affiliation>Dharmacon, a Horizon Discovery Group Company, Lafayette, CO, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basila</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dharmacon, a Horizon Discovery Group Company, Lafayette, CO, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briner</LastName><ForeName>Alexandra E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrangou</LastName><ForeName>Rodolphe</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Anja van Brabant</ForeName><Initials>AVB</Initials><Identifier Source="ORCID">0000-0003-3145-6599</Identifier><AffiliationInfo><Affiliation>Dharmacon, a Horizon Discovery Group Company, Lafayette, CO, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Apr 20;169(3):559</RefSource><PMID Version="1">28431253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2017 Mar;15(3):169-182</RefSource><PMID Version="1">28111461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2015 Nov 5;60(3):385-97</RefSource><PMID Version="1">26593719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2013 May;10(5):891-9</RefSource><PMID Version="1">23403393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2013 Jan 29;2:e00471</RefSource><PMID Version="1">23386978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 9;520(7546):186-91</RefSource><PMID Version="1">25830891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Dec 28;11(12 ):e0168968</RefSource><PMID Version="1">28030641</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Protoc. 2016 Mar 01;2016(3):pdb.top086892</RefSource><PMID Version="1">26933254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2015 Sep;161(9):1752-61</RefSource><PMID Version="1">26297561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2017 Apr 20;66(2):221-233.e4</RefSource><PMID Version="1">28431230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2017 Jan 20;429(2):177-191</RefSource><PMID Version="1">27916599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Sep 25;513(7519):569-73</RefSource><PMID Version="1">25079318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2017 Jun 10;251:189-200</RefSource><PMID Version="1">28445693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Apr 7;62(1):137-47</RefSource><PMID Version="1">27041224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Sep 08;34(9):933-941</RefSource><PMID Version="1">27606440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2015 Oct 10;211:56-65</RefSource><PMID Version="1">26189696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 Oct 23;56(2):333-9</RefSource><PMID Version="1">25373540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Jun;34(6):634-6</RefSource><PMID Version="1">27159373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Mar;23(3):206-17</RefSource><PMID Version="1">11243834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 6;507(7490):62-7</RefSource><PMID Version="1">24476820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2016 Feb 27;428(5 Pt B):963-89</RefSource><PMID Version="1">26506267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1995 Jul 25;23(14):2677-84</RefSource><PMID Version="1">7544462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Dec 3;163(6):1515-26</RefSource><PMID Version="1">26627737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2017 Jan 19;65(2):310-322</RefSource><PMID Version="1">27989439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Oct 25;17 (5):1438-1452</RefSource><PMID Version="1">27783955</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29394276</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0192181</ArticleId><ArticleId IdType="pii">PONE-D-17-42313</ArticleId><ArticleId IdType="pmc">PMC5796720</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29394097</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-7125</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Foodborne pathogens and disease</Title><ISOAbbreviation>Foodborne Pathog. Dis.</ISOAbbreviation></Journal><ArticleTitle>CRISPR Typing and Antibiotic Resistance Correlates with Polyphyletic Distribution in Human Isolates of Salmonella Kentucky.</ArticleTitle><Pagination><MedlinePgn>101-108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/fpd.2017.2298</ELocationID><Abstract><AbstractText>Although infrequently associated with reported salmonellosis in humans, Salmonella enterica, subsp. enterica serovar Kentucky (ser. Kentucky) is the most common nonclinical, nonhuman serovar reported in the United States. The goal of this study was to use Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-multi-virulence-locus sequence typing (MVLST) to subtype a collection of human clinical isolates of ser. Kentucky submitted to the Pennsylvania Department of Health and to determine the extent of antibiotic resistance in these strains. This analysis highlighted the polyphyletic nature of ser. Kentucky, and separated our isolates into two groups, Group I and Group II, which were equally represented in our collection. Furthermore, antimicrobial susceptibility testing on all isolates using a National Antimicrobial Resistance Monitoring System (NARMS) panel of antibiotics demonstrated that resistance profiles could be divided into two groups. Group I isolates were resistant to cephems and penicillins, whereas Group II isolates were resistant to quinolones, gentamicin, and sulfisoxazole. Collectively, 50% of isolates were resistant to three or more classes of antibiotics and 30% were resistant to five or more classes. The correlation of antibiotic resistance with the two different lineages may reflect adaptation within two distinct reservoirs of ser. Kentucky, with differential exposure to antimicrobials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vosik</LastName><ForeName>Dorothy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>1 Department of Biology, Gettysburg College , Gettysburg, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tewari</LastName><ForeName>Deepanker</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>2 Pennsylvania Veterinary Laboratory , Pennsylvania Department of Agriculture, Harrisburg, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dettinger</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>3 Bureau of Laboratories , Pennsylvania Department of Health, Exton, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M'ikanatha</LastName><ForeName>Nkuchia M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>4 Division of Infectious Disease Epidemiology , Pennsylvania Department of Health, Harrisburg, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shariat</LastName><ForeName>Nikki W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>1 Department of Biology, Gettysburg College , Gettysburg, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Foodborne Pathog Dis</MedlineTA><NlmUniqueID>101120121</NlmUniqueID><ISSNLinking>1535-3141</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPRs</Keyword><Keyword MajorTopicYN="N">Salmonella Kentucky</Keyword><Keyword MajorTopicYN="N">antibiotic resistance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29394097</ArticleId><ArticleId IdType="doi">10.1089/fpd.2017.2298</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29394047</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8937</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>ACS chemical biology</Title><ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation></Journal><ArticleTitle>Understanding the Molecular Mechanisms of the CRISPR Toolbox Using Single Molecule Approaches.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.7b00905</ELocationID><Abstract><AbstractText>Adaptive immunity against foreign genetic elements conferred by the CRISPR systems in microbial species has been repurposed as a revolutionary technology for wide-ranging biological applications-chiefly genome engineering. Biochemical, structural, genetic, and genomics studies have revealed important insights into their function and mechanisms, but most ensemble studies cannot observe structural changes of these molecules during their function and are often blind to key reaction intermediates. Here, we review the use of single molecule approaches such as fluorescent particle tracking, FRET, magnetic tweezers, and atomic force microscopy imaging in improving our understanding of the CRISPR toolbox.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Digvijay</ForeName><Initials>D</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7411-4436</Identifier><AffiliationInfo><Affiliation>Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine , Baltimore, Maryland 21205, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Taekjip</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine , Baltimore, Maryland 21205, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biophysics, Johns Hopkins University , Baltimore, Maryland 21218, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University , Baltimore, Maryland 21205, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute , Baltimore, Maryland 21205, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Biol</MedlineTA><NlmUniqueID>101282906</NlmUniqueID><ISSNLinking>1554-8929</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29394047</ArticleId><ArticleId IdType="doi">10.1021/acschembio.7b00905</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29392682</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-1889</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Science China. Life sciences</Title><ISOAbbreviation>Sci China Life Sci</ISOAbbreviation></Journal><ArticleTitle>TRPC3 is required for the survival, pluripotency and neural differentiation of mouse embryonic stem cells (mESCs).</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11427-017-9222-9</ELocationID><Abstract><AbstractText>Transient receptor potential canonical subfamily member 3 (TRPC3) is known to be important for neural development and the formation of neuronal networks. Here, we investigated the role of TRPC3 in undifferentiated mouse embryonic stem cells (mESCs) and during the differentiation of mESCs into neurons. CRISPR/Cas9-mediated knockout (KO) of TRPC3 induced apoptosis and the disruption of mitochondrial membrane potential both in undifferentiated mESCs and in those undergoing neural differentiation. In addition, TRPC3 KO impaired the pluripotency of mESCs. TRPC3 KO also dramatically repressed the neural differentiation of mESCs by inhibiting the expression of markers for neural progenitors, neurons, astrocytes and oligodendrocytes. Taken together, our new data demonstrate an important function of TRPC3 with regards to the survival, pluripotency and neural differentiation of mESCs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Helen Baixia</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Division of Life Science and State Key Laboratory of Molecular Neuroscience, HKUST, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Division of Life Science and State Key Laboratory of Molecular Neuroscience, HKUST, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Jianbo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreau</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre de Biologie du Développement (CBD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, F-31062, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leclerc</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre de Biologie du Développement (CBD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, F-31062, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Andrew L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Division of Life Science and State Key Laboratory of Molecular Neuroscience, HKUST, Clear Water Bay, Hong Kong, China. almiller@ust.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Sci China Life Sci</MedlineTA><NlmUniqueID>101529880</NlmUniqueID><ISSNLinking>1674-7305</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">mitochondrial membrane potential</Keyword><Keyword MajorTopicYN="N">mouse embryonic stem cells (mESCs)</Keyword><Keyword MajorTopicYN="N">neuron differentiation</Keyword><Keyword MajorTopicYN="N">pluripotency</Keyword><Keyword MajorTopicYN="N">transient receptor potential canonical subfamily member 3 (TRPC3)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29392682</ArticleId><ArticleId IdType="doi">10.1007/s11427-017-9222-9</ArticleId><ArticleId IdType="pii">10.1007/s11427-017-9222-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29392632</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-9368</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Transgenic research</Title><ISOAbbreviation>Transgenic Res.</ISOAbbreviation></Journal><ArticleTitle>Arabidopsis glutamate:glyoxylate aminotransferase 1 (Ler) mutants generated by CRISPR/Cas9 and their characteristics.</ArticleTitle><Pagination><MedlinePgn>61-74</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11248-017-0052-z</ELocationID><Abstract><AbstractText>Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (CRISPR/Cas9) technology provides an efficient tool for editing the genomes of plants, animals and microorganisms. Glutamate:glyoxylate aminotransferase 1 (GGAT1) is a key enzyme in the photorespiration pathway; however, its regulation mechanism is largely unknown. Given that EMS-mutagenized ggat1 (Col-0 background) M2 pools have been generated, ggat1 (Ler background) should be very useful in the positional cloning of suppressor and/or enhancer genes of GGAT1. Unfortunately, such ggat1 (Ler) mutants are not currently available. In this study, CRISPR/Cas9 was used to generate ggat1 (Ler) mutants. Two GGAT1 target single-guide RNAs (sgRNAs) were constructed into pYLCRISPR/Cas9P<sub>35S</sub>-N, and flowering Arabidopsis (Ler) plants were transformed using an Agrobacterium tumefaciens-mediated floral dip protocol. Eleven chimeric and two heterozygous GGAT1-edited T1 lines of target 1 were separately screened from positive transgenic lines. Two ggat1 homozygous mutants, CTC-deletion and T-deletion at target 1, were generated from T2 generations of the 13 T1 lines. The edited mutation sites were found to be stable through generations regardless of whether the T-DNA was present. In addition, the genetic segregation of the mutation sites obeyed the Mendelian single gene segregation rule, and no mutations were detected at the possible off-target site. Also, the two independent ggat1 mutants had similar photorespiration phenotypes and down-regulated GGAT enzyme activity. Together, these results indicate that genetically stable ggat1 (Ler) mutants were generated by CRISPR/Cas9 genome editing, and these mutants will be used to promote the positional cloning of suppressor and/or enhancer genes of GGAT1 in our subsequent study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yaping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Research Center of Plant Stress Biology, College of Life Sciences, South-China Agricultural University, Guangzhou, 510642, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Xiuying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Research Center of Plant Stress Biology, College of Life Sciences, South-China Agricultural University, Guangzhou, 510642, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xinxiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Research Center of Plant Stress Biology, College of Life Sciences, South-China Agricultural University, Guangzhou, 510642, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Plant Functional Genomics and Biotechnology, Education Department of Guangdong Province, College of Life Sciences, South-China Agricultural University, Guangzhou, 510642, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Xuewen</ForeName><Initials>X</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6448-5292</Identifier><AffiliationInfo><Affiliation>Research Center of Plant Stress Biology, College of Life Sciences, South-China Agricultural University, Guangzhou, 510642, China. hxw1969@scau.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Plant Functional Genomics and Biotechnology, Education Department of Guangdong Province, College of Life Sciences, South-China Agricultural University, Guangzhou, 510642, China. hxw1969@scau.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>201607020006</GrantID><Agency>The Science and Technology Funding of Guangzhou</Agency><Country/></Grant><Grant><GrantID>201707010032</GrantID><Agency>the Science and Technology Funding of Guangzhou</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Transgenic Res</MedlineTA><NlmUniqueID>9209120</NlmUniqueID><ISSNLinking>0962-8819</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2014 Nov;166(3):1292-7</RefSource><PMID Version="1">25225186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Aug;31(8):686-8</RefSource><PMID Version="1">23929338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2016 Oct;46:1-8</RefSource><PMID Version="1">27519625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Mol Biol. 2007 May;64(1-2):205-17</RefSource><PMID Version="1">17318317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Cell. 2016 Aug;28(8):1844-59</RefSource><PMID Version="1">27432873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2013 Oct;23(10):1229-32</RefSource><PMID Version="1">23958582</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biol (Stuttg). 2013 Jul;15(4):713-22</RefSource><PMID Version="1">23452019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2012 Mar;190(3):841-54</RefSource><PMID Version="1">22419077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Feb 07;33(3):e24</RefSource><PMID Version="1">15699181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2014 Aug;12(6):797-807</RefSource><PMID Version="1">24854982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 1998 Dec;16(6):735-43</RefSource><PMID Version="1">10069079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2003 Mar;33(6):975-87</RefSource><PMID Version="1">12631323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Genet Genomics. 2014 Feb 20;41(2):63-8</RefSource><PMID Version="1">24576457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Cell Physiol. 2017 Jul 1;58(7):1260-1267</RefSource><PMID Version="1">28444368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Plant. 2015 Dec 7;8(12 ):1820-3</RefSource><PMID Version="1">26524930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2014;1062:211-24</RefSource><PMID Version="1">24057368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Plant. 2014 Sep;7(9):1494-1496</RefSource><PMID Version="1">24719468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2005 Dec;139(4):1704-16</RefSource><PMID Version="1">16286448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Genet Genomics. 2016 May 20;43(5):297-305</RefSource><PMID Version="1">27180265</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Bot. 2016 May;67(10 ):3003-14</RefSource><PMID Version="1">27029352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2017 Jun;15(6):713-717</RefSource><PMID Version="1">27875019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2015 Sep;83(6):1005-18</RefSource><PMID Version="1">26216646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Aug;31(8):688-91</RefSource><PMID Version="1">23929339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Biotechnol. 2004 Apr;15(2):139-43</RefSource><PMID Version="1">15081052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2016 Jul 15;5(7):721-32</RefSource><PMID Version="1">27115041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Plant Biol. 2009;60:455-84</RefSource><PMID Version="1">19575589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2011 Sep 30;333(6051):1843-6</RefSource><PMID Version="1">21960622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Jul 21;16:144</RefSource><PMID Version="1">26193878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Plant. 2015 Sep;8(9):1431-3</RefSource><PMID Version="1">26032088</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2006 Nov;142(3):901-10</RefSource><PMID Version="1">16950862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 May 15;30(10):1473-5</RefSource><PMID Version="1">24463181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2015 Oct;169(2):931-45</RefSource><PMID Version="1">26269544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2016 Oct;25(5):561-73</RefSource><PMID Version="1">27012546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2016 Jan;85(2):289-304</RefSource><PMID Version="1">26576489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 1970 Jan;33(1):143-57</RefSource><PMID Version="1">5413235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4632-7</RefSource><PMID Version="1">24550464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2005 Sep 23;335(2):447-57</RefSource><PMID Version="1">16084494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Cell. 1999 Dec;11(12):2283-90</RefSource><PMID Version="1">10590158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 May 29;5:10342</RefSource><PMID Version="1">26022141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Plants. 2016 Sep 12;2:16139</RefSource><PMID Version="1">27618611</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant J. 2017 Aug;91(4):714-724</RefSource><PMID Version="1">28502081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):822-6</RefSource><PMID Version="1">23792628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2016 Sep;172(1):313-27</RefSource><PMID Version="1">27418588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Plant. 2015 Aug;8(8):1274-84</RefSource><PMID Version="1">25917172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2018 Jan;16(1):176-185</RefSource><PMID Version="1">28509421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Plant Sci. 2017 Apr 25;8:540</RefSource><PMID Version="1">28487703</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Mol Res. 2016 May 06;15(2):</RefSource><PMID Version="1">27173326</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arabidopsis</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">GGAT1</Keyword><Keyword MajorTopicYN="N">Genome editing technology</Keyword><Keyword MajorTopicYN="N">Photorespiration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29392632</ArticleId><ArticleId IdType="doi">10.1007/s11248-017-0052-z</ArticleId><ArticleId IdType="pii">10.1007/s11248-017-0052-z</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29392354</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0724-6145</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2018</Year><Month>Feb</Month><Day>02</Day></PubDate></JournalIssue><Title>Advances in biochemical engineering/biotechnology</Title><ISOAbbreviation>Adv. Biochem. Eng. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Advances in Transcriptomics of Plants.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/10_2017_52</ELocationID><Abstract><AbstractText>The current global population of 7.3 billion is estimated to reach 9.7 billion in the year 2050. Rapid population growth is driving up global food demand. Additionally, global climate change, environmental degradation, drought, emerging diseases, and salty soils are the current threats to global food security. In order to mitigate the adverse effects of these diverse agricultural productivity constraints and enhance crop yield and stress-tolerance in plants, we need to go beyond traditional and molecular plant breeding. The powerful new tools for genome editing, Transcription Activator-Like Effector Nucleases (TALENs) and Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR)/Cas systems (CRISPR-Cas9), have been hailed as a quantum leap forward in the development of stress-resistant plants. Plant breeding techniques, however, have several drawbacks. Hence, identification of transcriptional regulatory elements and deciphering mechanisms underlying transcriptional regulation are crucial to avoiding unintended consequences in modified crop plants, which could ultimately have negative impacts on human health. RNA splicing as an essential regulated post-transcriptional process, alternative polyadenylation as an RNA-processing mechanism, along with non-coding RNAs (microRNAs, small interfering RNAs and long non-coding RNAs) have been identified as major players in gene regulation. In this chapter, we highlight new findings on the essential roles of alternative splicing and alternative polyadenylation in plant development and response to biotic and abiotic stresses. We also discuss biogenesis and the functions of microRNAs (miRNAs) and small interfering RNAs (siRNAs) in plants and recent advances in our knowledge of the roles of miRNAs and siRNAs in plant stress response. Graphical Abstract.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nejat</LastName><ForeName>Naghmeh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Pangenomics Group, School of Science, RMIT University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramalingam</LastName><ForeName>Abirami</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Pangenomics Group, School of Science, RMIT University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantri</LastName><ForeName>Nitin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Pangenomics Group, School of Science, RMIT University, Melbourne, VIC, Australia. nitin.mantri@rmit.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Adv Biochem Eng Biotechnol</MedlineTA><NlmUniqueID>8307733</NlmUniqueID><ISSNLinking>0724-6145</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abiotic stress</Keyword><Keyword MajorTopicYN="N">Alternative polyadenylation</Keyword><Keyword MajorTopicYN="N">Alternative splicing</Keyword><Keyword MajorTopicYN="N">Biotic stress</Keyword><Keyword MajorTopicYN="N">Small interfering RNAs</Keyword><Keyword MajorTopicYN="N">microRNAs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29392354</ArticleId><ArticleId IdType="doi">10.1007/10_2017_52</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29391533</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>'Cold shock' increases the frequency of homology directed repair gene editing in induced pluripotent stem cells.</ArticleTitle><Pagination><MedlinePgn>2080</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-20358-5</ELocationID><Abstract><AbstractText>Using CRISPR/Cas9 delivered as a RNA modality in conjunction with a lipid specifically formulated for large RNA molecules, we demonstrate that homology directed repair (HDR) rates between 20-40% can be achieved in induced pluripotent stem cells (iPSC). Furthermore, low HDR rates (between 1-20%) can be enhanced two- to ten-fold in both iPSCs and HEK293 cells by 'cold shocking' cells at 32 °C for 24-48 hours following transfection. This method can also increases the proportion of loci that have undergone complete sequence conversion across the donor sequence, or 'perfect HDR', as opposed to partial sequence conversion where nucleotides more distal to the CRISPR cut site are less efficiently incorporated ('partial HDR'). We demonstrate that the structure of the single-stranded DNA oligo donor can influence the fidelity of HDR, with oligos symmetric with respect to the CRISPR cleavage site and complementary to the target strand being more efficient at directing 'perfect HDR' compared to asymmetric non-target strand complementary oligos. Our protocol represents an efficient method for making CRISPR-mediated, specific DNA sequence changes within the genome that will facilitate the rapid generation of genetic models of human disease in iPSCs as well as other genome engineered cell lines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Q</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Emerging Technologies and Genomics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mintier</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Emerging Technologies and Genomics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lead Discovery and Optimization, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma-Edmonds</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emerging Technologies and Genomics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storton</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emerging Technologies and Genomics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Computational Bioinformatics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Emerging Technologies and Genomics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kienzle</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Emerging Technologies and Genomics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emerging Technologies and Genomics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lead Discovery and Optimization, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feder</LastName><ForeName>John N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Emerging Technologies and Genomics, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA. John.Feder@bms.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lead Discovery and Optimization, Bristol-Myers Squibb Co, Pennington, NJ, 08534, USA. John.Feder@bms.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Oct 12;478(7369):391-4</RefSource><PMID Version="1">21993621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2016 May 5;18(5):573-86</RefSource><PMID Version="1">27152442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Jul 22;146(2):318-31</RefSource><PMID Version="1">21757228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2006 Aug;3(8):637-46</RefSource><PMID Version="1">16862139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Mar;11(3):291-3</RefSource><PMID Version="1">24509632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 May 5;533(7601):125-9</RefSource><PMID Version="1">27120160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2010 Jun;7(6):459-60</RefSource><PMID Version="1">20436476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2017 Dec 1;33(23 ):3811-3812</RefSource><PMID Version="1">28961906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 May;33(5):538-42</RefSource><PMID Version="1">25798939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2016 Sep;135(9):1041-58</RefSource><PMID Version="1">27256364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2010 Mar;7(3):197-9</RefSource><PMID Version="1">20139967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2015 Jul 21;4:null</RefSource><PMID Version="1">26194807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Dec 21;318(5858):1917-20</RefSource><PMID Version="1">18029452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 31;6:23549</RefSource><PMID Version="1">27030102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2013 Apr;45(4):371-84, 384e1-2</RefSource><PMID Version="1">23535731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 Dec 15;3:e04766</RefSource><PMID Version="1">25497837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2011 Jul 17;8(9):753-5</RefSource><PMID Version="1">21765410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Oct;41(19):9049-61</RefSource><PMID Version="1">23907390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Mar;34(3):339-44</RefSource><PMID Version="1">26789497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2007 Nov 30;131(5):861-72</RefSource><PMID Version="1">18035408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Oct;30(19):2813-5</RefSource><PMID Version="1">24907369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2016 Jun 16;17(1):151-153</RefSource><PMID Version="1">27558614</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>02</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29391533</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-20358-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-20358-5</ArticleId><ArticleId IdType="pmc">PMC5794742</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29391232</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>274</Volume><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Journal of controlled release : official journal of the Controlled Release Society</Title><ISOAbbreviation>J Control Release</ISOAbbreviation></Journal><ArticleTitle>Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.</ArticleTitle><Pagination><MedlinePgn>24-34</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0168-3659(18)30046-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jconrel.2018.01.028</ELocationID><Abstract><AbstractText>Several cancer immunotherapy approaches have been recently introduced into the clinics and they have shown remarkable therapeutic potentials. The groundbreaking cancer immunotherapeutic agents function as a stimulant or modulator of the body immune system to fight against or kill cancers. Although targeted immunotherapies such as immune check point inhibitors (CTLA-4 or PD-1/PD-L1), DNA vaccination and CAR-T therapy are revolutionizing cancer treatment, the delivery efficacy can be further improved while their off-target toxicity can be mitigated through nanotechnology approaches. Recent research has demonstrated that nanotechnology has multifaceted role for (i) reeducating tumor associated macrophages (TAM) to function as tumor suppressor agent, (ii) serving as an efficient alternative for Chimeric Antigen Receptor (CAR)-T cell generation and transduction, and (iii) selective knockdown of Kras oncogene addiction by nano-Crisper-Cas9 delivery system. The function of host immune stimulatory signals and tumor immunotherapies can further be improved by repurposing of nanomedicine platform. This review summarizes the role of multifunctional polymeric, lipid, metallic and cell based nanoparticles for improving current immunotherapy.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sau</LastName><ForeName>Samaresh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Use-inspired Biomaterials &amp; Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, 259 Mack Ave, Wayne State University, Detroit, MI 48201, USA. Electronic address: samaresh.sau@wayne.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsaab</LastName><ForeName>Hashem O</ForeName><Initials>HO</Initials><AffiliationInfo><Affiliation>Use-inspired Biomaterials &amp; Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, 259 Mack Ave, Wayne State University, Detroit, MI 48201, USA; Department of Pharmaceutics and Pharmaceutical Technology, Taif University, Taif 26571, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhise</LastName><ForeName>Ketki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Use-inspired Biomaterials &amp; Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, 259 Mack Ave, Wayne State University, Detroit, MI 48201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzhrani</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Use-inspired Biomaterials &amp; Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, 259 Mack Ave, Wayne State University, Detroit, MI 48201, USA; Department of Pharmaceutics and Pharmaceutical Technology, Taif University, Taif 26571, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nabil</LastName><ForeName>Ghazal</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Use-inspired Biomaterials &amp; Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, 259 Mack Ave, Wayne State University, Detroit, MI 48201, USA; Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Arun K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Use-inspired Biomaterials &amp; Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, 259 Mack Ave, Wayne State University, Detroit, MI 48201, USA; Molecular Imaging Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, School of Medicine, Detroit, MI 48201, USA. Electronic address: arun.iyer@wayne.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 CA179652</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Control Release</MedlineTA><NlmUniqueID>8607908</NlmUniqueID><ISSNLinking>0168-3659</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAR-T</Keyword><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">CTLA-4 targeting</Keyword><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">Cytokine storm</Keyword><Keyword MajorTopicYN="N">Dendritic cell vaccine</Keyword><Keyword MajorTopicYN="N">Immunotherapy</Keyword><Keyword MajorTopicYN="N">Nanomedicine</Keyword><Keyword MajorTopicYN="N">PD-1/PDL-1 targeting</Keyword><Keyword MajorTopicYN="N">Tumor associated macrophages</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29391232</ArticleId><ArticleId IdType="pii">S0168-3659(18)30046-4</ArticleId><ArticleId IdType="doi">10.1016/j.jconrel.2018.01.028</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29391173</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8111</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Neuroscience research</Title><ISOAbbreviation>Neurosci. Res.</ISOAbbreviation></Journal><ArticleTitle>Generation of Pax6-IRES-EGFP knock-in mouse via the cloning-free CRISPR/Cas9 system to reliably visualize neurodevelopmental dynamics.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0168-0102(17)30718-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neures.2018.01.007</ELocationID><Abstract><AbstractText>Pax6 encodes a transcription factor that plays pivotal roles in eye development, early brain patterning, neocortical arealization, and so forth. Visualization of Pax6 expression dynamics in these events could offer numerous advantages to neurodevelopmental studies. While CRISPR/Cas9 system has dramatically accelerated one-step generation of knock-out mouse, establishment of gene-cassette knock-in mouse via zygote injection has been considered insufficient due to its low efficiency. Recently, an improved CRISPR/Cas9 system for effective gene-cassette knock-in has been reported, where the native form of guide RNAs (crRNA and tracrRNA) assembled with recombinant Cas9 protein are directly delivered into mouse fertilized eggs. Here we apply this strategy to insert IRES-EGFP-pA cassette into Pax6 locus and achieve efficient targeted insertions of the 1.8 kb reporter gene. In Pax6-IRES-EGFP mouse we have generated, EGFP-positive cells reside in the eyes and cerebellum as endogenous Pax6 expressing cells at postnatal day 2. At the early embryonic stages when the embryos are transparent, EGFP-positive regions can be easily identified without PCR-based genotyping, precisely recapitulating the endogenous Pax6 expression patterns. Remarkably, at E12.5, the graded expression patterns of Pax6 in the developing neocortex now become recognizable in our knock-in mice, serving a sufficiently sensitive and useful tool to precisely visualize neurodevelopmental processes.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Yukiko U</ForeName><Initials>YU</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, Japan. Electronic address: yinn3@ncnp.go.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimoto</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoshino</LastName><ForeName>Mikio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Takayoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Neurosci Res</MedlineTA><NlmUniqueID>8500749</NlmUniqueID><ISSNLinking>0168-0102</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">EGFP</Keyword><Keyword MajorTopicYN="N">IRES</Keyword><Keyword MajorTopicYN="N">Pax6</Keyword><Keyword MajorTopicYN="N">knock-in mouse</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29391173</ArticleId><ArticleId IdType="pii">S0168-0102(17)30718-6</ArticleId><ArticleId IdType="doi">10.1016/j.neures.2018.01.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29388938</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2799</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature protocols</Title><ISOAbbreviation>Nat Protoc</ISOAbbreviation></Journal><ArticleTitle>Genome editing of bread wheat using biolistic delivery of CRISPR/Cas9 in vitro transcripts or ribonucleoproteins.</ArticleTitle><Pagination><MedlinePgn>413-430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nprot.2017.145</ELocationID><Abstract><AbstractText>This protocol is an extension to: Nat. Protoc. 9, 2395-2410 (2014); doi:10.1038/nprot.2014.157; published online 18 September 2014In recent years, CRISPR/Cas9 has emerged as a powerful tool for improving crop traits. Conventional plant genome editing mainly relies on plasmid-carrying cassettes delivered by Agrobacterium or particle bombardment. Here, we describe DNA-free editing of bread wheat by delivering in vitro transcripts (IVTs) or ribonucleoprotein complexes (RNPs) of CRISPR/Cas9 by particle bombardment. This protocol serves as an extension of our previously published protocol on genome editing in bread wheat using CRISPR/Cas9 plasmids delivered by particle bombardment. The methods we describe not only eliminate random integration of CRISPR/Cas9 into genomic DNA, but also reduce off-target effects. In this protocol extension article, we present detailed protocols for preparation of IVTs and RNPs; validation by PCR/restriction enzyme (RE) and next-generation sequencing; delivery by biolistics; and recovery of mutants and identification of mutants by pooling methods and Sanger sequencing. To use these protocols, researchers should have basic skills and experience in molecular biology and biolistic transformation. By using these protocols, plants edited without the use of any foreign DNA can be generated and identified within 9-11 weeks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Cell and Chromosome Engineering, and Center for Genome Editing, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kunling</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Cell and Chromosome Engineering, and Center for Genome Editing, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Cell and Chromosome Engineering, and Center for Genome Editing, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Plant Stress Research, College of Life Science, Shandong Normal University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jinxing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Cell and Chromosome Engineering, and Center for Genome Editing, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Kangquan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Genomics, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Jin-Long</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Genomics, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Caixia</ForeName><Initials>C</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3169-8248</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Plant Cell and Chromosome Engineering, and Center for Genome Editing, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Protoc</MedlineTA><NlmUniqueID>101284307</NlmUniqueID><ISSNLinking>1750-2799</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Nov 16;7:13274</RefSource><PMID Version="1">27848933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2014 Nov;166(3):1292-7</RefSource><PMID Version="1">25225186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Aug;31(8):686-8</RefSource><PMID Version="1">23929338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2006;1(5):2320-5</RefSource><PMID Version="1">17406474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2014 Aug;12(6):797-807</RefSource><PMID Version="1">24854982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Genet Genomics. 2014 Feb 20;41(2):63-8</RefSource><PMID Version="1">24576457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Plant Sci. 2016 May 24;7:703</RefSource><PMID Version="1">27252719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Sep;32(9):947-51</RefSource><PMID Version="1">25038773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Biotechnol. 2015 Mar 12;15:16</RefSource><PMID Version="1">25879861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 1994;32:9-15</RefSource><PMID Version="1">7951753</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Jan 18;8:14261</RefSource><PMID Version="1">28098143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Adv. 2015 Jan-Feb;33(1):41-52</RefSource><PMID Version="1">25536441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Apr 15;30(8):1180-1182</RefSource><PMID Version="1">24389662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1997 Nov 15;25(22):4650-7</RefSource><PMID Version="1">9358178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Aug 25;7:12617</RefSource><PMID Version="1">27558837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2016 Jun 1;143(11):2025-37</RefSource><PMID Version="1">27130213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10437-42</RefSource><PMID Version="1">26216948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2016 Feb;14 (2):483-95</RefSource><PMID Version="1">26261084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2016 Jun;27(6):464-75</RefSource><PMID Version="1">27094534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Biotechnol J. 2017 Feb;15(2):257-268</RefSource><PMID Version="1">27510362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2015 Oct;169(2):960-70</RefSource><PMID Version="1">26294043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Biotechnol. 2015 Apr;32:76-84</RefSource><PMID Version="1">25437637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2014 Oct;9(10):2395-410</RefSource><PMID Version="1">25232936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Nov;33(11):1162-4</RefSource><PMID Version="1">26479191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Jun;24(6):1012-9</RefSource><PMID Version="1">24696461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Plant Biol. 2013;64:327-50</RefSource><PMID Version="1">23451779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Plant Biol. 2017 Apr;36:142-148</RefSource><PMID Version="1">28346895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2016 Jun 2;85:227-64</RefSource><PMID Version="1">27145843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Plant Sci. 2016 Dec 20;7:1904</RefSource><PMID Version="1">28066464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource><PMID Version="1">24584096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Physiol. 2015 Oct;169(2):931-45</RefSource><PMID Version="1">26269544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Sep 08;34(9):933-941</RefSource><PMID Version="1">27606440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Oct 11;34(10 ):1014-1015</RefSource><PMID Version="1">27727209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3570-5</RefSource><PMID Version="1">25733849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Dec 14;10(12):e0144591</RefSource><PMID Version="1">26657719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Cell Rep. 2014 Apr;33(4):575-83</RefSource><PMID Version="1">24277082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2013 Nov;195(3):1177-80</RefSource><PMID Version="1">23979576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2015 Nov;10(11):1842-59</RefSource><PMID Version="1">26492140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 May;35(5):431-434</RefSource><PMID Version="1">28191903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2016 Oct 12;8(360):360ra134</RefSource><PMID Version="1">27733558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jan 14;164(1-2):29-44</RefSource><PMID Version="1">26771484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Jan;33(1):73-80</RefSource><PMID Version="1">25357182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Oct 25;17 (5):1438-1452</RefSource><PMID Version="1">27783955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Genet Genomics. 2016 May 20;43(5):251-62</RefSource><PMID Version="1">27165865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Cell Rep. 2016 Jul;35(7):1535-44</RefSource><PMID Version="1">26825596</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29388938</ArticleId><ArticleId IdType="pii">nprot.2017.145</ArticleId><ArticleId IdType="doi">10.1038/nprot.2017.145</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29387984</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0920-9069</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Cytotechnology</Title><ISOAbbreviation>Cytotechnology</ISOAbbreviation></Journal><ArticleTitle>Generation of PTEN knockout bone marrow mesenchymal stem cell lines by CRISPR/Cas9-mediated genome editing.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10616-017-0183-3</ELocationID><Abstract><AbstractText>The tumor suppressor PTEN is involved in the regulation of cell proliferation, lineage determination, motility, adhesion and apoptosis. Loss of PTEN in the bone mesenchymal stem cells (BMSCs) was shown to change their function in the repair tissue. So far, the CRISPR/Cas9 system has been proven extremely simple and flexible. Using this system to manipulate PTEN gene editing could produce the PTEN-Knocking-out (PTEN-KO) strain. We knocked out PTEN in MSCs and validated the expression by PCR and Western blot. To clarify the changes in proliferation, CCK-8 assay was applied. In support, living cell proportion was assessed by Trypan blue staining. For osteogenic and adipogenic induction, cells were cultured in different media for 2 weeks. Oil red staining and alizarin red staining were performed for assessment of osteogenic or adipogenic differentiation. The expression of Id4, Runx2, ALP and PPARγ was examined by qPCR and immunocytochemistry staining. The PTEN-KO strain was identified by sequencing. The PTEN-KO cells had an increased cell viability and higher survival compared with the wild type. However, decreased expression of Runx2 and PPARγ was found in the PTEN loss strain after induction, and consistently decreased osteogenic or adipogenic differentiation was observed by alizarin and oil red staining. Together, PTEN-KO strain showed an increased proliferation capability but decreased multi-directional differentiation potential. When BMSCs serve as seed cells for tissue engineering, the PTEN gene may be used as an indicator.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Youliang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Jiao Zhou Central Hospital of Qingdao City, Qingdao, 266300, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Jiao Zhou Central Hospital of Qingdao City, Qingdao, 266300, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Tengbo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Orthopaedic Center, The Affiliated Hospital of Qingdao University, Qingdao, 266300, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Orthopaedic Center, The Affiliated Hospital of Qingdao University, Qingdao, 266300, China. qichao2002@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cytotechnology</MedlineTA><NlmUniqueID>8807027</NlmUniqueID><ISSNLinking>0920-9069</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adipogenic differentiation</Keyword><Keyword MajorTopicYN="N">Bone mesenchymal stem cells</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Osteogenic differentiation</Keyword><Keyword MajorTopicYN="N">PTEN</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29387984</ArticleId><ArticleId IdType="doi">10.1007/s10616-017-0183-3</ArticleId><ArticleId IdType="pii">10.1007/s10616-017-0183-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29386601</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-1784</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Nature reviews. Drug discovery</Title><ISOAbbreviation>Nat Rev Drug Discov</ISOAbbreviation></Journal><ArticleTitle>Gene therapy: CRISPR therapies - making the grade not the cut.</ArticleTitle><Pagination><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nrd.2018.3</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burgess</LastName><ForeName>Darren J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Nature Reviews Genetics.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Drug Discov</MedlineTA><NlmUniqueID>101124171</NlmUniqueID><ISSNLinking>1474-1776</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Dec 14;171(7):1495-1507.e15</RefSource><PMID Version="1">29224783</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29386601</ArticleId><ArticleId IdType="pii">nrd.2018.3</ArticleId><ArticleId IdType="doi">10.1038/nrd.2018.3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29386386</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>De novo mutation in<i>RING1</i>with epigenetic effects on neurodevelopment.</ArticleTitle><Pagination><MedlinePgn>1558-1563</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1721290115</ELocationID><Abstract><AbstractText>RING1 is an E3-ubiquitin ligase that is involved in epigenetic control of transcription during development. It is a component of the polycomb repressive complex 1, and its role in that complex is to ubiquitylate histone H2A. In a 13-year-old girl with syndromic neurodevelopmental disabilities, we identified a de novo mutation, RING1 p.R95Q, which alters a conserved arginine residue in the catalytic RING domain. In vitro assays demonstrated that the mutant RING1 retains capacity to catalyze ubiquitin chain formation, but is defective in its ability to ubiquitylate histone H2A in nucleosomes. Consistent with this in vitro effect, cells of the patient showed decreased monoubiquitylation of histone H2A. We modeled the mutant RING1 in<i>Caenorhabditis elegans</i>by editing the comparable amino acid change into<i>spat-3</i>, the suggested<i>RING1</i>ortholog. Animals with either the missense mutation or complete knockout of<i>spat-3</i>were defective in monoubiquitylation of histone H2A and had defects in neuronal migration and axon guidance. Relevant to our patient, animals heterozygous for either the missense or knockout allele also showed neuronal defects. Our results support three conclusions: mutation of<i>RING1</i>is the likely cause of a human neurodevelopmental syndrome, mutation of<i>RING1</i>can disrupt histone H2A ubiquitylation without disrupting RING1 catalytic activity, and the comparable mutation in<i>C. elegans spat-3</i>both recapitulates the effects on histone H2A ubiquitylation and leads to neurodevelopmental abnormalities. This role for<i>RING1</i>adds to our understanding of the importance of aberrant epigenetic effects as causes of human neurodevelopmental disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pierce</LastName><ForeName>Sarah B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Mikaela D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, University of Washington, Seattle, WA 98195.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulsuner</LastName><ForeName>Suleyman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhall</LastName><ForeName>Abhinav</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Washington, Seattle, WA 98195.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClellan</LastName><ForeName>Jon M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Washington, Seattle, WA 98195.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klevit</LastName><ForeName>Rachel E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3476-969X</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, University of Washington, Seattle, WA 98195.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Mary-Claire</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA 98195; mcking@uw.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, WA 98195.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM088055</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH083989</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA080416</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2468-73</RefSource><PMID Version="1">12589020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2012 Oct 1;26(19):2236-50</RefSource><PMID Version="1">23028147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2003 Oct 30;425(6961):962-7</RefSource><PMID Version="1">14574365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Jul 07;6:7621</RefSource><PMID Version="1">26151332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2016 Nov 15;30(22):2475-2485</RefSource><PMID Version="1">27913604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Mol Med. 2015 May;21(5):330-40</RefSource><PMID Version="1">25842254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 1996 May;122(5):1513-22</RefSource><PMID Version="1">8625838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 1997 Oct;124(19):3673-82</RefSource><PMID Version="1">9367423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2000 Dec;127(23 ):5093-100</RefSource><PMID Version="1">11060235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2017 Feb 8;45(1):193-205</RefSource><PMID Version="1">28202673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Apr 10;508(7495):199-206</RefSource><PMID Version="1">24695229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2009 Sep 10;63(5):600-13</RefSource><PMID Version="1">19755104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2013 Oct;29(10):600-8</RefSource><PMID Version="1">24008202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Aug 16;16(7):1829-37</RefSource><PMID Version="1">27498878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2013 Mar;27(3):523-33</RefSource><PMID Version="1">23257781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Philos Trans R Soc Lond B Biol Sci. 1986 Nov 12;314(1165):1-340</RefSource><PMID Version="1">22462104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Nov 13;515(7526):209-15</RefSource><PMID Version="1">25363760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2013 Jun 1;22(11):2200-13</RefSource><PMID Version="1">23418308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Allergy Asthma Rep. 2014 Dec;14(12):480</RefSource><PMID Version="1">25269404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Nov 15;367(20):1921-9</RefSource><PMID Version="1">23033978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Aug 17;536(7616):285-91</RefSource><PMID Version="1">27535533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 2006 Apr;123(4):312-20</RefSource><PMID Version="1">16624538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2009 Jul;27(7):1559-70</RefSource><PMID Version="1">19544461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genomics Hum Genet. 2014;15:269-93</RefSource><PMID Version="1">25184531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2014 Oct 30;10(10):e1004772</RefSource><PMID Version="1">25356899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Nov 24;5:5595</RefSource><PMID Version="1">25418537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Aug 1;154(3):518-29</RefSource><PMID Version="1">23911319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2009 Mar;136(6):943-53</RefSource><PMID Version="1">19211678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2014 Nov;141(22):4343-53</RefSource><PMID Version="1">25344075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Mar 12;519(7542):223-8</RefSource><PMID Version="1">25533962</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Med. 2013 Feb 05;5(2):11</RefSource><PMID Version="1">23383720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Oct 30;514(7524):591-6</RefSource><PMID Version="1">25355358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2011 Aug 07;43(9):864-8</RefSource><PMID Version="1">21822266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2006 Sep;174(1):285-95</RefSource><PMID Version="1">16816419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Dec 22;20(6):845-54</RefSource><PMID Version="1">16359901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 1993 Mar;117(3):1071-87</RefSource><PMID Version="1">8325236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Dec 18;516(7531):349-54</RefSource><PMID Version="1">25519132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Psychiatry. 2014 Jun;19(6):652-8</RefSource><PMID Version="1">24776741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2007 Jun 7;1(1):87-99</RefSource><PMID Version="1">18371338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1988 Dec 15;336(6200):638-46</RefSource><PMID Version="1">3200316</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">RING1</Keyword><Keyword MajorTopicYN="N">histone H2A</Keyword><Keyword MajorTopicYN="N">psychosis</Keyword><Keyword MajorTopicYN="N">ubiquitin</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>08</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29386386</ArticleId><ArticleId IdType="pii">1721290115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1721290115</ArticleId><ArticleId IdType="pmc">PMC5816211</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29386295</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1939-4586</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Molecular biology of the cell</Title><ISOAbbreviation>Mol. Biol. Cell</ISOAbbreviation></Journal><ArticleTitle>Dynamics of human telomerase recruitment depend on template- telomere base pairing.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">mbc.E17-11-0637</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1091/mbc.E17-11-0637</ELocationID><Abstract><AbstractText>The reverse transcriptase telomerase adds telomeric repeats to chromosome ends to counteract telomere shortening and thereby assures genomic stability in dividing human cells. Key parameters in telomere homeostasis are the frequency with which telomerase engages the chromosome end and the number of telomeric repeats it adds during each association event. To study telomere elongation<i>in vivo</i>we have established a live-cell imaging assay to track individual telomerase RNPs in CRISPR-edited HeLa cells. Using this assay and the drug imetelstat, which is a competitive inhibitor of telomeric DNA binding, we demonstrate that stable association of telomerase with the single-stranded overhang of the chromosome end requires telomerase-DNA base pairing. Furthermore, we show that telomerase processivity contributes to telomere elongation<i>in vivo</i>Together, these findings provide new insight into the dynamics of telomerase recruitment and the importance of processivity in maintaining telomere length in human cancer cells.</AbstractText><CopyrightInformation>© 2018 by The American Society for Cell Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Jens C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80309, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Present address: Department of Obstetrics, Gynecology, and Reproductive Biology, Institute for Quantitative Health Sciences and Engineering, Michigan State University, East Lansing, MI 48824, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaug</LastName><ForeName>Arthur J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80309, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kufer</LastName><ForeName>Regina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80309, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Present address: Roche Diagnostics GmbH, Penzberg, 82377, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cech</LastName><ForeName>Thomas R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80309, USA thomas.cech@colorado.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K99 GM120386</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM099705</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Biol Cell</MedlineTA><NlmUniqueID>9201390</NlmUniqueID><ISSNLinking>1059-1524</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29386295</ArticleId><ArticleId IdType="pii">mbc.E17-11-0637</ArticleId><ArticleId IdType="doi">10.1091/mbc.E17-11-0637</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29386245</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-9129</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Development (Cambridge, England)</Title><ISOAbbreviation>Development</ISOAbbreviation></Journal><ArticleTitle>Genome and epigenome engineering CRISPR toolkit for<i>in vivo</i>modulation of<i>cis</i>-regulatory interactions and gene expression in the chicken embryo.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dev160333</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1242/dev.160333</ELocationID><Abstract><AbstractText>CRISPR/Cas9 genome engineering has revolutionised all aspects of biological research, with epigenome engineering transforming gene regulation studies. Here, we present an optimised, adaptable toolkit enabling genome and epigenome engineering in the chicken embryo, and demonstrate its utility by probing gene regulatory interactions mediated by neural crest enhancers. First, we optimise novel efficient guide-RNA mini expression vectors utilising chick U6 promoters, provide a strategy for rapid somatic gene knockout and establish a protocol for evaluation of mutational penetrance by targeted next-generation sequencing. We show that CRISPR/Cas9-mediated disruption of transcription factors causes a reduction in their cognate enhancer-driven reporter activity. Next, we assess endogenous enhancer function using both enhancer deletion and nuclease-deficient Cas9 (dCas9) effector fusions to modulate enhancer chromatin landscape, thus providing the first report of epigenome engineering in a developing embryo. Finally, we use the synergistic activation mediator (SAM) system to activate an endogenous target promoter. The novel genome and epigenome engineering toolkit developed here enables manipulation of endogenous gene expression and enhancer activity in chicken embryos, facilitating high-resolution analysis of gene regulatory interactions<i>in vivo</i>.</AbstractText><CopyrightInformation>© 2018. Published by The Company of Biologists Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ruth M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2628-7834</Identifier><AffiliationInfo><Affiliation>University of Oxford, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford, OX3 9DS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senanayake</LastName><ForeName>Upeka</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>University of Oxford, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford, OX3 9DS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artibani</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Oxford, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford, OX3 9DS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Oxford, Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, Oxford, OX3 9DS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Gunes</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Oxford, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford, OX3 9DS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2007-8978</Identifier><AffiliationInfo><Affiliation>University of Oxford, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford, OX3 9DS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Ahmed Ashour</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>University of Oxford, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford, OX3 9DS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Oxford, Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, Oxford, OX3 9DS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauka-Spengler</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9289-0263</Identifier><AffiliationInfo><Affiliation>University of Oxford, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford, OX3 9DS, UK tatjana.sauka-spengler@imm.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Development</MedlineTA><NlmUniqueID>8701744</NlmUniqueID><ISSNLinking>0950-1991</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Chicken</Keyword><Keyword MajorTopicYN="N">Enhancer</Keyword><Keyword MajorTopicYN="N">Neural crest</Keyword><Keyword MajorTopicYN="N">dCas9-KRAB</Keyword><Keyword MajorTopicYN="N">dCas9-LSD1</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare no competing or financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29386245</ArticleId><ArticleId IdType="pii">dev.160333</ArticleId><ArticleId IdType="doi">10.1242/dev.160333</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29385696</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E55</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v10020055</ELocationID><Abstract><AbstractText>Clustered regularly interspaced short palindromic repeats (CRISPR) has greatly expanded the ability to genetically probe virus-host interactions. CRISPR systems enable focused or systematic, genomewide studies of nearly all aspects of a virus lifecycle. Combined with its relative ease of use and high reproducibility, CRISPR is becoming an essential tool in studies of the host factors important for viral pathogenesis. Here, we review the use of CRISPR-Cas9 for the loss-of-function analysis of host dependency factors. We focus on the use of CRISPR-pooled screens for the systematic identification of host dependency factors, particularly in Epstein-Barr virus-transformed B cells. We also discuss the use of CRISPR interference (CRISPRi) and gain-of-function CRISPR activation (CRISPRa) approaches to probe virus-host interactions. Finally, we comment on the future directions enabled by combinatorial CRISPR screens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gebre</LastName><ForeName>Makda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Harvard Program in Virology, Harvard Medical School, Boston, MA 02115, USA. Makda_Gebre@g.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nomburg</LastName><ForeName>Jason L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Harvard Program in Virology, Harvard Medical School, Boston, MA 02115, USA. jnomburg@g.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gewurz</LastName><ForeName>Benjamin E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Harvard Program in Virology, Harvard Medical School, Boston, MA 02115, USA. bgewurz@bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Medicine, Brigham &amp; Women's Hospital, Boston, MA 02115, USA. bgewurz@bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA. bgewurz@bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142, USA. bgewurz@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR activation</Keyword><Keyword MajorTopicYN="N">CRISPR interference</Keyword><Keyword MajorTopicYN="N">CRISPR screen</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">Epstein–Barr virus</Keyword><Keyword MajorTopicYN="N">combinatorial CRISPR</Keyword><Keyword MajorTopicYN="N">genome engineering</Keyword><Keyword MajorTopicYN="N">host dependency factor</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29385696</ArticleId><ArticleId IdType="pii">v10020055</ArticleId><ArticleId IdType="doi">10.3390/v10020055</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29385529</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-9053</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Plant &amp; cell physiology</Title><ISOAbbreviation>Plant Cell Physiol.</ISOAbbreviation></Journal><ArticleTitle>BES1 and BZR1 Redundantly Promote Phloem and Xylem Differentiation.</ArticleTitle><Pagination><MedlinePgn>590-600</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/pcp/pcy012</ELocationID><Abstract><AbstractText>Vascular development is a good model for studying cell differentiation in plants. Two conductive tissues, the xylem and phloem, are derived from common stem cells known as procambial/cambial cells. Glycogen synthase kinase 3 proteins (GSK3s) play crucial roles in maintaining procambial/cambial cells by suppressing their differentiation into xylem or phloem cells. We previously designed an in vitro culture system for analyzing vascular cell differentiation named VISUAL (Vascular cell Induction culture System Using Arabidopsis Leaves). Using this system, we found that the transcription factor BRI1-EMS-SUPPRESSOR 1 (BES1) functions as a downstream target of GSK3s during xylem differentiation. However, the function of BES1 in vascular development remains largely unknown. Here, we found that, in addition to xylem differentiation, BES1 positively regulates phloem differentiation downstream of GSK3s. Transcriptome analysis using VISUAL confirmed that BES1 promotes bi-directional differentiation of procambial cells into xylem and phloem cells. Genetic analysis of loss-of-function mutants newly generated using the CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) system revealed that BRASSINAZOLE RESISTANT 1 (BZR1), the closest homolog of BES1, functions in vascular development redundantly with BES1. Notably, BZR1 has a weaker impact on vascular cell differentiation than BES1, suggesting that they contribute differentially to this process. In conclusion, our findings indicate that BES1 and BZR1 are key regulators of both xylem and phloem cell differentiation from vascular stem cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukuda</LastName><ForeName>Hiroo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Plant Cell Physiol</MedlineTA><NlmUniqueID>9430925</NlmUniqueID><ISSNLinking>0032-0781</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29385529</ArticleId><ArticleId IdType="pii">4827626</ArticleId><ArticleId IdType="doi">10.1093/pcp/pcy012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29384366</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2373-8227</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>ACS infectious diseases</Title><ISOAbbreviation>ACS Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acsinfecdis.7b00244</ELocationID><Abstract><AbstractText>There has been a very limited number of high-throughput screening campaigns carried out with Leishmania drug targets. In part, this is due to the small number of suitable target genes that have been shown by genetic or chemical methods to be essential for the parasite. In this perspective, we discuss the state of genetic target validation in the field of Leishmania research and review the 200 Leishmania genes and 36 Trypanosoma cruzi genes for which gene deletion attempts have been made since the first published case in 1990. We define a quality score for the different genetic deletion techniques that can be used to identify potential drug targets. We also discuss how the advances in genome-scale gene disruption techniques have been used to assist target-based and phenotypic-based drug development in other parasitic protozoa and why Leishmania has lacked a similar approach so far. The prospects for this scale of work are considered in the context of the application of CRISPR/Cas9 gene editing as a useful tool in Leishmania.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Nathaniel G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7328-4487</Identifier><AffiliationInfo><Affiliation>Centre for Immunology and Infection, Department of Biology, University of York , Wentworth Way, Heslington, York YO10 5DD, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catta-Preta</LastName><ForeName>Carolina M C</ForeName><Initials>CMC</Initials><AffiliationInfo><Affiliation>Centre for Immunology and Infection, Department of Biology, University of York , Wentworth Way, Heslington, York YO10 5DD, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Ana Paula C A</ForeName><Initials>APCA</Initials><AffiliationInfo><Affiliation>Instituto de Biofisica Carlos Chagas Filho, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Cidade Universitária , Rio de Janeiro, RJ 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mottram</LastName><ForeName>Jeremy C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5574-3766</Identifier><AffiliationInfo><Affiliation>Centre for Immunology and Infection, Department of Biology, University of York , Wentworth Way, Heslington, York YO10 5DD, U.K.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Infect Dis</MedlineTA><NlmUniqueID>101654580</NlmUniqueID><ISSNLinking>2373-8227</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Leishmania</Keyword><Keyword MajorTopicYN="N">Trypanosoma cruzi</Keyword><Keyword MajorTopicYN="N">drug discovery</Keyword><Keyword MajorTopicYN="N">gene knockouts</Keyword><Keyword MajorTopicYN="N">null</Keyword><Keyword MajorTopicYN="N">pathogen</Keyword><Keyword MajorTopicYN="N">target validation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29384366</ArticleId><ArticleId IdType="doi">10.1021/acsinfecdis.7b00244</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29383752</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0045</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>The Prostate</Title><ISOAbbreviation>Prostate</ISOAbbreviation></Journal><ArticleTitle>Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/pros.23487</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">P62 (also named sequestosome-1, SQSTM1) is involved in autophagy regulation through multiple pathways. It interacts with autophagosomes-associated LC3-II and ubiquitinated protein aggregates to engulf the aggregates in autophagosomes, interacts with HDAC6 to inhibit its deacetylase activity to maintain the levels of acetylated α-tubulin and stabilities of microtubules to enhance autophagosome trafficking, and regulates autophagy initiation and cell survival. We performed immunohistochemistry staining of P62 in prostate tissues from prostate cancer patients and found that levels of P62 in patients with prostate adenocarcinomas (PCA) are significantly higher than those in patients with benign prostate hyperplasia (BPH). High levels of P62 predict high tumor grade and high intensity of metastasis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We created prostate cancer cell lines stably overexpressing P62 and then suppress the expression of P62 in the cell line stably overexpressing P62 with CRISPR technology. Cell proliferation assay with crystal violet, cell migration assay, cell invasion assay, Western blot analysis, and confocal fluorescent microscopy were conducted to test the impact of altered levels of P62 on the growth, migration, invasion, epithelial-to-mesenchymal transition, autophagy flux, HDAC6 activity, and microtubular acetylation of cancer cells.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">P62 increased the levels of HDAC6 and reduced the acetylation of α-tubulin and the stability of microtubules. Consequently, high levels of P62 caused a promotion of epithelial-to-mesenchymal transition in addition to an impairment of autophagy flux, and further led to an enhancement of proliferation, migration, and invasion of prostate cancer cells.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">P62 promotes metastasis of PCA by sustaining the level of HDAC6 to inhibit autophagy and promote epithelial-to-mesenchymal transition.</AbstractText><CopyrightInformation>© 2018 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xianhan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yiqiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Funeng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yongzhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guibin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Weiqing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ganggang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Zhengming</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Lingke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Leyuan</ForeName><Initials>L</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2151-8960</Identifier><AffiliationInfo><Affiliation>Department of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&amp;M University, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Cellular Medicine, College of Medicine, Texas A&amp;M University, College Station, Texas.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA142862</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prostate</MedlineTA><NlmUniqueID>8101368</NlmUniqueID><ISSNLinking>0270-4137</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SQSTM1</Keyword><Keyword MajorTopicYN="N">acetylation</Keyword><Keyword MajorTopicYN="N">microtubule</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">prostate adenocarcinoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29383752</ArticleId><ArticleId IdType="doi">10.1002/pros.23487</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29383664</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-2598</ISSN><JournalIssue CitedMedium="Print"><Volume>1050</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Advances in experimental medicine and biology</Title><ISOAbbreviation>Adv. Exp. Med. Biol.</ISOAbbreviation></Journal><ArticleTitle>Comparative Genomics of Clostridium difficile.</ArticleTitle><Pagination><MedlinePgn>59-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-3-319-72799-8_5</ELocationID><Abstract><AbstractText>Clostridium difficile, a gram-positive spore-forming anaerobic bacterium, has rapidly emerged as the leading cause of nosocomial diarrhoea in hospitals. The availability of genome sequences in large numbers, mainly due to the use of next-generation sequencing methods, have undoubtedly shown their immense advantages in the determination of the C. difficile population structure. The implementation of fine-scale comparative genomic approaches have paved the way to global transmission and recurrence studies, but also more targeted studies such as the PaLoc or the CRISPR/Cas systems. In this chapter, we provide an overview of the recent and significant findings on C. difficile using comparative genomics studies with implication for the epidemiology, infection control and understanding of the evolution of C. difficile.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Janezic</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Laboratory for Health, Environment and Food (NLZOH), Maribor, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Maribor, Faculty of Medicine, Maribor, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garneau</LastName><ForeName>Julian R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Département de Microbiologie, Institut Pasteur, Laboratoire Pathogenèse des bactéries anaérobies, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Département de Microbiologie et d'infectiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monot</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Département de Microbiologie, Institut Pasteur, Laboratoire Pathogenèse des bactéries anaérobies, Paris, France. marc.monot@pasteur.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Département de Microbiologie et d'infectiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC, Canada. marc.monot@pasteur.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Diderot, Sorbonne Paris Cité, Paris, France. marc.monot@pasteur.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Exp Med Biol</MedlineTA><NlmUniqueID>0121103</NlmUniqueID><ISSNLinking>0065-2598</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Evolution</Keyword><Keyword MajorTopicYN="N">Genomics</Keyword><Keyword MajorTopicYN="N">Nontoxigenic strains</Keyword><Keyword MajorTopicYN="N">Recurrence</Keyword><Keyword MajorTopicYN="N">Transmission</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29383664</ArticleId><ArticleId IdType="doi">10.1007/978-3-319-72799-8_5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29383448</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1617-4623</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Molecular genetics and genomics : MGG</Title><ISOAbbreviation>Mol. Genet. Genomics</ISOAbbreviation></Journal><ArticleTitle>A comparison of CRISPR/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00438-018-1420-y</ELocationID><Abstract><AbstractText>Gene knockdown and knockout using RNAi and CRISPR/Cas9 allow for efficient evaluation of gene function, but it is unclear how the choice of technology can influence the results. To compare the phenotypes obtained using siRNA and CRISPR/Cas9 technologies, aldehyde dehydrogenase 2 (ALDH2) was selected as an example. In this study, we constructed one HepG2 cell line with a homozygous mutation in the fifth exon of ALDH2 (ALDH2-KO1 cell) using the eukaryotic CRISPR/Cas9 expression system followed by the limited dilution method and one HepG2 cell line with different mutations in the ALDH2 gene (ALDH2-KO2 cell) using the lentivirus CRISPR/Cas9 system. Additionally, one ALDH2-knockdown (KD) HepG2 cell line was created using siRNA. The reproducibility of these methods was further verified in the HEK293FT cell line. We found that the mRNA expression level of ALDH2 was significantly decreased and the protein expression level of ALDH2 was completely abolished in the ALDH2-KO cell lines, but not in ALDH2-KD cells. Furthermore, the functional activity of ALDH2 was also markedly disrupted in the two ALDH2-KO cell lines compared with ALDH2-KD and wild-type cells. The lack of ALDH2 expression mediated by CRIPSR/Cas9 resulted in a more dramatic increase in the cellular susceptibility to chemical-induced reactive oxygen species generation, cytotoxicity, apoptosis, and inflammation, especially at low concentrations compared with ALDH2-KD and WT cells. Therefore, we consider the gene knockout cell line created by CRISPR/Cas9 to be a more useful tool for identifying the function of a gene.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hongmei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ruobi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Ni</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Guanghui</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Xiaowen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Daochuan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yongmei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Qiansheng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Xiumei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China. xingxm3@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>A Key Laboratory of Guangzhou Environmental Pollution and Risk Assessment, Department of Toxicology, Faculty of Preventive Medicine, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, 510080, China. wangq27@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81273098</GrantID><Agency>the National Natural Science Foundations of China</Agency><Country>United States</Country></Grant><Grant><GrantID>81673140</GrantID><Agency>the National Natural Science Foundations of China</Agency><Country>United States</Country></Grant><Grant><GrantID>81402715</GrantID><Agency>the National Natural Science Foundations of China</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Mol Genet Genomics</MedlineTA><NlmUniqueID>101093320</NlmUniqueID><ISSNLinking>1617-4623</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALDH2</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Gene knockout</Keyword><Keyword MajorTopicYN="N">HepG2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29383448</ArticleId><ArticleId IdType="doi">10.1007/s00438-018-1420-y</ArticleId><ArticleId IdType="pii">10.1007/s00438-018-1420-y</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29382940</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0080</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Nature reviews. Molecular cell biology</Title><ISOAbbreviation>Nat. Rev. Mol. Cell Biol.</ISOAbbreviation></Journal><ArticleTitle>The future of CRISPR technologies in agriculture.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/nrm.2018.2</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Caixia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Plant Cell and Chromosome Engineering and Center for Genome Editing, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Mol Cell Biol</MedlineTA><NlmUniqueID>100962782</NlmUniqueID><ISSNLinking>1471-0072</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29382940</ArticleId><ArticleId IdType="pii">nrm.2018.2</ArticleId><ArticleId IdType="doi">10.1038/nrm.2018.2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29382569</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-9867</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Molecular plant</Title><ISOAbbreviation>Mol Plant</ISOAbbreviation></Journal><ArticleTitle>Improved base editor for efficiently inducing genetic variations in rice with CRISPR/Cas9-guided hyperactive hAID mutant.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1674-2052(18)30025-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molp.2018.01.005</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China; Ministry of Education Key Laboratory of Bio-Resource and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu 610065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuang</LastName><ForeName>Yongjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dawei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Bio-Resource and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu 610065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xueping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China; State Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Honghui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Bio-Resource and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu 610065, China. Electronic address: hhlin@scu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Huanbin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China. Electronic address: hbzhou@ippcaas.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Plant</MedlineTA><NlmUniqueID>101465514</NlmUniqueID><ISSNLinking>1674-2052</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">base editing</Keyword><Keyword MajorTopicYN="N">gain-of-function</Keyword><Keyword MajorTopicYN="N">hAID</Keyword><Keyword MajorTopicYN="N">rice (Oryza sativa L.)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29382569</ArticleId><ArticleId IdType="pii">S1674-2052(18)30025-X</ArticleId><ArticleId IdType="doi">10.1016/j.molp.2018.01.005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29381698</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1545-7885</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>PLoS biology</Title><ISOAbbreviation>PLoS Biol.</ISOAbbreviation></Journal><ArticleTitle>Role of the AP-5 adaptor protein complex in late endosome-to-Golgi retrieval.</ArticleTitle><Pagination><MedlinePgn>e2004411</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pbio.2004411</ELocationID><Abstract><AbstractText>The AP-5 adaptor protein complex is presumed to function in membrane traffic, but so far nothing is known about its pathway or its cargo. We have used CRISPR-Cas9 to knock out the AP-5 ζ subunit gene, AP5Z1, in HeLa cells, and then analysed the phenotype by subcellular fractionation profiling and quantitative mass spectrometry. The retromer complex had an altered steady-state distribution in the knockout cells, and several Golgi proteins, including GOLIM4 and GOLM1, were depleted from vesicle-enriched fractions. Immunolocalisation showed that loss of AP-5 led to impaired retrieval of the cation-independent mannose 6-phosphate receptor (CIMPR), GOLIM4, and GOLM1 from endosomes back to the Golgi region. Knocking down the retromer complex exacerbated this phenotype. Both the CIMPR and sortilin interacted with the AP-5-associated protein SPG15 in pull-down assays, and we propose that sortilin may act as a link between Golgi proteins and the AP-5/SPG11/SPG15 complex. Together, our findings suggest that AP-5 functions in a novel sorting step out of late endosomes, acting as a backup pathway for retromer. This provides a mechanistic explanation for why mutations in AP-5/SPG11/SPG15 cause cells to accumulate aberrant endolysosomes, and highlights the role of endosome/lysosome dysfunction in the pathology of hereditary spastic paraplegia and other neurodegenerative disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirst</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Itzhak</LastName><ForeName>Daniel N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Max-Planck Institute of Biochemistry, Martinsried, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antrobus</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borner</LastName><ForeName>Georg H H</ForeName><Initials>GHH</Initials><AffiliationInfo><Affiliation>Max-Planck Institute of Biochemistry, Martinsried, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Margaret S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0631-0053</Identifier><AffiliationInfo><Affiliation>University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Biol</MedlineTA><NlmUniqueID>101183755</NlmUniqueID><ISSNLinking>1544-9173</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):712-23</RefSource><PMID Version="1">26496610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2017 May 1;216(5):1337-1355</RefSource><PMID Version="1">28389476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Traffic. 2007 Dec;8(12):1873-86</RefSource><PMID Version="1">17868075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Dec 11;9(5):1931-45</RefSource><PMID Version="1">25464851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuromolecular Med. 2009;11(4):252-66</RefSource><PMID Version="1">19657747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Histol Histopathol. 2009 Apr;24(4):481-92</RefSource><PMID Version="1">19224451</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Sep 12;20(11):2706-2718</RefSource><PMID Version="1">28903049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 1995 Jul 20;28(2):354-5</RefSource><PMID Version="1">8530051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Traffic. 2002 Sep;3(9):641-53</RefSource><PMID Version="1">12191016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Biol. 2013 Nov 01;5(11):a016790</RefSource><PMID Version="1">24186068</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2004 Mar 29;164(7):1065-76</RefSource><PMID Version="1">15051738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1996 May;133(4):749-60</RefSource><PMID Version="1">8666661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Traffic. 2015 Dec;16(12 ):1210-38</RefSource><PMID Version="1">26403691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2004 Apr;165(1):111-22</RefSource><PMID Version="1">15078902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2010 Jun 29;8(6):e1000408</RefSource><PMID Version="1">20613862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechniques. 2007 Jan;42(1):84, 86-9</RefSource><PMID Version="1">17269489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2000 May 16;249(1-2):53-65</RefSource><PMID Version="1">10831838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2015 Sep 1;24(17):4984-96</RefSource><PMID Version="1">26085577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2007 Jul 15;120(Pt 14):2378-89</RefSource><PMID Version="1">17606993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2012 Sep 25;22(18):1711-6</RefSource><PMID Version="1">22902756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2011 Jul 15;89(1):162-7</RefSource><PMID Version="1">21763482</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2002 Jan 21;156(2):327-36</RefSource><PMID Version="1">11807095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2013 Aug;24(16):2558-69</RefSource><PMID Version="1">23825025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2014 Sep;13(9):2513-26</RefSource><PMID Version="1">24942700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1995 Oct 13;270(41):24156-65</RefSource><PMID Version="1">7592619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2010 Apr 1;21(7):1282-92</RefSource><PMID Version="1">20130081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2016 Jun 09;5:</RefSource><PMID Version="1">27278775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Neurosci. 2012 Apr;35(4):261-70</RefSource><PMID Version="1">22341525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 2010 Aug;22(4):506-12</RefSource><PMID Version="1">20417083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Mar;11(3):319-24</RefSource><PMID Version="1">24487582</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2011 Oct;9(10):e1001170</RefSource><PMID Version="1">22022230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 2017 Aug;47:108-116</RefSource><PMID Version="1">28622586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2011 Jul 15;89(1):168-75</RefSource><PMID Version="1">21763483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Jan;1832(1):160-73</RefSource><PMID Version="1">23085491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2009 Apr;1793(4):605-14</RefSource><PMID Version="1">19046998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurol Genet. 2016 Aug 25;2(5):e98</RefSource><PMID Version="1">27606357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 1997 Jun;8(6):1073-87</RefSource><PMID Version="1">9201717</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2001 Oct;12(10):3152-60</RefSource><PMID Version="1">11598199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2002 May;1(5):376-86</RefSource><PMID Version="1">12118079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2012 Apr 2;197(1):141-60</RefSource><PMID Version="1">22472443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 May 1;20(9):2180-90</RefSource><PMID Version="1">11331584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Clin Transl Neurol. 2014 Jun 1;1(6):379-389</RefSource><PMID Version="1">24999486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Traffic. 2013 Feb;14(2):153-64</RefSource><PMID Version="1">23167973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2017 Sep 15;28(19):2569-2578</RefSource><PMID Version="1">28768823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 1999 Jan;3(1):11-21</RefSource><PMID Version="1">10024875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1980 Mar;84(3):513-30</RefSource><PMID Version="1">6153657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2008 Dec;26(12):1367-72</RefSource><PMID Version="1">19029910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurosci. 2011 Jan;12(1):31-42</RefSource><PMID Version="1">21139634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 May 27;3:e02866</RefSource><PMID Version="1">24867644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Jul 11;278(28):25958-63</RefSource><PMID Version="1">12716889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1994 May 15;13(10):2305-12</RefSource><PMID Version="1">8194522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2009 May;6(5):359-62</RefSource><PMID Version="1">19377485</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013;9(12):e1003988</RefSource><PMID Version="1">24367272</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1987 Nov;6(11):3373-8</RefSource><PMID Version="1">2828026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Sep;13(9):731-40</RefSource><PMID Version="1">27348712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2010 Feb 16;18(2):324-31</RefSource><PMID Version="1">20159602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2003;72:395-447</RefSource><PMID Version="1">12651740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2015 Dec 1;26(24):4427-37</RefSource><PMID Version="1">26446839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2004 Nov;15(11):4798-806</RefSource><PMID Version="1">15331763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2014 Dec;124(12):5249-62</RefSource><PMID Version="1">25365221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2015 Aug 18;11(8):e1005454</RefSource><PMID Version="1">26284655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2012 Dec 11;23(6):1255-62</RefSource><PMID Version="1">23177648</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29381698</ArticleId><ArticleId IdType="doi">10.1371/journal.pbio.2004411</ArticleId><ArticleId IdType="pii">pbio.2004411</ArticleId><ArticleId IdType="pmc">PMC5806898</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29381691</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7404</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>PLoS genetics</Title><ISOAbbreviation>PLoS Genet.</ISOAbbreviation></Journal><ArticleTitle>MGA, L3MBTL2 and E2F6 determine genomic binding of the non-canonical Polycomb repressive complex PRC1.6.</ArticleTitle><Pagination><MedlinePgn>e1007193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgen.1007193</ELocationID><Abstract><AbstractText>Diverse Polycomb repressive complexes 1 (PRC1) play essential roles in gene regulation, differentiation and development. Six major groups of PRC1 complexes that differ in their subunit composition have been identified in mammals. How the different PRC1 complexes are recruited to specific genomic sites is poorly understood. The Polycomb Ring finger protein PCGF6, the transcription factors MGA and E2F6, and the histone-binding protein L3MBTL2 are specific components of the non-canonical PRC1.6 complex. In this study, we have investigated their role in genomic targeting of PRC1.6. ChIP-seq analysis revealed colocalization of MGA, L3MBTL2, E2F6 and PCGF6 genome-wide. Ablation of MGA in a human cell line by CRISPR/Cas resulted in complete loss of PRC1.6 binding. Rescue experiments revealed that MGA recruits PRC1.6 to specific loci both by DNA binding-dependent and by DNA binding-independent mechanisms. Depletion of L3MBTL2 and E2F6 but not of PCGF6 resulted in differential, locus-specific loss of PRC1.6 binding illustrating that different subunits mediate PRC1.6 loading to distinct sets of promoters. Mga, L3mbtl2 and Pcgf6 colocalize also in mouse embryonic stem cells, where PRC1.6 has been linked to repression of germ cell-related genes. Our findings unveil strikingly different genomic recruitment mechanisms of the non-canonical PRC1.6 complex, which specify its cell type- and context-specific regulatory functions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stielow</LastName><ForeName>Bastian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Tumor Research (IMT), Philipps-University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finkernagel</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Tumor Research (IMT), Philipps-University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stiewe</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Genomics Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps-University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nist</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7524-6801</Identifier><AffiliationInfo><Affiliation>Genomics Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps-University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suske</LastName><ForeName>Guntram</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-4807-0513</Identifier><AffiliationInfo><Affiliation>Institute of Molecular Biology and Tumor Research (IMT), Philipps-University of Marburg, Marburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Genet</MedlineTA><NlmUniqueID>101239074</NlmUniqueID><ISSNLinking>1553-7390</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2012 Sep 7;11(3):319-32</RefSource><PMID Version="1">22770845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 May 6;363(6424):38-45</RefSource><PMID Version="1">8479534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2016 Sep;15(17 ):2235-6</RefSource><PMID Version="1">27267300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2007;2(6):1445-57</RefSource><PMID Version="1">17545981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2013 Oct;20(10):1147-55</RefSource><PMID Version="1">24096405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 May 1;41(10):e108</RefSource><PMID Version="1">23558742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2015 Jan 1;142(1):31-40</RefSource><PMID Version="1">25516968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Feb 17;148(4):664-78</RefSource><PMID Version="1">22325148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2012 Jan 6;10 (1):47-62</RefSource><PMID Version="1">22226355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Dec 16;280(50):41380-6</RefSource><PMID Version="1">16236716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7</RefSource><PMID Version="1">27141961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2011 Jun 15;27(12):1696-7</RefSource><PMID Version="1">21486936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2017 Feb 17;292(7):2773-2784</RefSource><PMID Version="1">28049731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2004;377:421-42</RefSource><PMID Version="1">14979043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jan;37(1):1-13</RefSource><PMID Version="1">19033363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Mar;42(5):3044-58</RefSource><PMID Version="1">24369422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2013 Mar 7;49(5):808-24</RefSource><PMID Version="1">23473600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2012 Feb 10;45(3):344-56</RefSource><PMID Version="1">22325352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1445-59</RefSource><PMID Version="1">24856970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jun 01;6:26899</RefSource><PMID Version="1">27247273</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2017 Feb 2;65(3):432-446.e5</RefSource><PMID Version="1">28157505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9190-5</RefSource><PMID Version="1">9689056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2017 Jun 9;356(6342):1081-1084</RefSource><PMID Version="1">28596365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8</RefSource><PMID Version="1">19458158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2009 Apr 1;23(7):837-48</RefSource><PMID Version="1">19339689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2011 Jul 8;9(1):37-49</RefSource><PMID Version="1">21726832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2008;9(9):R137</RefSource><PMID Version="1">18798982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jan 17;152(1-2):327-39</RefSource><PMID Version="1">23332764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2013 Aug;45(8):852-9</RefSource><PMID Version="1">23793028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2012 Jul 6;11(1):16-21</RefSource><PMID Version="1">22770239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2005 Jun 7;15(11):1051-7</RefSource><PMID Version="1">15936277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Apr;37(7):2204-10</RefSource><PMID Version="1">19233876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2014 Dec;32(12 ):3112-25</RefSource><PMID Version="1">25187489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Structure. 1997 Apr 15;5(4):509-20</RefSource><PMID Version="1">9115440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2010 Jun 3;584(11):2225-30</RefSource><PMID Version="1">20385135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Adv. 2015 Dec 04;1(11):e1500737</RefSource><PMID Version="1">26665172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Reprod. 2008 Nov;79(5):921-30</RefSource><PMID Version="1">18667754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2002 May 10;296(5570):1132-6</RefSource><PMID Version="1">12004135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2013 Apr 15;14:128</RefSource><PMID Version="1">23586463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2002 Aug;7(8):835-50</RefSource><PMID Version="1">12167161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Oct 4;17 (2):583-595</RefSource><PMID Version="1">27705803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2015 Sep 3;17 (3):300-15</RefSource><PMID Version="1">26340528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 Mar 17;6:</RefSource><PMID Version="1">28304275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2004 Dec 1;18(23):2941-51</RefSource><PMID Version="1">15574595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Genet Dev. 2016 Feb;36:50-8</RefSource><PMID Version="1">27151431</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2012 Dec 18;1:e00205</RefSource><PMID Version="1">23256043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2013;4:1754</RefSource><PMID Version="1">23612295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2016 Jul;23 (7):682-690</RefSource><PMID Version="1">27294783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2011 May 20;42(4):438-50</RefSource><PMID Version="1">21596310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jan;43(Database issue):D662-9</RefSource><PMID Version="1">25352552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2009;4(1):44-57</RefSource><PMID Version="1">19131956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 Jan 31;3(1):60-9</RefSource><PMID Version="1">23273917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 Dec 15;18(24):7019-28</RefSource><PMID Version="1">10601024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2013 Mar 28;49(6):1134-46</RefSource><PMID Version="1">23395003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Nov 1;8(1):1235</RefSource><PMID Version="1">29089522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Mar 30;7:11056</RefSource><PMID Version="1">27025988</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29381691</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1007193</ArticleId><ArticleId IdType="pii">PGENETICS-D-17-02016</ArticleId><ArticleId IdType="pmc">PMC5806899</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29381252</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1539-3429</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology</Title><ISOAbbreviation>Biochem Mol Biol Educ</ISOAbbreviation></Journal><ArticleTitle>Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/bmb.21108</ELocationID><Abstract><AbstractText>Disrupting a gene to determine its effect on an organism's phenotype is an indispensable tool in molecular biology. Such techniques are critical for understanding how a gene product contributes to the development and cellular identity of organisms. The explosion of genomic sequencing technologies combined with recent advances in genome-editing techniques has elevated the possibilities of genetic manipulations in numerous organisms in which these experiments were previously not readily accessible or possible. Introducing the next generation of molecular biologists to these emerging techniques is key in the modern biology classroom. This comprehensive review introduces undergraduates to CRISPR/Cas9 editing and its uses in genetic studies. The goals of this review are to explain how CRISPR functions as a prokaryotic immune system, describe how researchers generate mutations with CRISPR/Cas9, highlight how Cas9 has been adapted for new functions, and discuss ethical considerations of genome editing. Additionally, anticipatory guides and questions for discussion are posed throughout the review to encourage active exploration of these topics in the classroom. Finally, the supplement includes a study guide and practical suggestions to incorporate CRISPR/Cas9 experiments into lab courses at the undergraduate level. © 2018 The Authors Biochemistry and Molecular Biology Education published by Wiley Periodicals, Inc. on behalf of International Union of Biochemistry and Molecular Biology, 2018.</AbstractText><CopyrightInformation>© 2018 The Authors Biochemistry and Molecular Biology Education published by Wiley Periodicals, Inc. on behalf of International Union of Biochemistry and Molecular Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thurtle-Schmidt</LastName><ForeName>Deborah M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9747-9585</Identifier><AffiliationInfo><Affiliation>Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California 94143.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Davidson College, Davidson, North Carolina 28035.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Te-Wen</ForeName><Initials>TW</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1231-5531</Identifier><AffiliationInfo><Affiliation>Department of Biology, Ithaca College, Ithaca, New York 14850.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochem Mol Biol Educ</MedlineTA><NlmUniqueID>100970605</NlmUniqueID><ISSNLinking>1470-8175</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Cas9</Keyword><Keyword MajorTopicYN="N">dCas9</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29381252</ArticleId><ArticleId IdType="doi">10.1002/bmb.21108</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29381046</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8937</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>ACS chemical biology</Title><ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation></Journal><ArticleTitle>A Cleavage-Responsive Stem-Loop Hairpin for Assaying Guide RNA Activity.</ArticleTitle><Pagination><MedlinePgn>461-466</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.7b00899</ELocationID><Abstract><AbstractText>The scope of the CRISPR-Cas9 technology now reaches far beyond genomic engineering. While significant efforts are driving the evolution of this revolutionary biomedical tool, the in vitro cleavage assay remains the standard method implemented to validate the guide RNA that directs endonuclease Cas9 to a desired genomic target. Here, we report the development of an alternative guide RNA validation system called GUIDER. GUIDER features a hairpin loop structure with a proximal guanosine-rich unit, a distal fluorophore unit, and a gRNA-targeting stem component. Cleavage of GUIDER by its complementary RNA-guided Cas9 endonuclease complex yields a fluorescent emission at 525 nm, signaling effective cleavage of the hairpin structure. GUIDER was validated using the model gene target mpcsk9, and it was able to identify the gRNA that could most efficiently cleave the target mpcsk9 gene. The modular design of GUIDER should allow it to have broad applicability in validating gRNAs, and its fluorescent signal output offers a rapid, simple, and quantitative measure of Cas9-mediated DNA cleavage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>deBoer</LastName><ForeName>Tara R</ForeName><Initials>TR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1549-3157</Identifier><AffiliationInfo><Affiliation>Berkeley Department of Bioengineering, University of California , Berkeley, California 94720, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wauford</LastName><ForeName>Noreen</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Berkeley Department of Bioengineering, University of California , Berkeley, California 94720, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Jing-Yi</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Berkeley Department of Bioengineering, University of California , Berkeley, California 94720, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres Perez</LastName><ForeName>Miguel Salvador</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Berkeley Department of Bioengineering, University of California , Berkeley, California 94720, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murthy</LastName><ForeName>Niren</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Berkeley Department of Bioengineering, University of California , Berkeley, California 94720, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Biol</MedlineTA><NlmUniqueID>101282906</NlmUniqueID><ISSNLinking>1554-8929</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29381046</ArticleId><ArticleId IdType="doi">10.1021/acschembio.7b00899</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29380513</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-2825</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of clinical laboratory analysis</Title><ISOAbbreviation>J. Clin. Lab. Anal.</ISOAbbreviation></Journal><ArticleTitle>A novel cell line generated using the CRISPR/Cas9 technology as universal quality control material for KRAS G12V mutation testing.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/jcla.22391</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">KRAS mutations are the key indicator for EGFR monoclonal antibody-targeted therapy and acquired drug resistance, and their accurate detection is critical to the clinical decision-making of colorectal cancer. However, no proper quality control material is available for the current detection methods, particularly next-generation sequencing (NGS). The ideal quality control material for NGS needs to provide both the tumor mutation gene and the matched background genomic DNA, which is uncataloged in public databases, to accurately distinguish germline polymorphisms and somatic mutations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed a novel KRAS G12V mutant cell line using the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) technique to make up for the deficiencies in existing quality control material and further validated the feasibility of the cell line as quality control material by amplification refractory mutation system (ARMS), Sanger sequencing, digital PCR (dPCR), and NGS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We verified that the edited cell line specifically had the G12V mutation, and the validation results presented a high consistency among the four methods of detection. The three cell lines screened contained the G12V mutation and the mutation allele fractions of G12V-1, G12V-2, and G12V-3 were 52.01%, 82.06%, and 17.29%, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The novel KRAS G12V cell line generated using the CRISPR/Cas9 gene editing system is suitable as a quality control material for all current detection methods and provides a new direction in the development of quality control material.</AbstractText><CopyrightInformation>© 2018 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Shiyu</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8891-3394</Identifier><AffiliationInfo><Affiliation>Peking University Fifth School of Clinical Medicine, National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Guigao</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Rongxue</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yanxi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Jiansheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qisheng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kuo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jiehong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Peking University Fifth School of Clinical Medicine, National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Lab Anal</MedlineTA><NlmUniqueID>8801384</NlmUniqueID><ISSNLinking>0887-8013</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">KRAS</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">colorectal cancer</Keyword><Keyword MajorTopicYN="N">next-generation sequencing</Keyword><Keyword MajorTopicYN="N">quality control material</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29380513</ArticleId><ArticleId IdType="doi">10.1002/jcla.22391</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29379885</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2380-2367</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>13</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Reactive oxygen species (Apex, N.C.)</Title><ISOAbbreviation>React Oxyg Species (Apex)</ISOAbbreviation></Journal><ArticleTitle>A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity.</ArticleTitle><Pagination><MedlinePgn>35-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.20455/ros.2018.809</ELocationID><Abstract><AbstractText>Biliverdin reductase (BVR) is the enzyme responsible for the last step in the production of bilirubin from the breakdown of heme. Bilirubin is one of the most potent antioxidant molecules in the body. Monitoring BVR activity is essential in studying the antioxidant capacity of cells and tissues. Traditional methods of determining BVR activity have relied on the measurement of bilirubin converted from biliverdin using absorbance spectroscopy. The approach has limited sensitivity and requires large quantities of cells or tissues. We have developed a novel fluorescence-based method utilizing the eel protein, UnaG, for the detection of bilirubin produced by BVR. The UnaG protein only fluoresces by the induction of bilirubin. We have also used this approach to measure intracellular bilirubin content of cultured cells. We validated this assay using cell lysates from mouse liver and immortalized murine hepatic cell line (Hepa1c1c7) and kidney cell line (MCT) in which BVR isoform A (BVRA) was either knocked out via CRISPR or stably overexpressed by lentivirus. Also, we tested the method using previously reported putative BVRA inhibitors, Closantel and Ebselen. These studies show a new method for measuring bilirubin intracellularly and in lysates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adeosun</LastName><ForeName>Samuel O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Physiology &amp; Biophysics, Mississippi Center for Obesity Research, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Kyle H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Physiology &amp; Biophysics, Mississippi Center for Obesity Research, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Physiology &amp; Biophysics, Mississippi Center for Obesity Research, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwaneri</LastName><ForeName>Assumpta C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH 43614.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinds</LastName><ForeName>Terry D</ForeName><Initials>TD</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH 43614.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stec</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Physiology &amp; Biophysics, Mississippi Center for Obesity Research, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 HL125445</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL051971</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM104357</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL105324</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>React Oxyg Species (Apex)</MedlineTA><NlmUniqueID>101688617</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Tohoku J Exp Med. 2010 Jun;221(2):133-40</RefSource><PMID Version="1">20495302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Obesity (Silver Spring). 2014 Mar;22(3):705-12</RefSource><PMID Version="1">23839791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metabolism. 2009 Aug;58(8):1109-15</RefSource><PMID Version="1">19454355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1988 Oct;107(4):1359-68</RefSource><PMID Version="1">3170633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Endocrinol Metab. 2017 Apr 1;312(4):E244-E252</RefSource><PMID Version="1">28096081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Toxicol. 2002;Chapter 9:Unit9.4</RefSource><PMID Version="1">23045084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2016 Nov 25;291(48):25179-25191</RefSource><PMID Version="1">27738106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Apr 12;11(4):e0153427</RefSource><PMID Version="1">27071062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2004 Oct;6(5):841-9</RefSource><PMID Version="1">15345144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 2008 Mar;60(1):79-127</RefSource><PMID Version="1">18323402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Endocrinol Metab. 2015 Apr;26(4):212-20</RefSource><PMID Version="1">25726384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Mol Hepatol. 2012 Dec;18(4):383-90</RefSource><PMID Version="1">23323254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 May 10;7(1):1646</RefSource><PMID Version="1">28490767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2017 Jul;133:1-10</RefSource><PMID Version="1">28414974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 1989 Apr 3;1002(2):238-44</RefSource><PMID Version="1">2930772</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jun 20;153(7):1602-11</RefSource><PMID Version="1">23768684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1987 Feb 27;235(4792):1043-6</RefSource><PMID Version="1">3029864</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antioxidant</Keyword><Keyword MajorTopicYN="N">Bilirubin</Keyword><Keyword MajorTopicYN="N">Heme Oxygenase</Keyword><Keyword MajorTopicYN="N">Oxidative Stress</Keyword><Keyword MajorTopicYN="N">UnaG</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29379885</ArticleId><ArticleId IdType="doi">10.20455/ros.2018.809</ArticleId><ArticleId IdType="pmc">PMC5785779</ArticleId><ArticleId IdType="mid">NIHMS936070</ArticleId></ArticleIdList><?nihms?></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29379417</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-5102</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Frontiers in cellular neuroscience</Title><ISOAbbreviation>Front Cell Neurosci</ISOAbbreviation></Journal><ArticleTitle>Genome-Edited, TH-expressing Neuroblastoma Cells as a Disease Model for Dopamine-Related Disorders: A Proof-of-Concept Study on DJ-1-deficient Parkinsonism.</ArticleTitle><Pagination><MedlinePgn>426</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fncel.2017.00426</ELocationID><Abstract><AbstractText>Impairment of the dopaminergic (DA) system is a common cause of several movement disorders including Parkinson's disease (PD), however, little is known about the underlying disease mechanisms. The recent development of stem-cell-based protocols for the generation of DA neurons partially solved this issue, however, this technology is costly and time-consuming. Commonly used cell lines, i.e., neuroblastoma (SHSY5Y) and PC12 cells are still widely used to investigate PD and significantly contributed to our understanding of mechanisms involved in development of the disease. However, they either do not express DA at all or require additional, only partially efficient differentiations in order to produce DA. Here we generated and characterized transgenic SH-SY5Y cells, ectopically expressing tyrosine hydroxylase (SH<sup>TH+</sup>), that can be used as a homogenous, DA-producing model to study alterations in DA metabolism and oxidative stress. We demonstrated that SH<sup>TH+</sup>produce high levels of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) making this model suitable to investigate not only alterations in DA synthesis but also its turnover. We also provide evidence for the presence of other enzymes involved in DA synthesis and its turnover in these cells. Finally, we showed that these cells can easily be genetically modified using CRISPR/Cas9 technology in order to study genetically defined forms of movement disorders using DJ1-linked PD as a model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prasuhn</LastName><ForeName>Jannik</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mårtensson</LastName><ForeName>Christoph U</ForeName><Initials>CU</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krajka</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rakovic</LastName><ForeName>Aleksandar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Neurosci</MedlineTA><NlmUniqueID>101477935</NlmUniqueID><ISSNLinking>1662-5102</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Science. 2017 Sep 22;357(6357):1255-1261</RefSource><PMID Version="1">28882997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2013 Sep;62:132-44</RefSource><PMID Version="1">23380027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Nov 20;9(4):1173-82</RefSource><PMID Version="1">25456120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Neurodegener. 2017 Jan 24;12 (1):10</RefSource><PMID Version="1">28118852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2014 May;129(3):388-99</RefSource><PMID Version="1">24286589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2013;1078:9-21</RefSource><PMID Version="1">23975817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1996 May;46(5):1262-9</RefSource><PMID Version="1">8628464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Probes. 2016 Dec;30(6):386-396</RefSource><PMID Version="1">27818248</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Pharmacol. 2006 Jan;147 Suppl 1:S287-96</RefSource><PMID Version="1">16402116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Commun Signal. 2013 May 17;11(1):34</RefSource><PMID Version="1">23683503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2015 Oct;30(12):1591-601</RefSource><PMID Version="1">26474316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2014 Dec 20;15:1154</RefSource><PMID Version="1">25528190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2013 May 21;587(10 ):1562-70</RefSource><PMID Version="1">23587484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Jan 25;288(4):2223-37</RefSource><PMID Version="1">23212910</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DJ-1</Keyword><Keyword MajorTopicYN="N">Parkinson’s disease</Keyword><Keyword MajorTopicYN="N">TH</Keyword><Keyword MajorTopicYN="N">dopamine metabolism</Keyword><Keyword MajorTopicYN="N">genome editing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29379417</ArticleId><ArticleId IdType="doi">10.3389/fncel.2017.00426</ArticleId><ArticleId IdType="pmc">PMC5770810</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29379209</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2058-5276</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature microbiology</Title><ISOAbbreviation>Nat Microbiol</ISOAbbreviation></Journal><ArticleTitle>Spontaneous CRISPR loci generation in vivo by non-canonical spacer integration.</ArticleTitle><Pagination><MedlinePgn>310-318</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41564-017-0097-z</ELocationID><Abstract><AbstractText>The adaptation phase of CRISPR-Cas immunity depends on the precise integration of short segments of foreign DNA (spacers) into a specific genomic location within the CRISPR locus by the Cas1-Cas2 integration complex. Although off-target spacer integration outside of canonical CRISPR arrays has been described in vitro, no evidence of non-specific integration activity has been found in vivo. Here, we show that non-canonical off-target integrations can occur within bacterial chromosomes at locations that resemble the native CRISPR locus by characterizing hundreds of off-target integration locations within Escherichia coli. Considering whether such promiscuous Cas1-Cas2 activity could have an evolutionary role through the genesis of neo-CRISPR loci, we combed existing CRISPR databases and available genomes for evidence of off-target integration activity. This search uncovered several putative instances of naturally occurring off-target spacer integration events within the genomes of Yersinia pestis and Sulfolobus islandicus. These results are important in understanding alternative routes to CRISPR array genesis and evolution, as well as in the use of spacer acquisition in technological applications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nivala</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8210-5417</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shipman</LastName><ForeName>Seth L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Center for Brain Science, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Church</LastName><ForeName>George M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3535-2076</Identifier><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, MA, USA. gchurch@genetics.med.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA. gchurch@genetics.med.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH103910</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RM1 HG008525</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Microbiol</MedlineTA><NlmUniqueID>101674869</NlmUniqueID><ISSNLinking>2058-5276</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Dec 15;44(22):10849-10861</RefSource><PMID Version="1">27738137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Jun 16;62(6):824-833</RefSource><PMID Version="1">27211867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Dec 19;322(5909):1843-5</RefSource><PMID Version="1">19095942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Mar 17;61(6):797-808</RefSource><PMID Version="1">26949040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2014 Jun;21(6):528-34</RefSource><PMID Version="1">24793649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2010 Mar;192(6):1685-99</RefSource><PMID Version="1">20061468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 May 26;106(21):8605-10</RefSource><PMID Version="1">19435847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 29;9(9):e108353</RefSource><PMID Version="1">25265542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2016 Oct;23 (10 ):876-883</RefSource><PMID Version="1">27595346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Jul 20;547(7663):345-349</RefSource><PMID Version="1">28700573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2012 Jul 10;3:945</RefSource><PMID Version="1">22781758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 May 19;44(9):4266-77</RefSource><PMID Version="1">27085805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 23;520(7548):505-510</RefSource><PMID Version="1">25874675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2017 Sep 15;357(6356):1113-1118</RefSource><PMID Version="1">28729350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Mar 12;519(7542):193-8</RefSource><PMID Version="1">25707795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2015 Aug 18;4:null</RefSource><PMID Version="1">26284603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2016 Nov 3;64(3):616-623</RefSource><PMID Version="1">27618488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Nov 5;163(4):840-53</RefSource><PMID Version="1">26478180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2007;8(4):R61</RefSource><PMID Version="1">17442114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jul;40(12):5569-76</RefSource><PMID Version="1">22402487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Aug 15;321(5891):960-4</RefSource><PMID Version="1">18703739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Oct 1;526(7571):55-61</RefSource><PMID Version="1">26432244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Open Biol. 2013 Apr 17;3(4):130010</RefSource><PMID Version="1">23594878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jan 14;164(1-2):29-44</RefSource><PMID Version="1">26771484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 May;42(9):5907-16</RefSource><PMID Version="1">24728991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2013 May;10(5):716-25</RefSource><PMID Version="1">23619643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Sep 13;16(11):2811-2818</RefSource><PMID Version="1">27626652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Apr;81(7):2506-14</RefSource><PMID Version="1">25636838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2007 May 23;8:172</RefSource><PMID Version="1">17521438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2011 Jan;79(1):35-49</RefSource><PMID Version="1">21166892</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jul 29;353(6298):aaf1175</RefSource><PMID Version="1">27284167</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29379209</ArticleId><ArticleId IdType="doi">10.1038/s41564-017-0097-z</ArticleId><ArticleId IdType="pii">10.1038/s41564-017-0097-z</ArticleId><ArticleId IdType="pmc">PMC5832444</ArticleId><ArticleId IdType="mid">NIHMS942780</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29379062</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Spatiotemporal patterning of EpCAM is important for murine embryonic endo- and mesodermal differentiation.</ArticleTitle><Pagination><MedlinePgn>1801</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-20131-8</ELocationID><Abstract><AbstractText>Epithelial cell adhesion molecule EpCAM is expressed in pluripotent embryonic stem cells (ESC) in vitro, but is repressed in differentiated cells, except epithelia and carcinomas. Molecular functions of EpCAM, possibly imposing such repression, were primarily studied in malignant cells and might not apply to non-pathologic differentiation. Here, we comprehensively describe timing and rationale for EpCAM regulation in early murine gastrulation and ESC differentiation using single cell RNA-sequencing datasets, in vivo and in vitro models including CRISPR-Cas9-engineered ESC-mutants. We demonstrate expression of EpCAM in inner cell mass, epiblast, primitive/visceral endoderm, and strict repression in the most primitive, nascent Flk1<sup>+</sup>mesoderm progenitors at E7.0. Selective expression of EpCAM was confirmed at mid-gestation and perinatal stages. The rationale for strict patterning was studied in ESC differentiation. Gain/loss-of-function demonstrated supportive functions of EpCAM in achieving full pluripotency and guided endodermal differentiation, but repressive functions in mesodermal differentiation as exemplified with cardiomyocyte formation. We further identified embryonic Ras (ERas) as novel EpCAM interactor of EpCAM and an EpCAM/ERas/AKT axis that is instrumental in differentiation regulation. Hence, spatiotemporal patterning of EpCAM at the onset of gastrulation, resulting in early segregation of interdependent EpCAM<sup>+</sup>endodermal and EpCAM<sup>-</sup>/vimentin<sup>+</sup>mesodermal clusters represents a novel regulatory feature during ESC differentiation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sarrach</LastName><ForeName>Sannia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yuanchi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedics, Spine Surgery, Baoji Central Hospital, JiangTan Road. 8, 721008, Baoji, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niedermeyer</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hachmeister</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gille</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mack</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kranz</LastName><ForeName>Gisela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Libl</LastName><ForeName>Darko</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merl-Pham</LastName><ForeName>Juliane</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3422-4083</Identifier><AffiliationInfo><Affiliation>Research Unit Protein Science, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauck</LastName><ForeName>Stefanie M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1630-6827</Identifier><AffiliationInfo><Affiliation>Research Unit Protein Science, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paoluzzi Tomada</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kieslinger</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gene Vectors, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), Marchioninistr. 25, 81377, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Genetics, Medical University of Vienna, Austria, Währingerstr. 10, 1090, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeremias</LastName><ForeName>Irmela</ForeName><Initials>I</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1773-7677</Identifier><AffiliationInfo><Affiliation>Department of Gene Vectors, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), Marchioninistr. 25, 81377, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Consortium for Translational Cancer Research (DKTK), Partnering Site, Munich, 81337, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, München, 80337, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scialdone</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Marchioninistr. 25, 81377, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional Epigenetics, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Computational Biology, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gires</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2292-7064</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Marchioninistr. 15, 81377, Munich, Germany. olivier.gires@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2013 Jan 31;32(5):641-50</RefSource><PMID Version="1">22391566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Sep 23;286(38):33520-32</RefSource><PMID Version="1">21799003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2015 Jan 16;116(2):341-53</RefSource><PMID Version="1">25593278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Biosci. 2008 Jan 01;13:3096-100</RefSource><PMID Version="1">17981779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(11):e49302</RefSource><PMID Version="1">23209569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2007 Aug 6;204(8):1973-87</RefSource><PMID Version="1">17664288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2010 Jan;28(1):29-35</RefSource><PMID Version="1">19785009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Cell Cardiol. 2000 May;32(5):839-51</RefSource><PMID Version="1">10775488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Physiol. 2000 Nov;85(6):645-51</RefSource><PMID Version="1">11187960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2003 May 29;423(6939):541-5</RefSource><PMID Version="1">12774123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Apr 10;109 (15):E889-97</RefSource><PMID Version="1">22411813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2007 Jun;8(6):502-7</RefSource><PMID Version="1">17522593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Sep;11(9):879-80</RefSource><PMID Version="1">25317452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jul 06;535(7611):289-293</RefSource><PMID Version="1">27383781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2006 Oct;1080:85-96</RefSource><PMID Version="1">17132777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Jan 13;8:13998</RefSource><PMID Version="1">28084299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2016 Oct 11;7(4):764-776</RefSource><PMID Version="1">27641648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2013 Nov 11;27(3):263-77</RefSource><PMID Version="1">24183651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Med (Berl). 1999 Oct;77(10 ):699-712</RefSource><PMID Version="1">10606205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2010;11(10):R106</RefSource><PMID Version="1">20979621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2008 Nov 6;3(5):508-18</RefSource><PMID Version="1">18983966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2014 Feb;32(2):349-63</RefSource><PMID Version="1">23765875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2014 Dec;141(23):4418-31</RefSource><PMID Version="1">25406392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1979 Mar;76(3):1438-42</RefSource><PMID Version="1">286328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009 Dec 31;4(12 ):e8543</RefSource><PMID Version="1">20046825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Adhes Commun. 1994 Oct;2(5):417-28</RefSource><PMID Version="1">7842256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2011 Jul 31;13(9):1100-7</RefSource><PMID Version="1">21804545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Apr 10;7:46315</RefSource><PMID Version="1">28393933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2012 Jun;12(12):1902-11</RefSource><PMID Version="1">22623344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2009 Aug;27(8):1782-91</RefSource><PMID Version="1">19544432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2008 Nov 18;99(10 ):1635-43</RefSource><PMID Version="1">19002182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2013 Mar 11;24(5):543-53</RefSource><PMID Version="1">23484855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2012 Nov 15;371(2):136-45</RefSource><PMID Version="1">22819673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2013 Sep;9(9):e1003638</RefSource><PMID Version="1">24068939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1997 Dec 1;139(5):1337-48</RefSource><PMID Version="1">9382878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2004 Jul 29;23 (34):5748-58</RefSource><PMID Version="1">15195135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2010 Jan 1;337(1):63-73</RefSource><PMID Version="1">19850025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Feb 03;7:41852</RefSource><PMID Version="1">28157205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Embryol Exp Morphol. 1985 Jun;87:27-45</RefSource><PMID Version="1">3897439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2009 Jul;5(7):e1000563</RefSource><PMID Version="1">19609345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2009 Feb;11(2):162-71</RefSource><PMID Version="1">19136966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Mar 19;285(12 ):8719-32</RefSource><PMID Version="1">20064925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Open Biol. 2015 Aug;5(8):null</RefSource><PMID Version="1">26269429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Aug 28;5:4764</RefSource><PMID Version="1">25163760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2011 Mar;53(3):964-73</RefSource><PMID Version="1">21319194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Dev. 2008 Apr;17(2):279-89</RefSource><PMID Version="1">18447643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Nov;10(11):1093-5</RefSource><PMID Version="1">24056876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2008 Aug;135(2):429-37</RefSource><PMID Version="1">18572020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):16978-83</RefSource><PMID Version="1">19805103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2016 Jul 19;5:</RefSource><PMID Version="1">27431614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2016 Jan 12;6(1):150-62</RefSource><PMID Version="1">26724906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010 Nov 30;5(11):e14146</RefSource><PMID Version="1">21152387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2009 Jan 15;122(Pt 2):233-42</RefSource><PMID Version="1">19118216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Aug;18(8):4833-43</RefSource><PMID Version="1">9671492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2009 Feb;9(2):143; author reply 143</RefSource><PMID Version="1">19132011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2010 Nov;31(11):1913-21</RefSource><PMID Version="1">20837599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2001 Apr;21(7):2570-80</RefSource><PMID Version="1">11259604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Roux Arch Dev Biol. 1994 Jan;204(1):36-45</RefSource><PMID Version="1">28305815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Lett. 2015 Feb;37(2):475-81</RefSource><PMID Version="1">25312921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Adh Migr. 2012 Jan-Feb;6(1):30-8</RefSource><PMID Version="1">22647938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 May 11;475(7356):386-9</RefSource><PMID Version="1">21562492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2010 Nov 1;191(3):645-59</RefSource><PMID Version="1">20974811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Dev. 2005 Apr;14 (2):153-61</RefSource><PMID Version="1">15910241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Reports. 2014 May 22;2(6):751-60</RefSource><PMID Version="1">24936463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2002 Aug 9;91(3):189-201</RefSource><PMID Version="1">12169644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Aug 29;8(8):e71836</RefSource><PMID Version="1">24009667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Aug 1;20(5):1215-1228</RefSource><PMID Version="1">28768204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2009 Apr;66(8):1467-78</RefSource><PMID Version="1">19266163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Symp Quant Biol. 2008;73:59-66</RefSource><PMID Version="1">19028988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2005 Oct;9(4):555-64</RefSource><PMID Version="1">16198297</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29379062</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-20131-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-20131-8</ArticleId><ArticleId IdType="pmc">PMC5789065</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29379029</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9.</ArticleTitle><Pagination><MedlinePgn>1760</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-19784-2</ELocationID><Abstract><AbstractText>Site-specific modification of antibodies has become a critical aspect in the development of next-generation immunoconjugates meeting criteria of clinically acceptable homogeneity, reproducibility, efficacy, ease of manufacturability, and cost-effectiveness. Using CRISPR/Cas9 genomic editing, we developed a simple and novel approach to produce site-specifically modified antibodies. A sortase tag was genetically incorporated into the C-terminal end of the third immunoglobulin heavy chain constant region (CH3) within a hybridoma cell line to manufacture antibodies capable of site-specific conjugation. This enabled an effective enzymatic site-controlled conjugation of fluorescent and radioactive cargoes to a genetically tagged mAb without impairment of antigen binding activity. After injection in mice, these immunoconjugates showed almost doubled specific targeting in the lung vs. chemically conjugated maternal mAb, and concomitant reduction in uptake in the liver and spleen. The approach outlined in this work provides a facile method for the development of more homogeneous, reproducible, effective, and scalable antibody conjugates for use as therapeutic and diagnostic tools.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khoshnejad</LastName><ForeName>Makan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. makank@mail.med.upenn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brenner</LastName><ForeName>Jacob S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jake.brenner@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motley</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parhiz</LastName><ForeName>Hamideh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greineder</LastName><ForeName>Colin F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villa</LastName><ForeName>Carlos H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcos-Contreras</LastName><ForeName>Oscar A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsourkas</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7758-1753</Identifier><AffiliationInfo><Affiliation>Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muzykantov</LastName><ForeName>Vladimir R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. muzykant@mail.med.upenn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 HL007954</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2016 Mar;16(2):220-8</RefSource><PMID Version="1">26826926</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Nano. 2013 Mar 26;7(3):2461-9</RefSource><PMID Version="1">23383962</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2017 Feb 20;18(1):35</RefSource><PMID Version="1">28219395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Nano. 2014 May 27;8(5):4100-32</RefSource><PMID Version="1">24787360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2016 Feb 02;17 (2):null</RefSource><PMID Version="1">26848651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2017 May 1;23 (9):2255-2266</RefSource><PMID Version="1">27815355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jul 01;10 (7):e0131177</RefSource><PMID Version="1">26132162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioconjug Chem. 2016 Mar 16;27(3):628-37</RefSource><PMID Version="1">26718023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Metab Dispos. 2017 Aug;45(8):957-965</RefSource><PMID Version="1">28533324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol J. 2015 Sep;10(9):1446-56</RefSource><PMID Version="1">25864574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem. 2016 Mar;8(3):281</RefSource><PMID Version="1">26892562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Aug 17;7:12535</RefSource><PMID Version="1">27531490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15644-9</RefSource><PMID Version="1">23940360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2007 Nov;3(11):707-8</RefSource><PMID Version="1">17891153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Sep;8(9):1800-7</RefSource><PMID Version="1">23989674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2013 Feb 21;20(2):161-7</RefSource><PMID Version="1">23438745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Med Surg (Lond). 2014 Sep 11;3(4):113-6</RefSource><PMID Version="1">25568796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jan 14;9(1):e83865</RefSource><PMID Version="1">24454709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2015 May;52(5):289-96</RefSource><PMID Version="1">25713109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2012 Jul;33(21):5406-13</RefSource><PMID Version="1">22560201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Sep;24(9):1561-9</RefSource><PMID Version="1">27406980</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioconjug Chem. 2010 Jan;21(1):5-13</RefSource><PMID Version="1">19769391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Radiat Isot. 2006 Apr;64(4):470-4</RefSource><PMID Version="1">16352433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Adv. 2015 Nov 1;33(6 Pt 1):775-84</RefSource><PMID Version="1">25981886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioconjug Chem. 2014 Jul 16;25(7):1331-41</RefSource><PMID Version="1">24924618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2017 May;21:29-31</RefSource><PMID Version="1">28677535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Control Release. 2014 Mar 10;177:34-41</RefSource><PMID Version="1">24412573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Mar 09;7:10934</RefSource><PMID Version="1">26956543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioconjug Chem. 2014 Feb 19;25(2):351-61</RefSource><PMID Version="1">24437342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1766-71</RefSource><PMID Version="1">24443552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Small. 2017 Feb;13(6):</RefSource><PMID Version="1">27873460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2014 Apr;35(11):3708-15</RefSource><PMID Version="1">24480537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biosci Rep. 2015 Jun 12;35(4):null</RefSource><PMID Version="1">26182432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Control Release. 2011 Jul 15;153(1):56-63</RefSource><PMID Version="1">21457736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomol Ther (Seoul). 2015 Nov;23(6):493-509</RefSource><PMID Version="1">26535074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Cell Mol Biol. 1991 Mar;4(3):195-203</RefSource><PMID Version="1">2001288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Med. 2013;64:15-29</RefSource><PMID Version="1">23043493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nucl Med. 2014 Sep;55(9):1492-8</RefSource><PMID Version="1">24982438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2017 Mar;19:52-54</RefSource><PMID Version="1">28413007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2016 Nov;15(11):2698-2708</RefSource><PMID Version="1">27582525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucl Med Biol. 1999 Nov;26(8):977-82</RefSource><PMID Version="1">10708314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2004 Sep 5;87(5):614-22</RefSource><PMID Version="1">15352059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2004 Mar 10;126(9):2670-1</RefSource><PMID Version="1">14995162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2008 Aug;26(8):925-32</RefSource><PMID Version="1">18641636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2012 Jan 22;30(2):184-9</RefSource><PMID Version="1">22267010</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29379029</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-19784-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-19784-2</ArticleId><ArticleId IdType="pmc">PMC5789018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29379011</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>01</Month><Day>29</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated viruses.</ArticleTitle><Pagination><MedlinePgn>412</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-017-02706-7</ELocationID><Abstract><AbstractText>Recent advances using CRISPR-Cas9 approaches have dramatically enhanced the ease for genetic manipulation in rodents. Notwithstanding, the methods to deliver nucleic acids into pre-implantation embryos have hardly changed since the original description of mouse transgenesis more than 30 years ago. Here we report a novel strategy to generate genetically modified mice by transduction of CRISPR-Cas9 components into pre-implantation mouse embryos via recombinant adeno-associated viruses (rAAVs). Using this approach, we efficiently generated a variety of targeted mutations in explanted embryos, including indel events produced by non-homologous end joining and tailored mutations using homology-directed repair. We also achieved gene modification in vivo by direct delivery of rAAV particles into the oviduct of pregnant females. Our approach greatly simplifies the generation of genetically modified mice and, more importantly, opens the door for streamlined gene editing in other mammalian species.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Yeonsoo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Genes and Development, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>Phillip W L</ForeName><Initials>PWL</Initials><Identifier Source="ORCID">0000-0001-7409-8344</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riley</LastName><ForeName>Joy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Genes and Development, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Guangping</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA. guangping.gao@umassmed.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Horae Gene Therapy Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA. guangping.gao@umassmed.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera-Pérez</LastName><ForeName>Jaime A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-5776-6291</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Genes and Development, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA. jaime.rivera@umassmed.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 HL131471</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 HD089566</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI100263</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS076991</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD083311</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C485184">enhanced green fluorescent protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="C000606107">Cas9 endonuclease Streptococcus pyogenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004720">Endonucleases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nature. 1982 Dec 16;300(5893):611-5</RefSource><PMID Version="1">6958982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Apr 20;169(3):559</RefSource><PMID Version="1">28431253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8852-7</RefSource><PMID Version="1">8799116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2005 Nov;3(11):837-47</RefSource><PMID Version="1">16261169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2015 Jun;200(2):423-30</RefSource><PMID Version="1">25819794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2010;11(8):R86</RefSource><PMID Version="1">20738864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jun 22;5:11406</RefSource><PMID Version="1">26096991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2013 May;24(5):520-5</RefSource><PMID Version="1">23621841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2014 Feb 1;23 (3):668-81</RefSource><PMID Version="1">24108104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Sep 22;537(7621):508-514</RefSource><PMID Version="1">27626380</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Hum Genet. 2016 Jan 01;88:Unit 15.8</RefSource><PMID Version="1">26724720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Zool. 1977 Jun;200(3):365-76</RefSource><PMID Version="1">559722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 1996 Oct 15;37(2):245-8</RefSource><PMID Version="1">8921397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Virol. 2014 Nov;1(1):427-51</RefSource><PMID Version="1">26958729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2012 Aug 31;13(8):R77</RefSource><PMID Version="1">22937822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2016;1382:95-106</RefSource><PMID Version="1">26611581</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 1982 Apr;90(2):352-62</RefSource><PMID Version="1">7075865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genesis. 2007 Sep;45(9):593-605</RefSource><PMID Version="1">17868096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Jul 18;20(3):750-756</RefSource><PMID Version="1">28723575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 1994 Oct;75 ( Pt 10):2655-62</RefSource><PMID Version="1">7931151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Jan 2;323(5910):133-8</RefSource><PMID Version="1">19023044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2002 Feb 1;295(5556):868-72</RefSource><PMID Version="1">11786607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Feb;33(2):179-86</RefSource><PMID Version="1">25503383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2140-5</RefSource><PMID Version="1">11854510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1982 Mar 4;296(5852):39-42</RefSource><PMID Version="1">6278311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2016 Jul 8;291(28):14457-67</RefSource><PMID Version="1">27151215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2014 Aug;9(8):1956-68</RefSource><PMID Version="1">25058643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Jun 5;157(6):1262-78</RefSource><PMID Version="1">24906146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mamm Genome. 2014 Aug;25(7-8):327-34</RefSource><PMID Version="1">24879364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2014 Sep 1;393(1):3-9</RefSource><PMID Version="1">24984260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Jul 27;317(5837):477</RefSource><PMID Version="1">17656716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Apr 20;533(7603):420-4</RefSource><PMID Version="1">27096365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2005 Oct;15(10):1451-5</RefSource><PMID Version="1">16169926</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Mol Biol. 2010 Jan;Chapter 19:Unit 19.10.1-21</RefSource><PMID Version="1">20069535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jun 11;5:11315</RefSource><PMID Version="1">26066060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2010 Oct 1;26(19):2460-1</RefSource><PMID Version="1">20709691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2016 Oct 1;418(1):1-9</RefSource><PMID Version="1">27474397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2012 Apr;20(4):699-708</RefSource><PMID Version="1">22273577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 Jul 15;25(14):1754-60</RefSource><PMID Version="1">19451168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Dec 18;516(7531):428-31</RefSource><PMID Version="1">25337879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Genet Genomics. 2016 May 20;43(5):319-27</RefSource><PMID Version="1">27210041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1990 Dec 25;18(24):7293-8</RefSource><PMID Version="1">2124349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 9;159(2):440-55</RefSource><PMID Version="1">25263330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2017 Oct;35(10 ):983-996</RefSource><PMID Version="1">28739220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Jan;13(1):41-50</RefSource><PMID Version="1">26716561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Dec 1;540(7631):144-149</RefSource><PMID Version="1">27851729</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001755" MajorTopicYN="N">Blastocyst</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="Y">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064112" MajorTopicYN="Y">Clustered Regularly Interspaced Short Palindromic Repeats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059766" MajorTopicYN="N">DNA End-Joining Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000229" MajorTopicYN="N">Dependovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047108" MajorTopicYN="N">Embryonic Development</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004720" MajorTopicYN="N">Endonucleases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005187" MajorTopicYN="N">Fallopian Tubes</DescriptorName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005818" MajorTopicYN="N">Genetic Engineering</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059767" MajorTopicYN="N">Recombinational DNA Repair</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29379011</ArticleId><ArticleId IdType="doi">10.1038/s41467-017-02706-7</ArticleId><ArticleId IdType="pii">10.1038/s41467-017-02706-7</ArticleId><ArticleId IdType="pmc">PMC5788975</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29378962</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.</ArticleTitle><Pagination><MedlinePgn>E1570-E1577</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1719577115</ELocationID><Abstract><AbstractText>TTK protein kinase (TTK), also known as Monopolar spindle 1 (MPS1), is a key regulator of the spindle assembly checkpoint (SAC), which functions to maintain genomic integrity. TTK has emerged as a promising therapeutic target in human cancers, including triple-negative breast cancer (TNBC). Several TTK inhibitors (TTKis) are being evaluated in clinical trials, and an understanding of the mechanisms mediating TTKi sensitivity and resistance could inform the successful development of this class of agents. We evaluated the cellular effects of the potent clinical TTKi CFI-402257 in TNBC models. CFI-402257 induced apoptosis and potentiated aneuploidy in TNBC lines by accelerating progression through mitosis and inducing mitotic segregation errors. We used genome-wide CRISPR/Cas9 screens in multiple TNBC cell lines to identify mechanisms of resistance to CFI-402257. Our functional genomic screens identified members of the anaphase-promoting complex/cyclosome (APC/C) complex, which promotes mitotic progression following inactivation of the SAC. Several screen candidates were validated to confer resistance to CFI-402257 and other TTKis using CRISPR/Cas9 and siRNA methods. These findings extend the observation that impairment of the APC/C enables cells to tolerate genomic instability caused by SAC inactivation, and support the notion that a measure of APC/C function could predict the response to TTK inhibition. Indeed, an APC/C gene expression signature is significantly associated with CFI-402257 response in breast and lung adenocarcinoma cell line panels. This expression signature, along with somatic alterations in genes involved in mitotic progression, represent potential biomarkers that could be evaluated in ongoing clinical trials of CFI-402257 or other TTKis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thu</LastName><ForeName>K L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvester</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba-Alawi</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>M H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elia</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mer</LastName><ForeName>A S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smirnov</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9395-8450</Identifier><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safikhani</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haibe-Kains</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, University of Toronto, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada M5G 0A3.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mak</LastName><ForeName>T W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7; tak.mak@uhnresearch.ca dave.cescon@uhn.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cescon</LastName><ForeName>D W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7; tak.mak@uhnresearch.ca dave.cescon@uhn.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Toronto, Toronto, ON, Canada M5G 1L7.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2017 Feb;7(2):218-233</RefSource><PMID Version="1">28069571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 May;34(5):525-7</RefSource><PMID Version="1">27043002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</RefSource><PMID Version="1">16199517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014;15(12):554</RefSource><PMID Version="1">25476604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2017 Jun 1;77(11):3057-3069</RefSource><PMID Version="1">28314784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2017 Feb;7(2):134-136</RefSource><PMID Version="1">28167614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2011 Nov;22(22):4227-35</RefSource><PMID Version="1">21937719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2011 Dec;10(12):2267-75</RefSource><PMID Version="1">21980130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4459-64</RefSource><PMID Version="1">15070740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2017 Nov;16(11):2609-2617</RefSource><PMID Version="1">28751540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2004 Mar 15;23(11):2016-27</RefSource><PMID Version="1">15021889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7</RefSource><PMID Version="1">27141961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2014 Jan;232(2):142-50</RefSource><PMID Version="1">24114677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Jul 21;11(7):e0159646</RefSource><PMID Version="1">27441562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Feb 9;14 (5):1086-1099</RefSource><PMID Version="1">26832417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8699-704</RefSource><PMID Version="1">15159543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>F1000Res. 2016 Sep 16;5:2333</RefSource><PMID Version="3">28928933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2013 Mar 6;32(5):617-28</RefSource><PMID Version="1">23395906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Dec 15;70(24):10255-64</RefSource><PMID Version="1">21159646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2017 Mar 21;114(12 ):3127-3132</RefSource><PMID Version="1">28270606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2015 Oct 19;25(20):R1002-18</RefSource><PMID Version="1">26485365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2010 Sep 8;102(17):1310-21</RefSource><PMID Version="1">20679594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2011 Nov 15;124(Pt 22):3905-16</RefSource><PMID Version="1">22100920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2008 Feb 28;27(10 ):1355-65</RefSource><PMID Version="1">17724460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2015 Nov 19;60(4):524-36</RefSource><PMID Version="1">26590712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783</RefSource><PMID Version="1">27899578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Mar 1;14 (8):1829-40</RefSource><PMID Version="1">26904940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2009 Apr 8;28(7):902-14</RefSource><PMID Version="1">19229290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2016 Apr 15;32(8):1244-6</RefSource><PMID Version="1">26656004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2015 Feb;16(2):82-94</RefSource><PMID Version="1">25604195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2011 Sep 18;13(10 ):1234-43</RefSource><PMID Version="1">21926987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2013 Nov;20(11):1532-45</RefSource><PMID Version="1">23933817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2013 Apr 15;14:128</RefSource><PMID Version="1">23586463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jan 14;164(1-2):293-309</RefSource><PMID Version="1">26771497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Apr 18;486(7403):346-52</RefSource><PMID Version="1">22522925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 May 30;19(9):1832-1845</RefSource><PMID Version="1">28564602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Oct 4;490(7418):61-70</RefSource><PMID Version="1">23000897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2017 Oct 24;8(1):1126</RefSource><PMID Version="1">29066719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2012 May;2(5):401-4</RefSource><PMID Version="1">22588877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Mar 28;483(7391):603-7</RefSource><PMID Version="1">22460905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2014 Jan;60(1):122-33</RefSource><PMID Version="1">24298072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Jul 27;170(3):564-576.e16</RefSource><PMID Version="1">28753430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2014 Feb;13(2):307-315</RefSource><PMID Version="1">24282275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2017 Feb 9;168(4):575-578</RefSource><PMID Version="1">28187280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Dec 3;163(6):1515-26</RefSource><PMID Version="1">26627737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Med Chem Lett. 2016 May 06;7(7):671-5</RefSource><PMID Version="1">27437075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2016 May 12;35(19):2518-28</RefSource><PMID Version="1">26364596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>F1000Res. 2016 May 09;5:825</RefSource><PMID Version="1">27408686</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APC/C</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">TTK inhibitor</Keyword><Keyword MajorTopicYN="N">breast cancer</Keyword><Keyword MajorTopicYN="N">drug resistance</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>08</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29378962</ArticleId><ArticleId IdType="pii">1719577115</ArticleId><ArticleId IdType="doi">10.1073/pnas.1719577115</ArticleId><ArticleId IdType="pmc">PMC5816201</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29378893</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5530</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of bacteriology</Title><ISOAbbreviation>J. Bacteriol.</ISOAbbreviation></Journal><ArticleTitle>Regulation of the CRISPR-associated genes by Rv2837c (CnpB) via an Orn-like activity in TB complex mycobacteria.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">JB.00743-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JB.00743-17</ELocationID><Abstract><AbstractText>Clustered regularly interspaced short palindromic repeats (CRISPR) and the CRISPR-associated proteins (Cas) provide an adaptive immunity to bacteria and archaea against specific DNA invaders.<i>Mycobacterium tuberculosis</i>(Mtb) encodes a Type III CRISPR-Cas system, which has not been experimentally explored. In this study, we found that the CRISPR-Cas systems of both Mtb and<i>M. bovis</i>BCG were highly upregulated by deletion of Rv2837c (<i>cnpB</i>), which encodes a multifunctional protein that hydrolyzes cyclic di-AMP (c-di-AMP), cyclic di-GMP (c-di-GMP), and nanoRNAs (short oligonucleotides of five residues or shorter in length). By using genetic and biochemical approaches, we demonstrated that the CnpB-controlled transcriptional regulation of the CRISPR-Cas system is mediated by an Orn-like activity, rather than hydrolyzing the cyclic di-nucleotides. Additionally, our results revealed that tuberculosis (TB) complex mycobacteria are functional in processing CRISPR RNAs (crRNAs), which are also more abundant in Δ<i>cnpB</i>compared to the parent strain. The elevated crRNA levels in Δ<i>cnpB</i>can be partially reduced by expressing<i>E. coli orn</i>Our findings provide new insight into transcriptional regulation of bacterial CRISPR-Cas systems.<b>Importance</b>Clustered regularly interspaced short palindromic repeats (CRISPR) and the CRISPR-associated proteins (Cas) provide an adaptive immunity against specific DNA invaders.<i>Mycobacterium tuberculosis</i>(Mtb) encodes a Type III CRISPR-Cas system, which has not been experimentally explored. In this study, we first demonstrated that the CRISPR-Cas systems in tuberculosis (TB) complex mycobacteria are functional in processing CRISPR RNAs (crRNAs). We also showed that Rv2837c (CnpB) controls the expression of the CRISPR-Cas systems in TB complex mycobacteria through an oligoribonuclease (Orn)-like activity, which is very likely mediated by nanoRNA. Since little is known about regulation of CRISPR-Cas systems, our findings provide new insight into transcriptional regulation of bacterial CRISPR-Cas systems.</AbstractText><CopyrightInformation>Copyright © 2018 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Immunology and Microbial Disease, MC-151, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208-3479.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunology and Microbial Disease, MC-151, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208-3479.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Guangchun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Immunology and Microbial Disease, MC-151, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208-3479 baig@mail.amc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Bacteriol</MedlineTA><NlmUniqueID>2985120R</NlmUniqueID><ISSNLinking>0021-9193</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29378893</ArticleId><ArticleId IdType="pii">JB.00743-17</ArticleId><ArticleId IdType="doi">10.1128/JB.00743-17</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29378844</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Protein Arginine Methyltransferase 7-Mediated microRNA-221 Repression Maintains Oct4, Nanog, and Sox2 Levels in Mouse Embryonic Stem Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jbc.RA117.000425</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA117.000425</ELocationID><Abstract><AbstractText>The stemness maintenance of embryonic stem cells (ESCs) requires pluripotency transcription factors, including Oct4, Nanog, and Sox2. We have previously reported that protein arginine methyltransferase 7 (PRMT7), an epigenetic modifier, is an essential pluripotency factor that maintains the stemness of mouse ESCs, at least in part, by downregulating the expression of the anti-stemness microRNA (miRNA) miR-24-2. To gain greater insight into the molecular basis underlying PRMT7-mediated maintenance of mouse ESC stemness, we searched for new PRMT7-downregulated anti-stemness miRNAs. Here, we show that miR-221 gene-encoded miR-221-3p and miR-221-5p are anti-stemness miRNAs whose expression levels in mouse ESCs are directly repressed by PRMT7. Notably, both miR-221-3p and miR-221-5p targeted the 3' untranslated regions of mRNA transcripts of the major pluripotency factors Oct4, Nanog, and Sox2 to antagonize mouse ESC stemness. Moreover, miR-221-5p silenced also the expression of its own transcriptional repressor PRMT7. Transfection of miR-221-3p and miR-221-5p mimics induced spontaneous differentiation of mouse ESCs. CRISPR-mediated deletion of the miR-221 gene, as well as specific anti-sense inhibitors of miR-221-3p and miR-221-5p, inhibited the spontaneous differentiation of PRMT7-depleted mouse ESCs. Taken together, these findings reveal that the PRMT7-mediated repression of miR-221-3p and miR-221-5p expression plays a critical role in maintaining mouse ESC stemness. Our results also establish miR-221-3p and miR-221-5p as anti-stemness miRNAs that target Oct4, Nanog, and Sox2 mRNAs in mouse ESCs.</AbstractText><CopyrightInformation>Published under license by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tsai-Yu</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>The University of Texas M. D. Anderson Cancer Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sung-Hun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>The University of Texas M. D. Anderson Cancer Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhar</LastName><ForeName>Shilpa S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>The University of Texas M. D. Anderson Cancer Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Min Gyu</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA016672</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA207098</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA207109</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM095659</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nanog</Keyword><Keyword MajorTopicYN="N">Oct4</Keyword><Keyword MajorTopicYN="N">PRMT7</Keyword><Keyword MajorTopicYN="N">Stemness</Keyword><Keyword MajorTopicYN="N">embryonic stem cell</Keyword><Keyword MajorTopicYN="N">histone methylation</Keyword><Keyword MajorTopicYN="N">microRNA (miRNA)</Keyword><Keyword MajorTopicYN="N">microRNA mechanism</Keyword><Keyword MajorTopicYN="N">mir221</Keyword><Keyword MajorTopicYN="N">pluripotency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29378844</ArticleId><ArticleId IdType="pii">RA117.000425</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA117.000425</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29378824</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-9129</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Development (Cambridge, England)</Title><ISOAbbreviation>Development</ISOAbbreviation></Journal><ArticleTitle>Chromosomal instability during neurogenesis in Huntington's disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dev156844</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1242/dev.156844</ELocationID><Abstract><AbstractText>Huntington's disease (HD) is a fatal neurodegenerative disease caused by expansion of CAG repeats in the Huntingtin gene (<i>HTT</i>). Neither its pathogenic mechanisms nor the normal functions of HTT are well understood. To model HD in humans, we engineered a genetic allelic series of isogenic human embryonic stem cell (hESC) lines with graded increases in CAG repeat length. Neural differentiation of these lines unveiled a novel developmental HD phenotype: the appearance of giant multinucleated telencephalic neurons at an abundance directly proportional to CAG repeat length, generated by a chromosomal instability and failed cytokinesis over multiple rounds of DNA replication. We conclude that disrupted neurogenesis during development is an important, unrecognized aspect of HD pathogenesis. To address the function of normal HTT protein we generated<i>HTT</i><sup>+/-</sup>and<i>HTT</i><sup>-/-</sup>lines. Surprisingly, the same phenotype emerged in<i>HTT</i><sup>-/-</sup>but not<i>HTT</i><sup>+/-</sup>lines. We conclude that HD is a developmental disorder characterized by chromosomal instability that impairs neurogenesis, and that HD represents a genetic dominant-negative loss of function, contrary to the prevalent gain-of-toxic-function hypothesis. The consequences of developmental alterations should be considered as a new target for HD therapies.</AbstractText><CopyrightInformation>© 2018. Published by The Company of Biologists Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruzo</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croft</LastName><ForeName>Gist F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metzger</LastName><ForeName>Jakob J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Studies in Physics and Biology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galgoczi</LastName><ForeName>Szilvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerber</LastName><ForeName>Lauren J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hanbin</ForeName><Initials>H</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenner</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marks</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nchako</LastName><ForeName>Corbyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brivanlou</LastName><ForeName>Ali H</ForeName><Initials>AH</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1761-280X</Identifier><AffiliationInfo><Affiliation>Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller University, New York, NY 10065, USA brvnlou@rockefeller.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Development</MedlineTA><NlmUniqueID>8701744</NlmUniqueID><ISSNLinking>0950-1991</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">Chromosomal instability</Keyword><Keyword MajorTopicYN="N">DNA damage and repair</Keyword><Keyword MajorTopicYN="N">Disease modeling</Keyword><Keyword MajorTopicYN="N">Human embryonic stem cells</Keyword><Keyword MajorTopicYN="N">Huntington's disease</Keyword><Keyword MajorTopicYN="N">Neurogenesis</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare no competing or financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29378824</ArticleId><ArticleId IdType="pii">145/2/dev156844</ArticleId><ArticleId IdType="doi">10.1242/dev.156844</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29378572</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1475-2859</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Microbial cell factories</Title><ISOAbbreviation>Microb. Cell Fact.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in Myxococcus xanthus.</ArticleTitle><Pagination><MedlinePgn>15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12934-018-0867-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The CRISPR/dCas9 system is a powerful tool to activate the transcription of target genes in eukaryotic or prokaryotic cells, but lacks assays in complex conditions, such as the biosynthesis of secondary metabolites.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this study, to improve the transcription of the heterologously expressed biosynthetic genes for the production of epothilones, we established the CRISPR/dCas9-mediated activation technique in Myxococcus xanthus and analyzed some key factors involving in the CRISPR/dCas9 activation. We firstly optimized the cas9 codon to fit the M. xanthus cells, mutated the gene to inactivate the nuclease activity, and constructed the dCas9-activator system in an epothilone producer. We compared the improvement efficiency of different sgRNAs on the production of epothilones and the expression of the biosynthetic genes. We also compared the improvement effects of different activator proteins, the ω and α subunits of RNA polymerase, and the sigma factors σ54 and CarQ. By using a copper-inducible promoter, we determined that higher expressions of dCas9-activator improved the activation effects.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results showed that the CRISPR/dCas-mediated transcription activation is a simple and broadly applicable technique to improve the transcriptional efficiency for the production of secondary metabolites in microorganisms. This is the first time to construct the CRISPR/dCas9 activation system in myxobacteria and the first time to assay the CRISPR/dCas9 activations for the biosynthesis of microbial secondary metabolites.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Wan-Wan</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Xin-Jing</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiang-He</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xiao-Zhuang</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhi-Feng</ForeName><Initials>ZF</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Duo-Hong</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>You-Ming</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yue-Zhong</ForeName><Initials>YZ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8336-6638</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan, 250100, China. lilab@sdu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>31471183</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>United States</Country></Grant><Grant><GrantID>31670076</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>United States</Country></Grant><Grant><GrantID>31370123</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>United States</Country></Grant><Grant><GrantID>ZR2016QZ002</GrantID><Agency>Key Program of Shandong Natural Science Foundation</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Microb Cell Fact</MedlineTA><NlmUniqueID>101139812</NlmUniqueID><ISSNLinking>1475-2859</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Prod Rep. 2010 Sep;27(9):1276-95</RefSource><PMID Version="1">20520915</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Ind Microbiol Biotechnol. 2007 Sep;34(9):615-23</RefSource><PMID Version="1">17647035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2005 Mar;187(6):2105-12</RefSource><PMID Version="1">15743959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2015 Sep 18;4(9):1020-9</RefSource><PMID Version="1">25806970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013;3:2101</RefSource><PMID Version="1">23812535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1995 Jul 1;9(13):1633-44</RefSource><PMID Version="1">7628697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2009 Nov 26;8:63</RefSource><PMID Version="1">19941639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2009 Mar 10;140(1-2):135-42</RefSource><PMID Version="1">19041909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2013 Aug;97(15):6857-66</RefSource><PMID Version="1">23549746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2015 Mar;40(3):165-71</RefSource><PMID Version="1">25680757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1998 Mar 1;12(5):745-54</RefSource><PMID Version="1">9499408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2000 Feb 15;14(4):483-92</RefSource><PMID Version="1">10691740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Apr 15;30(8):1180-1182</RefSource><PMID Version="1">24389662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cells. 2015 Jun;38(6):475-81</RefSource><PMID Version="1">25985872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2017 May 23;16(1):92</RefSource><PMID Version="1">28535774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2013 Jan;11(1):21-32</RefSource><PMID Version="1">23178386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2015 Apr 17;4(4):414-20</RefSource><PMID Version="1">25140825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2004 Sep 16;431(7006):371-8</RefSource><PMID Version="1">15372045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2004 Jan;2(1):57-65</RefSource><PMID Version="1">15035009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Feb;31(2):170-4</RefSource><PMID Version="1">23334451</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2009 May;191(9):3108-19</RefSource><PMID Version="1">19251845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 Oct 23;6:null</RefSource><PMID Version="1">29058669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2003 Apr;48(1):237-51</RefSource><PMID Version="1">12657058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antibiot (Tokyo). 1996 Jun;49(6):560-3</RefSource><PMID Version="1">8698639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fungal Genet Biol. 2016 Apr;89:3-9</RefSource><PMID Version="1">26365384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Org Biomol Chem. 2008 Feb 7;6(3):500-6</RefSource><PMID Version="1">18219420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jan 8;327(5962):167-70</RefSource><PMID Version="1">20056882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Mar 12;160(6):1246-60</RefSource><PMID Version="1">25748654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2000 Feb;7(2):97-109</RefSource><PMID Version="1">10662695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Res Microbiol. 1990 May;141(4):425-35</RefSource><PMID Version="1">2119047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antibiot (Tokyo). 2000 Dec;53(12):1373-7</RefSource><PMID Version="1">11217802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2012 Apr;78(8):2515-21</RefSource><PMID Version="1">22287008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antimicrob Agents Chemother. 2002 Sep;46(9):2772-8</RefSource><PMID Version="1">12183227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Apr;12(4):326-8</RefSource><PMID Version="1">25730490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jan 29;517(7536):583-8</RefSource><PMID Version="1">25494202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Ind Microbiol Biotechnol. 2006 Jul;33(7):577-88</RefSource><PMID Version="1">16491362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2011 Jun;7(6):e1002106</RefSource><PMID Version="1">21655090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 23;159(3):647-61</RefSource><PMID Version="1">25307932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Pathog. 2003 Nov;35(5):189-96</RefSource><PMID Version="1">14521877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2015 Jul 22;14:105</RefSource><PMID Version="1">26194479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1995 Jun 1;55(11):2325-33</RefSource><PMID Version="1">7757983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2012 May;30(5):440-6</RefSource><PMID Version="1">22544021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2007 Mar;63(6):1783-96</RefSource><PMID Version="1">17367395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2014 Apr 17;5:172</RefSource><PMID Version="1">24860555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Aug;41(15):7429-37</RefSource><PMID Version="1">23761437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microb Cell Fact. 2017 Aug 16;16(1):142</RefSource><PMID Version="1">28814300</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Activator proteins</Keyword><Keyword MajorTopicYN="N">Biosynthetic gene cluster</Keyword><Keyword MajorTopicYN="N">CRISPR/dCas9 activation</Keyword><Keyword MajorTopicYN="N">Epothilones</Keyword><Keyword MajorTopicYN="N">Myxococcus xanthus</Keyword><Keyword MajorTopicYN="N">Promoter</Keyword><Keyword MajorTopicYN="N">Transcriptional improvement</Keyword><Keyword MajorTopicYN="N">sgRNAs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29378572</ArticleId><ArticleId IdType="doi">10.1186/s12934-018-0867-1</ArticleId><ArticleId IdType="pii">10.1186/s12934-018-0867-1</ArticleId><ArticleId IdType="pmc">PMC5787926</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29378335</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4596</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Free radical biology &amp; medicine</Title><ISOAbbreviation>Free Radic. Biol. Med.</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis.</ArticleTitle><Pagination><MedlinePgn>45-57</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0891-5849(18)30029-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2018.01.019</ELocationID><Abstract><AbstractText>Research into oxidative cell death is producing exciting new mechanisms, such as ferroptosis, in the neuropathologies of cerebral ischemia and hemorrhagic brain insults. Ferroptosis is an oxidative form of regulated necrotic cell death featuring glutathione (GSH) depletion, disrupted glutathione peroxidase-4 (GPX4) redox defense and detrimental lipid reactive oxygen species (ROS) formation. Further, our recent findings identified mitochondrial damage in models of oxidative glutamate toxicity, glutathione peroxidase depletion, and ferroptosis. Despite knowledge on the signaling pathways of ferroptosis increasing, the particular role of mitochondrial damage requires more in depth investigation in order to achieve effective treatment options targeting mitochondria. In the present study, we applied RSL3 to induce ferroptosis in neuronal HT22 cells and mouse embryonic fibroblasts. In both cell types, RSL3 mediated concentration-dependent inhibition of GPX4, lipid peroxidation, enhanced mitochondrial fragmentation, loss of mitochondrial membrane potential, and reduced mitochondrial respiration. Ferroptosis inhibitors, such as deferoxamine, ferrostatin-1 and liproxstatin-1, but also CRISPR/Cas9 Bid knockout and the BID inhibitor BI-6c9 protected against RSL3 toxicity. We found compelling new information that the mitochondria-targeted ROS scavenger mitoquinone (MitoQ) preserved mitochondrial integrity and function, and cell viability despite significant loss of GPX4 expression and associated increases in general lipid peroxidation after exposure to RSL3. Our data demonstrate that rescuing mitochondrial integrity and function through the inhibition of BID or by the mitochondria-targeted ROS scavenger MitoQ serves as a most effective strategy in the prevention of ferroptosis in different cell types. These findings expose mitochondria as promising targets for novel therapeutic intervention strategies in oxidative cell death.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jelinek</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut für Pharmakologie und Klinische Pharmazie, Biochemisch-Pharmakologisches Centrum Marburg, Philipps-Universität Marburg, Karl-von-Frisch-Straße 1, 35032 Marburg, Germany; Marburg Center for Mind, Brain and Behavior - MCMBB, Hans-Meerwein-Straße 6, 35032 Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyder</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut für Pharmazeutische Chemie, Zentrum für Tumor, und Immunbiologie, Philipps-Universität Marburg, Hans-Meerwein-Straße 3, 35032 Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daude</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Zentrum für Tumor, und Immunbiologie, Core Facility Medicinal Chemistry, Philipps-Universität Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plessner</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pharmakologisches Institut, Biochemisch-Pharmakologisches Centrum Marburg, Philipps-Universität Marburg, Karl-von-Frisch-Straße 1, 35032 Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krippner</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pharmakologisches Institut, Biochemisch-Pharmakologisches Centrum Marburg, Philipps-Universität Marburg, Karl-von-Frisch-Straße 1, 35032 Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosse</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pharmakologisches Institut, Biochemisch-Pharmakologisches Centrum Marburg, Philipps-Universität Marburg, Karl-von-Frisch-Straße 1, 35032 Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diederich</LastName><ForeName>Wibke E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Institut für Pharmazeutische Chemie, Zentrum für Tumor, und Immunbiologie, Philipps-Universität Marburg, Hans-Meerwein-Straße 3, 35032 Marburg, Germany; Zentrum für Tumor, und Immunbiologie, Core Facility Medicinal Chemistry, Philipps-Universität Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Culmsee</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut für Pharmakologie und Klinische Pharmazie, Biochemisch-Pharmakologisches Centrum Marburg, Philipps-Universität Marburg, Karl-von-Frisch-Straße 1, 35032 Marburg, Germany; Marburg Center for Mind, Brain and Behavior - MCMBB, Hans-Meerwein-Straße 6, 35032 Marburg, Germany. Electronic address: culmsee@staff.uni-marburg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Free Radic Biol Med</MedlineTA><NlmUniqueID>8709159</NlmUniqueID><ISSNLinking>0891-5849</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BID</Keyword><Keyword MajorTopicYN="N">Ferroptosis</Keyword><Keyword MajorTopicYN="N">GPX4</Keyword><Keyword MajorTopicYN="N">HT22 cells</Keyword><Keyword MajorTopicYN="N">Mitoquinone</Keyword><Keyword MajorTopicYN="N">RSL3</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29378335</ArticleId><ArticleId IdType="pii">S0891-5849(18)30029-7</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.01.019</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29378321</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1635</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Progress in retinal and eye research</Title><ISOAbbreviation>Prog Retin Eye Res</ISOAbbreviation></Journal><ArticleTitle>Personalised genome editing - The future for corneal dystrophies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1350-9462(17)30101-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.preteyeres.2018.01.004</ELocationID><Abstract><AbstractText>The potential of personalised genome editing reaching the clinic has come to light due to advancements in the field of gene editing, namely the development of CRISPR/Cas9. The different mechanisms of repair used to resolve the double strand breaks (DSBs) mediated by Cas9 allow targeting of a wide range of disease causing mutations. Collectively, the corneal dystrophies offer an ideal platform for personalised genome editing; the majority of corneal dystrophies are monogenic, highly penetrant diseases with a known pattern of inheritance. This genetic background coupled with the accessibility, ease of visualisation and immune privilege status of the cornea make a gene editing strategy for the treatment of corneal dystrophies an attractive option. Off-target cleavage is a major concern for the therapeutic use of CRISPR/Cas9, thus current efforts in the gene editing field are focused on improving the genome-wide specificity of Cas9 to minimise the risk of off-target events. In addition, the delivery of CRISPR/Cas9 to different tissues is a key focus; various viral and non-viral platforms are being explored to develop a vehicle that is highly efficient, specific and non-toxic. The rapid pace and enthusiasm with which CRISPR/Cas9 has taken over biomedical research has ensured the personalised medicine revolution has been realised. CRISPR/Cas9 has recently been utilised in the first wave of clinical trials, and the potential for a genome editing therapy to treat corneal dystrophies looks promising. This review will discuss the current status of therapeutic gene editing in relation to the corneal dystrophies.</AbstractText><CopyrightInformation>Copyright © 2018. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>C B Tara</ForeName><Initials>CBT</Initials><AffiliationInfo><Affiliation>Biomedical Sciences Research Institute, Ulster University, Coleraine, Northern Ireland, BT52 1SA, UK; Avellino Laboratories, Menlo Park, CA 94025, USA. Electronic address: t.moore@ulster.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christie</LastName><ForeName>Kathleen A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Biomedical Sciences Research Institute, Ulster University, Coleraine, Northern Ireland, BT52 1SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Genetics University College London (UCL) Institute of Ophthalmology, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nesbit</LastName><ForeName>M Andrew</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Biomedical Sciences Research Institute, Ulster University, Coleraine, Northern Ireland, BT52 1SA, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Prog Retin Eye Res</MedlineTA><NlmUniqueID>9431859</NlmUniqueID><ISSNLinking>1350-9462</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Corneal dystrophies</Keyword><Keyword MajorTopicYN="N">Genome editing</Keyword><Keyword MajorTopicYN="N">Personalised medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29378321</ArticleId><ArticleId IdType="pii">S1350-9462(17)30101-5</ArticleId><ArticleId IdType="doi">10.1016/j.preteyeres.2018.01.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29378238</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7980</ISSN><JournalIssue CitedMedium="Internet"><Volume>419</Volume><PubDate><Year>2018</Year><Month>Apr</Month><Day>10</Day></PubDate></JournalIssue><Title>Cancer letters</Title><ISOAbbreviation>Cancer Lett.</ISOAbbreviation></Journal><ArticleTitle>Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma.</ArticleTitle><Pagination><MedlinePgn>280-290</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0304-3835(18)30089-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canlet.2018.01.056</ELocationID><Abstract><AbstractText>Mutations in ATRX constitute the most prevalent genetic abnormalities in gliomas. The presence of ATRX mutations in glioma serves as a marker of better prognosis with longer patient survival although the underlying mechanisms are poorly understood. In the present study, we found that ATRX biological function was significantly involved in DNA replication and repair. CRISPR/Cas9-mediated genetic inactivation of ATRX induced inhibition of cell proliferation, invasion and vasculogenic mimicry. In addition, temozolomide (TMZ) treatment induced greater DNA damage and apoptotic changes in ATRX knockout glioma cells. Moreover, we confirmed that ATRX knockout resulted in a failure to trigger ATM phosphorylation and finally restrained the activation of downstream proteins of the ATM pathway. The ATM-associated DNA repair pathway was extensively compromised in ATRX knockout cells owing to decreased histone H3K9me3 availability. Public databases also showed that patients with low ATRX expression exhibited preferable overall survival and profited more from TMZ treatment. These data suggest that ATRX is involved in DNA damage repair by regulating the ATM pathway and might serve as a prognostic maker in predicting TMZ chemosensitivity.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Jinquan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China; Neuroscience Institute, Heilongjiang Academy of Medical Sciences, Harbin 150086, China. Electronic address: caijinquan666777@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Weida</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Xiangqi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Laboratory Diagnosis, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Chunbin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ruijia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinislam</LastName><ForeName>Magafurov</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Chunsheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China; Department of Neurosurgery, Tianjin Medical University General Hospital, Lab of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin, 300052, China. Electronic address: kang97061@tmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Chuanlu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China; Neuroscience Institute, Heilongjiang Academy of Medical Sciences, Harbin 150086, China. Electronic address: jcl6688@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Cancer Lett</MedlineTA><NlmUniqueID>7600053</NlmUniqueID><ISSNLinking>0304-3835</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATM</Keyword><Keyword MajorTopicYN="N">ATRX</Keyword><Keyword MajorTopicYN="N">Chemoresistance</Keyword><Keyword MajorTopicYN="N">DNA damage repair</Keyword><Keyword MajorTopicYN="N">Glioblastoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29378238</ArticleId><ArticleId IdType="pii">S0304-3835(18)30089-2</ArticleId><ArticleId IdType="doi">10.1016/j.canlet.2018.01.056</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29377933</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Tailor-made gene silencing of Staphylococcus aureus clinical isolates by CRISPR interference.</ArticleTitle><Pagination><MedlinePgn>e0185987</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0185987</ELocationID><Abstract><AbstractText>Preparing the genetically modified organisms have required much time and labor, making it the rate-limiting step but CRISPR/Cas9 technology appearance has changed this difficulty. Although reports on CRISPR/Cas9 technology such as genome editing and CRISPR interference (CRISPRi) in eukaryotes increased, those in prokaryotes especially in Staphylococci were limited. Thus, its potential in the bacteriology remains unexplored. This is attributed to ecological difference between eukaryotes and prokaryotes. Here, we constructed a novel CRISPRi plasmid vector, pBACi for Staphylococcus aureus. The transformation efficiency of S. aureus was ~104 CFU/μg DNA using a vector extracted from dcm negative, which encoded one of DNA modification genes, E. coli. Further, pBACi was introduced into various clinical isolates including that not accepting the conventional temperature-sensitive vector. dcas9 in the vector was expressed throughout the growth phases of S. aureus and this vector decreased various gene mRNA expressions based on the crRNA targeting sequences and altered the knockdown strains' phenotypes. The targeted genes included various virulence and antibiotic resistant genes. Bioinformatics suggest this vector can be introduced into wide range of low-GC Gram-positive bacteria. Because this new CRISPR/Cas9-based vector can easily prepare knockdown strains, we believe the novel vector will facilitate the characterization of the function of genes from S. aureus and other Gram-positive bacteria.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sato'o</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Bacteriology, Hiroshima University, Graduate school of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hisatsune</LastName><ForeName>Junzo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Bacteriology, Hiroshima University, Graduate school of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Liansheng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Bacteriology, Hiroshima University, Graduate school of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakuma</LastName><ForeName>Tetsushi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Mathematical and Life Sciences, Hiroshima University, Graduate School of Science, Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Mathematical and Life Sciences, Hiroshima University, Graduate School of Science, Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugai</LastName><ForeName>Motoyuki</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9252-7739</Identifier><AffiliationInfo><Affiliation>Department of Bacteriology, Hiroshima University, Graduate school of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017394">RNA, Guide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Innate Immun. 2012;4(2):141-8</RefSource><PMID Version="1">22222316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Mar;31(3):233-9</RefSource><PMID Version="1">23360965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2014 Jan;12(1):49-62</RefSource><PMID Version="1">24336184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Feb 25;6:6267</RefSource><PMID Version="1">25711368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Microbiol Methods. 2015 Feb;109:25-30</RefSource><PMID Version="1">25477024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Cell Infect Microbiol. 2012 Mar 26;2:38</RefSource><PMID Version="1">23061050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2015 Apr;83(4):1598-609</RefSource><PMID Version="1">25644005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):E1647-56</RefSource><PMID Version="1">22645353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Jul;39(13):5597-610</RefSource><PMID Version="1">21421560</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2005 Nov;62(22):2617-33</RefSource><PMID Version="1">16143832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2007 Nov;5(11):852-61</RefSource><PMID Version="1">17938628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nihon Saikingaku Zasshi. 1975 Nov;30(6):683-92</RefSource><PMID Version="1">1240325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):75-86</RefSource><PMID Version="1">17449137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Syst Biol. 2017 May 10;13(5):931</RefSource><PMID Version="1">28490437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2003 Jan;71(1):567-70</RefSource><PMID Version="1">12496213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 2012 Apr;20(4):192-8</RefSource><PMID Version="1">22386364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 1997 Jan;65(1):179-84</RefSource><PMID Version="1">8975909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2002 Mar;43(6):1367-78</RefSource><PMID Version="1">11952892</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Funct Integr Genomics. 2006 Jul;6(3):186-201</RefSource><PMID Version="1">16453141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2014 Jul;52(7):2637-40</RefSource><PMID Version="1">24759723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 1993 Mar;94(3):313-28</RefSource><PMID Version="1">8452155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plasmid. 2006 Jan;55(1):58-63</RefSource><PMID Version="1">16051359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2006 Jan;188(2):669-76</RefSource><PMID Version="1">16385056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Rev. 2012 Jul;36(4):815-36</RefSource><PMID Version="1">22091892</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathog Dis. 2014 Oct;72(1):19-23</RefSource><PMID Version="1">24700815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jun 2;165(6):1493-1506</RefSource><PMID Version="1">27238023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Resist Updat. 1998;1(2):135-50</RefSource><PMID Version="1">16904400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jan 8;327(5962):167-70</RefSource><PMID Version="1">20056882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2016 Aug 15;82(17 ):5421-7</RefSource><PMID Version="1">27342565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2017 Jan 31;8(1):</RefSource><PMID Version="1">28143981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2180-96</RefSource><PMID Version="1">24136345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Nov;81(22):7782-90</RefSource><PMID Version="1">26341202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiology. 2013 Mar;159(Pt 3):421-35</RefSource><PMID Version="1">23378573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Infect Control. 2006 Jun;34(5 Suppl 1):S3-10; discussion S64-73</RefSource><PMID Version="1">16813980</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxins (Basel). 2010 Jul;2(7):1751-73</RefSource><PMID Version="1">22069659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11954-8</RefSource><PMID Version="1">20547849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Sep 21;293(5538):2266-9</RefSource><PMID Version="1">11567142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jul 18;154(2):442-51</RefSource><PMID Version="1">23849981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Oct 23;159(3):647-61</RefSource><PMID Version="1">25307932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Cell Infect Microbiol. 2012 Apr 12;2:49</RefSource><PMID Version="1">22919640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Med Microbiol. 2013 Aug;303(6-7):324-30</RefSource><PMID Version="1">23517691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Lett. 2013 Feb;150(1-2):12-22</RefSource><PMID Version="1">23376548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Med Microbiol. 2014 Mar;304(2):103-9</RefSource><PMID Version="1">24439196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Mar 25;10(3):e0119487</RefSource><PMID Version="1">25807379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Feb 28;152(5):1173-83</RefSource><PMID Version="1">23452860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Aug;41(15):7429-37</RefSource><PMID Version="1">23761437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2012 Mar 20;3(2):null</RefSource><PMID Version="1">22434850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1998 Aug 20;339(8):520-32</RefSource><PMID Version="1">9709046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Syst. 2015 Jul 29;1(1):62-71</RefSource><PMID Version="1">26918244</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064112" MajorTopicYN="N">Clustered Regularly Interspaced Short Palindromic Repeats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020868" MajorTopicYN="N">Gene Silencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016680" MajorTopicYN="N">Genome, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017394" MajorTopicYN="N">RNA, Guide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>09</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29377933</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0185987</ArticleId><ArticleId IdType="pii">PONE-D-17-18547</ArticleId><ArticleId IdType="pmc">PMC5788344</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29377627</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1862-8354</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>Proteomics. Clinical applications</Title><ISOAbbreviation>Proteomics Clin Appl</ISOAbbreviation></Journal><ArticleTitle>Establishment of a CRISPR/Cas9-Mediated Cysltr1 Knockout Mouse Model and iTRAQ-Based Proteomic Analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/prca.201700087</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To clarify the role of Cysteinyl leukotrienes receptor type 1 (CYSLTR1) and find the potential predictors of CYSLTR1 antagonists (leukotriene receptor antagonists [LTRAs]) responsiveness in vivo.</AbstractText><AbstractText Label="EXPERIMENTAL DESIGN" NlmCategory="METHODS">Cysltr1 knockout (KO) mouse model is established by the CRISPR/Cas9 system. The phenotype of Cysltr1 KO mice are tested by western blotting (WB), histological examinations, and experiment of zymosan A-induced peritoneal inflammation. The differentially expressed proteins (DEPs) between the Cysltr1 KO and the wild type (WT) mice lung tissues are analyzed by the iTRAQ-based proteomic technology. WB is used to validate a subset of DEPs. The total nitric oxide (NO) concentration in lung tissues are measured.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Cysltr1 KO mice show the decrease of vascular permeability in comparison with the WT mice. Our quantitative proteomic analysis identified 239 DEPs in total. WB confirms an increased expression of protein kinase C-δ (PKC-δ), while N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH1) and β-Catenin expression are reduced. The total NO concentrations are significantly reduced in lungs from Cysltr1 KO mice.</AbstractText><AbstractText Label="CONCLUSIONS AND CLINICAL RELEVANCE" NlmCategory="CONCLUSIONS">This study not only provides a comprehensive dataset on overall protein changes in Cysltr1 KO mice lung tissues, but also sheds light on interpreting the description of lower vascular permeability in Cysltr1 KO mice.</AbstractText><CopyrightInformation>© 2018 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Interventional Medicine The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Interventional Medicine The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Interventional Radiology, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Interventional Medicine The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Interventional Radiology, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Interventional Medicine The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Interventional Radiology, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Interventional Medicine The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Interventional Radiology, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yaqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Interventional Radiology, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Interventional Medicine The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Interventional Radiology, Sun Yat-sen University, Zhuhai, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Proteomics Clin Appl</MedlineTA><NlmUniqueID>101298608</NlmUniqueID><ISSNLinking>1862-8346</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">cysteinyl leukotrienes receptor</Keyword><Keyword MajorTopicYN="N">iTRAQ</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29377627</ArticleId><ArticleId IdType="doi">10.1002/prca.201700087</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29377615</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1860-7314</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Biotechnology journal</Title><ISOAbbreviation>Biotechnol J</ISOAbbreviation></Journal><ArticleTitle>EasyCloneYALI: CRISPR/Cas9-Based Synthetic Toolbox for Engineering of the Yeast Yarrowia lipolytica.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/biot.201700543</ELocationID><Abstract><AbstractText>The oleaginous yeast Yarrowia lipolytica is an emerging host for production of fatty acid-derived chemicals. To enable rapid iterative metabolic engineering of this yeast, there is a need for well-characterized genetic parts and convenient and reliable methods for their incorporation into yeast. Here, the EasyCloneYALI genetic toolbox, which allows streamlined strain construction with high genome editing efficiencies in Y. lipolytica via the CRISPR/Cas9 technology is presented. The toolbox allows marker-free integration of gene expression vectors into characterized genome sites as well as marker-free deletion of genes with the help of CRISPR/Cas9. Genome editing efficiencies above 80% were achieved with transformation protocols using non-replicating DNA repair fragments (such as DNA oligos). Furthermore, the toolbox includes a set of integrative gene expression vectors with prototrophic markers conferring resistance to hygromycin and nourseothricin.</AbstractText><CopyrightInformation>© 2018 The Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH &amp; Co. KGaA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holkenbrink</LastName><ForeName>Carina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Dam</LastName><ForeName>Marie I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet 220, DK-2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kildegaard</LastName><ForeName>Kanchana R</ForeName><Initials>KR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-9885-380X</Identifier><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet 220, DK-2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beder</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet 220, DK-2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahlin</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet 220, DK-2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doménech Belda</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet 220, DK-2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borodina</LastName><ForeName>Irina</ForeName><Initials>I</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8452-1393</Identifier><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet 220, DK-2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Biotechnol J</MedlineTA><NlmUniqueID>101265833</NlmUniqueID><ISSNLinking>1860-6768</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Yarrowia lipolytica</Keyword><Keyword MajorTopicYN="N">integrative vectors</Keyword><Keyword MajorTopicYN="N">metabolic engineering</Keyword><Keyword MajorTopicYN="N">yeast</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29377615</ArticleId><ArticleId IdType="doi">10.1002/biot.201700543</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29377001</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4469</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature chemical biology</Title><ISOAbbreviation>Nat. Chem. Biol.</ISOAbbreviation></Journal><ArticleTitle>Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.</ArticleTitle><Pagination><MedlinePgn>311-316</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nchembio.2559</ELocationID><Abstract><AbstractText>CRISPR-Cas9 is a versatile RNA-guided genome editing tool. Here we demonstrate that partial replacement of RNA nucleotides with DNA nucleotides in CRISPR RNA (crRNA) enables efficient gene editing in human cells. This strategy of partial DNA replacement retains on-target activity when used with both crRNA and sgRNA, as well as with multiple guide sequences. Partial DNA replacement also works for crRNA of Cpf1, another CRISPR system. We find that partial DNA replacement in the guide sequence significantly reduces off-target genome editing through focused analysis of off-target cleavage, measurement of mismatch tolerance and genome-wide profiling of off-target sites. Using the structure of the Cas9-sgRNA complex as a guide, the majority of the 3' end of crRNA can be replaced with DNA nucleotide, and the 5 - and 3'-DNA-replaced crRNA enables efficient genome editing. Cas9 guided by a DNA-RNA chimera may provide a generalized strategy to reduce both the cost and the off-target genome editing in human cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Chun-Qing</ForeName><Initials>CQ</Initials><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suresh</LastName><ForeName>Sneha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Suet-Yan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiongqiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Junmei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogorad</LastName><ForeName>Roman L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Lihua Julie</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfe</LastName><ForeName>Scot A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koteliansky</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Skolkovo Institute of Science and Technology, Skolkovo, Moscow Region, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Wen</ForeName><Initials>W</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9797-8042</Identifier><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langer</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Daniel G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP2 HL137167</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL131471</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 CA169512</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Chem Biol</MedlineTA><NlmUniqueID>101231976</NlmUniqueID><ISSNLinking>1552-4450</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Chembiochem. 2016 Oct 4;17 (19):1809-1812</RefSource><PMID Version="1">27441384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Aug 5;19(3):405-19</RefSource><PMID Version="1">16061186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1995 Aug 29;34(34):10807-15</RefSource><PMID Version="1">7662660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Feb;33(2):187-197</RefSource><PMID Version="1">25513782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):833-8</RefSource><PMID Version="1">23907171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 13;507(7491):258-261</RefSource><PMID Version="1">24531762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):577-582</RefSource><PMID Version="1">24770324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1998 Jul 1;26(13):3104-10</RefSource><PMID Version="1">9628906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Dec;12(12):1150-6</RefSource><PMID Version="1">26480473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 9;520(7546):186-91</RefSource><PMID Version="1">25830891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Dec 16;42(22):e168</RefSource><PMID Version="1">25300484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Feb;33(2):175-8</RefSource><PMID Version="1">25599175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Mar;34(3):328-33</RefSource><PMID Version="1">26829318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15644-9</RefSource><PMID Version="1">23940360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2011 Aug 07;29(9):816-23</RefSource><PMID Version="1">21822255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2006 Jul;12(7):1197-205</RefSource><PMID Version="1">16682562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2017 Oct 19;550(7676):407-410</RefSource><PMID Version="1">28931002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Feb 27;156(5):935-49</RefSource><PMID Version="1">24529477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):551-3</RefSource><PMID Version="1">24681508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2015 Feb;21(2):121-31</RefSource><PMID Version="1">25654603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Nov;12(11):1051-4</RefSource><PMID Version="1">26344044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Mar;12(3):237-43, 1 p following 243</RefSource><PMID Version="1">25664545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Jan 28;529(7587):490-5</RefSource><PMID Version="1">26735016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Jun;32(6):569-76</RefSource><PMID Version="1">24770325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2009 Jul 2;5(1):97-110</RefSource><PMID Version="1">19540188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Mar;32(3):279-284</RefSource><PMID Version="1">24463574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Feb;33(2):179-86</RefSource><PMID Version="1">25503383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Nov;33(11):1159-61</RefSource><PMID Version="1">26436575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 May 02;6:</RefSource><PMID Version="1">28462777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Jun 26;348(6242):1477-81</RefSource><PMID Version="1">26113724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Aug;11(8):783-784</RefSource><PMID Version="1">25075903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2012 Aug 24;19(8):937-54</RefSource><PMID Version="1">22921062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):E7110-7</RefSource><PMID Version="1">26589814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource><PMID Version="1">23873081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Sep;33(9):985-989</RefSource><PMID Version="1">26121415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):822-6</RefSource><PMID Version="1">23792628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jul 18;154(2):442-51</RefSource><PMID Version="1">23849981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 1;351(6268):84-8</RefSource><PMID Version="1">26628643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2017 May 15;18(1):379</RefSource><PMID Version="1">28506212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2017 Dec;35(12 ):1179-1187</RefSource><PMID Version="1">29131148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Oct 22;163(3):759-71</RefSource><PMID Version="1">26422227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Oct;41(19):e181</RefSource><PMID Version="1">23945932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Org Biomol Chem. 2017 Dec 6;15(47):10029-10036</RefSource><PMID Version="1">29164215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29377001</ArticleId><ArticleId IdType="pii">nchembio.2559</ArticleId><ArticleId IdType="doi">10.1038/nchembio.2559</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29376001</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2222-3959</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>International journal of ophthalmology</Title><ISOAbbreviation>Int J Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders.</ArticleTitle><Pagination><MedlinePgn>117-134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18240/ijo.2018.01.20</ELocationID><Abstract><AbstractText>Past 25y have witnessed an exponential increase in knowledge and understanding of ocular diseases and their respective genetic underpinnings. As a result, scientists have mapped many genes and their variants that can influence vision and health of our eyes. Based on these findings, it is becoming clear that an early diagnosis employing genetic testing can help evaluate patients' conditions for instituting treatment plan(s) and follow-up care to avoid vision complications later. For example, knowing family history becomes crucial for inherited eye diseases as it can benefit members in family who may have similar eye diseases or predispositions. Therefore, gathering information from an elaborate examination along with complete assessment of past medical illness by ophthalmologists followed by consultation with geneticists can help create a roadmap for making diagnosis and treatment precise and beneficial. In this review, we present an update on ocular genomic medicine that we believe has tremendous potential towards unraveling genetic implications in ocular diseases and patients' susceptibilities. We also discuss translational aspects of genetic ophthalmology and genome engineering that may help advance molecular diagnostics and therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Mahavir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Eye and Vision Science Laboratory, Department of Physiology, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyagi</LastName><ForeName>Suresh C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Eye and Vision Science Laboratory, Department of Physiology, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS084823</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Int J Ophthalmol</MedlineTA><NlmUniqueID>101553860</NlmUniqueID><ISSNLinking>2222-3959</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2007 Oct;48(10 ):4421-5</RefSource><PMID Version="1">17898260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diagn Pathol. 2014 Jan 31;9:25</RefSource><PMID Version="1">24484584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2015 Nov 01;8(11):13928-44</RefSource><PMID Version="1">26823705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2009 May 20;15:1028-35</RefSource><PMID Version="1">19471602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2005 Apr 15;308(5720):419-21</RefSource><PMID Version="1">15761120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Melanoma Res. 2011 Jun;21(3):175-9</RefSource><PMID Version="1">21412176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2016 Nov;37(11):1223-1230</RefSource><PMID Version="1">27586871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Optom Vis Sci. 2009 Jan;86(1):E8-E22</RefSource><PMID Version="1">19104467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Jun 2;435(7042):646-51</RefSource><PMID Version="1">15806097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Isr Med Assoc J. 2008 Mar;10 (3):179-81</RefSource><PMID Version="1">18494227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2010 Mar;127(5):595-602</RefSource><PMID Version="1">20182747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2015 Aug 24;:null</RefSource><PMID Version="1">26322848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Res Notes. 2016 Feb 11;9:83</RefSource><PMID Version="1">26867756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2012 May 31;53(6):3175-82</RefSource><PMID Version="1">22491416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2005 Apr 15;308(5720):421-4</RefSource><PMID Version="1">15761121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genomics. 2014 Nov 18;8:19</RefSource><PMID Version="1">25403472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BBA Clin. 2016 Nov 11;7:1-7</RefSource><PMID Version="1">27904835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3777-82</RefSource><PMID Version="1">16936086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2010 Sep;120(9):3064-72</RefSource><PMID Version="1">20811162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Nov;39(21):9283-93</RefSource><PMID Version="1">21813459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2012 Dec;119(12):2526-36</RefSource><PMID Version="1">23009893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2016 Dec 02;22:1352-1360</RefSource><PMID Version="1">27994434</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2009;15:584-91</RefSource><PMID Version="1">19365591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genomics. 2012 Aug 31;6:13</RefSource><PMID Version="1">23244519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Aug 08;6:31191</RefSource><PMID Version="1">27499155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4579-88</RefSource><PMID Version="1">17003455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med Genomics. 2016 Mar 22;9:15</RefSource><PMID Version="1">27001270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genomics. 2016 Jun 21;10 (1):23</RefSource><PMID Version="1">27329102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Exp Med Biol. 2016;854:193-200</RefSource><PMID Version="1">26427411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jun 24;6:28639</RefSource><PMID Version="1">27338780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med Rep. 2016 Jul;14 (1):151-8</RefSource><PMID Version="1">27175573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2014 Apr;121(4):911-6</RefSource><PMID Version="1">24393350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2005 Apr 15;308(5720):385-9</RefSource><PMID Version="1">15761122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2006 Nov 10;314(5801):992-3</RefSource><PMID Version="1">17053109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2005 Mar 22;64(6):966-72</RefSource><PMID Version="1">15781809</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Aug 04;9(8):e104000</RefSource><PMID Version="1">25090642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2013 Jul;112:102-5</RefSource><PMID Version="1">23644223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2010 Dec 2;363(23 ):2191-9</RefSource><PMID Version="1">21083380</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Klin Monbl Augenheilkd. 2013 Jul;230(7):686-91</RefSource><PMID Version="1">23877823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):915-24</RefSource><PMID Version="1">25947639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Ophthalmol. 2003 Jan;87(1):48-53</RefSource><PMID Version="1">12488262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4989-95</RefSource><PMID Version="1">20484597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Ophthalmol. 2008 Oct;92(10):1333-6</RefSource><PMID Version="1">18653586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet A. 2015 Jun;167(6):1365-8</RefSource><PMID Version="1">25900864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32</RefSource><PMID Version="1">15870199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Test. 2008 Jun;12 (2):325-30</RefSource><PMID Version="1">18471089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2001 Dec;109(6):584-91</RefSource><PMID Version="1">11810270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Glob Health. 2014 Feb;2(2):e106-16</RefSource><PMID Version="1">25104651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oman J Ophthalmol. 2012 Sep;5(3):144-9</RefSource><PMID Version="1">23439654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2009 Mar;46(3):145-58</RefSource><PMID Version="1">19001017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3500-5</RefSource><PMID Version="1">21421876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4898-905</RefSource><PMID Version="1">20484589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2013 Apr;120(4):837-43</RefSource><PMID Version="1">23260260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2013 Aug;84(2):132-41</RefSource><PMID Version="1">23701314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4476-9</RefSource><PMID Version="1">20435602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet C Semin Med Genet. 2016 Dec;172(4):349-366</RefSource><PMID Version="1">27862925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1378-87</RefSource><PMID Version="1">27010695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Transl Oncol. 2008 Mar;10(3):137-42</RefSource><PMID Version="1">18321815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Ophthalmol. 2015 Feb;63(2):93-102</RefSource><PMID Version="1">25827538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2011 Dec 1;20(23):4707-13</RefSource><PMID Version="1">21873608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2010 Mar 19;16:467-75</RefSource><PMID Version="1">20309403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Retin Eye Res. 2011 Mar;30(2):81-114</RefSource><PMID Version="1">21112411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2016 Jun;48(6):640-7</RefSource><PMID Version="1">27089177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Med. 2015 Apr;17(4):300-6</RefSource><PMID Version="1">25741866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Mar 24;5:9424</RefSource><PMID Version="1">25800435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2017 Feb;136(2):205-225</RefSource><PMID Version="1">27878435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2012;18:1918-26</RefSource><PMID Version="1">22876116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Genomics. 2011 Jun;12(4):260-6</RefSource><PMID Version="1">22131871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Invest Med. 2010 Feb 01;33(1):E14-21</RefSource><PMID Version="1">20144264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(5):e33673</RefSource><PMID Version="1">22693542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 14;9(3):e91962</RefSource><PMID Version="1">24632595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2013 Mar 21;54(3):2076-86</RefSource><PMID Version="1">23422819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fam Cancer. 2010 Dec;9(4):663-7</RefSource><PMID Version="1">20842456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2015 Dec 01;8(12 ):16036-45</RefSource><PMID Version="1">26884880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2014 Jan 25;534(2):218-21</RefSource><PMID Version="1">24211322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Retina Vitreous. 2016 Feb 1;2:4</RefSource><PMID Version="1">27847622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2014 Jun 06;55(7):4455-60</RefSource><PMID Version="1">24906858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Thromb Haemost. 2015 Oct;114(4):748-56</RefSource><PMID Version="1">26063524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2012;18:816-29</RefSource><PMID Version="1">22509112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Ophthalmol. 2016 Jul;64(7):508-12</RefSource><PMID Version="1">27609163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Dec 5;13(6):659-62</RefSource><PMID Version="1">24315440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1459-63</RefSource><PMID Version="1">18385063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 2011 Feb;36(2):154-67</RefSource><PMID Version="1">21281067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asia Pac J Ophthalmol (Phila). 2016 Jul-Aug;5(4):236-44</RefSource><PMID Version="1">27488065</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2013 Apr 11;19:835-44</RefSource><PMID Version="1">23592921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Hum Genet. 2010 May;74(3):195-201</RefSource><PMID Version="1">20374233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2014 Sep 19;20:1281-95</RefSource><PMID Version="1">25352737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2015 May 7;96(5):816-25</RefSource><PMID Version="1">25865493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oman J Ophthalmol. 2009 Sep;2(3):108-10</RefSource><PMID Version="1">20927205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2011 Nov;93(5):720-5</RefSource><PMID Version="1">21945171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Ophthalmol. 2017 May;28(3):252-259</RefSource><PMID Version="1">28141764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2012 Oct 15;21(R1):R111-24</RefSource><PMID Version="1">22843501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med Genet A. 2009 May;149A(5):854-60</RefSource><PMID Version="1">19353630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2009 Apr;17 (4):491-501</RefSource><PMID Version="1">19002209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asia Pac J Ophthalmol (Phila). 2016 Jul-Aug;5(4):225-6</RefSource><PMID Version="1">27488062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Apr 15;9(4):e94165</RefSource><PMID Version="1">24736606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2011 Feb;118(2):396-401</RefSource><PMID Version="1">20869116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2013 Nov;21(11):1266-71</RefSource><PMID Version="1">23443024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2015 Dec;23 (12 ):1627-33</RefSource><PMID Version="1">25804400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2012 Jun;119(6):1199-210</RefSource><PMID Version="1">22449572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 2009 Jan;123(1):391-8</RefSource><PMID Version="1">19117906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Syndromol. 2016 May;7(2):87-92</RefSource><PMID Version="1">27385965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIMS Mol Sci. 2016;3(2):196-221</RefSource><PMID Version="1">27239555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2014 Sep 23;111(7):1373-80</RefSource><PMID Version="1">25058347</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2012 Jul;100:26-31</RefSource><PMID Version="1">22569040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Ophthalmol. 2016 May;64(5):364-8</RefSource><PMID Version="1">27380975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmic Genet. 2017 Jul-Aug;38(4):314-319</RefSource><PMID Version="1">27668351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2016 Jan;135(1):9-19</RefSource><PMID Version="1">26527198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Ophthalmol. 2016;57:1-14</RefSource><PMID Version="1">27043388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Genomics. 2016 Dec 1;48(12 ):922-927</RefSource><PMID Version="1">27764769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surv Ophthalmol. 2010 Nov-Dec;55(6):501-15</RefSource><PMID Version="1">20850857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>QJM. 2016 Nov;109 (11):731-735</RefSource><PMID Version="1">27081207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jun 26;9(6):e100455</RefSource><PMID Version="1">24968223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Mar 30;5:9497</RefSource><PMID Version="1">25820866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2016 Feb;48(2):134-43</RefSource><PMID Version="1">26691988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5559-64</RefSource><PMID Version="1">21659309</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Ophthalmol. 2013 Sep-Nov;28(5-6):361-71</RefSource><PMID Version="1">24010756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jul 06;10(7):e0131471</RefSource><PMID Version="1">26147294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Retin Eye Res. 2010 Jan;29(1):19-29</RefSource><PMID Version="1">19854291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2014 Mar;22(3):344-9</RefSource><PMID Version="1">23942204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2013 Oct 15;22(R1):R59-65</RefSource><PMID Version="1">23962718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eye (Lond). 2009 Jan;23(1):222-9</RefSource><PMID Version="1">18535602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jan 27;6:19969</RefSource><PMID Version="1">26814166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2012;18:2119-26</RefSource><PMID Version="1">22876139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2014 Dec 18;56(2):1261-6</RefSource><PMID Version="1">25525169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1557-65</RefSource><PMID Version="1">22328638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuroradiol. 2017 Jun;27(2):213-220</RefSource><PMID Version="1">26478204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2011 Dec;48(12 ):856-9</RefSource><PMID Version="1">21941004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Sep 24;10 (9):e0137973</RefSource><PMID Version="1">26402864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2012 Jun;33(6):963-72</RefSource><PMID Version="1">22334370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hum Genet. 2016 Nov;61(11):951-958</RefSource><PMID Version="1">27383656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 May 06;10(5):e0126679</RefSource><PMID Version="1">25946197</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Med Genet. 2016 Sep;59(9):488-91</RefSource><PMID Version="1">27456987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2012;18:634-44</RefSource><PMID Version="1">22509095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2014 Nov 12;4:7018</RefSource><PMID Version="1">25388911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2017 Feb 1;25(2):331-341</RefSource><PMID Version="1">28109959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Ophthalmol. 2011 Jun;31(3):227-32</RefSource><PMID Version="1">21626167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eye (Lond). 2013 Feb;27(2):230-42</RefSource><PMID Version="1">23222563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eye (Lond). 2009 Mar;23(3):519-21</RefSource><PMID Version="1">19218993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2001 Jun 15;10(13):1369-78</RefSource><PMID Version="1">11440989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Ophthalmol. 2012 Jul-Aug;22(4):667-9</RefSource><PMID Version="1">22034023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Ophthalmol. 2013 Apr 1;8(2):127-140</RefSource><PMID Version="1">24860613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2015 Sep;122(9):1854-65</RefSource><PMID Version="1">26081444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Korean J Pediatr. 2012 Jan;55(1):18-23</RefSource><PMID Version="1">22359526</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9 precision medicine</Keyword><Keyword MajorTopicYN="N">genetic ophthalmology</Keyword><Keyword MajorTopicYN="N">genome engineering</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">single nucleotide polymorphism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29376001</ArticleId><ArticleId IdType="doi">10.18240/ijo.2018.01.20</ArticleId><ArticleId IdType="pii">ijo-11-01-117</ArticleId><ArticleId IdType="pmc">PMC5767668</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29375513</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>High Hydrostatic Pressure Inducible Trimethylamine<i>N</i>-Oxide Reductase Improves the Pressure Tolerance of Piezosensitive Bacteria<i>Vibrio fluvialis</i>.</ArticleTitle><Pagination><MedlinePgn>2646</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2017.02646</ELocationID><Abstract><AbstractText>High hydrostatic pressure (HHP) exerts severe effects on cellular processes including impaired cell division, abolished motility and affected enzymatic activities. Transcriptomic and proteomic analyses showed that bacteria switch the expression of genes involved in multiple energy metabolism pathways to cope with HHP. We sought evidence of a changing bacterial metabolism by supplying appropriate substrates that might have beneficial effects on the bacterial lifestyle at elevated pressure. We isolated a piezosensitive marine bacterium<i>Vibrio fluvialis</i>strain QY27 from the South China Sea. When trimethylamine<i>N</i>-oxide (TMAO) was used as an electron acceptor for energy metabolism, QY27 exhibited a piezophilic-like phenotype with an optimal growth at 30 MPa. Raman spectrometry and biochemistry analyses revealed that both the efficiency of the TMAO metabolism and the activity of the TMAO reductase increased under high pressure conditions. Among the two genes coding for TMAO reductase catalytic subunits, the expression level and enzymatic activity of TorA was up-regulated by elevated pressure. Furthermore, a genetic interference assay with the CRISPR-dCas9 system demonstrated that TorA is essential for underpinning the improved pressure tolerance of QY27. We extended the study to<i>Vibrio fluvialis</i>type strain ATCC33809 and observed the same phenotype of TMAO-metabolism improved the pressure tolerance. These results provide compelling evidence for the determinant role of metabolism in the adaption of bacteria to the deep-sea ecosystems with HHP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Qun-Jian</ForeName><Initials>QJ</Initials><AffiliationInfo><Affiliation>Laboratory of Deep-sea Microbial Cell Biology, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Associated Laboratory of Evolution and Development of Magnetotactic Multicellular Organisms, CNRS-Marseille/CAS, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei-Jia</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Laboratory of Deep-sea Microbial Cell Biology, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Associated Laboratory of Evolution and Development of Magnetotactic Multicellular Organisms, CNRS-Marseille/CAS, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CAS Key Laboratory for Experimental Study under Deep-sea Extreme Conditions, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Xiao-Qing</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Laboratory of Deep-sea Microbial Cell Biology, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Associated Laboratory of Evolution and Development of Magnetotactic Multicellular Organisms, CNRS-Marseille/CAS, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Sheng-Da</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Laboratory of Deep-sea Microbial Cell Biology, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Deep-sea Microbial Cell Biology, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xue-Gong</ForeName><Initials>XG</Initials><AffiliationInfo><Affiliation>Laboratory of Deep-sea Microbial Cell Biology, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Associated Laboratory of Evolution and Development of Magnetotactic Multicellular Organisms, CNRS-Marseille/CAS, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CAS Key Laboratory for Experimental Study under Deep-sea Extreme Conditions, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory for Experimental Study under Deep-sea Extreme Conditions, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santini</LastName><ForeName>Claire-Lise</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>International Associated Laboratory of Evolution and Development of Magnetotactic Multicellular Organisms, CNRS-Marseille/CAS, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LCB UMR 7283, CNRS-Marseille, Aix-Marseille Université, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Engineering Laboratory of Engineering Department, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>I-Ming</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory for Experimental Study under Deep-sea Extreme Conditions, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Experimental Study under Deep-sea Extreme Conditions, Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Long-Fei</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>International Associated Laboratory of Evolution and Development of Magnetotactic Multicellular Organisms, CNRS-Marseille/CAS, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LCB UMR 7283, CNRS-Marseille, Aix-Marseille Université, Marseille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1998 Jan 2;17(1):101-12</RefSource><PMID Version="1">9427745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2008 Sep;190(17):5814-23</RefSource><PMID Version="1">18606737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Extremophiles. 1998 Jan;2(1):1-7</RefSource><PMID Version="1">9676237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 12;9(9):e106831</RefSource><PMID Version="1">25215865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jun 20;8(6):e66580</RefSource><PMID Version="1">23818946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biosci Biotechnol Biochem. 2012;76(8):1506-10</RefSource><PMID Version="1">22878211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Res Microbiol. 2010 Dec;161(10):799-809</RefSource><PMID Version="1">21035541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2005 Mar 4;307(5714):1459-61</RefSource><PMID Version="1">15746425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Bacteriol. 1981 Feb;50(1):73-94</RefSource><PMID Version="1">6971864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 1999 Nov;7(11):447-53</RefSource><PMID Version="1">10542424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 May 06;8(5):e63139</RefSource><PMID Version="1">23671663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Extremophiles. 1998 Aug;2(3):149-54</RefSource><PMID Version="1">9783159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 1995 Sep;17(5):971-80</RefSource><PMID Version="1">8596446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biophys J. 1997 Aug;73(2):994-1000</RefSource><PMID Version="1">9251816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2001 Apr;183(8):2691-5</RefSource><PMID Version="1">11274133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Extremophiles. 2002 Apr;6(2):89-95</RefSource><PMID Version="1">12013439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2001 Mar 9;1546(1):164-70</RefSource><PMID Version="1">11257519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1984 Dec;160(3):1181-3</RefSource><PMID Version="1">6501229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Extremophiles. 2005 Feb;9(1):65-73</RefSource><PMID Version="1">15340867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Extremophiles. 2016 May;20(3):301-10</RefSource><PMID Version="1">27039108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2015 Mar;9(3):760-9</RefSource><PMID Version="1">25148480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mar Biotechnol (NY). 2009 Nov-Dec;11(6):710-6</RefSource><PMID Version="1">19255806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1982 Sep 24;217(4566):1214-22</RefSource><PMID Version="1">7112124</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2710-5</RefSource><PMID Version="1">24550299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 1998 Mar;27(5):977-85</RefSource><PMID Version="1">9535087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2012 Oct 29;13:567</RefSource><PMID Version="1">23107454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biosci Biotechnol Biochem. 2013;77(7):1522-8</RefSource><PMID Version="1">23832349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2004 Jul;186(14):4502-9</RefSource><PMID Version="1">15231782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1998 Nov 27;284(2):421-33</RefSource><PMID Version="1">9813127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008 Apr 09;3(4):e1937</RefSource><PMID Version="1">18398463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Microb Physiol. 2005;50:147-98</RefSource><PMID Version="1">16221580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2000 Feb;182(4):961-6</RefSource><PMID Version="1">10648521</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Res Microbiol. 2008 Sep-Oct;159(7-8):530-6</RefSource><PMID Version="1">18639631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Biol. 2002 Feb;205(Pt 3):297-306</RefSource><PMID Version="1">11854367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Syst Evol Microbiol. 2012 Mar;62(Pt 3):716-21</RefSource><PMID Version="1">22140171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Microbiol. 1985;39:131-49</RefSource><PMID Version="1">3904597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2016 Sep 07;7:1418</RefSource><PMID Version="1">27656177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2002 Feb 20;124(7):1192-202</RefSource><PMID Version="1">11841287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 May 31;8(5):e60897</RefSource><PMID Version="1">23741291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol. 2000 Aug;2(4):399-406</RefSource><PMID Version="1">11234928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2005 Sep 14;6:122</RefSource><PMID Version="1">16162277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Channels (Austin). 2012 Jul-Aug;6(4):262-71</RefSource><PMID Version="1">22790324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Dec 15;281(50):38189-99</RefSource><PMID Version="1">17040909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Apr 22;280(16):15644-8</RefSource><PMID Version="1">15723832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biosyst. 2010 Jul;6(7):1216-26</RefSource><PMID Version="1">20458400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2001 Mar;183(5):1688-93</RefSource><PMID Version="1">11160100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mar Genomics. 2016 Dec;30:87-91</RefSource><PMID Version="1">27720170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2012 May;30(5):440-6</RefSource><PMID Version="1">22544021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4461-5</RefSource><PMID Version="1">24591588</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPRi</Keyword><Keyword MajorTopicYN="N">Raman spectrometry</Keyword><Keyword MajorTopicYN="N">Vibrio fluvialis</Keyword><Keyword MajorTopicYN="N">high hydrostatic pressure (HHP)</Keyword><Keyword MajorTopicYN="N">pressure tolerance</Keyword><Keyword MajorTopicYN="N">trimethylamine N-oxide (TMAO)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29375513</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2017.02646</ArticleId><ArticleId IdType="pmc">PMC5767261</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29375506</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Genomic Analysis of Two Phylogenetically Distinct<i>Nitrospira</i>Species Reveals Their Genomic Plasticity and Functional Diversity.</ArticleTitle><Pagination><MedlinePgn>2637</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2017.02637</ELocationID><Abstract><AbstractText>The genus<i>Nitrospira</i>represents a dominant group of nitrite-oxidizing bacteria in natural and engineered ecosystems. This genus is phylogenetically divided into six lineages, for which vast phylogenetic and functional diversity has been revealed by recent molecular ecophysiological analyses. However, the genetic basis underlying these phenotypic differences remains largely unknown because of the lack of genome sequences representing their diversity. To gain a more comprehensive understanding of<i>Nitrospira</i>, we performed genomic comparisons between two<i>Nitrospira</i>strains (ND1 and NJ1 belonging to lineages I and II, respectively) previously isolated from activated sludge. In addition, the genomes of these strains were systematically compared with previously reported six<i>Nitrospira</i>genomes to reveal their similarity and presence/absence of several functional genes/operons. Comparisons of<i>Nitrospira</i>genomes indicated that their genomic diversity reflects phenotypic differences and versatile nitrogen metabolisms. Although most genes involved in key metabolic pathways were conserved between strains ND1 and NJ1, assimilatory nitrite reduction pathways of the two<i>Nitrospira</i>strains were different. In addition, the genomes of both strains contain a phylogenetically different urease locus and we confirmed their ureolytic activity. During gene annotation of strain NJ1, we found a gene cluster encoding a quorum-sensing system. From the enriched supernatant of strain NJ1, we successfully identified seven types of acyl-homoserine lactones with a range of C10-C14. In addition, the genome of strain NJ1 lacks genes relevant to flagella and the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas (CRISPR-associated genes) systems, whereas most nitrifying bacteria including strain ND1 possess these genomic elements. These findings enhance our understanding of genomic plasticity and functional diversity among members of the genus<i>Nitrospira</i>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ushiki</LastName><ForeName>Norisuke</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujitani</LastName><ForeName>Hirotsugu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morohoshi</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Material and Environmental Chemistry, Graduate School of Engineering, Utsunomiya University, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekiguchi</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Bio-Measurement Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuneda</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2016 Sep;100(18):8225-37</RefSource><PMID Version="1">27287850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Rev. 2002 Aug;26(3):285-309</RefSource><PMID Version="1">12165429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Jan;81(2):745-53</RefSource><PMID Version="1">25398863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PeerJ. 2015 Jan 27;3:e740</RefSource><PMID Version="1">25650158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Cell Dev Biol. 2005;21:319-46</RefSource><PMID Version="1">16212498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Dec 24;528(7583):504-9</RefSource><PMID Version="1">26610024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Ecol. 2005 Oct 1;54(2):297-306</RefSource><PMID Version="1">16332328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2015 Sep 1;81(17):5917-26</RefSource><PMID Version="1">26092466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Water Sci Technol. 2006;54(1):21-7</RefSource><PMID Version="1">16898133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2001 Nov;67(11):5273-84</RefSource><PMID Version="1">11679356</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2002 Aug;45(4):1165-74</RefSource><PMID Version="1">12180933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2008 May;74(9):2852-63</RefSource><PMID Version="1">18326675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 1995 Dec;63(12):4868-76</RefSource><PMID Version="1">7591148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbes Environ. 2013;28(3):346-53</RefSource><PMID Version="1">24005844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol. 2006 Mar;8(3):405-15</RefSource><PMID Version="1">16478447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>mSystems. 2017 Sep 12;2(5):null</RefSource><PMID Version="1">28905001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2003 May;185(9):2759-73</RefSource><PMID Version="1">12700255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13479-84</RefSource><PMID Version="1">20624973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Mol Biol. 1993 Mar;21(6):1201-5</RefSource><PMID Version="1">8490140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1997 Sep;179(17):5574-81</RefSource><PMID Version="1">9287015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Evol. 2013 Dec;30(12):2725-9</RefSource><PMID Version="1">24132122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2015 Mar;9(3):643-55</RefSource><PMID Version="1">25148481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MBio. 2016 Oct 25;7(5):</RefSource><PMID Version="1">27795404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2006 Mar;72(3):2050-63</RefSource><PMID Version="1">16517654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiol Mol Biol Rev. 2015 Mar;79(1):153-69</RefSource><PMID Version="1">25694124</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sensors (Basel). 2016 Aug 02;16(8):</RefSource><PMID Version="1">27490553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2005 Dec;71(12):8323-34</RefSource><PMID Version="1">16332819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1999 Nov;181(21):6573-84</RefSource><PMID Version="1">10542156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Ecol. 2011 Feb;75(2):195-204</RefSource><PMID Version="1">21138449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Astrobiology. 2002 Fall;2(3):255-70</RefSource><PMID Version="1">12530236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Lett. 2008 Feb;279(1):124-30</RefSource><PMID Version="1">18177311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol. 2014 Oct;16(10):3055-71</RefSource><PMID Version="1">24118804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2008 Jun;74(11):3559-72</RefSource><PMID Version="1">18390676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jan;41(Database issue):D636-47</RefSource><PMID Version="1">23193269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Aug 6;524(7563):105-8</RefSource><PMID Version="1">26222031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2003 Nov;50(3):809-24</RefSource><PMID Version="1">14617143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol. 2006 Aug;8(8):1487-95</RefSource><PMID Version="1">16872410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2012 Nov;78(22):8067-74</RefSource><PMID Version="1">22983963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISME J. 2015 Mar;9(3):708-20</RefSource><PMID Version="1">25180967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2005 Aug;71(8):4906-9</RefSource><PMID Version="1">16085894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2014 Feb;80(3):951-8</RefSource><PMID Version="1">24271173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W52-7</RefSource><PMID Version="1">17537822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Microbiol Ecol. 2015 Mar;91(3):null</RefSource><PMID Version="1">25764560</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol. 2014 Oct;16(10):3030-40</RefSource><PMID Version="1">25312601</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11371-6</RefSource><PMID Version="1">26305944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biosci Bioeng. 2013 Nov;116(5):580-4</RefSource><PMID Version="1">23727350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Dec 24;528(7583):555-9</RefSource><PMID Version="1">26610025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sensors (Basel). 2015 Dec 30;16(1):null</RefSource><PMID Version="1">26729121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Extremophiles. 2012 May;16(3):553-66</RefSource><PMID Version="1">22527047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Microbiol. 2003 Sep;5(9):798-803</RefSource><PMID Version="1">12919415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Gen Genet. 1997 Apr 28;254(4):440-8</RefSource><PMID Version="1">9180698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Microbiol. 1995 Jul;164(1):16-23</RefSource><PMID Version="1">7646315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Aug 29;345(6200):1052-4</RefSource><PMID Version="1">25170152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 11;6:22903</RefSource><PMID Version="1">26965192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>mSphere. 2015 Dec 30;1(1):null</RefSource><PMID Version="1">27303675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Biol. 2012 May;19(5):455-77</RefSource><PMID Version="1">22506599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2004 Sep;70(9):5493-502</RefSource><PMID Version="1">15345437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biosci Bioeng. 2017 May;123(5):581-589</RefSource><PMID Version="1">28202306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2008 Nov 24;15(11):1141-7</RefSource><PMID Version="1">19022174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2007 Nov 1;23(21):2947-8</RefSource><PMID Version="1">17846036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2017 Oct 31;83(22):</RefSource><PMID Version="1">28887424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Microbiol. 2013 Feb 21;4:27</RefSource><PMID Version="1">23439773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Microbiol. 2010 Sep;13(3):143-50</RefSource><PMID Version="1">20890848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 2016 Sep;24(9):699-712</RefSource><PMID Version="1">27283264</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nitrospira</Keyword><Keyword MajorTopicYN="N">activated sludge</Keyword><Keyword MajorTopicYN="N">autoinducer</Keyword><Keyword MajorTopicYN="N">genome</Keyword><Keyword MajorTopicYN="N">nitrification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29375506</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2017.02637</ArticleId><ArticleId IdType="pmc">PMC5767232</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29374849</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1436-2236</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Marine biotechnology (New York, N.Y.)</Title><ISOAbbreviation>Mar. Biotechnol.</ISOAbbreviation></Journal><ArticleTitle>Zebrafish Embryonic Slow Muscle Is a Rapid System for Genetic Analysis of Sarcomere Organization by CRISPR/Cas9, but Not NgAgo.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10126-018-9794-8</ELocationID><Abstract><AbstractText>Zebrafish embryonic slow muscle cells, with their superficial localization and clear sarcomere organization, provide a useful model system for genetic analysis of muscle cell differentiation and sarcomere assembly. To develop a quick assay for testing CRISPR-mediated gene editing in slow muscles of zebrafish embryos, we targeted a red fluorescence protein (RFP) reporter gene specifically expressed in slow muscles of myomesin-3-RFP (Myom3-RFP) zebrafish embryos. We demonstrated that microinjection of RFP-sgRNA with Cas9 protein or Cas9 mRNA resulted in a mosaic pattern in loss of RFP expression in slow muscle fibers of the injected zebrafish embryos. To uncover gene functions in sarcomere organization, we targeted two endogenous genes, slow myosin heavy chain-1 (smyhc1) and heat shock protein 90 α1 (hsp90α1), which are specifically expressed in zebrafish muscle cells. We demonstrated that injection of Cas9 protein or mRNA with respective sgRNAs targeted to smyhc1 or hsp90a1 resulted in a mosaic pattern of myosin thick filament disruption in slow myofibers of the injected zebrafish embryos. Moreover, Myom3-RFP expression and M-line localization were also abolished in these defective myofibers. Given that zebrafish embryonic slow muscles are a rapid in vivo system for testing genome editing and uncovering gene functions in muscle cell differentiation, we investigated whether microinjection of Natronobacterium gregoryi Argonaute (NgAgo) system could induce genetic mutations and muscle defects in zebrafish embryos. Single-strand guide DNAs targeted to RFP, Smyhc1, or Hsp90α1 were injected with NgAgo mRNA into Myom3-RFP zebrafish embryos. Myom3-RFP expression was analyzed in the injected embryos. The results showed that, in contrast to the CRISPR/Cas9 system, injection of the NgAgo-gDNA system did not affect Myom3-RFP expression and sarcomere organization in myofibers of the injected embryos. Sequence analysis failed to detect genetic mutations at the target genes. Together, our studies demonstrate that zebrafish embryonic slow muscle is a rapid model for testing gene editing technologies in vivo and uncovering gene functions in muscle cell differentiation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Mengxin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Marine and Environmental Technology, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 701 E. Pratt St, Baltimore, MD, 21202, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Sports and Exercise Biology, Shaanxi Normal University, Xi'an, 710062, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Yufeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Marine and Environmental Technology, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 701 E. Pratt St, Baltimore, MD, 21202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jianshe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Bioengineering and Environmental Science, Changsha University, Hunan, 250014, China. jzhang@ccsu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Zhenjun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Sports and Exercise Biology, Shaanxi Normal University, Xi'an, 710062, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Shaojun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Marine and Environmental Technology, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 701 E. Pratt St, Baltimore, MD, 21202, USA. sdu@som.umaryland.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioengineering and Environmental Science, Changsha University, Hunan, 250014, China. sdu@som.umaryland.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>31230076</GrantID><Agency>NSFC</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mar Biotechnol (NY)</MedlineTA><NlmUniqueID>100892712</NlmUniqueID><ISSNLinking>1436-2228</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">Hsp90α1</Keyword><Keyword MajorTopicYN="N">Myomesin-3-RFP</Keyword><Keyword MajorTopicYN="N">NgAgo</Keyword><Keyword MajorTopicYN="N">Slow myofibers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29374849</ArticleId><ArticleId IdType="doi">10.1007/s10126-018-9794-8</ArticleId><ArticleId IdType="pii">10.1007/s10126-018-9794-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29374595</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1899</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Biotechnology advances</Title><ISOAbbreviation>Biotechnol. Adv.</ISOAbbreviation></Journal><ArticleTitle>Multigene delivery in mammalian cells: Recent advances and applications.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0734-9750(18)30012-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biotechadv.2018.01.012</ELocationID><Abstract><AbstractText>Systems for multigene delivery in mammalian cells, particularly in the context of genome engineering, have gained a lot of attention in biomolecular research and medicine. Initially these methods were based on RNA polymerase II promoters and were used for the production of protein complexes and for applications in cell biology such as reprogramming of somatic cells to stem cells. Emerging technologies such as CRISPR/Cas9-based genome engineering, which enable any alteration at the genomic level of an organism, require additional elements including U6-driven expression cassettes for RNA expression and homology constructs for designed genome modifications. For these applications, systems with high DNA capacity, flexibility and transfer rates are needed. In this article, we briefly give an update on some of recent strategies that facilitate multigene assembly and delivery into mammalian cells. Also, we review applications in various fields of biology that rely on multigene delivery systems.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mansouri</LastName><ForeName>Maysam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Paul Scherrer Institute, Biomolecular Research, Applied Molecular Biology, CH-5232 Villigen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Paul Scherrer Institute, Biomolecular Research, Applied Molecular Biology, CH-5232 Villigen, Switzerland. Electronic address: Philipp.Berger@psi.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biotechnol Adv</MedlineTA><NlmUniqueID>8403708</NlmUniqueID><ISSNLinking>0734-9750</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Genome engineering</Keyword><Keyword MajorTopicYN="N">Mammalian cells</Keyword><Keyword MajorTopicYN="N">Multigene delivery system</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29374595</ArticleId><ArticleId IdType="pii">S0734-9750(18)30012-0</ArticleId><ArticleId IdType="doi">10.1016/j.biotechadv.2018.01.012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29374058</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jbc.RA117.001065</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA117.001065</ELocationID><Abstract><AbstractText>The mammalian SWI/SNF chromatin remodeling complex is a heterogeneous collection of related protein complexes required for gene regulation and genome integrity. It contains a central ATPase (BRM or BRG1) and various combinations of 10-14 accessory subunits (BAFs for BRM/BRG1 Associated Factors). Two distinct complexes differing in size, BAF and the slightly larger Polybromo-BAF (PBAF), share many of the same core subunits but are differentiated primarily by having either AT-rich interaction domain 1A/B (ARID1A/B in BAF) or ARID2 (in PBAF). Using density gradient centrifugation and immunoprecipitation, we have identified and characterized a third and smaller SWI/SNF subcomplex. We termed this complex GBAF because it incorporates two mutually exclusive paralogs, glioma tumor suppressor candidate region gene 1 (GLTSCR1) or GLTSCR1-like (GLTSCR1L), instead of an ARID protein. In addition to GLTSCR1 or GLTSCR1L, the GBAF complex contains bromodomain-containing 9 (BRD9) and the BAF subunits BAF155, BAF60, SS18, BAF53a, and BRG1/BRM. We observed that GBAF does not contain the core BAF subunits BAF45, BAF47, or BAF57. Even without these subunits, GBAF displayed in vitro ATPase activity and bulk chromatin affinity comparable to those of BAF. GBAF associated with BRD4, but unlike BRD4, the GBAF component GLTSCR1 was not required for the viability of the LNCaP prostate cancer cell line. In contrast, GLTSCR1 or GLTSCR1L knockouts in the metastatic prostate cancer cell line PC3 resulted in loss in proliferation and colony-forming ability. Taken together, our results provide evidence for a compositionally novel SWI/SNF subcomplex with cell type-specific functions.</AbstractText><CopyrightInformation>Published under license by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alpsoy</LastName><ForeName>Aktan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Purdue University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dykhuizen</LastName><ForeName>Emily C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Medicinal Chemistry and Molecular Pharmacolog, Purdue University, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA023168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA207532</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BRD4</Keyword><Keyword MajorTopicYN="N">BRD9</Keyword><Keyword MajorTopicYN="N">BRG1</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas</Keyword><Keyword MajorTopicYN="N">GLTSCR1</Keyword><Keyword MajorTopicYN="N">SWI/SNF</Keyword><Keyword MajorTopicYN="N">chromatin remodeling</Keyword><Keyword MajorTopicYN="N">prostate cancer</Keyword><Keyword MajorTopicYN="N">protein complex</Keyword><Keyword MajorTopicYN="N">protein-protein interaction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29374058</ArticleId><ArticleId IdType="pii">RA117.001065</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA117.001065</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29373809</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1944-7930</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>134</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Discovery medicine</Title><ISOAbbreviation>Discov Med</ISOAbbreviation></Journal><ArticleTitle>Pressing diseases that represent promising targets for gene therapy.</ArticleTitle><Pagination><MedlinePgn>313-322</MedlinePgn></Pagination><Abstract><AbstractText>Over time, there has been a growing interest in the application of gene therapy within the healthcare industry as demonstrated by the nearly 3,000 clinical trials associated with gene therapy that are listed in clinicaltrials.gov. However, there are various difficulties associated with gene therapy that have limited the realization of licensed gene therapies to only a handful of treatments. Furthermore, efforts to develop gene therapeutics have been narrowly focused and most clinical trials have sought to develop treatments for cancer (64.6%), monogenic diseases (10.5%), infectious diseases (7.4%), and cardiovascular diseases (7.4%). In addition, nearly 70% of clinical trials have utilized viral-based delivery systems, despite various concerns associated with this strategy. Each of these factors highlights the lack of diversity in the development of gene therapeutics that should be addressed. In recent years, developments in gene manipulation and delivery such as CRISPR and non-viral vectors (e.g., liposomes) demonstrate promise for improving outcomes for gene therapy. The increased fidelity and capacity afforded by these technologies provide the potential to improve upon contemporary gene therapy approaches and enable the development of treatments for less-emphasized disorders. In this review, we provide a summary of gene delivery technology and discuss various developments in gene therapy technology. We conclude by proposing several genetic conditions that represent promising targets for gene therapy given recent developments in gene delivery and manipulation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beitelshees</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Abcombi Biosciences Inc., Buffalo, NY 14260, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally to this article.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rostami</LastName><ForeName>Pooya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Abcombi Biosciences Inc., Buffalo, NY 14260, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Charles H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Abcombi Biosciences Inc., Buffalo, NY 14260, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeifer</LastName><ForeName>Blaine A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Discov Med</MedlineTA><NlmUniqueID>101250006</NlmUniqueID><ISSNLinking>1539-6509</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29373809</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29373786</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>Biochemistry</Title><ISOAbbreviation>Biochemistry</ISOAbbreviation></Journal><ArticleTitle>Recent Advances in CRISPR Base Editing: From A to RNA.</ArticleTitle><Pagination><MedlinePgn>886-887</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.biochem.7b01276</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bjerke</LastName><ForeName>Jennifer N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Colorado State University , Fort Collins, Colorado 80523, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beardslee</LastName><ForeName>Patrick C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Colorado State University , Fort Collins, Colorado 80523, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNaughton</LastName><ForeName>Brian R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5002-2262</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Colorado State University , Fort Collins, Colorado 80523, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, Colorado State University , Fort Collins, Colorado 80523, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochemistry</MedlineTA><NlmUniqueID>0370623</NlmUniqueID><ISSNLinking>0006-2960</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29373786</ArticleId><ArticleId IdType="doi">10.1021/acs.biochem.7b01276</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29373746</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation></Journal><ArticleTitle>Distinct and redundant functions of three homologs of RNase III in the cyanobacterium Synechococcus sp. strain PCC 7002.</ArticleTitle><Pagination><MedlinePgn>1984-1997</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gky041</ELocationID><Abstract><AbstractText>RNase III is a ribonuclease that recognizes and cleaves double-stranded RNA. Across bacteria, RNase III is involved in rRNA maturation, CRISPR RNA maturation, controlling gene expression, and turnover of messenger RNAs. Many organisms have only one RNase III while others have both a full-length RNase III and another version that lacks a double-stranded RNA binding domain (mini-III). The genome of the cyanobacterium Synechococcus sp. strain PCC 7002 (PCC 7002) encodes three homologs of RNase III, two full-length and one mini-III, that are not essential even when deleted in combination. To discern if each enzyme had distinct responsibilities, we collected and sequenced global RNA samples from the wild type strain, the single, double, and triple RNase III mutants. Approximately 20% of genes were differentially expressed in various mutants with some operons and regulons showing complex changes in expression levels between mutants. Two RNase III's had a role in 23S rRNA maturation and the third was involved in copy number regulation one of six native plasmids. In vitro, purified RNase III enzymes were capable of cleaving some of the known Escherichia coli RNase III target sequences, highlighting the remarkably conserved substrate specificity between organisms yet complex regulation of gene expression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Gina C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology Doctoral Training Program, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cameron</LastName><ForeName>Jeffrey C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfleger</LastName><ForeName>Brian F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology Doctoral Training Program, University of Wisconsin-Madison, Madison, WI 53706, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Jan 15;31(2):166-9</RefSource><PMID Version="1">25260700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Photosynth Res. 2015 Oct;126(1):171-83</RefSource><PMID Version="1">25595545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Dec;32(12):1276-81</RefSource><PMID Version="1">25402616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1984 Jan;81(1):185-8</RefSource><PMID Version="1">6364133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2010 Dec;76(23):7881-4</RefSource><PMID Version="1">20935124</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Chem Biomol Eng. 2011;2:211-36</RefSource><PMID Version="1">22432617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Chem Biol. 2015 Oct;28:47-56</RefSource><PMID Version="1">26093826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioeng Bugs. 2010 Mar-Apr;1(2):116-31</RefSource><PMID Version="1">21326937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2008 Dec 15;22(24):3497-508</RefSource><PMID Version="1">19141481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2010 Jan 1;26(1):139-40</RefSource><PMID Version="1">19910308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteins. 1998 Aug 1;32(2):248-61</RefSource><PMID Version="1">9714164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2015 Jun;10(6):845-58</RefSource><PMID Version="1">25950237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Aug 16;488(7411):320-8</RefSource><PMID Version="1">22895337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 31;471(7340):602-7</RefSource><PMID Version="1">21455174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2008 Aug;190(15):5526-30</RefSource><PMID Version="1">18539734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1989 Nov;8(11):3401-7</RefSource><PMID Version="1">2583104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2017 Sep 26;7(1):12327</RefSource><PMID Version="1">28951570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 1997 Aug 5;55(3):577-80</RefSource><PMID Version="1">18636526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2008 Jun;68(5):1096-106</RefSource><PMID Version="1">18363798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2003;224:61-78</RefSource><PMID Version="1">12710666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biosci Rep. 2013 Nov 25;33(6):null</RefSource><PMID Version="1">24073828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2012 Dec 27;13:734</RefSource><PMID Version="1">23270466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2012 Jun;8(6):e1002782</RefSource><PMID Version="1">22761586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2000 Dec;66(12):5399-405</RefSource><PMID Version="1">11097920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2012;8(12):e1003181</RefSource><PMID Version="1">23300471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 1995 Dec;18(5):913-24</RefSource><PMID Version="1">8825095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Dec 1;28(23):4623-33</RefSource><PMID Version="1">11095671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Mol Biol. 2003 Jun 18;4:8</RefSource><PMID Version="1">12814522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1996 Apr 5;85(1):115-24</RefSource><PMID Version="1">8620530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2007 May;189(9):3335-47</RefSource><PMID Version="1">17307862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2009;502:171-6</RefSource><PMID Version="1">19082556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plasmid. 2013 Jul;70(1):69-77</RefSource><PMID Version="1">23419647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2005 Jul;57(2):318-25</RefSource><PMID Version="1">15978067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1973 Mar;113(3):1256-63</RefSource><PMID Version="1">4632397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Commun (Camb). 2013 May 14;49(39):4325-7</RefSource><PMID Version="1">23230569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 1992 Jan;6(1):83-94</RefSource><PMID Version="1">1371181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e41286</RefSource><PMID Version="1">22911771</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2001;342:143-58</RefSource><PMID Version="1">11586889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 1999 Nov;17(11):452-60</RefSource><PMID Version="1">10511704</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Dec 3;20(23):6845-55</RefSource><PMID Version="1">11726520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Mol Biol. 2009 Aug 07;10:79</RefSource><PMID Version="1">19660145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1978 Aug;75(8):3593-7</RefSource><PMID Version="1">358189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1987 Sep;84(18):6511-5</RefSource><PMID Version="1">2957696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Apr;39(8):3188-203</RefSource><PMID Version="1">21149258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Aug;41(15):7522-35</RefSource><PMID Version="1">23771137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Gen Genet. 1987 Mar;206(3):428-35</RefSource><PMID Version="1">3035343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2009 May;6(5):343-5</RefSource><PMID Version="1">19363495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2011 Sep;193(17):4371-9</RefSource><PMID Version="1">21742867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1983 May 10;258(9):5340-3</RefSource><PMID Version="1">6406499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Oct;39(19):8651-64</RefSource><PMID Version="1">21737428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1980 Dec;77(12):7084-8</RefSource><PMID Version="1">7012833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Oct 14;44(18):8810-8825</RefSource><PMID Version="1">27568004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Feb 13;279(7):5739-51</RefSource><PMID Version="1">14612435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plant Cell. 2015 Mar;27(3):724-40</RefSource><PMID Version="1">25724636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2003 Jul 1;31(13):3406-15</RefSource><PMID Version="1">12824337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5712-7</RefSource><PMID Version="1">21402902</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29373746</ArticleId><ArticleId IdType="pii">4823213</ArticleId><ArticleId IdType="doi">10.1093/nar/gky041</ArticleId><ArticleId IdType="pmc">PMC5829567</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29373607</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1.</ArticleTitle><Pagination><MedlinePgn>e0191709</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0191709</ELocationID><Abstract><AbstractText>The type I interferon (IFN-I)-inducible human restriction factor TRIM5α inhibits the infection of human cells by specific nonhuman retroviruses, such as N-MLV and EIAV, but does not generally target HIV-1. However, the introduction of two aminoacid substitutions, R332G and R355G, in the human TRIM5α (huTRIM5α) domain responsible for retroviral capsid recognition leads to efficient HIV-1 restriction upon stable over-expression. CRISPR-Cas-based approaches to precisely edit DNA could be employed to modify TRIM5 in human cells. Toward this aim, we used a DNA transfection-based CRISPR-Cas9 genome editing protocol to successfully mutate TRIM5 to its potentially HIV-1-restrictive version by homology-directed repair (HDR) in HEK293T cells. Nine clones bearing at least one HDR-edited TRIM5 allele containing both mutations were isolated (5.6% overall efficiency), whereas another one contained only the R332G mutation. Of concern, several of these HDR-edited clones contained on-target undesired mutations, and none had all the alleles corrected. Our study demonstrates the feasibility of editing the TRIM5 gene in human cells and identifies the main challenges to be addressed in order to use this approach to confer protection from HIV-1.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dufour</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Immunity, Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claudel</LastName><ForeName>Alix</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Immunity, Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joubarne</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Immunity, Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merindol</LastName><ForeName>Natacha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Immunity, Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maisonnet</LastName><ForeName>Tara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Immunity, Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masroori</LastName><ForeName>Nasser</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Immunity, Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plourde</LastName><ForeName>Mélodie B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Immunity, Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berthoux</LastName><ForeName>Lionel</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7776-5058</Identifier><AffiliationInfo><Affiliation>Laboratory of Antiviral Immunity, Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C477346">TRIM5 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2017 Jun;14 (6):615-620</RefSource><PMID Version="1">28417998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytogenet Genome Res. 2004;106(1):28-32</RefSource><PMID Version="1">15218237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2017 Jan 10;241:136-146</RefSource><PMID Version="1">27845164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2004 Feb 26;427(6977):848-53</RefSource><PMID Version="1">14985764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Virol. 2011 Dec;1(6):519-25</RefSource><PMID Version="1">22328912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2013 Mar;9(3):e1003214</RefSource><PMID Version="1">23505372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 May 5;533(7601):125-9</RefSource><PMID Version="1">27120160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2012 May;86(10):5719-29</RefSource><PMID Version="1">22398281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Dec 15;540(7633):448-452</RefSource><PMID Version="1">27919079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2017 Jul;27(7):1099-1111</RefSource><PMID Version="1">28356322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2006 Jul;80(14):6738-44</RefSource><PMID Version="1">16809279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2005 Dec;79(24):15175-88</RefSource><PMID Version="1">16306589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Retrovirology. 2016 Mar 22;13:19</RefSource><PMID Version="1">27000403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14849-53</RefSource><PMID Version="1">16203999</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2015 Oct;26(10 ):664-79</RefSource><PMID Version="1">26076730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virus Res. 2014 May 12;184:30-8</RefSource><PMID Version="1">24583231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virology. 2010 Sep 30;405(2):414-23</RefSource><PMID Version="1">20619429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2005 Jan 11;15(1):73-8</RefSource><PMID Version="1">15649369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2015 Sep 15;569(2):182-90</RefSource><PMID Version="1">26026906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2832-7</RefSource><PMID Version="1">15689398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 Dec 15;3:e04766</RefSource><PMID Version="1">25497837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Aug;11(8):783-784</RefSource><PMID Version="1">25075903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2008 Feb 11;180(3):549-61</RefSource><PMID Version="1">18250195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Oct;41(19):9049-61</RefSource><PMID Version="1">23907390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Virus Res. 2013 May;173(2):306-314</RefSource><PMID Version="1">23357295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2005 Jun;79(12):7883-8</RefSource><PMID Version="1">15919943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>mSphere. 2017 Jun 21;2(3):</RefSource><PMID Version="1">28656178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10780-5</RefSource><PMID Version="1">15249687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene Ther. 2010 Jul;17(7):859-71</RefSource><PMID Version="1">20357830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Mar 24;10(3):e0121199</RefSource><PMID Version="1">25803716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-87</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2011 Aug;85(15):7828-35</RefSource><PMID Version="1">21632761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Sep 03;5:4767</RefSource><PMID Version="1">25182477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Dec 21;6:39681</RefSource><PMID Version="1">28000776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Med. 2012 May;2(5):a006940</RefSource><PMID Version="1">22553496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Apr 21;472(7343):361-5</RefSource><PMID Version="1">21512573</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29373607</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0191709</ArticleId><ArticleId IdType="pii">PONE-D-17-35881</ArticleId><ArticleId IdType="pmc">PMC5786314</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29373314</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-4315</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Biological chemistry</Title><ISOAbbreviation>Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9-mediated modification of the extreme C-terminus impairs PDGF-stimulated activity of Duox2.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1515/hsz-2017-0229</ELocationID><ELocationID EIdType="pii" ValidYN="Y">/j/bchm.ahead-of-print/hsz-2017-0229/hsz-2017-0229.xml</ELocationID><Abstract><AbstractText>Duox2 belongs to the large family of NADPH-oxidase enzymes that are implicated in immune response, vasoregulation, hormone synthesis, cell growth and differentiation via the regulated synthesis of H2O2 and reactive oxygen species. We and others have shown that Duox2 and H2O2 are involved in platelet-derived growth factor (PDGF) induced migration of fibroblasts. Now, using the CRISPR/Cas9-mediated genome editing we demonstrate that the extreme C-terminal region of Duox2 is required for PDGF-stimulated activity of Duox2 and H2O2 production. We generated the fibroblast cells that stably co-express the wild-type or C-terminally modified Duox2 and fluorescent H2O2 probe Hyper. We found that nonsense substitution of the last 23 amino acids in Duox2 results in complete loss of PDGF stimulation of intracellular H2O2 and fibroblast migration, yet these mutations have no effects on the expression of Duox2 and other NADPH-oxidases in cells. These findings illustrate for the first time that the extreme C-terminus of Duox2 is required for the functional activity of the enzyme. Furthermore, the conservative nature of the C-terminus suggests its role for activity in other NADPH-oxidases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tyurin-Kuzmin</LastName><ForeName>Pyotr A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Lomonosovsky ave, 27-1, Moscow 119991, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karagyaur</LastName><ForeName>Maxim N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Lomonosovsky ave, 27-1, Moscow 119991, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubtsov</LastName><ForeName>Yury P</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Lomonosovsky ave, 27-1, Moscow 119991, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dyikanov</LastName><ForeName>Daniyar T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Lomonosovsky ave, 27-1, Moscow 119991, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasiliev</LastName><ForeName>Pyotr A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University, Lomonosovsky ave, 27-1, Moscow 119991, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vorotnikov</LastName><ForeName>Alexander V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>M.V. Lomonosov Moscow State University Medical Center, Lomonosovsky ave, 27-10, Moscow 119991, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Biol Chem</MedlineTA><NlmUniqueID>9700112</NlmUniqueID><ISSNLinking>1431-6730</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">Duox2</Keyword><Keyword MajorTopicYN="N">NADPH oxidases</Keyword><Keyword MajorTopicYN="N">PDGF</Keyword><Keyword MajorTopicYN="N">migration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29373314</ArticleId><ArticleId IdType="doi">10.1515/hsz-2017-0229</ArticleId><ArticleId IdType="pii">/j/bchm.just-accepted/hsz-2017-0229/hsz-2017-0229.xml</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29371815</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1445-5781</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Reproductive medicine and biology</Title><ISOAbbreviation>Reprod. Med. Biol.</ISOAbbreviation></Journal><ArticleTitle>Revolutionizing male fertility factor research in mice by using the genome editing tool CRISPR/Cas9.</ArticleTitle><Pagination><MedlinePgn>3-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/rmb2.12067</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED">Reproductive research is quintessential in understanding not only the cause of infertility, but also for creating family planning tools. The knockout (KO) system approach is conducive to discovering genes that are essential for fertility in mice. However, in vivo research has been limited due to its high cost and length of time needed to establish KO mice.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">The mechanisms behind the CRISPR/Cas9 system and its application in investigating male fertility in mice are described by using original and review articles.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">The CRISPR/CAS9 SYSTEM has enabled researchers to rapidly, efficiently, and inexpensively produce genetically modified mice to study male fertility. Several genes have been highlighted that were found to be indispensable for male fertility by using the CRISPR/Cas9 system, as well as more complicated gene manipulation techniques, such as point mutations, tag insertions, and double knockouts, which have become easier with this new technology.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">In order to increase efficiency and usage, new methods of CRISPR/Cas9 integration are being developed, such as electroporation and applying the system to embryonic stem cells. The hidden mysteries of male fertility will be unraveled with the help of this new technology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abbasi</LastName><ForeName>Ferheen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research Institute for Microbial DiseasesOsaka UniversitySuitaJapan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of MedicineOsaka UniversitySuitaJapan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyata</LastName><ForeName>Haruhiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research Institute for Microbial DiseasesOsaka UniversitySuitaJapan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikawa</LastName><ForeName>Masahito</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9859-6217</Identifier><AffiliationInfo><Affiliation>Research Institute for Microbial DiseasesOsaka UniversitySuitaJapan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of MedicineOsaka UniversitySuitaJapan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Reprod Med Biol</MedlineTA><NlmUniqueID>101213278</NlmUniqueID><ISSNLinking>1445-5781</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Dec 01;5:17517</RefSource><PMID Version="1">26620761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource><PMID Version="1">23992846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2002 Mar;13(3):1015-29</RefSource><PMID Version="1">11907279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):99-113</RefSource><PMID Version="1">18166982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2015 Jun;200(2):423-30</RefSource><PMID Version="1">25819794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Reproduction. 2016 Dec;152(6):665-672</RefSource><PMID Version="1">27624483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2015 Aug 6;17(2):213-20</RefSource><PMID Version="1">26212079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2013 Jul;31(7):397-405</RefSource><PMID Version="1">23664777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2017;1630:81-89</RefSource><PMID Version="1">28643251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Proteome Res. 2012 Nov 2;11(11):5252-64</RefSource><PMID Version="1">22954305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Aug 17;6:31666</RefSource><PMID Version="1">27530713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Growth Differ. 2014 Jan;56(1):122-9</RefSource><PMID Version="1">24372541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Jun 08;10(6):e0129457</RefSource><PMID Version="1">26053263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Proteome Res. 2010 Feb 5;9(2):718-29</RefSource><PMID Version="1">19947656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Anim. 2014;63(4):357-65</RefSource><PMID Version="1">24974794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):E5370-E5378</RefSource><PMID Version="1">28630322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2015 Apr 1;31(7):1120-3</RefSource><PMID Version="1">25414360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2017 Jan 23;13(1):e1006578</RefSource><PMID Version="1">28114340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Reprod Biol Endocrinol. 2010 Aug 23;8:101</RefSource><PMID Version="1">20731842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jul 23;523(7561):481-5</RefSource><PMID Version="1">26098369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2010 Sep;11(9):636-46</RefSource><PMID Version="1">20717154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Cell Biol. 2009 Sep;Chapter 19:Unit 19.13 19.13.1-24</RefSource><PMID Version="1">19731225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 May 9;153(4):910-8</RefSource><PMID Version="1">23643243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2015 Oct 16;16(10):24732-50</RefSource><PMID Version="1">26501274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2013 Jan;14(1):49-55</RefSource><PMID Version="1">23169466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Apr 20;282(16):12164-75</RefSource><PMID Version="1">17289678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Cell Mol Biol. 2010 Jul;43(1):55-63</RefSource><PMID Version="1">19675306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 Mar 23;315(5819):1709-12</RefSource><PMID Version="1">17379808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2013 Feb;22(1):195-200</RefSource><PMID Version="1">22826106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2014;546:319-36</RefSource><PMID Version="1">25398347</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013 Nov 27;3:3355</RefSource><PMID Version="1">24284873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1994 Dec 16;269(50):31845-9</RefSource><PMID Version="1">7989357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2012 Nov 1;125(Pt 21):4985-90</RefSource><PMID Version="1">22946049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1987 Dec;169(12):5429-33</RefSource><PMID Version="1">3316184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506</RefSource><PMID Version="1">28512351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource><PMID Version="1">24584096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Mar 10;434(7030):234-8</RefSource><PMID Version="1">15759005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2014 Oct;28(10):4434-40</RefSource><PMID Version="1">24970390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Oct 23;350(6259):385-6</RefSource><PMID Version="1">26494747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Proteome Res. 2009 Mar;8(3):1431-40</RefSource><PMID Version="1">19186949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2016 Dec 1;129(23 ):4379-4387</RefSource><PMID Version="1">27802166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2014 Sep 1;393(1):3-9</RefSource><PMID Version="1">24984260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Apr 29;16:87</RefSource><PMID Version="1">25924609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2011 Jun;9(6):467-77</RefSource><PMID Version="1">21552286</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2010 Apr;120(4):984-94</RefSource><PMID Version="1">20364096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Jun 11;5:11315</RefSource><PMID Version="1">26066060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):822-6</RefSource><PMID Version="1">23792628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2016 Oct 1;418(1):1-9</RefSource><PMID Version="1">27474397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2005 Mar;32(1):41-5</RefSource><PMID Version="1">15865209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Jan;24(1):125-31</RefSource><PMID Version="1">24253447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2015 Aug 6;17(2):233-44</RefSource><PMID Version="1">26145478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 6;507(7490):62-7</RefSource><PMID Version="1">24476820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2008 Nov;14(11):1197-213</RefSource><PMID Version="1">18989307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2016 Jan 1;351(6268):84-8</RefSource><PMID Version="1">26628643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Dec 21;6:39608</RefSource><PMID Version="1">28000783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7704-10</RefSource><PMID Version="1">27357688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 1990 Dec;110(4):1295-302</RefSource><PMID Version="1">2100264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Oct 23;350(6259):442-5</RefSource><PMID Version="1">26429887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2002 Feb 15;242(2):236-54</RefSource><PMID Version="1">11820818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Reprod. 2015 Oct;93(4):94</RefSource><PMID Version="1">26377222</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">fertility</Keyword><Keyword MajorTopicYN="N">gene editing</Keyword><Keyword MajorTopicYN="N">reproduction</Keyword><Keyword MajorTopicYN="N">spermatozoa</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>09</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29371815</ArticleId><ArticleId IdType="doi">10.1002/rmb2.12067</ArticleId><ArticleId IdType="pii">RMB212067</ArticleId><ArticleId IdType="pmc">PMC5768971</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29371699</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Identification of a biosynthetic gene cluster for the polyene macrolactam sceliphrolactam in a Streptomyces strain isolated from mangrove sediment.</ArticleTitle><Pagination><MedlinePgn>1594</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-20018-8</ELocationID><Abstract><AbstractText>Streptomyces are a genus of Actinobacteria capable of producing structurally diverse natural products. Here we report the isolation and characterization of a biosynthetically talented Streptomyces (Streptomyces sp. SD85) from tropical mangrove sediments. Whole-genome sequencing revealed that Streptomyces sp. SD85 harbors at least 52 biosynthetic gene clusters (BGCs), which constitute 21.2% of the 8.6-Mb genome. When cultivated under lab conditions, Streptomyces sp. SD85 produces sceliphrolactam, a 26-membered polyene macrolactam with unknown biosynthetic origin. Genome mining yielded a putative sceliphrolactam BGC (sce) that encodes a type I modular polyketide synthase (PKS) system, several β-amino acid starter biosynthetic enzymes, transporters, and transcriptional regulators. Using the CRISPR/Cas9-based gene knockout method, we demonstrated that the sce BGC is essential for sceliphrolactam biosynthesis. Unexpectedly, the PKS system encoded by sce is short of one module required for assembling the 26-membered macrolactam skeleton according to the collinearity rule. With experimental data disfavoring the involvement of a trans-PKS module, the biosynthesis of sceliphrolactam seems to be best rationalized by invoking a mechanism whereby the PKS system employs an iterative module to catalyze two successive chain extensions with different outcomes. The potential violation of the collinearity rule makes the mechanism distinct from those of other polyene macrolactams.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Low</LastName><ForeName>Zhen Jie</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Li Mei</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Yichen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Interdisciplinary Graduate School, Nanyang Technological University, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, 637551, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheang</LastName><ForeName>Qing Wei</ForeName><Initials>QW</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Mai Hoang</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Mathematics and Physics, Nanyang Technological University, Singapore, 637551, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thi Tran</LastName><ForeName>Hoa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, School of Basic Medical Sciences, Southern Medical University, 510515, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xue-Wei</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>School of Mathematics and Physics, Nanyang Technological University, Singapore, 637551, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanagasundaram</LastName><ForeName>Yoganathan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Bioinformatics Institute, Singapore, 138671, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Liang</ForeName><Initials>L</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2362-0128</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, 637551, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zhao-Xun</ForeName><Initials>ZX</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3128-1330</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore. zxliang@ntu.edu.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Science. 2004 Mar 19;303(5665):1805-10</RefSource><PMID Version="1">15031493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2015 Sep 18;4(9):1020-9</RefSource><PMID Version="1">25806970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antibiot (Tokyo). 2013 Jul;66(7):431-41</RefSource><PMID Version="1">23677034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2005 Oct;12(10):1145-53</RefSource><PMID Version="1">16242657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2014 Mar 18;588(6):995-1000</RefSource><PMID Version="1">24530530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2006 Jun;13(6):575-85</RefSource><PMID Version="1">16793515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Prod Rep. 2009 Nov;26(11):1362-84</RefSource><PMID Version="1">19844637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nat Prod. 2015 Dec 24;78(12):3011-7</RefSource><PMID Version="1">26624939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antibiot (Tokyo). 1982 Dec;35(12 ):1705-7</RefSource><PMID Version="1">7166535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1802-7</RefSource><PMID Version="1">26831085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 May 9;417(6885):141-7</RefSource><PMID Version="1">12000953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2008 Apr 2;582(7):1097-103</RefSource><PMID Version="1">18319060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2000 Jan;38(1):471</RefSource><PMID Version="1">10681211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antibiot (Tokyo). 2007 Nov;60(11):700-8</RefSource><PMID Version="1">18057700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Biol. 2015 Sep 18;10(9):1998-2006</RefSource><PMID Version="1">26039241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2015 Sep;11(9):625-31</RefSource><PMID Version="1">26284661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Chem Int Ed Engl. 2016 Jan 18;55(3):1118-23</RefSource><PMID Version="1">26630438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Apr 12;277(15):13082-90</RefSource><PMID Version="1">11809757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2001 Dec 25;40(51):15464-70</RefSource><PMID Version="1">11747421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2008 Feb;15(2):175-88</RefSource><PMID Version="1">18291322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Biol. 2009 Jan 16;4(1):41-52</RefSource><PMID Version="1">19146481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Org Lett. 2011 Feb 18;13(4):752-5</RefSource><PMID Version="1">21247188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2003 Jan;5(1):3-6</RefSource><PMID Version="1">12511880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2014 Nov;98(22):9311-24</RefSource><PMID Version="1">25104037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Org Lett. 2017 Mar 3;19(5):1000-1003</RefSource><PMID Version="1">28207275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angew Chem Int Ed Engl. 2017 May 8;56(20):5503-5506</RefSource><PMID Version="1">28418225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Biol. 2015 Oct 16;10(10):2373-81</RefSource><PMID Version="1">26270237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2003 May;21(5):526-31</RefSource><PMID Version="1">12692562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1995 Oct 30;374(2):246-8</RefSource><PMID Version="1">7589545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2004 Jan;11(1):79-86</RefSource><PMID Version="1">15112997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1998 Feb 10;37(6):1585-95</RefSource><PMID Version="1">9484229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2007 Oct 31;129(43):13082-94</RefSource><PMID Version="1">17918933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2007 Aug;14(8):898-908</RefSource><PMID Version="1">17719489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Environ Microbiol. 2010 Jan;76(1):283-93</RefSource><PMID Version="1">19854930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Microbiol Biotechnol. 2016 Jan;100(2):541-57</RefSource><PMID Version="1">26549236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Jun 29;287(27):23203-15</RefSource><PMID Version="1">22589546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10376-81</RefSource><PMID Version="1">17563368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Prod Rep. 2014 Jan;31(1):61-108</RefSource><PMID Version="1">24292120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Org Biomol Chem. 2014 Nov 14;12(42):8542-9</RefSource><PMID Version="1">25238086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Org Lett. 2012 Sep 7;14(17):4591-3</RefSource><PMID Version="1">22928983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1991 May 3;252(5006):675-9</RefSource><PMID Version="1">2024119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Biochim Biophys Sin (Shanghai). 2015 Apr;47(4):231-43</RefSource><PMID Version="1">25739462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antibiot (Tokyo). 2005 Jul;58(7):468-72</RefSource><PMID Version="1">16161486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2011 Apr 22;18(4):425-31</RefSource><PMID Version="1">21513878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Commun (Camb). 2003 Nov 21;(22):2780-2</RefSource><PMID Version="1">14651102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2011 Nov 16;133(45):18134-7</RefSource><PMID Version="1">22010945</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2004 Jan;11(1):87-97</RefSource><PMID Version="1">15112998</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29371699</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-20018-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-20018-8</ArticleId><ArticleId IdType="pmc">PMC5785472</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29371607</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Degradation routes of trafficking-defective VLDLR mutants associated with Dysequilibrium syndrome.</ArticleTitle><Pagination><MedlinePgn>1583</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-19053-8</ELocationID><Abstract><AbstractText>Low density lipoprotein receptor (LDLR) family members are involved in signaling in the developing brain. Previously we have reported that missense mutations in the Very Low Density Lipoprotein Receptor gene (VLDLR), causing Dysequilibrium syndrome (DES), disrupt ligand-binding, due to endoplasmic reticulum (ER) retention of the mutants. We explored the degradation routes of these VLDLR mutants in cultured cells. Our results indicate that VLDLR mutants are retained in the ER for prolonged periods which could be facilitated by association with the ER-resident chaperone calnexin. The mutants were prone to aggregation and capable of eliciting ER stress. The VLDLR mutants were found to be degraded predominantly by the proteasomal pathway, since ubiquitinated VLDLR was found to accumulate in response to proteasomal inhibition. Further, the mutants were found to interact with the ER degradation adaptor protein SEL1L. The degradation of VLDLR wild type and mutant were delayed in CRISPR/Cas9 edited SEL1L knock-out cells which was reversed by exogenous expression of SEL1L. In summary, ER retention of pathogenic VLDLR mutants involves binding to calnexin, elevated ER stress, and delayed degradation which is dependent on SEL1L. Since core LDLR family members share common structural domains, common mechanisms may be involved in their ER processing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kizhakkedath</LastName><ForeName>Praseetha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Gazali</LastName><ForeName>Lihadh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Bassam R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates. bassam.ali@uaeu.ac.ae.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zayed Center for Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, United Arab Emirates. bassam.ali@uaeu.ac.ae.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Neurodegener. 2011 May 09;6:30</RefSource><PMID Version="1">21554715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2014 Jul 15;23 (14 ):3746-58</RefSource><PMID Version="1">24565866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Oct 22;285(43):33423-34</RefSource><PMID Version="1">20628050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Jul 3;273(27):17064-72</RefSource><PMID Version="1">9642271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2012 Apr;1818(4):1108-14</RefSource><PMID Version="1">22100602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2014 Mar 17;204(6):869-79</RefSource><PMID Version="1">24637321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2014 Sep 2;20(3):458-70</RefSource><PMID Version="1">25066055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Neurodegener. 2012 Mar 19;7:9</RefSource><PMID Version="1">22429478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Pharmacol Sin. 2013 May;34(5):625-35</RefSource><PMID Version="1">23524572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12325-30</RefSource><PMID Version="1">18711132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2007 Apr;274(8):1881-93</RefSource><PMID Version="1">17408384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2005 Sep;77(3):477-83</RefSource><PMID Version="1">16080122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2008 Mar;10 (3):272-82</RefSource><PMID Version="1">18264092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Child Neurol. 2009 Oct;24(10):1310-5</RefSource><PMID Version="1">19332571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2014 Dec;1843(12 ):2871-7</RefSource><PMID Version="1">25173816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Jun 25;285(26):19720-6</RefSource><PMID Version="1">20427281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lipid Res. 2004 Mar;45(3):403-9</RefSource><PMID Version="1">14657206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 1997 Jun 1;324 ( Pt 2):371-7</RefSource><PMID Version="1">9182693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med Genet. 2012 Sep 14;13:80</RefSource><PMID Version="1">22973972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2008 Feb;4(2):141-50</RefSource><PMID Version="1">17986870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2010 Jan 1;19(1):79-89</RefSource><PMID Version="1">19825845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 May 13;286(19):16929-39</RefSource><PMID Version="1">21454652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2015 Dec;17 (12 ):1546-55</RefSource><PMID Version="1">26551274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2014 Nov 11;4:6992</RefSource><PMID Version="1">25385046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rev. 2011 Oct;91(4):1219-43</RefSource><PMID Version="1">22013210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pathol. 2008;3:399-425</RefSource><PMID Version="1">18039139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2012;8(6):e1002759</RefSource><PMID Version="1">22719266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lipid Res. 2004 Jun;45(6):1084-91</RefSource><PMID Version="1">14993243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1983 May 25;258(10):6093-100</RefSource><PMID Version="1">6133857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Atheroscler Thromb. 2017 Jun 1;24(6):552-559</RefSource><PMID Version="1">28428482</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Endocrinol Metab. 2014 Jan;25(1):8-14</RefSource><PMID Version="1">24189266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Nov;1833(11):2447-57</RefSource><PMID Version="1">23557783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2001 Jun 12;40(23):6766-75</RefSource><PMID Version="1">11389590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 May 24;113(21):5934-9</RefSource><PMID Version="1">27170191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2006 Oct 23;175(2):261-70</RefSource><PMID Version="1">17043138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rep. 2013 Sep;1(4):e00086</RefSource><PMID Version="1">24303155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Nov 1;288(44):31517-27</RefSource><PMID Version="1">24043630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2010 Jan 25;188(2):223-35</RefSource><PMID Version="1">20100910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 Apr 10;54(1):166-179</RefSource><PMID Version="1">24685158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Jan 6;281(1):468-76</RefSource><PMID Version="1">16257961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rev. 2012 Apr;92(2):537-76</RefSource><PMID Version="1">22535891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Genet Genomic Med. 2013 Jul;1(2):71-6</RefSource><PMID Version="1">24498604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Model Mech. 2014 Mar;7(3):331-41</RefSource><PMID Version="1">24609034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 2013 Aug 1;319(13):1956-72</RefSource><PMID Version="1">23701949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E582-91</RefSource><PMID Version="1">24453213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2016 Jan;283(1):157-72</RefSource><PMID Version="1">26471130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurosci. 2003 Jun;4(6):496-505</RefSource><PMID Version="1">12778121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2010 Apr 2;584(7):1393-8</RefSource><PMID Version="1">20040365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Traffic. 2016 Apr;17 (4):308-26</RefSource><PMID Version="1">26676362</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29371607</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-19053-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-017-19053-8</ArticleId><ArticleId IdType="pmc">PMC5785505</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29371485</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0917-5857</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Clinical calcium</Title><ISOAbbreviation>Clin Calcium</ISOAbbreviation></Journal><ArticleTitle>[Generation of Mice Carrying Reporter for live bone imaging.]</ArticleTitle><Pagination><MedlinePgn>201-210</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">CliCa1802201210</ELocationID><Abstract><AbstractText>Fluorescence imaging technology using two-photon excitation microscopy has been developed and utilized to observe cell dynamics in various developmental processes and pathological conditions in vivo. This technology is absolutely dependent on the fluorescent labelling technique of specific cells in a living state in vivo using various methods such as genetic engineering, chemiluminescent probes or fluorescent-conjugated antibodies. In this article, we demonstrate the methods of genetic engineering, particularly how to generate a genetically modified mouse(reporter mouse)that expresses fluorescent protein endogenously in the specific cells. In consideration of mouse genetic engineering technologies and the current state of bioresources, we describe the transgenic method, the knock-in method, the Cre/loxP-mediated recombination method and the genomic editing method by CRISPR/Cas9 system that have been used widely for generation of reporter mice. Among these methods, it is important to carefully select the suitable method according to the research purpose. We would like to compare the methods comprehensively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sakaguchi</LastName><ForeName>Yukako</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishikawa</LastName><ForeName>Keizo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>WPI-Immunology Frontier Research Center, Osaka University, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>jpn</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Clin Calcium</MedlineTA><NlmUniqueID>9433326</NlmUniqueID><ISSNLinking>0917-5857</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29371485</ArticleId><ArticleId IdType="pii">1802201210</ArticleId><ArticleId IdType="doi">CliCa1802201210</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29371424</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>359</Volume><Issue>6379</Issue><PubDate><Year>2018</Year><Month>03</Month><Day>02</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Systematic discovery of antiphage defense systems in the microbial pangenome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eaar4120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aar4120</ELocationID><Abstract><AbstractText>The arms race between bacteria and phages led to the development of sophisticated antiphage defense systems, including CRISPR-Cas and restriction-modification systems. Evidence suggests that known and unknown defense systems are located in "defense islands" in microbial genomes. Here, we comprehensively characterized the bacterial defensive arsenal by examining gene families that are clustered next to known defense genes in prokaryotic genomes. Candidate defense systems were systematically engineered and validated in model bacteria for their antiphage activities. We report nine previously unknown antiphage systems and one antiplasmid system that are widespread in microbes and strongly protect against foreign invaders. These include systems that adopted components of the bacterial flagella and condensin complexes. Our data also suggest a common, ancient ancestry of innate immunity components shared between animals, plants, and bacteria.</AbstractText><CopyrightInformation>Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doron</LastName><ForeName>Shany</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8392-6110</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melamed</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0604-3605</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ofir</LastName><ForeName>Gal</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8307-9388</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leavitt</LastName><ForeName>Azita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9137-9543</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopatina</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3484-6819</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keren</LastName><ForeName>Mai</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8635-3218</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amitai</LastName><ForeName>Gil</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2954-2503</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorek</LastName><ForeName>Rotem</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3872-4982</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. rotem.sorek@weizmann.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2018 Mar 2;359(6379):993</RefSource><PMID Version="1">29496868</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29371424</ArticleId><ArticleId IdType="pii">science.aar4120</ArticleId><ArticleId IdType="doi">10.1126/science.aar4120</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29371327</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-3178</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>EMBO reports</Title><ISOAbbreviation>EMBO Rep.</ISOAbbreviation></Journal><ArticleTitle>Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e44860</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embr.201744860</ELocationID><Abstract><AbstractText>Mitochondrial dysfunction in the nigrostriatal dopaminergic system is a critical hallmark of Parkinson's disease (PD). Mitochondrial toxins produce cellular and behavioural dysfunctions resembling those in patients with PD Causative gene products for familial PD play important roles in mitochondrial function. Therefore, targeting proteins that regulate mitochondrial integrity could provide convincing strategies for PD therapeutics. We have recently identified a novel 13-kDa protein (p13) that may be involved in mitochondrial oxidative phosphorylation. In the current study, we examine the mitochondrial function of p13 and its involvement in PD pathogenesis using mitochondrial toxin-induced PD models. We show that p13 overexpression induces mitochondrial dysfunction and apoptosis. p13 knockdown attenuates toxin-induced mitochondrial dysfunction and apoptosis in dopaminergic SH-SY5Y cells via the regulation of complex I. Importantly, we generate<i>p13</i>-deficient mice using the CRISPR/Cas9 system and observe that heterozygous<i>p13</i>knockout prevents toxin-induced motor deficits and the loss of dopaminergic neurons in the substantia nigra. Taken together, our results suggest that manipulating p13 expression may be a promising avenue for therapeutic intervention in PD.</AbstractText><CopyrightInformation>© 2018 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Program for Biomedical Sciences, Institute for Academic Initiatives, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Fellowships for Young Scientists of the Japan Society for the Promotion of Science, Chiyoda, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>Sae</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasai</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakazawa</LastName><ForeName>Takanobu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Graduate School of Dentistry, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higashi</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isotani</LastName><ForeName>Ayako</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Animal Resource Center for Infectious Diseases, Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baba</LastName><ForeName>Kousuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mochizuki</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujimura</LastName><ForeName>Harutoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Toneyama National Hospital, Toyonaka, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ago</LastName><ForeName>Yukio</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayata-Takano</LastName><ForeName>Atsuko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University Kanazawa University Hamamatsu University School of Medicine Chiba University and University of Fukui, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seiriki</LastName><ForeName>Kaoru</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Program for Biomedical Sciences, Institute for Academic Initiatives, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shintani</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shintani</LastName><ForeName>Norihito</ForeName><Initials>N</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7850-9064</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan shintani@phs.osaka-u.ac.jp hasimoto@phs.osaka-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Hitoshi</ForeName><Initials>H</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6548-4016</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan shintani@phs.osaka-u.ac.jp hasimoto@phs.osaka-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University Kanazawa University Hamamatsu University School of Medicine Chiba University and University of Fukui, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iPS Cell-based Research Project on Brain Neuropharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Bioscience, Institute for Datability Science, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Rep</MedlineTA><NlmUniqueID>100963049</NlmUniqueID><ISSNLinking>1469-221X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">cell death</Keyword><Keyword MajorTopicYN="N">complex I</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">p13</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29371327</ArticleId><ArticleId IdType="pii">embr.201744860</ArticleId><ArticleId IdType="doi">10.15252/embr.201744860</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29371126</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3649</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Vascular pharmacology</Title><ISOAbbreviation>Vascul. Pharmacol.</ISOAbbreviation></Journal><ArticleTitle>A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1537-1891(17)30336-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vph.2018.01.005</ELocationID><Abstract><AbstractText>Inflammation plays an important role in atherosclerosis, a notion supported by the beneficial effects of the IL-1β inhibitor canakinumab in the CANTOS trial. Sialic acids (Sias), components of the surface glycocalyx, regulate intercellular and intermolecular interactions. We investigated the expression of the Sia cleaving enzyme neuraminidase-1 (NEU1) in atherosclerotic plaques and its potential role in inflammatory processes. In isolated mononuclear blood cells from patients with myocardial infarction, NEU1 expression was increased compared to healthy controls. High expression of NEU1 in macrophages located on the intima layer, in calcified regions and the adventitia of the plaque was observed in human carotid arteries' atherectomies. IL-1β and LPS induced NEU1 expression in THP-1 monocytic cells. Lentiviral NEU1-overexpression in THP-1-cells enhanced expression of CD80, TNF-α, IL-1β, number of multinuclear cells, phagocytosis and chemotaxis indicative for M1 monocyte/macrophage polarization. CRISPR/Cas9-mediated knock-out of NEU1 in THP-1-cells did not affect differentiation of monocytes to macrophages but attenuated LPS- and IL-1β -induced TNF-α and IL-1β expression. SiRNA-mediated knock-down of NEU1 in M1-macrophages differentiated from primary human CD14<sup>+</sup>monocytes reduced the expression of TNF-α and IL-1β. Thus, in monocytes/macrophages, LPS, NEU1 and IL-1β act in a positive feedback loop as enhancers of inflammation and may therefore promote atherosclerosis and plaque instability.</AbstractText><CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sieve</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricke-Hoch</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasten</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battmer</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stapel</LastName><ForeName>Britta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falk</LastName><ForeName>Christine S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leisegang</LastName><ForeName>Matthias S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Institute for Cardiovascular Physiology, Goethe-University, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haverich</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherr</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilfiker-Kleiner</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. Electronic address: hilfiker.denise@mh-hannover.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Vascul Pharmacol</MedlineTA><NlmUniqueID>101130615</NlmUniqueID><ISSNLinking>1537-1891</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atherosclerosis</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Monocytes/macrophage</Keyword><Keyword MajorTopicYN="N">Neuraminidase 1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29371126</ArticleId><ArticleId IdType="pii">S1537-1891(17)30336-1</ArticleId><ArticleId IdType="doi">10.1016/j.vph.2018.01.005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29370868</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-3305</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Parasites &amp; vectors</Title><ISOAbbreviation>Parasit Vectors</ISOAbbreviation></Journal><ArticleTitle>mRNA export in the apicomplexan parasite Toxoplasma gondii: emerging divergent components of a crucial pathway.</ArticleTitle><Pagination><MedlinePgn>62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13071-018-2648-4</ELocationID><Abstract><AbstractText>Control of gene expression is crucial for parasite survival and is the result of a series of processes that are regulated to permit fine-tuning of gene expression in response to biological changes during the life-cycle of apicomplexan parasites. Control of mRNA nuclear export is a key process in eukaryotic cells but is poorly understood in apicomplexan parasites. Here, we review recent knowledge regarding this process with an emphasis on T. gondii. We describe the presence of divergent orthologs and discuss structural and functional differences in export factors between apicomplexans and other eukaryotic lineages. Undoubtedly, the use of the CRISPR/Cas9 system in high throughput screenings associated with the discovery of mRNA nuclear export complexes by proteomic analysis will contribute to identify these divergent factors. Ligand-based or structure-based strategies may be applied to investigate the potential use of these proteins as targets for new antiprotozoal agents.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ávila</LastName><ForeName>Andréa Rodrigues</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Instituto Carlos Chagas, FIOCRUZ, Rua Algacyr Munhoz Mader, 3775. CIC, Curitiba, PR, 81350-010, Brazil. andrea.avila@fiocruz.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR BIPAR, Animal Health Laboratory, ANSES, INRA, ENVA, Maisons Alfort, Cedex, France. andrea.avila@fiocruz.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabezas-Cruz</LastName><ForeName>Alexjandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UMR BIPAR, Animal Health Laboratory, ANSES, INRA, ENVA, Maisons Alfort, Cedex, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Parasitology, Biology Center, Czech Academy of Sciences, České Budějovice, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gissot</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0047-8189</Identifier><AffiliationInfo><Affiliation>University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France. mathieu.gissot@pasteur-lille.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ANR-13-JSV3-0006-01</GrantID><Agency>Agence Nationale de la Recherche</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Parasit Vectors</MedlineTA><NlmUniqueID>101462774</NlmUniqueID><ISSNLinking>1756-3305</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2005 Aug 17;24(16):2862-72</RefSource><PMID Version="1">16037817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2017 Mar 2;13(3):e1006170</RefSource><PMID Version="1">28253370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jan;41(2):1294-306</RefSource><PMID Version="1">23222130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cell Biol. 2002 Oct;81(10):549-56</RefSource><PMID Version="1">12437189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2012 Jun;1819(6):514-20</RefSource><PMID Version="1">22207203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2013 Feb 6;32(3):473-86</RefSource><PMID Version="1">23299939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2004 Jun;11(6):558-66</RefSource><PMID Version="1">15133499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1998 Aug 17;17(16):4859-72</RefSource><PMID Version="1">9707445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Biotechnol. 2010;2010:726045</RefSource><PMID Version="1">20204171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10181-6</RefSource><PMID Version="1">17535896</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Biol Macromol. 2017 May;98 :793-801</RefSource><PMID Version="1">28212935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleus. 2013 Jul-Aug;4(4):315-25</RefSource><PMID Version="1">23782956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2007 Jun 19;581(15):2783-93</RefSource><PMID Version="1">17509569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2008 Oct;70(2):410-20</RefSource><PMID Version="1">18761691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleus. 2016 Sep 2;7(5):430-446</RefSource><PMID Version="1">27673359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Evol Biol. 2011 Jan 11;11:7</RefSource><PMID Version="1">21223572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2001 Jun 8;498(2-3):150-6</RefSource><PMID Version="1">11412847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2009 Apr-Jun;6(2):145-8</RefSource><PMID Version="1">19229139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2001 Mar;7(3):351-60</RefSource><PMID Version="1">11333016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Parasitol. 2004 Mar 9;34(3):423-32</RefSource><PMID Version="1">15003501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2009 Feb;10(2):126-39</RefSource><PMID Version="1">19165215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleus. 2011 Nov-Dec;2(6):540-8</RefSource><PMID Version="1">22064466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Jun 27;278(26):24225-32</RefSource><PMID Version="1">12702719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Nov 16;43(20):9874-88</RefSource><PMID Version="1">26476453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1999 Apr 19;145(2):237-54</RefSource><PMID Version="1">10209021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2000 Jul;20(13):4562-71</RefSource><PMID Version="1">10848583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 Mar 13;156(6):1247-1258</RefSource><PMID Version="1">24582333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2017 Aug;74(16):2875-2897</RefSource><PMID Version="1">28314893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Jan;28(2):601-8</RefSource><PMID Version="1">17984224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1999 Aug 15;13(16):2118-33</RefSource><PMID Version="1">10465789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jul 21;33(13):3994-4006</RefSource><PMID Version="1">16040597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1997 Sep 19;90(6):1041-50</RefSource><PMID Version="1">9323132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wiley Interdiscip Rev RNA. 2017 May;8(3):</RefSource><PMID Version="1">28008720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Nov 29;450(7170):695-701</RefSource><PMID Version="1">18046406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Microbiol. 2017 Feb;19(2):null</RefSource><PMID Version="1">27385072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2016 Feb 18;14(2):e1002365</RefSource><PMID Version="1">26891179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Microbiol. 2007 Aug;10(4):357-62</RefSource><PMID Version="1">17719264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eukaryot Cell. 2009 Dec;8(12):1814-27</RefSource><PMID Version="1">19801417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2015 Mar;13(3):160-72</RefSource><PMID Version="1">25659318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Commun Integr Biol. 2010 Jul;3(4):318-26</RefSource><PMID Version="1">20798816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleus. 2016 Apr 25;7(2):126-31</RefSource><PMID Version="1">27028218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jun;42(10):6686-97</RefSource><PMID Version="1">24705649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2012;10(3):e1001287</RefSource><PMID Version="1">22479148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jan;42(Database issue):D222-30</RefSource><PMID Version="1">24288371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Apr 14;101(2):187-98</RefSource><PMID Version="1">10786834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2008 Oct;19(10):4310-8</RefSource><PMID Version="1">18667528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 May 4;18(9):2593-609</RefSource><PMID Version="1">10228171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Disord Drug Targets. 2010 Aug;10(4):303-11</RefSource><PMID Version="1">20429866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Traffic. 2000 Jun;1(6):448-56</RefSource><PMID Version="1">11208130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2007 Mar;8(3):195-208</RefSource><PMID Version="1">17287812</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biochem Parasitol. 2009 Mar;164(1):9-25</RefSource><PMID Version="1">19110008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2013 Jan;10(1):19-32</RefSource><PMID Version="1">22995829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2013 May;88(4):728-39</RefSource><PMID Version="1">23560737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Parasitol. 2009 Jan;39(2):145-51</RefSource><PMID Version="1">18983845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 May 16;417(6886):304-8</RefSource><PMID Version="1">11979277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Oct 11;413(6856):644-7</RefSource><PMID Version="1">11675789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5154-9</RefSource><PMID Version="1">18364396</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2004 Sep;6(9):840-8</RefSource><PMID Version="1">15311284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 May;40(10):4562-73</RefSource><PMID Version="1">22307388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1998 Aug 3;17(15):4491-502</RefSource><PMID Version="1">9687515</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2001 Dec;7(12):1768-80</RefSource><PMID Version="1">11780633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Mar 14;152(6):1252-69</RefSource><PMID Version="1">23498935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2003 Feb 15;116(Pt 4):587-97</RefSource><PMID Version="1">12538759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Protein J. 2014 Aug;33(4):354-68</RefSource><PMID Version="1">24861003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 May 19;43(9):4491-504</RefSource><PMID Version="1">25873624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1997 Jun 2;16(11):3256-71</RefSource><PMID Version="1">9214641</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Mar 27;33(6):727-37</RefSource><PMID Version="1">19328066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2012 Jun;1819(6):555-65</RefSource><PMID Version="1">22178374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2016 Nov;102(4):672-689</RefSource><PMID Version="1">27542978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2002 Jul 1;21(13):3526-35</RefSource><PMID Version="1">12093753</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Apr 14;472(7342):238-42</RefSource><PMID Version="1">21441902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2007 Oct;8(10):761-73</RefSource><PMID Version="1">17786152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2009 Jun;28(6):277-84</RefSource><PMID Version="1">19348590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Nov;18(11):6826-38</RefSource><PMID Version="1">9774696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2005 Dec;11(12):1869-83</RefSource><PMID Version="1">16314458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2017 Jun;74(11):2107-2125</RefSource><PMID Version="1">28138739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2010 Jan 12;20(1):25-31</RefSource><PMID Version="1">20005110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2005 Jul 1;19(13):1512-7</RefSource><PMID Version="1">15998806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 Jul 1;18(13):3746-56</RefSource><PMID Version="1">10393189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 2007 Apr;17 (4):193-201</RefSource><PMID Version="1">17317185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 May 25;282(21):15645-51</RefSource><PMID Version="1">17363367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 1998 Apr;4(4):351-64</RefSource><PMID Version="1">9630243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1997 Sep 19;90(6):1051-60</RefSource><PMID Version="1">9323133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Cell Dev Biol. 2017 Feb 13;5:8</RefSource><PMID Version="1">28243589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Nov;37(21):7151-62</RefSource><PMID Version="1">19786495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2004 Mar 15;117(Pt 8):1553-66</RefSource><PMID Version="1">15020682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2007 Dec 14;28(5):850-9</RefSource><PMID Version="1">18082609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eukaryot Cell. 2013 Feb;12(2):161-7</RefSource><PMID Version="1">23243065</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2013 Oct 23;425(20):3824-38</RefSource><PMID Version="1">23721653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Apr;42(8):5059-71</RefSource><PMID Version="1">24510098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2010 Sep 15;24(18):2043-53</RefSource><PMID Version="1">20844015</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apicomplexa</Keyword><Keyword MajorTopicYN="N">Cryptosporidium</Keyword><Keyword MajorTopicYN="N">Gene expression</Keyword><Keyword MajorTopicYN="N">Parasites</Keyword><Keyword MajorTopicYN="N">Plasmodium</Keyword><Keyword MajorTopicYN="N">Toxoplasma</Keyword><Keyword MajorTopicYN="N">mRNA export</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29370868</ArticleId><ArticleId IdType="doi">10.1186/s13071-018-2648-4</ArticleId><ArticleId IdType="pii">10.1186/s13071-018-2648-4</ArticleId><ArticleId IdType="pmc">PMC5785795</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29370725</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-7448</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Immunotherapy</Title><ISOAbbreviation>Immunotherapy</ISOAbbreviation></Journal><ArticleTitle>Pooled in vivo screens for cancer immunotherapy target discovery.</ArticleTitle><Pagination><MedlinePgn>167-170</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2217/imt-2017-0164</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lane-Reticker</LastName><ForeName>Sarah K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of Harvard &amp; Massachusetts Institute of Technology, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manguso</LastName><ForeName>Robert T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of Harvard &amp; Massachusetts Institute of Technology, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haining</LastName><ForeName>W Nicholas</ForeName><Initials>WN</Initials><AffiliationInfo><Affiliation>Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of Harvard &amp; Massachusetts Institute of Technology, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Hematology &amp; Oncology, Children's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immunotherapy</MedlineTA><NlmUniqueID>101485158</NlmUniqueID><ISSNLinking>1750-743X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">functional genomics screen</Keyword><Keyword MajorTopicYN="N">immune checkpoint blockade</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29370725</ArticleId><ArticleId IdType="doi">10.2217/imt-2017-0164</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29370514</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8937</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>ACS chemical biology</Title><ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation></Journal><ArticleTitle>Can CRISPR-Based Gene Drive Be Confined in the Wild? A Question for Molecular and Population Biology.</ArticleTitle><Pagination><MedlinePgn>424-430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.7b00923</ELocationID><Abstract><AbstractText>The recent discovery of CRISPR and its application as a gene editing tool has enabled a range of gene drive systems to be engineered with greater ease. In order for the benefits of this technology to be realized, in some circumstances drive systems should be developed that are capable of both spreading into populations to achieve their desired impact and being recalled in the event of unwanted consequences or public disfavor. We review the performance of three broad categories of drive systems at achieving these goals: threshold-dependent drives, homing-based drive and remediation systems, and temporally self-limiting systems such as daisy-chain drives.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Divisions of Biostatistics and Epidemiology, School of Public Health, University of California , Berkeley, California 94720, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari</LastName><ForeName>Omar S</ForeName><Initials>OS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6853-9884</Identifier><AffiliationInfo><Affiliation>Section of Cell and Developmental Biology, University of California, San Diego , La Jolla, California 92093, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Biol</MedlineTA><NlmUniqueID>101282906</NlmUniqueID><ISSNLinking>1554-8929</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29370514</ArticleId><ArticleId IdType="doi">10.1021/acschembio.7b00923</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29370156</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2799</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Nature protocols</Title><ISOAbbreviation>Nat Protoc</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9 genome editing in human hematopoietic stem cells.</ArticleTitle><Pagination><MedlinePgn>358-376</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nprot.2017.143</ELocationID><Abstract><AbstractText>Genome editing via homologous recombination (HR) (gene targeting) in human hematopoietic stem cells (HSCs) has the power to reveal gene-function relationships and potentially transform curative hematological gene and cell therapies. However, there are no comprehensive and reproducible protocols for targeting HSCs for HR. Herein, we provide a detailed protocol for the production, enrichment, and in vitro and in vivo analyses of HR-targeted HSCs by combining CRISPR/Cas9 technology with the use of rAAV6 and flow cytometry. Using this protocol, researchers can introduce single-nucleotide changes into the genome or longer gene cassettes with the precision of genome editing. Along with our troubleshooting and optimization guidelines, researchers can use this protocol to streamline HSC genome editing at any locus of interest. The in vitro HSC-targeting protocol and analyses can be completed in 3 weeks, and the long-term in vivo HSC engraftment analyses in immunodeficient mice can be achieved in 16 weeks. This protocol enables manipulation of genes for investigation of gene functions during hematopoiesis, as well as for the correction of genetic mutations in HSC transplantation-based therapies for diseases such as sickle cell disease, β-thalassemia, and primary immunodeficiencies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bak</LastName><ForeName>Rasmus O</ForeName><Initials>RO</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7383-0297</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dever</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porteus</LastName><ForeName>Matthew H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI097320</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI120766</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Protoc</MedlineTA><NlmUniqueID>101284307</NlmUniqueID><ISSNLinking>1750-2799</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 May 6;115(18):3704-7</RefSource><PMID Version="1">20207983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2017 Sep 28;6:null</RefSource><PMID Version="1">28956530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Aug 25;6:32230</RefSource><PMID Version="1">27557525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2016 Oct 25;17 (5):1453-1461</RefSource><PMID Version="1">27783956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2011 Jul 8;333(6039):218-21</RefSource><PMID Version="1">21737740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2012 Feb 3;10(2):120-36</RefSource><PMID Version="1">22305562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2007 Dec 13;1(6):635-45</RefSource><PMID Version="1">18371405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Immunol. 2001 May;Appendix 3:Appendix 3B</RefSource><PMID Version="1">18432654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Apr 9;520(7546):186-91</RefSource><PMID Version="1">25830891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Jan;18(1):93-101</RefSource><PMID Version="1">9418857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jan 15;517(7534):360-4</RefSource><PMID Version="1">25363772</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther Methods. 2012 Feb;23(1):18-28</RefSource><PMID Version="1">22428977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2017 Jan 11;9(372):null</RefSource><PMID Version="1">28077679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2016 May 03;17 :83</RefSource><PMID Version="1">27142433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2016 Feb 18;44(3):e30</RefSource><PMID Version="1">26527725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2015 Apr 23;125(17):2597-604</RefSource><PMID Version="1">25733580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2017 Jul 18;20(3):750-756</RefSource><PMID Version="1">28723575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e60298</RefSource><PMID Version="1">23555950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10437-42</RefSource><PMID Version="1">26216948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jul 23;523(7561):481-5</RefSource><PMID Version="1">26098369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2000 May;74(10):4612-20</RefSource><PMID Version="1">10775597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2015 Feb;21(2):121-31</RefSource><PMID Version="1">25654603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2007;2(11):2734-46</RefSource><PMID Version="1">18007609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1992 Jul 15;80(2):403-11</RefSource><PMID Version="1">1627798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2015 Sep 30;7(307):307ra156</RefSource><PMID Version="1">26424571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2011 May;12(5):301-15</RefSource><PMID Version="1">21445084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2016 Apr;34(4):424-9</RefSource><PMID Version="1">26950749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2804-8</RefSource><PMID Version="1">1372992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pharmacol Toxicol. 2016;56:163-90</RefSource><PMID Version="1">26566154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2003 May 2;300(5620):763</RefSource><PMID Version="1">12730593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2004 Aug;10(8):828-34</RefSource><PMID Version="1">15273747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Dec 22;16:286</RefSource><PMID Version="1">26694713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1998 Apr;18(4):325-30</RefSource><PMID Version="1">9537413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2008;3(12):1932-40</RefSource><PMID Version="1">19180077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2007 Feb;7(2):118-30</RefSource><PMID Version="1">17259968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2011 Apr;6(4):482-501</RefSource><PMID Version="1">21455185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2016 Jul;22(7):812-21</RefSource><PMID Version="1">27213817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 May;23(10):3550-7</RefSource><PMID Version="1">12724413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2016 May 26;127(21):2513-22</RefSource><PMID Version="1">26903548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e58757</RefSource><PMID Version="1">23516552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Sep;33(9):985-989</RefSource><PMID Version="1">26121415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6064-8</RefSource><PMID Version="1">8016116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2003 Jul;112(1):126-35</RefSource><PMID Version="1">12840067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2016 Mar;24(3):570-81</RefSource><PMID Version="1">26502778</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2016 Oct 12;8(360):360ra134</RefSource><PMID Version="1">27733558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Jun 12;510(7504):235-240</RefSource><PMID Version="1">24870228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2010 Sep 10;584(17):3703-8</RefSource><PMID Version="1">20691183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2016 Nov 17;539(7629):384-389</RefSource><PMID Version="1">27820943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2006;1(3):1412-28</RefSource><PMID Version="1">17406430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Apr 10;7(1):293-305</RefSource><PMID Version="1">24685129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Gene Ther. 2010 Oct;21(10):1273-85</RefSource><PMID Version="1">20486768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource><PMID Version="1">22745249</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29370156</ArticleId><ArticleId IdType="pii">nprot.2017.143</ArticleId><ArticleId IdType="doi">10.1038/nprot.2017.143</ArticleId><ArticleId IdType="pmc">PMC5826598</ArticleId><ArticleId IdType="mid">NIHMS943506</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29368602</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1476-4598</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>Molecular cancer</Title><ISOAbbreviation>Mol. Cancer</ISOAbbreviation></Journal><ArticleTitle>Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms.</ArticleTitle><Pagination><MedlinePgn>14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12943-018-0763-7</ELocationID><Abstract><AbstractText>Head and neck cancer (HNC) ranks as the 6th most common malignancy across the world. Metastasis is a hallmark of cancer, primarily contributing to the relapse and poor prognosis of HNC. Recently, long noncoding RNAs (lncRNAs), previously considered as non-functional, are increasingly appreciated by scholars to play crucial roles in mediating HNC metastasis. LncRNAs, which are located in the nucleus and cytoplasm, mainly exert their function via epigenetic modification, transcriptional control and translational regulation. As several lncRNAs are presently demonstrated to participate in HNC metastasis, we make a summary of the functions and mechanisms regarding these lncRNAs. As shown in the literature, most lncRNAs appear to promote the metastasis of HNC. Hence, we primarily discuss the lncRNAs involved in enhancing metastasis. Additionally, more studies are needed to understand those lncRNAs without clear mechanisms. Furthermore, we introduced the upstream regulator for the aberrant expression of lncRNAs in HNC. Finally, we concisely addressed future research prospects of lncRNAs, particularly the interplay between lncRNAs and tumor immunity as well as lncRNA-targeted therapeutic techniques, and we introduced clustered regularly interspaced short palindromic repeats (CRISPR)-Display as a possibly transformative tool to study lncRNAs. Although lncRNA research is still in the initial stage, it holds great promise to be applied as a prognosticator of HNC and a therapeutic target to inhibit HNC metastasis, which could significantly enhance the outcome of HNC patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Clinical Research Center for Oral Diseases &amp; Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry Comprehensive Cancer Center, 1600 Huron Parkway 2355, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Pathology, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yuchen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Clinical Research Center for Oral Diseases &amp; Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Fangman</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Clinical Research Center for Oral Diseases &amp; Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Clinical Research Center for Oral Diseases &amp; Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Clinical Research Center for Oral Diseases &amp; Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dan</LastName><ForeName>Hongxia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Clinical Research Center for Oral Diseases &amp; Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Clinical Research Center for Oral Diseases &amp; Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Yu L</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry Comprehensive Cancer Center, 1600 Huron Parkway 2355, Ann Arbor, MI, 48109, USA. leiyuleo@umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, 48109, USA. leiyuleo@umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Michigan Health System, 1600 Huron Parkway 2355, Ann Arbor, MI, 48109, USA. leiyuleo@umich.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qianming</ForeName><Initials>Q</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5371-4432</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Clinical Research Center for Oral Diseases &amp; Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China. qmchen@scu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>B14038</GrantID><Agency>111 Project of MOE China</Agency><Country>United States</Country></Grant><Grant><GrantID>SKLOD2017OF03</GrantID><Agency>the State Key Laboratory of Oral Diseases</Agency><Country>United States</Country></Grant><Grant><GrantID>81520108009</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>United States</Country></Grant><Grant><GrantID>81621062</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 DE024173</GrantID><Agency>NIH/NIDCR</Agency><Country>United States</Country></Grant><Grant><GrantID>81771081</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 DE024173</GrantID><Acronym>DE</Acronym><Agency>NIDCR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Cancer</MedlineTA><NlmUniqueID>101147698</NlmUniqueID><ISSNLinking>1476-4598</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2014 Mar 06;15(3):4060-76</RefSource><PMID Version="1">24663081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2014 Jun 12;5:e1287</RefSource><PMID Version="1">24922071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther Nucleic Acids. 2014 Nov 18;3:e196</RefSource><PMID Version="1">25405465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2017 May;50(5):1801-1809</RefSource><PMID Version="1">28358427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2013 Apr;104(4):458-64</RefSource><PMID Version="1">23281836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oral Oncol. 2016 Oct;61:159-65</RefSource><PMID Version="1">27553942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 May 29;109(22):8646-51</RefSource><PMID Version="1">22586128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Transl Res. 2016 Oct 15;8(10 ):4338-4345</RefSource><PMID Version="1">27830017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Oct 6;6(30):29209-23</RefSource><PMID Version="1">26353930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2016 Jul 15;139(2):269-80</RefSource><PMID Version="1">26875870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2015 Feb 19;34:18</RefSource><PMID Version="1">25884472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2014 Jul;32(1):395-402</RefSource><PMID Version="1">24840737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer. 2017 Feb 11;8(4):523-530</RefSource><PMID Version="1">28367232</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2016 Sep;107(9):1215-22</RefSource><PMID Version="1">27311700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2016 Nov 23;17 (11):</RefSource><PMID Version="1">27886062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Melanoma Res. 2014 Aug;24(4):335-41</RefSource><PMID Version="1">24892958</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2015 Mar;36(3):1477-86</RefSource><PMID Version="1">25431257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2017 Jul;39(7):1010428317714361</RefSource><PMID Version="1">28671045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nan Fang Yi Ke Da Xue Xue Bao. 2013 May;33(5):692-7</RefSource><PMID Version="1">23688988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oral Oncol. 2009 Apr-May;45(4-5):309-16</RefSource><PMID Version="1">18804401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 22;9(9):e108237</RefSource><PMID Version="1">25243407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Mar 8;7(10 ):11553-66</RefSource><PMID Version="1">26872375</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry (Mosc). 2017 Apr;82(4):438-445</RefSource><PMID Version="1">28371600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Res. 2016;23 (3):99-107</RefSource><PMID Version="1">26931432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2012 Jul;41(1):276-84</RefSource><PMID Version="1">22576688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2011 Sep 15;25(18):1915-27</RefSource><PMID Version="1">21890647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Sep 20;7(38):62520-62532</RefSource><PMID Version="1">27613832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med Rep. 2015 Apr;11(4):3155-9</RefSource><PMID Version="1">25516208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Sep 15;67(18):8800-9</RefSource><PMID Version="1">17875721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Dec;35(12):12181-8</RefSource><PMID Version="1">25185650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2015 Jan;22(1):5-7</RefSource><PMID Version="1">25565026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Mar 27;33(6):717-26</RefSource><PMID Version="1">19217333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biomark. 2016;16(2):291-300</RefSource><PMID Version="1">26756620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2017 Apr 15;77(8):1854-1867</RefSource><PMID Version="1">28130225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2016 Sep 01;16:706</RefSource><PMID Version="1">27586393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2017 Nov 15;77(22):6353-6364</RefSource><PMID Version="1">28904066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oral Pathol Med. 2017 Feb;46(2):98-105</RefSource><PMID Version="1">27353727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2017 Jun;39(6):1010428317699417</RefSource><PMID Version="1">28631575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2011 Jul;39(1):169-75</RefSource><PMID Version="1">21503572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Aug 6;329(5992):689-93</RefSource><PMID Version="1">20616235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2015 Aug 01;8(8):9052-61</RefSource><PMID Version="1">26464647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2015 Mar;36(3):1643-51</RefSource><PMID Version="1">25366138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Feb 15;482(7385):339-46</RefSource><PMID Version="1">22337053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2015 Jul;12(7):664-70</RefSource><PMID Version="1">26030444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med Rep. 2017 Oct;16(4):5587-5591</RefSource><PMID Version="1">28849215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2016 Jun 24;90(14 ):6475-88</RefSource><PMID Version="1">27147748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2009 Nov;221(2):394-401</RefSource><PMID Version="1">19591174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2016 Apr 11;29(4):452-463</RefSource><PMID Version="1">27070700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108</RefSource><PMID Version="1">15761078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Mar 7;8(10 ):16621-16632</RefSource><PMID Version="1">28039470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2014 Mar 15;7(4):1286-92</RefSource><PMID Version="1">24817925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2003 Mar 20;104(2):179-87</RefSource><PMID Version="1">12569573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2015 May 01;8(5):4881-91</RefSource><PMID Version="1">26191181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2006 Aug 15;12(16):4851-8</RefSource><PMID Version="1">16914571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Ther Med. 2013 Apr;5(4):1143-1146</RefSource><PMID Version="1">23599737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2016 Aug;37(8):10633-41</RefSource><PMID Version="1">26867765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2016 Sep 01;7(9):e2352</RefSource><PMID Version="1">27584791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2011 Oct 15;71(20):6320-6</RefSource><PMID Version="1">21862635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Nov 02;5:15972</RefSource><PMID Version="1">26522444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2017 Feb;50(2):708-716</RefSource><PMID Version="1">28000845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2017 Sep 30;16(1):155</RefSource><PMID Version="1">28964256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2014 Jan 23;5:e1008</RefSource><PMID Version="1">24457952</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2017 Jun 13;8(24):39001-39011</RefSource><PMID Version="1">28380458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Pharmacother. 2017 Apr;88:863-869</RefSource><PMID Version="1">28178615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2017 Jun;39(6):1010428317706054</RefSource><PMID Version="1">28635400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2015 Feb 1;75(3):508-518</RefSource><PMID Version="1">25480946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Pathol. 2016 Oct;101(2):267-273</RefSource><PMID Version="1">27693324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2013 Jan;182(1):64-70</RefSource><PMID Version="1">23141928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96</RefSource><PMID Version="1">24556840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3403-11</RefSource><PMID Version="1">26439035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2015 Jan 22;34:7</RefSource><PMID Version="1">25613496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2017 Apr 5;25(4):1014-1026</RefSource><PMID Version="1">28214253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Sep 6;489(7414):101-8</RefSource><PMID Version="1">22955620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2015;1262:321-31</RefSource><PMID Version="1">25555591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Physiol Biochem. 2016;40(5):1039-1051</RefSource><PMID Version="1">27941336</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2018 Mar;57(3):305-318</RefSource><PMID Version="1">29068471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2012 Jan 20;11(2):125-40</RefSource><PMID Version="1">22262036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Nov 25;9(11):e110674</RefSource><PMID Version="1">25422887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Pathol. 2017 Jun;102(3):500-504</RefSource><PMID Version="1">28506768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2015 Jun;21(6):1122-34</RefSource><PMID Version="1">25904139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Transl Med. 2016 Feb 08;14 :42</RefSource><PMID Version="1">26856330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biomark. 2016 Jun 24;17 (2):171-7</RefSource><PMID Version="1">27540975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2015 May 01;8(5):5427-34</RefSource><PMID Version="1">26191246</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Histol. 2013 Oct;44(5):545-54</RefSource><PMID Version="1">23529758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2016 Oct 21;22(39):8735-8749</RefSource><PMID Version="1">27818589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Biochem Cell Biol. 2013 Aug;45(8):1895-910</RefSource><PMID Version="1">23748105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2017 Apr;37(4):2087-2094</RefSource><PMID Version="1">28260102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2004 Aug;114(4):569-81</RefSource><PMID Version="1">15314694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2015 ;46(6):2586-94</RefSource><PMID Version="1">25901533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2014 May 15;7(6):2838-49</RefSource><PMID Version="1">25031703</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2016 Jul;142(7):1571-9</RefSource><PMID Version="1">27095450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jan;117(1):89-95</RefSource><PMID Version="1">24332332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocr Pathol. 2017 Mar;28(1):7-12</RefSource><PMID Version="1">27696303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioarchitecture. 2012 Nov-Dec;2(6):189-99</RefSource><PMID Version="1">23267412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2016 Nov;107(11):1581-1589</RefSource><PMID Version="1">27560546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2010 Sep 24;39(6):925-38</RefSource><PMID Version="1">20797886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2015 Jul 16;59(2):146-8</RefSource><PMID Version="1">26186289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2017 Feb;36(2):159-167</RefSource><PMID Version="1">28075173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2017 Jan 17;16(2):224-231</RefSource><PMID Version="1">27929737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2016 Jul;37(7):9699-707</RefSource><PMID Version="1">26803513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2008 Dec 18;272(2):177-85</RefSource><PMID Version="1">18579285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Res. 2017 Apr 12;:null</RefSource><PMID Version="1">28409554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2017 Mar 21;16(1):68</RefSource><PMID Version="1">28327194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Sep;35(9):9163-9</RefSource><PMID Version="1">24920070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2015 Jul 02;6:e1802</RefSource><PMID Version="1">26136075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2015 Jan;12(1):11-26</RefSource><PMID Version="1">25403939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2017 Apr 15;608:49-57</RefSource><PMID Version="1">28119088</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biochem. 2014 Sep;394(1-2):177-86</RefSource><PMID Version="1">24889262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Aug 21;6(24):20404-18</RefSource><PMID Version="1">26246469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 2015 Nov;25(11):675-86</RefSource><PMID Version="1">26437589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2016 May;37(5):6117-23</RefSource><PMID Version="1">26611646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA Biol. 2012 Aug;9(8):1076-87</RefSource><PMID Version="1">22858678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2015 Dec 01;8(12 ):15903-10</RefSource><PMID Version="1">26884862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Feb 1;73(3):1180-9</RefSource><PMID Version="1">23243023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2015;16(7):2851-5</RefSource><PMID Version="1">25854373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2015 Mar 9;27(3):370-81</RefSource><PMID Version="1">25759022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2015 Nov;36(11):8805-9</RefSource><PMID Version="1">26058875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2017 Apr 20;36(16):2243-2254</RefSource><PMID Version="1">27819679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Jun 10;6(16):14179-90</RefSource><PMID Version="1">25895025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Histol. 2016 Aug;47(4):421-8</RefSource><PMID Version="1">27323757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>RNA. 2007 Mar;13(3):313-6</RefSource><PMID Version="1">17237358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2015 Jan 08;16(1):1395-405</RefSource><PMID Version="1">25580533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2016 Jan;37(1):729-37</RefSource><PMID Version="1">26245991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Pharmacother. 2016 Oct;83:1-7</RefSource><PMID Version="1">27470543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2007 Feb;14(2):103-5</RefSource><PMID Version="1">17277804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2014 May 22;5:e1243</RefSource><PMID Version="1">24853421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Nov 15;135(10):2282-93</RefSource><PMID Version="1">24343426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2007 Jun 29;129(7):1311-23</RefSource><PMID Version="1">17604720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Apr 15;464(7291):1071-6</RefSource><PMID Version="1">20393566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Sep 29;6(29):27641-50</RefSource><PMID Version="1">26314847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2003 Sep 11;22(39):8031-41</RefSource><PMID Version="1">12970751</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2011 Sep 23;11(10):735-48</RefSource><PMID Version="1">21941285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2876-81</RefSource><PMID Version="1">23382218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Epigenetics. 2016 Nov 26;8:129</RefSource><PMID Version="1">27933111</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Head and neck cancer</Keyword><Keyword MajorTopicYN="N">Invasion</Keyword><Keyword MajorTopicYN="N">Long noncoding RNA</Keyword><Keyword MajorTopicYN="N">Mechanism</Keyword><Keyword MajorTopicYN="N">Metastasis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29368602</ArticleId><ArticleId IdType="doi">10.1186/s12943-018-0763-7</ArticleId><ArticleId IdType="pii">10.1186/s12943-018-0763-7</ArticleId><ArticleId IdType="pmc">PMC5784721</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29367930</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2322-1984</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of arthropod-borne diseases</Title><ISOAbbreviation>J Arthropod Borne Dis</ISOAbbreviation></Journal><ArticleTitle>Curbing Malaria: A New Hope through Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology.</ArticleTitle><Pagination><MedlinePgn>539-540</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Panigrahi</LastName><ForeName>Manjit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Animal Genetics Division, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panigrahi</LastName><ForeName>Ansuman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>J Arthropod Borne Dis</MedlineTA><NlmUniqueID>101593448</NlmUniqueID><ISSNLinking>2322-1984</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>MBio. 2014 Jul 01;5(4):e01414-14</RefSource><PMID Version="1">24987097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2014 Jul 17;3:</RefSource><PMID Version="1">25035423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Med. 2012;63:35-61</RefSource><PMID Version="1">22248320</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2011;45:273-97</RefSource><PMID Version="1">22060043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Microbiol. 2011 Jun;14(3):321-7</RefSource><PMID Version="1">21531607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Feb 15;482(7385):331-8</RefSource><PMID Version="1">22337052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2013 Oct;10(10):957-63</RefSource><PMID Version="1">24076990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource><PMID Version="1">23287722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Aug 23;341(6148):833-6</RefSource><PMID Version="1">23970676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2007 May 23;8:172</RefSource><PMID Version="1">17521438</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29367930</ArticleId><ArticleId IdType="pmc">PMC5775160</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29367674</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Tryptophan hydroxylase (TRH) loss of function mutations induce growth and behavioral defects in Daphnia magna.</ArticleTitle><Pagination><MedlinePgn>1518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-19778-0</ELocationID><Abstract><AbstractText>Tryptophan hydroxylase (TRH) is the rate limiting enzyme in the serotonin synthesis. CRISPR-Cas9 technology was used to generate seven indel TRH mutants in Daphnia magna. Mono-allelic indel TRH-/+ clones showed normal levels of serotonin, measured by both immunohistochemistry and mass spectrometry (LC-MS/MS), whereas bi-allelic indel TRH-/- clones showed no detectable levels of serotonin. Life history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin grew less and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate phenotype. The SSRI fluoxetine enhanced offspring production in all clones and decreased the response to light only in those clones having serotonin, thus indication that behavioral effects of this drug in D. magna are associated to serotonin. Results obtained with the TRH mutants are in line with reported ones in TRH knockouts of Caenorhabditis elegans, Drosophila and mice, indicating that there is one gene encoding TRH, which is the serotonin limiting enzyme in both the central and the periphery nervous system in Daphnia and that deprivation of serotonin increases anxiety-like behavior.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rivetti</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA, CSIC), Jordi Girona 18, 08017, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA, CSIC), Jordi Girona 18, 08017, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piña</LastName><ForeName>Benjamín</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA, CSIC), Jordi Girona 18, 08017, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raldúa</LastName><ForeName>Demetrio</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA, CSIC), Jordi Girona 18, 08017, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Yasuhiko</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-1041-1044</Identifier><AffiliationInfo><Affiliation>Graduate School of Engineering, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Hajime</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Graduate School of Engineering, Osaka University, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barata</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research (IDAEA, CSIC), Jordi Girona 18, 08017, Barcelona, Spain. cbmqam@cid.csic.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 May 22;98(11):6256-60</RefSource><PMID Version="1">11353872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Proteome Res. 2011 Oct 7;10(10):4478-504</RefSource><PMID Version="1">21830762</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2011 Oct;68(20):3403-23</RefSource><PMID Version="1">21365282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Brain Behav. 2007 Nov;6(8):756-69</RefSource><PMID Version="1">17376153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oecologia. 2001 Oct;129(2):220-227</RefSource><PMID Version="1">28547600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Anal Methods Chem. 2014;2014:506870</RefSource><PMID Version="1">25258696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Neurosci. 2013 Jul 17;4(7):1049-56</RefSource><PMID Version="1">23607816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ecotoxicol Environ Saf. 2014 Mar;101:124-30</RefSource><PMID Version="1">24507137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comp Physiol A. 2000 Mar;186(3):221-38</RefSource><PMID Version="1">10757238</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jun 13;344(6189):1293-7</RefSource><PMID Version="1">24926022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Sci Technol. 2002 Mar 15;36(6):1202-11</RefSource><PMID Version="1">11944670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Tissue Res. 1997 Feb;287(3):565-76</RefSource><PMID Version="1">9023085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aquat Toxicol. 2010 Sep 1;99(3):397-404</RefSource><PMID Version="1">20591511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Comp Biochem Physiol C. 1984;77(1):139-43</RefSource><PMID Version="1">6141868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2013;4:1856</RefSource><PMID Version="1">23673641</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aquat Toxicol. 2014 Jun;151:46-56</RefSource><PMID Version="1">24373616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Sci Technol. 2012 Mar 6;46(5):2943-50</RefSource><PMID Version="1">22324381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014 Dec 15;5:5778</RefSource><PMID Version="1">25502946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aquat Toxicol. 2012 Mar;109 :100-10</RefSource><PMID Version="1">22210498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Feb 25;463(7284):1079-83</RefSource><PMID Version="1">20147900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Sci Technol. 2013 Aug 20;47(16):9434-43</RefSource><PMID Version="1">23855649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Feb 3;403(6769):560-4</RefSource><PMID Version="1">10676966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 May 30;9(5):e98363</RefSource><PMID Version="1">24878568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Evol Biol. 2010 Oct 12;10:305</RefSource><PMID Version="1">20939922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gen Comp Endocrinol. 2012 Jan 15;175(2):217-33</RefSource><PMID Version="1">22146796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2008;9(2):R40</RefSource><PMID Version="1">18291039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genetics. 2005 Mar;169(3):1425-36</RefSource><PMID Version="1">15654117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neural Plast. 2016;2016:7291438</RefSource><PMID Version="1">26989517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Toxicol Chem. 2007 Jan;26(1):85-91</RefSource><PMID Version="1">17269464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2017 May 30;14 (6):547-548</RefSource><PMID Version="1">28557981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aquat Toxicol. 2016 Jan;170:289-96</RefSource><PMID Version="1">26277448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Sci Technol. 2016 Jun 7;50(11):6000-7</RefSource><PMID Version="1">27128505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Dec 2;366(6454):461-4</RefSource><PMID Version="1">8247153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Comput Biol. 2017 Mar 2;13(3):e1005341</RefSource><PMID Version="1">28253259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Chromatogr A. 2015 May 22;1395:79-87</RefSource><PMID Version="1">25869798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2013 Dec;140(24):4982-7</RefSource><PMID Version="1">24257628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Braz J Med Biol Res. 2001 Jan;34(1):75-80</RefSource><PMID Version="1">11151031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2008 Jul 15;22(14):1877-93</RefSource><PMID Version="1">18628395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Health Perspect. 2015 Aug;123(8):813-9</RefSource><PMID Version="1">25802986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2011 Feb 4;331(6017):555-61</RefSource><PMID Version="1">21292972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008;3(10):e3301</RefSource><PMID Version="1">18923670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aquat Toxicol. 2000 Mar 1;48(2-3):195-209</RefSource><PMID Version="1">10686326</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Tissue Res. 2016 Mar;363(3):649-77</RefSource><PMID Version="1">26391274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropeptides. 2017 Aug;64:101-107</RefSource><PMID Version="1">27866656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microsc Res Tech. 1999 Jan 15-Feb 1;44(2-3):105-20</RefSource><PMID Version="1">10084820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Sci Technol. 2016 Mar 15;50(6):3222-30</RefSource><PMID Version="1">26866575</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2003 Jan 3;299(5603):76</RefSource><PMID Version="1">12511643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ecotoxicology. 2011 May;20(3):552-62</RefSource><PMID Version="1">21380530</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29367674</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-19778-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-19778-0</ArticleId><ArticleId IdType="pmc">PMC5784079</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29367641</PMID><DateRevised><Year>2018</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>01</Month><Day>24</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca<sup>2+</sup>-permeable AMPA receptor-mediated excitotoxicity.</ArticleTitle><Pagination><MedlinePgn>347</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-017-02729-0</ELocationID><Abstract><AbstractText>Mutations in C9ORF72 are the most common cause of familial amyotrophic lateral sclerosis (ALS). Here, through a combination of RNA-Seq and electrophysiological studies on induced pluripotent stem cell (iPSC)-derived motor neurons (MNs), we show that increased expression of GluA1 AMPA receptor (AMPAR) subunit occurs in MNs with C9ORF72 mutations that leads to increased Ca<sup>2+</sup>-permeable AMPAR expression and results in enhanced selective MN vulnerability to excitotoxicity. These deficits are not found in iPSC-derived cortical neurons and are abolished by CRISPR/Cas9-mediated correction of the C9ORF72 repeat expansion in MNs. We also demonstrate that MN-specific dysregulation of AMPAR expression is also present in C9ORF72 patient post-mortem material. We therefore present multiple lines of evidence for the specific upregulation of GluA1 subunits in human mutant C9ORF72 MNs that could lead to a potential pathogenic excitotoxic mechanism in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Selvaraj</LastName><ForeName>Bhuvaneish T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livesey</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Owain T</ForeName><Initials>OT</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cleary</LastName><ForeName>Elaine M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chouhan</LastName><ForeName>Amit K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Psychology and Neuroscience, University of St Andrews, St Andrews, KY16 9JP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gane</LastName><ForeName>Angus B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perkins</LastName><ForeName>Emma M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dando</LastName><ForeName>Owen</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-6269-6408</Identifier><AffiliationInfo><Affiliation>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Development and Repair, inStem, Bangalore, 560065, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lillico</LastName><ForeName>Simon G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>The Roslin Institute and R(D)SVS, University of Edinburgh, Edinburgh, EH25 9RG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Youn-Bok</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Agnes L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poreci</LastName><ForeName>Urjana</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Global Biomarker and Drug Discovery, Biogen, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thankamony</LastName><ForeName>Sai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Global Biomarker and Drug Discovery, Biogen, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pray</LastName><ForeName>Meryll</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Global Biomarker and Drug Discovery, Biogen, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasistha</LastName><ForeName>Navneet A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Development and Repair, inStem, Bangalore, 560065, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnani</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borooah</LastName><ForeName>Shyamanga</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burr</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCampbell</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Research, Biogen, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kind</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Development and Repair, inStem, Bangalore, 560065, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aitman</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitelaw</LastName><ForeName>C Bruce A</ForeName><Initials>CBA</Initials><AffiliationInfo><Affiliation>The Roslin Institute and R(D)SVS, University of Edinburgh, Edinburgh, EH25 9RG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilmut</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miles</LastName><ForeName>Gareth B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Psychology and Neuroscience, University of St Andrews, St Andrews, KY16 9JP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardingham</LastName><ForeName>Giles E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK DRI Institute at Edinburgh, University of Edinburgh, Edinburgh, EH16 4UU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyllie</LastName><ForeName>David J A</ForeName><Initials>DJA</Initials><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK. david.j.a.wyllie@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK. david.j.a.wyllie@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Development and Repair, inStem, Bangalore, 560065, India. david.j.a.wyllie@ed.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandran</LastName><ForeName>Siddharthan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Development and Repair, inStem, Bangalore, 560065, India. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK DRI Institute at Edinburgh, University of Edinburgh, Edinburgh, EH16 4UU, UK. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Nov;23 (21):7448-59</RefSource><PMID Version="1">14559994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 1996 Sep;74(1):185-98</RefSource><PMID Version="1">8843086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5826-31</RefSource><PMID Version="1">15827116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2016 Sep 15;25(18):3908-3924</RefSource><PMID Version="1">27466192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2013 Jan;21(1):102-8</RefSource><PMID Version="1">22692064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Mar 7;12 (3):354-67</RefSource><PMID Version="1">23472874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 2006 Feb;197(2):505-14</RefSource><PMID Version="1">16309674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2015 Sep 23;87(6):1207-1214</RefSource><PMID Version="1">26402604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 2010 Sep;62(3):405-96</RefSource><PMID Version="1">20716669</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Nov;8(11):2281-2308</RefSource><PMID Version="1">24157548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2013 Oct 16;80(2):415-28</RefSource><PMID Version="1">24139042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2004 Feb 26;427(6977):801</RefSource><PMID Version="1">14985749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Apr 10;7(1):1-11</RefSource><PMID Version="1">24703839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Mar 13;507(7491):195-200</RefSource><PMID Version="1">24598541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2013 Jul;16(7):780-9</RefSource><PMID Version="1">23799470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Nov;1833(11):2392-402</RefSource><PMID Version="1">23481039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Physiol. 1996 Oct 15;496 ( Pt 2):431-7</RefSource><PMID Version="1">8910227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Essays Biochem. 2016 Oct 15;60(2):227-235</RefSource><PMID Version="1">27744338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Oct 13;13(2):234-41</RefSource><PMID Version="1">26440889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 2000 Nov 1;180(1-2):29-34</RefSource><PMID Version="1">11090861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2015 Sep 1;12(9):1385-90</RefSource><PMID Version="1">26299960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2013 Jan 1;29(1):15-21</RefSource><PMID Version="1">23104886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neuropathol. 2016 Aug;132(2):159-73</RefSource><PMID Version="1">27271576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2016 Apr;34(4):1040-53</RefSource><PMID Version="1">26763608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2011 Oct 20;72(2):245-56</RefSource><PMID Version="1">21944778</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2014 Mar 12;34(11):4070-5</RefSource><PMID Version="1">24623784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2015 Jan;33(1):89-96</RefSource><PMID Version="1">25383599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1999 Dec;46(6):806-15</RefSource><PMID Version="1">10589532</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res Dev Brain Res. 2004 Jan 31;148(1):151-5</RefSource><PMID Version="1">14757529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurosci. 2001 Nov;2(11):806-19</RefSource><PMID Version="1">11715057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Jul;11(7):1587-602</RefSource><PMID Version="1">19413484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1999 Dec 13;147(6):1195-204</RefSource><PMID Version="1">10601334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurosci. 2016 Jun;17 (6):383-95</RefSource><PMID Version="1">27150398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Sep 5;345(6201):1192-1194</RefSource><PMID Version="1">25103406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci Res. 2004 Aug 15;77(4):573-82</RefSource><PMID Version="1">15264227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurophysiol. 2013 Jun;109 (11):2803-14</RefSource><PMID Version="1">23486205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1992 May 28;326(22):1464-8</RefSource><PMID Version="1">1349424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2013 Oct 23;5(208):208ra149</RefSource><PMID Version="1">24154603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stress Chaperones. 2018 Jan;23 (1):1-12</RefSource><PMID Version="1">28608264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2016 Apr;19(4):542-53</RefSource><PMID Version="1">27021939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 2005 Nov 15;238(1-2):25-30</RefSource><PMID Version="1">16087196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2003 May;85(3):680-9</RefSource><PMID Version="1">12694394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2016 Sep;19(9):1256-67</RefSource><PMID Version="1">27428653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Res. 2006 Jan;54(1):11-4</RefSource><PMID Version="1">16225946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1991 Oct 4;67(1):11-9</RefSource><PMID Version="1">1717158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Jun;26(11):4257-67</RefSource><PMID Version="1">16705175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1993 Jan 30;341(8840):265-8</RefSource><PMID Version="1">8093916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1990 Jul;28(1):18-25</RefSource><PMID Version="1">2375630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Neurol. 1995;68:7-20; discussion 21-7</RefSource><PMID Version="1">8787245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroreport. 2002 Oct 7;13(14):1753-7</RefSource><PMID Version="1">12395117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2016 Aug;34(8):2063-78</RefSource><PMID Version="1">27097283</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2005 Feb 2;25(5):1095-102</RefSource><PMID Version="1">15689545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res Mol Brain Res. 1995 Jul;31(1-2):17-32</RefSource><PMID Version="1">7476026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci Res. 2006 Jan;83(1):134-46</RefSource><PMID Version="1">16323214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2015 Aug;18(8):1175-82</RefSource><PMID Version="1">26192745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2014 Apr 1;30(7):923-30</RefSource><PMID Version="1">24227677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jan 17;9(1):e85932</RefSource><PMID Version="1">24465796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neuropathol. 2013 Sep;126(3):385-99</RefSource><PMID Version="1">23836290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Jan 12;6:5999</RefSource><PMID Version="1">25580746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2016 Sep 15;17 (9):</RefSource><PMID Version="1">27649160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2010 Sep 8;30(36):11917-25</RefSource><PMID Version="1">20826656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2013 Sep;31(9):839-43</RefSource><PMID Version="1">23934178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurochem Int. 2016 Sep;98 :115-21</RefSource><PMID Version="1">26970394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Neurosci. 2008 Feb;27(3):572-9</RefSource><PMID Version="1">18279310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rev. 2000 Apr;80(2):767-852</RefSource><PMID Version="1">10747207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1068-82</RefSource><PMID Version="1">16806844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Physiol. 1998 Mar 15;507 ( Pt 3):653-65</RefSource><PMID Version="1">9508827</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2010 Sep 1;19(17 ):3440-56</RefSource><PMID Version="1">20570967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 2003 Nov 20;351(3):153-6</RefSource><PMID Version="1">14623129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2000 Oct 1;20(19):7158-66</RefSource><PMID Version="1">11007871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014;15(12):550</RefSource><PMID Version="1">25516281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Sep 3;525(7567):56-61</RefSource><PMID Version="1">26308891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Diagn. 2012 Jan;14(1):22-9</RefSource><PMID Version="1">22166544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2014 Dec;20(12):1444-51</RefSource><PMID Version="1">25401692</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29367641</ArticleId><ArticleId IdType="doi">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pii">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pmc">PMC5783946</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29367196</PMID><DateRevised><Year>2018</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2159-8290</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cancer discovery</Title><ISOAbbreviation>Cancer Discov</ISOAbbreviation></Journal><ArticleTitle>Chromatin-Remodeling Genes Promote Immunotherapy Resistance.</ArticleTitle><Pagination><MedlinePgn>OF1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1158/2159-8290.CD-NB2018-006</ELocationID><Abstract><AbstractText>Two studies show that genes that encode a chromatin-remodeling complex foster resistance to checkpoint inhibitors. One study identified the proteins by using CRISPR/Cas9 to knock out genes in mouse melanoma cells. The other study converged on the same result by identifying mutations in patients with clear cell renal cell carcinoma who responded to PD-1 inhibitors.</AbstractText><CopyrightInformation>©2018 American Association for Cancer Research.</CopyrightInformation></Abstract><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Discov</MedlineTA><NlmUniqueID>101561693</NlmUniqueID><ISSNLinking>2159-8274</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29367196</ArticleId><ArticleId IdType="pii">2159-8290.CD-NB2018-006</ArticleId><ArticleId IdType="doi">10.1158/2159-8290.CD-NB2018-006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">29367194</PMID><DateRevised><Year>2018</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0253-9772</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>Yi chuan = Hereditas</Title><ISOAbbreviation>Yi Chuan</ISOAbbreviation></Journal><ArticleTitle>Construction of FGF21 knockout mouse models by the CRISPR/Cas9 system.</ArticleTitle><Pagination><MedlinePgn>66-74</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.16288/j.yczz.17-011</ELocationID><Abstract><AbstractText>Fibroblast growth factors (FGFs) are multifunctional signal molecules between cells, regulating the various physiological functions of the organism. FGF21 is a regulatory factor of the FGF family and has been postulated to play important roles in hair follicle development and hair follicle growth cycle. To evaluate the roles of FGF21, we had established a FGF21 knockout mouse model, using the CRISPR/Cas9 technology. We had constructed a FGF21 targeting vector and microinjected it with Cas9 mRNA and gRNA into fertilized ova of FVB mice. The gRNA was designed to target the exon 1 of the endogenous mouse FGF21 gene. Three lines of Fgf21<sup>-/-</sup>mice were obtained from these experiments, and confirmed to harbor Fgf21<sup>-/-</sup>genotypes and null expression phenotype, using DNA sequencing, qRT-PCR and Western blotting. FGF21 mRNA and FGF21 protein were not detected in tissues of these Fgf21<sup>-/-</sup>mice. Depilation and histochemistry analyses showed that the Fgf21<sup>-/-</sup>mice had lower body weight, slower hair regrowth and poorer hair quantities and smaller hair follicles diameters, as compared to WT mice. The Fgf21<sup>-/-</sup>mice reported here could provide a useful genetic model for future studies of FGF21 functions in hair follicle development and hair follicle growth cycle.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Feng</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Ke-Rong</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xiao-Dong</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiao-Yan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dong-Jun</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xu-Dong</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>The Research Center for Laboratory Animal Sciense, College of Life Science, Inner Mongolia University, Hohhot 010070, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Yi Chuan</MedlineTA><NlmUniqueID>9436478</NlmUniqueID><ISSNLinking>0253-9772</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29367194</ArticleId><ArticleId IdType="doi">10.16288/j.yczz.17-011</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>
